data_1n4i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n4i _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 2.1 tt0 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 121.415 0.626 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.53 ' CD1' ' HB ' ' A' ' 27' ' ' VAL . 2.8 mm? -48.13 113.81 0.81 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.459 -0.776 . . . . 0.0 109.897 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' LEU . 57.1 p -32.93 -67.21 0.12 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.982 -0.449 . . . . 0.0 110.938 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.484 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . 179.93 -32.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.113 -0.992 . . . . 0.0 110.709 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -114.07 15.39 18.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 110.373 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.529 ' CB ' HD12 ' A' ' 11' ' ' LEU . 11.2 t -68.26 -171.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 1.3 tttp -143.96 142.32 30.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.976 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.67 126.83 8.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.04 -51.71 1.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.895 . . . . 0.0 110.404 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.02 55.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.379 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.4 p -101.17 -171.8 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 110.065 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -135.14 63.9 1.6 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.067 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 4.0 mt -78.89 -179.01 6.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 0.0 110.539 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 23.6 m -164.25 119.09 1.48 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 110.045 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 2.4 m120 57.97 45.75 17.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.882 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -155.54 0.55 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.301 -0.875 . . . . 0.0 110.784 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.498 ' HA ' ' HB3' ' A' ' 10' ' ' GLN . 4.1 t80 -167.51 -40.78 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.53 ' HB ' ' CD1' ' A' ' 11' ' ' LEU . 11.4 t 54.63 149.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.982 0.896 . . . . 0.0 111.773 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 4.9 t0 -156.4 122.3 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 11.1 mtpp 49.67 55.01 10.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.915 -1.116 . . . . 0.0 109.512 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.542 ' CB ' HG23 ' A' ' 45' ' ' VAL . 46.2 m -142.98 -175.63 4.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.111 -0.993 . . . . 0.0 110.436 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.521 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 5.6 mt-10 -128.2 -67.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.0 110.612 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.511 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 7.7 t 62.64 154.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.202 -0.936 . . . . 0.0 110.28 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 32' ' ' VAL . 22.6 m-85 -150.08 -43.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -138.0 25.37 2.92 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.511 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 10.6 m -71.75 151.47 43.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.32 -1.106 . . . . 0.0 110.51 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 36' ' ' THR . 52.1 m -109.13 55.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 109.917 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 17.5 t -40.31 140.76 0.58 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.465 -0.772 . . . . 0.0 110.348 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.6 m -123.69 13.3 9.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.921 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 128.46 51.84 0.13 Allowed Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.476 ' HB3' ' ND2' ' A' ' 90' ' ' ASN . 1.3 m -134.71 -169.22 2.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.355 -1.085 . . . . 0.0 110.205 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -147.38 170.71 16.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.277 -0.889 . . . . 0.0 110.183 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' A' ' 41' ' ' ARG . 19.8 m-85 -130.88 178.25 6.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.106 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -169.43 65.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 103.27 49.24 1.15 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.542 HG23 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -125.66 -176.5 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.729 -1.453 . . . . 0.0 110.962 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 62' ' ' CYS . 55.3 m -153.21 55.48 0.76 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.525 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 10.6 tt -82.25 174.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.382 -0.824 . . . . 0.0 110.898 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 50' ' ' SER . 45.1 p -146.24 -136.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -0.755 . . . . 0.0 109.31 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 66' ' ' THR . 99.9 m -58.33 82.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.054 -1.029 . . . . 0.0 110.046 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 48' ' ' THR . 29.3 t -142.36 145.61 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.996 -1.065 . . . . 0.0 110.926 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -98.41 128.16 44.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.142 -0.974 . . . . 0.0 110.231 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -141.16 130.35 23.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.194 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.01 105.3 15.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 109.889 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.46 ' HA2' ' OG ' ' A' ' 40' ' ' SER . . . 51.27 91.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 8.5 p -154.86 119.2 4.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.12 . . . . 0.0 110.53 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.526 ' CD ' ' HB2' ' A' ' 58' ' ' SER . 1.6 ttm180 -72.76 101.96 3.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.696 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 45' ' ' VAL . 7.9 mm -84.07 12.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.956 . . . . 0.0 110.28 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.526 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -42.68 153.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.402 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.53 147.63 4.95 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.56 55.27 4.7 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.911 1.48 . . . . 0.0 109.762 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 63' ' ' LYS . . . 123.6 21.51 2.43 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -46.97 123.31 5.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -1.156 . . . . 0.0 111.108 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.543 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -112.41 145.65 39.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.233 -0.917 . . . . 0.0 109.649 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 63' ' ' LYS . 11.3 mt -155.0 126.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.0 110.352 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -136.31 103.07 5.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.821 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.9 OUTLIER 68.17 80.12 0.21 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.526 -0.734 . . . . 0.0 110.382 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.7 t -138.96 120.38 14.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.611 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 2.6 mp -88.53 79.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 108.512 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 51' ' ' THR . 11.1 mt -89.42 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.243 0.544 . . . . 0.0 110.193 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.519 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 7.2 m -150.52 100.79 2.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.297 -0.877 . . . . 0.0 110.424 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.78 33.14 10.2 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.471 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 77.95 15.46 81.14 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 70' ' ' THR . 6.1 m -125.79 129.75 24.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.337 -1.096 . . . . 0.0 110.682 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 46.7 Cg_endo -75.96 144.59 27.37 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.831 1.437 . . . . 0.0 110.253 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -90.86 162.0 34.28 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.693 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.97 66.16 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.793 1.418 . . . . 0.0 110.121 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.07 125.78 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 110.345 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.79 -1.88 15.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 110.304 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.482 ' CB ' HG22 ' A' ' 66' ' ' THR . . . -94.2 -23.73 17.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.091 -1.006 . . . . 0.0 110.493 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 49.3 t -72.87 167.4 21.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.523 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -108.63 -41.31 4.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.014 -1.054 . . . . 0.0 111.765 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.537 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 34.0 mm 47.13 74.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.894 -1.128 . . . . 0.0 109.683 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.59 -80.98 0.6 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.069 -1.019 . . . . 0.0 110.939 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.23 37.99 3.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.5 t -132.04 178.64 6.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.053 -1.263 . . . . 0.0 109.872 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.555 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t -173.87 155.0 2.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.228 -0.92 . . . . 0.0 109.662 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.592 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -125.57 158.28 35.01 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.904 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.4 t -141.36 22.87 2.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.719 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.71 80.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.411 -0.806 . . . . 0.0 109.84 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.394 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.205 0.526 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.51 HD12 ' CB ' ' A' ' 15' ' ' SER . 14.4 tp -102.14 96.25 6.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.101 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -36.34 134.6 0.42 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.53 0.681 . . . . 0.0 111.117 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.85 -21.27 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 110.54 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -96.65 -2.55 44.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.998 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.51 ' CB ' HD12 ' A' ' 11' ' ' LEU . 19.4 t -73.08 -169.15 0.57 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.842 -1.161 . . . . 0.0 110.073 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.75 130.99 14.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.152 -0.968 . . . . 0.0 110.981 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 18' ' ' GLU . 10.3 p -139.64 -179.28 5.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.897 . . . . 0.0 109.804 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 169.65 -80.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 109.74 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.34 13.27 9.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.845 . . . . 0.0 109.602 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.434 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -77.0 -147.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.765 . . . . 0.0 110.297 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 35' ' ' THR . 18.9 m -153.23 88.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 110.321 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.5 mm? -106.31 90.5 3.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.64 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 9.3 m -93.32 139.93 30.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.189 -0.944 . . . . 0.0 111.176 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.467 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 2.5 m-80 37.05 40.91 0.17 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.765 -0.584 . . . . 0.0 110.76 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -81.69 -152.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.19 -0.944 . . . . 0.0 110.676 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 56.5 t80 179.46 42.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.58 ' CG1' ' OG ' ' A' ' 30' ' ' SER . 6.6 t -53.46 149.95 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.857 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -130.95 -29.03 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.441 0.639 . . . . 0.0 109.746 179.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.52 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 2.4 mtmt -168.86 68.48 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.307 -0.871 . . . . 0.0 109.329 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.58 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 84.0 p -141.34 168.68 19.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.119 -0.988 . . . . 0.0 111.706 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 47' ' ' ILE . 5.6 mt-10 -124.03 113.32 18.26 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.562 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 9.3 t -112.57 149.07 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 111.094 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CD1' HG21 ' A' ' 48' ' ' THR . 58.6 m-85 -128.77 -25.95 2.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -0.875 . . . . 0.0 110.905 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -167.82 32.59 0.19 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.562 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 4.8 m -81.98 146.44 29.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -1.157 . . . . 0.0 110.328 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 m -100.91 85.62 2.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.421 -0.8 . . . . 0.0 109.37 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.475 ' O ' ' HB ' ' A' ' 23' ' ' THR . 44.9 t -73.79 101.2 3.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.523 -0.735 . . . . 0.0 110.927 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -89.08 28.38 1.21 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.3 -0.875 . . . . 0.0 110.101 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 113.49 62.73 0.43 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 9.8 t -139.87 -173.94 3.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.44 -1.035 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.555 ' CB ' ' HB3' ' A' ' 26' ' ' TYR . 13.4 ptt180 -153.46 154.63 34.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.902 -1.124 . . . . 0.0 110.757 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 6.0 m-85 -119.15 -168.99 1.66 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.438 -0.789 . . . . 0.0 109.016 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.505 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 3.5 t0 -179.91 61.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.607 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 106.27 57.61 0.63 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.559 HG23 ' HB2' ' A' ' 30' ' ' SER . 1.0 OUTLIER -138.59 -157.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.887 -1.361 . . . . 0.0 110.601 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 45' ' ' VAL . 65.8 m -167.75 57.28 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.693 -0.629 . . . . 0.0 109.925 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 31' ' ' GLU . 16.0 tt -75.13 162.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 110.155 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 50' ' ' SER . 31.8 p -131.96 -134.34 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.068 -1.02 . . . . 0.0 109.963 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.5 m -65.89 64.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.981 -1.074 . . . . 0.0 110.257 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 48' ' ' THR . 3.1 t -128.08 139.85 52.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 0.0 110.588 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.459 ' OG1' HG13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -90.05 146.71 24.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.859 . . . . 0.0 109.691 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.38 130.99 11.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.04 -1.038 . . . . 0.0 110.597 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -113.29 111.66 22.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.106 -0.997 . . . . 0.0 110.068 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.9 79.03 0.08 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 13.4 p -148.26 134.82 19.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -1.184 . . . . 0.0 110.111 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -89.99 108.54 19.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.453 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.547 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 17.4 mm -88.04 -1.46 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.178 -0.951 . . . . 0.0 109.998 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.505 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 1.1 m -42.56 150.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.36 -0.838 . . . . 0.0 110.864 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 164.16 153.56 7.44 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.94 -2.08 11.45 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.064 1.56 . . . . 0.0 109.903 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.76 34.08 0.08 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.42 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.3 t -65.82 130.26 42.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -1.117 . . . . 0.0 110.452 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 14.5 tttm -135.3 125.1 25.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 110.402 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.541 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 4.3 mt -126.64 146.54 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.99 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 66' ' ' THR . 30.6 p -142.04 126.15 17.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.926 . . . . 0.0 110.516 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' THR . 25.0 m 39.77 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.57 -0.706 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 2.8 t -152.92 108.08 3.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -0.876 . . . . 0.0 110.047 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.587 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.8 mp -72.3 87.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.488 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 3.9 mt -90.22 155.7 3.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.555 -0.716 . . . . 0.0 110.62 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 73' ' ' VAL . 18.7 m -156.31 102.65 2.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.334 -0.854 . . . . 0.0 110.553 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.6 26.76 24.16 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.564 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.77 16.31 70.76 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 69' ' ' ILE . 4.0 m -127.24 133.72 25.37 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.536 -0.979 . . . . 0.0 110.155 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.18 148.09 16.66 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.793 1.417 . . . . 0.0 110.666 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -93.77 149.28 36.8 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.563 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.02 114.74 4.06 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.937 1.493 . . . . 0.0 110.85 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 78' ' ' ALA . 1.3 t -134.14 -0.6 3.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 110.44 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 77' ' ' SER . . . 66.2 6.84 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.966 . . . . 0.0 110.409 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.28 -32.34 1.37 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.404 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -57.15 151.89 14.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.985 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.541 ' HD2' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -104.13 175.18 5.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.504 -0.747 . . . . 0.0 109.958 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 81' ' ' LYS . 46.1 mm -155.99 38.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.9 m -59.71 -104.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.73 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.92 89.52 0.48 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 1.6 t -147.18 -149.39 0.29 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.235 . . . . 0.0 110.311 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.51 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER 169.98 142.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.391 -0.818 . . . . 0.0 109.539 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.564 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.4 m-85 -116.99 -19.62 9.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.517 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.598 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER 45.72 -92.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 110.031 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.598 ' CB ' ' O ' ' A' ' 88' ' ' SER . . . 157.36 64.92 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.904 -0.498 . . . . 0.0 110.031 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.004 -1.06 . . . . 0.0 109.978 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.452 ' O ' ' O ' ' A' ' 11' ' ' LEU . 1.6 tt0 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.198 0.523 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.461 HD12 ' OG ' ' A' ' 15' ' ' SER . 17.3 tp 57.03 111.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.11 -0.994 . . . . 0.0 109.922 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 12.9 t -68.39 161.11 28.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.284 -0.885 . . . . 0.0 110.405 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.74 -8.01 31.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.968 . . . . 0.0 110.073 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -97.74 -11.47 23.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.461 ' OG ' HD12 ' A' ' 11' ' ' LEU . 41.5 t -76.27 -163.29 0.29 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.972 . . . . 0.0 110.046 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.25 134.84 15.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.554 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.1 t -135.7 32.67 3.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.934 . . . . 0.0 110.2 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 19' ' ' LYS . 1.4 tm-20 -55.61 127.21 28.78 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 43.01 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -159.52 -171.07 3.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.044 -1.035 . . . . 0.0 111.005 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 36' ' ' THR . 8.5 m -156.55 72.78 0.75 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.486 -0.759 . . . . 0.0 109.71 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.662 ' O ' ' CB ' ' A' ' 23' ' ' THR . 4.0 mt -75.44 -116.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 110.369 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.662 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 1.1 m 146.21 -62.59 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 23' ' ' THR . 73.7 m-20 -132.03 34.87 3.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.444 -0.785 . . . . 0.0 110.162 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -67.85 -159.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.02 0.914 . . . . 0.0 110.904 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 25' ' ' CYS . 46.9 m-85 -162.96 -54.74 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 30' ' ' SER . 3.3 t 44.59 -179.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 122.14 0.971 . . . . 0.0 111.727 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 0.9 OUTLIER -175.81 -33.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 46.8 mtmt -150.45 56.3 0.93 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.515 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 75.5 m -135.5 164.11 28.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.953 -1.092 . . . . 0.0 111.86 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 2.4 tt0 -120.64 107.62 13.02 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.556 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 17.9 t -110.29 160.1 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.052 -1.03 . . . . 0.0 111.379 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.556 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 94.9 m-85 -157.33 44.66 0.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.427 -0.796 . . . . 0.0 110.455 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' ' OG ' ' A' ' 20' ' ' SER . . . 138.72 33.08 0.19 Allowed Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.15 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.519 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 5.6 m -95.24 144.07 26.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.24 . . . . 0.0 110.257 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 38' ' ' THR . 32.0 m -94.61 53.35 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.36 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.476 ' HB2' ' CB ' ' A' ' 22' ' ' LEU . 1.2 m -50.4 87.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.425 -0.797 . . . . 0.0 110.888 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 36' ' ' THR . 5.2 t -104.78 36.07 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.21 46.6 0.18 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -141.24 167.17 22.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.314 -1.11 . . . . 0.0 109.856 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' CB ' ' HB2' ' A' ' 26' ' ' TYR . 5.3 ptt180 -146.12 152.11 38.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.961 -1.087 . . . . 0.0 110.803 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.628 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 6.8 m-85 -116.64 -167.63 1.32 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 7.1 t0 -177.46 53.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.414 -0.804 . . . . 0.0 110.165 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 114.88 60.2 0.37 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.502 HG21 ' CB ' ' A' ' 30' ' ' SER . 1.4 m -139.28 -169.98 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.997 -1.296 . . . . 0.0 110.297 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.428 ' N ' HG23 ' A' ' 45' ' ' VAL . 35.8 m -149.47 51.02 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.309 -0.869 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 7.9 tt -68.2 173.58 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 110.45 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 47' ' ' ILE . 12.0 p -142.73 -98.76 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 110.067 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 49' ' ' THR . 15.8 m -104.05 69.83 0.96 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.986 -1.071 . . . . 0.0 109.715 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 67' ' ' CYS . 10.6 m -121.13 147.19 45.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.116 -0.99 . . . . 0.0 111.161 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -99.66 121.57 41.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.436 -0.79 . . . . 0.0 109.168 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -139.85 136.54 34.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.345 -0.847 . . . . 0.0 110.406 -179.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -121.63 89.27 3.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.824 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 85.09 76.29 1.21 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 p -148.97 124.53 10.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -1.094 . . . . 0.0 110.551 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HD2' ' HB2' ' A' ' 58' ' ' SER . 0.1 OUTLIER -90.35 96.66 10.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.242 -0.911 . . . . 0.0 109.896 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.628 ' CD1' ' CE1' ' A' ' 42' ' ' PHE . 3.1 mt -84.15 17.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.671 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.416 ' HB2' ' HD2' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -43.8 151.03 0.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.01 -1.057 . . . . 0.0 110.078 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 162.59 162.27 13.33 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.02 -1.35 11.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.134 1.597 . . . . 0.0 109.852 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.68 33.88 0.02 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.7 t -50.68 123.34 8.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.216 -1.167 . . . . 0.0 110.006 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 8.6 tttt -102.64 128.2 49.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.07 -1.019 . . . . 0.0 110.174 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 28.8 mm -133.81 141.3 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.907 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -151.62 126.38 9.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.298 -0.876 . . . . 0.0 110.101 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.5 m 39.02 71.59 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.573 0.702 . . . . 0.0 110.756 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 73.4 m -130.13 125.6 35.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.428 -0.795 . . . . 0.0 109.252 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.593 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.9 mp -93.47 88.48 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.836 -1.165 . . . . 0.0 110.131 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.541 HG12 ' CE2' ' A' ' 87' ' ' PHE . 14.3 mt -96.23 156.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.522 -0.736 . . . . 0.0 110.061 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 34.7 m -152.25 93.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 110.224 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.94 31.88 9.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 80.0 16.63 76.44 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 70' ' ' THR . 16.1 m -124.73 120.11 25.73 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.391 -1.064 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -73.72 145.81 37.4 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.949 1.5 . . . . 0.0 110.509 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -90.68 166.61 18.7 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.365 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.434 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.4 Cg_endo -72.03 56.3 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.723 1.38 . . . . 0.0 109.603 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.92 126.09 33.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.26 -9.13 59.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.837 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' A' ' 66' ' ' THR . . . -96.94 -12.61 23.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.353 -0.842 . . . . 0.0 110.526 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 65' ' ' SER . 38.2 t -77.44 168.84 19.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.107 -0.996 . . . . 0.0 109.619 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.523 ' HE3' ' N ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -98.64 -32.18 11.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.793 -1.192 . . . . 0.0 111.399 -178.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.523 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 28.3 mm 38.19 57.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.186 -0.946 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 m -113.37 -100.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.0 -1.062 . . . . 0.0 110.422 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -101.19 89.58 0.8 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -166.36 -172.72 2.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.147 -1.208 . . . . 0.0 110.759 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.512 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 2.6 t -178.02 157.51 1.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.484 -0.76 . . . . 0.0 109.52 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 2.2 m-30 -114.33 -54.68 2.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 110.076 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 65.07 11.08 6.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.087 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 47.14 95.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 109.963 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 89' ' ' ALA . 5.1 p30 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.305 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.474 ' CB ' ' CD2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.137 0.494 . . . . 0.0 110.155 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.514 HD11 ' CB ' ' A' ' 15' ' ' SER . 12.3 tp 41.19 84.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.365 -0.834 . . . . 0.0 109.892 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.514 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 86.1 p -45.46 164.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 110.187 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 -14.03 60.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.846 . . . . 0.0 110.299 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -93.95 -6.62 45.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.164 -0.96 . . . . 0.0 110.5 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.514 ' CB ' HD11 ' A' ' 11' ' ' LEU . 4.8 t -74.08 -176.65 2.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.957 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.418 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -142.09 131.43 23.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.274 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 t -138.6 159.88 40.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.262 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -172.86 -87.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.014 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -114.55 72.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.134 -0.979 . . . . 0.0 110.1 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -117.92 -164.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.855 . . . . 0.0 110.216 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -150.15 60.42 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 35' ' ' THR . 13.7 mt -84.62 -171.59 3.71 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.873 0.844 . . . . 0.0 111.455 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 1.5 m -164.78 101.63 0.79 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.497 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 0.8 OUTLIER 59.18 118.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.415 -0.803 . . . . 0.0 109.766 -178.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -171.0 -151.68 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.136 -0.978 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.474 ' CD2' ' CB ' ' A' ' 10' ' ' GLN . 17.9 t80 -157.68 -42.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.837 0.827 . . . . 0.0 108.958 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' TYR . 6.9 t 39.22 101.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.305 0.574 . . . . 0.0 112.174 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.514 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 4.6 t0 -88.71 -130.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.5 mttp -62.36 81.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.783 -1.198 . . . . 0.0 109.072 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.525 ' CB ' HG21 ' A' ' 45' ' ' VAL . 16.9 m -148.87 159.54 44.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.91 -1.119 . . . . 0.0 111.301 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 47' ' ' ILE . 2.2 mt-10 -119.1 115.66 24.73 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.578 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 34.2 t -117.21 156.28 18.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.225 -0.922 . . . . 0.0 111.065 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.475 ' O ' ' HB3' ' A' ' 20' ' ' SER . 41.9 m-85 -135.06 -71.75 0.48 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.143 -0.973 . . . . 0.0 110.913 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 48' ' ' THR . . . -118.36 41.83 1.94 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.578 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.7 m -87.24 172.24 10.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -1.106 . . . . 0.0 110.334 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 6.8 m -112.0 -13.07 13.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.859 -1.151 . . . . 0.0 110.933 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' CB ' ' HB3' ' A' ' 22' ' ' LEU . 0.1 OUTLIER 35.67 63.34 0.56 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.468 -0.77 . . . . 0.0 110.758 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.3 m -65.57 78.57 0.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.411 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 52.27 36.0 44.21 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 41' ' ' ARG . 94.2 p -107.09 -138.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.179 -1.189 . . . . 0.0 109.811 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' HB3' ' ND2' ' A' ' 90' ' ' ASN . 32.3 ttt-85 175.96 154.58 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 110.429 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.453 ' HB3' HG22 ' A' ' 45' ' ' VAL . 13.1 m-85 -120.11 168.85 10.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.923 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.529 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 3.9 t0 -159.6 73.49 0.57 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.998 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 96.57 49.85 1.92 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.525 HG21 ' CB ' ' A' ' 30' ' ' SER . 1.2 m -131.6 -165.02 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.947 -1.325 . . . . 0.0 111.152 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.439 ' CG2' ' O ' ' A' ' 46' ' ' THR . 35.9 m -159.92 58.55 0.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 50' ' ' SER . 13.2 tt -72.55 173.65 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.511 -0.743 . . . . 0.0 110.311 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -137.18 -92.07 0.24 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.373 -0.829 . . . . 0.0 109.886 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.8 m -111.97 65.96 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 47' ' ' ILE . 1.5 t -108.77 143.27 38.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.551 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 m -91.85 21.18 5.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.471 -0.768 . . . . 0.0 110.85 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -38.12 128.02 1.31 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.446 -0.783 . . . . 0.0 110.759 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 m -111.37 101.52 9.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 110.102 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 90' ' ' ASN . . . 61.17 77.76 0.18 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.5 p -148.82 122.35 9.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -1.11 . . . . 0.0 110.219 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.538 ' CB ' ' HB3' ' A' ' 88' ' ' SER . 3.7 ttp180 -72.23 103.88 3.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.137 -0.977 . . . . 0.0 110.089 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.494 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 22.6 mm -83.92 11.88 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.319 -0.863 . . . . 0.0 109.827 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -41.73 148.91 0.14 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.347 -0.846 . . . . 0.0 110.244 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 158.06 157.27 8.36 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.27 52.53 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.062 1.559 . . . . 0.0 109.951 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' O ' ' HD2' ' A' ' 63' ' ' LYS . . . 118.69 18.74 4.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.497 ' HB3' ' CG1' ' A' ' 45' ' ' VAL . 1.7 t -40.77 126.81 2.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.406 -1.055 . . . . 0.0 110.148 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.526 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -108.43 143.21 37.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 110.734 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.566 ' CD1' ' NZ ' ' A' ' 81' ' ' LYS . 17.4 mm -143.06 125.07 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 109.042 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -133.94 121.49 21.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 110.602 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 49' ' ' THR . 15.6 m 37.76 53.64 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.705 -0.622 . . . . 0.0 111.145 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.591 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 4.8 t -118.47 109.79 16.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.948 . . . . 0.0 109.339 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 52' ' ' SER . 2.0 mp -52.52 -66.28 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.711 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 9.5 mt 56.74 157.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -0.784 . . . . 0.0 109.923 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.543 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 5.7 m -169.66 107.51 0.39 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.898 -1.126 . . . . 0.0 111.186 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.41 28.08 31.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.56 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 85.38 10.9 76.4 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 70' ' ' THR . 11.7 m -120.5 136.73 25.5 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.207 -1.172 . . . . 0.0 110.033 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 69' ' ' ILE . 48.3 Cg_endo -77.4 138.02 17.22 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.993 1.523 . . . . 0.0 110.849 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.6 160.83 25.25 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 109.998 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.26 122.15 8.11 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.923 1.486 . . . . 0.0 110.365 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.77 4.1 2.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 110.551 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.46 23.96 2.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.112 -0.992 . . . . 0.0 110.143 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 80' ' ' CYS . . . -160.45 -37.4 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.89 . . . . 0.0 109.913 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.591 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 1.2 t -39.46 158.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.684 0.754 . . . . 0.0 110.931 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.566 ' NZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.56 -167.91 1.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 0.0 109.438 179.46 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.578 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 1.3 tp 177.51 31.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.178 -0.951 . . . . 0.0 110.042 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -70.71 -101.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.935 -1.103 . . . . 0.0 110.652 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.84 100.75 1.43 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -161.7 -159.64 0.64 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.29 -1.124 . . . . 0.0 109.887 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.553 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t 169.1 150.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.615 -0.678 . . . . 0.0 109.636 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.56 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -122.79 143.28 49.94 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.267 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.538 ' HB3' ' CB ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -122.02 9.66 9.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 65.17 66.94 0.53 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 110.088 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.508 ' ND2' ' HB3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.127 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.406 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 2.6 tt0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.115 0.483 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.503 HD12 ' CB ' ' A' ' 15' ' ' SER . 41.8 tp 46.34 86.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 109.996 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.461 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -42.71 148.66 0.22 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.358 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.65 -21.32 64.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.198 -0.939 . . . . 0.0 110.093 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -87.56 -4.09 58.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 110.209 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.503 ' CB ' HD12 ' A' ' 11' ' ' LEU . 39.0 t -79.42 -163.7 0.54 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.233 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 9.5 tttp -156.39 178.98 9.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.134 -0.979 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 3.9 p 174.69 47.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 110.068 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 4.0 tt0 -41.83 -50.18 4.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.648 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -161.68 77.07 0.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.646 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -115.31 -153.24 0.52 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.206 -0.934 . . . . 0.0 110.048 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -155.62 77.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 109.775 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 37' ' ' CYS . 5.0 mt -96.24 -167.3 1.56 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.365 -0.835 . . . . 0.0 110.456 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.4 m -155.02 -47.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.503 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 25' ' ' CYS . 12.0 m-20 -144.25 23.51 1.66 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.545 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -58.16 -152.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.024 . . . . 0.0 110.513 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -160.59 -52.85 0.05 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.599 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 26' ' ' TYR . 4.7 t 49.39 117.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.905 0.86 . . . . 0.0 112.226 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -108.72 -20.83 12.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.944 . . . . 0.0 108.884 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -167.4 84.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.746 -0.596 . . . . 0.0 109.671 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.535 ' CB ' HG23 ' A' ' 45' ' ' VAL . 24.5 m -159.58 164.28 34.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.784 -1.197 . . . . 0.0 111.51 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 47' ' ' ILE . 3.6 tt0 -119.68 96.58 5.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.538 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 6.5 t -94.67 168.68 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.141 -0.974 . . . . 0.0 110.531 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 19.1 m-85 -150.18 -42.86 0.13 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.064 -1.022 . . . . 0.0 111.315 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.97 27.56 1.88 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.537 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.7 m -82.01 150.03 27.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.08 -1.247 . . . . 0.0 110.526 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 36' ' ' THR . 13.9 t -95.95 54.49 1.49 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.539 -0.726 . . . . 0.0 109.443 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -38.31 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.689 -0.632 . . . . 0.0 110.691 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' THR . 19.0 m -104.38 69.62 0.92 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 110.077 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.72 59.45 3.48 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.6 m -136.88 -168.97 2.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -1.143 . . . . 0.0 109.783 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -162.78 143.38 9.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 110.673 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.522 ' CD1' ' CG1' ' A' ' 57' ' ' ILE . 10.8 m-85 -114.42 173.4 6.48 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.419 -0.8 . . . . 0.0 109.181 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.438 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -155.86 42.98 0.42 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 123.8 72.88 0.25 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.535 HG23 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -148.91 -168.74 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.043 -1.269 . . . . 0.0 110.475 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.2 m -155.38 58.82 0.64 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.49 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 8.8 tt -80.98 168.34 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.269 -0.894 . . . . 0.0 110.298 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' SER . 74.8 p -142.61 -138.05 0.11 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.621 -0.675 . . . . 0.0 109.233 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 66' ' ' THR . 52.8 m -58.24 83.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.984 -1.073 . . . . 0.0 110.145 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 48' ' ' THR . 73.0 m -141.57 139.41 33.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.961 -1.087 . . . . 0.0 110.502 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -88.88 117.77 28.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.373 -0.83 . . . . 0.0 109.592 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.5 p -133.78 113.49 12.36 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.567 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -98.37 91.42 5.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 109.485 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 72' ' ' GLY . . . 72.16 106.25 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 89.1 p -175.42 102.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -1.166 . . . . 0.0 110.467 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.519 ' HB2' ' CA ' ' A' ' 90' ' ' ASN . 7.6 ttm180 -62.79 106.26 0.78 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.929 -1.107 . . . . 0.0 108.984 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.524 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 16.5 mm -83.23 11.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.1 -1.0 . . . . 0.0 110.545 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -36.99 151.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.611 -0.681 . . . . 0.0 110.411 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 166.48 147.11 5.1 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.275 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -79.87 63.35 8.73 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 124.301 1.685 . . . . 0.0 109.461 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 106.05 24.3 6.97 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.461 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -41.58 161.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.409 -1.053 . . . . 0.0 110.323 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.46 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 17.1 tttm -152.89 110.48 3.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.012 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.511 ' CG1' ' HE3' ' A' ' 81' ' ' LYS . 3.1 mp -125.7 152.68 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.022 -1.049 . . . . 0.0 111.291 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.467 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.7 OUTLIER -156.12 107.91 2.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 0.0 109.895 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.2 OUTLIER 63.0 73.25 0.46 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 111.12 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.513 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 3.8 t -132.91 120.3 21.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.234 -0.917 . . . . 0.0 109.955 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.59 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 2.0 mp -83.29 85.24 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.027 -1.045 . . . . 0.0 108.839 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.574 HD11 ' CE2' ' A' ' 87' ' ' PHE . 9.6 mt -96.05 160.75 2.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.785 -0.572 . . . . 0.0 109.889 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.519 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 13.1 m -162.63 100.93 1.03 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.221 -0.924 . . . . 0.0 110.504 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 89.03 34.52 8.79 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 54' ' ' GLY . . . 75.42 17.95 80.03 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 70' ' ' THR . 9.5 m -123.56 128.94 25.04 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.24 -1.153 . . . . 0.0 110.834 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -83.33 142.56 10.73 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.967 1.509 . . . . 0.0 109.939 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -91.76 158.37 40.22 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.149 -0.969 . . . . 0.0 110.261 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.36 59.48 6.09 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.883 1.465 . . . . 0.0 110.12 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.06 134.1 42.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.499 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.72 -8.11 25.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.071 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 66' ' ' THR . . . -91.97 -16.96 25.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.869 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 66' ' ' THR . 40.4 t -78.87 165.61 23.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.902 -1.124 . . . . 0.0 110.18 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.534 ' O ' ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -101.21 -12.18 18.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.166 -0.959 . . . . 0.0 112.11 -178.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.534 ' C ' ' O ' ' A' ' 81' ' ' LYS . 37.1 mm 25.11 51.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.155 0.502 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 85' ' ' CYS . 0.4 OUTLIER -117.76 -141.75 0.36 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 111.375 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -59.35 83.5 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 6.0 t -177.96 178.37 0.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.11 . . . . 0.0 109.543 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.533 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -179.16 156.75 0.79 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.04 . . . . 0.0 110.491 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.574 ' CE2' HD11 ' A' ' 69' ' ' ILE . 2.3 m-85 -123.25 164.44 18.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -0.855 . . . . 0.0 110.287 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -142.21 12.58 1.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.841 . . . . 0.0 109.585 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 88' ' ' SER . . . 72.5 0.02 3.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 110.358 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.519 ' CA ' ' HB2' ' A' ' 56' ' ' ARG . 3.3 p30 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.444 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.544 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.552 ' CD1' ' HB3' ' A' ' 15' ' ' SER . 9.9 tp -40.48 117.48 0.81 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.801 -0.562 . . . . 0.0 110.017 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -37.73 158.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.725 -0.609 . . . . 0.0 110.342 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.8 -6.96 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.987 . . . . 0.0 110.583 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -138.61 23.78 2.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.914 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.552 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -84.67 -159.56 0.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.009 -1.057 . . . . 0.0 110.33 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 4.8 tttp -155.95 152.58 28.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 110.362 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 29.9 p -164.63 56.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 11.3 tp10 -88.65 111.57 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 110.386 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 4.6 tttp 67.63 56.3 0.58 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.273 -0.892 . . . . 0.0 110.429 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -136.86 166.49 23.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.1 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 36' ' ' THR . 3.1 m -113.55 101.97 9.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.869 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 1.7 mm? -107.16 147.77 29.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 110.639 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 17.9 m -148.15 109.8 4.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.354 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 23' ' ' THR . 1.1 m120 60.73 56.99 2.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.186 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -109.47 -169.12 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.191 0.996 . . . . 0.0 111.582 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 52.6 t80 -173.26 34.68 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.547 ' CG1' ' OG ' ' A' ' 15' ' ' SER . 12.1 t -33.16 142.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.532 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.526 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -143.5 121.5 12.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.525 -0.734 . . . . 0.0 109.867 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.438 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 53.35 38.77 28.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.318 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.531 ' CB ' HG23 ' A' ' 45' ' ' VAL . 21.0 m -132.1 179.31 6.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.641 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' HG2' ' HD2' ' A' ' 16' ' ' LYS . 2.8 tt0 -119.94 -64.2 1.29 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.377 -0.827 . . . . 0.0 110.556 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 11.7 t 62.05 150.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 110.004 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.515 ' O ' ' CB ' ' A' ' 20' ' ' SER . 19.3 m-85 -142.35 -47.43 0.34 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.059 -1.026 . . . . 0.0 110.803 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -132.59 20.32 4.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.524 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 8.6 m -66.68 154.91 39.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -1.18 . . . . 0.0 110.277 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 21' ' ' THR . 5.7 m -95.86 -21.46 18.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 11.9 t 48.86 76.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.805 . . . . 0.0 110.961 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.4 m -80.23 73.5 7.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 109.1 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 66.08 49.88 55.3 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -135.92 -178.08 4.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.266 -1.138 . . . . 0.0 110.018 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -153.4 176.4 12.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.034 -1.042 . . . . 0.0 110.56 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.466 ' HB3' ' OG ' ' A' ' 30' ' ' SER . 52.7 m-85 -123.18 -170.15 2.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.006 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.516 ' HB3' ' CB ' ' A' ' 58' ' ' SER . 9.8 t70 -178.35 63.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.773 . . . . 0.0 109.67 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 99.65 60.02 0.86 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.531 HG23 ' CB ' ' A' ' 30' ' ' SER . 1.4 m -137.37 -159.53 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.95 -1.324 . . . . 0.0 111.324 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.486 ' N ' ' O ' ' A' ' 62' ' ' CYS . 85.4 m -166.89 57.81 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.515 HG12 ' N ' ' A' ' 48' ' ' THR . 12.4 tt -83.7 171.65 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.47 -0.769 . . . . 0.0 111.088 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.515 ' N ' HG12 ' A' ' 47' ' ' ILE . 22.4 p -135.51 -134.03 0.15 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 66' ' ' THR . 23.1 m -66.12 89.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.737 -1.227 . . . . 0.0 109.758 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 35' ' ' THR . 0.6 OUTLIER -132.13 139.05 48.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.012 -1.055 . . . . 0.0 110.495 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.525 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 m -85.5 21.45 1.79 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 111.056 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 89.9 p -37.18 122.01 0.84 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.465 -0.772 . . . . 0.0 110.803 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 2.6 m -112.02 111.13 21.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.136 -0.978 . . . . 0.0 109.973 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 40' ' ' SER . . . 51.55 79.85 0.07 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 70' ' ' THR . 8.0 p -155.51 122.63 5.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -1.165 . . . . 0.0 110.528 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.519 ' HB2' ' CA ' ' A' ' 90' ' ' ASN . 36.9 ttt85 -75.97 103.85 6.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 109.675 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.53 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 18.1 mm -83.29 12.67 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 0.0 110.358 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.516 ' CB ' ' HB3' ' A' ' 43' ' ' ASP . 42.9 p -42.71 162.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.347 -0.846 . . . . 0.0 110.716 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 150.67 163.04 11.01 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -75.8 57.44 5.06 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.935 1.492 . . . . 0.0 109.844 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 106.43 21.82 8.15 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.486 ' O ' ' N ' ' A' ' 46' ' ' THR . 1.8 t -38.96 126.57 1.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.662 -0.905 . . . . 0.0 110.649 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.51 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 35.4 ttpt -115.08 140.47 49.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.053 -1.029 . . . . 0.0 110.593 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.508 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 25.4 mm -143.34 145.72 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.24 -0.912 . . . . 0.0 109.844 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.464 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 1.1 m -147.99 126.13 12.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.057 -1.027 . . . . 0.0 110.043 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.5 m 41.57 59.61 2.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.392 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 5.1 t -123.95 109.95 14.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.819 . . . . 0.0 109.532 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 1.9 mp -55.65 -64.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.979 -1.076 . . . . 0.0 109.697 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.545 ' CG1' ' SG ' ' A' ' 67' ' ' CYS . 8.1 mt 54.88 162.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.48 -0.763 . . . . 0.0 110.787 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.531 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 9.0 m -146.33 -121.78 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.83 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -65.18 77.5 0.08 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 58.54 16.73 30.45 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.531 ' CG2' ' HB ' ' A' ' 70' ' ' THR . 33.8 m -121.91 141.05 33.2 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.472 -1.017 . . . . 0.0 110.544 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -85.11 128.28 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.943 1.496 . . . . 0.0 110.133 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . . . -83.56 174.65 5.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 110.081 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 75' ' ' ALA . 43.0 Cg_endo -70.72 59.12 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.942 1.496 . . . . 0.0 110.106 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.413 ' HB2' HD13 ' A' ' 68' ' ' ILE . 22.8 t -88.09 112.93 23.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.382 -0.824 . . . . 0.0 110.223 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.32 -4.95 20.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.86 . . . . 0.0 110.347 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.455 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -106.07 -31.85 8.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.52 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 43.1 t -46.36 166.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.169 -0.957 . . . . 0.0 109.836 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.513 ' HE3' ' N ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -108.15 -41.19 4.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.043 -1.035 . . . . 0.0 111.43 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.513 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 19.0 mm 49.25 62.13 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.816 -1.177 . . . . 0.0 109.615 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.2 t -109.33 -73.19 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 110.815 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.43 67.79 0.54 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -134.53 -153.0 0.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -1.151 . . . . 0.0 110.009 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.566 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.2 t 176.91 143.21 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.566 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -128.24 153.06 47.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.55 -0.719 . . . . 0.0 109.158 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 1.3 m -140.95 12.17 2.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.978 . . . . 0.0 109.758 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 88' ' ' SER . . . 72.07 0.13 3.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.443 -0.786 . . . . 0.0 110.201 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.519 ' CA ' ' HB2' ' A' ' 56' ' ' ARG . 2.7 p30 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.013 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.586 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 3.9 pt20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.015 0.436 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.537 ' N ' ' CG ' ' A' ' 10' ' ' GLN . 16.5 tp 47.68 81.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.015 -1.053 . . . . 0.0 108.934 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -44.44 149.93 0.35 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 110.25 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.91 -10.1 12.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.858 . . . . 0.0 110.076 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.495 ' ND2' ' HG2' ' A' ' 29' ' ' LYS . 50.7 t-20 -90.18 -7.77 52.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.968 . . . . 0.0 110.268 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 30' ' ' SER . 32.1 t -80.42 -157.61 0.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.067 -1.02 . . . . 0.0 110.099 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.516 ' CE ' ' OH ' ' A' ' 33' ' ' TYR . 12.5 tttt -135.74 140.17 44.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.079 -1.013 . . . . 0.0 110.088 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.0 m -113.41 137.35 51.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 110.291 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.8 -129.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.246 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.63 19.55 15.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.817 -1.177 . . . . 0.0 110.667 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.98 167.49 1.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.0 109.865 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.415 ' C ' HD22 ' A' ' 22' ' ' LEU . 1.6 t -140.24 97.13 3.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.019 -1.051 . . . . 0.0 109.985 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.557 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -131.45 -165.56 1.59 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.431 -0.793 . . . . 0.0 110.139 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 98.2 m -166.94 142.03 4.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.351 -0.843 . . . . 0.0 110.363 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.469 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 4.2 m120 45.88 36.83 3.1 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.369 -0.832 . . . . 0.0 110.697 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -154.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.091 -1.006 . . . . 0.0 110.683 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.586 ' CE1' ' HB3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER 176.26 40.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 30' ' ' SER . 40.3 t -52.78 153.92 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.984 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.7 OUTLIER -158.83 129.14 5.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.476 -0.765 . . . . 0.0 110.138 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' HG2' ' ND2' ' A' ' 14' ' ' ASN . 4.7 mtmp? 50.78 34.53 10.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 45' ' ' VAL . 49.3 m -124.47 -161.13 0.98 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.499 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 3.5 tt0 -138.2 -63.13 0.56 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.513 -0.742 . . . . 0.0 110.089 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 15.9 t 61.16 156.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.516 ' OH ' ' CE ' ' A' ' 16' ' ' LYS . 9.9 m-85 -153.95 -39.11 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.199 -0.938 . . . . 0.0 110.477 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.2 34.07 1.66 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.519 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -79.27 158.33 27.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.397 -1.061 . . . . 0.0 110.73 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.514 ' N ' HG22 ' A' ' 35' ' ' THR . 0.2 OUTLIER -111.52 50.23 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.96 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 3.5 t -40.82 121.38 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 111.012 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 m -113.66 22.86 13.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 109.269 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 122.85 41.56 0.44 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.52 -159.29 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -1.178 . . . . 0.0 110.372 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 26' ' ' TYR . 28.4 ttt180 -166.88 145.06 5.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.914 . . . . 0.0 110.701 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.447 ' CE1' HG13 ' A' ' 57' ' ' ILE . 10.1 m-85 -115.16 172.39 7.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.0 109.301 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.54 42.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.921 -1.112 . . . . 0.0 110.407 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 127.0 57.5 0.13 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -136.34 -171.16 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.269 -1.136 . . . . 0.0 110.997 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 45' ' ' VAL . 87.9 m -152.89 58.2 0.79 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.515 HG13 ' CG2' ' A' ' 64' ' ' ILE . 9.7 tt -81.3 169.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.245 -0.909 . . . . 0.0 110.14 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 50' ' ' SER . 58.9 p -146.09 -139.7 0.1 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.048 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' THR . 51.9 m -52.94 91.48 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.07 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' THR . 2.4 m -152.96 143.72 22.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.155 -0.966 . . . . 0.0 110.286 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -98.66 135.32 40.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 59.9 p -155.64 130.88 9.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.33 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 71' ' ' GLY . 11.5 m -111.85 112.94 24.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.103 -0.998 . . . . 0.0 109.82 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.7 86.41 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 79.6 p -154.74 112.25 3.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -1.144 . . . . 0.0 110.514 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 4.1 ttt180 -67.03 118.6 10.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 109.66 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 26.8 mm -97.82 11.18 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 0.0 110.831 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -40.7 145.34 0.19 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.203 -0.936 . . . . 0.0 110.34 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 175.12 145.85 5.54 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -80.18 1.34 9.33 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.038 1.547 . . . . 0.0 109.629 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.06 33.23 0.07 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -60.74 152.73 26.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.535 -0.979 . . . . 0.0 110.804 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -156.95 113.93 3.07 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.515 ' CG2' HG13 ' A' ' 47' ' ' ILE . 3.0 mt -118.9 148.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.067 -1.021 . . . . 0.0 110.862 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -151.51 117.14 5.41 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.0 OUTLIER 51.21 71.14 0.46 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.101 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 50' ' ' SER . 60.5 m -139.11 111.04 7.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.447 -0.783 . . . . 0.0 110.478 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.0 OUTLIER -77.92 137.06 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.946 -1.096 . . . . 0.0 109.42 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 51' ' ' THR . 9.3 mt -146.51 158.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.079 -1.013 . . . . 0.0 110.309 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.464 ' HA ' ' HB ' ' A' ' 53' ' ' THR . 5.7 m -156.39 99.0 1.88 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.04 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 91.51 20.67 37.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.497 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 88.29 15.55 60.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 69' ' ' ILE . 4.1 m -124.3 132.87 24.35 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.476 -1.014 . . . . 0.0 109.507 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.36 144.93 23.47 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.59 1.311 . . . . 0.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . . . -99.17 176.02 2.17 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 75' ' ' ALA . 47.6 Cg_endo -73.15 102.6 1.48 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.94 1.495 . . . . 0.0 110.635 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 1.1 t -119.04 -23.52 6.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.34 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 61.15 12.35 4.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.255 -0.903 . . . . 0.0 109.966 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.7 -15.27 1.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.311 -0.868 . . . . 0.0 110.998 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 66' ' ' THR . 33.1 t -62.89 168.48 3.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.968 -1.082 . . . . 0.0 110.406 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HE2' ' N ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -102.99 -35.29 8.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.981 -1.074 . . . . 0.0 111.826 -178.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.503 ' N ' ' HE2' ' A' ' 81' ' ' LYS . 32.4 mm 43.66 60.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.093 -1.004 . . . . 0.0 109.35 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 85' ' ' CYS . 46.5 m -114.95 -130.11 0.31 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.31 -0.869 . . . . 0.0 110.594 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -65.12 66.05 0.08 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 83' ' ' SER . 5.0 t -160.94 -175.99 5.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.023 -1.281 . . . . 0.0 109.854 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.562 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 2.0 t -179.09 160.67 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.117 -0.989 . . . . 0.0 110.745 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -127.92 155.08 44.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.32 -0.863 . . . . 0.0 109.431 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.91 24.91 1.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.047 -1.033 . . . . 0.0 110.313 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 52.84 85.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 109.944 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.035 -1.04 . . . . 0.0 110.365 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.551 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 22.6 mt-30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.268 0.556 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.574 HD12 ' CB ' ' A' ' 15' ' ' SER . 8.7 tp -62.96 81.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 10' ' ' GLN . 97.9 p -30.62 134.16 0.06 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.529 0.681 . . . . 0.0 111.93 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.33 -22.51 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 109.81 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 61.4 t-20 -80.99 -10.28 59.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.473 -0.767 . . . . 0.0 110.086 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.574 ' CB ' HD12 ' A' ' 11' ' ' LEU . 45.6 t -79.38 -171.62 2.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.131 -0.98 . . . . 0.0 109.757 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.89 163.79 17.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.105 -0.997 . . . . 0.0 109.612 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' GLU . 6.4 m -134.66 -29.29 1.19 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.066 -1.022 . . . . 0.0 111.191 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' LYS . 10.4 tp10 -43.45 118.22 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.07 -1.018 . . . . 0.0 110.244 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 52.83 108.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.781 . . . . 0.0 110.552 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 5.9 p 178.69 146.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.048 -1.032 . . . . 0.0 110.899 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -139.14 84.08 1.98 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -0.792 . . . . 0.0 109.529 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 38.9 mt -101.91 -174.42 2.58 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.834 0.826 . . . . 0.0 111.267 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 91.7 m -164.42 125.02 2.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.637 -0.665 . . . . 0.0 109.298 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 51.07 66.47 1.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 108.878 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.78 169.91 11.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.78 0.8 . . . . 0.0 110.471 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.568 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -147.0 34.33 0.91 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 179.002 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.561 ' CG1' ' HB2' ' A' ' 30' ' ' SER . 7.6 t -30.52 147.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.587 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.525 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -150.47 123.31 8.68 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 9.8 mmmt 48.04 56.26 7.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 0.0 109.34 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.561 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 14.7 m -143.25 171.69 13.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.963 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 1.4 tt0 -115.06 -68.88 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.382 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.517 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 3.1 t 67.15 143.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.327 -0.858 . . . . 0.0 110.383 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 20' ' ' SER . 45.2 m-85 -137.62 -52.71 0.65 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.337 -0.852 . . . . 0.0 110.674 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.442 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -129.46 18.88 5.42 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.517 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.2 m -69.75 153.69 43.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -1.167 . . . . 0.0 110.216 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 37' ' ' CYS . 1.2 m -111.95 58.24 0.63 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.462 -0.774 . . . . 0.0 109.594 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 52.8 t -36.87 137.77 0.3 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.609 -0.682 . . . . 0.0 111.01 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.428 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 95.2 m -137.85 74.34 1.48 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.468 -0.77 . . . . 0.0 109.461 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.48 57.43 3.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.415 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -147.08 178.57 8.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.159 -1.201 . . . . 0.0 110.177 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' HG2' ' N ' ' A' ' 42' ' ' PHE . 4.0 ttt180 -150.65 153.02 34.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.302 -0.874 . . . . 0.0 110.176 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.515 ' N ' ' HG2' ' A' ' 41' ' ' ARG . 8.1 m-85 -116.04 -176.2 2.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.995 . . . . 0.0 110.566 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.9 t0 -170.09 50.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 110.179 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 118.44 61.36 0.28 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -140.98 -168.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.914 -1.345 . . . . 0.0 110.6 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 46' ' ' THR . 91.6 m -160.73 53.25 0.3 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.62 -0.675 . . . . 0.0 109.908 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 19.8 tt -73.54 169.45 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.783 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 50' ' ' SER . 71.9 p -138.21 -139.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.206 -0.934 . . . . 0.0 109.666 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 66' ' ' THR . 31.3 m -58.33 80.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' THR . 28.5 t -141.55 140.33 33.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 110.454 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -83.49 131.47 35.01 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.221 -0.924 . . . . 0.0 109.916 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 2.9 t -151.86 128.67 10.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.939 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.428 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 36.8 p -128.22 110.62 12.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.978 . . . . 0.0 110.212 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.41 84.03 0.13 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 p -161.37 127.87 3.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -1.13 . . . . 0.0 110.658 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.434 ' CD ' ' HB2' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.55 103.27 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 7.4 mm -85.07 10.78 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.083 -1.011 . . . . 0.0 110.498 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -36.02 142.77 0.07 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.457 -0.777 . . . . 0.0 110.727 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.459 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . 176.85 146.09 5.96 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.313 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.77 -8.31 17.95 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.965 1.508 . . . . 0.0 110.051 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.48 39.23 0.12 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.472 ' CB ' ' HA ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -56.15 159.42 3.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.525 -0.985 . . . . 0.0 111.37 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 27.5 tttt -161.08 98.71 1.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.694 -0.629 . . . . 0.0 109.347 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.484 ' CD1' HG22 ' A' ' 57' ' ' ILE . 12.8 mt -117.82 163.41 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.671 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -145.47 -163.35 1.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.405 -0.809 . . . . 0.0 110.155 179.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 4.0 m -33.36 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.569 ' N ' ' O ' ' A' ' 65' ' ' SER . 44.4 t -138.38 139.52 39.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.515 -0.741 . . . . 0.0 109.107 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.6 mp -97.22 82.73 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.884 -1.135 . . . . 0.0 108.704 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' THR . 13.1 mt -90.85 154.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.67 -0.644 . . . . 0.0 110.328 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.544 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 52.8 m -162.01 98.82 1.08 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.174 -0.954 . . . . 0.0 110.597 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.39 39.98 4.61 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 65.32 24.02 70.4 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 70' ' ' THR . 6.1 m -129.24 129.2 23.3 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.485 -1.009 . . . . 0.0 110.893 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -83.58 131.89 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.922 1.486 . . . . 0.0 110.228 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -79.04 150.85 75.37 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.002 -1.061 . . . . 0.0 110.057 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.56 58.47 1.94 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.118 1.588 . . . . 0.0 110.683 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.48 150.48 22.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 110.235 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.24 -10.96 55.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.926 . . . . 0.0 109.962 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 80' ' ' CYS . . . -112.66 -31.6 6.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.92 . . . . 0.0 111.002 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 66' ' ' THR . 13.0 t -44.53 137.06 3.94 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.945 -1.097 . . . . 0.0 110.141 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -110.28 164.88 12.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 111.49 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.553 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 1.0 OUTLIER -161.59 75.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -112.08 -86.55 0.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 0.0 110.56 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -104.79 65.91 0.3 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.464 ' SG ' ' CD1' ' A' ' 64' ' ' ILE . 4.4 t -162.48 -175.49 4.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -1.189 . . . . 0.0 110.26 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.559 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.5 t 179.81 158.87 0.73 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.288 -0.882 . . . . 0.0 110.108 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.3 OUTLIER -123.22 154.35 38.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 89' ' ' ALA . 2.7 m -134.96 32.67 3.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 109.591 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 88' ' ' SER . . . 37.87 72.01 0.14 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.757 -0.589 . . . . 0.0 110.199 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.434 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.307 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 11' ' ' LEU . 1.4 pt20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.261 0.553 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.538 ' N ' ' CG ' ' A' ' 10' ' ' GLN . 18.1 tp 43.46 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.549 -0.719 . . . . 0.0 110.149 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -37.91 150.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.693 -0.63 . . . . 0.0 110.451 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -24.98 67.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 110.24 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 14' ' ' ASN . 0.6 OUTLIER -103.93 6.26 36.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 111.129 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.51 ' CB ' HD11 ' A' ' 11' ' ' LEU . 28.8 t -69.21 -154.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.16 . . . . 0.0 109.391 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.521 ' CD ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -140.69 150.71 43.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 110.528 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' A' ' 18' ' ' GLU . 7.8 t -135.99 -92.18 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -0.917 . . . . 0.0 109.779 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.491 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 13.2 mt-10 38.05 -125.68 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.412 -0.805 . . . . 0.0 110.844 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' SER . 10.4 tptt -66.98 123.55 20.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.956 -1.09 . . . . 0.0 110.356 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.53 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . 10.3 p 175.94 172.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.115 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.8 t -154.04 76.41 1.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.36 -0.837 . . . . 0.0 109.56 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.576 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -114.48 -170.56 1.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.793 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 3.9 m -164.89 124.94 1.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.849 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.6 m120 57.17 33.38 23.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 110.713 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -64.31 -141.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.754 -1.216 . . . . 0.0 109.929 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.557 ' CG ' ' O ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER 166.34 45.82 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 30' ' ' SER . 8.0 t -66.96 140.45 19.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.762 0.791 . . . . 0.0 111.715 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.9 t0 -123.05 -14.03 7.66 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.429 0.633 . . . . 0.0 109.728 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER 179.99 67.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.57 ' CB ' HG22 ' A' ' 45' ' ' VAL . 14.8 m -147.26 151.31 36.44 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.176 -0.953 . . . . 0.0 111.442 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.521 ' HG3' ' CD ' ' A' ' 16' ' ' LYS . 6.5 tt0 -107.49 101.23 10.59 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 18.0 t -99.2 174.32 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.237 -0.915 . . . . 0.0 110.379 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.512 ' CD2' HG23 ' A' ' 48' ' ' THR . 47.1 m-85 -149.16 -32.0 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.193 -0.942 . . . . 0.0 111.391 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.452 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -164.48 26.79 0.2 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.51 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 0.9 OUTLIER -76.99 144.94 38.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.137 . . . . 0.0 110.398 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -91.13 60.04 4.16 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.417 -0.802 . . . . 0.0 110.501 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 2.0 t -47.04 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.0 110.157 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.456 HG21 HG22 ' A' ' 53' ' ' THR . 1.7 t -85.91 31.88 0.61 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.071 -1.018 . . . . 0.0 110.445 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.42 27.83 4.01 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 16.0 t -94.06 -163.09 1.0 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.384 -1.068 . . . . 0.0 110.229 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' HB2' ' CB ' ' A' ' 26' ' ' TYR . 2.7 ttp180 -165.73 144.69 6.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.544 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 2.9 m-85 -119.45 -172.44 2.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.971 -1.081 . . . . 0.0 110.227 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.22 55.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 110.204 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 115.29 54.64 0.37 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.274 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.57 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.1 m -133.6 -169.66 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.732 -1.452 . . . . 0.0 111.325 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.5 m -151.89 60.01 0.86 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.561 ' CG1' ' OG ' ' A' ' 50' ' ' SER . 14.6 tt -81.14 -179.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.751 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.512 HG23 ' CD2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -139.77 -89.82 0.19 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.789 -1.195 . . . . 0.0 110.195 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 5.9 m -114.3 74.35 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.022 -1.049 . . . . 0.0 110.451 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.561 ' OG ' ' CG1' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -114.53 152.34 31.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.144 -0.973 . . . . 0.0 111.413 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 52' ' ' SER . 1.5 m -99.79 27.91 5.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.462 -0.773 . . . . 0.0 111.085 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' ILE . 1.4 p -40.92 136.62 1.41 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.187 -0.946 . . . . 0.0 110.893 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.457 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 87.2 m -126.17 87.58 2.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.45 65.88 1.93 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.8 p -145.91 123.11 11.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.448 -1.031 . . . . 0.0 109.844 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -76.68 102.22 6.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.551 -0.718 . . . . 0.0 110.75 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 42' ' ' PHE . 3.1 mp -85.37 15.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.988 -1.07 . . . . 0.0 110.217 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.9 p -47.15 161.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.337 -0.852 . . . . 0.0 110.968 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 155.24 154.29 6.86 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -74.41 -0.84 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.825 1.434 . . . . 0.0 110.098 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.31 29.83 0.07 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.3 t -52.28 114.55 1.38 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.451 -1.029 . . . . 0.0 110.491 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -110.57 130.22 55.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.499 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 41.0 mt -140.95 147.89 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.073 -1.017 . . . . 0.0 110.587 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.476 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -140.53 108.87 5.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 110.64 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 49' ' ' THR . 5.9 m 50.33 71.86 0.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.522 -0.736 . . . . 0.0 112.027 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 43.9 t -132.81 112.31 11.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.359 -0.838 . . . . 0.0 109.235 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.7 mp -47.25 -68.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.556 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.532 ' CG1' ' SG ' ' A' ' 67' ' ' CYS . 27.3 mt 63.42 155.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.306 -0.871 . . . . 0.0 110.171 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.457 ' HA ' ' HB ' ' A' ' 53' ' ' THR . 12.4 m -147.73 -115.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -74.06 81.69 0.78 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.584 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 54.46 19.82 14.45 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 71' ' ' GLY . 4.3 m -125.64 133.91 25.34 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.611 -0.935 . . . . 0.0 110.138 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 48.3 Cg_endo -82.84 129.99 5.67 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.59 1.311 . . . . 0.0 110.373 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 68' ' ' ILE . . . -95.36 150.55 37.73 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 110.345 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.62 144.14 35.2 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.063 1.559 . . . . 0.0 110.375 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 78' ' ' ALA . 23.3 t -165.93 24.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.138 -0.977 . . . . 0.0 110.559 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 44.51 27.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.44 -34.43 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.898 . . . . 0.0 110.796 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 1.7 t -50.82 145.35 7.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.012 -1.055 . . . . 0.0 110.731 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.514 ' C ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -97.35 167.52 10.96 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.668 -0.645 . . . . 0.0 109.606 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.491 ' CD1' ' O ' ' A' ' 81' ' ' LYS . 29.9 mm -154.59 60.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.967 -1.083 . . . . 0.0 109.714 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.5 m -98.35 -116.94 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 111.009 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.39 83.41 0.54 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.452 ' SG ' HG13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -141.72 -165.05 1.91 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -1.156 . . . . 0.0 109.504 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.8 t -175.83 145.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.953 -1.092 . . . . 0.0 110.267 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.584 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.0 m-85 -111.71 -67.76 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.153 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER 69.66 11.84 7.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 110.4 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 48.13 91.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.169 -0.957 . . . . 0.0 109.867 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.417 -179.392 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.112 0.482 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.56 HD11 ' CB ' ' A' ' 15' ' ' SER . 19.2 tp 52.61 89.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.118 -0.989 . . . . 0.0 108.958 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -41.08 141.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.573 -0.704 . . . . 0.0 110.509 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.39 -17.11 4.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 110.458 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 17.5 p30 -94.01 -8.89 38.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 110.885 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.56 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.1 t -66.78 -174.59 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.858 -1.151 . . . . 0.0 109.213 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.501 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -122.39 159.88 26.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 110.252 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.3 t -151.79 111.97 4.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -175.43 125.1 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.804 . . . . 0.0 109.798 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt 51.74 55.32 9.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.754 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.498 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -140.35 161.97 36.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.0 110.719 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 36' ' ' THR . 2.9 t -135.43 61.77 1.65 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 109.248 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.556 ' HB3' ' CB ' ' A' ' 37' ' ' CYS . 3.0 mt -74.26 176.96 6.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 111.167 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 24' ' ' ASN . 3.1 m -164.13 118.86 1.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.468 -0.77 . . . . 0.0 109.841 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.535 ' O ' ' N ' ' A' ' 39' ' ' GLY . 27.3 m120 50.43 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.337 -0.852 . . . . 0.0 109.646 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.81 -160.38 0.91 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.59 -1.318 . . . . 0.0 110.913 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.512 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 13.8 t80 -164.29 34.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 11' ' ' LEU . 5.0 t -33.05 151.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.536 0.684 . . . . 0.0 110.783 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 1.3 t70 -153.21 118.78 5.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 44' ' ' GLY . 6.4 mtpm? 48.11 72.88 0.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.422 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 42' ' ' PHE . 45.3 m -157.71 157.92 34.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.973 -1.079 . . . . 0.0 111.095 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 3.8 mt-10 -120.58 119.75 33.82 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 46.9 t -123.04 156.32 28.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.101 -0.999 . . . . 0.0 110.623 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 32' ' ' VAL . 48.2 m-85 -154.42 32.14 0.42 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.186 -0.946 . . . . 0.0 111.223 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 162.28 -31.2 0.3 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.555 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 19.3 m -38.66 162.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.516 -0.991 . . . . 0.0 111.541 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -104.65 -13.43 15.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.4 -0.812 . . . . 0.0 110.648 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.556 ' CB ' ' HB3' ' A' ' 22' ' ' LEU . 0.1 OUTLIER 38.59 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.266 -0.896 . . . . 0.0 110.932 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.5 m -105.09 94.31 5.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.122 -0.986 . . . . 0.0 109.975 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 48.25 26.73 4.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.467 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -104.79 -166.09 1.2 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.175 -1.191 . . . . 0.0 110.361 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.448 ' HG2' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -164.85 155.57 14.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 110.388 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.584 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 7.4 m-85 -120.62 -175.06 2.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.338 -0.851 . . . . 0.0 109.403 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -165.95 46.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.139 -0.976 . . . . 0.0 109.932 179.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 121.65 53.34 0.22 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -132.94 -175.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.801 -1.411 . . . . 0.0 110.885 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -151.39 59.17 0.89 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.712 -0.618 . . . . 0.0 109.778 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 7.9 tt -81.0 167.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.767 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 50' ' ' SER . 54.3 p -139.36 -128.2 0.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.063 -1.023 . . . . 0.0 109.844 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 66' ' ' THR . 88.4 m -65.96 73.28 0.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.971 -1.08 . . . . 0.0 109.521 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 66' ' ' THR . 73.2 m -133.52 135.35 44.35 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.483 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 67' ' ' CYS . 1.6 m -88.62 139.09 30.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.9 p -153.69 130.08 10.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.412 -0.805 . . . . 0.0 110.075 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -111.54 112.4 24.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.008 -1.057 . . . . 0.0 109.696 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 50.53 90.76 0.01 OUTLIER Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 95.7 p -156.74 123.47 5.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.374 -1.074 . . . . 0.0 109.643 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.6 ttt180 -85.54 100.7 12.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.962 . . . . 0.0 110.69 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.604 ' CG2' HD13 ' A' ' 64' ' ' ILE . 2.9 mt -89.11 23.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.487 -0.758 . . . . 0.0 110.446 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -43.75 155.28 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.915 -1.115 . . . . 0.0 109.711 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 165.88 143.61 3.8 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.195 -1.478 . . . . 0.0 110.325 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.01 -19.37 23.18 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.061 1.559 . . . . 0.0 110.276 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.5 36.95 0.52 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.407 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -57.88 160.38 4.69 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -1.045 . . . . 0.0 111.505 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.554 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 30.3 tttp -160.51 114.02 2.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.584 -0.698 . . . . 0.0 109.822 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.604 HD13 ' CG2' ' A' ' 57' ' ' ILE . 12.1 mt -128.77 155.28 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.825 -1.172 . . . . 0.0 111.477 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.544 ' N ' HG21 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -156.44 126.16 6.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.503 ' N ' ' OG ' ' A' ' 50' ' ' SER . 0.7 OUTLIER 51.97 77.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 110.638 -179.291 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 89.5 m -138.9 118.41 12.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.134 -0.979 . . . . 0.0 109.63 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 2.5 mp -90.98 80.87 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 118.836 -1.146 . . . . 0.0 108.868 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 18.6 mt -89.91 159.27 2.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.294 0.569 . . . . 0.0 110.544 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.495 ' N ' HG23 ' A' ' 69' ' ' ILE . 18.2 m -158.28 97.82 1.53 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 110.421 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 94.63 16.78 41.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.505 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 91.53 16.01 53.63 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 69' ' ' ILE . 14.2 m -124.32 132.94 24.36 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.423 -1.046 . . . . 0.0 110.124 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HB3' HD11 ' A' ' 82' ' ' ILE . 52.1 Cg_endo -81.24 137.39 10.61 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.93 1.49 . . . . 0.0 110.65 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -90.75 159.16 41.23 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.91 . . . . 0.0 109.794 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.5 66.66 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.787 1.414 . . . . 0.0 110.282 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 78' ' ' ALA . 18.6 t -80.52 4.53 18.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.235 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 41.73 31.07 0.18 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 110.004 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -151.35 -38.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.481 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 44.8 t -49.52 170.45 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.311 -0.868 . . . . 0.0 108.849 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.554 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -106.99 -39.52 5.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.95 -1.094 . . . . 0.0 111.689 -178.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.49 ' CA ' ' HE3' ' A' ' 81' ' ' LYS . 43.0 mm 43.62 68.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.879 -1.138 . . . . 0.0 109.501 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.436 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 45.1 t -125.38 -116.03 0.28 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 110.48 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.68 59.92 0.48 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.503 ' CB ' ' NZ ' ' A' ' 81' ' ' LYS . 3.6 t -163.32 -171.76 2.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.265 . . . . 0.0 110.814 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.57 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.9 t 176.62 170.04 0.48 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.46 -0.775 . . . . 0.0 109.772 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -134.05 149.01 51.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.005 -1.06 . . . . 0.0 110.079 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 t -129.73 30.5 4.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.273 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 47.75 61.79 2.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.985 . . . . 0.0 110.065 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.288 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.478 0.656 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.555 ' CD1' ' HB3' ' A' ' 15' ' ' SER . 6.7 tp -47.74 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.752 -0.592 . . . . 0.0 109.772 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 10' ' ' GLN . 4.9 t -38.24 137.0 0.59 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.059 -0.657 . . . . 0.0 109.866 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.1 -17.51 0.43 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.21 -0.931 . . . . 0.0 111.289 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -90.72 -3.36 57.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.005 -1.06 . . . . 0.0 110.342 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.555 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -89.03 -157.48 0.45 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.098 -1.001 . . . . 0.0 110.054 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 8.4 tttm -165.7 156.27 13.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 110.057 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.476 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 40.7 t -144.14 156.41 44.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 110.48 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER 174.02 104.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.697 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 74.08 14.94 3.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.83 . . . . 0.0 110.052 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.477 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -102.48 165.97 10.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 0.0 110.474 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' CB ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -113.82 -43.65 3.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.429 -0.794 . . . . 0.0 110.121 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.476 ' O ' ' OG1' ' A' ' 23' ' ' THR . 1.1 tp 62.24 159.03 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.062 -1.024 . . . . 0.0 110.479 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 1.7 m -174.61 117.66 0.2 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.413 -0.804 . . . . 0.0 109.256 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 23' ' ' THR . 26.1 m120 53.59 63.19 2.3 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.565 ' C ' ' CG ' ' A' ' 26' ' ' TYR . 1.3 m -146.21 -166.66 2.53 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.736 0.779 . . . . 0.0 111.096 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CG ' ' C ' ' A' ' 25' ' ' CYS . 11.0 m-85 -155.13 -40.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.538 ' HB ' ' CD1' ' A' ' 11' ' ' LEU . 11.8 t 56.39 137.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.643 0.735 . . . . 0.0 111.618 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 0.4 OUTLIER -151.6 130.72 12.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.53 -0.731 . . . . 0.0 109.816 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.496 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 34.8 mttp 54.31 37.5 27.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.116 -0.99 . . . . 0.0 109.098 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.471 ' HB3' HG22 ' A' ' 45' ' ' VAL . 8.3 m -126.59 169.62 12.9 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.487 -0.758 . . . . 0.0 110.353 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 tt0 -113.02 -63.03 1.5 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.432 -0.793 . . . . 0.0 110.126 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 5.4 t 62.58 144.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -0.865 . . . . 0.0 110.141 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.5 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 42.4 m-85 -152.4 34.23 0.51 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 110.629 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 156.28 -31.32 0.59 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 50' ' ' SER . 8.9 m -40.34 151.02 0.05 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.462 -1.023 . . . . 0.0 111.072 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.416 ' O ' ' CA ' ' A' ' 22' ' ' LEU . 76.1 m -97.49 -16.55 20.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.423 -0.798 . . . . 0.0 109.261 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 23' ' ' THR . 1.6 t 52.21 83.68 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.572 -0.705 . . . . 0.0 110.057 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 m -93.71 102.62 14.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.37 -0.831 . . . . 0.0 110.303 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.12 61.51 5.33 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 45.2 t -150.81 -168.91 3.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -1.112 . . . . 0.0 109.914 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.5 ' HG2' ' N ' ' A' ' 42' ' ' PHE . 5.2 ttt180 -168.75 156.4 7.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.09 -1.006 . . . . 0.0 110.03 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.585 ' CE1' HD12 ' A' ' 57' ' ' ILE . 5.5 m-85 -117.93 179.35 4.11 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.273 -0.892 . . . . 0.0 110.161 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -168.14 41.1 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.401 -0.812 . . . . 0.0 109.474 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 59' ' ' GLY . . . 129.16 53.96 0.11 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -129.03 -165.84 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.065 -1.256 . . . . 0.0 110.324 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 46' ' ' THR . 23.5 m -163.44 57.9 0.18 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.562 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 10.4 tt -86.01 172.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.641 0.734 . . . . 0.0 111.695 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' SER . 32.7 p -129.93 -156.32 0.75 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.508 -0.745 . . . . 0.0 109.327 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.6 m -48.5 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.813 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -125.24 140.29 52.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.636 -1.29 . . . . 0.0 110.488 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 52' ' ' SER . 14.7 m -86.88 18.36 3.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.142 -0.974 . . . . 0.0 110.732 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.53 ' HA ' ' HB ' ' A' ' 69' ' ' ILE . 12.4 p -39.06 114.45 0.4 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.314 -0.866 . . . . 0.0 111.006 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.2 m -112.02 93.34 4.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.0 109.387 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 82.99 77.47 1.09 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.558 ' CB ' ' HB3' ' A' ' 87' ' ' PHE . 1.6 p -156.26 123.03 5.2 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.273 -1.134 . . . . 0.0 110.974 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -87.16 103.09 15.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 109.884 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.585 HD12 ' CE1' ' A' ' 42' ' ' PHE . 2.8 mp -89.03 14.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.056 -1.028 . . . . 0.0 110.122 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -42.58 141.45 1.02 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.335 -0.853 . . . . 0.0 109.789 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . 172.89 155.5 11.53 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.185 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.56 -2.61 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.173 1.617 . . . . 0.0 110.566 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.28 31.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.464 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -49.63 128.41 17.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 110.336 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -114.75 127.81 55.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.427 -0.796 . . . . 0.0 110.528 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.562 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 4.6 mt -138.99 149.87 23.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.139 -0.976 . . . . 0.0 109.853 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 81' ' ' LYS . 83.8 p -147.04 106.04 3.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.051 -1.031 . . . . 0.0 110.699 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.0 m 50.96 73.06 0.31 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 111.583 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.537 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 14.6 t -129.1 119.92 25.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.475 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.477 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 1.7 mp -48.32 -75.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 109.918 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 87' ' ' PHE . 10.8 mt 62.81 140.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 0.0 109.683 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 81.3 m -165.74 101.8 0.68 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.118 -0.989 . . . . 0.0 111.315 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.85 23.73 24.82 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.565 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 85.19 8.92 80.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 70' ' ' THR . 20.3 m -112.48 121.89 37.78 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.55 -0.971 . . . . 0.0 109.814 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.27 124.09 6.99 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.712 1.375 . . . . 0.0 110.381 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.22 139.34 34.29 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.879 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.68 91.99 0.79 Allowed 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.105 1.582 . . . . 0.0 111.035 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.46 147.35 45.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.107 -0.996 . . . . 0.0 110.464 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.76 -12.11 32.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 110.543 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.519 ' CB ' HG22 ' A' ' 66' ' ' THR . . . -103.82 -18.14 14.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.93 . . . . 0.0 110.664 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 14.1 t -71.9 157.95 36.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.147 -0.971 . . . . 0.0 109.939 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.531 ' HE3' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -101.53 -11.78 19.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.028 -1.045 . . . . 0.0 112.925 -177.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.522 ' N ' ' HD3' ' A' ' 81' ' ' LYS . 26.7 mm 26.41 50.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.443 -0.786 . . . . 0.0 111.423 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.6 m -108.21 -157.67 0.62 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.867 -1.146 . . . . 0.0 110.946 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.25 98.63 0.17 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.507 ' SG ' HG22 ' A' ' 57' ' ' ILE . 3.7 t -170.87 -168.43 0.66 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.354 -1.086 . . . . 0.0 109.662 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 2.7 t -177.03 158.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.919 -1.113 . . . . 0.0 109.653 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 69' ' ' ILE . 10.4 m-85 -118.95 -49.44 2.42 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 110.548 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 15.4 m 61.89 11.92 4.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.283 -0.885 . . . . 0.0 109.858 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 88' ' ' SER . . . 57.15 119.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.439 -0.788 . . . . 0.0 110.392 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.5 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 3.8 t30 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.183 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.508 ' CD ' ' CD1' ' A' ' 26' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.548 HD11 ' CB ' ' A' ' 15' ' ' SER . 1.6 mm? -39.42 101.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.544 0.687 . . . . 0.0 110.251 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.531 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -87.0 163.02 17.3 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.641 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HB3' ' C ' ' A' ' 28' ' ' ASP . . . 49.43 -157.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.068 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -90.49 57.58 3.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 111.482 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.548 ' CB ' HD11 ' A' ' 11' ' ' LEU . 22.0 p -58.54 -168.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.832 -1.167 . . . . 0.0 110.249 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.487 ' CB ' ' HG2' ' A' ' 31' ' ' GLU . 34.8 tttt -154.32 146.93 24.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.05 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.58 167.52 16.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.074 -1.016 . . . . 0.0 110.709 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -176.3 -154.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.504 -0.747 . . . . 0.0 109.651 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.44 54.09 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.017 . . . . 0.0 110.033 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 33' ' ' TYR . 7.9 t -111.99 168.63 9.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.223 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -104.67 105.92 16.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 109.709 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 22' ' ' LEU . 4.3 mm? -107.93 145.8 33.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.774 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 15.7 m -161.13 118.83 2.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 0.0 109.615 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' THR . 26.5 m-20 59.01 64.07 1.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 110.057 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -142.67 169.93 16.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.916 . . . . 0.0 110.581 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 13.5 m-85 -129.13 -40.83 1.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 11' ' ' LEU . 3.6 t 47.24 112.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.586 0.707 . . . . 0.0 112.017 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.531 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -98.13 -91.91 0.26 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.157 -0.964 . . . . 0.0 109.219 178.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -93.63 68.85 4.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.079 -1.013 . . . . 0.0 109.632 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.536 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 0.7 OUTLIER -135.76 -172.98 3.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 110.604 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.487 ' HG2' ' CB ' ' A' ' 16' ' ' LYS . 9.5 mt-10 -137.72 -66.4 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.396 -0.815 . . . . 0.0 110.242 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.539 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 2.5 t 69.99 150.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.348 -0.845 . . . . 0.0 110.371 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 20' ' ' SER . 51.0 m-85 -138.68 -46.39 0.49 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.192 -0.942 . . . . 0.0 110.687 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.4 18.36 3.27 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.539 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 33.0 m -67.37 162.14 23.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.181 -1.188 . . . . 0.0 110.369 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 38' ' ' THR . 6.4 m -121.11 64.93 0.87 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.497 ' O ' ' HB ' ' A' ' 23' ' ' THR . 5.3 t -42.42 97.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.495 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.456 ' O ' HG21 ' A' ' 38' ' ' THR . 27.9 m -89.95 20.36 4.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.98 -1.075 . . . . 0.0 109.622 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.16 47.1 0.19 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.9 p -126.54 -156.11 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 110.443 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' HG2' ' OD1' ' A' ' 90' ' ' ASN . 1.1 ptt85 -169.77 153.8 5.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.894 . . . . 0.0 110.199 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 4.2 m-85 -121.63 -175.11 3.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 110.172 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER 178.59 61.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.982 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 111.1 52.01 0.58 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -133.01 -167.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.969 -1.312 . . . . 0.0 110.627 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.447 HG23 ' HE2' ' A' ' 63' ' ' LYS . 32.8 m -160.85 54.81 0.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.416 HG12 ' N ' ' A' ' 48' ' ' THR . 17.3 tt -85.08 169.61 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.461 -0.774 . . . . 0.0 110.33 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 41.7 p -135.78 -127.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.307 -0.87 . . . . 0.0 109.962 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' THR . 38.3 m -69.74 72.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.907 -1.12 . . . . 0.0 110.398 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.471 ' OG ' ' N ' ' A' ' 66' ' ' THR . 57.8 m -130.06 136.31 49.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -95.81 117.77 31.2 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.107 -0.996 . . . . 0.0 109.788 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 1.5 m -125.2 137.73 54.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 109.845 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -115.35 126.37 54.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.046 -1.034 . . . . 0.0 110.535 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 43.64 50.67 6.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.458 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 7.8 p -127.33 141.52 51.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -1.112 . . . . 0.0 110.187 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -99.41 101.53 12.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 110.067 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.531 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 3.0 mp -82.15 7.64 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 m -56.15 163.3 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.056 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.0 155.7 7.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.03 55.37 2.85 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.054 1.555 . . . . 0.0 110.27 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.79 17.19 3.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -45.79 136.57 6.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -1.194 . . . . 0.0 110.518 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.525 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -140.98 120.22 12.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.195 -0.941 . . . . 0.0 110.033 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.541 ' HA ' ' CD ' ' A' ' 81' ' ' LYS . 21.6 mt -135.39 164.95 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.99 -1.069 . . . . 0.0 111.187 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.463 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -155.46 115.6 3.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.567 -0.708 . . . . 0.0 109.498 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.6 m 53.29 86.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.057 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 54.4 m -150.4 99.9 2.82 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.303 -0.873 . . . . 0.0 109.986 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.554 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.7 mp -67.6 96.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.98 -1.075 . . . . 0.0 109.445 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 51' ' ' THR . 9.6 mt -104.2 160.75 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.953 . . . . 0.0 110.717 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.533 ' N ' HG23 ' A' ' 69' ' ' ILE . 25.5 m -163.38 110.07 1.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 109.983 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.83 20.47 55.79 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.553 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 86.58 12.22 69.91 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 70' ' ' THR . 6.5 m -118.65 138.34 25.8 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.41 -1.053 . . . . 0.0 110.292 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HA ' HG12 ' A' ' 69' ' ' ILE . 51.2 Cg_endo -80.64 154.05 20.51 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.939 1.494 . . . . 0.0 110.106 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -83.31 162.36 54.2 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 110.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.46 53.43 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.119 1.589 . . . . 0.0 110.281 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.9 m -103.85 138.65 40.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 110.274 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.09 -23.81 35.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 110.23 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.98 6.04 17.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.428 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 66' ' ' THR . 1.2 t -100.76 154.14 18.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.937 . . . . 0.0 109.874 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.541 ' CD ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.56 -168.98 1.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 110.927 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 2.1 tp 179.03 33.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.8 0.809 . . . . 0.0 109.201 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -62.21 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.454 -0.779 . . . . 0.0 111.266 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.95 82.82 0.34 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.704 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.534 ' SG ' ' CG1' ' A' ' 64' ' ' ILE . 1.8 t -144.82 -152.47 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 110.055 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER 172.9 148.44 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 109.893 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.553 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 1.4 m-85 -119.08 -28.31 5.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.346 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 68.0 m 52.85 -90.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.944 -1.098 . . . . 0.0 109.482 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.596 ' CB ' ' O ' ' A' ' 88' ' ' SER . . . 157.41 74.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.269 0.557 . . . . 0.0 109.725 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.034 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.427 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.189 0.519 . . . . 0.0 110.049 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.436 HD12 ' CB ' ' A' ' 15' ' ' SER . 24.5 tp 48.91 89.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.061 -1.024 . . . . 0.0 109.994 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.502 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -44.48 156.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.747 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.91 -8.71 39.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.0 109.903 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -97.65 -10.32 25.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.325 -0.859 . . . . 0.0 110.135 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.436 ' CB ' HD12 ' A' ' 11' ' ' LEU . 10.7 t -78.18 -158.71 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -141.27 147.11 37.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 t -127.55 85.77 2.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 0.0 110.014 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' LYS . 21.1 tt0 -132.45 84.66 2.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 110.526 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' GLU . 1.2 mttp 52.41 104.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.326 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.403 ' OG ' HG13 ' A' ' 32' ' ' VAL . 35.3 t -158.95 -158.72 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 110.192 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 35' ' ' THR . 0.3 OUTLIER -152.48 86.57 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.277 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.463 ' HG ' ' SG ' ' A' ' 25' ' ' CYS . 4.0 mp -109.46 116.77 32.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.129 -0.982 . . . . 0.0 110.133 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 37' ' ' CYS . 85.8 m -104.29 119.67 39.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -0.956 . . . . 0.0 110.114 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 23' ' ' THR . 11.8 m-20 56.93 22.2 6.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.987 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.463 ' SG ' ' HG ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -71.2 -145.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 110.42 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.506 ' O ' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -179.34 -50.67 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 26' ' ' TYR . 2.6 t 52.05 121.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.775 0.798 . . . . 0.0 111.41 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.533 ' O ' ' CD ' ' A' ' 29' ' ' LYS . 3.2 t70 -111.49 -25.74 9.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 110.191 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.533 ' CD ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -166.65 58.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 109.955 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.541 ' CB ' HG22 ' A' ' 45' ' ' VAL . 16.9 m -132.89 154.83 50.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 111.237 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.61 96.35 6.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.619 -0.676 . . . . 0.0 109.192 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 12.0 t -91.03 164.52 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 110.941 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 20.5 m-85 -143.19 -36.6 0.37 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . -159.37 29.37 0.4 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 21' ' ' THR . 15.5 m -77.06 159.67 29.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.298 -1.119 . . . . 0.0 110.624 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.47 ' N ' HG21 ' A' ' 35' ' ' THR . 0.6 OUTLIER -112.45 53.36 0.74 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.441 -0.787 . . . . 0.0 109.695 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' THR . 5.1 t -39.48 103.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.487 -0.758 . . . . 0.0 110.839 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 23.4 m -103.56 79.37 1.68 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.989 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.51 69.22 1.43 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 41' ' ' ARG . 1.5 m -161.27 -148.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -1.099 . . . . 0.0 110.184 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 40' ' ' SER . 1.3 ttp180 172.79 158.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.917 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CD1' ' CG1' ' A' ' 57' ' ' ILE . 2.5 m-85 -121.72 -173.2 2.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 0.0 110.166 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -173.65 57.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.252 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 117.17 47.71 0.46 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.541 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.73 -166.15 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.724 -1.457 . . . . 0.0 111.156 -179.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 64' ' ' ILE . 22.1 m -156.16 58.16 0.58 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.339 0.59 . . . . 0.0 109.433 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.527 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 11.1 tt -84.76 154.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 111.239 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 66' ' ' THR . 72.8 p -148.98 148.5 29.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.605 -0.684 . . . . 0.0 109.913 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.569 ' OG1' ' HA ' ' A' ' 66' ' ' THR . 0.1 OUTLIER 43.28 33.32 0.57 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.009 -1.057 . . . . 0.0 110.772 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.477 ' OG ' HD12 ' A' ' 47' ' ' ILE . 28.3 t -100.77 128.79 46.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.904 -1.122 . . . . 0.0 110.059 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 52' ' ' SER . 3.4 m -92.48 22.35 4.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 110.417 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -40.4 125.62 2.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.427 -0.796 . . . . 0.0 110.868 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.465 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 1.6 m -106.95 94.81 5.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 109.511 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 72.45 77.09 0.58 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 1.3 p -147.2 117.53 7.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.352 -1.087 . . . . 0.0 110.366 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.53 ' CG ' ' HB2' ' A' ' 90' ' ' ASN . 2.8 ttt-85 -68.4 107.25 2.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.587 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 15.2 mm -88.44 0.22 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.108 -0.995 . . . . 0.0 109.763 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -40.41 125.0 2.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.385 -0.822 . . . . 0.0 110.424 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -167.1 144.77 9.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.05 81.47 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.927 1.488 . . . . 0.0 109.952 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.0 15.73 53.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 15.7 t -44.18 164.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.334 -1.098 . . . . 0.0 111.221 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 62' ' ' CYS . 8.0 ttpp -150.45 114.03 4.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.483 -0.76 . . . . 0.0 110.168 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.587 ' CD1' ' CG2' ' A' ' 57' ' ' ILE . 4.4 mt -129.83 155.95 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.911 -1.118 . . . . 0.0 111.012 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.444 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -156.01 120.48 4.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.311 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.569 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 9.4 m 44.55 71.49 0.25 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -0.845 . . . . 0.0 111.008 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 98.1 m -122.58 120.8 34.86 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.407 -0.808 . . . . 0.0 109.64 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.618 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 2.3 mp -88.92 86.02 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.103 -0.998 . . . . 0.0 109.777 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 3.7 mt -102.49 157.22 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.435 -0.791 . . . . 0.0 110.356 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.47 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 53.6 m -153.95 105.49 2.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 0.0 110.24 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.448 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . 88.02 17.27 58.08 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.55 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 92.36 13.49 57.16 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 69' ' ' ILE . 12.9 m -121.76 129.2 25.27 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.454 -1.027 . . . . 0.0 110.436 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -81.24 132.76 8.37 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.928 1.489 . . . . 0.0 110.822 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.28 161.08 76.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.262 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.7 64.41 1.24 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.765 1.403 . . . . 0.0 109.953 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -99.58 118.08 35.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 0.0 110.242 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.62 -4.6 24.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 110.006 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.59 -19.13 18.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.854 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.534 ' SG ' ' CD1' ' A' ' 82' ' ' ILE . 26.0 t -68.6 165.48 19.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.09 -1.006 . . . . 0.0 109.934 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.594 ' O ' ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -105.14 7.21 33.67 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.289 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.594 ' C ' ' O ' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -15.01 82.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.543 0 CA-C-N 118.909 0.777 . . . . 0.0 111.56 -178.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -128.89 -70.21 0.68 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 111.308 -178.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -129.21 86.87 0.31 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.173 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.473 ' O ' ' HB ' ' A' ' 86' ' ' THR . 3.8 t -177.05 -150.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -1.161 . . . . 0.0 110.084 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 85' ' ' CYS . 1.7 t 174.0 161.87 0.17 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.55 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 3.1 m-85 -113.03 -52.56 2.77 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.945 -1.097 . . . . 0.0 110.011 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER 65.22 7.85 4.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 110.312 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 55.65 112.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 110.675 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.53 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . 7.9 t30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.16 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' CG ' ' N ' ' A' ' 11' ' ' LEU . 8.4 pt20 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.21 0.529 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.562 ' N ' ' CG ' ' A' ' 10' ' ' GLN . 14.4 tp 59.82 106.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.199 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -35.67 144.26 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.286 0.565 . . . . 0.0 110.747 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -13.78 6.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.421 -0.8 . . . . 0.0 110.13 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -112.53 8.52 19.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 110.71 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.547 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 2.0 t -82.46 -152.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.891 -1.131 . . . . 0.0 109.955 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -147.19 152.93 39.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.933 -1.104 . . . . 0.0 110.955 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.542 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 9.5 p -142.27 -153.44 0.46 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.313 -0.867 . . . . 0.0 109.911 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 17' ' ' CYS . 14.6 mm-40 57.05 159.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.114 -0.991 . . . . 0.0 110.173 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 44.31 63.21 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.0 109.946 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.532 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . 68.9 p -170.55 160.95 7.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.441 -0.787 . . . . 0.0 109.834 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.466 ' N ' HD21 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -125.37 104.47 8.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.087 -1.008 . . . . 0.0 108.79 179.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.607 ' CB ' ' HB3' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -144.2 -168.62 2.92 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.308 -178.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 24' ' ' ASN . 1.3 m -177.78 146.66 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 23' ' ' THR . 4.3 m-20 45.8 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -0.956 . . . . 0.0 109.871 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 26' ' ' TYR . 60.3 m -140.24 -155.4 0.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.093 -1.005 . . . . 0.0 111.007 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.535 ' CB ' ' O ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER 163.19 43.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 12' ' ' SER . 21.6 t -62.11 145.4 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.469 0.652 . . . . 0.0 110.961 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 16.0 m-20 -129.01 3.5 5.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 110.313 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.5 OUTLIER 175.67 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.322 -0.861 . . . . 0.0 109.837 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.522 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 54.3 m -165.26 -160.48 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.953 -1.092 . . . . 0.0 110.343 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 2.5 mt-10 -137.66 -62.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 0.0 110.542 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.531 HG21 ' CG2' ' A' ' 47' ' ' ILE . 3.9 t 64.61 153.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.892 . . . . 0.0 110.74 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.505 ' O ' ' CB ' ' A' ' 20' ' ' SER . 25.9 m-85 -149.86 -77.04 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.504 -0.748 . . . . 0.0 109.336 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 48' ' ' THR . . . -107.95 36.47 4.36 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 36' ' ' THR . 1.0 OUTLIER -82.96 171.79 13.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -1.081 . . . . 0.0 110.46 -179.475 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.528 ' N ' ' CG2' ' A' ' 35' ' ' THR . 1.7 m -119.52 58.81 0.87 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 110.234 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.607 ' HB3' ' CB ' ' A' ' 22' ' ' LEU . 36.2 t -39.03 103.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.443 -0.785 . . . . 0.0 110.579 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 m -106.39 75.84 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.981 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.74 49.03 71.47 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 4.9 p -138.9 169.08 18.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -1.119 . . . . 0.0 110.18 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.403 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -147.44 157.44 43.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 109.994 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 41' ' ' ARG . 2.5 m-85 -119.98 -179.44 3.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.154 -0.967 . . . . 0.0 110.454 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -155.71 46.93 0.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 109.47 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 123.94 75.03 0.28 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -150.28 -168.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.196 -1.179 . . . . 0.0 110.453 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 46' ' ' THR . 39.9 m -155.28 57.86 0.64 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.572 -0.705 . . . . 0.0 109.332 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' A' ' 32' ' ' VAL . 11.3 tt -78.33 168.05 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 110.054 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' THR . 2.4 p -143.06 -81.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.569 ' OG1' ' HA ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -110.61 39.91 2.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.233 -0.917 . . . . 0.0 109.386 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.497 ' HB2' ' CD1' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -96.31 124.36 40.28 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.351 -0.843 . . . . 0.0 110.943 -179.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -71.13 135.66 47.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.355 -0.841 . . . . 0.0 108.963 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.6 p -140.82 119.37 12.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.909 -1.12 . . . . 0.0 110.663 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.49 70.15 0.78 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 109.43 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 96.01 91.1 1.79 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 87.3 p -171.92 128.09 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -1.202 . . . . 0.0 110.811 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.535 ' CD ' ' HB2' ' A' ' 88' ' ' SER . 1.4 ptp180 -87.71 105.05 17.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 109.365 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.517 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 5.1 mm -81.66 16.08 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.023 . . . . 0.0 110.992 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.91 156.06 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.025 -1.047 . . . . 0.0 110.038 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.59 143.77 3.77 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.29 -3.35 13.78 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.985 1.519 . . . . 0.0 110.225 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.49 27.65 0.28 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -58.28 141.03 52.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -1.126 . . . . 0.0 110.472 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 6.1 ttpp -151.66 117.04 5.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.529 -0.732 . . . . 0.0 109.2 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.588 ' HA ' ' CD ' ' A' ' 81' ' ' LYS . 2.2 mp -129.36 147.11 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.956 -1.09 . . . . 0.0 111.172 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.518 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -143.2 111.93 6.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 110.181 179.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.569 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 19.8 m 51.76 57.54 6.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.647 -0.658 . . . . 0.0 111.108 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 2.0 t -110.46 129.3 55.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.425 -0.797 . . . . 0.0 110.154 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.541 ' O ' ' CB ' ' A' ' 75' ' ' ALA . 2.0 mp -87.03 93.36 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.029 . . . . 0.0 108.676 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.562 HG22 ' CD2' ' A' ' 87' ' ' PHE . 10.1 mt -106.9 149.55 10.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.392 -0.818 . . . . 0.0 110.489 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 7.5 m -156.04 103.81 2.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 110.734 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.5 24.85 27.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 87' ' ' PHE . . . 83.09 17.14 67.86 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 70' ' ' THR . 14.2 m -124.0 128.53 25.06 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.523 -0.986 . . . . 0.0 110.701 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -82.04 130.65 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.904 1.476 . . . . 0.0 110.313 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -93.02 147.3 33.6 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.09 -1.006 . . . . 0.0 110.153 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.24 101.31 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.948 1.499 . . . . 0.0 109.796 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 78' ' ' ALA . 40.3 t -111.73 -5.63 14.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 110.72 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 77' ' ' SER . . . 70.45 3.63 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.157 -0.964 . . . . 0.0 109.57 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 80' ' ' CYS . . . -125.65 -34.03 2.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 109.318 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 18.2 t -45.09 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.59 -0.694 . . . . 0.0 109.536 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.588 ' CD ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.96 7.45 46.61 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.961 -1.087 . . . . 0.0 112.357 -178.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.579 ' C ' ' O ' ' A' ' 81' ' ' LYS . 17.6 mm -6.69 73.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 81' ' ' LYS . 43.9 t -124.35 -52.06 1.74 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 109.864 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' CYS . . . -147.82 -114.95 0.81 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' GLY . 2.9 t 44.07 -167.82 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.343 -1.092 . . . . 0.0 109.972 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.467 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.6 OUTLIER 175.18 140.22 0.05 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 110.459 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.562 ' CD2' HG22 ' A' ' 69' ' ' ILE . 1.6 m-30 -115.69 170.26 8.58 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.4 -0.813 . . . . 0.0 109.677 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.535 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 6.7 m -165.52 25.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 109.644 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.483 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.02 83.41 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.36 -0.837 . . . . 0.0 109.967 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.441 ' CB ' ' HB3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.317 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.55 ' O ' ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 10' ' ' GLN . 14.2 tp 10.2 107.24 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.356 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.563 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -39.56 155.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.636 -0.665 . . . . 0.0 110.328 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.28 -8.46 25.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 110.203 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.7 -9.39 6.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.09 -1.006 . . . . 0.0 110.454 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.524 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -66.24 -161.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.865 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.448 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 24.6 tttt -165.34 150.28 9.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.126 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 p -126.02 -35.93 2.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.917 . . . . 0.0 110.242 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 58.14 -162.77 0.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.765 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -87.86 62.66 7.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.861 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.533 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 77.9 p -97.63 -172.25 2.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 110.743 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.468 ' C ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -106.65 10.74 30.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' A' ' 37' ' ' CYS . 2.3 tp -37.95 159.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.496 0.665 . . . . 0.0 110.814 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 94.6 m -162.36 123.69 2.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.69 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.1 m120 56.52 60.51 3.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 110.314 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.598 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -120.59 -157.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 110.448 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 25' ' ' CYS . 47.2 m-85 -154.82 -55.98 0.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 30' ' ' SER . 2.4 t 57.72 119.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.477 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.563 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 4.1 m-20 -112.58 -24.68 9.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.49 -0.756 . . . . 0.0 109.817 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 28' ' ' ASP . 5.1 mtpp -163.41 59.23 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.528 -0.732 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.541 ' CB ' HG23 ' A' ' 45' ' ' VAL . 39.1 m -139.88 153.53 47.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.026 . . . . 0.0 111.562 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -115.9 112.2 21.54 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.483 HG11 ' HB ' ' A' ' 35' ' ' THR . 7.0 t -106.84 159.06 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -0.957 . . . . 0.0 110.93 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.521 ' CD1' HG22 ' A' ' 48' ' ' THR . 46.1 m-85 -130.91 -36.41 1.36 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.354 -0.841 . . . . 0.0 110.946 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -151.0 12.76 0.83 Allowed Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.582 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.483 ' HB ' HG11 ' A' ' 32' ' ' VAL . 27.5 m -62.44 162.13 10.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.989 -1.301 . . . . 0.0 110.648 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.468 ' HA ' ' C ' ' A' ' 21' ' ' THR . 19.9 m -109.94 -22.52 11.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.358 -0.839 . . . . 0.0 110.266 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.465 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 4.0 t 42.24 81.13 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.24 -0.913 . . . . 0.0 110.42 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.455 ' HB ' HG23 ' A' ' 53' ' ' THR . 88.8 m -77.06 57.2 1.34 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 109.421 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.39 74.11 1.28 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.469 ' HB3' ' OD1' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -157.35 -161.77 1.11 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.261 -1.14 . . . . 0.0 110.008 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 10.7 ptt180 -167.56 162.33 14.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.031 . . . . 0.0 110.658 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.576 ' CE1' HD12 ' A' ' 57' ' ' ILE . 2.6 m-85 -120.31 -162.72 0.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.371 -0.831 . . . . 0.0 110.217 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER 171.98 53.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 117.27 56.49 0.3 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.541 HG23 ' CB ' ' A' ' 30' ' ' SER . 1.3 m -139.35 -164.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.09 -1.241 . . . . 0.0 110.475 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 46' ' ' THR . 91.5 m -161.07 56.52 0.3 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLU . 17.4 tt -83.86 165.47 2.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.378 -0.826 . . . . 0.0 110.589 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 33' ' ' TYR . 66.4 p -129.53 -140.04 0.23 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 109.131 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.531 ' HA ' ' CA ' ' A' ' 34' ' ' GLY . 41.6 m -51.32 129.44 24.84 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.057 -1.027 . . . . 0.0 108.941 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' THR . 41.0 t -171.21 163.18 7.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.006 -1.059 . . . . 0.0 110.587 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.505 ' HB ' HD12 ' A' ' 68' ' ' ILE . 52.9 m -116.83 13.99 15.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.079 -1.013 . . . . 0.0 110.339 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.474 ' C ' ' O ' ' A' ' 51' ' ' THR . 54.5 p -36.18 133.94 0.45 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.644 -0.66 . . . . 0.0 110.653 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 69' ' ' ILE . 6.9 m -127.22 107.64 10.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 110.19 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 64.84 78.93 0.19 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.8 p -158.3 127.47 5.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.153 -1.204 . . . . 0.0 110.611 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.469 ' HB3' ' CB ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -78.54 103.6 8.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.576 HD12 ' CE1' ' A' ' 42' ' ' PHE . 3.1 mp -89.48 16.47 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.963 -1.085 . . . . 0.0 110.66 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.49 159.73 0.69 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.2 -0.937 . . . . 0.0 110.266 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.29 166.82 18.99 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.77 54.03 3.87 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.073 1.565 . . . . 0.0 109.873 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 107.56 22.51 7.35 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 5.0 t -40.56 103.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.584 -0.95 . . . . 0.0 110.384 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 64' ' ' ILE . 13.2 tttt -97.12 146.06 25.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.572 -0.705 . . . . 0.0 109.725 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.511 HG12 ' NZ ' ' A' ' 81' ' ' LYS . 19.2 mt -154.5 144.08 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.052 -1.03 . . . . 0.0 110.783 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.445 ' N ' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -136.4 107.87 6.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.284 -0.885 . . . . 0.0 110.653 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 49' ' ' THR . 5.9 m 58.02 79.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.37 -0.831 . . . . 0.0 111.469 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.512 ' O ' HG13 ' A' ' 69' ' ' ILE . 0.9 OUTLIER -135.63 117.4 15.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 109.981 178.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.555 ' HB ' ' CB ' ' A' ' 75' ' ' ALA . 1.1 mm -76.33 101.75 2.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' THR . 17.4 mt -115.2 155.87 16.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 O-C-N 120.899 -1.126 . . . . 0.0 109.97 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.544 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 86.4 m -159.98 103.02 1.48 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 0.0 110.426 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.94 25.93 28.03 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.17 17.29 69.75 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 70' ' ' THR . 12.4 m -127.63 132.86 24.55 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.393 -1.063 . . . . 0.0 110.859 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -81.46 147.06 15.69 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.02 1.537 . . . . 0.0 110.656 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.646 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . . . -73.15 -153.59 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.154 -0.966 . . . . 0.0 108.403 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.646 ' CD ' ' CB ' ' A' ' 75' ' ' ALA . 43.5 Cg_endo -75.62 9.48 2.24 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 O-C-N 122.404 0.686 . . . . 0.0 111.018 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.498 ' CB ' ' HB3' ' A' ' 80' ' ' CYS . 5.3 p 45.0 50.17 9.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.89 . . . . 0.0 111.448 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.07 -23.6 3.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.02 -1.05 . . . . 0.0 109.153 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.54 40.88 0.25 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 1.2 t -109.49 164.64 12.32 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.902 0.858 . . . . 0.0 110.98 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -96.27 173.71 7.25 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.53 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 17.9 mm -160.1 53.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 t -97.95 -126.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 110.386 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.48 91.54 1.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.428 ' SG ' ' C ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER -162.76 177.51 9.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.147 . . . . 0.0 109.874 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.527 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -177.43 149.57 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.35 -0.844 . . . . 0.0 110.022 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -117.13 166.6 12.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.113 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -148.58 23.91 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.901 -1.125 . . . . 0.0 110.371 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 47.16 62.7 2.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.257 -0.902 . . . . 0.0 109.695 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.469 ' OD1' ' HB3' ' A' ' 40' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.21 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.54 ' CD ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.571 ' CD1' ' HB ' ' A' ' 27' ' ' VAL . 3.4 mm? -41.25 103.18 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.95 0.881 . . . . 0.0 109.35 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' ALA . 50.8 m -64.94 55.49 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.842 -0.536 . . . . 0.0 111.5 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 56.76 154.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 110.627 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 70.51 -4.68 1.57 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.209 -0.932 . . . . 0.0 111.807 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.559 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -74.42 176.69 6.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.458 -1.401 . . . . 0.0 110.574 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD3' ' CG ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -160.42 151.53 19.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.392 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 p -166.65 -172.01 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 110.263 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 22.3 tt0 -169.61 -39.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.384 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -177.62 54.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.366 -0.834 . . . . 0.0 109.987 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.454 ' HB2' ' N ' ' A' ' 34' ' ' GLY . 52.0 p -102.92 -163.44 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 110.557 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' THR . 68.8 m -126.77 77.0 1.68 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.979 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.461 ' O ' ' OG1' ' A' ' 23' ' ' THR . 3.5 tp -95.19 165.83 12.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 21.7 m -167.51 128.81 1.52 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.426 -0.796 . . . . 0.0 109.902 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 23' ' ' THR . 28.8 m-80 56.34 29.14 14.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.075 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -101.8 154.57 18.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.86 . . . . 0.0 110.375 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' CD1' ' CD ' ' A' ' 10' ' ' GLN . 1.9 m-85 -116.69 -40.31 3.2 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.571 ' HB ' ' CD1' ' A' ' 11' ' ' LEU . 6.5 t 52.99 137.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.107 0.956 . . . . 0.0 113.096 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 14.7 t0 -142.2 118.08 10.54 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 14' ' ' ASN . 30.8 mttm 53.11 66.07 1.34 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.009 -1.057 . . . . 0.0 109.301 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.463 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 69.3 m -153.51 151.97 30.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.038 -1.039 . . . . 0.0 110.65 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' CG ' ' HD3' ' A' ' 16' ' ' LYS . 11.0 mt-10 -121.12 112.91 19.28 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.534 -0.729 . . . . 0.0 109.166 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.515 HG11 ' HB ' ' A' ' 35' ' ' THR . 17.0 t -111.13 152.55 13.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.57 -0.707 . . . . 0.0 110.392 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.424 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 51.2 m-85 -144.93 34.71 1.12 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.263 -0.898 . . . . 0.0 110.841 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' N ' ' HB2' ' A' ' 20' ' ' SER . . . 140.9 41.46 0.07 OUTLIER Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.122 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.515 ' HB ' HG11 ' A' ' 32' ' ' VAL . 3.5 m -97.41 124.9 41.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.075 -1.25 . . . . 0.0 110.582 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 21' ' ' THR . 90.4 m -79.98 55.49 2.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.143 -0.973 . . . . 0.0 109.71 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.459 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 29.8 t -46.11 143.6 2.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.534 -0.728 . . . . 0.0 110.689 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -124.08 10.3 8.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 129.89 40.92 0.25 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.409 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 47.2 m -122.38 -167.74 1.61 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 110.075 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 42' ' ' PHE . 2.6 ttt180 -158.19 165.83 33.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 110.35 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' A' ' 41' ' ' ARG . 7.0 m-85 -121.97 -172.2 2.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.814 . . . . 0.0 109.692 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 20.2 t0 -167.8 49.37 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.0 110.562 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 118.47 51.17 0.32 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.1 m -127.87 -166.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.092 -1.24 . . . . 0.0 110.828 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.6 m -161.37 56.28 0.28 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.45 HG12 ' N ' ' A' ' 48' ' ' THR . 13.7 tt -76.56 172.04 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.498 -0.751 . . . . 0.0 110.735 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.45 ' N ' HG12 ' A' ' 47' ' ' ILE . 47.0 p -138.28 -137.04 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 109.551 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 66' ' ' THR . 40.5 m -65.34 81.99 0.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.835 -1.165 . . . . 0.0 109.888 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 67' ' ' CYS . 23.2 t -135.89 148.5 48.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.04 -1.037 . . . . 0.0 111.357 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -95.49 126.36 40.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.078 -1.014 . . . . 0.0 109.12 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.444 ' OG ' ' OG ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -137.04 105.08 5.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 110.004 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -95.11 102.54 14.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.477 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 61.12 92.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 83.7 p -166.15 121.08 1.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -1.213 . . . . 0.0 110.414 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.5 ' HG3' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -81.25 112.72 18.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.008 -1.057 . . . . 0.0 109.458 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.494 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 18.0 mm -88.57 13.27 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.339 -0.851 . . . . 0.0 110.823 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -42.59 141.21 1.07 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.233 -0.917 . . . . 0.0 110.286 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 178.8 146.03 6.4 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -76.39 55.82 4.82 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.024 1.539 . . . . 0.0 109.103 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 117.23 20.17 4.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -39.43 147.25 0.08 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.381 -1.07 . . . . 0.0 110.964 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 24.1 tttt -147.16 100.74 3.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.867 . . . . 0.0 110.048 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.592 ' HA ' ' CG ' ' A' ' 81' ' ' LYS . 3.4 mt -116.19 149.92 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.0 110.431 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -142.18 118.05 10.54 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.202 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.1 m 54.35 80.57 0.12 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 111.892 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.8 t -137.99 128.78 26.9 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.574 ' O ' ' CG2' ' A' ' 68' ' ' ILE . 1.7 mp -82.66 9.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.879 -1.138 . . . . 0.0 110.55 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 68' ' ' ILE . 62.5 mt -18.35 138.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 CA-C-O 121.434 0.635 . . . . 0.0 112.04 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.551 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 52.3 m -148.66 100.9 3.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.961 -1.087 . . . . 0.0 111.477 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 91.67 37.75 6.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 72.07 13.2 76.09 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 70' ' ' THR . 5.3 m -120.3 136.52 25.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.39 -1.065 . . . . 0.0 110.013 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' A' ' 69' ' ' ILE . 44.8 Cg_endo -75.93 142.13 24.82 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.789 1.415 . . . . 0.0 110.682 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.59 167.77 12.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 109.604 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.09 72.95 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.683 1.36 . . . . 0.0 110.031 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.545 ' HB3' ' CB ' ' A' ' 80' ' ' CYS . 4.9 t -115.29 107.41 15.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.477 -0.764 . . . . 0.0 110.242 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.34 -13.9 15.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.964 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.71 -14.44 23.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.392 -0.818 . . . . 0.0 110.108 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 7.2 t -72.39 161.34 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.419 -0.801 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' CG ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -124.55 154.84 40.0 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.53 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 81' ' ' LYS . 18.1 mm -140.77 70.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -137.48 106.54 6.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.828 . . . . 0.0 111.684 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.5 30.23 53.96 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.652 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.454 ' HB2' ' NZ ' ' A' ' 81' ' ' LYS . 5.5 t -150.31 179.31 8.23 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.984 -1.304 . . . . 0.0 110.231 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.0 t -177.31 161.25 1.78 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.383 -0.823 . . . . 0.0 109.726 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -121.68 169.91 10.25 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 109.525 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.48 24.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.8 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 46.61 78.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.463 -0.773 . . . . 0.0 109.965 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.5 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.394 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.322 0.582 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 13' ' ' ALA . 2.3 mm? -43.44 117.42 1.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.566 ' OG ' ' CZ ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -58.6 71.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.517 -0.74 . . . . 0.0 111.134 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 11' ' ' LEU . . . 21.89 59.87 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 120.963 0.411 . . . . 0.0 111.79 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 41.1 t-20 -178.46 -32.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.964 . . . . 0.0 110.307 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.468 ' CB ' HD11 ' A' ' 11' ' ' LEU . 15.1 t -58.42 -176.56 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.558 -0.714 . . . . 0.0 110.998 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 9.9 ttmt -139.47 147.38 41.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 109.791 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.55 127.22 14.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.966 . . . . 0.0 110.32 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -120.72 -38.29 2.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.088 -1.008 . . . . 0.0 110.551 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -174.12 34.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -0.93 . . . . 0.0 109.686 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 p -84.68 -167.97 2.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 110.691 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 21' ' ' THR . 5.7 t -142.47 66.53 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.063 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 22' ' ' LEU . 5.3 mt -77.97 177.07 8.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.996 -1.065 . . . . 0.0 109.988 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 37' ' ' CYS . 55.5 m -164.7 121.44 1.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.866 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' THR . 31.0 m120 56.57 48.7 16.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 109.407 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.447 ' SG ' HG21 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -119.19 164.84 15.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.59 0.709 . . . . 0.0 110.839 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.592 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 25.1 t80 -138.22 26.06 2.67 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.582 ' HB ' ' CD1' ' A' ' 11' ' ' LEU . 15.1 t -21.67 144.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.016 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 42.8 t0 -145.56 147.05 31.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.467 -0.771 . . . . 0.0 109.801 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 41.9 mtpt 35.43 41.5 0.09 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.569 -0.707 . . . . 0.0 110.34 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.478 ' HB3' HG23 ' A' ' 45' ' ' VAL . 75.3 m -133.19 150.8 51.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 110.851 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 47' ' ' ILE . 7.7 mt-10 -118.29 99.66 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 0.0 109.64 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.525 HG11 ' HB ' ' A' ' 35' ' ' THR . 21.8 t -99.17 163.62 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.512 -0.742 . . . . 0.0 110.528 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -148.44 -14.23 0.34 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.073 -1.017 . . . . 0.0 111.926 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.15 26.45 0.2 Allowed Glycine 0 N--CA 1.494 2.549 0 O-C-N 120.556 -1.34 . . . . 0.0 109.962 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.525 ' HB ' HG11 ' A' ' 32' ' ' VAL . 43.5 m -82.07 168.83 17.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -1.126 . . . . 0.0 110.732 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.482 ' N ' HG23 ' A' ' 35' ' ' THR . 40.0 m -129.33 52.65 1.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.383 -0.823 . . . . 0.0 109.62 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.503 ' O ' ' N ' ' A' ' 23' ' ' THR . 5.9 t -44.02 102.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 110.158 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.404 ' O ' HG21 ' A' ' 38' ' ' THR . 13.5 t -95.84 35.64 1.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 0.0 110.142 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.02 24.5 2.48 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -115.14 -166.98 1.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -1.075 . . . . 0.0 109.489 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' N ' ' OG ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -164.66 164.53 21.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.898 -1.126 . . . . 0.0 111.159 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 41' ' ' ARG . 7.0 m-85 -123.13 -177.4 3.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.316 -0.865 . . . . 0.0 109.922 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.1 t70 -165.81 53.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.237 -0.914 . . . . 0.0 110.482 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 117.53 66.96 0.36 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.7 m -143.68 -160.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.911 -1.347 . . . . 0.0 111.604 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 62' ' ' CYS . 97.5 m -165.08 58.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.565 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 10.1 tt -81.42 165.29 2.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.345 -0.847 . . . . 0.0 110.923 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 25.0 p -131.34 -143.34 0.24 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 66' ' ' THR . 26.8 m -56.42 110.45 0.77 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.581 -1.325 . . . . 0.0 108.236 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 35' ' ' THR . 1.4 t -161.61 136.96 7.54 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.706 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -98.48 122.03 41.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.335 -0.853 . . . . 0.0 109.637 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.448 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -135.77 129.49 32.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.114 -0.991 . . . . 0.0 110.507 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.1 101.7 10.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.365 -0.834 . . . . 0.0 109.427 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 64.74 99.21 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 85.6 p -174.42 110.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -1.163 . . . . 0.0 110.564 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.528 ' CA ' ' HB3' ' A' ' 90' ' ' ASN . 3.8 ptp180 -77.4 112.12 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.104 -0.997 . . . . 0.0 109.166 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.528 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 32.6 mm -87.57 21.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.083 -1.011 . . . . 0.0 110.548 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.6 m -45.36 160.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 110.144 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.69 163.36 11.59 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.7 47.83 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.005 1.529 . . . . 0.0 109.826 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 123.8 16.22 3.38 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' THR . 3.1 t -36.62 116.75 0.45 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.604 -0.939 . . . . 0.0 110.998 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.569 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 32.2 tttm -107.79 153.76 22.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.882 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.565 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 30.1 mm -152.38 130.66 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.83 -1.168 . . . . 0.0 109.642 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.499 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 62.4 p -132.58 118.51 19.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 0.0 110.257 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.6 OUTLIER 43.44 56.95 4.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.475 -0.766 . . . . 0.0 110.056 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 80' ' ' CYS . 0.8 OUTLIER -113.17 99.05 7.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.943 . . . . 0.0 109.862 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.515 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.9 mp -69.49 86.56 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.978 -1.076 . . . . 0.0 109.114 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' THR . 9.0 mt -89.64 159.9 2.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.624 -0.673 . . . . 0.0 110.189 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.536 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 8.6 m -157.99 96.27 1.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 110.281 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.59 33.25 8.07 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 75.52 16.98 80.31 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 70' ' ' THR . 13.8 m -126.18 131.44 23.96 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.376 -1.073 . . . . 0.0 110.177 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -79.68 151.0 21.86 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.768 1.404 . . . . 0.0 110.453 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . . . -82.82 173.53 7.41 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.093 -1.004 . . . . 0.0 110.094 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -82.4 9.98 3.77 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.759 1.399 . . . . 0.0 109.751 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.9 t -54.97 132.94 48.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.539 -0.725 . . . . 0.0 110.343 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.67 -10.84 55.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.419 -0.801 . . . . 0.0 110.391 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.411 ' HB2' ' HB ' ' A' ' 66' ' ' THR . . . -94.69 -14.25 25.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 109.732 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.467 ' CB ' ' HA ' ' A' ' 67' ' ' CYS . 36.4 t -77.03 123.55 26.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.331 -0.856 . . . . 0.0 109.444 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -100.42 172.89 6.85 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.054 -1.029 . . . . 0.0 110.476 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.557 ' HA ' ' HE3' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -163.23 82.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.46 74.67 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.718 -0.614 . . . . 0.0 111.4 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.18 -13.82 44.27 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.371 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -82.04 -164.63 0.84 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.969 -1.312 . . . . 0.0 109.961 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.573 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t 168.82 147.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 109.657 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.573 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -130.57 156.08 45.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.825 . . . . 0.0 109.395 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.427 ' HB3' ' CD ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -145.25 30.34 1.14 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.142 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 51.72 82.14 0.07 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.411 -0.805 . . . . 0.0 108.867 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.528 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.68 -178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.022 0.439 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 17' ' ' CYS . 22.8 tp 47.57 81.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.11 -0.994 . . . . 0.0 108.478 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -43.05 147.13 0.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.825 . . . . 0.0 110.387 -178.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.21 -13.37 12.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.964 . . . . 0.0 109.651 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 53.7 t-20 -90.4 -1.95 57.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.516 -0.74 . . . . 0.0 110.216 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.458 ' OG ' HG13 ' A' ' 27' ' ' VAL . 39.8 t -91.72 -157.52 0.51 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.042 -1.036 . . . . 0.0 109.843 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.495 ' NZ ' ' OH ' ' A' ' 33' ' ' TYR . 4.8 tttt -138.79 159.14 42.85 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 110.113 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 34.9 t -148.87 116.7 6.3 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.286 -0.884 . . . . 0.0 110.744 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 19' ' ' LYS . 2.2 mt-10 -147.68 71.7 1.21 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.493 -0.755 . . . . 0.0 109.272 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 61.83 117.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 108.996 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -158.02 173.43 16.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.025 . . . . 0.0 110.722 -178.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -119.79 30.26 7.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 0.0 109.736 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 35' ' ' THR . 11.2 mt -60.95 -178.79 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 109.963 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 37' ' ' CYS . 24.2 m -166.24 122.23 1.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.787 . . . . 0.0 109.507 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 47.48 46.73 17.47 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.118 -0.989 . . . . 0.0 109.059 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 40' ' ' SER . 0.9 OUTLIER -88.08 -151.12 0.19 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.971 0.891 . . . . 0.0 111.254 -178.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 1.2 t80 174.35 41.77 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.458 HG13 ' OG ' ' A' ' 15' ' ' SER . 26.1 t -50.7 149.43 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.7 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -157.05 131.18 8.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 1.2 mtpt 55.6 19.37 3.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -0.985 . . . . 0.0 110.154 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.463 ' HB3' HG23 ' A' ' 45' ' ' VAL . 69.8 m -122.48 -178.15 3.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.969 -1.082 . . . . 0.0 110.612 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 3.6 tt0 -116.33 -71.91 0.72 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -0.858 . . . . 0.0 110.419 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.474 ' C ' ' CD1' ' A' ' 33' ' ' TYR . 3.7 t 66.45 140.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.594 -0.691 . . . . 0.0 110.266 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.495 ' OH ' ' NZ ' ' A' ' 16' ' ' LYS . 44.1 m-85 -141.34 -70.81 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 110.587 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.61 22.06 33.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.483 ' HB ' HD22 ' A' ' 22' ' ' LEU . 98.3 m -70.54 160.14 33.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.397 -1.061 . . . . 0.0 111.29 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 37' ' ' CYS . 22.2 m -116.01 49.97 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.495 -0.753 . . . . 0.0 109.742 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' THR . 31.2 t -39.38 104.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 111.162 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.4 m -98.95 89.84 4.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.156 -0.965 . . . . 0.0 109.838 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.78 38.44 95.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -130.8 -150.65 0.44 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.171 -1.194 . . . . 0.0 110.063 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 40' ' ' SER . 18.7 ptt180 177.66 -176.68 0.18 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.317 -0.865 . . . . 0.0 110.518 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 20.4 m-85 -133.16 -169.4 2.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.387 -0.821 . . . . 0.0 109.301 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.88 50.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 109.814 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 115.72 58.14 0.34 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.543 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 2.3 m -138.53 -159.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.989 -1.301 . . . . 0.0 110.709 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.467 ' HB ' ' HA ' ' A' ' 63' ' ' LYS . 87.8 m -161.79 51.04 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.44 -0.788 . . . . 0.0 109.809 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.47 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 6.6 tt -80.27 164.41 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.368 -0.833 . . . . 0.0 110.435 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.461 ' O ' ' OG1' ' A' ' 35' ' ' THR . 46.2 p -136.48 -120.04 0.16 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.347 -0.846 . . . . 0.0 110.333 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 66' ' ' THR . 94.3 m -70.33 70.54 0.41 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.674 -1.266 . . . . 0.0 110.114 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' THR . 1.1 t -124.27 144.79 49.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.147 -0.97 . . . . 0.0 110.529 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -104.65 125.43 50.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.881 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.455 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -136.66 136.17 38.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.999 -1.063 . . . . 0.0 110.122 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.84 89.69 3.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.916 -1.115 . . . . 0.0 109.545 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.1 92.37 0.17 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.9 p -165.2 130.19 2.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -1.143 . . . . 0.0 110.532 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 14.7 ttp85 -93.38 106.66 18.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.125 -0.984 . . . . 0.0 109.157 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.553 HD12 ' CD1' ' A' ' 87' ' ' PHE . 8.7 mm -81.63 13.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 110.435 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -34.43 146.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 0.0 110.8 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.94 153.65 9.68 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.22 36.46 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.972 1.511 . . . . 0.0 109.683 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.92 32.72 0.5 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 45' ' ' VAL . 1.6 t -49.87 166.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.29 -1.123 . . . . 0.0 110.086 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' SG ' ' A' ' 62' ' ' CYS . 31.8 tttp -149.13 106.24 3.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 109.555 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.543 HG12 ' HD3' ' A' ' 81' ' ' LYS . 1.7 mt -121.7 158.56 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.888 -1.133 . . . . 0.0 111.046 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 65' ' ' SER . 1.3 p -163.09 105.76 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.548 -0.72 . . . . 0.0 109.479 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 2.3 m 67.07 78.2 0.25 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.216 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 74.1 m -140.37 121.8 15.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.431 -0.793 . . . . 0.0 109.598 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.9 mp -93.47 83.62 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.937 -1.102 . . . . 0.0 109.324 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' THR . 29.1 mt -86.54 162.46 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.618 -0.676 . . . . 0.0 110.791 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.537 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 27.9 m -158.81 95.29 1.29 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.253 -0.905 . . . . 0.0 110.76 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.57 30.32 13.91 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 81.45 15.32 76.53 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 70' ' ' THR . 10.6 m -127.83 123.78 23.0 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.412 -1.052 . . . . 0.0 110.604 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.455 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 44.8 Cg_endo -75.1 138.88 23.35 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.837 1.441 . . . . 0.0 111.274 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 68' ' ' ILE . . . -73.55 164.29 62.16 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.359 -0.838 . . . . 0.0 109.466 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.0 58.91 2.2 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.75 1.395 . . . . 0.0 110.115 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 m -92.63 119.04 31.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.469 -0.77 . . . . 0.0 110.675 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.15 1.51 15.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.259 -0.9 . . . . 0.0 111.064 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.67 -16.73 14.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.954 -1.091 . . . . 0.0 110.174 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 4.4 t -69.91 165.78 20.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 110.952 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.549 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -60.17 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.651 -0.655 . . . . 0.0 111.876 -179.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 81' ' ' LYS . 4.9 mm 71.96 33.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.2 m -112.12 -84.76 0.58 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.705 -0.622 . . . . 0.0 111.571 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -117.35 84.79 0.38 Allowed Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.737 -1.22 . . . . 0.0 111.0 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 8.7 t -178.95 174.66 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -1.137 . . . . 0.0 110.255 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.505 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 7.4 t -169.6 168.79 9.03 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.553 ' CD1' HD12 ' A' ' 57' ' ' ILE . 1.6 m-85 -126.41 157.06 39.54 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.022 -1.049 . . . . 0.0 109.389 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.462 ' HB2' ' HB3' ' A' ' 56' ' ' ARG . 4.0 m -129.3 20.42 5.75 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 90' ' ' ASN . . . 53.37 59.58 4.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.5 -0.75 . . . . 0.0 109.921 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.576 ' NE2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.311 0.577 . . . . 0.0 110.417 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CD1' ' OG ' ' A' ' 15' ' ' SER . 11.5 tp -178.66 92.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.716 . . . . 0.0 109.843 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -40.62 146.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.537 -0.727 . . . . 0.0 110.581 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.27 -13.85 14.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.128 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -92.71 -5.36 51.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 109.989 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.543 ' OG ' ' CD1' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -68.63 -170.22 0.2 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.16 -0.962 . . . . 0.0 110.245 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 1.5 tttp -146.77 116.01 7.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 110.231 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 15.5 p -110.96 -164.25 0.9 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 0.0 110.242 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 17' ' ' CYS . 17.6 tp10 69.71 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 64.39 40.16 6.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.248 -0.907 . . . . 0.0 109.892 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 t -160.85 169.29 22.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.785 . . . . 0.0 109.575 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 36' ' ' THR . 32.7 m -106.88 104.61 14.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.008 -1.058 . . . . 0.0 109.64 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 1.5 mm? -101.29 150.52 22.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.106 -0.996 . . . . 0.0 110.888 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 16.5 m -163.67 95.0 0.8 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.623 -0.673 . . . . 0.0 109.216 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 23' ' ' THR . 0.4 OUTLIER 66.33 32.93 7.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.552 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 98.3 m -59.69 -159.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.663 0.744 . . . . 0.0 110.901 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.576 ' CE2' ' NE2' ' A' ' 10' ' ' GLN . 1.9 t80 179.77 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.52 ' CG2' HD13 ' A' ' 11' ' ' LEU . 1.9 t 36.6 -159.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.58 0.705 . . . . 0.0 111.148 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 12' ' ' SER . 0.5 OUTLIER 171.93 -31.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 5.6 mtmt -169.28 51.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.535 ' CB ' HG22 ' A' ' 45' ' ' VAL . 35.2 m -127.34 -166.63 1.63 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 111.051 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.491 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 2.2 tt0 -129.09 -65.02 0.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.553 -0.717 . . . . 0.0 110.073 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 3.8 t 67.71 147.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.427 -0.796 . . . . 0.0 110.278 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 33.1 m-85 -134.77 -50.98 0.78 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.14 -0.975 . . . . 0.0 110.614 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.422 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -135.56 35.06 2.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.532 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 5.6 m -83.21 136.45 34.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.169 -1.195 . . . . 0.0 109.888 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.526 ' HA ' ' CG2' ' A' ' 21' ' ' THR . 28.3 m -69.0 -10.92 59.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.265 -0.897 . . . . 0.0 110.43 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.478 ' O ' ' N ' ' A' ' 39' ' ' GLY . 5.9 t 42.62 49.59 4.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 110.54 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.8 m -67.37 66.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.73 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 37' ' ' CYS . . . 68.95 75.17 0.55 Allowed Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.66 158.4 43.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 0.0 110.125 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.565 ' HD2' ' CD1' ' A' ' 26' ' ' TYR . 5.3 ttp180 -131.73 160.54 35.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.343 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.441 ' CD1' ' O ' ' A' ' 41' ' ' ARG . 10.4 m-85 -133.21 -169.0 2.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.325 -0.859 . . . . 0.0 109.914 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.453 ' OD1' ' CB ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -174.48 49.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 110.076 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 115.41 60.58 0.36 Allowed Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.535 HG22 ' CB ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -134.91 -167.4 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.812 -1.405 . . . . 0.0 110.651 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.7 m -155.7 56.24 0.61 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.548 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 9.2 tt -78.62 170.02 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.38 -0.825 . . . . 0.0 110.544 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 44.2 p -139.36 -131.63 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' THR . 23.9 m -60.87 123.8 18.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.762 -1.211 . . . . 0.0 109.008 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 35' ' ' THR . 0.4 OUTLIER -166.26 154.83 10.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.007 -1.058 . . . . 0.0 110.605 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 52' ' ' SER . 1.9 m -107.68 17.27 22.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.021 -1.05 . . . . 0.0 109.991 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -39.61 125.02 1.74 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.482 -0.761 . . . . 0.0 110.495 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.485 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 25.0 m -114.97 111.8 21.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.017 . . . . 0.0 110.143 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.72 86.14 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 p -162.06 131.08 4.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -1.165 . . . . 0.0 110.409 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' CA ' ' HB3' ' A' ' 90' ' ' ASN . 4.1 ttm180 -88.66 107.53 18.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.793 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.485 HG21 HG13 ' A' ' 64' ' ' ILE . 19.0 mm -87.47 21.29 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 110.611 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -41.86 143.25 0.56 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.221 -0.924 . . . . 0.0 110.324 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 175.92 153.02 10.0 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.263 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -87.13 62.72 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.036 1.545 . . . . 0.0 109.744 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 62' ' ' CYS . . . 109.16 19.63 8.38 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -42.55 170.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.597 -0.943 . . . . 0.0 111.238 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 17.3 ttmm -157.15 112.61 2.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.509 -0.744 . . . . 0.0 110.092 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.548 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 3.8 mm -119.85 164.41 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.006 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -168.37 113.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.3 m 49.46 65.63 1.35 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 110.376 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 63.7 m -122.45 97.24 5.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.619 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 75' ' ' ALA . 1.9 mp -64.31 82.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 109.7 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.528 HG12 ' CE2' ' A' ' 87' ' ' PHE . 18.8 mt -97.71 155.36 3.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.821 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.492 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 12.8 m -155.02 101.69 2.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.038 -1.039 . . . . 0.0 110.213 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.03 29.0 16.3 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.528 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 79.18 16.6 78.24 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 70' ' ' THR . 5.5 m -122.91 128.56 25.31 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.364 -1.08 . . . . 0.0 110.537 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.481 ' HG3' HD11 ' A' ' 82' ' ' ILE . 45.1 Cg_endo -76.01 149.28 32.52 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.893 1.47 . . . . 0.0 110.652 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -96.49 164.52 18.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.332 -0.855 . . . . 0.0 109.953 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.31 57.84 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.915 1.482 . . . . 0.0 109.862 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.3 m -91.62 149.76 21.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 0.0 110.535 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.96 -17.96 22.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 110.248 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.86 -9.25 37.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.651 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.508 ' SG ' HG12 ' A' ' 82' ' ' ILE . 31.2 t -75.98 166.32 23.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -1.0 . . . . 0.0 110.013 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -111.28 -46.76 3.26 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.977 -1.077 . . . . 0.0 112.761 -178.504 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.544 ' N ' ' CD ' ' A' ' 81' ' ' LYS . 16.7 mm 46.77 71.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.564 -1.335 . . . . 0.0 109.961 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.449 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 18.6 t -128.79 -106.67 0.3 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 0.0 110.46 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.35 63.69 2.92 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 81' ' ' LYS . 2.0 t -167.52 -172.54 1.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.082 -1.246 . . . . 0.0 110.787 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.538 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.7 t 177.44 162.61 0.52 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.475 -0.766 . . . . 0.0 109.333 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.542 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -120.19 166.52 13.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.021 -1.049 . . . . 0.0 110.048 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -146.16 22.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.437 -0.79 . . . . 0.0 109.74 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 54.25 63.06 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.718 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.485 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.278 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.197 0.523 . . . . 0.0 110.449 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.546 HD12 ' CB ' ' A' ' 15' ' ' SER . 41.3 tp -105.01 97.45 7.3 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.248 -0.908 . . . . 0.0 109.903 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.542 ' HB2' ' CA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -35.67 133.41 0.4 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.359 0.6 . . . . 0.0 111.205 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.55 -22.66 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 0.0 110.477 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 12' ' ' SER . 0.6 OUTLIER -95.83 -12.57 25.04 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.971 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.546 ' CB ' HD12 ' A' ' 11' ' ' LEU . 4.1 t -64.54 -176.85 0.27 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.928 -1.107 . . . . 0.0 109.729 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.405 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 7.2 tttp -127.58 146.2 50.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.033 -1.042 . . . . 0.0 110.61 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.94 110.81 14.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.031 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.63 -143.42 0.39 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.222 -0.924 . . . . 0.0 110.514 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.24 11.42 28.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.256 -0.902 . . . . 0.0 110.444 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 1.2 p -62.53 169.3 3.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.601 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.482 ' HB ' ' HA ' ' A' ' 36' ' ' THR . 55.3 m -99.11 109.63 22.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.995 -1.066 . . . . 0.0 109.578 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 2.5 mm? -99.57 144.03 29.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 110.847 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 19.9 m -150.87 107.97 3.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.397 -0.814 . . . . 0.0 109.443 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 54.07 44.43 29.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -0.936 . . . . 0.0 109.007 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 92.8 m -67.59 -157.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.416 -0.803 . . . . 0.0 111.011 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.6 OUTLIER 167.11 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.53 ' CG1' ' OG ' ' A' ' 15' ' ' SER . 5.1 t -70.66 168.16 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.113 0.959 . . . . 0.0 111.409 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.542 ' CA ' ' HB2' ' A' ' 12' ' ' SER . 2.8 t70 -148.39 -35.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.42 0.629 . . . . 0.0 109.512 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -157.85 64.54 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.529 -0.732 . . . . 0.0 109.825 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.504 ' OG ' ' CG2' ' A' ' 45' ' ' VAL . 25.7 m -143.84 -175.95 4.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.854 -1.154 . . . . 0.0 111.093 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.508 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -123.43 -66.14 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.6 -0.687 . . . . 0.0 110.353 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.571 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 6.8 t 69.07 165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.628 -0.67 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 50.2 m-85 -159.85 -51.0 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.386 -0.821 . . . . 0.0 110.417 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 49' ' ' THR . . . -123.49 -2.7 8.85 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.571 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 34.0 m -49.82 162.16 0.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -1.226 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.482 ' HA ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -102.81 -16.68 15.86 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.171 -0.955 . . . . 0.0 110.063 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 12.6 t 50.85 99.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 0.0 111.18 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.428 ' CG2' HG21 ' A' ' 53' ' ' THR . 20.9 m -114.34 89.88 3.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.113 -0.992 . . . . 0.0 109.483 178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 38' ' ' THR . . . 45.32 56.93 5.95 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 1.3 t -132.62 -175.99 3.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.135 -1.215 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.463 ' N ' ' OG ' ' A' ' 40' ' ' SER . 15.4 ptt180 -155.52 151.16 27.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.119 -0.988 . . . . 0.0 110.498 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.454 ' CB ' ' OG ' ' A' ' 30' ' ' SER . 4.8 m-85 -117.46 -175.4 2.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.861 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.454 ' HB3' ' OG ' ' A' ' 58' ' ' SER . 24.0 t70 -166.75 38.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.421 -0.8 . . . . 0.0 109.778 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 129.78 66.7 0.11 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -141.78 -166.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.574 -1.545 . . . . 0.0 111.445 -179.228 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 63' ' ' LYS . 72.3 m -164.95 56.17 0.13 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.518 HG13 ' CG2' ' A' ' 64' ' ' ILE . 7.8 tt -76.6 171.44 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.63 -0.669 . . . . 0.0 110.924 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 44.2 p -135.39 -138.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.827 . . . . 0.0 109.91 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 66' ' ' THR . 53.0 m -65.02 90.28 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.996 -1.065 . . . . 0.0 110.4 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 35' ' ' THR . 44.6 m -145.94 145.9 30.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.858 -1.151 . . . . 0.0 110.558 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -99.8 117.97 35.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.952 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -136.88 124.18 21.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.845 . . . . 0.0 110.124 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -109.1 100.33 9.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.915 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.7 83.72 0.48 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 5.8 p -159.01 116.46 2.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -1.108 . . . . 0.0 110.428 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -75.36 109.87 9.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 109.729 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.521 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 11.1 mm -87.9 3.02 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.071 -1.018 . . . . 0.0 111.171 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 74.8 m -42.03 163.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.218 -0.926 . . . . 0.0 110.403 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 145.92 150.45 5.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.35 59.33 1.91 Allowed 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.902 1.475 . . . . 0.0 109.523 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . 112.53 28.64 3.42 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.438 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 2.0 t -52.6 128.8 27.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.345 -1.091 . . . . 0.0 110.337 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.524 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 2.0 mmtm -120.97 149.77 42.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.095 -1.003 . . . . 0.0 110.968 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.518 ' CG2' HG13 ' A' ' 47' ' ' ILE . 12.6 mm -149.27 135.06 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.48 -0.762 . . . . 0.0 109.334 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.461 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -140.27 116.73 10.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.996 -1.065 . . . . 0.0 110.778 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.7 OUTLIER 45.89 70.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.613 -0.679 . . . . 0.0 111.644 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 52.9 t -133.72 125.88 29.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.612 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 2.3 mp -88.01 81.08 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.237 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.4 mt -88.9 160.43 2.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.706 -0.621 . . . . 0.0 109.742 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.516 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 55.4 m -161.0 96.61 1.11 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.104 -0.998 . . . . 0.0 110.619 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 91.47 30.07 11.29 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.569 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 81.22 14.76 78.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 70' ' ' THR . 11.6 m -123.63 127.36 25.53 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.489 -1.006 . . . . 0.0 110.098 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -80.01 143.02 15.9 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.706 1.372 . . . . 0.0 110.075 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -87.5 149.96 47.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.139 -0.975 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.13 57.73 1.21 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.152 1.606 . . . . 0.0 110.498 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.06 150.74 20.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.758 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.67 -7.1 50.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.522 ' CB ' HG23 ' A' ' 66' ' ' THR . . . -107.55 -16.46 14.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 111.241 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 15.0 t -68.16 129.56 40.29 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.813 -1.179 . . . . 0.0 109.573 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -106.12 171.78 7.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.916 -1.115 . . . . 0.0 110.305 -179.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.537 ' HA ' ' HE3' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -166.64 91.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.524 -0.735 . . . . 0.0 109.027 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.48 -59.18 1.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.056 -1.027 . . . . 0.0 110.555 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.28 52.22 0.64 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 1.7 t -124.55 -150.04 0.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 110.032 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.517 ' CB ' ' O ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER 165.05 143.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.497 -0.752 . . . . 0.0 110.54 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 1.8 m-30 -107.1 -65.0 1.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.537 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER 71.4 8.34 6.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.432 -0.792 . . . . 0.0 110.45 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.408 ' O ' ' OXT' ' A' ' 90' ' ' ASN . . . 54.21 85.73 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.99 . . . . 0.0 109.635 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.446 ' C ' ' OD1' ' A' ' 90' ' ' ASN . 4.5 p30 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.358 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.57 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.532 0.682 . . . . 0.0 110.844 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.546 HD12 ' CB ' ' A' ' 15' ' ' SER . 18.9 tp -176.0 90.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.498 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 31.0 t -36.53 137.05 0.31 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.636 -0.665 . . . . 0.0 110.54 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.6 -17.33 2.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 110.567 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -90.88 -7.16 52.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 110.324 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.546 ' CB ' HD12 ' A' ' 11' ' ' LEU . 39.7 t -74.66 -158.76 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.027 . . . . 0.0 109.732 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.407 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 5.5 tttp -148.57 125.92 11.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 109.576 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.538 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 9.8 t -109.89 120.74 43.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.714 -179.199 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 19' ' ' LYS . 8.3 tt0 -167.79 114.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.432 -0.792 . . . . 0.0 110.064 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' GLU . 11.7 mttt 41.73 -123.33 0.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.0 110.309 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.4 OUTLIER 60.4 160.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.889 -1.132 . . . . 0.0 110.071 -179.916 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.38 23.63 9.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.078 -1.014 . . . . 0.0 109.497 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 37' ' ' CYS . 2.3 tp -51.53 152.26 2.77 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.49 -0.756 . . . . 0.0 110.496 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 37' ' ' CYS . 41.6 m -164.83 134.58 3.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.409 -0.807 . . . . 0.0 109.829 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.422 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 3.5 m120 50.45 63.52 2.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.032 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -132.55 165.1 25.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.327 -179.9 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.57 ' CD2' ' HB2' ' A' ' 10' ' ' GLN . 44.7 m-85 -121.5 -40.15 2.59 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 30' ' ' SER . 3.6 t 55.21 141.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 122.11 0.957 . . . . 0.0 111.637 178.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -144.87 113.01 6.47 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.551 -0.718 . . . . 0.0 109.347 179.384 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.548 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 54.81 57.53 5.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 109.354 -179.044 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.502 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 6.0 m -134.82 -157.49 0.81 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.758 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.461 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 0.8 OUTLIER -152.34 -62.55 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.567 -0.708 . . . . 0.0 109.968 179.876 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 13.0 t 61.91 162.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.435 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.463 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 11.7 m-85 -155.66 -46.91 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.3 -0.875 . . . . 0.0 110.455 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -134.73 21.6 3.75 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.533 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 6.5 m -74.76 146.52 42.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.134 . . . . 0.0 110.944 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.0 m -106.68 70.31 0.81 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.452 -0.78 . . . . 0.0 109.37 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 13.9 t -60.7 113.6 2.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.519 -0.738 . . . . 0.0 111.273 -179.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.53 ' O ' ' CG2' ' A' ' 38' ' ' THR . 14.3 m -106.03 60.22 0.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 178.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 91.04 71.69 1.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.481 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 70.4 m -154.34 171.58 19.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -1.125 . . . . 0.0 110.315 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -141.12 154.82 46.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.912 . . . . 0.0 110.434 179.77 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 28' ' ' ASP . 8.5 m-85 -118.36 -174.0 2.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 0.0 110.533 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.469 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -173.18 81.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 109.971 179.816 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 84.66 54.23 3.0 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' A' ' 62' ' ' CYS . 0.8 OUTLIER -128.95 -172.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.752 -1.44 . . . . 0.0 110.939 -179.53 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 62' ' ' CYS . 9.3 m -160.4 56.63 0.34 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.461 HG21 ' HA ' ' A' ' 32' ' ' VAL . 11.5 tt -80.99 168.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.454 -0.779 . . . . 0.0 110.573 -179.253 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 43.2 p -136.16 -150.26 0.36 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.395 -0.816 . . . . 0.0 108.834 179.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.7 m -46.75 108.23 0.13 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.878 -1.139 . . . . 0.0 109.185 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 35' ' ' THR . 70.9 m -164.13 140.64 6.51 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 110.131 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -101.05 123.3 45.02 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 109.758 179.608 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -136.11 129.8 32.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 110.234 -179.804 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.57 100.16 9.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 66.88 80.19 0.19 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.22 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.4 p -151.32 113.74 4.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -1.02 . . . . 0.0 110.312 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -73.24 111.36 8.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.165 -0.96 . . . . 0.0 110.134 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.472 ' O ' HG12 ' A' ' 45' ' ' VAL . 11.6 mm -88.41 7.18 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 43' ' ' ASP . 43.3 m -44.83 141.16 2.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.0 110.486 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 171.41 164.24 26.74 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.989 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.53 56.62 6.04 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.06 1.558 . . . . 0.0 109.796 179.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 110.91 19.93 7.47 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.587 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -37.24 113.7 0.27 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.421 -1.047 . . . . 0.0 110.884 179.96 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.499 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 10.1 tttm -107.19 122.21 46.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.984 -1.072 . . . . 0.0 109.809 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.517 ' CD1' ' SG ' ' A' ' 85' ' ' CYS . 5.3 mp -131.54 148.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.111 -0.993 . . . . 0.0 111.223 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.47 ' OG ' ' HB3' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -148.08 120.73 8.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 110.724 179.395 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.7 OUTLIER 48.06 57.35 6.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.402 -0.811 . . . . 0.0 111.277 179.615 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.3 m -115.88 106.6 14.0 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.022 -1.049 . . . . 0.0 109.976 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.589 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.4 mp -76.73 95.77 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.955 . . . . 0.0 109.316 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.0 mt -103.87 158.99 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 110.595 -179.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.407 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 29.8 m -159.22 98.33 1.43 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.33 -0.856 . . . . 0.0 109.589 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.03 23.5 22.48 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.526 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 83.39 15.9 70.31 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 69' ' ' ILE . 11.4 m -120.34 124.41 27.73 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.522 -0.987 . . . . 0.0 110.124 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.48 147.48 28.66 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.916 1.482 . . . . 0.0 111.191 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -92.5 144.95 29.6 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.447 -0.783 . . . . 0.0 108.896 178.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.44 60.35 2.64 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 O-C-N 123.814 1.428 . . . . 0.0 110.393 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -81.91 161.63 23.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 109.909 179.697 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.39 -18.16 57.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.131 -0.981 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 66' ' ' THR . . . -109.31 -25.66 10.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.969 -1.082 . . . . 0.0 110.62 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 19.5 t -47.49 128.42 12.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.106 -0.996 . . . . 0.0 109.958 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.552 ' O ' ' CD1' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -90.59 161.94 15.21 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.984 -1.073 . . . . 0.0 110.259 -179.731 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.552 ' CD1' ' O ' ' A' ' 81' ' ' LYS . 18.4 mm -143.79 67.99 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -146.1 107.85 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 112.417 -177.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . 65.22 73.02 0.63 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.334 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.517 ' SG ' ' CD1' ' A' ' 64' ' ' ILE . 4.6 t -175.39 -174.91 0.76 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -1.227 . . . . 0.0 110.075 178.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.419 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -179.44 152.15 0.51 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.016 -1.053 . . . . 0.0 110.484 -179.066 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.526 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.9 m-30 -109.0 -63.54 1.34 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.438 -0.788 . . . . 0.0 109.422 179.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER 71.14 4.13 4.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.535 -0.728 . . . . 0.0 110.699 179.74 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 57.15 96.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.072 -1.017 . . . . 0.0 109.992 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.136 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.461 ' O ' HD23 ' A' ' 11' ' ' LEU . 1.8 tt0 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.468 0.651 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.616 ' CD1' ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -173.39 117.36 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.582 -0.699 . . . . 0.0 109.396 -179.936 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 27' ' ' VAL . 45.3 p -35.14 144.74 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.642 -0.661 . . . . 0.0 110.801 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.16 -25.1 30.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 110.588 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -106.22 3.83 28.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 110.375 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.616 ' CB ' ' CD1' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -55.56 -173.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 110.582 -179.827 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -150.36 119.81 6.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 179.902 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 31.7 p -116.24 72.02 0.8 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.015 -1.053 . . . . 0.0 110.491 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.89 136.37 35.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.145 -0.972 . . . . 0.0 110.15 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 mttt 54.35 36.75 26.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 109.868 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.479 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 6.8 m -143.89 162.91 34.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.557 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -113.8 106.17 14.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.408 -0.807 . . . . 0.0 109.612 179.557 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.6 mm? -92.87 156.99 16.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 110.6 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 11.2 m -166.25 121.24 1.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.421 -0.8 . . . . 0.0 109.772 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' THR . 3.6 m-20 42.98 66.17 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.173 -0.955 . . . . 0.0 110.023 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.5 m -137.1 166.24 24.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.189 -0.944 . . . . 0.0 110.671 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 7.9 m-85 -130.09 -47.27 1.11 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.244 179.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.559 ' CG2' HD11 ' A' ' 11' ' ' LEU . 2.8 t 57.46 123.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.539 0.685 . . . . 0.0 110.668 179.025 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.464 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 1.9 m-20 -115.13 -14.97 11.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.284 -0.885 . . . . 0.0 110.362 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.482 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -175.65 66.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.898 . . . . 0.0 110.064 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.523 ' CB ' HG21 ' A' ' 45' ' ' VAL . 68.0 m -138.81 -170.47 2.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.183 -0.948 . . . . 0.0 110.24 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 32' ' ' VAL . 3.3 tt0 -127.88 -63.4 1.02 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.708 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.544 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 2.4 t 68.0 135.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.438 -0.789 . . . . 0.0 110.093 179.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.456 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 10.4 m-85 -147.52 46.61 1.12 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 110.505 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 142.95 -10.39 2.31 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.544 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 45.3 m -61.27 151.38 31.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.237 . . . . 0.0 110.609 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 21' ' ' THR . 51.5 m -88.37 -14.03 39.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.749 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER 47.42 70.92 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 179.696 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 99.6 m -87.71 100.77 13.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.133 -0.979 . . . . 0.0 110.15 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 90' ' ' ASN . . . 45.0 67.19 1.24 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.47 ' O ' ' NE ' ' A' ' 41' ' ' ARG . 32.3 t -153.01 173.18 15.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -1.093 . . . . 0.0 110.281 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.489 ' HB2' ' ND2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -149.79 159.68 44.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.393 -0.817 . . . . 0.0 110.044 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.488 ' CB ' ' OG ' ' A' ' 30' ' ' SER . 5.5 m-85 -125.28 -177.91 4.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.986 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -170.25 48.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.892 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 123.48 56.62 0.19 Allowed Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.523 HG21 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.27 -163.34 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.829 -1.395 . . . . 0.0 110.884 -179.775 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 45' ' ' VAL . 13.8 m -166.06 55.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.529 HD12 ' CB ' ' A' ' 50' ' ' SER . 21.4 tt -83.52 170.39 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.419 -0.801 . . . . 0.0 110.786 -179.239 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.476 ' O ' ' OG1' ' A' ' 35' ' ' THR . 62.6 p -128.63 -140.23 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.456 -0.777 . . . . 0.0 109.598 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' THR . 6.4 m -60.17 83.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.959 . . . . 0.0 110.092 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.529 ' CB ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -117.13 140.12 49.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.099 -1.001 . . . . 0.0 110.447 -179.753 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 26.6 m -91.18 19.37 5.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.213 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 68' ' ' ILE . 13.0 p -44.34 125.69 4.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 110.521 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 70' ' ' THR . 32.2 m -104.85 97.17 7.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.695 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 62.62 90.19 0.03 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 52' ' ' SER . 7.1 p -157.33 122.95 4.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.541 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.501 ' HG3' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -75.4 101.51 4.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.074 179.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.514 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 4.0 mt -90.13 16.25 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.62 156.83 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.259 -0.9 . . . . 0.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.68 147.83 5.44 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.67 63.24 7.34 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.978 1.515 . . . . 0.0 110.009 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 113.98 17.4 7.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.52 ' CB ' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -40.28 159.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.543 -0.975 . . . . 0.0 110.946 -179.702 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 12.4 tttt -158.85 117.07 2.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.504 -0.747 . . . . 0.0 109.648 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.527 ' HA ' ' CD ' ' A' ' 81' ' ' LYS . 3.0 mp -135.14 161.56 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.551 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.76 121.35 7.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 110.321 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 49' ' ' THR . 3.5 m 46.45 69.85 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.395 -0.816 . . . . 0.0 110.738 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.569 ' HB3' ' CD1' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -123.48 104.39 9.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.467 -0.771 . . . . 0.0 109.541 179.164 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.7 mp -48.5 -64.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.739 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.612 ' CD1' ' CE2' ' A' ' 87' ' ' PHE . 20.4 mt 55.04 164.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 110.308 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.503 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 55.7 m -145.23 -106.33 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.905 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.96 76.08 2.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' PHE . . . 63.28 12.32 44.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 70' ' ' THR . 13.9 m -116.34 136.33 23.04 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.383 -1.069 . . . . 0.0 110.254 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -78.12 138.24 16.05 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.897 1.472 . . . . 0.0 110.088 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -84.53 159.28 58.85 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.408 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.41 53.21 4.62 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 124.04 1.547 . . . . 0.0 110.555 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 t -89.96 158.17 17.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.608 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.2 -14.15 50.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.267 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.06 -22.45 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.336 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.482 ' CB ' ' HA ' ' A' ' 67' ' ' CYS . 34.7 t -63.79 123.14 18.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 110.054 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 82' ' ' ILE . 0.4 OUTLIER -93.15 -169.95 2.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.927 . . . . 0.0 110.481 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.565 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 3.2 tp -179.94 40.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.803 0.811 . . . . 0.0 109.501 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 m -72.78 -96.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 111.64 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.84 66.31 0.95 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.111 -1.043 . . . . 0.0 110.637 -178.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.8 t -160.3 -175.31 4.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.254 . . . . 0.0 110.022 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.547 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.5 t -177.23 159.29 1.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.98 . . . . 0.0 110.423 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.612 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 1.8 m-85 -118.87 156.68 29.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.787 . . . . 0.0 109.7 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.41 20.35 2.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.243 -0.91 . . . . 0.0 110.38 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 56.6 83.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.235 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.501 ' CB ' ' HG3' ' A' ' 56' ' ' ARG . 43.4 t30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.095 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.533 ' HB3' ' CB ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.472 0.654 . . . . 0.0 109.736 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.531 HD11 ' CB ' ' A' ' 15' ' ' SER . 13.6 tp -49.51 95.91 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -41.25 146.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 109.899 -179.808 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 14' ' ' ASN . . . -64.48 67.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.09 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 12' ' ' SER . 0.5 OUTLIER 179.9 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.541 -0.725 . . . . 0.0 109.782 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.531 ' CB ' HD11 ' A' ' 11' ' ' LEU . 13.5 t -50.62 -176.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.34 -0.85 . . . . 0.0 110.249 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.16 160.66 41.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.206 -0.934 . . . . 0.0 110.4 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 t -178.55 148.17 0.43 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.162 -0.962 . . . . 0.0 110.24 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.93 -29.42 1.02 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 0.0 110.753 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -170.19 43.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.969 -1.082 . . . . 0.0 110.59 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -93.18 179.01 5.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.252 179.915 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.4 82.64 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 109.807 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 35' ' ' THR . 46.1 mt -94.22 -177.96 4.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -0.89 . . . . 0.0 110.605 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 1.8 m -161.74 118.58 2.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.499 -0.751 . . . . 0.0 109.357 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.468 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 43.8 m-20 58.58 75.73 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.419 -0.8 . . . . 0.0 110.261 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 40' ' ' SER . 0.5 OUTLIER -145.5 -157.26 0.78 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.071 -1.018 . . . . 0.0 110.206 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -160.29 -39.56 0.05 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.496 ' O ' ' CE1' ' A' ' 26' ' ' TYR . 9.3 t 53.25 160.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.011 0.91 . . . . 0.0 111.649 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.577 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.2 t70 -171.37 127.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 66.2 mttt 46.48 43.11 11.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -0.984 . . . . 0.0 109.587 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.492 ' CB ' HG22 ' A' ' 45' ' ' VAL . 58.6 m -129.97 157.69 41.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' O ' ' O ' ' A' ' 47' ' ' ILE . 1.1 mt-10 -121.17 98.07 5.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.283 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.475 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 40.6 t -99.93 159.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.413 -0.804 . . . . 0.0 110.53 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 20' ' ' SER . 39.3 m-85 -139.02 -45.85 0.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 110.808 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.423 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -146.0 28.51 1.71 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.475 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 2.3 m -73.47 154.29 40.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.233 -1.157 . . . . 0.0 110.338 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.1 m -114.78 80.73 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -0.831 . . . . 0.0 109.815 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -63.31 151.77 39.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -0.89 . . . . 0.0 110.533 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.8 m -138.22 41.17 2.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.315 -0.866 . . . . 0.0 109.982 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 104.64 33.49 3.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.462 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 14.4 m -122.41 -152.46 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -1.151 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.452 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -178.18 168.04 1.95 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.078 -1.014 . . . . 0.0 110.53 179.889 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.452 ' CD1' ' C ' ' A' ' 41' ' ' ARG . 8.3 m-85 -122.49 -169.98 2.0 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -0.891 . . . . 0.0 110.559 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -175.21 48.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.106 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 119.62 61.49 0.26 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.492 HG22 ' CB ' ' A' ' 30' ' ' SER . 2.4 m -137.34 -158.84 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.988 -1.301 . . . . 0.0 111.279 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 62' ' ' CYS . 94.5 m -167.09 58.79 0.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.5 ' O ' ' O ' ' A' ' 31' ' ' GLU . 14.3 tt -85.81 169.41 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 111.234 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 78.0 p -142.24 -148.9 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 109.175 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 59.8 m -46.05 111.97 0.42 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.17 -0.957 . . . . 0.0 108.699 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' THR . 4.3 t -173.36 158.46 3.54 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.125 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -116.98 131.6 56.91 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.044 -1.035 . . . . 0.0 109.783 179.57 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB3' ' HB ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.8 125.65 13.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 109.961 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.7 m -105.48 123.42 47.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.967 . . . . 0.0 109.94 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 45.0 83.33 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 78.7 p -158.15 128.98 6.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.231 -1.158 . . . . 0.0 110.432 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 6.6 ttp180 -94.18 107.55 19.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 110.12 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.473 ' CG2' HD13 ' A' ' 64' ' ' ILE . 2.5 mp -84.52 12.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.94 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 57' ' ' ILE . 1.1 m -42.54 139.78 1.44 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 110.3 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 172.72 175.53 40.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.63 63.24 6.5 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.078 1.568 . . . . 0.0 110.128 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 94.99 2.5 62.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.561 ' C ' ' O ' ' A' ' 61' ' ' GLY . 2.4 t -11.37 121.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -105.98 144.13 33.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.223 -0.923 . . . . 0.0 109.817 179.356 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 63' ' ' LYS . 5.4 mt -152.96 127.18 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.977 . . . . 0.0 110.029 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.449 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -130.99 117.2 18.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 -179.84 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 49' ' ' THR . 3.1 m 54.05 86.15 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -145.7 117.02 7.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.277 -0.89 . . . . 0.0 109.66 179.369 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 3.4 mp -86.15 74.14 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.844 -1.16 . . . . 0.0 108.551 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 51' ' ' THR . 13.7 mt -80.91 160.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.962 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.528 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 97.1 m -158.71 98.85 1.53 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.004 . . . . 0.0 110.985 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 89.24 30.25 14.7 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.454 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.37 14.28 76.79 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 70' ' ' THR . 11.4 m -124.32 135.95 27.09 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.468 -1.019 . . . . 0.0 110.412 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.404 ' HB2' HD13 ' A' ' 82' ' ' ILE . 49.6 Cg_endo -85.58 119.88 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.89 1.468 . . . . 0.0 110.466 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -77.47 167.09 39.22 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.273 -0.892 . . . . 0.0 109.788 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 42.2 Cg_endo -68.87 84.55 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.688 1.362 . . . . 0.0 109.409 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.471 ' OG ' HD13 ' A' ' 68' ' ' ILE . 66.9 m -85.92 -6.35 59.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.631 -0.668 . . . . 0.0 111.155 -178.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 43.8 25.65 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 109.545 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -158.59 -40.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.523 -0.736 . . . . 0.0 109.301 -179.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 66' ' ' THR . 29.1 t -46.95 169.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.555 -0.716 . . . . 0.0 109.738 179.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.542 ' HE3' ' CA ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -108.99 -32.23 7.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.936 -1.103 . . . . 0.0 112.156 -178.108 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.542 ' CA ' ' HE3' ' A' ' 81' ' ' LYS . 4.1 mt 34.15 79.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.403 -0.81 . . . . 0.0 110.322 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.5 m -122.74 -98.14 0.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.92 -1.113 . . . . 0.0 111.088 -179.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.58 21.25 33.61 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -97.33 -163.54 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.253 . . . . 0.0 110.766 -179.726 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.539 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.9 OUTLIER 175.62 148.85 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.55 -0.719 . . . . 0.0 109.941 179.815 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -120.38 173.42 7.15 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.421 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.78 24.35 0.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.012 -1.055 . . . . 0.0 110.228 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 46.87 61.77 2.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.911 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.155 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.513 0.673 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.593 ' CD1' ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -165.23 69.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.726 . . . . 0.0 109.675 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.527 ' HB3' ' CA ' ' A' ' 28' ' ' ASP . 3.4 p 42.36 23.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.801 . . . . 0.0 110.896 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 41.66 23.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.985 -1.072 . . . . 0.0 110.641 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 28.6 p30 174.4 30.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.494 -0.754 . . . . 0.0 109.682 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.593 ' CB ' ' CD1' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -69.8 -168.66 0.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 0.0 109.844 -179.674 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.524 ' CE ' ' HG3' ' A' ' 31' ' ' GLU . 1.3 mptp? -119.38 107.38 13.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 110.09 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -91.07 -140.23 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.528 -179.632 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 67.35 107.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.881 . . . . 0.0 109.867 -179.503 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 5.2 tttt 66.21 54.85 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 12.6 m -119.63 155.78 31.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 110.964 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 36' ' ' THR . 17.7 m -150.62 82.18 1.35 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.494 -0.754 . . . . 0.0 109.566 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -124.76 -163.54 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 0.0 110.775 -179.122 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 10.1 m -165.85 113.53 0.93 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.412 -0.805 . . . . 0.0 109.812 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' THR . 1.0 OUTLIER 59.05 127.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.432 -0.793 . . . . 0.0 110.047 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER 172.9 -169.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 110.12 179.98 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' O ' ' O ' ' A' ' 27' ' ' VAL . 10.5 t80 -142.35 -46.63 0.34 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 108.679 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' SER . 3.5 t 57.14 133.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.673 0.749 . . . . 0.0 111.166 179.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.527 ' CA ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -137.66 124.33 21.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.226 179.336 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.2 mtmp? 42.21 55.37 3.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.503 ' CB ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -134.98 163.5 29.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.985 -1.072 . . . . 0.0 110.835 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' HG3' ' CE ' ' A' ' 16' ' ' LYS . 3.8 tt0 -96.74 -71.02 0.69 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.417 -0.802 . . . . 0.0 109.846 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.577 HG22 ' CE2' ' A' ' 42' ' ' PHE . 13.6 t 59.9 138.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.838 . . . . 0.0 110.614 179.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 20' ' ' SER . 60.5 m-85 -140.33 -81.21 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 109.551 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.42 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -94.41 29.65 8.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.503 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -73.65 161.85 29.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -1.028 . . . . 0.0 110.373 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 36' ' ' THR . 63.7 m -116.39 57.32 0.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.795 . . . . 0.0 109.733 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -40.84 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 110.336 -179.839 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 36' ' ' THR . 85.8 m -89.66 48.91 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 110.261 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.47 24.94 37.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 86.4 p -99.44 -154.39 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -1.057 . . . . 0.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.444 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -167.7 156.29 9.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.099 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.577 ' CE2' HG22 ' A' ' 32' ' ' VAL . 10.0 m-85 -119.88 176.63 5.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.219 -0.926 . . . . 0.0 110.582 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' HB2' ' CB ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -157.49 61.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.5 -0.75 . . . . 0.0 109.814 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 96.92 67.37 0.94 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.4 m -135.92 -160.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.972 -1.311 . . . . 0.0 111.274 -179.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.479 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . 69.8 m -166.17 54.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.391 0.615 . . . . 0.0 109.403 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.443 HG23 HG21 ' A' ' 32' ' ' VAL . 11.9 tt -80.46 172.17 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 110.551 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 14.8 p -140.1 -113.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 66' ' ' THR . 55.3 m -83.55 71.66 10.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.917 -1.114 . . . . 0.0 109.632 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 66' ' ' THR . 4.8 m -128.67 141.76 51.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 110.649 -179.451 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -89.46 133.64 34.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.692 179.593 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.42 121.08 12.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 110.33 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.3 93.73 5.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 109.789 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 62.21 92.69 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 87.5 p -161.21 122.09 2.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -1.099 . . . . 0.0 110.418 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.513 ' HB2' ' CB ' ' A' ' 90' ' ' ASN . 10.3 ttp180 -77.6 103.59 7.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.318 -0.864 . . . . 0.0 109.657 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 32.4 mm -78.63 9.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 110.763 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.451 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 53.1 p -40.84 150.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.143 -0.973 . . . . 0.0 110.602 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 168.09 140.75 3.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.66 57.93 3.12 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.089 1.573 . . . . 0.0 109.762 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.4 20.61 3.23 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -42.83 148.92 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -1.113 . . . . 0.0 110.589 -179.865 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -152.27 112.73 4.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.522 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 1.9 mp -128.81 157.53 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.161 -0.962 . . . . 0.0 110.868 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.462 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -156.87 106.88 2.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.376 -0.828 . . . . 0.0 109.909 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.2 m 63.33 82.18 0.19 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.255 -0.903 . . . . 0.0 110.325 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.487 ' N ' ' OG ' ' A' ' 50' ' ' SER . 16.1 m -146.52 109.09 4.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.441 -0.787 . . . . 0.0 109.662 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.577 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.8 mp -73.44 90.21 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.046 -1.033 . . . . 0.0 109.624 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 70' ' ' THR . 10.0 mt -98.25 156.88 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.397 -0.814 . . . . 0.0 110.292 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 5.2 m -155.01 100.79 2.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.193 -0.942 . . . . 0.0 110.45 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.43 35.07 8.88 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 76.61 15.93 81.16 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 70' ' ' THR . 7.9 m -126.01 132.97 24.49 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.314 -1.109 . . . . 0.0 110.838 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.64 153.46 20.26 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.917 1.483 . . . . 0.0 110.601 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -96.25 162.62 23.06 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.907 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.27 75.77 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.062 1.559 . . . . 0.0 110.569 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.57 140.03 45.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.15 -27.92 53.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.31 -2.92 57.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 0.0 110.278 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 66' ' ' THR . 2.5 t -90.03 146.94 23.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 110.061 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -103.02 -164.12 1.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.351 -0.843 . . . . 0.0 111.282 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.56 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 2.3 tp 175.99 34.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.1 m -70.32 -100.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.471 -0.768 . . . . 0.0 111.569 -179.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -99.8 78.96 0.48 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.702 -178.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 86' ' ' THR . 3.8 t -158.43 -174.02 4.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.172 -1.193 . . . . 0.0 109.221 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.571 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 8.0 t -179.7 158.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 0.0 111.153 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -128.35 161.53 29.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.586 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 5.8 t -145.05 12.24 1.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.953 -1.092 . . . . 0.0 110.015 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.527 ' O ' ' OXT' ' A' ' 90' ' ' ASN . . . 68.21 5.11 4.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.213 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.546 ' OXT' ' CG ' ' A' ' 90' ' ' ASN . 1.6 p30 . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 117.375 -1.298 . . . . 0.0 112.152 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.56 ' NE2' ' CE2' ' A' ' 26' ' ' TYR . 1.3 mt-30 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.05 0.452 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.521 HD13 ' CB ' ' A' ' 15' ' ' SER . 6.8 tp 48.02 82.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 108.995 -178.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 79.7 p -39.46 137.8 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.7 -0.625 . . . . 0.0 110.683 -179.208 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.02 -20.68 2.56 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 109.248 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.492 ' ND2' ' HG3' ' A' ' 29' ' ' LYS . 59.2 t-20 -77.39 -7.09 55.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.507 -0.746 . . . . 0.0 110.146 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.521 ' CB ' HD13 ' A' ' 11' ' ' LEU . 39.8 t -85.7 -163.01 0.79 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 109.915 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.19 133.32 21.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.056 -1.027 . . . . 0.0 110.172 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.487 ' HB3' HD22 ' A' ' 11' ' ' LEU . 25.7 p -132.31 132.92 43.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.164 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -160.48 -84.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 110.234 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.7 39.82 2.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 110.444 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.509 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 48.1 m -105.49 153.32 21.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 110.468 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.1 m -111.54 84.81 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.362 -0.836 . . . . 0.0 109.165 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.544 ' HB3' ' CB ' ' A' ' 37' ' ' CYS . 6.2 mt -101.03 175.58 5.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.139 -0.975 . . . . 0.0 111.102 -178.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 22.9 m -157.09 107.27 2.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.638 -0.664 . . . . 0.0 109.737 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 39' ' ' GLY . 3.7 m-20 56.99 100.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 110.427 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -157.92 -173.65 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.162 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.56 ' CE2' ' NE2' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -134.69 -48.43 0.75 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 179.021 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.537 ' CG1' ' HB2' ' A' ' 30' ' ' SER . 14.1 t 55.22 144.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 122.027 0.917 . . . . 0.0 111.532 178.235 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -152.19 121.96 6.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.53 -0.731 . . . . 0.0 109.716 179.271 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.492 ' HG3' ' ND2' ' A' ' 14' ' ' ASN . 0.1 OUTLIER 54.99 39.19 31.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.015 . . . . 0.0 109.97 -179.602 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.537 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 50.3 m -123.36 -163.08 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.257 -0.902 . . . . 0.0 110.52 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' VAL . 1.1 mt-10 -146.21 -72.0 0.24 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.352 -0.842 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 2.6 t 73.15 141.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.602 -0.686 . . . . 0.0 111.038 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.476 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 38.8 m-85 -145.75 35.89 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.453 -0.779 . . . . 0.0 110.154 179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 145.86 -7.7 1.47 Allowed Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.292 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.524 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -57.87 167.29 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.969 -1.312 . . . . 0.0 110.165 -179.857 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 38' ' ' THR . 9.2 t -108.45 62.14 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 0.0 110.309 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.544 ' CB ' ' HB3' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -47.02 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.2 179.899 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' THR . 2.3 m -100.96 101.43 12.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.153 -0.967 . . . . 0.0 109.724 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 44.21 52.33 7.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 3.8 m -128.16 179.89 5.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.072 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 41.5 mtt180 -149.53 147.85 28.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.873 . . . . 0.0 110.38 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 17.9 m-30 -116.74 175.84 5.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -0.839 . . . . 0.0 109.593 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.538 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 2.3 t0 -157.85 50.03 0.42 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.058 -1.027 . . . . 0.0 110.376 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 114.34 63.14 0.41 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -132.25 -166.86 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.028 -1.278 . . . . 0.0 110.625 -179.72 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 45' ' ' VAL . 51.4 m -166.16 56.47 0.1 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.533 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 17.5 tt -82.44 170.74 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.584 -0.697 . . . . 0.0 111.102 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 44.9 p -133.25 -127.06 0.17 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.661 -0.649 . . . . 0.0 109.615 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' THR . 20.5 m -76.43 74.49 3.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.998 -1.064 . . . . 0.0 109.935 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 35' ' ' THR . 7.7 m -128.88 142.92 50.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.043 -1.036 . . . . 0.0 110.372 -179.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -86.61 135.13 33.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.021 -1.049 . . . . 0.0 110.19 179.909 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -154.69 125.46 7.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 110.149 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -111.68 121.06 44.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.32 -0.863 . . . . 0.0 110.014 -179.843 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 44.97 85.32 0.01 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 74.9 p -153.42 123.74 7.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.999 . . . . 0.0 110.581 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -86.24 99.87 11.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.178 -0.951 . . . . 0.0 109.466 179.358 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.616 ' CD1' ' CE1' ' A' ' 42' ' ' PHE . 2.7 mp -82.93 18.49 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 110.533 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.538 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -41.17 155.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.386 -0.821 . . . . 0.0 110.031 179.488 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 157.54 151.7 6.11 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.72 53.63 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.088 1.573 . . . . 0.0 110.263 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 119.87 22.47 3.27 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.447 ' O ' HD13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -39.78 108.23 0.08 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.236 -1.155 . . . . 0.0 110.766 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.433 ' C ' HD13 ' A' ' 64' ' ' ILE . 17.2 tttp -101.56 122.43 43.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.034 . . . . 0.0 109.669 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.533 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 4.5 mp -128.4 139.83 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.083 -1.011 . . . . 0.0 110.447 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.482 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -143.25 112.43 6.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.015 -1.053 . . . . 0.0 111.065 -179.908 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 1.9 m 48.37 80.37 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.566 -0.709 . . . . 0.0 112.055 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 80' ' ' CYS . 40.0 t -139.2 136.99 35.61 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.604 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 2.0 mp -90.75 88.07 2.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.27 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.584 HG22 ' CD2' ' A' ' 87' ' ' PHE . 12.3 mt -96.6 158.71 3.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.787 -0.571 . . . . 0.0 110.223 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.546 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 3.2 m -166.21 106.49 0.68 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -0.91 . . . . 0.0 110.445 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.29 34.53 12.17 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 71.28 21.09 78.53 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 70' ' ' THR . 3.5 m -125.74 120.84 24.41 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.29 -1.124 . . . . 0.0 110.65 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.4 ' HA ' HG12 ' A' ' 69' ' ' ILE . 48.5 Cg_endo -77.83 141.06 18.91 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.721 1.379 . . . . 0.0 110.354 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -95.29 138.66 21.89 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.773 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.22 70.84 3.77 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.9 1.474 . . . . 0.0 110.219 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -97.66 166.55 11.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.35 -15.28 62.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.422 ' CB ' HG21 ' A' ' 66' ' ' THR . . . -112.36 -36.93 5.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.14 -0.975 . . . . 0.0 110.745 -179.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 66' ' ' THR . 15.5 t -44.64 127.11 5.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.099 -1.0 . . . . 0.0 110.777 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -94.71 -172.34 2.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 110.135 179.751 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.569 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 2.6 tp 179.09 39.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.492 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.0 m -104.82 87.27 2.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.052 -1.03 . . . . 0.0 111.766 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.11 52.75 2.67 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.459 178.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' A' ' 57' ' ' ILE . 10.0 t -165.46 170.46 14.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.263 -1.139 . . . . 0.0 109.927 179.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.541 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 9.2 t -176.38 159.53 1.99 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.96 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.584 ' CD2' HG22 ' A' ' 69' ' ' ILE . 1.7 m-85 -126.03 151.66 46.82 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.066 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.54 29.41 4.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.313 -0.867 . . . . 0.0 109.239 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 51.41 83.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.402 -0.811 . . . . 0.0 109.648 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.447 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.264 0.554 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.02 -162.27 21.91 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.44 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER 46.99 -158.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -1.126 . . . . 0.0 110.246 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.469 ' O ' ' OG1' ' A' ' 5' ' ' THR . 0.0 OUTLIER 65.22 142.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.892 . . . . 0.0 110.14 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.534 ' HA ' ' CB ' ' A' ' 9' ' ' SER . 84.1 m -167.62 84.26 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.452 -0.78 . . . . 0.0 109.357 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.483 ' O ' ' HB ' ' A' ' 7' ' ' THR . 24.7 p30 -62.35 72.48 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.58 -0.7 . . . . 0.0 110.059 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 5' ' ' THR . 4.5 m 70.53 2.59 4.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.575 -0.703 . . . . 0.0 110.359 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 9' ' ' SER . 2.2 t-20 175.02 -31.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.617 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.534 ' CB ' ' HA ' ' A' ' 5' ' ' THR . 0.2 OUTLIER 73.8 111.59 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.648 -0.658 . . . . 0.0 110.981 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 2.1 tt0 -139.61 33.14 2.03 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.485 -0.759 . . . . 0.0 109.531 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.53 ' CD1' ' HB ' ' A' ' 27' ' ' VAL . 2.8 mm? -48.13 113.81 0.81 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.459 -0.776 . . . . 0.0 109.897 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.489 ' C ' ' O ' ' A' ' 11' ' ' LEU . 57.1 p -32.93 -67.21 0.12 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.982 -0.449 . . . . 0.0 110.938 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . 179.93 -32.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.113 -0.992 . . . . 0.0 110.709 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -114.07 15.39 18.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 110.373 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.529 ' CB ' HD12 ' A' ' 11' ' ' LEU . 11.2 t -68.26 -171.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 1.3 tttp -143.96 142.32 30.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.976 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.67 126.83 8.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.04 -51.71 1.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.895 . . . . 0.0 110.404 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.02 55.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.379 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.4 p -101.17 -171.8 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 110.065 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -135.14 63.9 1.6 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.067 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 4.0 mt -78.89 -179.01 6.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 0.0 110.539 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 23.6 m -164.25 119.09 1.48 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 110.045 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.461 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 2.4 m120 57.97 45.75 17.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.882 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -155.54 0.55 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.301 -0.875 . . . . 0.0 110.784 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.498 ' HA ' ' HB3' ' A' ' 10' ' ' GLN . 4.1 t80 -167.51 -40.78 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.53 ' HB ' ' CD1' ' A' ' 11' ' ' LEU . 11.4 t 54.63 149.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.982 0.896 . . . . 0.0 111.773 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 4.9 t0 -156.4 122.3 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 11.1 mtpp 49.67 55.01 10.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.915 -1.116 . . . . 0.0 109.512 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.542 ' CB ' HG23 ' A' ' 45' ' ' VAL . 46.2 m -142.98 -175.63 4.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.111 -0.993 . . . . 0.0 110.436 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.521 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 5.6 mt-10 -128.2 -67.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.0 110.612 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.511 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 7.7 t 62.64 154.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.202 -0.936 . . . . 0.0 110.28 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 32' ' ' VAL . 22.6 m-85 -150.08 -43.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -138.0 25.37 2.92 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.511 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 10.6 m -71.75 151.47 43.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.32 -1.106 . . . . 0.0 110.51 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 36' ' ' THR . 52.1 m -109.13 55.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 109.917 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 17.5 t -40.31 140.76 0.58 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.465 -0.772 . . . . 0.0 110.348 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.6 m -123.69 13.3 9.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.921 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 128.46 51.84 0.13 Allowed Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.476 ' HB3' ' ND2' ' A' ' 90' ' ' ASN . 1.3 m -134.71 -169.22 2.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.355 -1.085 . . . . 0.0 110.205 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -147.38 170.71 16.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.277 -0.889 . . . . 0.0 110.183 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' A' ' 41' ' ' ARG . 19.8 m-85 -130.88 178.25 6.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.106 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -169.43 65.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 103.27 49.24 1.15 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.542 HG23 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -125.66 -176.5 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.729 -1.453 . . . . 0.0 110.962 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 62' ' ' CYS . 55.3 m -153.21 55.48 0.76 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.525 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 10.6 tt -82.25 174.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.382 -0.824 . . . . 0.0 110.898 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 50' ' ' SER . 45.1 p -146.24 -136.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -0.755 . . . . 0.0 109.31 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 66' ' ' THR . 99.9 m -58.33 82.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.054 -1.029 . . . . 0.0 110.046 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 48' ' ' THR . 29.3 t -142.36 145.61 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.996 -1.065 . . . . 0.0 110.926 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -98.41 128.16 44.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.142 -0.974 . . . . 0.0 110.231 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -141.16 130.35 23.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.194 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.01 105.3 15.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 109.889 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.46 ' HA2' ' OG ' ' A' ' 40' ' ' SER . . . 51.27 91.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 8.5 p -154.86 119.2 4.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.12 . . . . 0.0 110.53 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.526 ' CD ' ' HB2' ' A' ' 58' ' ' SER . 1.6 ttm180 -72.76 101.96 3.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.696 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 45' ' ' VAL . 7.9 mm -84.07 12.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.956 . . . . 0.0 110.28 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.526 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -42.68 153.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.402 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.53 147.63 4.95 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.56 55.27 4.7 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.911 1.48 . . . . 0.0 109.762 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 63' ' ' LYS . . . 123.6 21.51 2.43 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -46.97 123.31 5.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -1.156 . . . . 0.0 111.108 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.543 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -112.41 145.65 39.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.233 -0.917 . . . . 0.0 109.649 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 63' ' ' LYS . 11.3 mt -155.0 126.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.0 110.352 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -136.31 103.07 5.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.821 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.9 OUTLIER 68.17 80.12 0.21 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.526 -0.734 . . . . 0.0 110.382 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.7 t -138.96 120.38 14.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.611 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 2.6 mp -88.53 79.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 108.512 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 51' ' ' THR . 11.1 mt -89.42 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.243 0.544 . . . . 0.0 110.193 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.519 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 7.2 m -150.52 100.79 2.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.297 -0.877 . . . . 0.0 110.424 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.78 33.14 10.2 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.471 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 77.95 15.46 81.14 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 70' ' ' THR . 6.1 m -125.79 129.75 24.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.337 -1.096 . . . . 0.0 110.682 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 46.7 Cg_endo -75.96 144.59 27.37 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.831 1.437 . . . . 0.0 110.253 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -90.86 162.0 34.28 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.693 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.97 66.16 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.793 1.418 . . . . 0.0 110.121 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.07 125.78 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 110.345 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.79 -1.88 15.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 110.304 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.482 ' CB ' HG22 ' A' ' 66' ' ' THR . . . -94.2 -23.73 17.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.091 -1.006 . . . . 0.0 110.493 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 49.3 t -72.87 167.4 21.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.523 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -108.63 -41.31 4.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.014 -1.054 . . . . 0.0 111.765 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.537 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 34.0 mm 47.13 74.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.894 -1.128 . . . . 0.0 109.683 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.59 -80.98 0.6 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.069 -1.019 . . . . 0.0 110.939 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.23 37.99 3.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.5 t -132.04 178.64 6.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.053 -1.263 . . . . 0.0 109.872 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.555 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t -173.87 155.0 2.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.228 -0.92 . . . . 0.0 109.662 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.592 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -125.57 158.28 35.01 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.904 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.4 t -141.36 22.87 2.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.719 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.71 80.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.411 -0.806 . . . . 0.0 109.84 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.394 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.8 t0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.294 0.569 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.68 -90.39 1.16 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 m -115.33 -81.05 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.128 -1.219 . . . . 0.0 110.409 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 0.5 OUTLIER 59.32 174.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 110.022 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.522 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 44.0 m -161.87 17.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.533 ' ND2' ' HB2' ' A' ' 9' ' ' SER . 0.7 OUTLIER 32.16 59.11 0.36 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.441 0.639 . . . . 0.0 110.126 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER 72.88 -54.42 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.43 -0.794 . . . . 0.0 109.827 -178.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.8 OUTLIER 170.5 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.03 -1.044 . . . . 0.0 110.922 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.533 ' HB2' ' ND2' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -172.08 -86.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.042 -1.036 . . . . 0.0 110.565 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -173.08 103.51 0.13 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.628 -1.295 . . . . 0.0 111.327 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CD2' ' HB3' ' A' ' 4' ' ' CYS . 14.4 tp -102.14 96.25 6.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.101 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -36.34 134.6 0.42 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.53 0.681 . . . . 0.0 111.117 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.85 -21.27 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 110.54 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -96.65 -2.55 44.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.998 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.51 ' CB ' HD12 ' A' ' 11' ' ' LEU . 19.4 t -73.08 -169.15 0.57 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.842 -1.161 . . . . 0.0 110.073 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.75 130.99 14.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.152 -0.968 . . . . 0.0 110.981 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 18' ' ' GLU . 10.3 p -139.64 -179.28 5.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.897 . . . . 0.0 109.804 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 169.65 -80.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 109.74 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.34 13.27 9.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.845 . . . . 0.0 109.602 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.434 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -77.0 -147.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.765 . . . . 0.0 110.297 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 35' ' ' THR . 18.9 m -153.23 88.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 110.321 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 3.5 mm? -106.31 90.5 3.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.64 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 9.3 m -93.32 139.93 30.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.189 -0.944 . . . . 0.0 111.176 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.467 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 2.5 m-80 37.05 40.91 0.17 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.765 -0.584 . . . . 0.0 110.76 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -81.69 -152.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.19 -0.944 . . . . 0.0 110.676 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 56.5 t80 179.46 42.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.58 ' CG1' ' OG ' ' A' ' 30' ' ' SER . 6.6 t -53.46 149.95 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.857 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -130.95 -29.03 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.441 0.639 . . . . 0.0 109.746 179.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.52 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 2.4 mtmt -168.86 68.48 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.307 -0.871 . . . . 0.0 109.329 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.58 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 84.0 p -141.34 168.68 19.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.119 -0.988 . . . . 0.0 111.706 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 47' ' ' ILE . 5.6 mt-10 -124.03 113.32 18.26 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.562 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 9.3 t -112.57 149.07 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 111.094 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CD1' HG21 ' A' ' 48' ' ' THR . 58.6 m-85 -128.77 -25.95 2.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -0.875 . . . . 0.0 110.905 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -167.82 32.59 0.19 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.562 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 4.8 m -81.98 146.44 29.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -1.157 . . . . 0.0 110.328 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 m -100.91 85.62 2.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.421 -0.8 . . . . 0.0 109.37 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.475 ' O ' ' HB ' ' A' ' 23' ' ' THR . 44.9 t -73.79 101.2 3.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.523 -0.735 . . . . 0.0 110.927 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 t -89.08 28.38 1.21 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.3 -0.875 . . . . 0.0 110.101 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 113.49 62.73 0.43 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 9.8 t -139.87 -173.94 3.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.44 -1.035 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.555 ' CB ' ' HB3' ' A' ' 26' ' ' TYR . 13.4 ptt180 -153.46 154.63 34.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.902 -1.124 . . . . 0.0 110.757 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 6.0 m-85 -119.15 -168.99 1.66 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.438 -0.789 . . . . 0.0 109.016 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.505 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 3.5 t0 -179.91 61.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.607 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 106.27 57.61 0.63 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.559 HG23 ' HB2' ' A' ' 30' ' ' SER . 1.0 OUTLIER -138.59 -157.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.887 -1.361 . . . . 0.0 110.601 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 45' ' ' VAL . 65.8 m -167.75 57.28 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.693 -0.629 . . . . 0.0 109.925 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 31' ' ' GLU . 16.0 tt -75.13 162.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 110.155 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 50' ' ' SER . 31.8 p -131.96 -134.34 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.068 -1.02 . . . . 0.0 109.963 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' THR . 95.5 m -65.89 64.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.981 -1.074 . . . . 0.0 110.257 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 48' ' ' THR . 3.1 t -128.08 139.85 52.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 0.0 110.588 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.459 ' OG1' HG13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -90.05 146.71 24.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.859 . . . . 0.0 109.691 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.38 130.99 11.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.04 -1.038 . . . . 0.0 110.597 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -113.29 111.66 22.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.106 -0.997 . . . . 0.0 110.068 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.9 79.03 0.08 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 13.4 p -148.26 134.82 19.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -1.184 . . . . 0.0 110.111 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -89.99 108.54 19.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.453 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.547 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 17.4 mm -88.04 -1.46 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.178 -0.951 . . . . 0.0 109.998 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.505 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 1.1 m -42.56 150.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.36 -0.838 . . . . 0.0 110.864 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 164.16 153.56 7.44 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.94 -2.08 11.45 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.064 1.56 . . . . 0.0 109.903 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.76 34.08 0.08 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.42 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.3 t -65.82 130.26 42.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -1.117 . . . . 0.0 110.452 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 14.5 tttm -135.3 125.1 25.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 110.402 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.541 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 4.3 mt -126.64 146.54 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.99 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 66' ' ' THR . 30.6 p -142.04 126.15 17.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.926 . . . . 0.0 110.516 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' THR . 25.0 m 39.77 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.57 -0.706 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 2.8 t -152.92 108.08 3.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -0.876 . . . . 0.0 110.047 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.587 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.8 mp -72.3 87.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.488 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 3.9 mt -90.22 155.7 3.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.555 -0.716 . . . . 0.0 110.62 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 73' ' ' VAL . 18.7 m -156.31 102.65 2.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.334 -0.854 . . . . 0.0 110.553 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.6 26.76 24.16 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.564 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.77 16.31 70.76 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 69' ' ' ILE . 4.0 m -127.24 133.72 25.37 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.536 -0.979 . . . . 0.0 110.155 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.18 148.09 16.66 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.793 1.417 . . . . 0.0 110.666 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -93.77 149.28 36.8 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.563 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.02 114.74 4.06 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.937 1.493 . . . . 0.0 110.85 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 78' ' ' ALA . 1.3 t -134.14 -0.6 3.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 110.44 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 77' ' ' SER . . . 66.2 6.84 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.966 . . . . 0.0 110.409 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.28 -32.34 1.37 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.404 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -57.15 151.89 14.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.985 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.541 ' HD2' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -104.13 175.18 5.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.504 -0.747 . . . . 0.0 109.958 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 81' ' ' LYS . 46.1 mm -155.99 38.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.9 m -59.71 -104.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.73 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.92 89.52 0.48 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 1.6 t -147.18 -149.39 0.29 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.235 . . . . 0.0 110.311 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.51 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER 169.98 142.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.391 -0.818 . . . . 0.0 109.539 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.564 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.4 m-85 -116.99 -19.62 9.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.517 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.598 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER 45.72 -92.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 110.031 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.598 ' CB ' ' O ' ' A' ' 88' ' ' SER . . . 157.36 64.92 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.904 -0.498 . . . . 0.0 110.031 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.004 -1.06 . . . . 0.0 109.978 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 2' ' ' GLY . 22.5 m-20 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.288 0.566 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 1' ' ' ASP . . . 43.76 -163.25 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -137.3 121.25 17.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -1.096 . . . . 0.0 110.358 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.6 p -166.54 -109.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.362 -0.836 . . . . 0.0 110.015 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.516 ' CG2' ' HA ' ' A' ' 23' ' ' THR . 4.1 m -157.41 -3.9 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.718 -1.239 . . . . 0.0 110.938 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 9' ' ' SER . 0.4 OUTLIER -50.67 -22.75 2.2 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.501 -1.374 . . . . 0.0 107.524 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 6' ' ' ASN 0.251 1.4 m -41.77 -61.89 1.01 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -54.85 -29.49 55.37 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 6' ' ' ASN . 9.4 p -86.04 -125.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.596 -0.69 . . . . 0.0 109.827 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.52 ' N ' ' OG ' ' A' ' 9' ' ' SER . 1.6 tt0 -131.39 -71.73 0.56 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.661 -1.274 . . . . 0.0 110.877 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD22 ' ND2' ' A' ' 6' ' ' ASN . 17.3 tp 57.03 111.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.11 -0.994 . . . . 0.0 109.922 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 12.9 t -68.39 161.11 28.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.284 -0.885 . . . . 0.0 110.405 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.74 -8.01 31.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.968 . . . . 0.0 110.073 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -97.74 -11.47 23.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.461 ' OG ' HD12 ' A' ' 11' ' ' LEU . 41.5 t -76.27 -163.29 0.29 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.972 . . . . 0.0 110.046 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.25 134.84 15.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.554 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.1 t -135.7 32.67 3.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.934 . . . . 0.0 110.2 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 19' ' ' LYS . 1.4 tm-20 -55.61 127.21 28.78 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 43.01 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -159.52 -171.07 3.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.044 -1.035 . . . . 0.0 111.005 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 36' ' ' THR . 8.5 m -156.55 72.78 0.75 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.486 -0.759 . . . . 0.0 109.71 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.662 ' O ' ' CB ' ' A' ' 23' ' ' THR . 4.0 mt -75.44 -116.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 110.369 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.662 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 1.1 m 146.21 -62.59 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.424 ' C ' ' HB2' ' A' ' 9' ' ' SER . 73.7 m-20 -132.03 34.87 3.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.444 -0.785 . . . . 0.0 110.162 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -67.85 -159.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.02 0.914 . . . . 0.0 110.904 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 25' ' ' CYS . 46.9 m-85 -162.96 -54.74 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 30' ' ' SER . 3.3 t 44.59 -179.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 122.14 0.971 . . . . 0.0 111.727 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 0.9 OUTLIER -175.81 -33.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 46.8 mtmt -150.45 56.3 0.93 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.515 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 75.5 m -135.5 164.11 28.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.953 -1.092 . . . . 0.0 111.86 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 2.4 tt0 -120.64 107.62 13.02 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.556 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 17.9 t -110.29 160.1 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.052 -1.03 . . . . 0.0 111.379 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.556 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 94.9 m-85 -157.33 44.66 0.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.427 -0.796 . . . . 0.0 110.455 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' ' OG ' ' A' ' 20' ' ' SER . . . 138.72 33.08 0.19 Allowed Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.15 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.519 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 5.6 m -95.24 144.07 26.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.24 . . . . 0.0 110.257 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 38' ' ' THR . 32.0 m -94.61 53.35 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.36 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' HB2' ' CB ' ' A' ' 22' ' ' LEU . 1.2 m -50.4 87.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.425 -0.797 . . . . 0.0 110.888 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 36' ' ' THR . 5.2 t -104.78 36.07 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.21 46.6 0.18 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -141.24 167.17 22.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.314 -1.11 . . . . 0.0 109.856 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' CB ' ' HB2' ' A' ' 26' ' ' TYR . 5.3 ptt180 -146.12 152.11 38.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.961 -1.087 . . . . 0.0 110.803 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.628 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 6.8 m-85 -116.64 -167.63 1.32 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 7.1 t0 -177.46 53.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.414 -0.804 . . . . 0.0 110.165 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 114.88 60.2 0.37 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.502 HG21 ' CB ' ' A' ' 30' ' ' SER . 1.4 m -139.28 -169.98 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.997 -1.296 . . . . 0.0 110.297 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.428 ' N ' HG23 ' A' ' 45' ' ' VAL . 35.8 m -149.47 51.02 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.309 -0.869 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 7.9 tt -68.2 173.58 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 110.45 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 47' ' ' ILE . 12.0 p -142.73 -98.76 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 110.067 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 49' ' ' THR . 15.8 m -104.05 69.83 0.96 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.986 -1.071 . . . . 0.0 109.715 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 67' ' ' CYS . 10.6 m -121.13 147.19 45.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.116 -0.99 . . . . 0.0 111.161 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -99.66 121.57 41.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.436 -0.79 . . . . 0.0 109.168 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -139.85 136.54 34.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.345 -0.847 . . . . 0.0 110.406 -179.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -121.63 89.27 3.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.824 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 85.09 76.29 1.21 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 p -148.97 124.53 10.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -1.094 . . . . 0.0 110.551 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.416 ' HD2' ' HB2' ' A' ' 58' ' ' SER . 0.1 OUTLIER -90.35 96.66 10.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.242 -0.911 . . . . 0.0 109.896 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.628 ' CD1' ' CE1' ' A' ' 42' ' ' PHE . 3.1 mt -84.15 17.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.671 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.416 ' HB2' ' HD2' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -43.8 151.03 0.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.01 -1.057 . . . . 0.0 110.078 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 162.59 162.27 13.33 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.02 -1.35 11.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.134 1.597 . . . . 0.0 109.852 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.68 33.88 0.02 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.7 t -50.68 123.34 8.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.216 -1.167 . . . . 0.0 110.006 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 8.6 tttt -102.64 128.2 49.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.07 -1.019 . . . . 0.0 110.174 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 28.8 mm -133.81 141.3 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.907 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -151.62 126.38 9.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.298 -0.876 . . . . 0.0 110.101 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.5 m 39.02 71.59 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.573 0.702 . . . . 0.0 110.756 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 73.4 m -130.13 125.6 35.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.428 -0.795 . . . . 0.0 109.252 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.593 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.9 mp -93.47 88.48 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.836 -1.165 . . . . 0.0 110.131 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.541 HG12 ' CE2' ' A' ' 87' ' ' PHE . 14.3 mt -96.23 156.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.522 -0.736 . . . . 0.0 110.061 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 34.7 m -152.25 93.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 110.224 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.94 31.88 9.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 80.0 16.63 76.44 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 70' ' ' THR . 16.1 m -124.73 120.11 25.73 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.391 -1.064 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -73.72 145.81 37.4 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.949 1.5 . . . . 0.0 110.509 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -90.68 166.61 18.7 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.365 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.434 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.4 Cg_endo -72.03 56.3 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.723 1.38 . . . . 0.0 109.603 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.92 126.09 33.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.26 -9.13 59.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.837 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' A' ' 66' ' ' THR . . . -96.94 -12.61 23.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.353 -0.842 . . . . 0.0 110.526 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 65' ' ' SER . 38.2 t -77.44 168.84 19.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.107 -0.996 . . . . 0.0 109.619 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.523 ' HE3' ' N ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -98.64 -32.18 11.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.793 -1.192 . . . . 0.0 111.399 -178.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.523 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 28.3 mm 38.19 57.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.186 -0.946 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 m -113.37 -100.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.0 -1.062 . . . . 0.0 110.422 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -101.19 89.58 0.8 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -166.36 -172.72 2.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.147 -1.208 . . . . 0.0 110.759 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.512 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 2.6 t -178.02 157.51 1.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.484 -0.76 . . . . 0.0 109.52 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 2.2 m-30 -114.33 -54.68 2.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 110.076 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 65.07 11.08 6.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.087 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 47.14 95.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 109.963 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 89' ' ' ALA . 5.1 p30 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.305 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.241 0.543 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.85 -80.22 0.54 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 p -162.93 47.12 0.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -1.162 . . . . 0.0 110.135 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.516 ' O ' ' HB ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -50.86 -50.65 56.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 110.325 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 4' ' ' CYS . 4.3 m 73.17 0.24 3.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.578 ' ND2' ' HB2' ' A' ' 25' ' ' CYS . 7.1 t-20 45.34 33.33 1.22 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.506 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER 69.39 70.14 0.25 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.029 -1.044 . . . . 0.0 108.25 -178.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 7' ' ' THR . 1.3 m-80 67.45 93.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.63 -0.668 . . . . 0.0 109.727 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 25' ' ' CYS . 6.4 p -167.65 -139.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.19 -0.943 . . . . 0.0 110.4 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.476 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -126.17 -46.45 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 110.155 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.514 HD11 ' CB ' ' A' ' 15' ' ' SER . 12.3 tp 41.19 84.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.365 -0.834 . . . . 0.0 109.892 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.514 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 86.1 p -45.46 164.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 110.187 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 -14.03 60.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.846 . . . . 0.0 110.299 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -93.95 -6.62 45.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.164 -0.96 . . . . 0.0 110.5 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.514 ' CB ' HD11 ' A' ' 11' ' ' LEU . 4.8 t -74.08 -176.65 2.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.957 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.418 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -142.09 131.43 23.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.274 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 t -138.6 159.88 40.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.262 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -172.86 -87.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.014 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -114.55 72.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.134 -0.979 . . . . 0.0 110.1 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -117.92 -164.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.855 . . . . 0.0 110.216 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -150.15 60.42 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.556 ' CB ' ' ND2' ' A' ' 6' ' ' ASN . 13.7 mt -84.62 -171.59 3.71 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.873 0.844 . . . . 0.0 111.455 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 1.5 m -164.78 101.63 0.79 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.497 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 0.8 OUTLIER 59.18 118.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.415 -0.803 . . . . 0.0 109.766 -178.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.578 ' HB2' ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -171.0 -151.68 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.136 -0.978 . . . . 0.0 110.361 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.474 ' CD2' ' CB ' ' A' ' 10' ' ' GLN . 17.9 t80 -157.68 -42.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.837 0.827 . . . . 0.0 108.958 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' TYR . 6.9 t 39.22 101.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.305 0.574 . . . . 0.0 112.174 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.514 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 4.6 t0 -88.71 -130.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.5 mttp -62.36 81.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.783 -1.198 . . . . 0.0 109.072 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.525 ' CB ' HG21 ' A' ' 45' ' ' VAL . 16.9 m -148.87 159.54 44.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.91 -1.119 . . . . 0.0 111.301 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 47' ' ' ILE . 2.2 mt-10 -119.1 115.66 24.73 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.578 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 34.2 t -117.21 156.28 18.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.225 -0.922 . . . . 0.0 111.065 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.475 ' O ' ' HB3' ' A' ' 20' ' ' SER . 41.9 m-85 -135.06 -71.75 0.48 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.143 -0.973 . . . . 0.0 110.913 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 48' ' ' THR . . . -118.36 41.83 1.94 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.578 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.7 m -87.24 172.24 10.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -1.106 . . . . 0.0 110.334 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 6.8 m -112.0 -13.07 13.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.859 -1.151 . . . . 0.0 110.933 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' CB ' ' HB3' ' A' ' 22' ' ' LEU . 0.1 OUTLIER 35.67 63.34 0.56 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.468 -0.77 . . . . 0.0 110.758 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.3 m -65.57 78.57 0.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.411 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 52.27 36.0 44.21 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 41' ' ' ARG . 94.2 p -107.09 -138.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.179 -1.189 . . . . 0.0 109.811 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.508 ' HB3' ' ND2' ' A' ' 90' ' ' ASN . 32.3 ttt-85 175.96 154.58 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 110.429 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.453 ' HB3' HG22 ' A' ' 45' ' ' VAL . 13.1 m-85 -120.11 168.85 10.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.923 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.529 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 3.9 t0 -159.6 73.49 0.57 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.998 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 96.57 49.85 1.92 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.525 HG21 ' CB ' ' A' ' 30' ' ' SER . 1.2 m -131.6 -165.02 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.947 -1.325 . . . . 0.0 111.152 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.439 ' CG2' ' O ' ' A' ' 46' ' ' THR . 35.9 m -159.92 58.55 0.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 50' ' ' SER . 13.2 tt -72.55 173.65 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.511 -0.743 . . . . 0.0 110.311 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER -137.18 -92.07 0.24 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.373 -0.829 . . . . 0.0 109.886 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.8 m -111.97 65.96 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 47' ' ' ILE . 1.5 t -108.77 143.27 38.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.551 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 m -91.85 21.18 5.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.471 -0.768 . . . . 0.0 110.85 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -38.12 128.02 1.31 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.446 -0.783 . . . . 0.0 110.759 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.3 m -111.37 101.52 9.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 110.102 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 90' ' ' ASN . . . 61.17 77.76 0.18 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.5 p -148.82 122.35 9.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -1.11 . . . . 0.0 110.219 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.538 ' CB ' ' HB3' ' A' ' 88' ' ' SER . 3.7 ttp180 -72.23 103.88 3.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.137 -0.977 . . . . 0.0 110.089 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.494 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 22.6 mm -83.92 11.88 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.319 -0.863 . . . . 0.0 109.827 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -41.73 148.91 0.14 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.347 -0.846 . . . . 0.0 110.244 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 158.06 157.27 8.36 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.27 52.53 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.062 1.559 . . . . 0.0 109.951 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' O ' ' HD2' ' A' ' 63' ' ' LYS . . . 118.69 18.74 4.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.497 ' HB3' ' CG1' ' A' ' 45' ' ' VAL . 1.7 t -40.77 126.81 2.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.406 -1.055 . . . . 0.0 110.148 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -108.43 143.21 37.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 110.734 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.566 ' CD1' ' NZ ' ' A' ' 81' ' ' LYS . 17.4 mm -143.06 125.07 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 109.042 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -133.94 121.49 21.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 110.602 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 49' ' ' THR . 15.6 m 37.76 53.64 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.705 -0.622 . . . . 0.0 111.145 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.591 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 4.8 t -118.47 109.79 16.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.948 . . . . 0.0 109.339 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 52' ' ' SER . 2.0 mp -52.52 -66.28 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.711 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 9.5 mt 56.74 157.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -0.784 . . . . 0.0 109.923 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.543 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 5.7 m -169.66 107.51 0.39 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.898 -1.126 . . . . 0.0 111.186 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.41 28.08 31.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.56 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 85.38 10.9 76.4 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 70' ' ' THR . 11.7 m -120.5 136.73 25.5 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.207 -1.172 . . . . 0.0 110.033 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 69' ' ' ILE . 48.3 Cg_endo -77.4 138.02 17.22 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.993 1.523 . . . . 0.0 110.849 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.6 160.83 25.25 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 109.998 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.26 122.15 8.11 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.923 1.486 . . . . 0.0 110.365 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.77 4.1 2.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 110.551 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.46 23.96 2.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.112 -0.992 . . . . 0.0 110.143 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 80' ' ' CYS . . . -160.45 -37.4 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.89 . . . . 0.0 109.913 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.591 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 1.2 t -39.46 158.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.684 0.754 . . . . 0.0 110.931 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.566 ' NZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.56 -167.91 1.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 0.0 109.438 179.46 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.578 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 1.3 tp 177.51 31.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.178 -0.951 . . . . 0.0 110.042 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -70.71 -101.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.935 -1.103 . . . . 0.0 110.652 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.84 100.75 1.43 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -161.7 -159.64 0.64 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.29 -1.124 . . . . 0.0 109.887 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.553 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t 169.1 150.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.615 -0.678 . . . . 0.0 109.636 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.56 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -122.79 143.28 49.94 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.267 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.538 ' HB3' ' CB ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -122.02 9.66 9.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 65.17 66.94 0.53 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 110.088 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.508 ' ND2' ' HB3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.127 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.287 0.565 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.28 -80.99 0.03 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 5' ' ' THR . 34.3 m -101.17 -101.39 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -1.162 . . . . 0.0 110.602 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 1.1 m 58.78 -80.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.038 -1.039 . . . . 0.0 110.052 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 5' ' ' THR . 0.3 OUTLIER 58.23 15.96 3.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.135 -0.978 . . . . 0.0 109.22 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.562 ' O ' ' CB ' ' A' ' 7' ' ' THR . 0.0 OUTLIER 50.44 28.29 3.25 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.042 -1.036 . . . . 0.0 108.453 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.562 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.9 m 77.61 -3.16 2.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.731 -0.606 . . . . 0.0 109.759 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER 162.68 86.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.666 -0.646 . . . . 0.0 110.136 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.527 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 61.9 p -177.11 -149.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.349 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.406 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 2.6 tt0 -111.98 -44.12 3.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.014 . . . . 0.0 110.532 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.523 ' CD2' ' HB3' ' A' ' 4' ' ' CYS . 41.8 tp 46.34 86.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 109.996 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.461 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -42.71 148.66 0.22 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.358 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.65 -21.32 64.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.198 -0.939 . . . . 0.0 110.093 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -87.56 -4.09 58.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 110.209 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.503 ' CB ' HD12 ' A' ' 11' ' ' LEU . 39.0 t -79.42 -163.7 0.54 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.233 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 9.5 tttp -156.39 178.98 9.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.134 -0.979 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 3.9 p 174.69 47.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 110.068 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 4.0 tt0 -41.83 -50.18 4.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.648 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -161.68 77.07 0.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.646 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -115.31 -153.24 0.52 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.206 -0.934 . . . . 0.0 110.048 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -155.62 77.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 109.775 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 37' ' ' CYS . 5.0 mt -96.24 -167.3 1.56 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.365 -0.835 . . . . 0.0 110.456 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.523 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 53.4 m -155.02 -47.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.503 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 25' ' ' CYS . 12.0 m-20 -144.25 23.51 1.66 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.545 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 9' ' ' SER . 0.1 OUTLIER -58.16 -152.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.024 . . . . 0.0 110.513 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -160.59 -52.85 0.05 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.599 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.498 ' O ' ' O ' ' A' ' 26' ' ' TYR . 4.7 t 49.39 117.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.905 0.86 . . . . 0.0 112.226 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -108.72 -20.83 12.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.944 . . . . 0.0 108.884 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -167.4 84.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.746 -0.596 . . . . 0.0 109.671 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.535 ' CB ' HG23 ' A' ' 45' ' ' VAL . 24.5 m -159.58 164.28 34.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.784 -1.197 . . . . 0.0 111.51 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 47' ' ' ILE . 3.6 tt0 -119.68 96.58 5.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.538 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 6.5 t -94.67 168.68 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.141 -0.974 . . . . 0.0 110.531 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 19.1 m-85 -150.18 -42.86 0.13 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.064 -1.022 . . . . 0.0 111.315 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.97 27.56 1.88 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.537 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.7 m -82.01 150.03 27.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.08 -1.247 . . . . 0.0 110.526 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.451 ' CG2' ' O ' ' A' ' 36' ' ' THR . 13.9 t -95.95 54.49 1.49 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.539 -0.726 . . . . 0.0 109.443 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -38.31 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.689 -0.632 . . . . 0.0 110.691 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' THR . 19.0 m -104.38 69.62 0.92 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 110.077 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.72 59.45 3.48 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.6 m -136.88 -168.97 2.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -1.143 . . . . 0.0 109.783 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -162.78 143.38 9.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 110.673 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.522 ' CD1' ' CG1' ' A' ' 57' ' ' ILE . 10.8 m-85 -114.42 173.4 6.48 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.419 -0.8 . . . . 0.0 109.181 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.438 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -155.86 42.98 0.42 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 123.8 72.88 0.25 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.535 HG23 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -148.91 -168.74 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.043 -1.269 . . . . 0.0 110.475 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.2 m -155.38 58.82 0.64 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.49 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 8.8 tt -80.98 168.34 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.269 -0.894 . . . . 0.0 110.298 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' SER . 74.8 p -142.61 -138.05 0.11 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.621 -0.675 . . . . 0.0 109.233 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 66' ' ' THR . 52.8 m -58.24 83.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.984 -1.073 . . . . 0.0 110.145 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 48' ' ' THR . 73.0 m -141.57 139.41 33.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.961 -1.087 . . . . 0.0 110.502 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -88.88 117.77 28.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.373 -0.83 . . . . 0.0 109.592 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.5 p -133.78 113.49 12.36 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.567 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -98.37 91.42 5.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 109.485 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 72' ' ' GLY . . . 72.16 106.25 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 89.1 p -175.42 102.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -1.166 . . . . 0.0 110.467 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.519 ' HB2' ' CA ' ' A' ' 90' ' ' ASN . 7.6 ttm180 -62.79 106.26 0.78 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.929 -1.107 . . . . 0.0 108.984 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 16.5 mm -83.23 11.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.1 -1.0 . . . . 0.0 110.545 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -36.99 151.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.611 -0.681 . . . . 0.0 110.411 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 166.48 147.11 5.1 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.275 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -79.87 63.35 8.73 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 124.301 1.685 . . . . 0.0 109.461 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 106.05 24.3 6.97 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.461 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -41.58 161.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.409 -1.053 . . . . 0.0 110.323 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.46 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 17.1 tttm -152.89 110.48 3.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.012 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.511 ' CG1' ' HE3' ' A' ' 81' ' ' LYS . 3.1 mp -125.7 152.68 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.022 -1.049 . . . . 0.0 111.291 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.467 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.7 OUTLIER -156.12 107.91 2.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 0.0 109.895 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.2 OUTLIER 63.0 73.25 0.46 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 111.12 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.513 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 3.8 t -132.91 120.3 21.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.234 -0.917 . . . . 0.0 109.955 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.59 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 2.0 mp -83.29 85.24 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.027 -1.045 . . . . 0.0 108.839 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.574 HD11 ' CE2' ' A' ' 87' ' ' PHE . 9.6 mt -96.05 160.75 2.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.785 -0.572 . . . . 0.0 109.889 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.519 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 13.1 m -162.63 100.93 1.03 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.221 -0.924 . . . . 0.0 110.504 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 89.03 34.52 8.79 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 54' ' ' GLY . . . 75.42 17.95 80.03 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 70' ' ' THR . 9.5 m -123.56 128.94 25.04 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.24 -1.153 . . . . 0.0 110.834 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -83.33 142.56 10.73 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.967 1.509 . . . . 0.0 109.939 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -91.76 158.37 40.22 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.149 -0.969 . . . . 0.0 110.261 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.36 59.48 6.09 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.883 1.465 . . . . 0.0 110.12 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.06 134.1 42.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.499 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.72 -8.11 25.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.071 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 66' ' ' THR . . . -91.97 -16.96 25.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.869 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 66' ' ' THR . 40.4 t -78.87 165.61 23.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.902 -1.124 . . . . 0.0 110.18 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.534 ' O ' ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -101.21 -12.18 18.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.166 -0.959 . . . . 0.0 112.11 -178.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.534 ' C ' ' O ' ' A' ' 81' ' ' LYS . 37.1 mm 25.11 51.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.155 0.502 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 85' ' ' CYS . 0.4 OUTLIER -117.76 -141.75 0.36 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 111.375 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -59.35 83.5 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 6.0 t -177.96 178.37 0.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.11 . . . . 0.0 109.543 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.533 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -179.16 156.75 0.79 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.04 . . . . 0.0 110.491 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.574 ' CE2' HD11 ' A' ' 69' ' ' ILE . 2.3 m-85 -123.25 164.44 18.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -0.855 . . . . 0.0 110.287 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -142.21 12.58 1.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.841 . . . . 0.0 109.585 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 88' ' ' SER . . . 72.5 0.02 3.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 110.358 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.519 ' CA ' ' HB2' ' A' ' 56' ' ' ARG . 3.3 p30 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.444 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 2' ' ' GLY . 24.8 p-10 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.071 0.463 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 1' ' ' ASP . . . -136.52 20.53 3.49 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m 50.37 29.31 3.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -1.125 . . . . 0.0 110.326 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.3 m -78.26 131.86 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 110.324 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.6 m -117.12 -16.35 10.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 110.344 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' A' ' 7' ' ' THR . 13.8 p30 35.76 50.8 0.65 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.964 -1.085 . . . . 0.0 111.196 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.2 m 73.03 4.37 4.93 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.412 -0.805 . . . . 0.0 112.067 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.642 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.2 t-20 -171.06 -48.87 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.724 -1.235 . . . . 0.0 110.772 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.642 ' CB ' ' O ' ' A' ' 8' ' ' ASN . 3.5 p 92.71 86.23 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.613 0.721 . . . . 0.0 111.646 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.544 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -130.66 14.59 5.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.148 -0.97 . . . . 0.0 108.448 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.552 ' CD1' ' HB3' ' A' ' 15' ' ' SER . 9.9 tp -40.48 117.48 0.81 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.801 -0.562 . . . . 0.0 110.017 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -37.73 158.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.725 -0.609 . . . . 0.0 110.342 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.8 -6.96 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.987 . . . . 0.0 110.583 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -138.61 23.78 2.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.914 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.552 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -84.67 -159.56 0.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.009 -1.057 . . . . 0.0 110.33 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 4.8 tttp -155.95 152.58 28.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 110.362 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 29.9 p -164.63 56.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 11.3 tp10 -88.65 111.57 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 110.386 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 4.6 tttp 67.63 56.3 0.58 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.273 -0.892 . . . . 0.0 110.429 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -136.86 166.49 23.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.1 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 36' ' ' THR . 3.1 m -113.55 101.97 9.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.869 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 1.7 mm? -107.16 147.77 29.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 110.639 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 17.9 m -148.15 109.8 4.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.354 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 6' ' ' ASN . 1.1 m120 60.73 56.99 2.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.186 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -109.47 -169.12 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.191 0.996 . . . . 0.0 111.582 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 52.6 t80 -173.26 34.68 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.547 ' CG1' ' OG ' ' A' ' 15' ' ' SER . 12.1 t -33.16 142.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.532 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.526 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -143.5 121.5 12.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.525 -0.734 . . . . 0.0 109.867 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 53.35 38.77 28.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.318 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.531 ' CB ' HG23 ' A' ' 45' ' ' VAL . 21.0 m -132.1 179.31 6.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.641 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' HG2' ' HD2' ' A' ' 16' ' ' LYS . 2.8 tt0 -119.94 -64.2 1.29 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.377 -0.827 . . . . 0.0 110.556 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 11.7 t 62.05 150.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 110.004 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.515 ' O ' ' CB ' ' A' ' 20' ' ' SER . 19.3 m-85 -142.35 -47.43 0.34 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.059 -1.026 . . . . 0.0 110.803 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -132.59 20.32 4.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.524 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 8.6 m -66.68 154.91 39.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -1.18 . . . . 0.0 110.277 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 21' ' ' THR . 5.7 m -95.86 -21.46 18.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 11.9 t 48.86 76.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.805 . . . . 0.0 110.961 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.4 m -80.23 73.5 7.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 109.1 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 66.08 49.88 55.3 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -135.92 -178.08 4.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.266 -1.138 . . . . 0.0 110.018 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -153.4 176.4 12.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.034 -1.042 . . . . 0.0 110.56 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.466 ' HB3' ' OG ' ' A' ' 30' ' ' SER . 52.7 m-85 -123.18 -170.15 2.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.006 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.516 ' HB3' ' CB ' ' A' ' 58' ' ' SER . 9.8 t70 -178.35 63.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.773 . . . . 0.0 109.67 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 99.65 60.02 0.86 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.531 HG23 ' CB ' ' A' ' 30' ' ' SER . 1.4 m -137.37 -159.53 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.95 -1.324 . . . . 0.0 111.324 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.486 ' N ' ' O ' ' A' ' 62' ' ' CYS . 85.4 m -166.89 57.81 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.515 HG12 ' N ' ' A' ' 48' ' ' THR . 12.4 tt -83.7 171.65 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.47 -0.769 . . . . 0.0 111.088 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.515 ' N ' HG12 ' A' ' 47' ' ' ILE . 22.4 p -135.51 -134.03 0.15 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 66' ' ' THR . 23.1 m -66.12 89.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.737 -1.227 . . . . 0.0 109.758 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 35' ' ' THR . 0.6 OUTLIER -132.13 139.05 48.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.012 -1.055 . . . . 0.0 110.495 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.525 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 m -85.5 21.45 1.79 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 111.056 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 89.9 p -37.18 122.01 0.84 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.465 -0.772 . . . . 0.0 110.803 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 2.6 m -112.02 111.13 21.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.136 -0.978 . . . . 0.0 109.973 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 40' ' ' SER . . . 51.55 79.85 0.07 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 70' ' ' THR . 8.0 p -155.51 122.63 5.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -1.165 . . . . 0.0 110.528 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.519 ' HB2' ' CA ' ' A' ' 90' ' ' ASN . 36.9 ttt85 -75.97 103.85 6.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 109.675 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.53 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 18.1 mm -83.29 12.67 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 0.0 110.358 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.516 ' CB ' ' HB3' ' A' ' 43' ' ' ASP . 42.9 p -42.71 162.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.347 -0.846 . . . . 0.0 110.716 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 150.67 163.04 11.01 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -75.8 57.44 5.06 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.935 1.492 . . . . 0.0 109.844 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 106.43 21.82 8.15 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.486 ' O ' ' N ' ' A' ' 46' ' ' THR . 1.8 t -38.96 126.57 1.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.662 -0.905 . . . . 0.0 110.649 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.51 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 35.4 ttpt -115.08 140.47 49.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.053 -1.029 . . . . 0.0 110.593 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.508 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 25.4 mm -143.34 145.72 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.24 -0.912 . . . . 0.0 109.844 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.464 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 1.1 m -147.99 126.13 12.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.057 -1.027 . . . . 0.0 110.043 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.5 m 41.57 59.61 2.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.392 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 5.1 t -123.95 109.95 14.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.819 . . . . 0.0 109.532 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 1.9 mp -55.65 -64.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.979 -1.076 . . . . 0.0 109.697 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.545 ' CG1' ' SG ' ' A' ' 67' ' ' CYS . 8.1 mt 54.88 162.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.48 -0.763 . . . . 0.0 110.787 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.531 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 9.0 m -146.33 -121.78 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.83 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' ' 73' ' ' VAL . . . -65.18 77.5 0.08 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.532 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 58.54 16.73 30.45 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.531 ' CG2' ' HB ' ' A' ' 70' ' ' THR . 33.8 m -121.91 141.05 33.2 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.472 -1.017 . . . . 0.0 110.544 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -85.11 128.28 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.943 1.496 . . . . 0.0 110.133 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . . . -83.56 174.65 5.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 110.081 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 75' ' ' ALA . 43.0 Cg_endo -70.72 59.12 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.942 1.496 . . . . 0.0 110.106 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.413 ' HB2' HD13 ' A' ' 68' ' ' ILE . 22.8 t -88.09 112.93 23.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.382 -0.824 . . . . 0.0 110.223 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.32 -4.95 20.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.86 . . . . 0.0 110.347 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.455 ' HB1' HG22 ' A' ' 66' ' ' THR . . . -106.07 -31.85 8.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.52 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 43.1 t -46.36 166.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.169 -0.957 . . . . 0.0 109.836 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.513 ' HE3' ' N ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -108.15 -41.19 4.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.043 -1.035 . . . . 0.0 111.43 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.513 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 19.0 mm 49.25 62.13 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.816 -1.177 . . . . 0.0 109.615 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.2 t -109.33 -73.19 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 110.815 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.43 67.79 0.54 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -134.53 -153.0 0.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -1.151 . . . . 0.0 110.009 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.566 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.2 t 176.91 143.21 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.566 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -128.24 153.06 47.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.55 -0.719 . . . . 0.0 109.158 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 1.3 m -140.95 12.17 2.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.978 . . . . 0.0 109.758 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 88' ' ' SER . . . 72.07 0.13 3.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.443 -0.786 . . . . 0.0 110.201 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.519 ' CA ' ' HB2' ' A' ' 56' ' ' ARG . 2.7 p30 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.013 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.285 0.565 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.6 67.46 0.53 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t 49.21 95.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.331 -1.1 . . . . 0.0 110.445 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p -159.33 160.03 34.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.096 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 7' ' ' THR . 30.6 m -154.1 25.89 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 109.427 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 5' ' ' THR . 0.2 OUTLIER 65.85 -61.84 0.26 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.673 0.749 . . . . 0.0 108.992 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 5' ' ' THR . 25.1 m -161.86 -38.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 177.21 32.94 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.657 -0.652 . . . . 0.0 109.45 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 13.4 m -111.78 -107.07 0.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.855 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.586 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 3.9 pt20 -140.39 -43.56 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.863 -1.148 . . . . 0.0 111.511 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' N ' ' CG ' ' A' ' 10' ' ' GLN . 16.5 tp 47.68 81.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.015 -1.053 . . . . 0.0 108.934 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -44.44 149.93 0.35 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 110.25 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.91 -10.1 12.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.858 . . . . 0.0 110.076 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.495 ' ND2' ' HG2' ' A' ' 29' ' ' LYS . 50.7 t-20 -90.18 -7.77 52.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.968 . . . . 0.0 110.268 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 30' ' ' SER . 32.1 t -80.42 -157.61 0.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.067 -1.02 . . . . 0.0 110.099 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.516 ' CE ' ' OH ' ' A' ' 33' ' ' TYR . 12.5 tttt -135.74 140.17 44.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.079 -1.013 . . . . 0.0 110.088 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.0 m -113.41 137.35 51.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 110.291 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.8 -129.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.246 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.63 19.55 15.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.817 -1.177 . . . . 0.0 110.667 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.98 167.49 1.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.0 109.865 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.415 ' C ' HD22 ' A' ' 22' ' ' LEU . 1.6 t -140.24 97.13 3.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.019 -1.051 . . . . 0.0 109.985 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.557 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -131.45 -165.56 1.59 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.431 -0.793 . . . . 0.0 110.139 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 98.2 m -166.94 142.03 4.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.351 -0.843 . . . . 0.0 110.363 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.469 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 4.2 m120 45.88 36.83 3.1 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.369 -0.832 . . . . 0.0 110.697 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.501 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.7 OUTLIER -78.83 -154.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.091 -1.006 . . . . 0.0 110.683 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.586 ' CE1' ' HB3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER 176.26 40.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 30' ' ' SER . 40.3 t -52.78 153.92 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.984 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.7 OUTLIER -158.83 129.14 5.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.476 -0.765 . . . . 0.0 110.138 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' HG2' ' ND2' ' A' ' 14' ' ' ASN . 4.7 mtmp? 50.78 34.53 10.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 45' ' ' VAL . 49.3 m -124.47 -161.13 0.98 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.499 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 3.5 tt0 -138.2 -63.13 0.56 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.513 -0.742 . . . . 0.0 110.089 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.519 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 15.9 t 61.16 156.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.516 ' OH ' ' CE ' ' A' ' 16' ' ' LYS . 9.9 m-85 -153.95 -39.11 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.199 -0.938 . . . . 0.0 110.477 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.2 34.07 1.66 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.519 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -79.27 158.33 27.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.397 -1.061 . . . . 0.0 110.73 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.514 ' N ' HG22 ' A' ' 35' ' ' THR . 0.2 OUTLIER -111.52 50.23 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.96 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 3.5 t -40.82 121.38 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 111.012 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 m -113.66 22.86 13.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 109.269 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 122.85 41.56 0.44 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.52 -159.29 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -1.178 . . . . 0.0 110.372 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 26' ' ' TYR . 28.4 ttt180 -166.88 145.06 5.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.914 . . . . 0.0 110.701 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.447 ' CE1' HG13 ' A' ' 57' ' ' ILE . 10.1 m-85 -115.16 172.39 7.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.0 109.301 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.54 42.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.921 -1.112 . . . . 0.0 110.407 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 127.0 57.5 0.13 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -136.34 -171.16 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.269 -1.136 . . . . 0.0 110.997 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.453 ' N ' HG22 ' A' ' 45' ' ' VAL . 87.9 m -152.89 58.2 0.79 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.515 HG13 ' CG2' ' A' ' 64' ' ' ILE . 9.7 tt -81.3 169.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.245 -0.909 . . . . 0.0 110.14 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 50' ' ' SER . 58.9 p -146.09 -139.7 0.1 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.048 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' THR . 51.9 m -52.94 91.48 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.07 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' THR . 2.4 m -152.96 143.72 22.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.155 -0.966 . . . . 0.0 110.286 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -98.66 135.32 40.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 59.9 p -155.64 130.88 9.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.33 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 71' ' ' GLY . 11.5 m -111.85 112.94 24.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.103 -0.998 . . . . 0.0 109.82 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.7 86.41 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 79.6 p -154.74 112.25 3.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -1.144 . . . . 0.0 110.514 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 4.1 ttt180 -67.03 118.6 10.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 109.66 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 26.8 mm -97.82 11.18 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 0.0 110.831 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -40.7 145.34 0.19 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.203 -0.936 . . . . 0.0 110.34 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 175.12 145.85 5.54 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -80.18 1.34 9.33 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.038 1.547 . . . . 0.0 109.629 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.06 33.23 0.07 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -60.74 152.73 26.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.535 -0.979 . . . . 0.0 110.804 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -156.95 113.93 3.07 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.515 ' CG2' HG13 ' A' ' 47' ' ' ILE . 3.0 mt -118.9 148.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.067 -1.021 . . . . 0.0 110.862 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -151.51 117.14 5.41 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.0 OUTLIER 51.21 71.14 0.46 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.101 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 50' ' ' SER . 60.5 m -139.11 111.04 7.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.447 -0.783 . . . . 0.0 110.478 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' THR . 1.0 OUTLIER -77.92 137.06 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.946 -1.096 . . . . 0.0 109.42 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 51' ' ' THR . 9.3 mt -146.51 158.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.079 -1.013 . . . . 0.0 110.309 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.464 ' HA ' ' HB ' ' A' ' 53' ' ' THR . 5.7 m -156.39 99.0 1.88 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.04 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 91.51 20.67 37.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.497 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 88.29 15.55 60.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 69' ' ' ILE . 4.1 m -124.3 132.87 24.35 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.476 -1.014 . . . . 0.0 109.507 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.36 144.93 23.47 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.59 1.311 . . . . 0.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . . . -99.17 176.02 2.17 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 75' ' ' ALA . 47.6 Cg_endo -73.15 102.6 1.48 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.94 1.495 . . . . 0.0 110.635 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 1.1 t -119.04 -23.52 6.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.34 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 61.15 12.35 4.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.255 -0.903 . . . . 0.0 109.966 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.7 -15.27 1.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.311 -0.868 . . . . 0.0 110.998 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 66' ' ' THR . 33.1 t -62.89 168.48 3.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.968 -1.082 . . . . 0.0 110.406 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.503 ' HE2' ' N ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -102.99 -35.29 8.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.981 -1.074 . . . . 0.0 111.826 -178.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.503 ' N ' ' HE2' ' A' ' 81' ' ' LYS . 32.4 mm 43.66 60.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.093 -1.004 . . . . 0.0 109.35 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 85' ' ' CYS . 46.5 m -114.95 -130.11 0.31 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.31 -0.869 . . . . 0.0 110.594 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -65.12 66.05 0.08 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.505 ' N ' ' O ' ' A' ' 83' ' ' SER . 5.0 t -160.94 -175.99 5.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.023 -1.281 . . . . 0.0 109.854 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.562 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 2.0 t -179.09 160.67 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.117 -0.989 . . . . 0.0 110.745 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -127.92 155.08 44.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.32 -0.863 . . . . 0.0 109.431 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.91 24.91 1.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.047 -1.033 . . . . 0.0 110.313 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 52.84 85.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 109.944 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.035 -1.04 . . . . 0.0 110.365 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.353 0.597 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.43 123.33 0.65 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -55.99 -60.92 2.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -1.159 . . . . 0.0 110.022 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' O ' ' OG1' ' A' ' 5' ' ' THR . 14.3 m 56.67 -147.38 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 110.425 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.525 ' OG1' ' O ' ' A' ' 4' ' ' CYS . 1.3 m 178.91 -29.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 6' ' ' ASN . 0.1 OUTLIER 62.91 55.42 2.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.38 1.086 . . . . 0.0 108.257 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 23' ' ' THR . 1.8 m 63.66 -63.81 0.13 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.473 -1.392 . . . . 0.0 108.912 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.637 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.6 OUTLIER -73.16 -88.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.06 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.637 ' CB ' ' O ' ' A' ' 8' ' ' ASN . 2.5 p 152.93 58.4 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 122.124 -0.36 . . . . 0.0 111.678 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.551 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 22.6 mt-30 -140.69 16.56 2.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.312 -1.493 . . . . 0.0 110.538 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.574 HD12 ' CB ' ' A' ' 15' ' ' SER . 8.7 tp -62.96 81.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 10' ' ' GLN . 97.9 p -30.62 134.16 0.06 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.529 0.681 . . . . 0.0 111.93 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.33 -22.51 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 109.81 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 61.4 t-20 -80.99 -10.28 59.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.473 -0.767 . . . . 0.0 110.086 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.574 ' CB ' HD12 ' A' ' 11' ' ' LEU . 45.6 t -79.38 -171.62 2.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.131 -0.98 . . . . 0.0 109.757 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.89 163.79 17.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.105 -0.997 . . . . 0.0 109.612 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 18' ' ' GLU . 6.4 m -134.66 -29.29 1.19 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.066 -1.022 . . . . 0.0 111.191 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' LYS . 10.4 tp10 -43.45 118.22 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.07 -1.018 . . . . 0.0 110.244 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 52.83 108.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.781 . . . . 0.0 110.552 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 5.9 p 178.69 146.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.048 -1.032 . . . . 0.0 110.899 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -139.14 84.08 1.98 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -0.792 . . . . 0.0 109.529 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 38.9 mt -101.91 -174.42 2.58 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.834 0.826 . . . . 0.0 111.267 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.465 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 91.7 m -164.42 125.02 2.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.637 -0.665 . . . . 0.0 109.298 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 51.07 66.47 1.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 108.878 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB2' ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -123.78 169.91 11.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.78 0.8 . . . . 0.0 110.471 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.568 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -147.0 34.33 0.91 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 179.002 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.561 ' CG1' ' HB2' ' A' ' 30' ' ' SER . 7.6 t -30.52 147.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.587 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.525 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -150.47 123.31 8.68 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 9.8 mmmt 48.04 56.26 7.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 0.0 109.34 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.561 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 14.7 m -143.25 171.69 13.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.963 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 1.4 tt0 -115.06 -68.88 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.382 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.517 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 3.1 t 67.15 143.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.327 -0.858 . . . . 0.0 110.383 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 20' ' ' SER . 45.2 m-85 -137.62 -52.71 0.65 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.337 -0.852 . . . . 0.0 110.674 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.442 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -129.46 18.88 5.42 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.517 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.2 m -69.75 153.69 43.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -1.167 . . . . 0.0 110.216 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 37' ' ' CYS . 1.2 m -111.95 58.24 0.63 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.462 -0.774 . . . . 0.0 109.594 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 52.8 t -36.87 137.77 0.3 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.609 -0.682 . . . . 0.0 111.01 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.428 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 95.2 m -137.85 74.34 1.48 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.468 -0.77 . . . . 0.0 109.461 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.48 57.43 3.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.415 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -147.08 178.57 8.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.159 -1.201 . . . . 0.0 110.177 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' HG2' ' N ' ' A' ' 42' ' ' PHE . 4.0 ttt180 -150.65 153.02 34.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.302 -0.874 . . . . 0.0 110.176 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.515 ' N ' ' HG2' ' A' ' 41' ' ' ARG . 8.1 m-85 -116.04 -176.2 2.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.995 . . . . 0.0 110.566 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.9 t0 -170.09 50.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 110.179 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 118.44 61.36 0.28 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -140.98 -168.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.914 -1.345 . . . . 0.0 110.6 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 46' ' ' THR . 91.6 m -160.73 53.25 0.3 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.62 -0.675 . . . . 0.0 109.908 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 19.8 tt -73.54 169.45 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.783 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 50' ' ' SER . 71.9 p -138.21 -139.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.206 -0.934 . . . . 0.0 109.666 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 66' ' ' THR . 31.3 m -58.33 80.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' THR . 28.5 t -141.55 140.33 33.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 110.454 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -83.49 131.47 35.01 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.221 -0.924 . . . . 0.0 109.916 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 2.9 t -151.86 128.67 10.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.939 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.428 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 36.8 p -128.22 110.62 12.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.978 . . . . 0.0 110.212 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.41 84.03 0.13 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 p -161.37 127.87 3.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -1.13 . . . . 0.0 110.658 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.434 ' CD ' ' HB2' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.55 103.27 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 7.4 mm -85.07 10.78 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.083 -1.011 . . . . 0.0 110.498 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -36.02 142.77 0.07 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.457 -0.777 . . . . 0.0 110.727 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.459 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . 176.85 146.09 5.96 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.313 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.77 -8.31 17.95 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.965 1.508 . . . . 0.0 110.051 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.48 39.23 0.12 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.472 ' CB ' ' HA ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -56.15 159.42 3.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.525 -0.985 . . . . 0.0 111.37 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 27.5 tttt -161.08 98.71 1.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.694 -0.629 . . . . 0.0 109.347 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.484 ' CD1' HG22 ' A' ' 57' ' ' ILE . 12.8 mt -117.82 163.41 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.671 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -145.47 -163.35 1.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.405 -0.809 . . . . 0.0 110.155 179.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 4.0 m -33.36 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.569 ' N ' ' O ' ' A' ' 65' ' ' SER . 44.4 t -138.38 139.52 39.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.515 -0.741 . . . . 0.0 109.107 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.624 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.6 mp -97.22 82.73 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.884 -1.135 . . . . 0.0 108.704 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' THR . 13.1 mt -90.85 154.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.67 -0.644 . . . . 0.0 110.328 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.544 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 52.8 m -162.01 98.82 1.08 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.174 -0.954 . . . . 0.0 110.597 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.39 39.98 4.61 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 65.32 24.02 70.4 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 70' ' ' THR . 6.1 m -129.24 129.2 23.3 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.485 -1.009 . . . . 0.0 110.893 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -83.58 131.89 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.922 1.486 . . . . 0.0 110.228 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -79.04 150.85 75.37 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.002 -1.061 . . . . 0.0 110.057 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.56 58.47 1.94 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.118 1.588 . . . . 0.0 110.683 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.48 150.48 22.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 110.235 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.24 -10.96 55.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.926 . . . . 0.0 109.962 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 80' ' ' CYS . . . -112.66 -31.6 6.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.92 . . . . 0.0 111.002 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 66' ' ' THR . 13.0 t -44.53 137.06 3.94 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.945 -1.097 . . . . 0.0 110.141 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -110.28 164.88 12.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 111.49 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.553 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 1.0 OUTLIER -161.59 75.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -112.08 -86.55 0.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 0.0 110.56 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -104.79 65.91 0.3 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.464 ' SG ' ' CD1' ' A' ' 64' ' ' ILE . 4.4 t -162.48 -175.49 4.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -1.189 . . . . 0.0 110.26 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.559 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.5 t 179.81 158.87 0.73 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.288 -0.882 . . . . 0.0 110.108 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.3 OUTLIER -123.22 154.35 38.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 89' ' ' ALA . 2.7 m -134.96 32.67 3.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 109.591 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 88' ' ' SER . . . 37.87 72.01 0.14 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.757 -0.589 . . . . 0.0 110.199 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.434 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.307 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 2' ' ' GLY . 7.5 t0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.317 0.579 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 1' ' ' ASP . . . -56.57 -161.29 0.02 OUTLIER Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 t -125.14 48.48 2.01 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.314 -1.109 . . . . 0.0 110.839 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.8 173.73 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.181 -0.949 . . . . 0.0 111.034 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 5' ' ' THR . 1.2 m -136.19 5.37 3.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.496 -0.753 . . . . 0.0 109.321 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.54 ' O ' ' CG ' ' A' ' 6' ' ' ASN . 0.7 OUTLIER 50.93 69.43 0.64 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.182 -0.949 . . . . 0.0 109.165 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.501 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 1.5 p 63.8 -56.15 0.21 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.193 -0.942 . . . . 0.0 110.648 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 6' ' ' ASN . 1.2 t-20 177.11 64.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.918 -1.113 . . . . 0.0 110.162 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.449 ' OG ' ' OD1' ' A' ' 6' ' ' ASN . 19.7 m -131.2 -121.98 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.919 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 11' ' ' LEU . 1.4 pt20 -131.08 -41.55 1.12 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.855 -1.153 . . . . 0.0 109.895 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.538 ' N ' ' CG ' ' A' ' 10' ' ' GLN . 18.1 tp 43.46 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.549 -0.719 . . . . 0.0 110.149 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -37.91 150.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.693 -0.63 . . . . 0.0 110.451 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -24.98 67.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 110.24 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 14' ' ' ASN . 0.6 OUTLIER -103.93 6.26 36.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 111.129 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.51 ' CB ' HD11 ' A' ' 11' ' ' LEU . 28.8 t -69.21 -154.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.16 . . . . 0.0 109.391 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' CD ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -140.69 150.71 43.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 110.528 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' A' ' 18' ' ' GLU . 7.8 t -135.99 -92.18 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -0.917 . . . . 0.0 109.779 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.491 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 13.2 mt-10 38.05 -125.68 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.412 -0.805 . . . . 0.0 110.844 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' SER . 10.4 tptt -66.98 123.55 20.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.956 -1.09 . . . . 0.0 110.356 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.53 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . 10.3 p 175.94 172.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.115 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.8 t -154.04 76.41 1.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.36 -0.837 . . . . 0.0 109.56 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.576 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -114.48 -170.56 1.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.793 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 3.9 m -164.89 124.94 1.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.849 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.6 m120 57.17 33.38 23.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 110.713 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -64.31 -141.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.754 -1.216 . . . . 0.0 109.929 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' CG ' ' O ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER 166.34 45.82 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 30' ' ' SER . 8.0 t -66.96 140.45 19.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.762 0.791 . . . . 0.0 111.715 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.9 t0 -123.05 -14.03 7.66 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.429 0.633 . . . . 0.0 109.728 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER 179.99 67.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.57 ' CB ' HG22 ' A' ' 45' ' ' VAL . 14.8 m -147.26 151.31 36.44 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.176 -0.953 . . . . 0.0 111.442 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.521 ' HG3' ' CD ' ' A' ' 16' ' ' LYS . 6.5 tt0 -107.49 101.23 10.59 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 18.0 t -99.2 174.32 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.237 -0.915 . . . . 0.0 110.379 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.512 ' CD2' HG23 ' A' ' 48' ' ' THR . 47.1 m-85 -149.16 -32.0 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.193 -0.942 . . . . 0.0 111.391 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.452 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -164.48 26.79 0.2 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.51 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 0.9 OUTLIER -76.99 144.94 38.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.137 . . . . 0.0 110.398 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -91.13 60.04 4.16 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.417 -0.802 . . . . 0.0 110.501 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 2.0 t -47.04 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.0 110.157 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.456 HG21 HG22 ' A' ' 53' ' ' THR . 1.7 t -85.91 31.88 0.61 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.071 -1.018 . . . . 0.0 110.445 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.42 27.83 4.01 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 16.0 t -94.06 -163.09 1.0 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.384 -1.068 . . . . 0.0 110.229 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' HB2' ' CB ' ' A' ' 26' ' ' TYR . 2.7 ttp180 -165.73 144.69 6.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.544 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 2.9 m-85 -119.45 -172.44 2.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.971 -1.081 . . . . 0.0 110.227 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.22 55.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 110.204 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 115.29 54.64 0.37 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.274 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.57 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.1 m -133.6 -169.66 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.732 -1.452 . . . . 0.0 111.325 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.5 m -151.89 60.01 0.86 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.561 ' CG1' ' OG ' ' A' ' 50' ' ' SER . 14.6 tt -81.14 -179.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.751 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.512 HG23 ' CD2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -139.77 -89.82 0.19 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.789 -1.195 . . . . 0.0 110.195 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 5.9 m -114.3 74.35 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.022 -1.049 . . . . 0.0 110.451 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.561 ' OG ' ' CG1' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -114.53 152.34 31.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.144 -0.973 . . . . 0.0 111.413 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 52' ' ' SER . 1.5 m -99.79 27.91 5.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.462 -0.773 . . . . 0.0 111.085 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' ILE . 1.4 p -40.92 136.62 1.41 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.187 -0.946 . . . . 0.0 110.893 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.457 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 87.2 m -126.17 87.58 2.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.45 65.88 1.93 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.8 p -145.91 123.11 11.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.448 -1.031 . . . . 0.0 109.844 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -76.68 102.22 6.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.551 -0.718 . . . . 0.0 110.75 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.544 ' CD1' ' CE1' ' A' ' 42' ' ' PHE . 3.1 mp -85.37 15.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.988 -1.07 . . . . 0.0 110.217 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.9 p -47.15 161.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.337 -0.852 . . . . 0.0 110.968 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 155.24 154.29 6.86 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -74.41 -0.84 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.825 1.434 . . . . 0.0 110.098 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.31 29.83 0.07 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.3 t -52.28 114.55 1.38 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.451 -1.029 . . . . 0.0 110.491 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -110.57 130.22 55.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.499 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 41.0 mt -140.95 147.89 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.073 -1.017 . . . . 0.0 110.587 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.476 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -140.53 108.87 5.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 110.64 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 49' ' ' THR . 5.9 m 50.33 71.86 0.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.522 -0.736 . . . . 0.0 112.027 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 43.9 t -132.81 112.31 11.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.359 -0.838 . . . . 0.0 109.235 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.7 mp -47.25 -68.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.556 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.532 ' CG1' ' SG ' ' A' ' 67' ' ' CYS . 27.3 mt 63.42 155.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.306 -0.871 . . . . 0.0 110.171 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.457 ' HA ' ' HB ' ' A' ' 53' ' ' THR . 12.4 m -147.73 -115.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -74.06 81.69 0.78 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.584 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 54.46 19.82 14.45 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 71' ' ' GLY . 4.3 m -125.64 133.91 25.34 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.611 -0.935 . . . . 0.0 110.138 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 48.3 Cg_endo -82.84 129.99 5.67 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.59 1.311 . . . . 0.0 110.373 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 68' ' ' ILE . . . -95.36 150.55 37.73 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 110.345 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.62 144.14 35.2 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.063 1.559 . . . . 0.0 110.375 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 78' ' ' ALA . 23.3 t -165.93 24.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.138 -0.977 . . . . 0.0 110.559 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 44.51 27.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.44 -34.43 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.898 . . . . 0.0 110.796 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 1.7 t -50.82 145.35 7.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.012 -1.055 . . . . 0.0 110.731 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.514 ' C ' ' CD ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -97.35 167.52 10.96 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.668 -0.645 . . . . 0.0 109.606 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.491 ' CD1' ' O ' ' A' ' 81' ' ' LYS . 29.9 mm -154.59 60.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.967 -1.083 . . . . 0.0 109.714 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.5 m -98.35 -116.94 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 111.009 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.39 83.41 0.54 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.452 ' SG ' HG13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -141.72 -165.05 1.91 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -1.156 . . . . 0.0 109.504 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.8 t -175.83 145.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.953 -1.092 . . . . 0.0 110.267 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.584 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.0 m-85 -111.71 -67.76 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.153 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER 69.66 11.84 7.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 110.4 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 48.13 91.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.169 -0.957 . . . . 0.0 109.867 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.417 -179.392 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 8.9 m-20 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.009 0.433 . . . . 0.0 109.855 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.11 -148.51 19.93 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.63 134.87 50.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -1.084 . . . . 0.0 110.508 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' O ' ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -132.65 -29.35 1.53 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.096 -1.002 . . . . 0.0 111.023 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.586 ' HB ' ' O ' ' A' ' 4' ' ' CYS . 92.7 m 65.96 7.58 4.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.3 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.504 ' CG ' ' N ' ' A' ' 7' ' ' THR . 0.0 OUTLIER 67.31 -59.31 0.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.504 ' N ' ' CG ' ' A' ' 6' ' ' ASN . 21.3 m -162.17 -37.8 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.59 42.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.462 -0.774 . . . . 0.0 109.916 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 25' ' ' CYS . 97.7 p -129.2 -74.92 0.55 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.03 -1.044 . . . . 0.0 110.951 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.427 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -161.58 -57.75 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.917 -1.115 . . . . 0.0 111.198 -179.249 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.56 HD11 ' CB ' ' A' ' 15' ' ' SER . 19.2 tp 52.61 89.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.118 -0.989 . . . . 0.0 108.958 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -41.08 141.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.573 -0.704 . . . . 0.0 110.509 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.39 -17.11 4.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 110.458 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 17.5 p30 -94.01 -8.89 38.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 110.885 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.56 ' CB ' HD11 ' A' ' 11' ' ' LEU . 1.1 t -66.78 -174.59 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.858 -1.151 . . . . 0.0 109.213 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.501 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -122.39 159.88 26.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 110.252 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.3 t -151.79 111.97 4.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -175.43 125.1 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.804 . . . . 0.0 109.798 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt 51.74 55.32 9.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.754 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.498 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -140.35 161.97 36.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.0 110.719 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 36' ' ' THR . 2.9 t -135.43 61.77 1.65 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 109.248 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.556 ' HB3' ' CB ' ' A' ' 37' ' ' CYS . 3.0 mt -74.26 176.96 6.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 111.167 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 24' ' ' ASN . 3.1 m -164.13 118.86 1.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.468 -0.77 . . . . 0.0 109.841 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.535 ' O ' ' N ' ' A' ' 39' ' ' GLY . 27.3 m120 50.43 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.337 -0.852 . . . . 0.0 109.646 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -157.81 -160.38 0.91 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.59 -1.318 . . . . 0.0 110.913 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.512 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 13.8 t80 -164.29 34.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 11' ' ' LEU . 5.0 t -33.05 151.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.536 0.684 . . . . 0.0 110.783 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 1.3 t70 -153.21 118.78 5.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 44' ' ' GLY . 6.4 mtpm? 48.11 72.88 0.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.422 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 42' ' ' PHE . 45.3 m -157.71 157.92 34.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.973 -1.079 . . . . 0.0 111.095 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 3.8 mt-10 -120.58 119.75 33.82 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.555 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 46.9 t -123.04 156.32 28.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.101 -0.999 . . . . 0.0 110.623 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 32' ' ' VAL . 48.2 m-85 -154.42 32.14 0.42 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.186 -0.946 . . . . 0.0 111.223 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 162.28 -31.2 0.3 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.555 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 19.3 m -38.66 162.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.516 -0.991 . . . . 0.0 111.541 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -104.65 -13.43 15.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.4 -0.812 . . . . 0.0 110.648 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.556 ' CB ' ' HB3' ' A' ' 22' ' ' LEU . 0.1 OUTLIER 38.59 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.266 -0.896 . . . . 0.0 110.932 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.5 m -105.09 94.31 5.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.122 -0.986 . . . . 0.0 109.975 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 48.25 26.73 4.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.467 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -104.79 -166.09 1.2 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.175 -1.191 . . . . 0.0 110.361 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.448 ' HG2' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -164.85 155.57 14.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 110.388 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.584 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 7.4 m-85 -120.62 -175.06 2.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.338 -0.851 . . . . 0.0 109.403 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -165.95 46.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.139 -0.976 . . . . 0.0 109.932 179.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 121.65 53.34 0.22 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -132.94 -175.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.801 -1.411 . . . . 0.0 110.885 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.0 m -151.39 59.17 0.89 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.712 -0.618 . . . . 0.0 109.778 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 7.9 tt -81.0 167.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.767 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 50' ' ' SER . 54.3 p -139.36 -128.2 0.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.063 -1.023 . . . . 0.0 109.844 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 66' ' ' THR . 88.4 m -65.96 73.28 0.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.971 -1.08 . . . . 0.0 109.521 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 66' ' ' THR . 73.2 m -133.52 135.35 44.35 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.483 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 67' ' ' CYS . 1.6 m -88.62 139.09 30.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.9 p -153.69 130.08 10.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.412 -0.805 . . . . 0.0 110.075 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -111.54 112.4 24.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.008 -1.057 . . . . 0.0 109.696 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 50.53 90.76 0.01 OUTLIER Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 95.7 p -156.74 123.47 5.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.374 -1.074 . . . . 0.0 109.643 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.6 ttt180 -85.54 100.7 12.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.962 . . . . 0.0 110.69 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.604 ' CG2' HD13 ' A' ' 64' ' ' ILE . 2.9 mt -89.11 23.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.487 -0.758 . . . . 0.0 110.446 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -43.75 155.28 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.915 -1.115 . . . . 0.0 109.711 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 165.88 143.61 3.8 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.195 -1.478 . . . . 0.0 110.325 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.01 -19.37 23.18 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.061 1.559 . . . . 0.0 110.276 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.5 36.95 0.52 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.407 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -57.88 160.38 4.69 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -1.045 . . . . 0.0 111.505 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.554 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 30.3 tttp -160.51 114.02 2.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.584 -0.698 . . . . 0.0 109.822 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.604 HD13 ' CG2' ' A' ' 57' ' ' ILE . 12.1 mt -128.77 155.28 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.825 -1.172 . . . . 0.0 111.477 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.544 ' N ' HG21 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -156.44 126.16 6.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.503 ' N ' ' OG ' ' A' ' 50' ' ' SER . 0.7 OUTLIER 51.97 77.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 110.638 -179.291 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 89.5 m -138.9 118.41 12.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.134 -0.979 . . . . 0.0 109.63 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 2.5 mp -90.98 80.87 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 118.836 -1.146 . . . . 0.0 108.868 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 18.6 mt -89.91 159.27 2.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.294 0.569 . . . . 0.0 110.544 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.495 ' N ' HG23 ' A' ' 69' ' ' ILE . 18.2 m -158.28 97.82 1.53 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 110.421 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 94.63 16.78 41.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.505 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 91.53 16.01 53.63 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 69' ' ' ILE . 14.2 m -124.32 132.94 24.36 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.423 -1.046 . . . . 0.0 110.124 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HB3' HD11 ' A' ' 82' ' ' ILE . 52.1 Cg_endo -81.24 137.39 10.61 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.93 1.49 . . . . 0.0 110.65 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -90.75 159.16 41.23 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.91 . . . . 0.0 109.794 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.5 66.66 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.787 1.414 . . . . 0.0 110.282 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 78' ' ' ALA . 18.6 t -80.52 4.53 18.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.235 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 41.73 31.07 0.18 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 110.004 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -151.35 -38.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.481 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 44.8 t -49.52 170.45 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.311 -0.868 . . . . 0.0 108.849 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.554 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -106.99 -39.52 5.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.95 -1.094 . . . . 0.0 111.689 -178.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.49 ' CA ' ' HE3' ' A' ' 81' ' ' LYS . 43.0 mm 43.62 68.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.879 -1.138 . . . . 0.0 109.501 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.436 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 45.1 t -125.38 -116.03 0.28 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 110.48 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.68 59.92 0.48 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.503 ' CB ' ' NZ ' ' A' ' 81' ' ' LYS . 3.6 t -163.32 -171.76 2.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.265 . . . . 0.0 110.814 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.57 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.9 t 176.62 170.04 0.48 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.46 -0.775 . . . . 0.0 109.772 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -134.05 149.01 51.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.005 -1.06 . . . . 0.0 110.079 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 t -129.73 30.5 4.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.273 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 47.75 61.79 2.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.985 . . . . 0.0 110.065 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.288 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.501 ' OD2' ' N ' ' A' ' 2' ' ' GLY . 3.6 p-10 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.17 0.51 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.501 ' N ' ' OD2' ' A' ' 1' ' ' ASP . . . -69.54 88.52 0.27 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 19.7 m 48.29 -140.24 0.66 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.23 -1.159 . . . . 0.0 110.784 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 3' ' ' SER . 2.9 t 71.59 145.08 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.305 -0.872 . . . . 0.0 110.244 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.6 HG21 ' N ' ' A' ' 9' ' ' SER . 20.1 m -172.73 169.92 4.82 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -143.08 64.35 1.36 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.189 -0.944 . . . . 0.0 109.865 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 6' ' ' ASN . 2.1 m 67.52 18.84 10.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.562 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 178.17 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.727 -0.608 . . . . 0.0 110.151 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.6 ' N ' HG21 ' A' ' 5' ' ' THR . 0.3 OUTLIER 78.8 85.35 0.06 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.823 -0.548 . . . . 0.0 110.701 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -127.98 17.87 6.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.097 -1.002 . . . . 0.0 109.494 179.069 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.555 ' CD1' ' HB3' ' A' ' 15' ' ' SER . 6.7 tp -47.74 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.752 -0.592 . . . . 0.0 109.772 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 10' ' ' GLN . 4.9 t -38.24 137.0 0.59 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.059 -0.657 . . . . 0.0 109.866 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.1 -17.51 0.43 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.21 -0.931 . . . . 0.0 111.289 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -90.72 -3.36 57.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.005 -1.06 . . . . 0.0 110.342 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.555 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -89.03 -157.48 0.45 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.098 -1.001 . . . . 0.0 110.054 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 8.4 tttm -165.7 156.27 13.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 110.057 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.476 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 40.7 t -144.14 156.41 44.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 110.48 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER 174.02 104.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.697 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 74.08 14.94 3.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.83 . . . . 0.0 110.052 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.477 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -102.48 165.97 10.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 0.0 110.474 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' CB ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -113.82 -43.65 3.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.429 -0.794 . . . . 0.0 110.121 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.476 ' O ' ' OG1' ' A' ' 23' ' ' THR . 1.1 tp 62.24 159.03 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.062 -1.024 . . . . 0.0 110.479 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 1.7 m -174.61 117.66 0.2 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.413 -0.804 . . . . 0.0 109.256 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.462 ' N ' ' OG1' ' A' ' 7' ' ' THR . 26.1 m120 53.59 63.19 2.3 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.565 ' C ' ' CG ' ' A' ' 26' ' ' TYR . 1.3 m -146.21 -166.66 2.53 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.736 0.779 . . . . 0.0 111.096 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CG ' ' C ' ' A' ' 25' ' ' CYS . 11.0 m-85 -155.13 -40.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.538 ' HB ' ' CD1' ' A' ' 11' ' ' LEU . 11.8 t 56.39 137.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.643 0.735 . . . . 0.0 111.618 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 0.4 OUTLIER -151.6 130.72 12.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.53 -0.731 . . . . 0.0 109.816 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.496 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 34.8 mttp 54.31 37.5 27.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.116 -0.99 . . . . 0.0 109.098 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.471 ' HB3' HG22 ' A' ' 45' ' ' VAL . 8.3 m -126.59 169.62 12.9 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.487 -0.758 . . . . 0.0 110.353 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 16' ' ' LYS . 1.2 tt0 -113.02 -63.03 1.5 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.432 -0.793 . . . . 0.0 110.126 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 5.4 t 62.58 144.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -0.865 . . . . 0.0 110.141 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.5 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 42.4 m-85 -152.4 34.23 0.51 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 110.629 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 156.28 -31.32 0.59 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 50' ' ' SER . 8.9 m -40.34 151.02 0.05 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.462 -1.023 . . . . 0.0 111.072 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.416 ' O ' ' CA ' ' A' ' 22' ' ' LEU . 76.1 m -97.49 -16.55 20.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.423 -0.798 . . . . 0.0 109.261 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 23' ' ' THR . 1.6 t 52.21 83.68 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.572 -0.705 . . . . 0.0 110.057 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 m -93.71 102.62 14.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.37 -0.831 . . . . 0.0 110.303 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.12 61.51 5.33 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 45.2 t -150.81 -168.91 3.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -1.112 . . . . 0.0 109.914 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.5 ' HG2' ' N ' ' A' ' 42' ' ' PHE . 5.2 ttt180 -168.75 156.4 7.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.09 -1.006 . . . . 0.0 110.03 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.585 ' CE1' HD12 ' A' ' 57' ' ' ILE . 5.5 m-85 -117.93 179.35 4.11 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.273 -0.892 . . . . 0.0 110.161 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -168.14 41.1 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.401 -0.812 . . . . 0.0 109.474 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 59' ' ' GLY . . . 129.16 53.96 0.11 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -129.03 -165.84 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.065 -1.256 . . . . 0.0 110.324 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 46' ' ' THR . 23.5 m -163.44 57.9 0.18 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.562 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 10.4 tt -86.01 172.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.641 0.734 . . . . 0.0 111.695 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' SER . 32.7 p -129.93 -156.32 0.75 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.508 -0.745 . . . . 0.0 109.327 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.6 m -48.5 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.813 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -125.24 140.29 52.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.636 -1.29 . . . . 0.0 110.488 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 52' ' ' SER . 14.7 m -86.88 18.36 3.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.142 -0.974 . . . . 0.0 110.732 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.53 ' HA ' ' HB ' ' A' ' 69' ' ' ILE . 12.4 p -39.06 114.45 0.4 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.314 -0.866 . . . . 0.0 111.006 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.2 m -112.02 93.34 4.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.0 109.387 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 82.99 77.47 1.09 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.558 ' CB ' ' HB3' ' A' ' 87' ' ' PHE . 1.6 p -156.26 123.03 5.2 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.273 -1.134 . . . . 0.0 110.974 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -87.16 103.09 15.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 109.884 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.585 HD12 ' CE1' ' A' ' 42' ' ' PHE . 2.8 mp -89.03 14.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.056 -1.028 . . . . 0.0 110.122 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -42.58 141.45 1.02 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.335 -0.853 . . . . 0.0 109.789 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . 172.89 155.5 11.53 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.185 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.56 -2.61 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.173 1.617 . . . . 0.0 110.566 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.28 31.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.464 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -49.63 128.41 17.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 110.336 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -114.75 127.81 55.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.427 -0.796 . . . . 0.0 110.528 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.562 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 4.6 mt -138.99 149.87 23.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.139 -0.976 . . . . 0.0 109.853 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 81' ' ' LYS . 83.8 p -147.04 106.04 3.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.051 -1.031 . . . . 0.0 110.699 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.0 m 50.96 73.06 0.31 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 111.583 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.537 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 14.6 t -129.1 119.92 25.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.475 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.477 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 1.7 mp -48.32 -75.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 109.918 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 87' ' ' PHE . 10.8 mt 62.81 140.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 0.0 109.683 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 81.3 m -165.74 101.8 0.68 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.118 -0.989 . . . . 0.0 111.315 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.85 23.73 24.82 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.565 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 85.19 8.92 80.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 70' ' ' THR . 20.3 m -112.48 121.89 37.78 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.55 -0.971 . . . . 0.0 109.814 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.27 124.09 6.99 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.712 1.375 . . . . 0.0 110.381 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.22 139.34 34.29 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.879 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.68 91.99 0.79 Allowed 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.105 1.582 . . . . 0.0 111.035 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.46 147.35 45.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.107 -0.996 . . . . 0.0 110.464 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.76 -12.11 32.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 110.543 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.519 ' CB ' HG22 ' A' ' 66' ' ' THR . . . -103.82 -18.14 14.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.93 . . . . 0.0 110.664 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 14.1 t -71.9 157.95 36.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.147 -0.971 . . . . 0.0 109.939 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.531 ' HE3' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -101.53 -11.78 19.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.028 -1.045 . . . . 0.0 112.925 -177.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.522 ' N ' ' HD3' ' A' ' 81' ' ' LYS . 26.7 mm 26.41 50.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.443 -0.786 . . . . 0.0 111.423 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.6 m -108.21 -157.67 0.62 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.867 -1.146 . . . . 0.0 110.946 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.25 98.63 0.17 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.507 ' SG ' HG22 ' A' ' 57' ' ' ILE . 3.7 t -170.87 -168.43 0.66 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.354 -1.086 . . . . 0.0 109.662 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 2.7 t -177.03 158.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.919 -1.113 . . . . 0.0 109.653 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 69' ' ' ILE . 10.4 m-85 -118.95 -49.44 2.42 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 110.548 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 15.4 m 61.89 11.92 4.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.283 -0.885 . . . . 0.0 109.858 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 88' ' ' SER . . . 57.15 119.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.439 -0.788 . . . . 0.0 110.392 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.5 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 3.8 t30 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.183 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.297 0.57 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.19 -177.56 35.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.6 m -129.33 45.07 2.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -1.132 . . . . 0.0 110.032 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 5' ' ' THR . 6.8 m -78.19 -61.4 2.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 109.84 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 9' ' ' SER . 3.2 m 76.91 -13.78 0.9 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.878 -0.514 . . . . 0.0 111.398 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 24' ' ' ASN . 13.6 p30 35.82 40.61 0.09 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.065 -1.022 . . . . 0.0 110.611 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER 70.8 35.37 1.78 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.109 -0.995 . . . . 0.0 111.195 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.2 OUTLIER 168.93 -42.32 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.932 -1.105 . . . . 0.0 110.602 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 5' ' ' THR . 0.2 OUTLIER 73.16 89.55 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.467 -0.771 . . . . 0.0 110.751 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.508 ' CD ' ' CD1' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -131.24 18.33 4.92 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.155 -0.966 . . . . 0.0 109.565 179.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.548 HD11 ' CB ' ' A' ' 15' ' ' SER . 1.6 mm? -39.42 101.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.544 0.687 . . . . 0.0 110.251 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.531 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -87.0 163.02 17.3 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.641 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HB3' ' C ' ' A' ' 28' ' ' ASP . . . 49.43 -157.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.068 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -90.49 57.58 3.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 111.482 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.548 ' CB ' HD11 ' A' ' 11' ' ' LEU . 22.0 p -58.54 -168.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.832 -1.167 . . . . 0.0 110.249 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' CB ' ' HG2' ' A' ' 31' ' ' GLU . 34.8 tttt -154.32 146.93 24.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.05 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.58 167.52 16.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.074 -1.016 . . . . 0.0 110.709 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -176.3 -154.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.504 -0.747 . . . . 0.0 109.651 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.44 54.09 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.017 . . . . 0.0 110.033 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 33' ' ' TYR . 7.9 t -111.99 168.63 9.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.223 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -104.67 105.92 16.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 109.709 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 22' ' ' LEU . 4.3 mm? -107.93 145.8 33.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.774 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 15.7 m -161.13 118.83 2.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 0.0 109.615 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 6' ' ' ASN . 26.5 m-20 59.01 64.07 1.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 110.057 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -142.67 169.93 16.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.916 . . . . 0.0 110.581 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 13.5 m-85 -129.13 -40.83 1.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 11' ' ' LEU . 3.6 t 47.24 112.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.586 0.707 . . . . 0.0 112.017 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.531 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -98.13 -91.91 0.26 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.157 -0.964 . . . . 0.0 109.219 178.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -93.63 68.85 4.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.079 -1.013 . . . . 0.0 109.632 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.536 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 0.7 OUTLIER -135.76 -172.98 3.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 110.604 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.487 ' HG2' ' CB ' ' A' ' 16' ' ' LYS . 9.5 mt-10 -137.72 -66.4 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.396 -0.815 . . . . 0.0 110.242 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.539 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 2.5 t 69.99 150.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.348 -0.845 . . . . 0.0 110.371 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 20' ' ' SER . 51.0 m-85 -138.68 -46.39 0.49 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.192 -0.942 . . . . 0.0 110.687 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.4 18.36 3.27 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.539 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 33.0 m -67.37 162.14 23.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.181 -1.188 . . . . 0.0 110.369 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 38' ' ' THR . 6.4 m -121.11 64.93 0.87 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.497 ' O ' ' HB ' ' A' ' 23' ' ' THR . 5.3 t -42.42 97.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.495 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.456 ' O ' HG21 ' A' ' 38' ' ' THR . 27.9 m -89.95 20.36 4.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.98 -1.075 . . . . 0.0 109.622 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.16 47.1 0.19 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.9 p -126.54 -156.11 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 110.443 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' HG2' ' OD1' ' A' ' 90' ' ' ASN . 1.1 ptt85 -169.77 153.8 5.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.894 . . . . 0.0 110.199 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 4.2 m-85 -121.63 -175.11 3.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 110.172 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER 178.59 61.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.982 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 111.1 52.01 0.58 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -133.01 -167.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.969 -1.312 . . . . 0.0 110.627 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.447 HG23 ' HE2' ' A' ' 63' ' ' LYS . 32.8 m -160.85 54.81 0.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.416 HG12 ' N ' ' A' ' 48' ' ' THR . 17.3 tt -85.08 169.61 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.461 -0.774 . . . . 0.0 110.33 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 41.7 p -135.78 -127.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.307 -0.87 . . . . 0.0 109.962 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' THR . 38.3 m -69.74 72.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.907 -1.12 . . . . 0.0 110.398 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.471 ' OG ' ' N ' ' A' ' 66' ' ' THR . 57.8 m -130.06 136.31 49.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -95.81 117.77 31.2 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.107 -0.996 . . . . 0.0 109.788 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 1.5 m -125.2 137.73 54.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 109.845 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -115.35 126.37 54.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.046 -1.034 . . . . 0.0 110.535 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 43.64 50.67 6.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.458 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 7.8 p -127.33 141.52 51.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -1.112 . . . . 0.0 110.187 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -99.41 101.53 12.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 110.067 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.531 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 3.0 mp -82.15 7.64 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 m -56.15 163.3 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.056 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.0 155.7 7.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.03 55.37 2.85 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.054 1.555 . . . . 0.0 110.27 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.79 17.19 3.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -45.79 136.57 6.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -1.194 . . . . 0.0 110.518 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.525 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -140.98 120.22 12.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.195 -0.941 . . . . 0.0 110.033 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.541 ' HA ' ' CD ' ' A' ' 81' ' ' LYS . 21.6 mt -135.39 164.95 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.99 -1.069 . . . . 0.0 111.187 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.463 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -155.46 115.6 3.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.567 -0.708 . . . . 0.0 109.498 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.6 m 53.29 86.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.057 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 54.4 m -150.4 99.9 2.82 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.303 -0.873 . . . . 0.0 109.986 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.554 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.7 mp -67.6 96.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.98 -1.075 . . . . 0.0 109.445 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 51' ' ' THR . 9.6 mt -104.2 160.75 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.953 . . . . 0.0 110.717 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.533 ' N ' HG23 ' A' ' 69' ' ' ILE . 25.5 m -163.38 110.07 1.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 109.983 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.83 20.47 55.79 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.553 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 86.58 12.22 69.91 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 70' ' ' THR . 6.5 m -118.65 138.34 25.8 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.41 -1.053 . . . . 0.0 110.292 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HA ' HG12 ' A' ' 69' ' ' ILE . 51.2 Cg_endo -80.64 154.05 20.51 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.939 1.494 . . . . 0.0 110.106 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -83.31 162.36 54.2 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 110.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.46 53.43 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.119 1.589 . . . . 0.0 110.281 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.9 m -103.85 138.65 40.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 110.274 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.09 -23.81 35.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 110.23 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.98 6.04 17.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.428 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 66' ' ' THR . 1.2 t -100.76 154.14 18.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.937 . . . . 0.0 109.874 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.541 ' CD ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.56 -168.98 1.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 110.927 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 2.1 tp 179.03 33.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.8 0.809 . . . . 0.0 109.201 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -62.21 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.454 -0.779 . . . . 0.0 111.266 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.95 82.82 0.34 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.704 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.534 ' SG ' ' CG1' ' A' ' 64' ' ' ILE . 1.8 t -144.82 -152.47 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 110.055 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER 172.9 148.44 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 109.893 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.553 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 1.4 m-85 -119.08 -28.31 5.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.346 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 68.0 m 52.85 -90.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.944 -1.098 . . . . 0.0 109.482 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.596 ' CB ' ' O ' ' A' ' 88' ' ' SER . . . 157.41 74.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.269 0.557 . . . . 0.0 109.725 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.438 ' OD1' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.034 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.331 0.586 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.06 48.55 0.05 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -152.11 63.51 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -1.128 . . . . 0.0 110.241 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.476 ' O ' ' OG1' ' A' ' 5' ' ' THR . 55.8 m -108.8 -117.34 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 109.836 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 9' ' ' SER . 86.7 m -166.78 -36.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.889 -1.132 . . . . 0.0 109.335 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.529 ' HB3' ' CB ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER 49.94 68.05 0.81 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.493 -0.754 . . . . 0.0 109.309 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 95.7 m 50.41 42.71 26.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 109.4 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 7' ' ' THR . 1.3 t-20 70.2 83.58 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.42 -0.8 . . . . 0.0 109.81 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 5' ' ' THR . 3.0 m -138.84 -95.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.201 -0.937 . . . . 0.0 110.421 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER 173.28 -44.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.07 -1.019 . . . . 0.0 110.049 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.436 HD12 ' CB ' ' A' ' 15' ' ' SER . 24.5 tp 48.91 89.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.061 -1.024 . . . . 0.0 109.994 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.502 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -44.48 156.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.747 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.91 -8.71 39.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.0 109.903 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -97.65 -10.32 25.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.325 -0.859 . . . . 0.0 110.135 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.436 ' CB ' HD12 ' A' ' 11' ' ' LEU . 10.7 t -78.18 -158.71 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -141.27 147.11 37.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 t -127.55 85.77 2.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 0.0 110.014 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' LYS . 21.1 tt0 -132.45 84.66 2.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 110.526 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' GLU . 1.2 mttp 52.41 104.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.326 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.403 ' OG ' HG13 ' A' ' 32' ' ' VAL . 35.3 t -158.95 -158.72 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 110.192 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 35' ' ' THR . 0.3 OUTLIER -152.48 86.57 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.277 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.529 ' CB ' ' HB3' ' A' ' 6' ' ' ASN . 4.0 mp -109.46 116.77 32.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.129 -0.982 . . . . 0.0 110.133 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.511 ' N ' ' O ' ' A' ' 37' ' ' CYS . 85.8 m -104.29 119.67 39.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -0.956 . . . . 0.0 110.114 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 23' ' ' THR . 11.8 m-20 56.93 22.2 6.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.987 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.463 ' SG ' ' HG ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -71.2 -145.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 110.42 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.506 ' O ' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -179.34 -50.67 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 26' ' ' TYR . 2.6 t 52.05 121.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.775 0.798 . . . . 0.0 111.41 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.533 ' O ' ' CD ' ' A' ' 29' ' ' LYS . 3.2 t70 -111.49 -25.74 9.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 110.191 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.533 ' CD ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -166.65 58.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 109.955 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.541 ' CB ' HG22 ' A' ' 45' ' ' VAL . 16.9 m -132.89 154.83 50.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 111.237 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.61 96.35 6.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.619 -0.676 . . . . 0.0 109.192 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 12.0 t -91.03 164.52 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 110.941 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 20.5 m-85 -143.19 -36.6 0.37 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . -159.37 29.37 0.4 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 21' ' ' THR . 15.5 m -77.06 159.67 29.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.298 -1.119 . . . . 0.0 110.624 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.47 ' N ' HG21 ' A' ' 35' ' ' THR . 0.6 OUTLIER -112.45 53.36 0.74 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.441 -0.787 . . . . 0.0 109.695 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 23' ' ' THR . 5.1 t -39.48 103.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.487 -0.758 . . . . 0.0 110.839 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 23.4 m -103.56 79.37 1.68 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.989 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.51 69.22 1.43 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 41' ' ' ARG . 1.5 m -161.27 -148.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -1.099 . . . . 0.0 110.184 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 40' ' ' SER . 1.3 ttp180 172.79 158.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.917 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CD1' ' CG1' ' A' ' 57' ' ' ILE . 2.5 m-85 -121.72 -173.2 2.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 0.0 110.166 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -173.65 57.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.252 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 117.17 47.71 0.46 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.541 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.73 -166.15 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.724 -1.457 . . . . 0.0 111.156 -179.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 64' ' ' ILE . 22.1 m -156.16 58.16 0.58 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.339 0.59 . . . . 0.0 109.433 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.527 ' HA ' ' HB ' ' A' ' 64' ' ' ILE . 11.1 tt -84.76 154.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 111.239 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 66' ' ' THR . 72.8 p -148.98 148.5 29.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.605 -0.684 . . . . 0.0 109.913 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.569 ' OG1' ' HA ' ' A' ' 66' ' ' THR . 0.1 OUTLIER 43.28 33.32 0.57 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.009 -1.057 . . . . 0.0 110.772 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.477 ' OG ' HD12 ' A' ' 47' ' ' ILE . 28.3 t -100.77 128.79 46.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.904 -1.122 . . . . 0.0 110.059 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 52' ' ' SER . 3.4 m -92.48 22.35 4.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 110.417 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -40.4 125.62 2.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.427 -0.796 . . . . 0.0 110.868 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.465 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 1.6 m -106.95 94.81 5.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 109.511 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 72.45 77.09 0.58 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 1.3 p -147.2 117.53 7.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.352 -1.087 . . . . 0.0 110.366 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.53 ' CG ' ' HB2' ' A' ' 90' ' ' ASN . 2.8 ttt-85 -68.4 107.25 2.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.587 ' CG2' ' CD1' ' A' ' 64' ' ' ILE . 15.2 mm -88.44 0.22 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.108 -0.995 . . . . 0.0 109.763 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -40.41 125.0 2.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.385 -0.822 . . . . 0.0 110.424 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -167.1 144.77 9.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.05 81.47 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.927 1.488 . . . . 0.0 109.952 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.0 15.73 53.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 15.7 t -44.18 164.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.334 -1.098 . . . . 0.0 111.221 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 62' ' ' CYS . 8.0 ttpp -150.45 114.03 4.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.483 -0.76 . . . . 0.0 110.168 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.587 ' CD1' ' CG2' ' A' ' 57' ' ' ILE . 4.4 mt -129.83 155.95 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.911 -1.118 . . . . 0.0 111.012 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.444 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -156.01 120.48 4.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.311 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.569 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 9.4 m 44.55 71.49 0.25 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -0.845 . . . . 0.0 111.008 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 98.1 m -122.58 120.8 34.86 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.407 -0.808 . . . . 0.0 109.64 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.618 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 2.3 mp -88.92 86.02 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.103 -0.998 . . . . 0.0 109.777 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 3.7 mt -102.49 157.22 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.435 -0.791 . . . . 0.0 110.356 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.47 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 53.6 m -153.95 105.49 2.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 0.0 110.24 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' O ' ' HB1' ' A' ' 89' ' ' ALA . . . 88.02 17.27 58.08 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.55 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 92.36 13.49 57.16 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 69' ' ' ILE . 12.9 m -121.76 129.2 25.27 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.454 -1.027 . . . . 0.0 110.436 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -81.24 132.76 8.37 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.928 1.489 . . . . 0.0 110.822 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.28 161.08 76.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.262 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.7 64.41 1.24 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.765 1.403 . . . . 0.0 109.953 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -99.58 118.08 35.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 0.0 110.242 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.62 -4.6 24.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 110.006 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.59 -19.13 18.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.854 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.534 ' SG ' ' CD1' ' A' ' 82' ' ' ILE . 26.0 t -68.6 165.48 19.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.09 -1.006 . . . . 0.0 109.934 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.594 ' O ' ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -105.14 7.21 33.67 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.289 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.594 ' C ' ' O ' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -15.01 82.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.543 0 CA-C-N 118.909 0.777 . . . . 0.0 111.56 -178.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -128.89 -70.21 0.68 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 111.308 -178.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -129.21 86.87 0.31 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.173 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.473 ' O ' ' HB ' ' A' ' 86' ' ' THR . 3.8 t -177.05 -150.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -1.161 . . . . 0.0 110.084 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 85' ' ' CYS . 1.7 t 174.0 161.87 0.17 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.55 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 3.1 m-85 -113.03 -52.56 2.77 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.945 -1.097 . . . . 0.0 110.011 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER 65.22 7.85 4.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 110.312 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 55.65 112.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 110.675 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.53 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . 7.9 t30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.16 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 28.6 p-10 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.155 0.502 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.47 -65.99 0.3 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -123.93 124.91 43.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.171 -1.194 . . . . 0.0 110.216 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.48 ' HB3' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -161.58 -157.21 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.123 -0.986 . . . . 0.0 110.453 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.556 ' CG2' ' O ' ' A' ' 5' ' ' THR . 7.3 m -171.23 35.15 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 7' ' ' THR . 8.1 t-20 55.94 -88.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.558 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 3.2 m -142.5 -0.71 1.21 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.573 -0.704 . . . . 0.0 109.744 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.558 ' HB3' ' O ' ' A' ' 7' ' ' THR . 1.2 p30 173.13 -19.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.534 -0.729 . . . . 0.0 111.061 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 25' ' ' CYS . 60.4 p -87.91 -115.9 0.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.908 -1.12 . . . . 0.0 112.448 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' CG ' ' N ' ' A' ' 11' ' ' LEU . 8.4 pt20 -128.36 -43.53 1.44 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.974 -1.079 . . . . 0.0 111.264 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.562 ' N ' ' CG ' ' A' ' 10' ' ' GLN . 14.4 tp 59.82 106.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.199 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -35.67 144.26 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.286 0.565 . . . . 0.0 110.747 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -13.78 6.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.421 -0.8 . . . . 0.0 110.13 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -112.53 8.52 19.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 110.71 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.547 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 2.0 t -82.46 -152.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.891 -1.131 . . . . 0.0 109.955 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -147.19 152.93 39.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.933 -1.104 . . . . 0.0 110.955 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.542 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 9.5 p -142.27 -153.44 0.46 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.313 -0.867 . . . . 0.0 109.911 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 17' ' ' CYS . 14.6 mm-40 57.05 159.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.114 -0.991 . . . . 0.0 110.173 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 44.31 63.21 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.0 109.946 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.532 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . 68.9 p -170.55 160.95 7.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.441 -0.787 . . . . 0.0 109.834 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.466 ' N ' HD21 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -125.37 104.47 8.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.087 -1.008 . . . . 0.0 108.79 179.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.607 ' CB ' ' HB3' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -144.2 -168.62 2.92 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.308 -178.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 24' ' ' ASN . 1.3 m -177.78 146.66 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.494 ' HA ' ' OD1' ' A' ' 8' ' ' ASN . 4.3 m-20 45.8 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -0.956 . . . . 0.0 109.871 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 26' ' ' TYR . 60.3 m -140.24 -155.4 0.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.093 -1.005 . . . . 0.0 111.007 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.535 ' CB ' ' O ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER 163.19 43.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 12' ' ' SER . 21.6 t -62.11 145.4 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.469 0.652 . . . . 0.0 110.961 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 16.0 m-20 -129.01 3.5 5.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 110.313 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.5 OUTLIER 175.67 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.322 -0.861 . . . . 0.0 109.837 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.522 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 54.3 m -165.26 -160.48 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.953 -1.092 . . . . 0.0 110.343 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 2.5 mt-10 -137.66 -62.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 0.0 110.542 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.531 HG21 ' CG2' ' A' ' 47' ' ' ILE . 3.9 t 64.61 153.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.892 . . . . 0.0 110.74 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.505 ' O ' ' CB ' ' A' ' 20' ' ' SER . 25.9 m-85 -149.86 -77.04 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.504 -0.748 . . . . 0.0 109.336 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 48' ' ' THR . . . -107.95 36.47 4.36 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 36' ' ' THR . 1.0 OUTLIER -82.96 171.79 13.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -1.081 . . . . 0.0 110.46 -179.475 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.528 ' N ' ' CG2' ' A' ' 35' ' ' THR . 1.7 m -119.52 58.81 0.87 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 110.234 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.607 ' HB3' ' CB ' ' A' ' 22' ' ' LEU . 36.2 t -39.03 103.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.443 -0.785 . . . . 0.0 110.579 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.3 m -106.39 75.84 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.981 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.74 49.03 71.47 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 4.9 p -138.9 169.08 18.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -1.119 . . . . 0.0 110.18 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.403 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -147.44 157.44 43.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 109.994 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 41' ' ' ARG . 2.5 m-85 -119.98 -179.44 3.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.154 -0.967 . . . . 0.0 110.454 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -155.71 46.93 0.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 109.47 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 123.94 75.03 0.28 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -150.28 -168.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.196 -1.179 . . . . 0.0 110.453 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 46' ' ' THR . 39.9 m -155.28 57.86 0.64 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.572 -0.705 . . . . 0.0 109.332 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' A' ' 32' ' ' VAL . 11.3 tt -78.33 168.05 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 110.054 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' THR . 2.4 p -143.06 -81.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.569 ' OG1' ' HA ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -110.61 39.91 2.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.233 -0.917 . . . . 0.0 109.386 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.497 ' HB2' ' CD1' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -96.31 124.36 40.28 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.351 -0.843 . . . . 0.0 110.943 -179.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -71.13 135.66 47.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.355 -0.841 . . . . 0.0 108.963 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.6 p -140.82 119.37 12.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.909 -1.12 . . . . 0.0 110.663 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.49 70.15 0.78 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 109.43 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 96.01 91.1 1.79 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 87.3 p -171.92 128.09 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -1.202 . . . . 0.0 110.811 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.535 ' CD ' ' HB2' ' A' ' 88' ' ' SER . 1.4 ptp180 -87.71 105.05 17.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 109.365 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.517 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 5.1 mm -81.66 16.08 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.023 . . . . 0.0 110.992 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.91 156.06 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.025 -1.047 . . . . 0.0 110.038 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.59 143.77 3.77 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.29 -3.35 13.78 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.985 1.519 . . . . 0.0 110.225 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.49 27.65 0.28 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -58.28 141.03 52.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -1.126 . . . . 0.0 110.472 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 6.1 ttpp -151.66 117.04 5.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.529 -0.732 . . . . 0.0 109.2 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.588 ' HA ' ' CD ' ' A' ' 81' ' ' LYS . 2.2 mp -129.36 147.11 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.956 -1.09 . . . . 0.0 111.172 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.518 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -143.2 111.93 6.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 110.181 179.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.569 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 19.8 m 51.76 57.54 6.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.647 -0.658 . . . . 0.0 111.108 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 2.0 t -110.46 129.3 55.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.425 -0.797 . . . . 0.0 110.154 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.541 ' O ' ' CB ' ' A' ' 75' ' ' ALA . 2.0 mp -87.03 93.36 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.029 . . . . 0.0 108.676 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.562 HG22 ' CD2' ' A' ' 87' ' ' PHE . 10.1 mt -106.9 149.55 10.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.392 -0.818 . . . . 0.0 110.489 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 7.5 m -156.04 103.81 2.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 110.734 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.5 24.85 27.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 87' ' ' PHE . . . 83.09 17.14 67.86 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 70' ' ' THR . 14.2 m -124.0 128.53 25.06 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.523 -0.986 . . . . 0.0 110.701 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -82.04 130.65 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.904 1.476 . . . . 0.0 110.313 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -93.02 147.3 33.6 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.09 -1.006 . . . . 0.0 110.153 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.24 101.31 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.948 1.499 . . . . 0.0 109.796 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 78' ' ' ALA . 40.3 t -111.73 -5.63 14.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 110.72 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 77' ' ' SER . . . 70.45 3.63 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.157 -0.964 . . . . 0.0 109.57 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 80' ' ' CYS . . . -125.65 -34.03 2.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 109.318 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 18.2 t -45.09 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.59 -0.694 . . . . 0.0 109.536 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.588 ' CD ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.96 7.45 46.61 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.961 -1.087 . . . . 0.0 112.357 -178.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.579 ' C ' ' O ' ' A' ' 81' ' ' LYS . 17.6 mm -6.69 73.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 81' ' ' LYS . 43.9 t -124.35 -52.06 1.74 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 109.864 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' CYS . . . -147.82 -114.95 0.81 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' GLY . 2.9 t 44.07 -167.82 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.343 -1.092 . . . . 0.0 109.972 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.467 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.6 OUTLIER 175.18 140.22 0.05 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 110.459 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.562 ' CD2' HG22 ' A' ' 69' ' ' ILE . 1.6 m-30 -115.69 170.26 8.58 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.4 -0.813 . . . . 0.0 109.677 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.535 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 6.7 m -165.52 25.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 109.644 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.483 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.02 83.41 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.36 -0.837 . . . . 0.0 109.967 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.441 ' CB ' ' HB3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.317 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.201 0.524 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.88 -121.78 5.35 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 p -59.62 -38.9 82.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -1.158 . . . . 0.0 110.163 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.479 ' O ' ' OG1' ' A' ' 5' ' ' THR . 6.9 t -44.9 141.75 2.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.155 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.599 ' CG2' ' HA ' ' A' ' 9' ' ' SER . 9.0 m -171.87 -84.69 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 5' ' ' THR . 4.3 p30 166.13 71.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.684 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' A' ' 24' ' ' ASN . 3.9 m 63.06 -70.94 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.476 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.573 ' OD1' ' CD2' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -52.22 -47.23 65.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 109.737 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.599 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 0.3 OUTLIER 74.14 50.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.525 -0.735 . . . . 0.0 112.116 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.55 ' O ' ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -109.13 -29.78 8.36 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.867 -1.146 . . . . 0.0 108.289 178.085 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 10' ' ' GLN . 14.2 tp 10.2 107.24 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.356 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.563 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -39.56 155.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.636 -0.665 . . . . 0.0 110.328 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.28 -8.46 25.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 110.203 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.7 -9.39 6.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.09 -1.006 . . . . 0.0 110.454 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.524 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -66.24 -161.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.865 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.448 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 24.6 tttt -165.34 150.28 9.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.126 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 p -126.02 -35.93 2.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.917 . . . . 0.0 110.242 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 58.14 -162.77 0.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.765 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -87.86 62.66 7.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.861 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.533 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 77.9 p -97.63 -172.25 2.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 110.743 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.468 ' C ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -106.65 10.74 30.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' A' ' 37' ' ' CYS . 2.3 tp -37.95 159.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.496 0.665 . . . . 0.0 110.814 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 94.6 m -162.36 123.69 2.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.69 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.1 m120 56.52 60.51 3.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 110.314 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.598 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -120.59 -157.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 110.448 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 25' ' ' CYS . 47.2 m-85 -154.82 -55.98 0.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 30' ' ' SER . 2.4 t 57.72 119.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.477 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.563 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 4.1 m-20 -112.58 -24.68 9.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.49 -0.756 . . . . 0.0 109.817 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 28' ' ' ASP . 5.1 mtpp -163.41 59.23 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.528 -0.732 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.541 ' CB ' HG23 ' A' ' 45' ' ' VAL . 39.1 m -139.88 153.53 47.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.026 . . . . 0.0 111.562 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -115.9 112.2 21.54 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.483 HG11 ' HB ' ' A' ' 35' ' ' THR . 7.0 t -106.84 159.06 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -0.957 . . . . 0.0 110.93 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.521 ' CD1' HG22 ' A' ' 48' ' ' THR . 46.1 m-85 -130.91 -36.41 1.36 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.354 -0.841 . . . . 0.0 110.946 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -151.0 12.76 0.83 Allowed Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.582 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.483 ' HB ' HG11 ' A' ' 32' ' ' VAL . 27.5 m -62.44 162.13 10.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.989 -1.301 . . . . 0.0 110.648 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.468 ' HA ' ' C ' ' A' ' 21' ' ' THR . 19.9 m -109.94 -22.52 11.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.358 -0.839 . . . . 0.0 110.266 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.465 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 4.0 t 42.24 81.13 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.24 -0.913 . . . . 0.0 110.42 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.455 ' HB ' HG23 ' A' ' 53' ' ' THR . 88.8 m -77.06 57.2 1.34 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 109.421 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.39 74.11 1.28 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.469 ' HB3' ' OD1' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -157.35 -161.77 1.11 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.261 -1.14 . . . . 0.0 110.008 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 10.7 ptt180 -167.56 162.33 14.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.031 . . . . 0.0 110.658 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.576 ' CE1' HD12 ' A' ' 57' ' ' ILE . 2.6 m-85 -120.31 -162.72 0.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.371 -0.831 . . . . 0.0 110.217 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER 171.98 53.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 117.27 56.49 0.3 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.541 HG23 ' CB ' ' A' ' 30' ' ' SER . 1.3 m -139.35 -164.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.09 -1.241 . . . . 0.0 110.475 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 46' ' ' THR . 91.5 m -161.07 56.52 0.3 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 31' ' ' GLU . 17.4 tt -83.86 165.47 2.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.378 -0.826 . . . . 0.0 110.589 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 33' ' ' TYR . 66.4 p -129.53 -140.04 0.23 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 109.131 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.531 ' HA ' ' CA ' ' A' ' 34' ' ' GLY . 41.6 m -51.32 129.44 24.84 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.057 -1.027 . . . . 0.0 108.941 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' THR . 41.0 t -171.21 163.18 7.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.006 -1.059 . . . . 0.0 110.587 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.505 ' HB ' HD12 ' A' ' 68' ' ' ILE . 52.9 m -116.83 13.99 15.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.079 -1.013 . . . . 0.0 110.339 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.474 ' C ' ' O ' ' A' ' 51' ' ' THR . 54.5 p -36.18 133.94 0.45 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.644 -0.66 . . . . 0.0 110.653 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 69' ' ' ILE . 6.9 m -127.22 107.64 10.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 110.19 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 64.84 78.93 0.19 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.8 p -158.3 127.47 5.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.153 -1.204 . . . . 0.0 110.611 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.469 ' HB3' ' CB ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -78.54 103.6 8.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.576 HD12 ' CE1' ' A' ' 42' ' ' PHE . 3.1 mp -89.48 16.47 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.963 -1.085 . . . . 0.0 110.66 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.49 159.73 0.69 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.2 -0.937 . . . . 0.0 110.266 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.29 166.82 18.99 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.77 54.03 3.87 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.073 1.565 . . . . 0.0 109.873 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 107.56 22.51 7.35 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 5.0 t -40.56 103.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.584 -0.95 . . . . 0.0 110.384 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 64' ' ' ILE . 13.2 tttt -97.12 146.06 25.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.572 -0.705 . . . . 0.0 109.725 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.511 HG12 ' NZ ' ' A' ' 81' ' ' LYS . 19.2 mt -154.5 144.08 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.052 -1.03 . . . . 0.0 110.783 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.445 ' N ' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -136.4 107.87 6.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.284 -0.885 . . . . 0.0 110.653 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 49' ' ' THR . 5.9 m 58.02 79.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.37 -0.831 . . . . 0.0 111.469 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.512 ' O ' HG13 ' A' ' 69' ' ' ILE . 0.9 OUTLIER -135.63 117.4 15.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 109.981 178.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.555 ' HB ' ' CB ' ' A' ' 75' ' ' ALA . 1.1 mm -76.33 101.75 2.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' THR . 17.4 mt -115.2 155.87 16.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 O-C-N 120.899 -1.126 . . . . 0.0 109.97 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.544 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 86.4 m -159.98 103.02 1.48 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 0.0 110.426 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.94 25.93 28.03 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.17 17.29 69.75 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 70' ' ' THR . 12.4 m -127.63 132.86 24.55 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.393 -1.063 . . . . 0.0 110.859 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -81.46 147.06 15.69 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.02 1.537 . . . . 0.0 110.656 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.646 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . . . -73.15 -153.59 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.154 -0.966 . . . . 0.0 108.403 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.646 ' CD ' ' CB ' ' A' ' 75' ' ' ALA . 43.5 Cg_endo -75.62 9.48 2.24 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 O-C-N 122.404 0.686 . . . . 0.0 111.018 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.498 ' CB ' ' HB3' ' A' ' 80' ' ' CYS . 5.3 p 45.0 50.17 9.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.89 . . . . 0.0 111.448 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.07 -23.6 3.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.02 -1.05 . . . . 0.0 109.153 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.54 40.88 0.25 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 1.2 t -109.49 164.64 12.32 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.902 0.858 . . . . 0.0 110.98 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -96.27 173.71 7.25 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.53 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 17.9 mm -160.1 53.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 t -97.95 -126.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 110.386 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.48 91.54 1.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.428 ' SG ' ' C ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER -162.76 177.51 9.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.147 . . . . 0.0 109.874 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.527 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -177.43 149.57 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.35 -0.844 . . . . 0.0 110.022 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -117.13 166.6 12.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.113 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -148.58 23.91 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.901 -1.125 . . . . 0.0 110.371 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 47.16 62.7 2.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.257 -0.902 . . . . 0.0 109.695 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.469 ' OD1' ' HB3' ' A' ' 40' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.21 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 47.7 t0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.211 0.529 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.45 -126.49 1.84 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.22 42.57 1.9 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -1.158 . . . . 0.0 109.728 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.3 m -93.6 119.37 32.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.459 -0.776 . . . . 0.0 110.49 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 9' ' ' SER . 27.6 m -125.09 -12.67 6.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 110.329 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 7' ' ' THR . 8.4 p30 41.07 43.37 1.83 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.904 -1.123 . . . . 0.0 110.321 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.553 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.0 m 76.48 -5.02 2.25 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.5 -0.75 . . . . 0.0 111.443 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.4 t-20 -160.45 -51.1 0.05 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.812 -1.18 . . . . 0.0 110.633 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.591 ' CB ' ' O ' ' A' ' 8' ' ' ASN . 0.9 OUTLIER 85.18 92.79 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.787 0.803 . . . . 0.0 111.267 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.54 ' CD ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -131.21 26.97 4.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.945 -1.097 . . . . 0.0 108.265 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.571 ' CD1' ' HB ' ' A' ' 27' ' ' VAL . 3.4 mm? -41.25 103.18 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.95 0.881 . . . . 0.0 109.35 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' ALA . 50.8 m -64.94 55.49 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.842 -0.536 . . . . 0.0 111.5 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 56.76 154.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 110.627 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 70.51 -4.68 1.57 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.209 -0.932 . . . . 0.0 111.807 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.559 ' CB ' HD11 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -74.42 176.69 6.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.458 -1.401 . . . . 0.0 110.574 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD3' ' CG ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -160.42 151.53 19.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.392 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 p -166.65 -172.01 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 110.263 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 22.3 tt0 -169.61 -39.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.384 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -177.62 54.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.366 -0.834 . . . . 0.0 109.987 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.454 ' HB2' ' N ' ' A' ' 34' ' ' GLY . 52.0 p -102.92 -163.44 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 110.557 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' THR . 68.8 m -126.77 77.0 1.68 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.979 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.461 ' O ' ' OG1' ' A' ' 23' ' ' THR . 3.5 tp -95.19 165.83 12.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 21.7 m -167.51 128.81 1.52 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.426 -0.796 . . . . 0.0 109.902 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 6' ' ' ASN . 28.8 m-80 56.34 29.14 14.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.075 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -101.8 154.57 18.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.86 . . . . 0.0 110.375 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' CD1' ' CD ' ' A' ' 10' ' ' GLN . 1.9 m-85 -116.69 -40.31 3.2 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.571 ' HB ' ' CD1' ' A' ' 11' ' ' LEU . 6.5 t 52.99 137.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.107 0.956 . . . . 0.0 113.096 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 14.7 t0 -142.2 118.08 10.54 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 14' ' ' ASN . 30.8 mttm 53.11 66.07 1.34 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.009 -1.057 . . . . 0.0 109.301 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.463 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 69.3 m -153.51 151.97 30.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.038 -1.039 . . . . 0.0 110.65 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' CG ' ' HD3' ' A' ' 16' ' ' LYS . 11.0 mt-10 -121.12 112.91 19.28 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.534 -0.729 . . . . 0.0 109.166 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.515 HG11 ' HB ' ' A' ' 35' ' ' THR . 17.0 t -111.13 152.55 13.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.57 -0.707 . . . . 0.0 110.392 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.424 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 51.2 m-85 -144.93 34.71 1.12 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.263 -0.898 . . . . 0.0 110.841 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' N ' ' HB2' ' A' ' 20' ' ' SER . . . 140.9 41.46 0.07 OUTLIER Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.122 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.515 ' HB ' HG11 ' A' ' 32' ' ' VAL . 3.5 m -97.41 124.9 41.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.075 -1.25 . . . . 0.0 110.582 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 21' ' ' THR . 90.4 m -79.98 55.49 2.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.143 -0.973 . . . . 0.0 109.71 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.459 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 29.8 t -46.11 143.6 2.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.534 -0.728 . . . . 0.0 110.689 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -124.08 10.3 8.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 129.89 40.92 0.25 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.409 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 47.2 m -122.38 -167.74 1.61 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 110.075 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 42' ' ' PHE . 2.6 ttt180 -158.19 165.83 33.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 110.35 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.454 ' N ' ' CG ' ' A' ' 41' ' ' ARG . 7.0 m-85 -121.97 -172.2 2.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.814 . . . . 0.0 109.692 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 20.2 t0 -167.8 49.37 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.0 110.562 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 118.47 51.17 0.32 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.1 m -127.87 -166.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.092 -1.24 . . . . 0.0 110.828 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.6 m -161.37 56.28 0.28 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.45 HG12 ' N ' ' A' ' 48' ' ' THR . 13.7 tt -76.56 172.04 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.498 -0.751 . . . . 0.0 110.735 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.45 ' N ' HG12 ' A' ' 47' ' ' ILE . 47.0 p -138.28 -137.04 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 109.551 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 66' ' ' THR . 40.5 m -65.34 81.99 0.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.835 -1.165 . . . . 0.0 109.888 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 67' ' ' CYS . 23.2 t -135.89 148.5 48.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.04 -1.037 . . . . 0.0 111.357 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -95.49 126.36 40.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.078 -1.014 . . . . 0.0 109.12 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.444 ' OG ' ' OG ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -137.04 105.08 5.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 110.004 -179.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -95.11 102.54 14.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.477 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 61.12 92.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 83.7 p -166.15 121.08 1.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -1.213 . . . . 0.0 110.414 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.5 ' HG3' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -81.25 112.72 18.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.008 -1.057 . . . . 0.0 109.458 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.494 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 18.0 mm -88.57 13.27 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.339 -0.851 . . . . 0.0 110.823 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -42.59 141.21 1.07 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.233 -0.917 . . . . 0.0 110.286 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 178.8 146.03 6.4 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -76.39 55.82 4.82 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.024 1.539 . . . . 0.0 109.103 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 117.23 20.17 4.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -39.43 147.25 0.08 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.381 -1.07 . . . . 0.0 110.964 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 24.1 tttt -147.16 100.74 3.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.867 . . . . 0.0 110.048 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.592 ' HA ' ' CG ' ' A' ' 81' ' ' LYS . 3.4 mt -116.19 149.92 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.0 110.431 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -142.18 118.05 10.54 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.202 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.1 m 54.35 80.57 0.12 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 111.892 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.8 t -137.99 128.78 26.9 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.574 ' O ' ' CG2' ' A' ' 68' ' ' ILE . 1.7 mp -82.66 9.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.879 -1.138 . . . . 0.0 110.55 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 68' ' ' ILE . 62.5 mt -18.35 138.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 CA-C-O 121.434 0.635 . . . . 0.0 112.04 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.551 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 52.3 m -148.66 100.9 3.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.961 -1.087 . . . . 0.0 111.477 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 91.67 37.75 6.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 72.07 13.2 76.09 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 70' ' ' THR . 5.3 m -120.3 136.52 25.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.39 -1.065 . . . . 0.0 110.013 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' A' ' 69' ' ' ILE . 44.8 Cg_endo -75.93 142.13 24.82 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.789 1.415 . . . . 0.0 110.682 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.59 167.77 12.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 109.604 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.09 72.95 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.683 1.36 . . . . 0.0 110.031 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.545 ' HB3' ' CB ' ' A' ' 80' ' ' CYS . 4.9 t -115.29 107.41 15.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.477 -0.764 . . . . 0.0 110.242 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.34 -13.9 15.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.964 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.71 -14.44 23.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.392 -0.818 . . . . 0.0 110.108 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 7.2 t -72.39 161.34 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.419 -0.801 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' CG ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -124.55 154.84 40.0 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.53 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 81' ' ' LYS . 18.1 mm -140.77 70.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -137.48 106.54 6.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.828 . . . . 0.0 111.684 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.5 30.23 53.96 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.652 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.454 ' HB2' ' NZ ' ' A' ' 81' ' ' LYS . 5.5 t -150.31 179.31 8.23 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.984 -1.304 . . . . 0.0 110.231 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.0 t -177.31 161.25 1.78 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.383 -0.823 . . . . 0.0 109.726 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -121.68 169.91 10.25 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 109.525 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.48 24.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.8 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 46.61 78.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.463 -0.773 . . . . 0.0 109.965 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.5 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.394 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.202 0.525 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.31 64.32 0.83 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.0 25.86 3.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -1.156 . . . . 0.0 109.916 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.7 p -134.69 150.2 50.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.332 -0.855 . . . . 0.0 109.798 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.577 HG23 ' N ' ' A' ' 9' ' ' SER . 79.3 m -126.82 4.32 6.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.585 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.557 ' OD1' ' N ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER 28.54 41.84 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.602 -0.686 . . . . 0.0 111.873 -179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.543 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER 75.96 22.37 1.45 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.441 -0.787 . . . . 0.0 112.681 178.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.1 OUTLIER 167.81 -25.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.778 -1.201 . . . . 0.0 111.293 179.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.577 ' N ' HG23 ' A' ' 5' ' ' THR . 0.3 OUTLIER 63.75 90.51 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.869 . . . . 0.0 110.121 -178.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -129.46 20.3 5.69 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.68 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.589 ' O ' ' N ' ' A' ' 13' ' ' ALA . 2.3 mm? -43.44 117.42 1.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.566 ' OG ' ' CZ ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -58.6 71.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.517 -0.74 . . . . 0.0 111.134 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 11' ' ' LEU . . . 21.89 59.87 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 120.963 0.411 . . . . 0.0 111.79 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 41.1 t-20 -178.46 -32.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.964 . . . . 0.0 110.307 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.468 ' CB ' HD11 ' A' ' 11' ' ' LEU . 15.1 t -58.42 -176.56 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.558 -0.714 . . . . 0.0 110.998 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 9.9 ttmt -139.47 147.38 41.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 109.791 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.55 127.22 14.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.966 . . . . 0.0 110.32 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -120.72 -38.29 2.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.088 -1.008 . . . . 0.0 110.551 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -174.12 34.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -0.93 . . . . 0.0 109.686 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 p -84.68 -167.97 2.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 110.691 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 21' ' ' THR . 5.7 t -142.47 66.53 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.063 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 22' ' ' LEU . 5.3 mt -77.97 177.07 8.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.996 -1.065 . . . . 0.0 109.988 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 37' ' ' CYS . 55.5 m -164.7 121.44 1.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.866 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' THR . 31.0 m120 56.57 48.7 16.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 109.407 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -119.19 164.84 15.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.59 0.709 . . . . 0.0 110.839 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.592 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 25.1 t80 -138.22 26.06 2.67 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.582 ' HB ' ' CD1' ' A' ' 11' ' ' LEU . 15.1 t -21.67 144.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.016 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 42.8 t0 -145.56 147.05 31.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.467 -0.771 . . . . 0.0 109.801 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 41.9 mtpt 35.43 41.5 0.09 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.569 -0.707 . . . . 0.0 110.34 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.478 ' HB3' HG23 ' A' ' 45' ' ' VAL . 75.3 m -133.19 150.8 51.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 110.851 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 47' ' ' ILE . 7.7 mt-10 -118.29 99.66 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 0.0 109.64 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.525 HG11 ' HB ' ' A' ' 35' ' ' THR . 21.8 t -99.17 163.62 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.512 -0.742 . . . . 0.0 110.528 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -148.44 -14.23 0.34 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.073 -1.017 . . . . 0.0 111.926 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.15 26.45 0.2 Allowed Glycine 0 N--CA 1.494 2.549 0 O-C-N 120.556 -1.34 . . . . 0.0 109.962 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.525 ' HB ' HG11 ' A' ' 32' ' ' VAL . 43.5 m -82.07 168.83 17.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -1.126 . . . . 0.0 110.732 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.482 ' N ' HG23 ' A' ' 35' ' ' THR . 40.0 m -129.33 52.65 1.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.383 -0.823 . . . . 0.0 109.62 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.503 ' O ' ' N ' ' A' ' 23' ' ' THR . 5.9 t -44.02 102.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 110.158 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.404 ' O ' HG21 ' A' ' 38' ' ' THR . 13.5 t -95.84 35.64 1.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 0.0 110.142 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.02 24.5 2.48 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -115.14 -166.98 1.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -1.075 . . . . 0.0 109.489 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.501 ' N ' ' OG ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -164.66 164.53 21.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.898 -1.126 . . . . 0.0 111.159 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 41' ' ' ARG . 7.0 m-85 -123.13 -177.4 3.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.316 -0.865 . . . . 0.0 109.922 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.1 t70 -165.81 53.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.237 -0.914 . . . . 0.0 110.482 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 117.53 66.96 0.36 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.7 m -143.68 -160.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.911 -1.347 . . . . 0.0 111.604 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 62' ' ' CYS . 97.5 m -165.08 58.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.565 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 10.1 tt -81.42 165.29 2.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.345 -0.847 . . . . 0.0 110.923 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 25.0 p -131.34 -143.34 0.24 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 66' ' ' THR . 26.8 m -56.42 110.45 0.77 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.581 -1.325 . . . . 0.0 108.236 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 35' ' ' THR . 1.4 t -161.61 136.96 7.54 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.706 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -98.48 122.03 41.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.335 -0.853 . . . . 0.0 109.637 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.448 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -135.77 129.49 32.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.114 -0.991 . . . . 0.0 110.507 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.1 101.7 10.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.365 -0.834 . . . . 0.0 109.427 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 64.74 99.21 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 85.6 p -174.42 110.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -1.163 . . . . 0.0 110.564 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.528 ' CA ' ' HB3' ' A' ' 90' ' ' ASN . 3.8 ptp180 -77.4 112.12 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.104 -0.997 . . . . 0.0 109.166 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.528 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 32.6 mm -87.57 21.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.083 -1.011 . . . . 0.0 110.548 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.6 m -45.36 160.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 110.144 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.69 163.36 11.59 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.7 47.83 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.005 1.529 . . . . 0.0 109.826 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 123.8 16.22 3.38 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' THR . 3.1 t -36.62 116.75 0.45 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.604 -0.939 . . . . 0.0 110.998 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.569 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 32.2 tttm -107.79 153.76 22.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.882 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.565 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 30.1 mm -152.38 130.66 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.83 -1.168 . . . . 0.0 109.642 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.499 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 62.4 p -132.58 118.51 19.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 0.0 110.257 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.6 OUTLIER 43.44 56.95 4.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.475 -0.766 . . . . 0.0 110.056 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 80' ' ' CYS . 0.8 OUTLIER -113.17 99.05 7.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.943 . . . . 0.0 109.862 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.515 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.9 mp -69.49 86.56 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.978 -1.076 . . . . 0.0 109.114 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' THR . 9.0 mt -89.64 159.9 2.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.624 -0.673 . . . . 0.0 110.189 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.536 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 8.6 m -157.99 96.27 1.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 110.281 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.59 33.25 8.07 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 75.52 16.98 80.31 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 70' ' ' THR . 13.8 m -126.18 131.44 23.96 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.376 -1.073 . . . . 0.0 110.177 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -79.68 151.0 21.86 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.768 1.404 . . . . 0.0 110.453 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . . . -82.82 173.53 7.41 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.093 -1.004 . . . . 0.0 110.094 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -82.4 9.98 3.77 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.759 1.399 . . . . 0.0 109.751 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.9 t -54.97 132.94 48.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.539 -0.725 . . . . 0.0 110.343 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.67 -10.84 55.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.419 -0.801 . . . . 0.0 110.391 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.411 ' HB2' ' HB ' ' A' ' 66' ' ' THR . . . -94.69 -14.25 25.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 109.732 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.467 ' CB ' ' HA ' ' A' ' 67' ' ' CYS . 36.4 t -77.03 123.55 26.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.331 -0.856 . . . . 0.0 109.444 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -100.42 172.89 6.85 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.054 -1.029 . . . . 0.0 110.476 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.557 ' HA ' ' HE3' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -163.23 82.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.46 74.67 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.718 -0.614 . . . . 0.0 111.4 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.18 -13.82 44.27 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.371 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.509 ' O ' ' HB ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -82.04 -164.63 0.84 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.969 -1.312 . . . . 0.0 109.961 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.573 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t 168.82 147.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 109.657 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.573 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -130.57 156.08 45.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.825 . . . . 0.0 109.395 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.427 ' HB3' ' CD ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -145.25 30.34 1.14 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.142 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 51.72 82.14 0.07 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.411 -0.805 . . . . 0.0 108.867 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.528 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.68 -178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.208 0.528 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.41 -47.75 1.0 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m -124.42 -76.97 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.131 -1.217 . . . . 0.0 110.511 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 5' ' ' THR . 59.6 m 49.42 -154.29 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.746 -1.221 . . . . 0.0 110.705 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 4' ' ' CYS . 1.0 OUTLIER 167.47 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.512 ' O ' ' CB ' ' A' ' 7' ' ' THR . 0.9 OUTLIER 64.58 58.12 1.06 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.5 m 75.55 -52.05 0.64 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.316 0.579 . . . . 0.0 109.568 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER 176.2 56.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 179.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 3.7 m -117.45 -140.54 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.423 -0.798 . . . . 0.0 110.341 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -132.06 -37.31 1.13 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.955 . . . . 0.0 110.593 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 17' ' ' CYS . 22.8 tp 47.57 81.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.11 -0.994 . . . . 0.0 108.478 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -43.05 147.13 0.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.825 . . . . 0.0 110.387 -178.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.21 -13.37 12.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.964 . . . . 0.0 109.651 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 53.7 t-20 -90.4 -1.95 57.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.516 -0.74 . . . . 0.0 110.216 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.458 ' OG ' HG13 ' A' ' 27' ' ' VAL . 39.8 t -91.72 -157.52 0.51 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.042 -1.036 . . . . 0.0 109.843 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.495 ' NZ ' ' OH ' ' A' ' 33' ' ' TYR . 4.8 tttt -138.79 159.14 42.85 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 110.113 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 34.9 t -148.87 116.7 6.3 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.286 -0.884 . . . . 0.0 110.744 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 19' ' ' LYS . 2.2 mt-10 -147.68 71.7 1.21 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.493 -0.755 . . . . 0.0 109.272 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 61.83 117.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 108.996 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -158.02 173.43 16.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.025 . . . . 0.0 110.722 -178.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -119.79 30.26 7.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 0.0 109.736 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 35' ' ' THR . 11.2 mt -60.95 -178.79 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 109.963 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 37' ' ' CYS . 24.2 m -166.24 122.23 1.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.787 . . . . 0.0 109.507 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 47.48 46.73 17.47 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.118 -0.989 . . . . 0.0 109.059 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.9 OUTLIER -88.08 -151.12 0.19 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.971 0.891 . . . . 0.0 111.254 -178.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 1.2 t80 174.35 41.77 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.458 HG13 ' OG ' ' A' ' 15' ' ' SER . 26.1 t -50.7 149.43 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.7 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -157.05 131.18 8.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 1.2 mtpt 55.6 19.37 3.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -0.985 . . . . 0.0 110.154 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.463 ' HB3' HG23 ' A' ' 45' ' ' VAL . 69.8 m -122.48 -178.15 3.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.969 -1.082 . . . . 0.0 110.612 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 3.6 tt0 -116.33 -71.91 0.72 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -0.858 . . . . 0.0 110.419 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.474 ' C ' ' CD1' ' A' ' 33' ' ' TYR . 3.7 t 66.45 140.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.594 -0.691 . . . . 0.0 110.266 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.495 ' OH ' ' NZ ' ' A' ' 16' ' ' LYS . 44.1 m-85 -141.34 -70.81 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 110.587 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.61 22.06 33.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.483 ' HB ' HD22 ' A' ' 22' ' ' LEU . 98.3 m -70.54 160.14 33.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.397 -1.061 . . . . 0.0 111.29 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 37' ' ' CYS . 22.2 m -116.01 49.97 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.495 -0.753 . . . . 0.0 109.742 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.484 ' O ' ' N ' ' A' ' 23' ' ' THR . 31.2 t -39.38 104.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 111.162 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.4 m -98.95 89.84 4.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.156 -0.965 . . . . 0.0 109.838 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.78 38.44 95.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -130.8 -150.65 0.44 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.171 -1.194 . . . . 0.0 110.063 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.514 ' HB3' ' O ' ' A' ' 40' ' ' SER . 18.7 ptt180 177.66 -176.68 0.18 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.317 -0.865 . . . . 0.0 110.518 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 20.4 m-85 -133.16 -169.4 2.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.387 -0.821 . . . . 0.0 109.301 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.88 50.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 109.814 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 115.72 58.14 0.34 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.543 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 2.3 m -138.53 -159.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.989 -1.301 . . . . 0.0 110.709 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.467 ' HB ' ' HA ' ' A' ' 63' ' ' LYS . 87.8 m -161.79 51.04 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.44 -0.788 . . . . 0.0 109.809 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.47 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 6.6 tt -80.27 164.41 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.368 -0.833 . . . . 0.0 110.435 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.461 ' O ' ' OG1' ' A' ' 35' ' ' THR . 46.2 p -136.48 -120.04 0.16 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.347 -0.846 . . . . 0.0 110.333 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 66' ' ' THR . 94.3 m -70.33 70.54 0.41 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.674 -1.266 . . . . 0.0 110.114 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' THR . 1.1 t -124.27 144.79 49.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.147 -0.97 . . . . 0.0 110.529 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -104.65 125.43 50.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.881 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.455 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -136.66 136.17 38.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.999 -1.063 . . . . 0.0 110.122 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.84 89.69 3.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.916 -1.115 . . . . 0.0 109.545 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.1 92.37 0.17 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.9 p -165.2 130.19 2.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -1.143 . . . . 0.0 110.532 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 14.7 ttp85 -93.38 106.66 18.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.125 -0.984 . . . . 0.0 109.157 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.553 HD12 ' CD1' ' A' ' 87' ' ' PHE . 8.7 mm -81.63 13.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 110.435 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -34.43 146.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 0.0 110.8 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.94 153.65 9.68 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.22 36.46 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.972 1.511 . . . . 0.0 109.683 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.92 32.72 0.5 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 45' ' ' VAL . 1.6 t -49.87 166.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.29 -1.123 . . . . 0.0 110.086 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' SG ' ' A' ' 62' ' ' CYS . 31.8 tttp -149.13 106.24 3.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 109.555 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.543 HG12 ' HD3' ' A' ' 81' ' ' LYS . 1.7 mt -121.7 158.56 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.888 -1.133 . . . . 0.0 111.046 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 65' ' ' SER . 1.3 p -163.09 105.76 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.548 -0.72 . . . . 0.0 109.479 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 2.3 m 67.07 78.2 0.25 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.216 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 74.1 m -140.37 121.8 15.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.431 -0.793 . . . . 0.0 109.598 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.9 mp -93.47 83.62 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.937 -1.102 . . . . 0.0 109.324 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' THR . 29.1 mt -86.54 162.46 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.618 -0.676 . . . . 0.0 110.791 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.537 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 27.9 m -158.81 95.29 1.29 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.253 -0.905 . . . . 0.0 110.76 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.57 30.32 13.91 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 81.45 15.32 76.53 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 70' ' ' THR . 10.6 m -127.83 123.78 23.0 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.412 -1.052 . . . . 0.0 110.604 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.455 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 44.8 Cg_endo -75.1 138.88 23.35 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.837 1.441 . . . . 0.0 111.274 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 68' ' ' ILE . . . -73.55 164.29 62.16 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.359 -0.838 . . . . 0.0 109.466 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.0 58.91 2.2 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.75 1.395 . . . . 0.0 110.115 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 m -92.63 119.04 31.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.469 -0.77 . . . . 0.0 110.675 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.15 1.51 15.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.259 -0.9 . . . . 0.0 111.064 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.67 -16.73 14.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.954 -1.091 . . . . 0.0 110.174 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 4.4 t -69.91 165.78 20.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 110.952 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.549 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -60.17 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.651 -0.655 . . . . 0.0 111.876 -179.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 81' ' ' LYS . 4.9 mm 71.96 33.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.2 m -112.12 -84.76 0.58 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.705 -0.622 . . . . 0.0 111.571 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -117.35 84.79 0.38 Allowed Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.737 -1.22 . . . . 0.0 111.0 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 8.7 t -178.95 174.66 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -1.137 . . . . 0.0 110.255 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.505 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 7.4 t -169.6 168.79 9.03 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.553 ' CD1' HD12 ' A' ' 57' ' ' ILE . 1.6 m-85 -126.41 157.06 39.54 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.022 -1.049 . . . . 0.0 109.389 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.462 ' HB2' ' HB3' ' A' ' 56' ' ' ARG . 4.0 m -129.3 20.42 5.75 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 90' ' ' ASN . . . 53.37 59.58 4.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.5 -0.75 . . . . 0.0 109.921 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.356 0.598 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 3' ' ' SER . . . -74.37 -135.04 0.34 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 2' ' ' GLY . 0.5 OUTLIER 59.65 13.35 3.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -1.181 . . . . 0.0 110.197 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.457 ' HB2' HD22 ' A' ' 11' ' ' LEU . 5.1 m -87.38 -177.75 6.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 109.406 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.49 ' O ' ' C ' ' A' ' 6' ' ' ASN . 31.0 m -129.14 1.18 5.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.079 -1.013 . . . . 0.0 110.114 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 7' ' ' THR . 8.9 p30 35.93 66.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.847 -0.533 . . . . 0.0 110.123 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.5 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.7 OUTLIER 70.31 -57.59 0.57 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 109.297 -178.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER 169.58 81.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.495 ' CB ' ' OD1' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -166.74 -144.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.931 . . . . 0.0 110.313 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.576 ' NE2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -105.6 170.93 7.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.002 . . . . 0.0 110.417 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CD1' ' OG ' ' A' ' 15' ' ' SER . 11.5 tp -178.66 92.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.716 . . . . 0.0 109.843 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -40.62 146.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.537 -0.727 . . . . 0.0 110.581 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.27 -13.85 14.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.128 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -92.71 -5.36 51.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 109.989 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.543 ' OG ' ' CD1' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -68.63 -170.22 0.2 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.16 -0.962 . . . . 0.0 110.245 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 1.5 tttp -146.77 116.01 7.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 110.231 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 15.5 p -110.96 -164.25 0.9 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 0.0 110.242 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 17' ' ' CYS . 17.6 tp10 69.71 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 64.39 40.16 6.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.248 -0.907 . . . . 0.0 109.892 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 t -160.85 169.29 22.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.785 . . . . 0.0 109.575 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 36' ' ' THR . 32.7 m -106.88 104.61 14.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.008 -1.058 . . . . 0.0 109.64 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 1.5 mm? -101.29 150.52 22.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.106 -0.996 . . . . 0.0 110.888 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 16.5 m -163.67 95.0 0.8 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.623 -0.673 . . . . 0.0 109.216 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 23' ' ' THR . 0.4 OUTLIER 66.33 32.93 7.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.552 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 6' ' ' ASN . 98.3 m -59.69 -159.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.663 0.744 . . . . 0.0 110.901 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.576 ' CE2' ' NE2' ' A' ' 10' ' ' GLN . 1.9 t80 179.77 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.52 ' CG2' HD13 ' A' ' 11' ' ' LEU . 1.9 t 36.6 -159.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.58 0.705 . . . . 0.0 111.148 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 12' ' ' SER . 0.5 OUTLIER 171.93 -31.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 5.6 mtmt -169.28 51.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.535 ' CB ' HG22 ' A' ' 45' ' ' VAL . 35.2 m -127.34 -166.63 1.63 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 111.051 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.491 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 2.2 tt0 -129.09 -65.02 0.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.553 -0.717 . . . . 0.0 110.073 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.532 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 3.8 t 67.71 147.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.427 -0.796 . . . . 0.0 110.278 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 33.1 m-85 -134.77 -50.98 0.78 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.14 -0.975 . . . . 0.0 110.614 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -135.56 35.06 2.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.532 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 5.6 m -83.21 136.45 34.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.169 -1.195 . . . . 0.0 109.888 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.526 ' HA ' ' CG2' ' A' ' 21' ' ' THR . 28.3 m -69.0 -10.92 59.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.265 -0.897 . . . . 0.0 110.43 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.478 ' O ' ' N ' ' A' ' 39' ' ' GLY . 5.9 t 42.62 49.59 4.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 110.54 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.8 m -67.37 66.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.73 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 37' ' ' CYS . . . 68.95 75.17 0.55 Allowed Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.66 158.4 43.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 0.0 110.125 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.565 ' HD2' ' CD1' ' A' ' 26' ' ' TYR . 5.3 ttp180 -131.73 160.54 35.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.343 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.441 ' CD1' ' O ' ' A' ' 41' ' ' ARG . 10.4 m-85 -133.21 -169.0 2.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.325 -0.859 . . . . 0.0 109.914 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.453 ' OD1' ' CB ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -174.48 49.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 110.076 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 115.41 60.58 0.36 Allowed Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.535 HG22 ' CB ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -134.91 -167.4 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.812 -1.405 . . . . 0.0 110.651 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.7 m -155.7 56.24 0.61 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.548 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 9.2 tt -78.62 170.02 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.38 -0.825 . . . . 0.0 110.544 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 44.2 p -139.36 -131.63 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' THR . 23.9 m -60.87 123.8 18.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.762 -1.211 . . . . 0.0 109.008 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 35' ' ' THR . 0.4 OUTLIER -166.26 154.83 10.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.007 -1.058 . . . . 0.0 110.605 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 52' ' ' SER . 1.9 m -107.68 17.27 22.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.021 -1.05 . . . . 0.0 109.991 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -39.61 125.02 1.74 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.482 -0.761 . . . . 0.0 110.495 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.485 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 25.0 m -114.97 111.8 21.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.017 . . . . 0.0 110.143 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.72 86.14 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 p -162.06 131.08 4.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -1.165 . . . . 0.0 110.409 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' CA ' ' HB3' ' A' ' 90' ' ' ASN . 4.1 ttm180 -88.66 107.53 18.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.793 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.485 HG21 HG13 ' A' ' 64' ' ' ILE . 19.0 mm -87.47 21.29 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 110.611 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -41.86 143.25 0.56 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.221 -0.924 . . . . 0.0 110.324 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 175.92 153.02 10.0 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.263 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -87.13 62.72 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.036 1.545 . . . . 0.0 109.744 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 62' ' ' CYS . . . 109.16 19.63 8.38 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -42.55 170.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.597 -0.943 . . . . 0.0 111.238 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 17.3 ttmm -157.15 112.61 2.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.509 -0.744 . . . . 0.0 110.092 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.548 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 3.8 mm -119.85 164.41 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.006 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -168.37 113.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.3 m 49.46 65.63 1.35 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 110.376 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.492 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 63.7 m -122.45 97.24 5.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.619 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 75' ' ' ALA . 1.9 mp -64.31 82.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 109.7 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.528 HG12 ' CE2' ' A' ' 87' ' ' PHE . 18.8 mt -97.71 155.36 3.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.821 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.492 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 12.8 m -155.02 101.69 2.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.038 -1.039 . . . . 0.0 110.213 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.03 29.0 16.3 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.528 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 79.18 16.6 78.24 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 70' ' ' THR . 5.5 m -122.91 128.56 25.31 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.364 -1.08 . . . . 0.0 110.537 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.481 ' HG3' HD11 ' A' ' 82' ' ' ILE . 45.1 Cg_endo -76.01 149.28 32.52 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.893 1.47 . . . . 0.0 110.652 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -96.49 164.52 18.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.332 -0.855 . . . . 0.0 109.953 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.31 57.84 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.915 1.482 . . . . 0.0 109.862 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.3 m -91.62 149.76 21.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 0.0 110.535 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.96 -17.96 22.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 110.248 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.86 -9.25 37.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.651 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.508 ' SG ' HG12 ' A' ' 82' ' ' ILE . 31.2 t -75.98 166.32 23.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -1.0 . . . . 0.0 110.013 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -111.28 -46.76 3.26 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.977 -1.077 . . . . 0.0 112.761 -178.504 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.544 ' N ' ' CD ' ' A' ' 81' ' ' LYS . 16.7 mm 46.77 71.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.564 -1.335 . . . . 0.0 109.961 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.449 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 18.6 t -128.79 -106.67 0.3 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 0.0 110.46 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.35 63.69 2.92 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 81' ' ' LYS . 2.0 t -167.52 -172.54 1.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.082 -1.246 . . . . 0.0 110.787 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.538 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.7 t 177.44 162.61 0.52 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.475 -0.766 . . . . 0.0 109.333 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.542 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -120.19 166.52 13.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.021 -1.049 . . . . 0.0 110.048 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -146.16 22.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.437 -0.79 . . . . 0.0 109.74 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 54.25 63.06 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.718 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.485 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.278 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.208 0.528 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.05 161.8 30.56 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t -63.32 -49.48 73.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.305 -1.115 . . . . 0.0 109.941 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 59.47 -173.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 110.15 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 8' ' ' ASN . 28.4 m -153.82 18.82 0.52 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.151 -0.968 . . . . 0.0 109.699 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.544 ' OD1' ' CB ' ' A' ' 9' ' ' SER . 7.1 p30 18.74 57.39 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.177 0.513 . . . . 0.0 112.151 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 97.9 m 55.17 55.4 7.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 5' ' ' THR . 17.6 m-20 60.89 89.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.267 0.556 . . . . 0.0 111.316 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.544 ' CB ' ' OD1' ' A' ' 6' ' ' ASN . 0.5 OUTLIER -165.93 -149.22 0.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.147 -0.971 . . . . 0.0 109.857 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -126.78 101.16 6.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.224 -0.922 . . . . 0.0 110.449 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.546 HD12 ' CB ' ' A' ' 15' ' ' SER . 41.3 tp -105.01 97.45 7.3 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.248 -0.908 . . . . 0.0 109.903 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.542 ' HB2' ' CA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -35.67 133.41 0.4 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.359 0.6 . . . . 0.0 111.205 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.55 -22.66 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 0.0 110.477 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 12' ' ' SER . 0.6 OUTLIER -95.83 -12.57 25.04 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.971 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.546 ' CB ' HD12 ' A' ' 11' ' ' LEU . 4.1 t -64.54 -176.85 0.27 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.928 -1.107 . . . . 0.0 109.729 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.405 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 7.2 tttp -127.58 146.2 50.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.033 -1.042 . . . . 0.0 110.61 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.94 110.81 14.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.031 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.63 -143.42 0.39 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.222 -0.924 . . . . 0.0 110.514 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.24 11.42 28.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.256 -0.902 . . . . 0.0 110.444 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 1.2 p -62.53 169.3 3.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.601 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.482 ' HB ' ' HA ' ' A' ' 36' ' ' THR . 55.3 m -99.11 109.63 22.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.995 -1.066 . . . . 0.0 109.578 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.595 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 2.5 mm? -99.57 144.03 29.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 110.847 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 19.9 m -150.87 107.97 3.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.397 -0.814 . . . . 0.0 109.443 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 54.07 44.43 29.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -0.936 . . . . 0.0 109.007 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 92.8 m -67.59 -157.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.416 -0.803 . . . . 0.0 111.011 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.6 OUTLIER 167.11 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.53 ' CG1' ' OG ' ' A' ' 15' ' ' SER . 5.1 t -70.66 168.16 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.113 0.959 . . . . 0.0 111.409 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' CA ' ' HB2' ' A' ' 12' ' ' SER . 2.8 t70 -148.39 -35.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.42 0.629 . . . . 0.0 109.512 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -157.85 64.54 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.529 -0.732 . . . . 0.0 109.825 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.504 ' OG ' ' CG2' ' A' ' 45' ' ' VAL . 25.7 m -143.84 -175.95 4.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.854 -1.154 . . . . 0.0 111.093 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.508 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -123.43 -66.14 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.6 -0.687 . . . . 0.0 110.353 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.571 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 6.8 t 69.07 165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.628 -0.67 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 50.2 m-85 -159.85 -51.0 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.386 -0.821 . . . . 0.0 110.417 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' A' ' 49' ' ' THR . . . -123.49 -2.7 8.85 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.571 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 34.0 m -49.82 162.16 0.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -1.226 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.482 ' HA ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -102.81 -16.68 15.86 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.171 -0.955 . . . . 0.0 110.063 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 12.6 t 50.85 99.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 0.0 111.18 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.428 ' CG2' HG21 ' A' ' 53' ' ' THR . 20.9 m -114.34 89.88 3.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.113 -0.992 . . . . 0.0 109.483 178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 38' ' ' THR . . . 45.32 56.93 5.95 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 1.3 t -132.62 -175.99 3.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.135 -1.215 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' N ' ' OG ' ' A' ' 40' ' ' SER . 15.4 ptt180 -155.52 151.16 27.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.119 -0.988 . . . . 0.0 110.498 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.454 ' CB ' ' OG ' ' A' ' 30' ' ' SER . 4.8 m-85 -117.46 -175.4 2.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.861 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.454 ' HB3' ' OG ' ' A' ' 58' ' ' SER . 24.0 t70 -166.75 38.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.421 -0.8 . . . . 0.0 109.778 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 129.78 66.7 0.11 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -141.78 -166.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.574 -1.545 . . . . 0.0 111.445 -179.228 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 63' ' ' LYS . 72.3 m -164.95 56.17 0.13 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.518 HG13 ' CG2' ' A' ' 64' ' ' ILE . 7.8 tt -76.6 171.44 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.63 -0.669 . . . . 0.0 110.924 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 44.2 p -135.39 -138.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.827 . . . . 0.0 109.91 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 66' ' ' THR . 53.0 m -65.02 90.28 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.996 -1.065 . . . . 0.0 110.4 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 35' ' ' THR . 44.6 m -145.94 145.9 30.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.858 -1.151 . . . . 0.0 110.558 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -99.8 117.97 35.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.952 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -136.88 124.18 21.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.845 . . . . 0.0 110.124 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -109.1 100.33 9.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.915 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.7 83.72 0.48 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 5.8 p -159.01 116.46 2.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -1.108 . . . . 0.0 110.428 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -75.36 109.87 9.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 109.729 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.521 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 11.1 mm -87.9 3.02 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.071 -1.018 . . . . 0.0 111.171 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 74.8 m -42.03 163.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.218 -0.926 . . . . 0.0 110.403 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 145.92 150.45 5.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.35 59.33 1.91 Allowed 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.902 1.475 . . . . 0.0 109.523 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . 112.53 28.64 3.42 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.438 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 2.0 t -52.6 128.8 27.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.345 -1.091 . . . . 0.0 110.337 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.524 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 2.0 mmtm -120.97 149.77 42.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.095 -1.003 . . . . 0.0 110.968 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.518 ' CG2' HG13 ' A' ' 47' ' ' ILE . 12.6 mm -149.27 135.06 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.48 -0.762 . . . . 0.0 109.334 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.461 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -140.27 116.73 10.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.996 -1.065 . . . . 0.0 110.778 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.7 OUTLIER 45.89 70.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.613 -0.679 . . . . 0.0 111.644 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 52.9 t -133.72 125.88 29.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.612 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 2.3 mp -88.01 81.08 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.237 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.4 mt -88.9 160.43 2.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.706 -0.621 . . . . 0.0 109.742 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.516 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 55.4 m -161.0 96.61 1.11 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.104 -0.998 . . . . 0.0 110.619 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 91.47 30.07 11.29 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.569 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 81.22 14.76 78.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 70' ' ' THR . 11.6 m -123.63 127.36 25.53 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.489 -1.006 . . . . 0.0 110.098 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -80.01 143.02 15.9 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.706 1.372 . . . . 0.0 110.075 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -87.5 149.96 47.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.139 -0.975 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.13 57.73 1.21 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.152 1.606 . . . . 0.0 110.498 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.06 150.74 20.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.758 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.67 -7.1 50.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.522 ' CB ' HG23 ' A' ' 66' ' ' THR . . . -107.55 -16.46 14.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 111.241 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 15.0 t -68.16 129.56 40.29 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.813 -1.179 . . . . 0.0 109.573 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -106.12 171.78 7.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.916 -1.115 . . . . 0.0 110.305 -179.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.537 ' HA ' ' HE3' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -166.64 91.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.524 -0.735 . . . . 0.0 109.027 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.48 -59.18 1.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.056 -1.027 . . . . 0.0 110.555 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.28 52.22 0.64 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 1.7 t -124.55 -150.04 0.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 110.032 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.517 ' CB ' ' O ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER 165.05 143.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.497 -0.752 . . . . 0.0 110.54 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 1.8 m-30 -107.1 -65.0 1.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.537 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER 71.4 8.34 6.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.432 -0.792 . . . . 0.0 110.45 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.408 ' O ' ' OXT' ' A' ' 90' ' ' ASN . . . 54.21 85.73 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.99 . . . . 0.0 109.635 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.446 ' C ' ' OD1' ' A' ' 90' ' ' ASN . 4.5 p30 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.358 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.182 0.515 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.56 69.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.54 61.0 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -1.099 . . . . 0.0 110.514 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.521 ' O ' ' HB ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -96.14 -19.09 19.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.274 -0.891 . . . . 0.0 109.973 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' THR . 42.0 m 63.26 6.74 2.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.708 -0.62 . . . . 0.0 110.651 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.522 ' HB2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER 66.59 -59.83 0.35 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.127 -0.983 . . . . 0.0 109.702 179.733 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 5' ' ' THR . 90.0 m -160.76 -37.25 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.474 -0.766 . . . . 0.0 109.451 179.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.409 ' N ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER 178.08 31.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.393 -0.817 . . . . 0.0 109.834 179.74 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.476 ' OG ' ' CZ ' ' A' ' 26' ' ' TYR . 21.0 t -138.21 -73.21 0.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 110.084 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.57 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -170.25 179.61 3.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.122 -0.986 . . . . 0.0 110.844 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.546 HD12 ' CB ' ' A' ' 15' ' ' SER . 18.9 tp -176.0 90.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.498 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 31.0 t -36.53 137.05 0.31 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.636 -0.665 . . . . 0.0 110.54 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.6 -17.33 2.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 110.567 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -90.88 -7.16 52.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 110.324 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.546 ' CB ' HD12 ' A' ' 11' ' ' LEU . 39.7 t -74.66 -158.76 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.027 . . . . 0.0 109.732 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.407 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 5.5 tttp -148.57 125.92 11.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 109.576 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.538 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 9.8 t -109.89 120.74 43.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.714 -179.199 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 19' ' ' LYS . 8.3 tt0 -167.79 114.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.432 -0.792 . . . . 0.0 110.064 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' GLU . 11.7 mttt 41.73 -123.33 0.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.0 110.309 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.4 OUTLIER 60.4 160.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.889 -1.132 . . . . 0.0 110.071 -179.916 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.38 23.63 9.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.078 -1.014 . . . . 0.0 109.497 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 6' ' ' ASN . 2.3 tp -51.53 152.26 2.77 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.49 -0.756 . . . . 0.0 110.496 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.487 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 41.6 m -164.83 134.58 3.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.409 -0.807 . . . . 0.0 109.829 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.422 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 3.5 m120 50.45 63.52 2.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.032 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -132.55 165.1 25.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.327 -179.9 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.57 ' CD2' ' HB2' ' A' ' 10' ' ' GLN . 44.7 m-85 -121.5 -40.15 2.59 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 30' ' ' SER . 3.6 t 55.21 141.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 122.11 0.957 . . . . 0.0 111.637 178.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -144.87 113.01 6.47 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.551 -0.718 . . . . 0.0 109.347 179.384 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.548 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 54.81 57.53 5.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 109.354 -179.044 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.502 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 6.0 m -134.82 -157.49 0.81 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.758 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.461 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 0.8 OUTLIER -152.34 -62.55 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.567 -0.708 . . . . 0.0 109.968 179.876 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 13.0 t 61.91 162.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.435 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.463 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 11.7 m-85 -155.66 -46.91 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.3 -0.875 . . . . 0.0 110.455 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -134.73 21.6 3.75 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.533 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 6.5 m -74.76 146.52 42.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.134 . . . . 0.0 110.944 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.0 m -106.68 70.31 0.81 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.452 -0.78 . . . . 0.0 109.37 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 13.9 t -60.7 113.6 2.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.519 -0.738 . . . . 0.0 111.273 -179.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.53 ' O ' ' CG2' ' A' ' 38' ' ' THR . 14.3 m -106.03 60.22 0.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 178.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 91.04 71.69 1.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.481 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 70.4 m -154.34 171.58 19.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -1.125 . . . . 0.0 110.315 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -141.12 154.82 46.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.912 . . . . 0.0 110.434 179.77 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 28' ' ' ASP . 8.5 m-85 -118.36 -174.0 2.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 0.0 110.533 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.469 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -173.18 81.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 109.971 179.816 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 84.66 54.23 3.0 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' A' ' 62' ' ' CYS . 0.8 OUTLIER -128.95 -172.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.752 -1.44 . . . . 0.0 110.939 -179.53 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 62' ' ' CYS . 9.3 m -160.4 56.63 0.34 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.461 HG21 ' HA ' ' A' ' 32' ' ' VAL . 11.5 tt -80.99 168.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.454 -0.779 . . . . 0.0 110.573 -179.253 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 43.2 p -136.16 -150.26 0.36 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.395 -0.816 . . . . 0.0 108.834 179.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.7 m -46.75 108.23 0.13 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.878 -1.139 . . . . 0.0 109.185 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 35' ' ' THR . 70.9 m -164.13 140.64 6.51 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 110.131 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -101.05 123.3 45.02 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 109.758 179.608 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -136.11 129.8 32.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 110.234 -179.804 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.57 100.16 9.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 66.88 80.19 0.19 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.22 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.4 p -151.32 113.74 4.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -1.02 . . . . 0.0 110.312 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -73.24 111.36 8.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.165 -0.96 . . . . 0.0 110.134 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.472 ' O ' HG12 ' A' ' 45' ' ' VAL . 11.6 mm -88.41 7.18 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 43' ' ' ASP . 43.3 m -44.83 141.16 2.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.0 110.486 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 171.41 164.24 26.74 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.989 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.53 56.62 6.04 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.06 1.558 . . . . 0.0 109.796 179.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 110.91 19.93 7.47 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.587 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -37.24 113.7 0.27 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.421 -1.047 . . . . 0.0 110.884 179.96 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.499 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 10.1 tttm -107.19 122.21 46.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.984 -1.072 . . . . 0.0 109.809 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.517 ' CD1' ' SG ' ' A' ' 85' ' ' CYS . 5.3 mp -131.54 148.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.111 -0.993 . . . . 0.0 111.223 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.47 ' OG ' ' HB3' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -148.08 120.73 8.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 110.724 179.395 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.7 OUTLIER 48.06 57.35 6.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.402 -0.811 . . . . 0.0 111.277 179.615 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.3 m -115.88 106.6 14.0 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.022 -1.049 . . . . 0.0 109.976 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.589 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.4 mp -76.73 95.77 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.955 . . . . 0.0 109.316 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.56 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.0 mt -103.87 158.99 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 110.595 -179.197 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.407 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 29.8 m -159.22 98.33 1.43 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.33 -0.856 . . . . 0.0 109.589 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.03 23.5 22.48 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.526 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 83.39 15.9 70.31 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 69' ' ' ILE . 11.4 m -120.34 124.41 27.73 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.522 -0.987 . . . . 0.0 110.124 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.48 147.48 28.66 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.916 1.482 . . . . 0.0 111.191 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -92.5 144.95 29.6 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.447 -0.783 . . . . 0.0 108.896 178.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.44 60.35 2.64 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 O-C-N 123.814 1.428 . . . . 0.0 110.393 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -81.91 161.63 23.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 109.909 179.697 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.39 -18.16 57.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.131 -0.981 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 66' ' ' THR . . . -109.31 -25.66 10.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.969 -1.082 . . . . 0.0 110.62 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 19.5 t -47.49 128.42 12.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.106 -0.996 . . . . 0.0 109.958 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.552 ' O ' ' CD1' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -90.59 161.94 15.21 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.984 -1.073 . . . . 0.0 110.259 -179.731 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.552 ' CD1' ' O ' ' A' ' 81' ' ' LYS . 18.4 mm -143.79 67.99 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -146.1 107.85 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 112.417 -177.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . 65.22 73.02 0.63 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.334 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.517 ' SG ' ' CD1' ' A' ' 64' ' ' ILE . 4.6 t -175.39 -174.91 0.76 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -1.227 . . . . 0.0 110.075 178.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.419 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -179.44 152.15 0.51 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.016 -1.053 . . . . 0.0 110.484 -179.066 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.526 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.9 m-30 -109.0 -63.54 1.34 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.438 -0.788 . . . . 0.0 109.422 179.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER 71.14 4.13 4.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.535 -0.728 . . . . 0.0 110.699 179.74 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 57.15 96.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.072 -1.017 . . . . 0.0 109.992 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.136 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 8.8 p-10 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.177 0.513 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.2 -69.21 1.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.3 t -125.18 81.37 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -1.11 . . . . 0.0 109.62 179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.52 ' O ' ' HB ' ' A' ' 5' ' ' THR . 4.3 m -99.07 -23.34 15.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.835 . . . . 0.0 110.304 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 4' ' ' CYS . 31.3 m 66.44 1.87 2.24 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.519 -0.738 . . . . 0.0 110.995 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER 65.59 -54.78 0.35 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.206 -0.934 . . . . 0.0 110.194 -179.812 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 5' ' ' THR . 53.4 m -163.09 -35.56 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.06 -1.025 . . . . 0.0 109.702 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.74 28.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 110.493 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 25' ' ' CYS . 0.6 OUTLIER -132.75 -85.47 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.024 -1.048 . . . . 0.0 110.62 -179.843 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.461 ' O ' HD23 ' A' ' 11' ' ' LEU . 1.8 tt0 -165.87 -164.03 0.68 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.043 -1.035 . . . . 0.0 111.18 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.616 ' CD1' ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -173.39 117.36 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.582 -0.699 . . . . 0.0 109.396 -179.936 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 27' ' ' VAL . 45.3 p -35.14 144.74 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.642 -0.661 . . . . 0.0 110.801 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.16 -25.1 30.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 110.588 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -106.22 3.83 28.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 110.375 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.616 ' CB ' ' CD1' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -55.56 -173.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 110.582 -179.827 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -150.36 119.81 6.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 179.902 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 31.7 p -116.24 72.02 0.8 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.015 -1.053 . . . . 0.0 110.491 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.89 136.37 35.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.145 -0.972 . . . . 0.0 110.15 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 mttt 54.35 36.75 26.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 109.868 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.479 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 6.8 m -143.89 162.91 34.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.557 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -113.8 106.17 14.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.408 -0.807 . . . . 0.0 109.612 179.557 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.536 ' HB3' ' CA ' ' A' ' 6' ' ' ASN . 4.6 mm? -92.87 156.99 16.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 110.6 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.468 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 11.2 m -166.25 121.24 1.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.421 -0.8 . . . . 0.0 109.772 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' THR . 3.6 m-20 42.98 66.17 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.173 -0.955 . . . . 0.0 110.023 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 9' ' ' SER . 14.5 m -137.1 166.24 24.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.189 -0.944 . . . . 0.0 110.671 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 7.9 m-85 -130.09 -47.27 1.11 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.244 179.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.559 ' CG2' HD11 ' A' ' 11' ' ' LEU . 2.8 t 57.46 123.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.539 0.685 . . . . 0.0 110.668 179.025 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.464 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 1.9 m-20 -115.13 -14.97 11.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.284 -0.885 . . . . 0.0 110.362 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.482 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -175.65 66.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.898 . . . . 0.0 110.064 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.523 ' CB ' HG21 ' A' ' 45' ' ' VAL . 68.0 m -138.81 -170.47 2.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.183 -0.948 . . . . 0.0 110.24 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 32' ' ' VAL . 3.3 tt0 -127.88 -63.4 1.02 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.708 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.544 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 2.4 t 68.0 135.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.438 -0.789 . . . . 0.0 110.093 179.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.456 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 10.4 m-85 -147.52 46.61 1.12 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 110.505 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 142.95 -10.39 2.31 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.544 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 45.3 m -61.27 151.38 31.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.237 . . . . 0.0 110.609 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 21' ' ' THR . 51.5 m -88.37 -14.03 39.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.749 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 23' ' ' THR . 0.5 OUTLIER 47.42 70.92 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 179.696 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 99.6 m -87.71 100.77 13.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.133 -0.979 . . . . 0.0 110.15 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 90' ' ' ASN . . . 45.0 67.19 1.24 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.47 ' O ' ' NE ' ' A' ' 41' ' ' ARG . 32.3 t -153.01 173.18 15.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -1.093 . . . . 0.0 110.281 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.489 ' HB2' ' ND2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -149.79 159.68 44.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.393 -0.817 . . . . 0.0 110.044 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.488 ' CB ' ' OG ' ' A' ' 30' ' ' SER . 5.5 m-85 -125.28 -177.91 4.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.986 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -170.25 48.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.892 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 123.48 56.62 0.19 Allowed Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.523 HG21 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.27 -163.34 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.829 -1.395 . . . . 0.0 110.884 -179.775 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 45' ' ' VAL . 13.8 m -166.06 55.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.529 HD12 ' CB ' ' A' ' 50' ' ' SER . 21.4 tt -83.52 170.39 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.419 -0.801 . . . . 0.0 110.786 -179.239 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.476 ' O ' ' OG1' ' A' ' 35' ' ' THR . 62.6 p -128.63 -140.23 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.456 -0.777 . . . . 0.0 109.598 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' THR . 6.4 m -60.17 83.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.959 . . . . 0.0 110.092 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.529 ' CB ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -117.13 140.12 49.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.099 -1.001 . . . . 0.0 110.447 -179.753 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 26.6 m -91.18 19.37 5.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.213 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 68' ' ' ILE . 13.0 p -44.34 125.69 4.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 110.521 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 70' ' ' THR . 32.2 m -104.85 97.17 7.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.695 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 62.62 90.19 0.03 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 52' ' ' SER . 7.1 p -157.33 122.95 4.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.541 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.501 ' HG3' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -75.4 101.51 4.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.074 179.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.514 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 4.0 mt -90.13 16.25 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.62 156.83 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.259 -0.9 . . . . 0.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.68 147.83 5.44 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.67 63.24 7.34 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.978 1.515 . . . . 0.0 110.009 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 113.98 17.4 7.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.52 ' CB ' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -40.28 159.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.543 -0.975 . . . . 0.0 110.946 -179.702 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 12.4 tttt -158.85 117.07 2.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.504 -0.747 . . . . 0.0 109.648 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.527 ' HA ' ' CD ' ' A' ' 81' ' ' LYS . 3.0 mp -135.14 161.56 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.551 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.76 121.35 7.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 110.321 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 49' ' ' THR . 3.5 m 46.45 69.85 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.395 -0.816 . . . . 0.0 110.738 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.569 ' HB3' ' CD1' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -123.48 104.39 9.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.467 -0.771 . . . . 0.0 109.541 179.164 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.7 mp -48.5 -64.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.739 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.612 ' CD1' ' CE2' ' A' ' 87' ' ' PHE . 20.4 mt 55.04 164.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 110.308 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.503 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 55.7 m -145.23 -106.33 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.905 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.96 76.08 2.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' PHE . . . 63.28 12.32 44.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' A' ' 70' ' ' THR . 13.9 m -116.34 136.33 23.04 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.383 -1.069 . . . . 0.0 110.254 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -78.12 138.24 16.05 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.897 1.472 . . . . 0.0 110.088 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -84.53 159.28 58.85 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.408 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.41 53.21 4.62 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 124.04 1.547 . . . . 0.0 110.555 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 t -89.96 158.17 17.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.608 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.2 -14.15 50.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.267 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.06 -22.45 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.336 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.482 ' CB ' ' HA ' ' A' ' 67' ' ' CYS . 34.7 t -63.79 123.14 18.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 110.054 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 82' ' ' ILE . 0.4 OUTLIER -93.15 -169.95 2.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.927 . . . . 0.0 110.481 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.565 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 3.2 tp -179.94 40.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.803 0.811 . . . . 0.0 109.501 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 m -72.78 -96.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 111.64 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.84 66.31 0.95 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.111 -1.043 . . . . 0.0 110.637 -178.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.8 t -160.3 -175.31 4.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.254 . . . . 0.0 110.022 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.547 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.5 t -177.23 159.29 1.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.98 . . . . 0.0 110.423 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.612 ' CE2' ' CD1' ' A' ' 69' ' ' ILE . 1.8 m-85 -118.87 156.68 29.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.787 . . . . 0.0 109.7 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.41 20.35 2.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.243 -0.91 . . . . 0.0 110.38 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 56.6 83.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.235 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.501 ' CB ' ' HG3' ' A' ' 56' ' ' ARG . 43.4 t30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.095 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 1' ' ' ASP . 54.7 p30 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.264 0.554 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -134.44 -129.62 2.93 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.5 p -94.14 0.03 55.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.309 -1.112 . . . . 0.0 110.208 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.457 ' O ' HD22 ' A' ' 11' ' ' LEU . 8.8 t -78.43 152.75 32.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.326 -0.859 . . . . 0.0 110.519 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.551 ' CG2' ' HA ' ' A' ' 9' ' ' SER . 3.3 m -169.9 -83.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.548 ' HB3' ' O ' ' A' ' 5' ' ' THR . 7.5 p30 163.47 50.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.386 0.612 . . . . 0.0 109.863 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.6 OUTLIER 64.64 -64.64 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 110.568 179.893 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.554 ' ND2' ' HB2' ' A' ' 10' ' ' GLN . 0.6 OUTLIER -49.26 -34.46 15.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.097 -1.002 . . . . 0.0 109.964 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 0.7 OUTLIER 72.94 55.53 0.13 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.516 -0.74 . . . . 0.0 111.662 179.49 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.554 ' HB2' ' ND2' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -126.7 18.31 7.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.731 -1.23 . . . . 0.0 109.736 178.811 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.531 HD11 ' CB ' ' A' ' 15' ' ' SER . 13.6 tp -49.51 95.91 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -41.25 146.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 109.899 -179.808 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 14' ' ' ASN . . . -64.48 67.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.09 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 12' ' ' SER . 0.5 OUTLIER 179.9 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.541 -0.725 . . . . 0.0 109.782 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.531 ' CB ' HD11 ' A' ' 11' ' ' LEU . 13.5 t -50.62 -176.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.34 -0.85 . . . . 0.0 110.249 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.16 160.66 41.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.206 -0.934 . . . . 0.0 110.4 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 t -178.55 148.17 0.43 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.162 -0.962 . . . . 0.0 110.24 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.93 -29.42 1.02 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 0.0 110.753 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -170.19 43.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.969 -1.082 . . . . 0.0 110.59 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -93.18 179.01 5.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.252 179.915 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.4 82.64 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 109.807 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 35' ' ' THR . 46.1 mt -94.22 -177.96 4.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -0.89 . . . . 0.0 110.605 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 1.8 m -161.74 118.58 2.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.499 -0.751 . . . . 0.0 109.357 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 43.8 m-20 58.58 75.73 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.419 -0.8 . . . . 0.0 110.261 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.512 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 0.5 OUTLIER -145.5 -157.26 0.78 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.071 -1.018 . . . . 0.0 110.206 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -160.29 -39.56 0.05 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.496 ' O ' ' CE1' ' A' ' 26' ' ' TYR . 9.3 t 53.25 160.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.011 0.91 . . . . 0.0 111.649 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.577 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.2 t70 -171.37 127.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 66.2 mttt 46.48 43.11 11.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -0.984 . . . . 0.0 109.587 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.492 ' CB ' HG22 ' A' ' 45' ' ' VAL . 58.6 m -129.97 157.69 41.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' O ' ' O ' ' A' ' 47' ' ' ILE . 1.1 mt-10 -121.17 98.07 5.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.283 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.475 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 40.6 t -99.93 159.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.413 -0.804 . . . . 0.0 110.53 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 20' ' ' SER . 39.3 m-85 -139.02 -45.85 0.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 110.808 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.423 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -146.0 28.51 1.71 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.475 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 2.3 m -73.47 154.29 40.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.233 -1.157 . . . . 0.0 110.338 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.1 m -114.78 80.73 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -0.831 . . . . 0.0 109.815 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -63.31 151.77 39.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -0.89 . . . . 0.0 110.533 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 66.8 m -138.22 41.17 2.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.315 -0.866 . . . . 0.0 109.982 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 104.64 33.49 3.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.462 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 14.4 m -122.41 -152.46 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -1.151 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.452 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -178.18 168.04 1.95 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.078 -1.014 . . . . 0.0 110.53 179.889 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.452 ' CD1' ' C ' ' A' ' 41' ' ' ARG . 8.3 m-85 -122.49 -169.98 2.0 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -0.891 . . . . 0.0 110.559 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -175.21 48.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.106 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 119.62 61.49 0.26 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.492 HG22 ' CB ' ' A' ' 30' ' ' SER . 2.4 m -137.34 -158.84 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.988 -1.301 . . . . 0.0 111.279 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 62' ' ' CYS . 94.5 m -167.09 58.79 0.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.5 ' O ' ' O ' ' A' ' 31' ' ' GLU . 14.3 tt -85.81 169.41 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 111.234 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 78.0 p -142.24 -148.9 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 109.175 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 59.8 m -46.05 111.97 0.42 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.17 -0.957 . . . . 0.0 108.699 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' THR . 4.3 t -173.36 158.46 3.54 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.125 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -116.98 131.6 56.91 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.044 -1.035 . . . . 0.0 109.783 179.57 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB3' ' HB ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.8 125.65 13.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 109.961 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.7 m -105.48 123.42 47.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.967 . . . . 0.0 109.94 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 45.0 83.33 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 78.7 p -158.15 128.98 6.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.231 -1.158 . . . . 0.0 110.432 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 6.6 ttp180 -94.18 107.55 19.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 110.12 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.473 ' CG2' HD13 ' A' ' 64' ' ' ILE . 2.5 mp -84.52 12.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.94 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 57' ' ' ILE . 1.1 m -42.54 139.78 1.44 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 110.3 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 172.72 175.53 40.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.63 63.24 6.5 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.078 1.568 . . . . 0.0 110.128 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 94.99 2.5 62.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.561 ' C ' ' O ' ' A' ' 61' ' ' GLY . 2.4 t -11.37 121.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -105.98 144.13 33.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.223 -0.923 . . . . 0.0 109.817 179.356 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 63' ' ' LYS . 5.4 mt -152.96 127.18 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.977 . . . . 0.0 110.029 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.449 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -130.99 117.2 18.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 -179.84 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 49' ' ' THR . 3.1 m 54.05 86.15 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -145.7 117.02 7.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.277 -0.89 . . . . 0.0 109.66 179.369 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 3.4 mp -86.15 74.14 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.844 -1.16 . . . . 0.0 108.551 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 51' ' ' THR . 13.7 mt -80.91 160.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.962 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.528 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 97.1 m -158.71 98.85 1.53 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.004 . . . . 0.0 110.985 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 89.24 30.25 14.7 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.454 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.37 14.28 76.79 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 70' ' ' THR . 11.4 m -124.32 135.95 27.09 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.468 -1.019 . . . . 0.0 110.412 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.404 ' HB2' HD13 ' A' ' 82' ' ' ILE . 49.6 Cg_endo -85.58 119.88 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.89 1.468 . . . . 0.0 110.466 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -77.47 167.09 39.22 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.273 -0.892 . . . . 0.0 109.788 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 42.2 Cg_endo -68.87 84.55 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.688 1.362 . . . . 0.0 109.409 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.471 ' OG ' HD13 ' A' ' 68' ' ' ILE . 66.9 m -85.92 -6.35 59.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.631 -0.668 . . . . 0.0 111.155 -178.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 43.8 25.65 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 109.545 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -158.59 -40.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.523 -0.736 . . . . 0.0 109.301 -179.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 66' ' ' THR . 29.1 t -46.95 169.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.555 -0.716 . . . . 0.0 109.738 179.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.542 ' HE3' ' CA ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -108.99 -32.23 7.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.936 -1.103 . . . . 0.0 112.156 -178.108 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.542 ' CA ' ' HE3' ' A' ' 81' ' ' LYS . 4.1 mt 34.15 79.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.403 -0.81 . . . . 0.0 110.322 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.5 m -122.74 -98.14 0.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.92 -1.113 . . . . 0.0 111.088 -179.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.58 21.25 33.61 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -97.33 -163.54 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.253 . . . . 0.0 110.766 -179.726 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.539 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.9 OUTLIER 175.62 148.85 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.55 -0.719 . . . . 0.0 109.941 179.815 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -120.38 173.42 7.15 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.421 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.78 24.35 0.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.012 -1.055 . . . . 0.0 110.228 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 46.87 61.77 2.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.911 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.155 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.2 0.524 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.31 -140.94 3.82 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.0 t -116.69 106.51 13.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.164 -1.198 . . . . 0.0 110.223 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 5' ' ' THR . 4.3 m -92.94 -10.66 35.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' ASN . 3.8 m 71.95 10.91 6.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 110.737 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.588 ' O ' ' CB ' ' A' ' 7' ' ' THR . 4.2 p-10 36.38 46.17 0.4 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.661 . . . . 0.0 109.978 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.588 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.8 m 84.96 -33.81 0.05 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.052 -0.405 . . . . 0.0 110.738 -179.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 5' ' ' THR . 1.9 t-20 179.97 44.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.664 -1.273 . . . . 0.0 112.18 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.542 ' HB2' ' OD1' ' A' ' 6' ' ' ASN . 0.7 OUTLIER -160.99 -132.41 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.766 -1.209 . . . . 0.0 110.472 178.763 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -113.94 -168.48 1.36 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.699 -1.251 . . . . 0.0 111.268 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.593 ' CD1' ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -165.23 69.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.726 . . . . 0.0 109.675 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.527 ' HB3' ' CA ' ' A' ' 28' ' ' ASP . 3.4 p 42.36 23.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.801 . . . . 0.0 110.896 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 41.66 23.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.985 -1.072 . . . . 0.0 110.641 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 28.6 p30 174.4 30.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.494 -0.754 . . . . 0.0 109.682 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.593 ' CB ' ' CD1' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -69.8 -168.66 0.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 0.0 109.844 -179.674 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.524 ' CE ' ' HG3' ' A' ' 31' ' ' GLU . 1.3 mptp? -119.38 107.38 13.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 110.09 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -91.07 -140.23 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.528 -179.632 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 67.35 107.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.881 . . . . 0.0 109.867 -179.503 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 5.2 tttt 66.21 54.85 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 12.6 m -119.63 155.78 31.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 110.964 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 36' ' ' THR . 17.7 m -150.62 82.18 1.35 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.494 -0.754 . . . . 0.0 109.566 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -124.76 -163.54 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 0.0 110.775 -179.122 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 10.1 m -165.85 113.53 0.93 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.412 -0.805 . . . . 0.0 109.812 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' THR . 1.0 OUTLIER 59.05 127.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.432 -0.793 . . . . 0.0 110.047 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.487 ' N ' ' ND2' ' A' ' 6' ' ' ASN . 0.5 OUTLIER 172.9 -169.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 110.12 179.98 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' O ' ' O ' ' A' ' 27' ' ' VAL . 10.5 t80 -142.35 -46.63 0.34 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 108.679 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' SER . 3.5 t 57.14 133.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.673 0.749 . . . . 0.0 111.166 179.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.527 ' CA ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -137.66 124.33 21.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.226 179.336 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.2 mtmp? 42.21 55.37 3.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.503 ' CB ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -134.98 163.5 29.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.985 -1.072 . . . . 0.0 110.835 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' HG3' ' CE ' ' A' ' 16' ' ' LYS . 3.8 tt0 -96.74 -71.02 0.69 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.417 -0.802 . . . . 0.0 109.846 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.577 HG22 ' CE2' ' A' ' 42' ' ' PHE . 13.6 t 59.9 138.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.838 . . . . 0.0 110.614 179.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 20' ' ' SER . 60.5 m-85 -140.33 -81.21 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 109.551 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.42 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -94.41 29.65 8.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.503 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -73.65 161.85 29.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -1.028 . . . . 0.0 110.373 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 36' ' ' THR . 63.7 m -116.39 57.32 0.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.795 . . . . 0.0 109.733 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -40.84 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 110.336 -179.839 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 36' ' ' THR . 85.8 m -89.66 48.91 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 110.261 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.47 24.94 37.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 86.4 p -99.44 -154.39 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -1.057 . . . . 0.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.444 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -167.7 156.29 9.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.099 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.577 ' CE2' HG22 ' A' ' 32' ' ' VAL . 10.0 m-85 -119.88 176.63 5.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.219 -0.926 . . . . 0.0 110.582 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' HB2' ' CB ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -157.49 61.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.5 -0.75 . . . . 0.0 109.814 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 96.92 67.37 0.94 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.4 m -135.92 -160.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.972 -1.311 . . . . 0.0 111.274 -179.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.479 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . 69.8 m -166.17 54.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.391 0.615 . . . . 0.0 109.403 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.443 HG23 HG21 ' A' ' 32' ' ' VAL . 11.9 tt -80.46 172.17 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 110.551 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 14.8 p -140.1 -113.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 66' ' ' THR . 55.3 m -83.55 71.66 10.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.917 -1.114 . . . . 0.0 109.632 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 66' ' ' THR . 4.8 m -128.67 141.76 51.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 110.649 -179.451 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -89.46 133.64 34.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.692 179.593 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.42 121.08 12.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 110.33 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.3 93.73 5.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 109.789 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 62.21 92.69 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 87.5 p -161.21 122.09 2.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -1.099 . . . . 0.0 110.418 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.513 ' HB2' ' CB ' ' A' ' 90' ' ' ASN . 10.3 ttp180 -77.6 103.59 7.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.318 -0.864 . . . . 0.0 109.657 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 32.4 mm -78.63 9.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 110.763 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.451 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 53.1 p -40.84 150.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.143 -0.973 . . . . 0.0 110.602 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 168.09 140.75 3.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.66 57.93 3.12 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.089 1.573 . . . . 0.0 109.762 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.4 20.61 3.23 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -42.83 148.92 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -1.113 . . . . 0.0 110.589 -179.865 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -152.27 112.73 4.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.522 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 1.9 mp -128.81 157.53 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.161 -0.962 . . . . 0.0 110.868 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.462 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -156.87 106.88 2.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.376 -0.828 . . . . 0.0 109.909 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.2 m 63.33 82.18 0.19 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.255 -0.903 . . . . 0.0 110.325 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.487 ' N ' ' OG ' ' A' ' 50' ' ' SER . 16.1 m -146.52 109.09 4.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.441 -0.787 . . . . 0.0 109.662 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.577 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 1.8 mp -73.44 90.21 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.046 -1.033 . . . . 0.0 109.624 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 70' ' ' THR . 10.0 mt -98.25 156.88 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.397 -0.814 . . . . 0.0 110.292 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 5.2 m -155.01 100.79 2.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.193 -0.942 . . . . 0.0 110.45 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.43 35.07 8.88 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 76.61 15.93 81.16 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 70' ' ' THR . 7.9 m -126.01 132.97 24.49 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.314 -1.109 . . . . 0.0 110.838 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.64 153.46 20.26 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.917 1.483 . . . . 0.0 110.601 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -96.25 162.62 23.06 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.907 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.27 75.77 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.062 1.559 . . . . 0.0 110.569 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.57 140.03 45.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.15 -27.92 53.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.31 -2.92 57.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 0.0 110.278 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 66' ' ' THR . 2.5 t -90.03 146.94 23.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 110.061 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -103.02 -164.12 1.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.351 -0.843 . . . . 0.0 111.282 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.56 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 2.3 tp 175.99 34.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.1 m -70.32 -100.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.471 -0.768 . . . . 0.0 111.569 -179.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -99.8 78.96 0.48 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.702 -178.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 86' ' ' THR . 3.8 t -158.43 -174.02 4.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.172 -1.193 . . . . 0.0 109.221 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.571 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 8.0 t -179.7 158.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 0.0 111.153 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -128.35 161.53 29.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.586 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 5.8 t -145.05 12.24 1.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.953 -1.092 . . . . 0.0 110.015 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.527 ' O ' ' OXT' ' A' ' 90' ' ' ASN . . . 68.21 5.11 4.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.213 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.546 ' OXT' ' CG ' ' A' ' 90' ' ' ASN . 1.6 p30 . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 117.375 -1.298 . . . . 0.0 112.152 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 1' ' ' ASP . 18.5 t0 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.212 0.53 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.57 161.81 12.62 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.56 92.66 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -1.154 . . . . 0.0 110.208 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' CB ' HD23 ' A' ' 11' ' ' LEU . 63.5 m -79.03 -160.11 0.22 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.941 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.467 HG23 ' CA ' ' A' ' 8' ' ' ASN . 72.6 m -158.56 10.59 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.004 . . . . 0.0 111.072 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.593 ' O ' ' CB ' ' A' ' 7' ' ' THR . 6.1 t30 42.37 40.35 1.81 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.087 -1.008 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.593 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.6 m 80.71 -25.81 0.17 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.581 -0.699 . . . . 0.0 110.794 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 7' ' ' THR . 1.5 m-80 166.87 65.6 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.857 -1.152 . . . . 0.0 110.494 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 10' ' ' GLN . 10.9 p -160.33 -121.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.924 -1.11 . . . . 0.0 111.126 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.56 ' NE2' ' CE2' ' A' ' 26' ' ' TYR . 1.3 mt-30 -122.65 -54.83 1.84 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.806 -1.184 . . . . 0.0 110.987 -178.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.521 HD13 ' CB ' ' A' ' 15' ' ' SER . 6.8 tp 48.02 82.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 108.995 -178.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 79.7 p -39.46 137.8 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.7 -0.625 . . . . 0.0 110.683 -179.208 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.02 -20.68 2.56 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 109.248 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.492 ' ND2' ' HG3' ' A' ' 29' ' ' LYS . 59.2 t-20 -77.39 -7.09 55.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.507 -0.746 . . . . 0.0 110.146 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.521 ' CB ' HD13 ' A' ' 11' ' ' LEU . 39.8 t -85.7 -163.01 0.79 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 109.915 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.19 133.32 21.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.056 -1.027 . . . . 0.0 110.172 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.487 ' HB3' HD22 ' A' ' 11' ' ' LEU . 25.7 p -132.31 132.92 43.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.164 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -160.48 -84.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 110.234 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.7 39.82 2.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 110.444 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.509 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 48.1 m -105.49 153.32 21.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 110.468 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.1 m -111.54 84.81 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.362 -0.836 . . . . 0.0 109.165 179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.544 ' HB3' ' CB ' ' A' ' 37' ' ' CYS . 6.2 mt -101.03 175.58 5.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.139 -0.975 . . . . 0.0 111.102 -178.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 22.9 m -157.09 107.27 2.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.638 -0.664 . . . . 0.0 109.737 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 39' ' ' GLY . 3.7 m-20 56.99 100.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 110.427 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.545 ' N ' ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -157.92 -173.65 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.162 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.56 ' CE2' ' NE2' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -134.69 -48.43 0.75 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 179.021 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.537 ' CG1' ' HB2' ' A' ' 30' ' ' SER . 14.1 t 55.22 144.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 122.027 0.917 . . . . 0.0 111.532 178.235 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -152.19 121.96 6.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.53 -0.731 . . . . 0.0 109.716 179.271 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.492 ' HG3' ' ND2' ' A' ' 14' ' ' ASN . 0.1 OUTLIER 54.99 39.19 31.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.015 . . . . 0.0 109.97 -179.602 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.537 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 50.3 m -123.36 -163.08 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.257 -0.902 . . . . 0.0 110.52 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' VAL . 1.1 mt-10 -146.21 -72.0 0.24 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.352 -0.842 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.524 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 2.6 t 73.15 141.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.602 -0.686 . . . . 0.0 111.038 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.476 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 38.8 m-85 -145.75 35.89 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.453 -0.779 . . . . 0.0 110.154 179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 145.86 -7.7 1.47 Allowed Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.292 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.524 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -57.87 167.29 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.969 -1.312 . . . . 0.0 110.165 -179.857 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 38' ' ' THR . 9.2 t -108.45 62.14 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 0.0 110.309 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.544 ' CB ' ' HB3' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -47.02 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.2 179.899 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' THR . 2.3 m -100.96 101.43 12.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.153 -0.967 . . . . 0.0 109.724 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 44.21 52.33 7.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 3.8 m -128.16 179.89 5.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.072 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 41.5 mtt180 -149.53 147.85 28.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.873 . . . . 0.0 110.38 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.616 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 17.9 m-30 -116.74 175.84 5.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -0.839 . . . . 0.0 109.593 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.538 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 2.3 t0 -157.85 50.03 0.42 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.058 -1.027 . . . . 0.0 110.376 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 114.34 63.14 0.41 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -132.25 -166.86 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.028 -1.278 . . . . 0.0 110.625 -179.72 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 45' ' ' VAL . 51.4 m -166.16 56.47 0.1 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.533 ' CB ' ' HB ' ' A' ' 64' ' ' ILE . 17.5 tt -82.44 170.74 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.584 -0.697 . . . . 0.0 111.102 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 44.9 p -133.25 -127.06 0.17 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.661 -0.649 . . . . 0.0 109.615 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 66' ' ' THR . 20.5 m -76.43 74.49 3.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.998 -1.064 . . . . 0.0 109.935 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 35' ' ' THR . 7.7 m -128.88 142.92 50.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.043 -1.036 . . . . 0.0 110.372 -179.427 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -86.61 135.13 33.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.021 -1.049 . . . . 0.0 110.19 179.909 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -154.69 125.46 7.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 110.149 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -111.68 121.06 44.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.32 -0.863 . . . . 0.0 110.014 -179.843 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 44.97 85.32 0.01 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 74.9 p -153.42 123.74 7.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.999 . . . . 0.0 110.581 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -86.24 99.87 11.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.178 -0.951 . . . . 0.0 109.466 179.358 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.616 ' CD1' ' CE1' ' A' ' 42' ' ' PHE . 2.7 mp -82.93 18.49 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 110.533 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.538 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -41.17 155.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.386 -0.821 . . . . 0.0 110.031 179.488 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 157.54 151.7 6.11 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.72 53.63 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.088 1.573 . . . . 0.0 110.263 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 119.87 22.47 3.27 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.447 ' O ' HD13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -39.78 108.23 0.08 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.236 -1.155 . . . . 0.0 110.766 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' C ' HD13 ' A' ' 64' ' ' ILE . 17.2 tttp -101.56 122.43 43.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.034 . . . . 0.0 109.669 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.533 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 4.5 mp -128.4 139.83 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.083 -1.011 . . . . 0.0 110.447 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.482 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -143.25 112.43 6.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.015 -1.053 . . . . 0.0 111.065 -179.908 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 1.9 m 48.37 80.37 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.566 -0.709 . . . . 0.0 112.055 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 80' ' ' CYS . 40.0 t -139.2 136.99 35.61 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.604 ' N ' ' CD1' ' A' ' 68' ' ' ILE . 2.0 mp -90.75 88.07 2.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.27 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.584 HG22 ' CD2' ' A' ' 87' ' ' PHE . 12.3 mt -96.6 158.71 3.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.787 -0.571 . . . . 0.0 110.223 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.546 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 3.2 m -166.21 106.49 0.68 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -0.91 . . . . 0.0 110.445 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.29 34.53 12.17 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 71.28 21.09 78.53 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.546 ' CG2' ' O ' ' A' ' 70' ' ' THR . 3.5 m -125.74 120.84 24.41 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.29 -1.124 . . . . 0.0 110.65 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.4 ' HA ' HG12 ' A' ' 69' ' ' ILE . 48.5 Cg_endo -77.83 141.06 18.91 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.721 1.379 . . . . 0.0 110.354 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -95.29 138.66 21.89 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.773 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.22 70.84 3.77 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.9 1.474 . . . . 0.0 110.219 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -97.66 166.55 11.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.35 -15.28 62.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.422 ' CB ' HG21 ' A' ' 66' ' ' THR . . . -112.36 -36.93 5.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.14 -0.975 . . . . 0.0 110.745 -179.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 66' ' ' THR . 15.5 t -44.64 127.11 5.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.099 -1.0 . . . . 0.0 110.777 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -94.71 -172.34 2.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 110.135 179.751 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.569 ' CG2' ' O ' ' A' ' 82' ' ' ILE . 2.6 tp 179.09 39.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.492 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.0 m -104.82 87.27 2.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.052 -1.03 . . . . 0.0 111.766 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.11 52.75 2.67 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.459 178.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.43 ' SG ' HG23 ' A' ' 57' ' ' ILE . 10.0 t -165.46 170.46 14.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.263 -1.139 . . . . 0.0 109.927 179.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.541 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 9.2 t -176.38 159.53 1.99 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.96 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.584 ' CD2' HG22 ' A' ' 69' ' ' ILE . 1.7 m-85 -126.03 151.66 46.82 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.066 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.54 29.41 4.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.313 -0.867 . . . . 0.0 109.239 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 51.41 83.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.402 -0.811 . . . . 0.0 109.648 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.447 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 2.1 tt0 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 121.415 0.626 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.846 HD12 ' OG ' ' A' ' 15' ' ' SER . 2.8 mm? -48.13 113.81 0.81 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.459 -0.776 . . . . 0.0 109.897 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 57.1 p -32.93 -67.21 0.12 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.982 -0.449 . . . . 0.0 110.938 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 12' ' ' SER . . . 179.93 -32.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.113 -0.992 . . . . 0.0 110.709 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -114.07 15.39 18.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 110.373 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.846 ' OG ' HD12 ' A' ' 11' ' ' LEU . 11.2 t -68.26 -171.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.548 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 1.3 tttp -143.96 142.32 30.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.976 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.67 126.83 8.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.04 -51.71 1.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.895 . . . . 0.0 110.404 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.02 55.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.379 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.4 p -101.17 -171.8 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 110.065 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -135.14 63.9 1.6 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.067 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.649 HD23 ' N ' ' A' ' 22' ' ' LEU . 4.0 mt -78.89 -179.01 6.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 0.0 110.539 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 23.6 m -164.25 119.09 1.48 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 110.045 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.466 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 2.4 m120 57.97 45.75 17.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.882 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -155.54 0.55 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.301 -0.875 . . . . 0.0 110.784 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.534 ' HA ' ' HB3' ' A' ' 10' ' ' GLN . 4.1 t80 -167.51 -40.78 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.833 HG13 ' HD2' ' A' ' 42' ' ' PHE . 11.4 t 54.63 149.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.982 0.896 . . . . 0.0 111.773 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 42' ' ' PHE . 4.9 t0 -156.4 122.3 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 11.1 mtpp 49.67 55.01 10.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.915 -1.116 . . . . 0.0 109.512 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.661 ' OG ' HG22 ' A' ' 45' ' ' VAL . 46.2 m -142.98 -175.63 4.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.111 -0.993 . . . . 0.0 110.436 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 5.6 mt-10 -128.2 -67.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.0 110.612 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.703 HG22 ' CG2' ' A' ' 47' ' ' ILE . 7.7 t 62.64 154.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.202 -0.936 . . . . 0.0 110.28 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.427 ' CD2' HG22 ' A' ' 48' ' ' THR . 22.6 m-85 -150.08 -43.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -138.0 25.37 2.92 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.52 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 10.6 m -71.75 151.47 43.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.32 -1.106 . . . . 0.0 110.51 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 36' ' ' THR . 52.1 m -109.13 55.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 109.917 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 17.5 t -40.31 140.76 0.58 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.465 -0.772 . . . . 0.0 110.348 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 38' ' ' THR . 99.6 m -123.69 13.3 9.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.921 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 128.46 51.84 0.13 Allowed Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.52 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 1.3 m -134.71 -169.22 2.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.355 -1.085 . . . . 0.0 110.205 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -147.38 170.71 16.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.277 -0.889 . . . . 0.0 110.183 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.833 ' HD2' HG13 ' A' ' 27' ' ' VAL . 19.8 m-85 -130.88 178.25 6.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.106 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -169.43 65.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 103.27 49.24 1.15 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.661 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -125.66 -176.5 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.729 -1.453 . . . . 0.0 110.962 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.654 ' O ' HG22 ' A' ' 46' ' ' THR . 55.3 m -153.21 55.48 0.76 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.727 HD12 HG21 ' A' ' 64' ' ' ILE . 10.6 tt -82.25 174.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.382 -0.824 . . . . 0.0 110.898 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 50' ' ' SER . 45.1 p -146.24 -136.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -0.755 . . . . 0.0 109.31 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 66' ' ' THR . 99.9 m -58.33 82.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.054 -1.029 . . . . 0.0 110.046 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 48' ' ' THR . 29.3 t -142.36 145.61 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.996 -1.065 . . . . 0.0 110.926 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -98.41 128.16 44.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.142 -0.974 . . . . 0.0 110.231 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -141.16 130.35 23.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.194 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.01 105.3 15.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 109.889 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA2' ' OG ' ' A' ' 40' ' ' SER . . . 51.27 91.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 8.5 p -154.86 119.2 4.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.12 . . . . 0.0 110.53 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.53 ' CD ' ' HB2' ' A' ' 58' ' ' SER . 1.6 ttm180 -72.76 101.96 3.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.696 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.471 ' O ' HG12 ' A' ' 45' ' ' VAL . 7.9 mm -84.07 12.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.956 . . . . 0.0 110.28 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.53 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -42.68 153.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.402 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.53 147.63 4.95 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.56 55.27 4.7 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.911 1.48 . . . . 0.0 109.762 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 63' ' ' LYS . . . 123.6 21.51 2.43 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -46.97 123.31 5.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -1.156 . . . . 0.0 111.108 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.543 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -112.41 145.65 39.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.233 -0.917 . . . . 0.0 109.649 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.727 HG21 HD12 ' A' ' 47' ' ' ILE . 11.3 mt -155.0 126.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.0 110.352 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.482 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -136.31 103.07 5.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.821 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.9 OUTLIER 68.17 80.12 0.21 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.526 -0.734 . . . . 0.0 110.382 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.7 t -138.96 120.38 14.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.846 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.6 mp -88.53 79.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 108.512 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.685 HG23 ' C ' ' A' ' 73' ' ' VAL . 11.1 mt -89.42 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.243 0.544 . . . . 0.0 110.193 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.845 ' O ' HG22 ' A' ' 73' ' ' VAL . 7.2 m -150.52 100.79 2.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.297 -0.877 . . . . 0.0 110.424 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.78 33.14 10.2 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 77.95 15.46 81.14 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 70' ' ' THR . 6.1 m -125.79 129.75 24.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.337 -1.096 . . . . 0.0 110.682 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 46.7 Cg_endo -75.96 144.59 27.37 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.831 1.437 . . . . 0.0 110.253 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -90.86 162.0 34.28 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.693 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.97 66.16 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.793 1.418 . . . . 0.0 110.121 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.489 ' OG ' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -108.07 125.78 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 110.345 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.79 -1.88 15.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 110.304 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.2 -23.73 17.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.091 -1.006 . . . . 0.0 110.493 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 49.3 t -72.87 167.4 21.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.523 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -108.63 -41.31 4.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.014 -1.054 . . . . 0.0 111.765 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.533 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 34.0 mm 47.13 74.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.894 -1.128 . . . . 0.0 109.683 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.59 -80.98 0.6 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.069 -1.019 . . . . 0.0 110.939 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.23 37.99 3.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.5 t -132.04 178.64 6.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.053 -1.263 . . . . 0.0 109.872 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.555 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t -173.87 155.0 2.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.228 -0.92 . . . . 0.0 109.662 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.592 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -125.57 158.28 35.01 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.904 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 26.4 t -141.36 22.87 2.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.719 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.71 80.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.411 -0.806 . . . . 0.0 109.84 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.52 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.394 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.205 0.526 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.707 HD11 ' OG ' ' A' ' 15' ' ' SER . 14.4 tp -102.14 96.25 6.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.101 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -36.34 134.6 0.42 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.53 0.681 . . . . 0.0 111.117 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.85 -21.27 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 110.54 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -96.65 -2.55 44.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.998 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.848 ' OG ' HG11 ' A' ' 27' ' ' VAL . 19.4 t -73.08 -169.15 0.57 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.842 -1.161 . . . . 0.0 110.073 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.75 130.99 14.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.152 -0.968 . . . . 0.0 110.981 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 18' ' ' GLU . 10.3 p -139.64 -179.28 5.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.897 . . . . 0.0 109.804 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 169.65 -80.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 109.74 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.34 13.27 9.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.845 . . . . 0.0 109.602 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -77.0 -147.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.765 . . . . 0.0 110.297 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.621 ' C ' HD22 ' A' ' 22' ' ' LEU . 18.9 m -153.23 88.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 110.321 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.869 HD21 HG11 ' A' ' 32' ' ' VAL . 3.5 mm? -106.31 90.5 3.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.64 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 9.3 m -93.32 139.93 30.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.189 -0.944 . . . . 0.0 111.176 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.471 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 4.4 m120 37.05 40.91 0.17 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.765 -0.584 . . . . 0.0 110.76 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -81.69 -152.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.19 -0.944 . . . . 0.0 110.676 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.564 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 56.5 t80 179.46 42.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.848 HG11 ' OG ' ' A' ' 15' ' ' SER . 6.6 t -53.46 149.95 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.857 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.493 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.1 OUTLIER -130.95 -29.03 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.441 0.639 . . . . 0.0 109.746 179.095 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.52 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 2.4 mtmt -168.86 68.48 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.307 -0.871 . . . . 0.0 109.329 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.759 ' HB2' HG22 ' A' ' 45' ' ' VAL . 84.0 p -141.34 168.68 19.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.119 -0.988 . . . . 0.0 111.706 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 47' ' ' ILE . 5.6 mt-10 -124.03 113.32 18.26 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.869 HG11 HD21 ' A' ' 22' ' ' LEU . 9.3 t -112.57 149.07 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 111.094 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CD1' HG22 ' A' ' 48' ' ' THR . 58.6 m-85 -128.77 -25.95 2.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -0.875 . . . . 0.0 110.905 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -167.82 32.59 0.19 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.576 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 4.8 m -81.98 146.44 29.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -1.157 . . . . 0.0 110.328 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 m -100.91 85.62 2.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.421 -0.8 . . . . 0.0 109.37 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.584 ' HB2' HD13 ' A' ' 22' ' ' LEU . 44.9 t -73.79 101.2 3.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.523 -0.735 . . . . 0.0 110.927 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 38' ' ' THR . 4.3 t -89.08 28.38 1.21 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.3 -0.875 . . . . 0.0 110.101 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 113.49 62.73 0.43 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 9.8 t -139.87 -173.94 3.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.44 -1.035 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.564 ' CB ' ' HB3' ' A' ' 26' ' ' TYR . 13.4 ptt180 -153.46 154.63 34.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.902 -1.124 . . . . 0.0 110.757 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.486 ' HD2' HG13 ' A' ' 27' ' ' VAL . 6.0 m-85 -119.15 -168.99 1.66 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.438 -0.789 . . . . 0.0 109.016 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.505 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 3.5 t0 -179.91 61.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.607 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 106.27 57.61 0.63 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.759 HG22 ' HB2' ' A' ' 30' ' ' SER . 1.0 OUTLIER -138.59 -157.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.887 -1.361 . . . . 0.0 110.601 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.702 ' N ' HG23 ' A' ' 45' ' ' VAL . 65.8 m -167.75 57.28 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.693 -0.629 . . . . 0.0 109.925 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 31' ' ' GLU . 16.0 tt -75.13 162.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 110.155 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' SER . 31.8 p -131.96 -134.34 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.068 -1.02 . . . . 0.0 109.963 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.524 ' O ' HG22 ' A' ' 49' ' ' THR . 95.5 m -65.89 64.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.981 -1.074 . . . . 0.0 110.257 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 48' ' ' THR . 3.1 t -128.08 139.85 52.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 0.0 110.588 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.459 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -90.05 146.71 24.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.859 . . . . 0.0 109.691 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.38 130.99 11.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.04 -1.038 . . . . 0.0 110.597 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.29 111.66 22.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.106 -0.997 . . . . 0.0 110.068 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.9 79.03 0.08 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 13.4 p -148.26 134.82 19.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -1.184 . . . . 0.0 110.111 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -89.99 108.54 19.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.453 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.599 HG23 ' CD1' ' A' ' 64' ' ' ILE . 17.4 mm -88.04 -1.46 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.178 -0.951 . . . . 0.0 109.998 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.505 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 1.1 m -42.56 150.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.36 -0.838 . . . . 0.0 110.864 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 164.16 153.56 7.44 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.94 -2.08 11.45 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.064 1.56 . . . . 0.0 109.903 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.76 34.08 0.08 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.415 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.3 t -65.82 130.26 42.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -1.117 . . . . 0.0 110.452 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 14.5 tttm -135.3 125.1 25.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 110.402 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.605 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 4.3 mt -126.64 146.54 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.99 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 66' ' ' THR . 30.6 p -142.04 126.15 17.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.926 . . . . 0.0 110.516 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 49' ' ' THR . 25.0 m 39.77 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.57 -0.706 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 2.8 t -152.92 108.08 3.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -0.876 . . . . 0.0 110.047 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.733 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -72.3 87.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.488 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.758 HG23 ' C ' ' A' ' 73' ' ' VAL . 3.9 mt -90.22 155.7 3.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.555 -0.716 . . . . 0.0 110.62 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.793 ' O ' HG22 ' A' ' 73' ' ' VAL . 18.7 m -156.31 102.65 2.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.334 -0.854 . . . . 0.0 110.553 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.6 26.76 24.16 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.576 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.77 16.31 70.76 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 70' ' ' THR . 4.0 m -127.24 133.72 25.37 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.536 -0.979 . . . . 0.0 110.155 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.18 148.09 16.66 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.793 1.417 . . . . 0.0 110.666 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -93.77 149.28 36.8 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.563 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.02 114.74 4.06 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.937 1.493 . . . . 0.0 110.85 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.675 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 1.3 t -134.14 -0.6 3.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 110.44 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 66.2 6.84 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.966 . . . . 0.0 110.409 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.28 -32.34 1.37 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.404 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -57.15 151.89 14.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.985 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.66 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -104.13 175.18 5.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.504 -0.747 . . . . 0.0 109.958 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.752 ' O ' HG22 ' A' ' 82' ' ' ILE . 46.1 mm -155.99 38.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.9 m -59.71 -104.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.73 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.92 89.52 0.48 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.708 ' C ' HG22 ' A' ' 86' ' ' THR . 1.6 t -147.18 -149.39 0.29 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.235 . . . . 0.0 110.311 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.708 HG22 ' C ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER 169.98 142.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.391 -0.818 . . . . 0.0 109.539 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.576 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.4 m-85 -116.99 -19.62 9.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.517 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.773 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 0.4 OUTLIER 45.72 -92.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 110.031 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . 157.36 64.92 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.904 -0.498 . . . . 0.0 110.031 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.43 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.004 -1.06 . . . . 0.0 109.978 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 3.9 tt0 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.198 0.523 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 17.3 tp 57.03 111.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.11 -0.994 . . . . 0.0 109.922 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 12.9 t -68.39 161.11 28.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.284 -0.885 . . . . 0.0 110.405 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.74 -8.01 31.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.968 . . . . 0.0 110.073 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -97.74 -11.47 23.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.645 ' OG ' HG11 ' A' ' 27' ' ' VAL . 41.5 t -76.27 -163.29 0.29 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.972 . . . . 0.0 110.046 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.25 134.84 15.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.554 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.1 t -135.7 32.67 3.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.934 . . . . 0.0 110.2 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 19' ' ' LYS . 1.4 tm-20 -55.61 127.21 28.78 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 43.01 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -159.52 -171.07 3.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.044 -1.035 . . . . 0.0 111.005 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' THR . 8.5 m -156.55 72.78 0.75 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.486 -0.759 . . . . 0.0 109.71 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.662 ' O ' ' CB ' ' A' ' 23' ' ' THR . 4.0 mt -75.44 -116.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 110.369 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.662 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 1.1 m 146.21 -62.59 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.479 ' N ' HG22 ' A' ' 23' ' ' THR . 73.7 m-20 -132.03 34.87 3.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.444 -0.785 . . . . 0.0 110.162 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -67.85 -159.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.02 0.914 . . . . 0.0 110.904 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 25' ' ' CYS . 46.9 m-85 -162.96 -54.74 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.654 HG12 ' H ' ' A' ' 28' ' ' ASP . 3.3 t 44.59 -179.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 122.14 0.971 . . . . 0.0 111.727 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.654 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -175.81 -33.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 46.8 mtmt -150.45 56.3 0.93 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.534 ' HB2' HG13 ' A' ' 27' ' ' VAL . 75.5 m -135.5 164.11 28.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.953 -1.092 . . . . 0.0 111.86 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 2.4 tt0 -120.64 107.62 13.02 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.63 HG22 ' CG2' ' A' ' 47' ' ' ILE . 17.9 t -110.29 160.1 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.052 -1.03 . . . . 0.0 111.379 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.556 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 94.9 m-85 -157.33 44.66 0.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.427 -0.796 . . . . 0.0 110.455 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' ' OG ' ' A' ' 20' ' ' SER . . . 138.72 33.08 0.19 Allowed Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.15 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.606 ' HB ' HG11 ' A' ' 32' ' ' VAL . 5.6 m -95.24 144.07 26.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.24 . . . . 0.0 110.257 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 36' ' ' THR . 32.0 m -94.61 53.35 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.36 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.499 ' HB2' ' CB ' ' A' ' 22' ' ' LEU . 1.2 m -50.4 87.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.425 -0.797 . . . . 0.0 110.888 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 36' ' ' THR . 5.2 t -104.78 36.07 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.21 46.6 0.18 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -141.24 167.17 22.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.314 -1.11 . . . . 0.0 109.856 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.471 ' CB ' ' HB2' ' A' ' 26' ' ' TYR . 5.3 ptt180 -146.12 152.11 38.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.961 -1.087 . . . . 0.0 110.803 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.628 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 6.8 m-85 -116.64 -167.63 1.32 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 7.1 t0 -177.46 53.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.414 -0.804 . . . . 0.0 110.165 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 114.88 60.2 0.37 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.512 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.4 m -139.28 -169.98 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.997 -1.296 . . . . 0.0 110.297 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.456 ' O ' HG22 ' A' ' 46' ' ' THR . 35.8 m -149.47 51.02 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.309 -0.869 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.63 ' CG2' HG22 ' A' ' 32' ' ' VAL . 7.9 tt -68.2 173.58 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 110.45 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 12.0 p -142.73 -98.76 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 110.067 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.737 ' O ' HG22 ' A' ' 49' ' ' THR . 15.8 m -104.05 69.83 0.96 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.986 -1.071 . . . . 0.0 109.715 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB2' HD11 ' A' ' 47' ' ' ILE . 10.6 m -121.13 147.19 45.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.116 -0.99 . . . . 0.0 111.161 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -99.66 121.57 41.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.436 -0.79 . . . . 0.0 109.168 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -139.85 136.54 34.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.345 -0.847 . . . . 0.0 110.406 -179.333 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -121.63 89.27 3.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.824 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.09 76.29 1.21 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 p -148.97 124.53 10.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -1.094 . . . . 0.0 110.551 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.46 ' HD2' ' HB2' ' A' ' 58' ' ' SER . 0.1 OUTLIER -90.35 96.66 10.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.242 -0.911 . . . . 0.0 109.896 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.628 ' CD1' ' CE1' ' A' ' 42' ' ' PHE . 3.1 mt -84.15 17.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.671 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -43.8 151.03 0.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.01 -1.057 . . . . 0.0 110.078 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 162.59 162.27 13.33 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.02 -1.35 11.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.134 1.597 . . . . 0.0 109.852 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.68 33.88 0.02 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.447 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.7 t -50.68 123.34 8.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.216 -1.167 . . . . 0.0 110.006 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.515 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 8.6 tttt -102.64 128.2 49.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.07 -1.019 . . . . 0.0 110.174 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 28.8 mm -133.81 141.3 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.907 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -151.62 126.38 9.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.298 -0.876 . . . . 0.0 110.101 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.5 m 39.02 71.59 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.573 0.702 . . . . 0.0 110.756 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.466 ' C ' HD12 ' A' ' 68' ' ' ILE . 73.4 m -130.13 125.6 35.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.428 -0.795 . . . . 0.0 109.252 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.9 mp -93.47 88.48 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.836 -1.165 . . . . 0.0 110.131 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.536 HG12 ' CE2' ' A' ' 87' ' ' PHE . 14.3 mt -96.23 156.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.522 -0.736 . . . . 0.0 110.061 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.787 ' O ' HG22 ' A' ' 73' ' ' VAL . 34.7 m -152.25 93.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 110.224 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.94 31.88 9.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 80.0 16.63 76.44 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 70' ' ' THR . 16.1 m -124.73 120.11 25.73 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.391 -1.064 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -73.72 145.81 37.4 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.949 1.5 . . . . 0.0 110.509 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -90.68 166.61 18.7 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.365 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.4 Cg_endo -72.03 56.3 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.723 1.38 . . . . 0.0 109.603 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.563 ' OG ' HD13 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -84.92 126.09 33.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.242 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.26 -9.13 59.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.837 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.94 -12.61 23.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.353 -0.842 . . . . 0.0 110.526 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' SER . 38.2 t -77.44 168.84 19.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.107 -0.996 . . . . 0.0 109.619 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HE3' ' N ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -98.64 -32.18 11.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.793 -1.192 . . . . 0.0 111.399 -178.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.527 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 28.3 mm 38.19 57.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.186 -0.946 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 m -113.37 -100.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.0 -1.062 . . . . 0.0 110.422 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -101.19 89.58 0.8 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -166.36 -172.72 2.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.147 -1.208 . . . . 0.0 110.759 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.512 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 2.6 t -178.02 157.51 1.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.484 -0.76 . . . . 0.0 109.52 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 2.2 m-30 -114.33 -54.68 2.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 110.076 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 65.07 11.08 6.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.087 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 47.14 95.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 109.963 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 89' ' ' ALA . 5.1 p30 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.305 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.474 ' CB ' ' CD2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.137 0.494 . . . . 0.0 110.155 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.619 HD11 ' OG ' ' A' ' 15' ' ' SER . 12.3 tp 41.19 84.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.365 -0.834 . . . . 0.0 109.892 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.543 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 86.1 p -45.46 164.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 110.187 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 -14.03 60.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.846 . . . . 0.0 110.299 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -93.95 -6.62 45.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.164 -0.96 . . . . 0.0 110.5 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.619 ' OG ' HD11 ' A' ' 11' ' ' LEU . 4.8 t -74.08 -176.65 2.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.957 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.418 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -142.09 131.43 23.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.274 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 t -138.6 159.88 40.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.262 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -172.86 -87.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.014 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -114.55 72.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.134 -0.979 . . . . 0.0 110.1 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -117.92 -164.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.855 . . . . 0.0 110.216 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 21' ' ' THR . 5.2 t -150.15 60.42 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.765 HD23 ' O ' ' A' ' 35' ' ' THR . 13.7 mt -84.62 -171.59 3.71 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.873 0.844 . . . . 0.0 111.455 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 1.5 m -164.78 101.63 0.79 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.484 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 5.6 m-20 59.18 118.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.415 -0.803 . . . . 0.0 109.766 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -171.0 -151.68 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.136 -0.978 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.474 ' CD2' ' CB ' ' A' ' 10' ' ' GLN . 17.9 t80 -157.68 -42.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.837 0.827 . . . . 0.0 108.958 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.838 HG13 ' HD2' ' A' ' 42' ' ' PHE . 6.9 t 39.22 101.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.305 0.574 . . . . 0.0 112.174 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 4.6 t0 -88.71 -130.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.5 mttp -62.36 81.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.783 -1.198 . . . . 0.0 109.072 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.772 ' OG ' HG22 ' A' ' 45' ' ' VAL . 16.9 m -148.87 159.54 44.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.91 -1.119 . . . . 0.0 111.301 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 47' ' ' ILE . 2.2 mt-10 -119.1 115.66 24.73 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.624 HG22 ' CG2' ' A' ' 47' ' ' ILE . 34.2 t -117.21 156.28 18.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.225 -0.922 . . . . 0.0 111.065 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.518 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 41.9 m-85 -135.06 -71.75 0.48 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.143 -0.973 . . . . 0.0 110.913 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 48' ' ' THR . . . -118.36 41.83 1.94 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.765 ' O ' HD23 ' A' ' 22' ' ' LEU . 1.7 m -87.24 172.24 10.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -1.106 . . . . 0.0 110.334 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 6.8 m -112.0 -13.07 13.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.859 -1.151 . . . . 0.0 110.933 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.69 ' HB2' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 35.67 63.34 0.56 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.468 -0.77 . . . . 0.0 110.758 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.632 HG21 HG23 ' A' ' 53' ' ' THR . 88.3 m -65.57 78.57 0.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.411 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 52.27 36.0 44.21 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 41' ' ' ARG . 94.2 p -107.09 -138.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.179 -1.189 . . . . 0.0 109.811 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HB3' ' ND2' ' A' ' 90' ' ' ASN . 32.3 ttt-85 175.96 154.58 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 110.429 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.838 ' HD2' HG13 ' A' ' 27' ' ' VAL . 13.1 m-85 -120.11 168.85 10.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.923 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 3.9 t0 -159.6 73.49 0.57 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.998 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 96.57 49.85 1.92 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.772 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.2 m -131.6 -165.02 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.947 -1.325 . . . . 0.0 111.152 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.675 ' O ' HG22 ' A' ' 46' ' ' THR . 35.9 m -159.92 58.55 0.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.876 HD11 ' HB3' ' A' ' 50' ' ' SER . 13.2 tt -72.55 173.65 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.511 -0.743 . . . . 0.0 110.311 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -137.18 -92.07 0.24 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.373 -0.829 . . . . 0.0 109.886 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.807 ' O ' HG22 ' A' ' 49' ' ' THR . 7.8 m -111.97 65.96 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.876 ' HB3' HD11 ' A' ' 47' ' ' ILE . 1.5 t -108.77 143.27 38.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.551 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.533 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 m -91.85 21.18 5.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.471 -0.768 . . . . 0.0 110.85 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -38.12 128.02 1.31 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.446 -0.783 . . . . 0.0 110.759 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.632 HG23 HG21 ' A' ' 38' ' ' THR . 13.3 m -111.37 101.52 9.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 110.102 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 61.17 77.76 0.18 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.5 p -148.82 122.35 9.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -1.11 . . . . 0.0 110.219 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.553 ' CB ' ' HB3' ' A' ' 88' ' ' SER . 3.7 ttp180 -72.23 103.88 3.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.137 -0.977 . . . . 0.0 110.089 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.494 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 22.6 mm -83.92 11.88 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.319 -0.863 . . . . 0.0 109.827 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -41.73 148.91 0.14 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.347 -0.846 . . . . 0.0 110.244 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 158.06 157.27 8.36 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.27 52.53 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.062 1.559 . . . . 0.0 109.951 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.459 ' O ' ' HD2' ' A' ' 63' ' ' LYS . . . 118.69 18.74 4.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.522 ' HB3' ' CG1' ' A' ' 45' ' ' VAL . 1.7 t -40.77 126.81 2.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.406 -1.055 . . . . 0.0 110.148 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.526 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -108.43 143.21 37.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 110.734 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.096 HD13 ' NZ ' ' A' ' 81' ' ' LYS . 17.4 mm -143.06 125.07 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 109.042 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -133.94 121.49 21.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 110.602 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 49' ' ' THR . 15.6 m 37.76 53.64 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.705 -0.622 . . . . 0.0 111.145 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.587 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 4.8 t -118.47 109.79 16.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.948 . . . . 0.0 109.339 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 68' ' ' ILE . 2.0 mp -52.52 -66.28 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.711 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 73' ' ' VAL . 9.5 mt 56.74 157.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -0.784 . . . . 0.0 109.923 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.853 ' O ' HG22 ' A' ' 73' ' ' VAL . 5.7 m -169.66 107.51 0.39 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.898 -1.126 . . . . 0.0 111.186 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.41 28.08 31.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.572 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 85.38 10.9 76.4 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 70' ' ' THR . 11.7 m -120.5 136.73 25.5 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.207 -1.172 . . . . 0.0 110.033 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.454 ' HA ' HG12 ' A' ' 69' ' ' ILE . 48.3 Cg_endo -77.4 138.02 17.22 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.993 1.523 . . . . 0.0 110.849 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -107.6 160.83 25.25 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 109.998 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.26 122.15 8.11 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.923 1.486 . . . . 0.0 110.365 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.77 4.1 2.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 110.551 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.46 23.96 2.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.112 -0.992 . . . . 0.0 110.143 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 80' ' ' CYS . . . -160.45 -37.4 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.89 . . . . 0.0 109.913 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 1.2 t -39.46 158.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.684 0.754 . . . . 0.0 110.931 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 1.096 ' NZ ' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.56 -167.91 1.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 0.0 109.438 179.46 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 82' ' ' ILE . 1.3 tp 177.51 31.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.178 -0.951 . . . . 0.0 110.042 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -70.71 -101.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.935 -1.103 . . . . 0.0 110.652 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.84 100.75 1.43 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -161.7 -159.64 0.64 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.29 -1.124 . . . . 0.0 109.887 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.553 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t 169.1 150.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.615 -0.678 . . . . 0.0 109.636 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.572 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -122.79 143.28 49.94 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.267 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.658 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -122.02 9.66 9.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 65.17 66.94 0.53 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 110.088 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.534 ' HB2' ' CB ' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.127 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 2.6 tt0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.115 0.483 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 26' ' ' TYR . 41.8 tp 46.34 86.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 109.996 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.504 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -42.71 148.66 0.22 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.358 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.65 -21.32 64.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.198 -0.939 . . . . 0.0 110.093 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -87.56 -4.09 58.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 110.209 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.507 ' OG ' HG11 ' A' ' 27' ' ' VAL . 39.0 t -79.42 -163.7 0.54 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.233 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 9.5 tttp -156.39 178.98 9.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.134 -0.979 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 3.9 p 174.69 47.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 110.068 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 4.0 tt0 -41.83 -50.18 4.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.648 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -161.68 77.07 0.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.646 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 21' ' ' THR . 0.8 OUTLIER -115.31 -153.24 0.52 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.206 -0.934 . . . . 0.0 110.048 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -155.62 77.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 109.775 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.805 HD22 ' HB2' ' A' ' 37' ' ' CYS . 5.0 mt -96.24 -167.3 1.56 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.365 -0.835 . . . . 0.0 110.456 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.4 m -155.02 -47.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.503 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 25' ' ' CYS . 12.0 m-20 -144.25 23.51 1.66 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.545 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -58.16 -152.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.024 . . . . 0.0 110.513 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -160.59 -52.85 0.05 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.599 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 30' ' ' SER . 4.7 t 49.39 117.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.905 0.86 . . . . 0.0 112.226 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -108.72 -20.83 12.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.944 . . . . 0.0 108.884 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -167.4 84.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.746 -0.596 . . . . 0.0 109.671 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.909 ' OG ' HG22 ' A' ' 45' ' ' VAL . 24.5 m -159.58 164.28 34.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.784 -1.197 . . . . 0.0 111.51 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 47' ' ' ILE . 3.6 tt0 -119.68 96.58 5.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.547 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 6.5 t -94.67 168.68 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.141 -0.974 . . . . 0.0 110.531 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 19.1 m-85 -150.18 -42.86 0.13 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.064 -1.022 . . . . 0.0 111.315 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.97 27.56 1.88 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.547 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.7 m -82.01 150.03 27.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.08 -1.247 . . . . 0.0 110.526 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 36' ' ' THR . 13.9 t -95.95 54.49 1.49 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.539 -0.726 . . . . 0.0 109.443 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.805 ' HB2' HD22 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -38.31 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.689 -0.632 . . . . 0.0 110.691 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' THR . 19.0 m -104.38 69.62 0.92 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 110.077 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.72 59.45 3.48 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.6 m -136.88 -168.97 2.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -1.143 . . . . 0.0 109.783 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -162.78 143.38 9.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 110.673 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.544 ' CE1' HG13 ' A' ' 57' ' ' ILE . 10.8 m-85 -114.42 173.4 6.48 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.419 -0.8 . . . . 0.0 109.181 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -155.86 42.98 0.42 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 123.8 72.88 0.25 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.909 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -148.91 -168.74 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.043 -1.269 . . . . 0.0 110.475 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.557 ' N ' HG23 ' A' ' 45' ' ' VAL . 50.2 m -155.38 58.82 0.64 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.579 ' HB ' HD13 ' A' ' 64' ' ' ILE . 8.8 tt -80.98 168.34 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.269 -0.894 . . . . 0.0 110.298 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' SER . 74.8 p -142.61 -138.05 0.11 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.621 -0.675 . . . . 0.0 109.233 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' THR . 52.8 m -58.24 83.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.984 -1.073 . . . . 0.0 110.145 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 48' ' ' THR . 73.0 m -141.57 139.41 33.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.961 -1.087 . . . . 0.0 110.502 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -88.88 117.77 28.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.373 -0.83 . . . . 0.0 109.592 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.5 p -133.78 113.49 12.36 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.567 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -98.37 91.42 5.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 109.485 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 72' ' ' GLY . . . 72.16 106.25 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 89.1 p -175.42 102.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -1.166 . . . . 0.0 110.467 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.539 ' HB2' ' CA ' ' A' ' 90' ' ' ASN . 7.6 ttm180 -62.79 106.26 0.78 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.929 -1.107 . . . . 0.0 108.984 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.544 HG13 ' CE1' ' A' ' 42' ' ' PHE . 16.5 mm -83.23 11.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.1 -1.0 . . . . 0.0 110.545 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.501 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -36.99 151.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.611 -0.681 . . . . 0.0 110.411 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 166.48 147.11 5.1 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.275 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -79.87 63.35 8.73 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 124.301 1.685 . . . . 0.0 109.461 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 106.05 24.3 6.97 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -41.58 161.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.409 -1.053 . . . . 0.0 110.323 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.479 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 17.1 tttm -152.89 110.48 3.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.012 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.579 HD13 ' HB ' ' A' ' 47' ' ' ILE . 3.1 mp -125.7 152.68 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.022 -1.049 . . . . 0.0 111.291 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.48 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.7 OUTLIER -156.12 107.91 2.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 0.0 109.895 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER 63.0 73.25 0.46 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 111.12 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 3.8 t -132.91 120.3 21.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.234 -0.917 . . . . 0.0 109.955 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.798 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.0 mp -83.29 85.24 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.027 -1.045 . . . . 0.0 108.839 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.697 HG21 ' CD2' ' A' ' 87' ' ' PHE . 9.6 mt -96.05 160.75 2.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.785 -0.572 . . . . 0.0 109.889 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.793 ' O ' HG22 ' A' ' 73' ' ' VAL . 13.1 m -162.63 100.93 1.03 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.221 -0.924 . . . . 0.0 110.504 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 89.03 34.52 8.79 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 54' ' ' GLY . . . 75.42 17.95 80.03 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 70' ' ' THR . 9.5 m -123.56 128.94 25.04 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.24 -1.153 . . . . 0.0 110.834 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -83.33 142.56 10.73 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.967 1.509 . . . . 0.0 109.939 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -91.76 158.37 40.22 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.149 -0.969 . . . . 0.0 110.261 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.36 59.48 6.09 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.883 1.465 . . . . 0.0 110.12 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.06 134.1 42.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.499 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.72 -8.11 25.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.071 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 66' ' ' THR . . . -91.97 -16.96 25.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.869 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 66' ' ' THR . 40.4 t -78.87 165.61 23.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.902 -1.124 . . . . 0.0 110.18 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HE3' ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -101.21 -12.18 18.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.166 -0.959 . . . . 0.0 112.11 -178.106 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 82' ' ' ILE . 37.1 mm 25.11 51.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.155 0.502 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 85' ' ' CYS . 0.4 OUTLIER -117.76 -141.75 0.36 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 111.375 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -59.35 83.5 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 6.0 t -177.96 178.37 0.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.11 . . . . 0.0 109.543 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.533 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -179.16 156.75 0.79 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.04 . . . . 0.0 110.491 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.697 ' CD2' HG21 ' A' ' 69' ' ' ILE . 2.3 m-85 -123.25 164.44 18.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -0.855 . . . . 0.0 110.287 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.747 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -142.21 12.58 1.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.841 . . . . 0.0 109.585 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 72.5 0.02 3.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 110.358 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.539 ' CA ' ' HB2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.444 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.784 ' N ' HE21 ' A' ' 10' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.681 HD12 ' HB ' ' A' ' 27' ' ' VAL . 9.9 tp -40.48 117.48 0.81 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.801 -0.562 . . . . 0.0 110.017 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.545 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -37.73 158.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.725 -0.609 . . . . 0.0 110.342 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.8 -6.96 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.987 . . . . 0.0 110.583 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -138.61 23.78 2.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.914 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.607 ' OG ' HG12 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -84.67 -159.56 0.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.009 -1.057 . . . . 0.0 110.33 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 4.8 tttp -155.95 152.58 28.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 110.362 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 29.9 p -164.63 56.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 11.3 tp10 -88.65 111.57 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 110.386 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 4.6 tttp 67.63 56.3 0.58 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.273 -0.892 . . . . 0.0 110.429 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.66 ' HB2' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -136.86 166.49 23.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.1 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 36' ' ' THR . 3.1 m -113.55 101.97 9.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.869 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.831 ' N ' HD22 ' A' ' 22' ' ' LEU . 1.7 mm? -107.16 147.77 29.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 110.639 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 17.9 m -148.15 109.8 4.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.354 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 23' ' ' THR . 1.1 m120 60.73 56.99 2.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.186 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -109.47 -169.12 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.191 0.996 . . . . 0.0 111.582 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 52.6 t80 -173.26 34.68 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.681 ' HB ' HD12 ' A' ' 11' ' ' LEU . 12.1 t -33.16 142.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.532 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.545 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -143.5 121.5 12.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.525 -0.734 . . . . 0.0 109.867 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.429 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 53.35 38.77 28.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.318 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.979 ' OG ' HG22 ' A' ' 45' ' ' VAL . 21.0 m -132.1 179.31 6.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.641 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG2' ' HD2' ' A' ' 16' ' ' LYS . 2.8 tt0 -119.94 -64.2 1.29 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.377 -0.827 . . . . 0.0 110.556 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.834 HG22 ' CG2' ' A' ' 47' ' ' ILE . 11.7 t 62.05 150.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 110.004 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.551 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 19.3 m-85 -142.35 -47.43 0.34 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.059 -1.026 . . . . 0.0 110.803 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.433 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -132.59 20.32 4.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.533 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 8.6 m -66.68 154.91 39.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -1.18 . . . . 0.0 110.277 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 21' ' ' THR . 5.7 m -95.86 -21.46 18.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.547 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 11.9 t 48.86 76.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.805 . . . . 0.0 110.961 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.4 m -80.23 73.5 7.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 109.1 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 66.08 49.88 55.3 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -135.92 -178.08 4.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.266 -1.138 . . . . 0.0 110.018 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -153.4 176.4 12.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.034 -1.042 . . . . 0.0 110.56 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.598 ' CE2' HG21 ' A' ' 47' ' ' ILE . 52.7 m-85 -123.18 -170.15 2.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.006 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 58' ' ' SER . 9.8 t70 -178.35 63.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.773 . . . . 0.0 109.67 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 99.65 60.02 0.86 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.979 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.4 m -137.37 -159.53 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.95 -1.324 . . . . 0.0 111.324 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.621 ' N ' HG23 ' A' ' 45' ' ' VAL . 85.4 m -166.89 57.81 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.834 ' CG2' HG22 ' A' ' 32' ' ' VAL . 12.4 tt -83.7 171.65 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.47 -0.769 . . . . 0.0 111.088 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.551 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 22.4 p -135.51 -134.03 0.15 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' THR . 23.1 m -66.12 89.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.737 -1.227 . . . . 0.0 109.758 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.684 ' CB ' HD11 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -132.13 139.05 48.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.012 -1.055 . . . . 0.0 110.495 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.567 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 m -85.5 21.45 1.79 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 111.056 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 89.9 p -37.18 122.01 0.84 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.465 -0.772 . . . . 0.0 110.803 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 2.6 m -112.02 111.13 21.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.136 -0.978 . . . . 0.0 109.973 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 51.55 79.85 0.07 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 8.0 p -155.51 122.63 5.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -1.165 . . . . 0.0 110.528 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' CA ' ' A' ' 90' ' ' ASN . 36.9 ttt85 -75.97 103.85 6.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 109.675 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.53 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 18.1 mm -83.29 12.67 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 0.0 110.358 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.535 ' CB ' ' HB3' ' A' ' 43' ' ' ASP . 42.9 p -42.71 162.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.347 -0.846 . . . . 0.0 110.716 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 150.67 163.04 11.01 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -75.8 57.44 5.06 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.935 1.492 . . . . 0.0 109.844 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 106.43 21.82 8.15 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 1.8 t -38.96 126.57 1.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.662 -0.905 . . . . 0.0 110.649 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 35.4 ttpt -115.08 140.47 49.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.053 -1.029 . . . . 0.0 110.593 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.973 HD13 ' HE2' ' A' ' 81' ' ' LYS . 25.4 mm -143.34 145.72 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.24 -0.912 . . . . 0.0 109.844 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.469 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 1.1 m -147.99 126.13 12.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.057 -1.027 . . . . 0.0 110.043 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.5 m 41.57 59.61 2.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.392 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.591 ' SG ' HD11 ' A' ' 69' ' ' ILE . 5.1 t -123.95 109.95 14.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.819 . . . . 0.0 109.532 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.567 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 1.9 mp -55.65 -64.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.979 -1.076 . . . . 0.0 109.697 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.591 HD11 ' SG ' ' A' ' 67' ' ' CYS . 8.1 mt 54.88 162.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.48 -0.763 . . . . 0.0 110.787 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.541 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 9.0 m -146.33 -121.78 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.83 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.781 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -65.18 77.5 0.08 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 58.54 16.73 30.45 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 71' ' ' GLY . 33.8 m -121.91 141.05 33.2 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.472 -1.017 . . . . 0.0 110.544 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 73' ' ' VAL . 49.1 Cg_endo -85.11 128.28 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.943 1.496 . . . . 0.0 110.133 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.82 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -83.56 174.65 5.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 110.081 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.82 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 43.0 Cg_endo -70.72 59.12 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.942 1.496 . . . . 0.0 110.106 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -88.09 112.93 23.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.382 -0.824 . . . . 0.0 110.223 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.32 -4.95 20.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.86 . . . . 0.0 110.347 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.07 -31.85 8.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.52 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 43.1 t -46.36 166.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.169 -0.957 . . . . 0.0 109.836 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.973 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -108.15 -41.19 4.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.043 -1.035 . . . . 0.0 111.43 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.714 ' O ' HG22 ' A' ' 82' ' ' ILE . 19.0 mm 49.25 62.13 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.816 -1.177 . . . . 0.0 109.615 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.401 ' H ' ' NZ ' ' A' ' 81' ' ' LYS . 23.2 t -109.33 -73.19 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 110.815 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.43 67.79 0.54 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -134.53 -153.0 0.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -1.151 . . . . 0.0 110.009 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.566 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.2 t 176.91 143.21 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.566 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -128.24 153.06 47.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.55 -0.719 . . . . 0.0 109.158 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.74 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 1.3 m -140.95 12.17 2.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.978 . . . . 0.0 109.758 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.74 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 72.07 0.13 3.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.443 -0.786 . . . . 0.0 110.201 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.533 ' CA ' ' HB2' ' A' ' 56' ' ' ARG . 1.5 p-10 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.013 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.599 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 3.9 pt20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.015 0.436 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.537 ' N ' ' CG ' ' A' ' 10' ' ' GLN . 16.5 tp 47.68 81.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.015 -1.053 . . . . 0.0 108.934 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -44.44 149.93 0.35 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 110.25 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.91 -10.1 12.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.858 . . . . 0.0 110.076 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -90.18 -7.77 52.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.968 . . . . 0.0 110.268 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 30' ' ' SER . 32.1 t -80.42 -157.61 0.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.067 -1.02 . . . . 0.0 110.099 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.516 ' CE ' ' OH ' ' A' ' 33' ' ' TYR . 12.5 tttt -135.74 140.17 44.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.079 -1.013 . . . . 0.0 110.088 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.0 m -113.41 137.35 51.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 110.291 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.8 -129.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.246 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.63 19.55 15.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.817 -1.177 . . . . 0.0 110.667 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.525 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -58.98 167.49 1.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.0 109.865 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.804 ' C ' HD23 ' A' ' 22' ' ' LEU . 1.6 t -140.24 97.13 3.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.019 -1.051 . . . . 0.0 109.985 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.804 HD23 ' C ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -131.45 -165.56 1.59 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.431 -0.793 . . . . 0.0 110.139 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 98.2 m -166.94 142.03 4.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.351 -0.843 . . . . 0.0 110.363 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.472 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 4.2 m120 45.88 36.83 3.1 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.369 -0.832 . . . . 0.0 110.697 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -154.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.091 -1.006 . . . . 0.0 110.683 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.599 ' CE1' ' HB3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER 176.26 40.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.491 HG13 ' HD2' ' A' ' 42' ' ' PHE . 40.3 t -52.78 153.92 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.984 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.7 OUTLIER -158.83 129.14 5.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.476 -0.765 . . . . 0.0 110.138 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.7 mtmp? 50.78 34.53 10.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 15' ' ' SER . 49.3 m -124.47 -161.13 0.98 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.499 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 3.5 tt0 -138.2 -63.13 0.56 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.513 -0.742 . . . . 0.0 110.089 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.562 HG22 ' CG2' ' A' ' 47' ' ' ILE . 15.9 t 61.16 156.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.516 ' OH ' ' CE ' ' A' ' 16' ' ' LYS . 9.9 m-85 -153.95 -39.11 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.199 -0.938 . . . . 0.0 110.477 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.2 34.07 1.66 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 37' ' ' CYS . 1.1 m -79.27 158.33 27.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.397 -1.061 . . . . 0.0 110.73 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -111.52 50.23 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.96 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 3.5 t -40.82 121.38 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 111.012 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 38' ' ' THR . 24.1 m -113.66 22.86 13.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 109.269 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 122.85 41.56 0.44 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.734 ' HA ' HD22 ' A' ' 90' ' ' ASN . 0.1 OUTLIER -115.52 -159.29 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -1.178 . . . . 0.0 110.372 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 26' ' ' TYR . 28.4 ttt180 -166.88 145.06 5.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.914 . . . . 0.0 110.701 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.491 ' HD2' HG13 ' A' ' 27' ' ' VAL . 10.1 m-85 -115.16 172.39 7.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.0 109.301 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.54 42.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.921 -1.112 . . . . 0.0 110.407 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 127.0 57.5 0.13 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -136.34 -171.16 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.269 -1.136 . . . . 0.0 110.997 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 46' ' ' THR . 87.9 m -152.89 58.2 0.79 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.562 ' CG2' HG22 ' A' ' 32' ' ' VAL . 9.7 tt -81.3 169.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.245 -0.909 . . . . 0.0 110.14 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 50' ' ' SER . 58.9 p -146.09 -139.7 0.1 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.048 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 66' ' ' THR . 51.9 m -52.94 91.48 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.07 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' THR . 2.4 m -152.96 143.72 22.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.155 -0.966 . . . . 0.0 110.286 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -98.66 135.32 40.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 59.9 p -155.64 130.88 9.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.33 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 71' ' ' GLY . 11.5 m -111.85 112.94 24.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.103 -0.998 . . . . 0.0 109.82 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.7 86.41 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 79.6 p -154.74 112.25 3.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -1.144 . . . . 0.0 110.514 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 4.1 ttt180 -67.03 118.6 10.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 109.66 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 26.8 mm -97.82 11.18 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 0.0 110.831 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -40.7 145.34 0.19 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.203 -0.936 . . . . 0.0 110.34 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 175.12 145.85 5.54 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -80.18 1.34 9.33 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.038 1.547 . . . . 0.0 109.629 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.06 33.23 0.07 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.508 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -60.74 152.73 26.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.535 -0.979 . . . . 0.0 110.804 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -156.95 113.93 3.07 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.653 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.0 mt -118.9 148.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.067 -1.021 . . . . 0.0 110.862 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.51 117.14 5.41 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.0 OUTLIER 51.21 71.14 0.46 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.101 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 50' ' ' SER . 60.5 m -139.11 111.04 7.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.447 -0.783 . . . . 0.0 110.478 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -77.92 137.06 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.946 -1.096 . . . . 0.0 109.42 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.641 HG23 ' C ' ' A' ' 73' ' ' VAL . 9.3 mt -146.51 158.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.079 -1.013 . . . . 0.0 110.309 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.74 ' O ' HG22 ' A' ' 73' ' ' VAL . 5.7 m -156.39 99.0 1.88 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.04 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.835 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 91.51 20.67 37.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.525 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 88.29 15.55 60.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 70' ' ' THR . 4.1 m -124.3 132.87 24.35 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.476 -1.014 . . . . 0.0 109.507 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.36 144.93 23.47 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.59 1.311 . . . . 0.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.82 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -99.17 176.02 2.17 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.82 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 47.6 Cg_endo -73.15 102.6 1.48 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.94 1.495 . . . . 0.0 110.635 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 1.1 t -119.04 -23.52 6.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.34 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 61.15 12.35 4.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.255 -0.903 . . . . 0.0 109.966 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.7 -15.27 1.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.311 -0.868 . . . . 0.0 110.998 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 33.1 t -62.89 168.48 3.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.968 -1.082 . . . . 0.0 110.406 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HD2' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.99 -35.29 8.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.981 -1.074 . . . . 0.0 111.826 -178.481 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.489 ' N ' ' HE2' ' A' ' 81' ' ' LYS . 32.4 mm 43.66 60.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.093 -1.004 . . . . 0.0 109.35 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 85' ' ' CYS . 46.5 m -114.95 -130.11 0.31 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.31 -0.869 . . . . 0.0 110.594 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -65.12 66.05 0.08 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.653 ' SG ' HD11 ' A' ' 64' ' ' ILE . 5.0 t -160.94 -175.99 5.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.023 -1.281 . . . . 0.0 109.854 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.562 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 2.0 t -179.09 160.67 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.117 -0.989 . . . . 0.0 110.745 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -127.92 155.08 44.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.32 -0.863 . . . . 0.0 109.431 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.91 24.91 1.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.047 -1.033 . . . . 0.0 110.313 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.835 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 52.84 85.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 109.944 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.734 HD22 ' HA ' ' A' ' 40' ' ' SER . 2.8 p-10 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.035 -1.04 . . . . 0.0 110.365 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 22.6 mt-30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.268 0.556 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.782 HD11 ' OG ' ' A' ' 15' ' ' SER . 8.7 tp -62.96 81.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 10' ' ' GLN . 97.9 p -30.62 134.16 0.06 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.529 0.681 . . . . 0.0 111.93 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.33 -22.51 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 109.81 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.589 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -80.99 -10.28 59.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.473 -0.767 . . . . 0.0 110.086 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.782 ' OG ' HD11 ' A' ' 11' ' ' LEU . 45.6 t -79.38 -171.62 2.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.131 -0.98 . . . . 0.0 109.757 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.89 163.79 17.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.105 -0.997 . . . . 0.0 109.612 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.491 ' SG ' HD23 ' A' ' 11' ' ' LEU . 6.4 m -134.66 -29.29 1.19 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.066 -1.022 . . . . 0.0 111.191 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' LYS . 10.4 tp10 -43.45 118.22 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.07 -1.018 . . . . 0.0 110.244 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 52.83 108.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.781 . . . . 0.0 110.552 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 5.9 p 178.69 146.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.048 -1.032 . . . . 0.0 110.899 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -139.14 84.08 1.98 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -0.792 . . . . 0.0 109.529 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 38.9 mt -101.91 -174.42 2.58 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.834 0.826 . . . . 0.0 111.267 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 91.7 m -164.42 125.02 2.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.637 -0.665 . . . . 0.0 109.298 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.2 m120 51.07 66.47 1.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 108.878 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -123.78 169.91 11.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.78 0.8 . . . . 0.0 110.471 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.637 ' HA ' ' HB3' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -147.0 34.33 0.91 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 179.002 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.868 HG13 ' HD2' ' A' ' 42' ' ' PHE . 7.6 t -30.52 147.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.587 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.522 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -150.47 123.31 8.68 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 9.8 mmmt 48.04 56.26 7.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 0.0 109.34 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.574 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 14.7 m -143.25 171.69 13.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.963 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.648 ' OE1' HG23 ' A' ' 46' ' ' THR . 1.4 tt0 -115.06 -68.88 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.382 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.53 HG23 ' C ' ' A' ' 31' ' ' GLU . 3.1 t 67.15 143.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.327 -0.858 . . . . 0.0 110.383 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CD1' HG22 ' A' ' 48' ' ' THR . 45.2 m-85 -137.62 -52.71 0.65 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.337 -0.852 . . . . 0.0 110.674 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.452 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -129.46 18.88 5.42 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.525 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.2 m -69.75 153.69 43.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -1.167 . . . . 0.0 110.216 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.2 m -111.95 58.24 0.63 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.462 -0.774 . . . . 0.0 109.594 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 52.8 t -36.87 137.77 0.3 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.609 -0.682 . . . . 0.0 111.01 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 95.2 m -137.85 74.34 1.48 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.468 -0.77 . . . . 0.0 109.461 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.48 57.43 3.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.412 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -147.08 178.57 8.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.159 -1.201 . . . . 0.0 110.177 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 42' ' ' PHE . 4.0 ttt180 -150.65 153.02 34.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.302 -0.874 . . . . 0.0 110.176 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.868 ' HD2' HG13 ' A' ' 27' ' ' VAL . 8.1 m-85 -116.04 -176.2 2.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.995 . . . . 0.0 110.566 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.522 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.9 t0 -170.09 50.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 110.179 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 118.44 61.36 0.28 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -140.98 -168.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.914 -1.345 . . . . 0.0 110.6 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.65 ' O ' HG22 ' A' ' 46' ' ' THR . 91.6 m -160.73 53.25 0.3 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.62 -0.675 . . . . 0.0 109.908 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 19.8 tt -73.54 169.45 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.783 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 50' ' ' SER . 71.9 p -138.21 -139.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.206 -0.934 . . . . 0.0 109.666 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 31.3 m -58.33 80.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' THR . 28.5 t -141.55 140.33 33.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 110.454 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -83.49 131.47 35.01 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.221 -0.924 . . . . 0.0 109.916 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 2.9 t -151.86 128.67 10.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.939 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.598 ' OG1' HG23 ' A' ' 70' ' ' THR . 36.8 p -128.22 110.62 12.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.978 . . . . 0.0 110.212 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.41 84.03 0.13 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 p -161.37 127.87 3.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -1.13 . . . . 0.0 110.658 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' CD ' ' HB2' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.55 103.27 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 7.4 mm -85.07 10.78 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.083 -1.011 . . . . 0.0 110.498 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -36.02 142.77 0.07 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.457 -0.777 . . . . 0.0 110.727 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 176.85 146.09 5.96 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.313 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.77 -8.31 17.95 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.965 1.508 . . . . 0.0 110.051 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.48 39.23 0.12 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.505 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -56.15 159.42 3.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.525 -0.985 . . . . 0.0 111.37 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 27.5 tttt -161.08 98.71 1.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.694 -0.629 . . . . 0.0 109.347 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.791 HD11 ' SG ' ' A' ' 85' ' ' CYS . 12.8 mt -117.82 163.41 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.671 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -145.47 -163.35 1.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.405 -0.809 . . . . 0.0 110.155 179.332 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.0 m -33.36 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.603 ' C ' HD12 ' A' ' 68' ' ' ILE . 44.4 t -138.38 139.52 39.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.515 -0.741 . . . . 0.0 109.107 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.723 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.6 mp -97.22 82.73 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.884 -1.135 . . . . 0.0 108.704 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.59 HG23 ' C ' ' A' ' 73' ' ' VAL . 13.1 mt -90.85 154.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.67 -0.644 . . . . 0.0 110.328 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.732 ' O ' HG22 ' A' ' 73' ' ' VAL . 52.8 m -162.01 98.82 1.08 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.174 -0.954 . . . . 0.0 110.597 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.767 ' O ' HG13 ' A' ' 73' ' ' VAL . . . 94.39 39.98 4.61 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.561 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 65.32 24.02 70.4 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 71' ' ' GLY . 6.1 m -129.24 129.2 23.3 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.485 -1.009 . . . . 0.0 110.893 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HB2' HD11 ' A' ' 82' ' ' ILE . 46.4 Cg_endo -83.58 131.89 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.922 1.486 . . . . 0.0 110.228 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -79.04 150.85 75.37 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.002 -1.061 . . . . 0.0 110.057 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.56 58.47 1.94 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.118 1.588 . . . . 0.0 110.683 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.48 150.48 22.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 110.235 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.24 -10.96 55.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.926 . . . . 0.0 109.962 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 80' ' ' CYS . . . -112.66 -31.6 6.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.92 . . . . 0.0 111.002 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 67' ' ' CYS . 13.0 t -44.53 137.06 3.94 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.945 -1.097 . . . . 0.0 110.141 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.548 ' C ' HD12 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -110.28 164.88 12.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 111.49 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.798 ' O ' HG22 ' A' ' 82' ' ' ILE . 1.0 OUTLIER -161.59 75.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.494 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -112.08 -86.55 0.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 0.0 110.56 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -104.79 65.91 0.3 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.791 ' SG ' HD11 ' A' ' 64' ' ' ILE . 4.4 t -162.48 -175.49 4.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -1.189 . . . . 0.0 110.26 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.559 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.5 t 179.81 158.87 0.73 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.288 -0.882 . . . . 0.0 110.108 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.3 OUTLIER -123.22 154.35 38.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 89' ' ' ALA . 2.7 m -134.96 32.67 3.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 109.591 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 88' ' ' SER . . . 37.87 72.01 0.14 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.757 -0.589 . . . . 0.0 110.199 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.452 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.307 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 11' ' ' LEU . 1.4 pt20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.261 0.553 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.656 HD12 ' HB ' ' A' ' 27' ' ' VAL . 18.1 tp 43.46 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.549 -0.719 . . . . 0.0 110.149 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -37.91 150.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.693 -0.63 . . . . 0.0 110.451 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -24.98 67.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 110.24 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 14' ' ' ASN . 0.6 OUTLIER -103.93 6.26 36.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 111.129 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.496 ' OG ' HD11 ' A' ' 11' ' ' LEU . 28.8 t -69.21 -154.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.16 . . . . 0.0 109.391 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.545 ' CD ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -140.69 150.71 43.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 110.528 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' A' ' 18' ' ' GLU . 7.8 t -135.99 -92.18 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -0.917 . . . . 0.0 109.779 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.491 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 13.2 mt-10 38.05 -125.68 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.412 -0.805 . . . . 0.0 110.844 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 20' ' ' SER . 10.4 tptt -66.98 123.55 20.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.956 -1.09 . . . . 0.0 110.356 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.533 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . 10.3 p 175.94 172.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.115 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 21' ' ' THR . 1.8 t -154.04 76.41 1.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.36 -0.837 . . . . 0.0 109.56 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.783 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -114.48 -170.56 1.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.793 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 3.9 m -164.89 124.94 1.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.849 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.6 m120 57.17 33.38 23.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 110.713 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -64.31 -141.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.754 -1.216 . . . . 0.0 109.929 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.557 ' CG ' ' O ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER 166.34 45.82 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.687 HG13 ' HB2' ' A' ' 30' ' ' SER . 8.0 t -66.96 140.45 19.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.762 0.791 . . . . 0.0 111.715 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.9 t0 -123.05 -14.03 7.66 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.429 0.633 . . . . 0.0 109.728 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER 179.99 67.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.98 ' OG ' HG22 ' A' ' 45' ' ' VAL . 14.8 m -147.26 151.31 36.44 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.176 -0.953 . . . . 0.0 111.442 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' HG3' ' CD ' ' A' ' 16' ' ' LYS . 6.5 tt0 -107.49 101.23 10.59 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 18.0 t -99.2 174.32 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.237 -0.915 . . . . 0.0 110.379 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.531 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 47.1 m-85 -149.16 -32.0 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.193 -0.942 . . . . 0.0 111.391 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -164.48 26.79 0.2 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 50' ' ' SER . 0.9 OUTLIER -76.99 144.94 38.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.137 . . . . 0.0 110.398 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -91.13 60.04 4.16 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.417 -0.802 . . . . 0.0 110.501 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 2.0 t -47.04 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.0 110.157 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.84 HG21 HG23 ' A' ' 53' ' ' THR . 1.7 t -85.91 31.88 0.61 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.071 -1.018 . . . . 0.0 110.445 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.42 27.83 4.01 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 16.0 t -94.06 -163.09 1.0 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.384 -1.068 . . . . 0.0 110.229 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HB2' ' CB ' ' A' ' 26' ' ' TYR . 2.7 ttp180 -165.73 144.69 6.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.65 ' CE1' HD13 ' A' ' 57' ' ' ILE . 2.9 m-85 -119.45 -172.44 2.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.971 -1.081 . . . . 0.0 110.227 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.22 55.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 110.204 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 115.29 54.64 0.37 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.274 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.98 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.1 m -133.6 -169.66 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.732 -1.452 . . . . 0.0 111.325 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.478 ' N ' HG23 ' A' ' 45' ' ' VAL . 33.5 m -151.89 60.01 0.86 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.583 HG12 ' HG ' ' A' ' 50' ' ' SER . 14.6 tt -81.14 -179.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.751 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.531 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -139.77 -89.82 0.19 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.789 -1.195 . . . . 0.0 110.195 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 49' ' ' THR . 5.9 m -114.3 74.35 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.022 -1.049 . . . . 0.0 110.451 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.583 ' HG ' HG12 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -114.53 152.34 31.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.144 -0.973 . . . . 0.0 111.413 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.429 ' H ' ' HA ' ' A' ' 68' ' ' ILE . 1.5 m -99.79 27.91 5.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.462 -0.773 . . . . 0.0 111.085 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' ILE . 1.4 p -40.92 136.62 1.41 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.187 -0.946 . . . . 0.0 110.893 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.84 HG23 HG21 ' A' ' 38' ' ' THR . 87.2 m -126.17 87.58 2.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.45 65.88 1.93 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.8 p -145.91 123.11 11.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.448 -1.031 . . . . 0.0 109.844 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -76.68 102.22 6.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.551 -0.718 . . . . 0.0 110.75 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.65 HD13 ' CE1' ' A' ' 42' ' ' PHE . 3.1 mp -85.37 15.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.988 -1.07 . . . . 0.0 110.217 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.9 p -47.15 161.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.337 -0.852 . . . . 0.0 110.968 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 155.24 154.29 6.86 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -74.41 -0.84 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.825 1.434 . . . . 0.0 110.098 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.31 29.83 0.07 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.3 t -52.28 114.55 1.38 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.451 -1.029 . . . . 0.0 110.491 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -110.57 130.22 55.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.829 HG23 ' HD2' ' A' ' 81' ' ' LYS . 41.0 mt -140.95 147.89 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.073 -1.017 . . . . 0.0 110.587 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.492 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -140.53 108.87 5.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 110.64 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 49' ' ' THR . 5.9 m 50.33 71.86 0.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.522 -0.736 . . . . 0.0 112.027 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.532 ' SG ' ' CG1' ' A' ' 69' ' ' ILE . 43.9 t -132.81 112.31 11.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.359 -0.838 . . . . 0.0 109.235 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.7 mp -47.25 -68.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.556 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.532 ' CG1' ' SG ' ' A' ' 67' ' ' CYS . 27.3 mt 63.42 155.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.306 -0.871 . . . . 0.0 110.171 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.528 ' HB ' HG23 ' A' ' 73' ' ' VAL . 12.4 m -147.73 -115.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.51 ' C ' HG22 ' A' ' 73' ' ' VAL . . . -74.06 81.69 0.78 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.6 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 54.46 19.82 14.45 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.528 HG23 ' HB ' ' A' ' 70' ' ' THR . 4.3 m -125.64 133.91 25.34 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.611 -0.935 . . . . 0.0 110.138 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 48.3 Cg_endo -82.84 129.99 5.67 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.59 1.311 . . . . 0.0 110.373 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.508 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -95.36 150.55 37.73 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 110.345 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.62 144.14 35.2 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.063 1.559 . . . . 0.0 110.375 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.454 ' HB2' HD13 ' A' ' 68' ' ' ILE . 23.3 t -165.93 24.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.138 -0.977 . . . . 0.0 110.559 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 44.51 27.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.44 -34.43 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.898 . . . . 0.0 110.796 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 1.7 t -50.82 145.35 7.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.012 -1.055 . . . . 0.0 110.731 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.829 ' HD2' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -97.35 167.52 10.96 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.668 -0.645 . . . . 0.0 109.606 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.719 ' O ' HG22 ' A' ' 82' ' ' ILE . 29.9 mm -154.59 60.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.967 -1.083 . . . . 0.0 109.714 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.5 m -98.35 -116.94 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 111.009 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.39 83.41 0.54 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -141.72 -165.05 1.91 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -1.156 . . . . 0.0 109.504 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.8 t -175.83 145.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.953 -1.092 . . . . 0.0 110.267 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.6 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.0 m-85 -111.71 -67.76 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.153 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER 69.66 11.84 7.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 110.4 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 48.13 91.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.169 -0.957 . . . . 0.0 109.867 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.417 -179.392 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.112 0.482 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.885 HD11 ' OG ' ' A' ' 15' ' ' SER . 19.2 tp 52.61 89.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.118 -0.989 . . . . 0.0 108.958 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -41.08 141.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.573 -0.704 . . . . 0.0 110.509 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.39 -17.11 4.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 110.458 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 17.5 p30 -94.01 -8.89 38.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 110.885 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.885 ' OG ' HD11 ' A' ' 11' ' ' LEU . 1.1 t -66.78 -174.59 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.858 -1.151 . . . . 0.0 109.213 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -122.39 159.88 26.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 110.252 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.3 t -151.79 111.97 4.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -175.43 125.1 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.804 . . . . 0.0 109.798 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt 51.74 55.32 9.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.754 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.491 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -140.35 161.97 36.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.0 110.719 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 36' ' ' THR . 2.9 t -135.43 61.77 1.65 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 109.248 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 22' ' ' LEU . 3.0 mt -74.26 176.96 6.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 111.167 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 24' ' ' ASN . 3.1 m -164.13 118.86 1.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.468 -0.77 . . . . 0.0 109.841 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.535 ' O ' ' N ' ' A' ' 39' ' ' GLY . 27.3 m120 50.43 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.337 -0.852 . . . . 0.0 109.646 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.81 -160.38 0.91 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.59 -1.318 . . . . 0.0 110.913 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.512 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 13.8 t80 -164.29 34.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.789 ' HB ' HD12 ' A' ' 11' ' ' LEU . 5.0 t -33.05 151.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.536 0.684 . . . . 0.0 110.783 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 1.3 t70 -153.21 118.78 5.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 44' ' ' GLY . 6.4 mtpm? 48.11 72.88 0.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.422 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 45.3 m -157.71 157.92 34.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.973 -1.079 . . . . 0.0 111.095 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 3.8 mt-10 -120.58 119.75 33.82 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.567 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 46.9 t -123.04 156.32 28.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.101 -0.999 . . . . 0.0 110.623 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 32' ' ' VAL . 48.2 m-85 -154.42 32.14 0.42 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.186 -0.946 . . . . 0.0 111.223 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 162.28 -31.2 0.3 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.669 HG22 ' H ' ' A' ' 37' ' ' CYS . 19.3 m -38.66 162.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.516 -0.991 . . . . 0.0 111.541 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -104.65 -13.43 15.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.4 -0.812 . . . . 0.0 110.648 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.669 ' H ' HG22 ' A' ' 35' ' ' THR . 0.1 OUTLIER 38.59 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.266 -0.896 . . . . 0.0 110.932 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.5 m -105.09 94.31 5.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.122 -0.986 . . . . 0.0 109.975 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 48.25 26.73 4.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.514 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -104.79 -166.09 1.2 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.175 -1.191 . . . . 0.0 110.361 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HG2' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -164.85 155.57 14.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 110.388 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.788 ' HD2' HG13 ' A' ' 27' ' ' VAL . 7.4 m-85 -120.62 -175.06 2.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.338 -0.851 . . . . 0.0 109.403 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -165.95 46.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.139 -0.976 . . . . 0.0 109.932 179.46 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 121.65 53.34 0.22 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -132.94 -175.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.801 -1.411 . . . . 0.0 110.885 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.527 ' O ' HG22 ' A' ' 46' ' ' THR . 88.0 m -151.39 59.17 0.89 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.712 -0.618 . . . . 0.0 109.778 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 50' ' ' SER . 7.9 tt -81.0 167.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.767 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 50' ' ' SER . 54.3 p -139.36 -128.2 0.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.063 -1.023 . . . . 0.0 109.844 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 66' ' ' THR . 88.4 m -65.96 73.28 0.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.971 -1.08 . . . . 0.0 109.521 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.522 ' HB2' HD11 ' A' ' 47' ' ' ILE . 73.2 m -133.52 135.35 44.35 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.483 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 67' ' ' CYS . 1.6 m -88.62 139.09 30.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 53.9 p -153.69 130.08 10.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.412 -0.805 . . . . 0.0 110.075 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -111.54 112.4 24.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.008 -1.057 . . . . 0.0 109.696 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 50.53 90.76 0.01 OUTLIER Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.494 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 95.7 p -156.74 123.47 5.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.374 -1.074 . . . . 0.0 109.643 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.6 ttt180 -85.54 100.7 12.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.962 . . . . 0.0 110.69 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 64' ' ' ILE . 2.9 mt -89.11 23.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.487 -0.758 . . . . 0.0 110.446 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -43.75 155.28 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.915 -1.115 . . . . 0.0 109.711 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 165.88 143.61 3.8 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.195 -1.478 . . . . 0.0 110.325 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.01 -19.37 23.18 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.061 1.559 . . . . 0.0 110.276 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.5 36.95 0.52 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.44 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -57.88 160.38 4.69 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -1.045 . . . . 0.0 111.505 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.554 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 30.3 tttp -160.51 114.02 2.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.584 -0.698 . . . . 0.0 109.822 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.686 ' CD1' HG21 ' A' ' 57' ' ' ILE . 12.1 mt -128.77 155.28 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.825 -1.172 . . . . 0.0 111.477 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.44 126.16 6.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.503 ' N ' ' OG ' ' A' ' 50' ' ' SER . 0.7 OUTLIER 51.97 77.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 110.638 -179.291 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' A' ' 64' ' ' ILE . 89.5 m -138.9 118.41 12.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.134 -0.979 . . . . 0.0 109.63 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.812 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.5 mp -90.98 80.87 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 118.836 -1.146 . . . . 0.0 108.868 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 73' ' ' VAL . 18.6 mt -89.91 159.27 2.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.294 0.569 . . . . 0.0 110.544 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.629 ' O ' HG22 ' A' ' 73' ' ' VAL . 18.2 m -158.28 97.82 1.53 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 110.421 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 94.63 16.78 41.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 87' ' ' PHE . . . 91.53 16.01 53.63 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 70' ' ' THR . 14.2 m -124.32 132.94 24.36 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.423 -1.046 . . . . 0.0 110.124 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.447 ' HB3' HD11 ' A' ' 82' ' ' ILE . 52.1 Cg_endo -81.24 137.39 10.61 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.93 1.49 . . . . 0.0 110.65 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -90.75 159.16 41.23 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.91 . . . . 0.0 109.794 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.5 66.66 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.787 1.414 . . . . 0.0 110.282 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 78' ' ' ALA . 18.6 t -80.52 4.53 18.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.235 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 41.73 31.07 0.18 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 110.004 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -151.35 -38.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 44.8 t -49.52 170.45 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.311 -0.868 . . . . 0.0 108.849 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.554 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -106.99 -39.52 5.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.95 -1.094 . . . . 0.0 111.689 -178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.494 ' CA ' ' HE3' ' A' ' 81' ' ' LYS . 43.0 mm 43.62 68.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.879 -1.138 . . . . 0.0 109.501 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.445 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 45.1 t -125.38 -116.03 0.28 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 110.48 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -68.68 59.92 0.48 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.517 ' SG ' HD11 ' A' ' 64' ' ' ILE . 3.6 t -163.32 -171.76 2.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.265 . . . . 0.0 110.814 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.57 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.9 t 176.62 170.04 0.48 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.46 -0.775 . . . . 0.0 109.772 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -134.05 149.01 51.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.005 -1.06 . . . . 0.0 110.079 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 t -129.73 30.5 4.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.273 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 47.75 61.79 2.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.985 . . . . 0.0 110.065 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.288 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.478 0.656 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.568 ' CD1' ' HB3' ' A' ' 15' ' ' SER . 6.7 tp -47.74 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.752 -0.592 . . . . 0.0 109.772 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 10' ' ' GLN . 4.9 t -38.24 137.0 0.59 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.059 -0.657 . . . . 0.0 109.866 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.1 -17.51 0.43 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.21 -0.931 . . . . 0.0 111.289 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -90.72 -3.36 57.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.005 -1.06 . . . . 0.0 110.342 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.71 ' OG ' HG12 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -89.03 -157.48 0.45 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.098 -1.001 . . . . 0.0 110.054 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 8.4 tttm -165.7 156.27 13.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 110.057 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 40.7 t -144.14 156.41 44.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 110.48 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER 174.02 104.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.697 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 74.08 14.94 3.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.83 . . . . 0.0 110.052 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.433 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -102.48 165.97 10.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 0.0 110.474 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' CB ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -113.82 -43.65 3.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.429 -0.794 . . . . 0.0 110.121 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.425 ' CB ' ' O ' ' A' ' 21' ' ' THR . 1.1 tp 62.24 159.03 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.062 -1.024 . . . . 0.0 110.479 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' CYS . 1.7 m -174.61 117.66 0.2 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.413 -0.804 . . . . 0.0 109.256 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 23' ' ' THR . 26.1 m120 53.59 63.19 2.3 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.565 ' C ' ' CG ' ' A' ' 26' ' ' TYR . 1.3 m -146.21 -166.66 2.53 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.736 0.779 . . . . 0.0 111.096 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CG ' ' C ' ' A' ' 25' ' ' CYS . 11.0 m-85 -155.13 -40.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.831 HG13 ' HD2' ' A' ' 42' ' ' PHE . 11.8 t 56.39 137.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.643 0.735 . . . . 0.0 111.618 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.452 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 0.4 OUTLIER -151.6 130.72 12.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.53 -0.731 . . . . 0.0 109.816 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 34.8 mttp 54.31 37.5 27.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.116 -0.99 . . . . 0.0 109.098 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.605 ' HB3' HG22 ' A' ' 45' ' ' VAL . 8.3 m -126.59 169.62 12.9 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.487 -0.758 . . . . 0.0 110.353 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.91 ' OE1' HG23 ' A' ' 46' ' ' THR . 1.2 tt0 -113.02 -63.03 1.5 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.432 -0.793 . . . . 0.0 110.126 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 5.4 t 62.58 144.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -0.865 . . . . 0.0 110.141 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.501 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 42.4 m-85 -152.4 34.23 0.51 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 110.629 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 19' ' ' LYS . . . 156.28 -31.32 0.59 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 50' ' ' SER . 8.9 m -40.34 151.02 0.05 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.462 -1.023 . . . . 0.0 111.072 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.416 ' O ' ' CA ' ' A' ' 22' ' ' LEU . 76.1 m -97.49 -16.55 20.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.423 -0.798 . . . . 0.0 109.261 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.482 ' H ' HG22 ' A' ' 35' ' ' THR . 1.6 t 52.21 83.68 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.572 -0.705 . . . . 0.0 110.057 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 m -93.71 102.62 14.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.37 -0.831 . . . . 0.0 110.303 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.12 61.51 5.33 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 45.2 t -150.81 -168.91 3.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -1.112 . . . . 0.0 109.914 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' A' ' 42' ' ' PHE . 5.2 ttt180 -168.75 156.4 7.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.09 -1.006 . . . . 0.0 110.03 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.831 ' HD2' HG13 ' A' ' 27' ' ' VAL . 5.5 m-85 -117.93 179.35 4.11 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.273 -0.892 . . . . 0.0 110.161 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -168.14 41.1 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.401 -0.812 . . . . 0.0 109.474 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 59' ' ' GLY . . . 129.16 53.96 0.11 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.605 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -129.03 -165.84 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.065 -1.256 . . . . 0.0 110.324 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.91 HG23 ' OE1' ' A' ' 31' ' ' GLU . 23.5 m -163.44 57.9 0.18 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.683 HD11 ' CB ' ' A' ' 50' ' ' SER . 10.4 tt -86.01 172.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.641 0.734 . . . . 0.0 111.695 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' SER . 32.7 p -129.93 -156.32 0.75 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.508 -0.745 . . . . 0.0 109.327 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.572 ' O ' HG22 ' A' ' 49' ' ' THR . 3.6 m -48.5 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.813 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.683 ' CB ' HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -125.24 140.29 52.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.636 -1.29 . . . . 0.0 110.488 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 51' ' ' THR . 14.7 m -86.88 18.36 3.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.142 -0.974 . . . . 0.0 110.732 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.495 ' HA ' ' HB ' ' A' ' 69' ' ' ILE . 12.4 p -39.06 114.45 0.4 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.314 -0.866 . . . . 0.0 111.006 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.2 m -112.02 93.34 4.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.0 109.387 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 82.99 77.47 1.09 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.564 ' CB ' ' HB3' ' A' ' 87' ' ' PHE . 1.6 p -156.26 123.03 5.2 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.273 -1.134 . . . . 0.0 110.974 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -87.16 103.09 15.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 109.884 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 57' ' ' ILE . 2.8 mp -89.03 14.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.056 -1.028 . . . . 0.0 110.122 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -42.58 141.45 1.02 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.335 -0.853 . . . . 0.0 109.789 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.491 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . 172.89 155.5 11.53 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.185 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.56 -2.61 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.173 1.617 . . . . 0.0 110.566 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.28 31.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -49.63 128.41 17.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 110.336 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -114.75 127.81 55.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.427 -0.796 . . . . 0.0 110.528 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.578 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 4.6 mt -138.99 149.87 23.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.139 -0.976 . . . . 0.0 109.853 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 81' ' ' LYS . 83.8 p -147.04 106.04 3.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.051 -1.031 . . . . 0.0 110.699 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.0 m 50.96 73.06 0.31 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 111.583 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.574 ' HB3' HD11 ' A' ' 69' ' ' ILE . 14.6 t -129.1 119.92 25.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.475 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 69' ' ' ILE . 1.7 mp -48.32 -75.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 109.918 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.934 HD13 ' CZ ' ' A' ' 87' ' ' PHE . 10.8 mt 62.81 140.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 0.0 109.683 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.771 ' O ' HG22 ' A' ' 73' ' ' VAL . 81.3 m -165.74 101.8 0.68 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.118 -0.989 . . . . 0.0 111.315 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.85 23.73 24.82 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.58 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 85.19 8.92 80.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 70' ' ' THR . 20.3 m -112.48 121.89 37.78 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.55 -0.971 . . . . 0.0 109.814 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.27 124.09 6.99 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.712 1.375 . . . . 0.0 110.381 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -86.22 139.34 34.29 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.879 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.68 91.99 0.79 Allowed 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.105 1.582 . . . . 0.0 111.035 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.46 147.35 45.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.107 -0.996 . . . . 0.0 110.464 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.76 -12.11 32.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 110.543 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' SER . . . -103.82 -18.14 14.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.93 . . . . 0.0 110.664 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 14.1 t -71.9 157.95 36.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.147 -0.971 . . . . 0.0 109.939 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.558 ' HE3' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -101.53 -11.78 19.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.028 -1.045 . . . . 0.0 112.925 -177.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 81' ' ' LYS . 26.7 mm 26.41 50.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.443 -0.786 . . . . 0.0 111.423 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.6 m -108.21 -157.67 0.62 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.867 -1.146 . . . . 0.0 110.946 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.25 98.63 0.17 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.498 ' SG ' HG23 ' A' ' 57' ' ' ILE . 3.7 t -170.87 -168.43 0.66 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.354 -1.086 . . . . 0.0 109.662 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 2.7 t -177.03 158.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.919 -1.113 . . . . 0.0 109.653 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.934 ' CZ ' HD13 ' A' ' 69' ' ' ILE . 10.4 m-85 -118.95 -49.44 2.42 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 110.548 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 89' ' ' ALA . 15.4 m 61.89 11.92 4.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.283 -0.885 . . . . 0.0 109.858 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 88' ' ' SER . . . 57.15 119.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.439 -0.788 . . . . 0.0 110.392 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 1.6 t-20 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.183 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.866 HD12 ' CB ' ' A' ' 15' ' ' SER . 1.6 mm? -39.42 101.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.544 0.687 . . . . 0.0 110.251 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.519 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -87.0 163.02 17.3 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.641 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.427 ' HB3' ' C ' ' A' ' 28' ' ' ASP . . . 49.43 -157.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.068 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 14' ' ' ASN . 19.9 p-10 -90.49 57.58 3.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 111.482 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.866 ' CB ' HD12 ' A' ' 11' ' ' LEU . 22.0 p -58.54 -168.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.832 -1.167 . . . . 0.0 110.249 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.501 ' CB ' ' HG2' ' A' ' 31' ' ' GLU . 34.8 tttt -154.32 146.93 24.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.05 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.58 167.52 16.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.074 -1.016 . . . . 0.0 110.709 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -176.3 -154.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.504 -0.747 . . . . 0.0 109.651 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.44 54.09 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.017 . . . . 0.0 110.033 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 33' ' ' TYR . 7.9 t -111.99 168.63 9.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.223 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.62 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -104.67 105.92 16.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 109.709 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.62 HD22 ' C ' ' A' ' 21' ' ' THR . 4.3 mm? -107.93 145.8 33.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.774 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 15.7 m -161.13 118.83 2.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 0.0 109.615 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 23' ' ' THR . 26.5 m-20 59.01 64.07 1.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 110.057 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -142.67 169.93 16.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.916 . . . . 0.0 110.581 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 13.5 m-85 -129.13 -40.83 1.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.725 HG13 ' HD2' ' A' ' 42' ' ' PHE . 3.6 t 47.24 112.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.586 0.707 . . . . 0.0 112.017 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.519 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -98.13 -91.91 0.26 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.157 -0.964 . . . . 0.0 109.219 178.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -93.63 68.85 4.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.079 -1.013 . . . . 0.0 109.632 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.664 ' HB3' HG22 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -135.76 -172.98 3.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 110.604 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.643 ' C ' HG23 ' A' ' 32' ' ' VAL . 9.5 mt-10 -137.72 -66.4 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.396 -0.815 . . . . 0.0 110.242 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.643 HG23 ' C ' ' A' ' 31' ' ' GLU . 2.5 t 69.99 150.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.348 -0.845 . . . . 0.0 110.371 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.922 ' CD2' HG22 ' A' ' 48' ' ' THR . 51.0 m-85 -138.68 -46.39 0.49 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.192 -0.942 . . . . 0.0 110.687 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.4 18.36 3.27 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.551 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 33.0 m -67.37 162.14 23.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.181 -1.188 . . . . 0.0 110.369 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 21' ' ' THR . 6.4 m -121.11 64.93 0.87 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.511 ' O ' ' HB ' ' A' ' 23' ' ' THR . 5.3 t -42.42 97.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.495 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 38' ' ' THR . 27.9 m -89.95 20.36 4.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.98 -1.075 . . . . 0.0 109.622 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.16 47.1 0.19 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.592 ' HA ' HD22 ' A' ' 90' ' ' ASN . 53.9 p -126.54 -156.11 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 110.443 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.62 ' HG2' HD21 ' A' ' 90' ' ' ASN . 1.1 ptt85 -169.77 153.8 5.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.894 . . . . 0.0 110.199 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.725 ' HD2' HG13 ' A' ' 27' ' ' VAL . 4.2 m-85 -121.63 -175.11 3.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 110.172 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER 178.59 61.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.982 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 111.1 52.01 0.58 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.664 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.01 -167.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.969 -1.312 . . . . 0.0 110.627 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.549 ' N ' HG23 ' A' ' 45' ' ' VAL . 32.8 m -160.85 54.81 0.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 50' ' ' SER . 17.3 tt -85.08 169.61 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.461 -0.774 . . . . 0.0 110.33 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.922 HG22 ' CD2' ' A' ' 33' ' ' TYR . 41.7 p -135.78 -127.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.307 -0.87 . . . . 0.0 109.962 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.611 ' O ' HG22 ' A' ' 49' ' ' THR . 38.3 m -69.74 72.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.907 -1.12 . . . . 0.0 110.398 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.619 ' HB2' HD11 ' A' ' 47' ' ' ILE . 57.8 m -130.06 136.31 49.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -95.81 117.77 31.2 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.107 -0.996 . . . . 0.0 109.788 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 1.5 m -125.2 137.73 54.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 109.845 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.508 ' HB ' HG23 ' A' ' 70' ' ' THR . 1.0 OUTLIER -115.35 126.37 54.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.046 -1.034 . . . . 0.0 110.535 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 43.64 50.67 6.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 7.8 p -127.33 141.52 51.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -1.112 . . . . 0.0 110.187 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -99.41 101.53 12.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 110.067 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 57' ' ' ILE . 3.0 mp -82.15 7.64 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 m -56.15 163.3 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.056 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.0 155.7 7.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.03 55.37 2.85 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.054 1.555 . . . . 0.0 110.27 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.79 17.19 3.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -45.79 136.57 6.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -1.194 . . . . 0.0 110.518 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.525 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -140.98 120.22 12.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.195 -0.941 . . . . 0.0 110.033 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.562 ' CD1' HG23 ' A' ' 57' ' ' ILE . 21.6 mt -135.39 164.95 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.99 -1.069 . . . . 0.0 111.187 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.481 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -155.46 115.6 3.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.567 -0.708 . . . . 0.0 109.498 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.6 m 53.29 86.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.057 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.409 ' H ' ' CB ' ' A' ' 50' ' ' SER . 54.4 m -150.4 99.9 2.82 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.303 -0.873 . . . . 0.0 109.986 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.823 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.7 mp -67.6 96.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.98 -1.075 . . . . 0.0 109.445 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 73' ' ' VAL . 9.6 mt -104.2 160.75 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.953 . . . . 0.0 110.717 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.913 ' O ' HG22 ' A' ' 73' ' ' VAL . 25.5 m -163.38 110.07 1.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 109.983 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.83 20.47 55.79 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.569 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 86.58 12.22 69.91 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.913 HG22 ' O ' ' A' ' 70' ' ' THR . 6.5 m -118.65 138.34 25.8 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.41 -1.053 . . . . 0.0 110.292 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -80.64 154.05 20.51 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.939 1.494 . . . . 0.0 110.106 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.823 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -83.31 162.36 54.2 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 110.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.3 Cg_endo -74.46 53.43 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.119 1.589 . . . . 0.0 110.281 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.9 m -103.85 138.65 40.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 110.274 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.09 -23.81 35.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 110.23 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.98 6.04 17.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.428 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 66' ' ' THR . 1.2 t -100.76 154.14 18.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.937 . . . . 0.0 109.874 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.559 ' CD ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.56 -168.98 1.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 110.927 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.742 HG23 ' O ' ' A' ' 82' ' ' ILE . 2.1 tp 179.03 33.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.8 0.809 . . . . 0.0 109.201 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -62.21 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.454 -0.779 . . . . 0.0 111.266 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.95 82.82 0.34 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.704 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.549 ' SG ' HD11 ' A' ' 64' ' ' ILE . 1.8 t -144.82 -152.47 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 110.055 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER 172.9 148.44 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 109.893 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 1.4 m-85 -119.08 -28.31 5.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.346 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.778 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 68.0 m 52.85 -90.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.944 -1.098 . . . . 0.0 109.482 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.778 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . 157.41 74.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.269 0.557 . . . . 0.0 109.725 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.62 HD21 ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.034 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.189 0.519 . . . . 0.0 110.049 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 24.5 tp 48.91 89.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.061 -1.024 . . . . 0.0 109.994 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.564 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -44.48 156.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.747 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.91 -8.71 39.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.0 109.903 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -97.65 -10.32 25.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.325 -0.859 . . . . 0.0 110.135 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -78.18 -158.71 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -141.27 147.11 37.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 t -127.55 85.77 2.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 0.0 110.014 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' LYS . 21.1 tt0 -132.45 84.66 2.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 110.526 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' GLU . 1.2 mttp 52.41 104.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.326 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 21' ' ' THR . 35.3 t -158.95 -158.72 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 110.192 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 35' ' ' THR . 0.3 OUTLIER -152.48 86.57 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.277 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.554 HD11 HG11 ' A' ' 32' ' ' VAL . 4.0 mp -109.46 116.77 32.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.129 -0.982 . . . . 0.0 110.133 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 85.8 m -104.29 119.67 39.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -0.956 . . . . 0.0 110.114 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 23' ' ' THR . 11.8 m-20 56.93 22.2 6.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.987 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.472 ' SG ' ' HG ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -71.2 -145.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 110.42 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.506 ' O ' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -179.34 -50.67 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 26' ' ' TYR . 2.6 t 52.05 121.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.775 0.798 . . . . 0.0 111.41 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.564 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 3.2 t70 -111.49 -25.74 9.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 110.191 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.533 ' CD ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -166.65 58.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 109.955 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.892 ' OG ' HG22 ' A' ' 45' ' ' VAL . 16.9 m -132.89 154.83 50.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 111.237 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.61 96.35 6.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.619 -0.676 . . . . 0.0 109.192 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.554 HG11 HD11 ' A' ' 22' ' ' LEU . 12.0 t -91.03 164.52 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 110.941 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.566 ' HB2' HG22 ' A' ' 48' ' ' THR . 20.5 m-85 -143.19 -36.6 0.37 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . -159.37 29.37 0.4 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' SER . 15.5 m -77.06 159.67 29.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.298 -1.119 . . . . 0.0 110.624 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -112.45 53.36 0.74 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.441 -0.787 . . . . 0.0 109.695 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 5.1 t -39.48 103.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.487 -0.758 . . . . 0.0 110.839 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.531 HG22 ' O ' ' A' ' 38' ' ' THR . 23.4 m -103.56 79.37 1.68 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.989 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.51 69.22 1.43 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.55 ' HG ' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -161.27 -148.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -1.099 . . . . 0.0 110.184 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 40' ' ' SER . 1.3 ttp180 172.79 158.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.917 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CD1' ' CG1' ' A' ' 57' ' ' ILE . 2.5 m-85 -121.72 -173.2 2.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 0.0 110.166 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -173.65 57.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.252 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 117.17 47.71 0.46 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.892 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.73 -166.15 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.724 -1.457 . . . . 0.0 111.156 -179.288 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.56 ' N ' HG23 ' A' ' 45' ' ' VAL . 22.1 m -156.16 58.16 0.58 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.339 0.59 . . . . 0.0 109.433 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.75 HD11 ' OG ' ' A' ' 50' ' ' SER . 11.1 tt -84.76 154.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 111.239 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.595 ' C ' HG23 ' A' ' 49' ' ' THR . 72.8 p -148.98 148.5 29.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.605 -0.684 . . . . 0.0 109.913 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.595 HG23 ' C ' ' A' ' 48' ' ' THR . 0.1 OUTLIER 43.28 33.32 0.57 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.009 -1.057 . . . . 0.0 110.772 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.75 ' OG ' HD11 ' A' ' 47' ' ' ILE . 28.3 t -100.77 128.79 46.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.904 -1.122 . . . . 0.0 110.059 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 52' ' ' SER . 3.4 m -92.48 22.35 4.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 110.417 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -40.4 125.62 2.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.427 -0.796 . . . . 0.0 110.868 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 1.6 m -106.95 94.81 5.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 109.511 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.55 ' HA2' ' HG ' ' A' ' 40' ' ' SER . . . 72.45 77.09 0.58 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.501 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 1.3 p -147.2 117.53 7.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.352 -1.087 . . . . 0.0 110.366 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.548 ' CG ' ' HB2' ' A' ' 90' ' ' ASN . 2.8 ttt-85 -68.4 107.25 2.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.665 ' O ' HG11 ' A' ' 45' ' ' VAL . 15.2 mm -88.44 0.22 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.108 -0.995 . . . . 0.0 109.763 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -40.41 125.0 2.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.385 -0.822 . . . . 0.0 110.424 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -167.1 144.77 9.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.05 81.47 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.927 1.488 . . . . 0.0 109.952 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.0 15.73 53.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.647 ' SG ' HD11 ' A' ' 64' ' ' ILE . 15.7 t -44.18 164.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.334 -1.098 . . . . 0.0 111.221 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 62' ' ' CYS . 8.0 ttpp -150.45 114.03 4.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.483 -0.76 . . . . 0.0 110.168 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.647 HD11 ' SG ' ' A' ' 62' ' ' CYS . 4.4 mt -129.83 155.95 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.911 -1.118 . . . . 0.0 111.012 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.453 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -156.01 120.48 4.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.311 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 48' ' ' THR . 9.4 m 44.55 71.49 0.25 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -0.845 . . . . 0.0 111.008 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 98.1 m -122.58 120.8 34.86 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.407 -0.808 . . . . 0.0 109.64 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.841 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.3 mp -88.92 86.02 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.103 -0.998 . . . . 0.0 109.777 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.767 HG23 ' C ' ' A' ' 73' ' ' VAL . 3.7 mt -102.49 157.22 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.435 -0.791 . . . . 0.0 110.356 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.815 ' O ' HG22 ' A' ' 73' ' ' VAL . 53.6 m -153.95 105.49 2.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 0.0 110.24 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 88.02 17.27 58.08 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.565 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 92.36 13.49 57.16 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 70' ' ' THR . 12.9 m -121.76 129.2 25.27 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.454 -1.027 . . . . 0.0 110.436 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -81.24 132.76 8.37 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.928 1.489 . . . . 0.0 110.822 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 77' ' ' SER . . . -76.28 161.08 76.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.262 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.7 64.41 1.24 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.765 1.403 . . . . 0.0 109.953 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.9 t -99.58 118.08 35.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 0.0 110.242 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.62 -4.6 24.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 110.006 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.59 -19.13 18.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.854 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.855 ' SG ' HD12 ' A' ' 82' ' ' ILE . 26.0 t -68.6 165.48 19.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.09 -1.006 . . . . 0.0 109.934 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.599 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -105.14 7.21 33.67 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.289 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.855 HD12 ' SG ' ' A' ' 80' ' ' CYS . 0.9 OUTLIER -15.01 82.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.543 0 CA-C-N 118.909 0.777 . . . . 0.0 111.56 -178.277 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -128.89 -70.21 0.68 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 111.308 -178.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -129.21 86.87 0.31 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.173 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 86' ' ' THR . 3.8 t -177.05 -150.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -1.161 . . . . 0.0 110.084 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 85' ' ' CYS . 1.7 t 174.0 161.87 0.17 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.634 ' CD2' HG21 ' A' ' 69' ' ' ILE . 3.1 m-85 -113.03 -52.56 2.77 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.945 -1.097 . . . . 0.0 110.011 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER 65.22 7.85 4.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 110.312 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 55.65 112.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 110.675 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.548 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . 8.0 t-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.16 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' CG ' ' N ' ' A' ' 11' ' ' LEU . 3.9 pt20 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.21 0.529 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.766 HD12 ' HB ' ' A' ' 27' ' ' VAL . 14.4 tp 59.82 106.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.199 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -35.67 144.26 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.286 0.565 . . . . 0.0 110.747 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -13.78 6.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.421 -0.8 . . . . 0.0 110.13 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.403 ' CG ' ' HG ' ' A' ' 12' ' ' SER . 2.4 p-10 -112.53 8.52 19.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 110.71 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.557 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 2.0 t -82.46 -152.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.891 -1.131 . . . . 0.0 109.955 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.464 ' O ' HD21 ' A' ' 11' ' ' LEU . 26.7 tttm -147.19 152.93 39.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.933 -1.104 . . . . 0.0 110.955 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.545 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 9.5 p -142.27 -153.44 0.46 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.313 -0.867 . . . . 0.0 109.911 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' CYS . 14.6 mm-40 57.05 159.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.114 -0.991 . . . . 0.0 110.173 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 44.31 63.21 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.0 109.946 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.737 ' HB2' HD21 ' A' ' 22' ' ' LEU . 68.9 p -170.55 160.95 7.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.441 -0.787 . . . . 0.0 109.834 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.844 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -125.37 104.47 8.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.087 -1.008 . . . . 0.0 108.79 179.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.844 HD23 ' C ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -144.2 -168.62 2.92 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.308 -178.515 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 24' ' ' ASN . 1.3 m -177.78 146.66 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 23' ' ' THR . 4.3 m-20 45.8 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -0.956 . . . . 0.0 109.871 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 26' ' ' TYR . 60.3 m -140.24 -155.4 0.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.093 -1.005 . . . . 0.0 111.007 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.535 ' CB ' ' O ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER 163.19 43.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.766 ' HB ' HD12 ' A' ' 11' ' ' LEU . 21.6 t -62.11 145.4 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.469 0.652 . . . . 0.0 110.961 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 16.0 m-20 -129.01 3.5 5.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 110.313 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.5 OUTLIER 175.67 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.322 -0.861 . . . . 0.0 109.837 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.809 ' OG ' HG22 ' A' ' 45' ' ' VAL . 54.3 m -165.26 -160.48 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.953 -1.092 . . . . 0.0 110.343 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 2.5 mt-10 -137.66 -62.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 0.0 110.542 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 47' ' ' ILE . 3.9 t 64.61 153.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.892 . . . . 0.0 110.74 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.691 ' CD1' HG22 ' A' ' 48' ' ' THR . 25.9 m-85 -149.86 -77.04 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.504 -0.748 . . . . 0.0 109.336 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 48' ' ' THR . . . -107.95 36.47 4.36 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 36' ' ' THR . 1.0 OUTLIER -82.96 171.79 13.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -1.081 . . . . 0.0 110.46 -179.475 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.528 ' N ' ' CG2' ' A' ' 35' ' ' THR . 1.7 m -119.52 58.81 0.87 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 110.234 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.644 ' HB3' ' CB ' ' A' ' 22' ' ' LEU . 36.2 t -39.03 103.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.443 -0.785 . . . . 0.0 110.579 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 38' ' ' THR . 24.3 m -106.39 75.84 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.981 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.74 49.03 71.47 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 4.9 p -138.9 169.08 18.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -1.119 . . . . 0.0 110.18 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.403 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -147.44 157.44 43.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 109.994 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 41' ' ' ARG . 2.5 m-85 -119.98 -179.44 3.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.154 -0.967 . . . . 0.0 110.454 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -155.71 46.93 0.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 109.47 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 123.94 75.03 0.28 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.809 HG22 ' OG ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -150.28 -168.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.196 -1.179 . . . . 0.0 110.453 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' VAL . 39.9 m -155.28 57.86 0.64 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.572 -0.705 . . . . 0.0 109.332 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.879 HD11 ' HB2' ' A' ' 50' ' ' SER . 11.3 tt -78.33 168.05 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 110.054 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.691 HG22 ' CD1' ' A' ' 33' ' ' TYR . 2.4 p -143.06 -81.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -110.61 39.91 2.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.233 -0.917 . . . . 0.0 109.386 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.879 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -96.31 124.36 40.28 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.351 -0.843 . . . . 0.0 110.943 -179.442 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -71.13 135.66 47.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.355 -0.841 . . . . 0.0 108.963 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.6 p -140.82 119.37 12.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.909 -1.12 . . . . 0.0 110.663 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.401 ' H ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -117.49 70.15 0.78 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 109.43 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 96.01 91.1 1.79 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 87.3 p -171.92 128.09 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -1.202 . . . . 0.0 110.811 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.543 ' CD ' ' HB2' ' A' ' 88' ' ' SER . 1.4 ptp180 -87.71 105.05 17.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 109.365 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.534 HD13 ' N ' ' A' ' 57' ' ' ILE . 5.1 mm -81.66 16.08 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.023 . . . . 0.0 110.992 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.91 156.06 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.025 -1.047 . . . . 0.0 110.038 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.59 143.77 3.77 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.29 -3.35 13.78 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.985 1.519 . . . . 0.0 110.225 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.49 27.65 0.28 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -58.28 141.03 52.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -1.126 . . . . 0.0 110.472 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 6.1 ttpp -151.66 117.04 5.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.529 -0.732 . . . . 0.0 109.2 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.609 ' HA ' ' CD ' ' A' ' 81' ' ' LYS . 2.2 mp -129.36 147.11 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.956 -1.09 . . . . 0.0 111.172 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.541 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -143.2 111.93 6.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 110.181 179.398 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.527 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 19.8 m 51.76 57.54 6.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.647 -0.658 . . . . 0.0 111.108 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 2.0 t -110.46 129.3 55.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.425 -0.797 . . . . 0.0 110.154 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.715 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.0 mp -87.03 93.36 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.029 . . . . 0.0 108.676 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.706 HG21 ' CD2' ' A' ' 87' ' ' PHE . 10.1 mt -106.9 149.55 10.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.392 -0.818 . . . . 0.0 110.489 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.801 ' O ' HG22 ' A' ' 73' ' ' VAL . 7.5 m -156.04 103.81 2.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 110.734 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.5 24.85 27.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 87' ' ' PHE . . . 83.09 17.14 67.86 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 70' ' ' THR . 14.2 m -124.0 128.53 25.06 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.523 -0.986 . . . . 0.0 110.701 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -82.04 130.65 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.904 1.476 . . . . 0.0 110.313 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -93.02 147.3 33.6 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.09 -1.006 . . . . 0.0 110.153 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.24 101.31 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.948 1.499 . . . . 0.0 109.796 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.721 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 40.3 t -111.73 -5.63 14.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 110.72 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 70.45 3.63 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.157 -0.964 . . . . 0.0 109.57 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 80' ' ' CYS . . . -125.65 -34.03 2.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 109.318 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 18.2 t -45.09 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.59 -0.694 . . . . 0.0 109.536 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.609 ' CD ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.96 7.45 46.61 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.961 -1.087 . . . . 0.0 112.357 -178.126 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.579 ' C ' ' O ' ' A' ' 81' ' ' LYS . 17.6 mm -6.69 73.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 81' ' ' LYS . 43.9 t -124.35 -52.06 1.74 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 109.864 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' CYS . . . -147.82 -114.95 0.81 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' GLY . 2.9 t 44.07 -167.82 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.343 -1.092 . . . . 0.0 109.972 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.467 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.6 OUTLIER 175.18 140.22 0.05 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 110.459 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CD2' HG21 ' A' ' 69' ' ' ILE . 1.6 m-30 -115.69 170.26 8.58 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.4 -0.813 . . . . 0.0 109.677 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.543 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 6.7 m -165.52 25.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 109.644 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.498 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.02 83.41 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.36 -0.837 . . . . 0.0 109.967 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.452 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.317 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.55 ' O ' ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 10' ' ' GLN . 14.2 tp 10.2 107.24 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.356 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.624 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -39.56 155.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.636 -0.665 . . . . 0.0 110.328 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.28 -8.46 25.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 110.203 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.7 -9.39 6.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.09 -1.006 . . . . 0.0 110.454 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.697 ' OG ' HG12 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -66.24 -161.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.865 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 24.6 tttt -165.34 150.28 9.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.126 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 p -126.02 -35.93 2.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.917 . . . . 0.0 110.242 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 58.14 -162.77 0.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.765 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -87.86 62.66 7.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.861 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.531 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 77.9 p -97.63 -172.25 2.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 110.743 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.5 ' C ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -106.65 10.74 30.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.566 HD13 HG11 ' A' ' 32' ' ' VAL . 2.3 tp -37.95 159.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.496 0.665 . . . . 0.0 110.814 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 94.6 m -162.36 123.69 2.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.69 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.1 m120 56.52 60.51 3.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 110.314 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.598 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -120.59 -157.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 110.448 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 25' ' ' CYS . 47.2 m-85 -154.82 -55.98 0.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.697 HG12 ' OG ' ' A' ' 15' ' ' SER . 2.4 t 57.72 119.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.477 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.624 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 4.1 m-20 -112.58 -24.68 9.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.49 -0.756 . . . . 0.0 109.817 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 28' ' ' ASP . 5.1 mtpp -163.41 59.23 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.528 -0.732 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.927 ' OG ' HG22 ' A' ' 45' ' ' VAL . 39.1 m -139.88 153.53 47.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.026 . . . . 0.0 111.562 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' OE2' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -115.9 112.2 21.54 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.566 HG11 HD13 ' A' ' 22' ' ' LEU . 7.0 t -106.84 159.06 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -0.957 . . . . 0.0 110.93 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.567 ' CD1' HG22 ' A' ' 48' ' ' THR . 46.1 m-85 -130.91 -36.41 1.36 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.354 -0.841 . . . . 0.0 110.946 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -151.0 12.76 0.83 Allowed Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.582 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' SER . 27.5 m -62.44 162.13 10.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.989 -1.301 . . . . 0.0 110.648 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.5 ' HA ' ' C ' ' A' ' 21' ' ' THR . 19.9 m -109.94 -22.52 11.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.358 -0.839 . . . . 0.0 110.266 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.496 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 4.0 t 42.24 81.13 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.24 -0.913 . . . . 0.0 110.42 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 38' ' ' THR . 88.8 m -77.06 57.2 1.34 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 109.421 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.39 74.11 1.28 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -157.35 -161.77 1.11 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.261 -1.14 . . . . 0.0 110.008 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 10.7 ptt180 -167.56 162.33 14.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.031 . . . . 0.0 110.658 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.601 ' CE1' HD13 ' A' ' 57' ' ' ILE . 2.6 m-85 -120.31 -162.72 0.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.371 -0.831 . . . . 0.0 110.217 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER 171.98 53.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 29' ' ' LYS . . . 117.27 56.49 0.3 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.927 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.3 m -139.35 -164.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.09 -1.241 . . . . 0.0 110.475 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.545 ' O ' HG22 ' A' ' 46' ' ' THR . 91.5 m -161.07 56.52 0.3 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 17.4 tt -83.86 165.47 2.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.378 -0.826 . . . . 0.0 110.589 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.567 HG22 ' CD1' ' A' ' 33' ' ' TYR . 66.4 p -129.53 -140.04 0.23 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 109.131 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.517 ' HA ' ' CA ' ' A' ' 34' ' ' GLY . 41.6 m -51.32 129.44 24.84 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.057 -1.027 . . . . 0.0 108.941 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' THR . 41.0 t -171.21 163.18 7.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.006 -1.059 . . . . 0.0 110.587 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 51' ' ' THR . 52.9 m -116.83 13.99 15.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.079 -1.013 . . . . 0.0 110.339 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.474 ' C ' ' O ' ' A' ' 51' ' ' THR . 54.5 p -36.18 133.94 0.45 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.644 -0.66 . . . . 0.0 110.653 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 69' ' ' ILE . 6.9 m -127.22 107.64 10.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 110.19 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 64.84 78.93 0.19 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.453 ' O ' HD12 ' A' ' 57' ' ' ILE . 51.8 p -158.3 127.47 5.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.153 -1.204 . . . . 0.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HB3' ' CB ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -78.54 103.6 8.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.656 ' O ' HG22 ' A' ' 57' ' ' ILE . 3.1 mp -89.48 16.47 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.963 -1.085 . . . . 0.0 110.66 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.49 159.73 0.69 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.2 -0.937 . . . . 0.0 110.266 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.29 166.82 18.99 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.77 54.03 3.87 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.073 1.565 . . . . 0.0 109.873 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 107.56 22.51 7.35 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.527 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 5.0 t -40.56 103.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.584 -0.95 . . . . 0.0 110.384 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 64' ' ' ILE . 13.2 tttt -97.12 146.06 25.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.572 -0.705 . . . . 0.0 109.725 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.672 HG23 ' NZ ' ' A' ' 81' ' ' LYS . 19.2 mt -154.5 144.08 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.052 -1.03 . . . . 0.0 110.783 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.438 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -136.4 107.87 6.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.284 -0.885 . . . . 0.0 110.653 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' THR . 5.9 m 58.02 79.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.37 -0.831 . . . . 0.0 111.469 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.523 ' O ' HG13 ' A' ' 69' ' ' ILE . 0.9 OUTLIER -135.63 117.4 15.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 109.981 178.183 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.665 ' HB ' ' HB3' ' A' ' 75' ' ' ALA . 1.1 mm -76.33 101.75 2.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 17.4 mt -115.2 155.87 16.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 O-C-N 120.899 -1.126 . . . . 0.0 109.97 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.845 ' O ' HG22 ' A' ' 73' ' ' VAL . 86.4 m -159.98 103.02 1.48 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 0.0 110.426 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.73 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 88.94 25.93 28.03 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.17 17.29 69.75 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 70' ' ' THR . 12.4 m -127.63 132.86 24.55 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.393 -1.063 . . . . 0.0 110.859 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -81.46 147.06 15.69 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.02 1.537 . . . . 0.0 110.656 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.853 ' HB1' ' CD ' ' A' ' 76' ' ' PRO . . . -73.15 -153.59 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.154 -0.966 . . . . 0.0 108.403 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.853 ' CD ' ' HB1' ' A' ' 75' ' ' ALA . 43.5 Cg_endo -75.62 9.48 2.24 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 O-C-N 122.404 0.686 . . . . 0.0 111.018 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.503 ' CB ' ' HB3' ' A' ' 80' ' ' CYS . 5.3 p 45.0 50.17 9.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.89 . . . . 0.0 111.448 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.07 -23.6 3.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.02 -1.05 . . . . 0.0 109.153 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.54 40.88 0.25 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 1.2 t -109.49 164.64 12.32 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.902 0.858 . . . . 0.0 110.98 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.672 ' NZ ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.27 173.71 7.25 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.342 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.797 ' O ' HG22 ' A' ' 82' ' ' ILE . 17.9 mm -160.1 53.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 t -97.95 -126.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 110.386 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.48 91.54 1.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.428 ' SG ' ' C ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER -162.76 177.51 9.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.147 . . . . 0.0 109.874 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.527 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -177.43 149.57 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.35 -0.844 . . . . 0.0 110.022 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -117.13 166.6 12.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.113 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.491 ' CB ' ' HB3' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -148.58 23.91 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.901 -1.125 . . . . 0.0 110.371 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 47.16 62.7 2.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.257 -0.902 . . . . 0.0 109.695 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 40' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.21 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.54 ' CD ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.052 HD12 ' CB ' ' A' ' 15' ' ' SER . 3.4 mm? -41.25 103.18 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.95 0.881 . . . . 0.0 109.35 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' ALA . 50.8 m -64.94 55.49 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.842 -0.536 . . . . 0.0 111.5 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 56.76 154.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 110.627 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 70.51 -4.68 1.57 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.209 -0.932 . . . . 0.0 111.807 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 1.052 ' CB ' HD12 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -74.42 176.69 6.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.458 -1.401 . . . . 0.0 110.574 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HD3' ' CG ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -160.42 151.53 19.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.392 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 p -166.65 -172.01 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 110.263 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 22.3 tt0 -169.61 -39.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.384 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -177.62 54.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.366 -0.834 . . . . 0.0 109.987 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.482 ' HB2' ' N ' ' A' ' 34' ' ' GLY . 52.0 p -102.92 -163.44 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 110.557 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' THR . 68.8 m -126.77 77.0 1.68 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.979 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 37' ' ' CYS . 3.5 tp -95.19 165.83 12.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 21.7 m -167.51 128.81 1.52 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.426 -0.796 . . . . 0.0 109.902 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.46 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 8.7 m120 56.34 29.14 14.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.075 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -101.8 154.57 18.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.86 . . . . 0.0 110.375 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' CD1' ' CD ' ' A' ' 10' ' ' GLN . 1.9 m-85 -116.69 -40.31 3.2 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.784 ' HB ' HD13 ' A' ' 11' ' ' LEU . 6.5 t 52.99 137.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.107 0.956 . . . . 0.0 113.096 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 14.7 t0 -142.2 118.08 10.54 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 14' ' ' ASN . 30.8 mttm 53.11 66.07 1.34 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.009 -1.057 . . . . 0.0 109.301 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 45' ' ' VAL . 69.3 m -153.51 151.97 30.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.038 -1.039 . . . . 0.0 110.65 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' CG ' ' HD3' ' A' ' 16' ' ' LYS . 11.0 mt-10 -121.12 112.91 19.28 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.534 -0.729 . . . . 0.0 109.166 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.515 HG11 ' HB ' ' A' ' 35' ' ' THR . 17.0 t -111.13 152.55 13.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.57 -0.707 . . . . 0.0 110.392 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.456 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 51.2 m-85 -144.93 34.71 1.12 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.263 -0.898 . . . . 0.0 110.841 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.482 ' N ' ' HB2' ' A' ' 20' ' ' SER . . . 140.9 41.46 0.07 OUTLIER Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.122 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.515 ' HB ' HG11 ' A' ' 32' ' ' VAL . 3.5 m -97.41 124.9 41.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.075 -1.25 . . . . 0.0 110.582 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 36' ' ' THR . 90.4 m -79.98 55.49 2.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.143 -0.973 . . . . 0.0 109.71 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 29.8 t -46.11 143.6 2.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.534 -0.728 . . . . 0.0 110.689 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -124.08 10.3 8.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 129.89 40.92 0.25 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.405 ' HA ' HD21 ' A' ' 90' ' ' ASN . 47.2 m -122.38 -167.74 1.61 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 110.075 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 42' ' ' PHE . 2.6 ttt180 -158.19 165.83 33.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 110.35 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.648 ' HD2' HG13 ' A' ' 27' ' ' VAL . 7.0 m-85 -121.97 -172.2 2.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.814 . . . . 0.0 109.692 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 20.2 t0 -167.8 49.37 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.0 110.562 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 118.47 51.17 0.32 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 46' ' ' THR . 1.1 m -127.87 -166.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.092 -1.24 . . . . 0.0 110.828 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.548 ' N ' HG23 ' A' ' 45' ' ' VAL . 24.6 m -161.37 56.28 0.28 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 50' ' ' SER . 13.7 tt -76.56 172.04 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.498 -0.751 . . . . 0.0 110.735 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.462 ' N ' HG12 ' A' ' 47' ' ' ILE . 47.0 p -138.28 -137.04 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 109.551 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 40.5 m -65.34 81.99 0.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.835 -1.165 . . . . 0.0 109.888 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.676 ' HB3' HD11 ' A' ' 47' ' ' ILE . 23.2 t -135.89 148.5 48.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.04 -1.037 . . . . 0.0 111.357 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.555 ' CB ' ' HA ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -95.49 126.36 40.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.078 -1.014 . . . . 0.0 109.12 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.04 105.08 5.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 110.004 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -95.11 102.54 14.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.477 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 61.12 92.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 83.7 p -166.15 121.08 1.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -1.213 . . . . 0.0 110.414 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -81.25 112.72 18.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.008 -1.057 . . . . 0.0 109.458 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.494 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 18.0 mm -88.57 13.27 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.339 -0.851 . . . . 0.0 110.823 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -42.59 141.21 1.07 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.233 -0.917 . . . . 0.0 110.286 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 178.8 146.03 6.4 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -76.39 55.82 4.82 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.024 1.539 . . . . 0.0 109.103 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 117.23 20.17 4.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -39.43 147.25 0.08 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.381 -1.07 . . . . 0.0 110.964 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 24.1 tttt -147.16 100.74 3.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.867 . . . . 0.0 110.048 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.85 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.4 mt -116.19 149.92 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.0 110.431 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -142.18 118.05 10.54 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.202 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.1 m 54.35 80.57 0.12 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 111.892 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.8 t -137.99 128.78 26.9 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 68' ' ' ILE . 1.7 mp -82.66 9.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.879 -1.138 . . . . 0.0 110.55 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.533 HG13 ' SG ' ' A' ' 67' ' ' CYS . 62.5 mt -18.35 138.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 CA-C-O 121.434 0.635 . . . . 0.0 112.04 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.815 ' O ' HG22 ' A' ' 73' ' ' VAL . 52.3 m -148.66 100.9 3.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.961 -1.087 . . . . 0.0 111.477 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.538 ' O ' HG13 ' A' ' 73' ' ' VAL . . . 91.67 37.75 6.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.448 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 72.07 13.2 76.09 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 70' ' ' THR . 5.3 m -120.3 136.52 25.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.39 -1.065 . . . . 0.0 110.013 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HA ' HG12 ' A' ' 69' ' ' ILE . 44.8 Cg_endo -75.93 142.13 24.82 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.789 1.415 . . . . 0.0 110.682 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -94.59 167.77 12.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 109.604 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 45.4 Cg_endo -72.09 72.95 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.683 1.36 . . . . 0.0 110.031 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.555 ' HB3' ' CB ' ' A' ' 80' ' ' CYS . 4.9 t -115.29 107.41 15.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.477 -0.764 . . . . 0.0 110.242 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.34 -13.9 15.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.964 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.71 -14.44 23.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.392 -0.818 . . . . 0.0 110.108 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 7.2 t -72.39 161.34 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.419 -0.801 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.909 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -124.55 154.84 40.0 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.53 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.909 HD13 ' O ' ' A' ' 81' ' ' LYS . 18.1 mm -140.77 70.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -137.48 106.54 6.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.828 . . . . 0.0 111.684 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.5 30.23 53.96 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.652 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.85 ' SG ' HD11 ' A' ' 64' ' ' ILE . 5.5 t -150.31 179.31 8.23 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.984 -1.304 . . . . 0.0 110.231 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.0 t -177.31 161.25 1.78 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.383 -0.823 . . . . 0.0 109.726 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -121.68 169.91 10.25 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 109.525 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.48 24.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.8 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 46.61 78.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.463 -0.773 . . . . 0.0 109.965 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.552 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.394 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 1.6 tt0 . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.322 0.582 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.794 HD12 ' CB ' ' A' ' 15' ' ' SER . 2.3 mm? -43.44 117.42 1.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.538 ' OG ' ' CZ ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -58.6 71.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.517 -0.74 . . . . 0.0 111.134 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 11' ' ' LEU . . . 21.89 59.87 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 120.963 0.411 . . . . 0.0 111.79 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -178.46 -32.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.964 . . . . 0.0 110.307 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.794 ' CB ' HD12 ' A' ' 11' ' ' LEU . 15.1 t -58.42 -176.56 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.558 -0.714 . . . . 0.0 110.998 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 9.9 ttmt -139.47 147.38 41.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 109.791 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.55 127.22 14.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.966 . . . . 0.0 110.32 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -120.72 -38.29 2.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.088 -1.008 . . . . 0.0 110.551 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -174.12 34.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -0.93 . . . . 0.0 109.686 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 p -84.68 -167.97 2.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 110.691 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 21' ' ' THR . 5.7 t -142.47 66.53 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.063 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 22' ' ' LEU . 5.3 mt -77.97 177.07 8.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.996 -1.065 . . . . 0.0 109.988 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 37' ' ' CYS . 55.5 m -164.7 121.44 1.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.866 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 23' ' ' THR . 31.0 m120 56.57 48.7 16.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 109.407 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.19 164.84 15.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.59 0.709 . . . . 0.0 110.839 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.592 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 25.1 t80 -138.22 26.06 2.67 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.798 HG13 ' HD2' ' A' ' 42' ' ' PHE . 15.1 t -21.67 144.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.016 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 42.8 t0 -145.56 147.05 31.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.467 -0.771 . . . . 0.0 109.801 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 41.9 mtpt 35.43 41.5 0.09 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.569 -0.707 . . . . 0.0 110.34 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.822 ' CB ' HG22 ' A' ' 45' ' ' VAL . 75.3 m -133.19 150.8 51.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 110.851 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 47' ' ' ILE . 7.7 mt-10 -118.29 99.66 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 0.0 109.64 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.589 HG22 ' CG2' ' A' ' 47' ' ' ILE . 21.8 t -99.17 163.62 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.512 -0.742 . . . . 0.0 110.528 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.427 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 49.4 m-85 -148.44 -14.23 0.34 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.073 -1.017 . . . . 0.0 111.926 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.15 26.45 0.2 Allowed Glycine 0 N--CA 1.494 2.549 0 O-C-N 120.556 -1.34 . . . . 0.0 109.962 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 36' ' ' THR . 43.5 m -82.07 168.83 17.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -1.126 . . . . 0.0 110.732 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.566 ' N ' HG22 ' A' ' 35' ' ' THR . 40.0 m -129.33 52.65 1.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.383 -0.823 . . . . 0.0 109.62 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.503 ' O ' ' N ' ' A' ' 23' ' ' THR . 5.9 t -44.02 102.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 110.158 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 38' ' ' THR . 13.5 t -95.84 35.64 1.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 0.0 110.142 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.02 24.5 2.48 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -115.14 -166.98 1.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -1.075 . . . . 0.0 109.489 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' N ' ' OG ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -164.66 164.53 21.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.898 -1.126 . . . . 0.0 111.159 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.798 ' HD2' HG13 ' A' ' 27' ' ' VAL . 7.0 m-85 -123.13 -177.4 3.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.316 -0.865 . . . . 0.0 109.922 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.1 t70 -165.81 53.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.237 -0.914 . . . . 0.0 110.482 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 117.53 66.96 0.36 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.822 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.7 m -143.68 -160.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.911 -1.347 . . . . 0.0 111.604 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.557 ' N ' HG23 ' A' ' 45' ' ' VAL . 97.5 m -165.08 58.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.589 ' CG2' HG22 ' A' ' 32' ' ' VAL . 10.1 tt -81.42 165.29 2.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.345 -0.847 . . . . 0.0 110.923 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 25.0 p -131.34 -143.34 0.24 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 66' ' ' THR . 26.8 m -56.42 110.45 0.77 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.581 -1.325 . . . . 0.0 108.236 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' THR . 1.4 t -161.61 136.96 7.54 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.706 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -98.48 122.03 41.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.335 -0.853 . . . . 0.0 109.637 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.465 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -135.77 129.49 32.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.114 -0.991 . . . . 0.0 110.507 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.1 101.7 10.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.365 -0.834 . . . . 0.0 109.427 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 64.74 99.21 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.482 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 85.6 p -174.42 110.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -1.163 . . . . 0.0 110.564 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.548 ' CA ' ' HB3' ' A' ' 90' ' ' ASN . 3.8 ptp180 -77.4 112.12 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.104 -0.997 . . . . 0.0 109.166 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.528 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 32.6 mm -87.57 21.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.083 -1.011 . . . . 0.0 110.548 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.6 m -45.36 160.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 110.144 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.69 163.36 11.59 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.7 47.83 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.005 1.529 . . . . 0.0 109.826 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 123.8 16.22 3.38 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.495 ' HB3' ' CB ' ' A' ' 45' ' ' VAL . 3.1 t -36.62 116.75 0.45 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.604 -0.939 . . . . 0.0 110.998 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.558 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 32.2 tttm -107.79 153.76 22.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.882 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.038 HD13 ' HE2' ' A' ' 81' ' ' LYS . 30.1 mm -152.38 130.66 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.83 -1.168 . . . . 0.0 109.642 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.497 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 62.4 p -132.58 118.51 19.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 0.0 110.257 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.6 OUTLIER 43.44 56.95 4.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.475 -0.766 . . . . 0.0 110.056 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HB2' HG23 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -113.17 99.05 7.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.943 . . . . 0.0 109.862 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.9 mp -69.49 86.56 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.978 -1.076 . . . . 0.0 109.114 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.609 HG23 ' C ' ' A' ' 73' ' ' VAL . 9.0 mt -89.64 159.9 2.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.624 -0.673 . . . . 0.0 110.189 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.776 ' O ' HG22 ' A' ' 73' ' ' VAL . 8.6 m -157.99 96.27 1.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 110.281 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.59 33.25 8.07 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 75.52 16.98 80.31 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 70' ' ' THR . 13.8 m -126.18 131.44 23.96 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.376 -1.073 . . . . 0.0 110.177 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -79.68 151.0 21.86 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.768 1.404 . . . . 0.0 110.453 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -82.82 173.53 7.41 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.093 -1.004 . . . . 0.0 110.094 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -82.4 9.98 3.77 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.759 1.399 . . . . 0.0 109.751 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.9 t -54.97 132.94 48.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.539 -0.725 . . . . 0.0 110.343 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.67 -10.84 55.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.419 -0.801 . . . . 0.0 110.391 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.69 -14.25 25.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 109.732 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 67' ' ' CYS . 36.4 t -77.03 123.55 26.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.331 -0.856 . . . . 0.0 109.444 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 1.038 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.42 172.89 6.85 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.054 -1.029 . . . . 0.0 110.476 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.76 ' O ' HG22 ' A' ' 82' ' ' ILE . 0.6 OUTLIER -163.23 82.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.46 74.67 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.718 -0.614 . . . . 0.0 111.4 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.18 -13.82 44.27 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.371 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -82.04 -164.63 0.84 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.969 -1.312 . . . . 0.0 109.961 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.573 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t 168.82 147.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 109.657 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.642 ' HE1' HD11 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -130.57 156.08 45.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.825 . . . . 0.0 109.395 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.447 ' HB3' ' CD ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -145.25 30.34 1.14 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.142 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.482 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 51.72 82.14 0.07 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.411 -0.805 . . . . 0.0 108.867 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.548 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.68 -178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.022 0.439 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.877 HD21 ' HB2' ' A' ' 17' ' ' CYS . 22.8 tp 47.57 81.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.11 -0.994 . . . . 0.0 108.478 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -43.05 147.13 0.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.825 . . . . 0.0 110.387 -178.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.21 -13.37 12.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.964 . . . . 0.0 109.651 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 53.7 t-20 -90.4 -1.95 57.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.516 -0.74 . . . . 0.0 110.216 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 39.8 t -91.72 -157.52 0.51 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.042 -1.036 . . . . 0.0 109.843 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 4.8 tttt -138.79 159.14 42.85 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 110.113 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.877 ' HB2' HD21 ' A' ' 11' ' ' LEU . 34.9 t -148.87 116.7 6.3 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.286 -0.884 . . . . 0.0 110.744 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 19' ' ' LYS . 2.2 mt-10 -147.68 71.7 1.21 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.493 -0.755 . . . . 0.0 109.272 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 61.83 117.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 108.996 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -158.02 173.43 16.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.025 . . . . 0.0 110.722 -178.735 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -119.79 30.26 7.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 0.0 109.736 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 37' ' ' CYS . 11.2 mt -60.95 -178.79 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 109.963 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 24.2 m -166.24 122.23 1.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.787 . . . . 0.0 109.507 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 47.48 46.73 17.47 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.118 -0.989 . . . . 0.0 109.059 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 40' ' ' SER . 0.9 OUTLIER -88.08 -151.12 0.19 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.971 0.891 . . . . 0.0 111.254 -178.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 1.2 t80 174.35 41.77 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 42' ' ' PHE . 26.1 t -50.7 149.43 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.7 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -157.05 131.18 8.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 1.2 mtpt 55.6 19.37 3.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -0.985 . . . . 0.0 110.154 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.47 ' HB3' HG22 ' A' ' 45' ' ' VAL . 69.8 m -122.48 -178.15 3.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.969 -1.082 . . . . 0.0 110.612 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' C ' HG23 ' A' ' 32' ' ' VAL . 3.6 tt0 -116.33 -71.91 0.72 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -0.858 . . . . 0.0 110.419 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG23 ' C ' ' A' ' 31' ' ' GLU . 3.7 t 66.45 140.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.594 -0.691 . . . . 0.0 110.266 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 32' ' ' VAL . 44.1 m-85 -141.34 -70.81 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 110.587 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.61 22.06 33.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.556 ' O ' HD23 ' A' ' 22' ' ' LEU . 98.3 m -70.54 160.14 33.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.397 -1.061 . . . . 0.0 111.29 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 37' ' ' CYS . 22.2 m -116.01 49.97 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.495 -0.753 . . . . 0.0 109.742 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.576 ' HB2' HD22 ' A' ' 22' ' ' LEU . 31.2 t -39.38 104.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 111.162 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.4 m -98.95 89.84 4.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.156 -0.965 . . . . 0.0 109.838 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.78 38.44 95.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -130.8 -150.65 0.44 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.171 -1.194 . . . . 0.0 110.063 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 40' ' ' SER . 18.7 ptt180 177.66 -176.68 0.18 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.317 -0.865 . . . . 0.0 110.518 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' A' ' 47' ' ' ILE . 20.4 m-85 -133.16 -169.4 2.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.387 -0.821 . . . . 0.0 109.301 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.88 50.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 109.814 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 115.72 58.14 0.34 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 2.3 m -138.53 -159.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.989 -1.301 . . . . 0.0 110.709 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.572 ' O ' HG22 ' A' ' 46' ' ' THR . 87.8 m -161.79 51.04 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.44 -0.788 . . . . 0.0 109.809 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.652 HG21 ' CE2' ' A' ' 42' ' ' PHE . 6.6 tt -80.27 164.41 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.368 -0.833 . . . . 0.0 110.435 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 46.2 p -136.48 -120.04 0.16 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.347 -0.846 . . . . 0.0 110.333 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' THR . 94.3 m -70.33 70.54 0.41 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.674 -1.266 . . . . 0.0 110.114 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.615 ' OG ' HD11 ' A' ' 47' ' ' ILE . 1.1 t -124.27 144.79 49.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.147 -0.97 . . . . 0.0 110.529 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -104.65 125.43 50.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.881 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -136.66 136.17 38.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.999 -1.063 . . . . 0.0 110.122 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.84 89.69 3.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.916 -1.115 . . . . 0.0 109.545 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.1 92.37 0.17 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.9 p -165.2 130.19 2.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -1.143 . . . . 0.0 110.532 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 88' ' ' SER . 14.7 ttp85 -93.38 106.66 18.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.125 -0.984 . . . . 0.0 109.157 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.695 HG23 HD11 ' A' ' 64' ' ' ILE . 8.7 mm -81.63 13.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 110.435 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -34.43 146.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 0.0 110.8 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.94 153.65 9.68 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.22 36.46 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.972 1.511 . . . . 0.0 109.683 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.92 32.72 0.5 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 45' ' ' VAL . 1.6 t -49.87 166.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.29 -1.123 . . . . 0.0 110.086 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' SG ' ' A' ' 62' ' ' CYS . 31.8 tttp -149.13 106.24 3.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 109.555 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.695 HD11 HG23 ' A' ' 57' ' ' ILE . 1.7 mt -121.7 158.56 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.888 -1.133 . . . . 0.0 111.046 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 65' ' ' SER . 1.3 p -163.09 105.76 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.548 -0.72 . . . . 0.0 109.479 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.3 m 67.07 78.2 0.25 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.216 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' A' ' 64' ' ' ILE . 74.1 m -140.37 121.8 15.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.431 -0.793 . . . . 0.0 109.598 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.763 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.9 mp -93.47 83.62 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.937 -1.102 . . . . 0.0 109.324 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' THR . 29.1 mt -86.54 162.46 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.618 -0.676 . . . . 0.0 110.791 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.817 ' O ' HG22 ' A' ' 73' ' ' VAL . 27.9 m -158.81 95.29 1.29 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.253 -0.905 . . . . 0.0 110.76 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.57 30.32 13.91 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.55 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 81.45 15.32 76.53 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 70' ' ' THR . 10.6 m -127.83 123.78 23.0 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.412 -1.052 . . . . 0.0 110.604 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 44.8 Cg_endo -75.1 138.88 23.35 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.837 1.441 . . . . 0.0 111.274 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -73.55 164.29 62.16 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.359 -0.838 . . . . 0.0 109.466 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 44.0 Cg_endo -71.0 58.91 2.2 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.75 1.395 . . . . 0.0 110.115 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 m -92.63 119.04 31.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.469 -0.77 . . . . 0.0 110.675 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.15 1.51 15.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.259 -0.9 . . . . 0.0 111.064 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.67 -16.73 14.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.954 -1.091 . . . . 0.0 110.174 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 82' ' ' ILE . 4.4 t -69.91 165.78 20.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 110.952 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.573 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -60.17 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.651 -0.655 . . . . 0.0 111.876 -179.358 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 80' ' ' CYS . 4.9 mm 71.96 33.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.2 m -112.12 -84.76 0.58 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.705 -0.622 . . . . 0.0 111.571 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -117.35 84.79 0.38 Allowed Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.737 -1.22 . . . . 0.0 111.0 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 8.7 t -178.95 174.66 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -1.137 . . . . 0.0 110.255 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.505 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 7.4 t -169.6 168.79 9.03 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.609 ' CD1' HD12 ' A' ' 57' ' ' ILE . 1.6 m-85 -126.41 157.06 39.54 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.022 -1.049 . . . . 0.0 109.389 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 56' ' ' ARG . 4.0 m -129.3 20.42 5.75 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 90' ' ' ASN . . . 53.37 59.58 4.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.5 -0.75 . . . . 0.0 109.921 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.576 ' NE2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.311 0.577 . . . . 0.0 110.417 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.627 ' CD1' HG21 ' A' ' 27' ' ' VAL . 11.5 tp -178.66 92.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.716 . . . . 0.0 109.843 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -40.62 146.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.537 -0.727 . . . . 0.0 110.581 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.27 -13.85 14.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.128 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.71 -5.36 51.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 109.989 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.626 ' OG ' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -68.63 -170.22 0.2 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.16 -0.962 . . . . 0.0 110.245 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 1.5 tttp -146.77 116.01 7.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 110.231 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 15.5 p -110.96 -164.25 0.9 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 0.0 110.242 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 17' ' ' CYS . 17.6 tp10 69.71 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 64.39 40.16 6.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.248 -0.907 . . . . 0.0 109.892 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 t -160.85 169.29 22.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.785 . . . . 0.0 109.575 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.557 ' CG2' ' HA ' ' A' ' 36' ' ' THR . 32.7 m -106.88 104.61 14.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.008 -1.058 . . . . 0.0 109.64 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.843 ' N ' HD22 ' A' ' 22' ' ' LEU . 1.5 mm? -101.29 150.52 22.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.106 -0.996 . . . . 0.0 110.888 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 16.5 m -163.67 95.0 0.8 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.623 -0.673 . . . . 0.0 109.216 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.464 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 66.33 32.93 7.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.552 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 98.3 m -59.69 -159.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.663 0.744 . . . . 0.0 110.901 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.581 ' CD1' ' HD2' ' A' ' 41' ' ' ARG . 1.9 t80 179.77 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.818 HG13 ' HD2' ' A' ' 42' ' ' PHE . 1.9 t 36.6 -159.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.58 0.705 . . . . 0.0 111.148 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.744 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER 171.93 -31.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 5.6 mtmt -169.28 51.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.984 ' OG ' HG22 ' A' ' 45' ' ' VAL . 35.2 m -127.34 -166.63 1.63 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 111.051 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 2.2 tt0 -129.09 -65.02 0.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.553 -0.717 . . . . 0.0 110.073 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.719 HG22 ' CG2' ' A' ' 47' ' ' ILE . 3.8 t 67.71 147.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.427 -0.796 . . . . 0.0 110.278 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.927 ' CD1' HG22 ' A' ' 48' ' ' THR . 33.1 m-85 -134.77 -50.98 0.78 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.14 -0.975 . . . . 0.0 110.614 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.44 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -135.56 35.06 2.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.845 HG22 ' H ' ' A' ' 37' ' ' CYS . 5.6 m -83.21 136.45 34.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.169 -1.195 . . . . 0.0 109.888 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.557 ' HA ' ' CG2' ' A' ' 21' ' ' THR . 28.3 m -69.0 -10.92 59.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.265 -0.897 . . . . 0.0 110.43 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.845 ' H ' HG22 ' A' ' 35' ' ' THR . 5.9 t 42.62 49.59 4.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 110.54 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 38' ' ' THR . 85.8 m -67.37 66.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.73 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 37' ' ' CYS . . . 68.95 75.17 0.55 Allowed Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.66 158.4 43.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 0.0 110.125 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.581 ' HD2' ' CD1' ' A' ' 26' ' ' TYR . 5.3 ttp180 -131.73 160.54 35.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.343 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.818 ' HD2' HG13 ' A' ' 27' ' ' VAL . 10.4 m-85 -133.21 -169.0 2.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.325 -0.859 . . . . 0.0 109.914 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.475 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 0.4 OUTLIER -174.48 49.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 110.076 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 115.41 60.58 0.36 Allowed Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.984 HG22 ' OG ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -134.91 -167.4 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.812 -1.405 . . . . 0.0 110.651 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' VAL . 57.7 m -155.7 56.24 0.61 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.719 ' CG2' HG22 ' A' ' 32' ' ' VAL . 9.2 tt -78.62 170.02 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.38 -0.825 . . . . 0.0 110.544 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.927 HG22 ' CD1' ' A' ' 33' ' ' TYR . 44.2 p -139.36 -131.63 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 66' ' ' THR . 23.9 m -60.87 123.8 18.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.762 -1.211 . . . . 0.0 109.008 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 35' ' ' THR . 0.4 OUTLIER -166.26 154.83 10.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.007 -1.058 . . . . 0.0 110.605 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 52' ' ' SER . 1.9 m -107.68 17.27 22.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.021 -1.05 . . . . 0.0 109.991 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -39.61 125.02 1.74 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.482 -0.761 . . . . 0.0 110.495 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 25.0 m -114.97 111.8 21.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.017 . . . . 0.0 110.143 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.72 86.14 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 p -162.06 131.08 4.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -1.165 . . . . 0.0 110.409 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.502 ' CA ' ' HB3' ' A' ' 90' ' ' ASN . 4.1 ttm180 -88.66 107.53 18.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.793 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.475 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 19.0 mm -87.47 21.29 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 110.611 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -41.86 143.25 0.56 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.221 -0.924 . . . . 0.0 110.324 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 175.92 153.02 10.0 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.263 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 59' ' ' GLY . 50.7 Cg_endo -87.13 62.72 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.036 1.545 . . . . 0.0 109.744 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 62' ' ' CYS . . . 109.16 19.63 8.38 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.532 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -42.55 170.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.597 -0.943 . . . . 0.0 111.238 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 17.3 ttmm -157.15 112.61 2.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.509 -0.744 . . . . 0.0 110.092 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.73 HD13 ' HE2' ' A' ' 81' ' ' LYS . 3.8 mm -119.85 164.41 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.006 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -168.37 113.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.3 m 49.46 65.63 1.35 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 110.376 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 63.7 m -122.45 97.24 5.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.619 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.678 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.9 mp -64.31 82.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 109.7 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.643 HG23 ' C ' ' A' ' 73' ' ' VAL . 18.8 mt -97.71 155.36 3.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.821 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.809 ' O ' HG22 ' A' ' 73' ' ' VAL . 12.8 m -155.02 101.69 2.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.038 -1.039 . . . . 0.0 110.213 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.03 29.0 16.3 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 79.18 16.6 78.24 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 70' ' ' THR . 5.5 m -122.91 128.56 25.31 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.364 -1.08 . . . . 0.0 110.537 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.882 ' HB3' HD11 ' A' ' 82' ' ' ILE . 45.1 Cg_endo -76.01 149.28 32.52 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.893 1.47 . . . . 0.0 110.652 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -96.49 164.52 18.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.332 -0.855 . . . . 0.0 109.953 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -71.31 57.84 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.915 1.482 . . . . 0.0 109.862 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.3 m -91.62 149.76 21.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 0.0 110.535 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.96 -17.96 22.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 110.248 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.86 -9.25 37.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.651 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.536 ' SG ' HG12 ' A' ' 82' ' ' ILE . 31.2 t -75.98 166.32 23.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -1.0 . . . . 0.0 110.013 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.73 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -111.28 -46.76 3.26 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.977 -1.077 . . . . 0.0 112.761 -178.504 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.882 HD11 ' HB3' ' A' ' 74' ' ' PRO . 16.7 mm 46.77 71.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.564 -1.335 . . . . 0.0 109.961 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.458 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 18.6 t -128.79 -106.67 0.3 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 0.0 110.46 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.35 63.69 2.92 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.574 ' CB ' ' HZ1' ' A' ' 81' ' ' LYS . 2.0 t -167.52 -172.54 1.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.082 -1.246 . . . . 0.0 110.787 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.538 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.7 t 177.44 162.61 0.52 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.475 -0.766 . . . . 0.0 109.333 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.542 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.5 OUTLIER -120.19 166.52 13.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.021 -1.049 . . . . 0.0 110.048 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 7.9 t -146.16 22.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.437 -0.79 . . . . 0.0 109.74 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 54.25 63.06 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.718 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.502 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.278 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.197 0.523 . . . . 0.0 110.449 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.715 HD12 ' HB ' ' A' ' 27' ' ' VAL . 41.3 tp -105.01 97.45 7.3 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.248 -0.908 . . . . 0.0 109.903 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -35.67 133.41 0.4 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.359 0.6 . . . . 0.0 111.205 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.55 -22.66 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 0.0 110.477 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 12' ' ' SER . 0.6 OUTLIER -95.83 -12.57 25.04 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.971 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.791 ' OG ' HG11 ' A' ' 27' ' ' VAL . 4.1 t -64.54 -176.85 0.27 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.928 -1.107 . . . . 0.0 109.729 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 7.2 tttp -127.58 146.2 50.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.033 -1.042 . . . . 0.0 110.61 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.94 110.81 14.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.031 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.63 -143.42 0.39 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.222 -0.924 . . . . 0.0 110.514 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.24 11.42 28.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.256 -0.902 . . . . 0.0 110.444 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 1.2 p -62.53 169.3 3.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.601 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 36' ' ' THR . 55.3 m -99.11 109.63 22.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.995 -1.066 . . . . 0.0 109.578 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.844 ' N ' HD22 ' A' ' 22' ' ' LEU . 2.5 mm? -99.57 144.03 29.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 110.847 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 19.9 m -150.87 107.97 3.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.397 -0.814 . . . . 0.0 109.443 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 54.07 44.43 29.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -0.936 . . . . 0.0 109.007 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 92.8 m -67.59 -157.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.416 -0.803 . . . . 0.0 111.011 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.6 OUTLIER 167.11 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.401 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.791 HG11 ' OG ' ' A' ' 15' ' ' SER . 5.1 t -70.66 168.16 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.113 0.959 . . . . 0.0 111.409 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.559 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 2.8 t70 -148.39 -35.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.42 0.629 . . . . 0.0 109.512 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -157.85 64.54 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.529 -0.732 . . . . 0.0 109.825 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.001 ' OG ' HG22 ' A' ' 45' ' ' VAL . 25.7 m -143.84 -175.95 4.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.854 -1.154 . . . . 0.0 111.093 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.586 ' OE1' HG23 ' A' ' 46' ' ' THR . 1.0 OUTLIER -123.43 -66.14 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.6 -0.687 . . . . 0.0 110.353 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.581 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 6.8 t 69.07 165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.628 -0.67 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 50.2 m-85 -159.85 -51.0 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.386 -0.821 . . . . 0.0 110.417 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.436 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -123.49 -2.7 8.85 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.676 HG22 ' H ' ' A' ' 37' ' ' CYS . 34.0 m -49.82 162.16 0.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -1.226 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.495 ' HA ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -102.81 -16.68 15.86 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.171 -0.955 . . . . 0.0 110.063 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.676 ' H ' HG22 ' A' ' 35' ' ' THR . 12.6 t 50.85 99.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 0.0 111.18 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.699 HG21 HG23 ' A' ' 53' ' ' THR . 20.9 m -114.34 89.88 3.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.113 -0.992 . . . . 0.0 109.483 178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 38' ' ' THR . . . 45.32 56.93 5.95 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 1.3 t -132.62 -175.99 3.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.135 -1.215 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.471 ' HD3' ' CE2' ' A' ' 26' ' ' TYR . 15.4 ptt180 -155.52 151.16 27.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.119 -0.988 . . . . 0.0 110.498 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.539 ' HD2' HG13 ' A' ' 27' ' ' VAL . 4.8 m-85 -117.46 -175.4 2.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.861 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.481 ' HB3' ' OG ' ' A' ' 58' ' ' SER . 24.0 t70 -166.75 38.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.421 -0.8 . . . . 0.0 109.778 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 129.78 66.7 0.11 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.001 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -141.78 -166.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.574 -1.545 . . . . 0.0 111.445 -179.228 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.597 ' O ' HG22 ' A' ' 46' ' ' THR . 72.3 m -164.95 56.17 0.13 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.549 ' CG2' HG22 ' A' ' 32' ' ' VAL . 7.8 tt -76.6 171.44 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.63 -0.669 . . . . 0.0 110.924 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.513 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 44.2 p -135.39 -138.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.827 . . . . 0.0 109.91 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 66' ' ' THR . 53.0 m -65.02 90.28 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.996 -1.065 . . . . 0.0 110.4 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' THR . 44.6 m -145.94 145.9 30.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.858 -1.151 . . . . 0.0 110.558 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -99.8 117.97 35.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.952 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -136.88 124.18 21.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.845 . . . . 0.0 110.124 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.699 HG23 HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER -109.1 100.33 9.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.915 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.7 83.72 0.48 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 5.8 p -159.01 116.46 2.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -1.108 . . . . 0.0 110.428 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -75.36 109.87 9.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 109.729 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.521 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 11.1 mm -87.9 3.02 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.071 -1.018 . . . . 0.0 111.171 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 74.8 m -42.03 163.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.218 -0.926 . . . . 0.0 110.403 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 145.92 150.45 5.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.35 59.33 1.91 Allowed 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.902 1.475 . . . . 0.0 109.523 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . 112.53 28.64 3.42 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 2.0 t -52.6 128.8 27.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.345 -1.091 . . . . 0.0 110.337 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.563 ' HD2' ' HB ' ' A' ' 46' ' ' THR . 2.0 mmtm -120.97 149.77 42.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.095 -1.003 . . . . 0.0 110.968 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.923 HD13 ' HE2' ' A' ' 81' ' ' LYS . 12.6 mm -149.27 135.06 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.48 -0.762 . . . . 0.0 109.334 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.461 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -140.27 116.73 10.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.996 -1.065 . . . . 0.0 110.778 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.7 OUTLIER 45.89 70.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.613 -0.679 . . . . 0.0 111.644 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 52.9 t -133.72 125.88 29.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.833 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.3 mp -88.01 81.08 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.237 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.598 HG21 ' CD2' ' A' ' 87' ' ' PHE . 4.4 mt -88.9 160.43 2.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.706 -0.621 . . . . 0.0 109.742 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.763 ' O ' HG22 ' A' ' 73' ' ' VAL . 55.4 m -161.0 96.61 1.11 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.104 -0.998 . . . . 0.0 110.619 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 91.47 30.07 11.29 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.582 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 81.22 14.76 78.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 70' ' ' THR . 11.6 m -123.63 127.36 25.53 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.489 -1.006 . . . . 0.0 110.098 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -80.01 143.02 15.9 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.706 1.372 . . . . 0.0 110.075 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -87.5 149.96 47.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.139 -0.975 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.13 57.73 1.21 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.152 1.606 . . . . 0.0 110.498 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.06 150.74 20.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.758 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.67 -7.1 50.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.55 -16.46 14.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 111.241 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 15.0 t -68.16 129.56 40.29 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.813 -1.179 . . . . 0.0 109.573 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.923 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.12 171.78 7.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.916 -1.115 . . . . 0.0 110.305 -179.621 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.716 ' O ' HG22 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -166.64 91.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.524 -0.735 . . . . 0.0 109.027 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.48 -59.18 1.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.056 -1.027 . . . . 0.0 110.555 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.28 52.22 0.64 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.697 ' C ' HG22 ' A' ' 86' ' ' THR . 1.7 t -124.55 -150.04 0.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 110.032 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.697 HG22 ' C ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER 165.05 143.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.497 -0.752 . . . . 0.0 110.54 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.79 ' HE1' HD11 ' A' ' 64' ' ' ILE . 1.8 m-30 -107.1 -65.0 1.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.537 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER 71.4 8.34 6.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.432 -0.792 . . . . 0.0 110.45 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 54.21 85.73 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.99 . . . . 0.0 109.635 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.621 ' C ' HD21 ' A' ' 90' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.358 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.59 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.532 0.682 . . . . 0.0 110.844 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.723 HD11 ' OG ' ' A' ' 15' ' ' SER . 18.9 tp -176.0 90.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 31.0 t -36.53 137.05 0.31 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.636 -0.665 . . . . 0.0 110.54 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.6 -17.33 2.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 110.567 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' A' ' 29' ' ' LYS . 20.9 t-20 -90.88 -7.16 52.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 110.324 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.723 ' OG ' HD11 ' A' ' 11' ' ' LEU . 39.7 t -74.66 -158.76 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.027 . . . . 0.0 109.732 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 5.5 tttp -148.57 125.92 11.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 109.576 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.551 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 9.8 t -109.89 120.74 43.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.714 -179.199 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 19' ' ' LYS . 8.3 tt0 -167.79 114.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.432 -0.792 . . . . 0.0 110.064 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' GLU . 11.7 mttt 41.73 -123.33 0.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.0 110.309 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.4 160.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.889 -1.132 . . . . 0.0 110.071 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.541 ' HB ' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -100.38 23.63 9.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.078 -1.014 . . . . 0.0 109.497 179.754 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.648 HD13 HG11 ' A' ' 32' ' ' VAL . 2.3 tp -51.53 152.26 2.77 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.49 -0.756 . . . . 0.0 110.496 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 37' ' ' CYS . 41.6 m -164.83 134.58 3.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.409 -0.807 . . . . 0.0 109.829 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 3.5 m120 50.45 63.52 2.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.032 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -132.55 165.1 25.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.327 -179.9 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 10' ' ' GLN . 44.7 m-85 -121.5 -40.15 2.59 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.692 HG11 ' OG ' ' A' ' 15' ' ' SER . 3.6 t 55.21 141.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 122.11 0.957 . . . . 0.0 111.637 178.148 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -144.87 113.01 6.47 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.551 -0.718 . . . . 0.0 109.347 179.384 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HA ' ' OD1' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 54.81 57.53 5.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 109.354 -179.044 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 45' ' ' VAL . 6.0 m -134.82 -157.49 0.81 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.758 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 0.8 OUTLIER -152.34 -62.55 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.567 -0.708 . . . . 0.0 109.968 179.876 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.648 HG11 HD13 ' A' ' 22' ' ' LEU . 13.0 t 61.91 162.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.435 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.488 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 11.7 m-85 -155.66 -46.91 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.3 -0.875 . . . . 0.0 110.455 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.73 21.6 3.75 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.544 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 6.5 m -74.76 146.52 42.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.134 . . . . 0.0 110.944 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.541 HG23 ' HB ' ' A' ' 21' ' ' THR . 48.0 m -106.68 70.31 0.81 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.452 -0.78 . . . . 0.0 109.37 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.509 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 13.9 t -60.7 113.6 2.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.519 -0.738 . . . . 0.0 111.273 -179.097 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.798 HG22 ' O ' ' A' ' 38' ' ' THR . 14.3 m -106.03 60.22 0.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 178.683 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 91.04 71.69 1.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.523 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 70.4 m -154.34 171.58 19.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -1.125 . . . . 0.0 110.315 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -141.12 154.82 46.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.912 . . . . 0.0 110.434 179.77 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.663 ' HD2' HG13 ' A' ' 27' ' ' VAL . 8.5 m-85 -118.36 -174.0 2.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 0.0 110.533 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.49 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -173.18 81.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 109.971 179.816 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 84.66 54.23 3.0 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.633 ' HB ' ' HB3' ' A' ' 62' ' ' CYS . 0.8 OUTLIER -128.95 -172.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.752 -1.44 . . . . 0.0 110.939 -179.53 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.526 ' N ' HG23 ' A' ' 45' ' ' VAL . 9.3 m -160.4 56.63 0.34 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.629 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 50' ' ' SER . 11.5 tt -80.99 168.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.454 -0.779 . . . . 0.0 110.573 -179.253 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 43.2 p -136.16 -150.26 0.36 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.395 -0.816 . . . . 0.0 108.834 179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.7 m -46.75 108.23 0.13 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.878 -1.139 . . . . 0.0 109.185 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' THR . 70.9 m -164.13 140.64 6.51 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 110.131 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -101.05 123.3 45.02 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 109.758 179.608 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -136.11 129.8 32.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 110.234 -179.804 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.57 100.16 9.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 66.88 80.19 0.19 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.22 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.4 p -151.32 113.74 4.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -1.02 . . . . 0.0 110.312 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -73.24 111.36 8.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.165 -0.96 . . . . 0.0 110.134 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.409 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 11.6 mm -88.41 7.18 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.49 ' OG ' ' HB2' ' A' ' 43' ' ' ASP . 43.3 m -44.83 141.16 2.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.0 110.486 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 171.41 164.24 26.74 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.989 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.53 56.62 6.04 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.06 1.558 . . . . 0.0 109.796 179.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 110.91 19.93 7.47 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.633 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -37.24 113.7 0.27 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.421 -1.047 . . . . 0.0 110.884 179.96 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.522 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 10.1 tttm -107.19 122.21 46.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.984 -1.072 . . . . 0.0 109.809 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.865 HD11 ' SG ' ' A' ' 85' ' ' CYS . 5.3 mp -131.54 148.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.111 -0.993 . . . . 0.0 111.223 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -148.08 120.73 8.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 110.724 179.395 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.7 OUTLIER 48.06 57.35 6.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.402 -0.811 . . . . 0.0 111.277 179.615 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.3 m -115.88 106.6 14.0 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.022 -1.049 . . . . 0.0 109.976 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.4 mp -76.73 95.77 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.955 . . . . 0.0 109.316 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.697 HG23 ' C ' ' A' ' 73' ' ' VAL . 6.0 mt -103.87 158.99 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 110.595 -179.197 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 73' ' ' VAL . 29.8 m -159.22 98.33 1.43 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.33 -0.856 . . . . 0.0 109.589 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.03 23.5 22.48 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 83.39 15.9 70.31 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.697 ' C ' HG23 ' A' ' 69' ' ' ILE . 11.4 m -120.34 124.41 27.73 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.522 -0.987 . . . . 0.0 110.124 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.48 147.48 28.66 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.916 1.482 . . . . 0.0 111.191 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -92.5 144.95 29.6 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.447 -0.783 . . . . 0.0 108.896 178.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.44 60.35 2.64 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 O-C-N 123.814 1.428 . . . . 0.0 110.393 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -81.91 161.63 23.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 109.909 179.697 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.39 -18.16 57.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.131 -0.981 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.31 -25.66 10.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.969 -1.082 . . . . 0.0 110.62 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 19.5 t -47.49 128.42 12.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.106 -0.996 . . . . 0.0 109.958 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.92 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -90.59 161.94 15.21 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.984 -1.073 . . . . 0.0 110.259 -179.731 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.92 HD13 ' O ' ' A' ' 81' ' ' LYS . 18.4 mm -143.79 67.99 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -146.1 107.85 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 112.417 -177.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . 65.22 73.02 0.63 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.334 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.865 ' SG ' HD11 ' A' ' 64' ' ' ILE . 4.6 t -175.39 -174.91 0.76 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -1.227 . . . . 0.0 110.075 178.377 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.419 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -179.44 152.15 0.51 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.016 -1.053 . . . . 0.0 110.484 -179.066 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.691 ' CD2' HG21 ' A' ' 69' ' ' ILE . 2.9 m-30 -109.0 -63.54 1.34 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.438 -0.788 . . . . 0.0 109.422 179.194 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER 71.14 4.13 4.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.535 -0.728 . . . . 0.0 110.699 179.74 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 57.15 96.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.072 -1.017 . . . . 0.0 109.992 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.136 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.56 ' O ' HD22 ' A' ' 11' ' ' LEU . 1.8 tt0 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.468 0.651 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.071 HD12 ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -173.39 117.36 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.582 -0.699 . . . . 0.0 109.396 -179.936 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 27' ' ' VAL . 45.3 p -35.14 144.74 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.642 -0.661 . . . . 0.0 110.801 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.16 -25.1 30.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 110.588 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -106.22 3.83 28.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 110.375 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . 1.071 ' CB ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -55.56 -173.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 110.582 -179.827 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -150.36 119.81 6.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 179.902 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 31.7 p -116.24 72.02 0.8 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.015 -1.053 . . . . 0.0 110.491 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.89 136.37 35.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.145 -0.972 . . . . 0.0 110.15 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 mttt 54.35 36.75 26.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 109.868 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.439 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 6.8 m -143.89 162.91 34.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.557 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -113.8 106.17 14.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.408 -0.807 . . . . 0.0 109.612 179.557 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.52 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.6 mm? -92.87 156.99 16.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 110.6 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 11.2 m -166.25 121.24 1.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.421 -0.8 . . . . 0.0 109.772 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' THR . 3.6 m-20 42.98 66.17 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.173 -0.955 . . . . 0.0 110.023 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.5 m -137.1 166.24 24.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.189 -0.944 . . . . 0.0 110.671 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 7.9 m-85 -130.09 -47.27 1.11 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.244 179.646 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.739 HG13 ' HD2' ' A' ' 42' ' ' PHE . 2.8 t 57.46 123.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.539 0.685 . . . . 0.0 110.668 179.025 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.468 ' C ' ' HB2' ' A' ' 12' ' ' SER . 1.9 m-20 -115.13 -14.97 11.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.284 -0.885 . . . . 0.0 110.362 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -175.65 66.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.898 . . . . 0.0 110.064 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.7 ' OG ' HG22 ' A' ' 45' ' ' VAL . 68.0 m -138.81 -170.47 2.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.183 -0.948 . . . . 0.0 110.24 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.622 ' C ' HG23 ' A' ' 32' ' ' VAL . 3.3 tt0 -127.88 -63.4 1.02 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.708 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.622 HG23 ' C ' ' A' ' 31' ' ' GLU . 2.4 t 68.0 135.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.438 -0.789 . . . . 0.0 110.093 179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.469 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 10.4 m-85 -147.52 46.61 1.12 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 110.505 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.465 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . 142.95 -10.39 2.31 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.83 HG22 ' H ' ' A' ' 37' ' ' CYS . 45.3 m -61.27 151.38 31.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.237 . . . . 0.0 110.609 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 21' ' ' THR . 51.5 m -88.37 -14.03 39.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.749 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.83 ' H ' HG22 ' A' ' 35' ' ' THR . 0.5 OUTLIER 47.42 70.92 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 179.696 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.503 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 99.6 m -87.71 100.77 13.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.133 -0.979 . . . . 0.0 110.15 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 90' ' ' ASN . . . 45.0 67.19 1.24 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.47 ' O ' ' NE ' ' A' ' 41' ' ' ARG . 32.3 t -153.01 173.18 15.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -1.093 . . . . 0.0 110.281 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -149.79 159.68 44.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.393 -0.817 . . . . 0.0 110.044 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.739 ' HD2' HG13 ' A' ' 27' ' ' VAL . 5.5 m-85 -125.28 -177.91 4.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.986 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -170.25 48.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.892 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 123.48 56.62 0.19 Allowed Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.7 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.27 -163.34 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.829 -1.395 . . . . 0.0 110.884 -179.775 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.608 ' N ' HG23 ' A' ' 45' ' ' VAL . 13.8 m -166.06 55.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.593 HD11 ' CB ' ' A' ' 50' ' ' SER . 21.4 tt -83.52 170.39 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.419 -0.801 . . . . 0.0 110.786 -179.239 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.469 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 62.6 p -128.63 -140.23 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.456 -0.777 . . . . 0.0 109.598 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.614 ' O ' HG22 ' A' ' 49' ' ' THR . 6.4 m -60.17 83.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.959 . . . . 0.0 110.092 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.593 ' CB ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -117.13 140.12 49.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.099 -1.001 . . . . 0.0 110.447 -179.753 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.529 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 26.6 m -91.18 19.37 5.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.213 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 68' ' ' ILE . 13.0 p -44.34 125.69 4.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 110.521 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.503 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 32.2 m -104.85 97.17 7.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.695 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 62.62 90.19 0.03 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 7.1 p -157.33 122.95 4.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.541 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.517 ' HB2' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -75.4 101.51 4.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.074 179.731 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 57' ' ' ILE . 4.0 mt -90.13 16.25 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.62 156.83 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.259 -0.9 . . . . 0.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.68 147.83 5.44 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.67 63.24 7.34 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.978 1.515 . . . . 0.0 110.009 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 113.98 17.4 7.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -40.28 159.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.543 -0.975 . . . . 0.0 110.946 -179.702 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 12.4 tttt -158.85 117.07 2.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.504 -0.747 . . . . 0.0 109.648 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 64' ' ' ILE . 3.0 mp -135.14 161.56 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.551 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.408 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -150.76 121.35 7.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 110.321 -179.874 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 49' ' ' THR . 3.5 m 46.45 69.85 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.395 -0.816 . . . . 0.0 110.738 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.618 ' HB3' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -123.48 104.39 9.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.467 -0.771 . . . . 0.0 109.541 179.164 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.529 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 1.7 mp -48.5 -64.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.739 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.819 HD13 ' CE2' ' A' ' 87' ' ' PHE . 20.4 mt 55.04 164.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 110.308 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.513 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 55.7 m -145.23 -106.33 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.905 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.789 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -83.96 76.08 2.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 87' ' ' PHE . . . 63.28 12.32 44.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 71' ' ' GLY . 13.9 m -116.34 136.33 23.04 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.383 -1.069 . . . . 0.0 110.254 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HA ' HG12 ' A' ' 69' ' ' ILE . 47.5 Cg_endo -78.12 138.24 16.05 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.897 1.472 . . . . 0.0 110.088 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -84.53 159.28 58.85 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.408 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.41 53.21 4.62 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 124.04 1.547 . . . . 0.0 110.555 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 t -89.96 158.17 17.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.608 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.2 -14.15 50.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.267 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.06 -22.45 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.336 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.481 ' CB ' ' HA ' ' A' ' 67' ' ' CYS . 34.7 t -63.79 123.14 18.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 110.054 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.63 ' HE2' HG23 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -93.15 -169.95 2.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.927 . . . . 0.0 110.481 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 82' ' ' ILE . 3.2 tp -179.94 40.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.803 0.811 . . . . 0.0 109.501 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 m -72.78 -96.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 111.64 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.84 66.31 0.95 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.111 -1.043 . . . . 0.0 110.637 -178.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 64' ' ' ILE . 4.8 t -160.3 -175.31 4.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.254 . . . . 0.0 110.022 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.547 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.5 t -177.23 159.29 1.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.98 . . . . 0.0 110.423 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.819 ' CE2' HD13 ' A' ' 69' ' ' ILE . 1.8 m-85 -118.87 156.68 29.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.787 . . . . 0.0 109.7 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -139.41 20.35 2.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.243 -0.91 . . . . 0.0 110.38 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 56.6 83.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.235 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 56' ' ' ARG . 3.2 t-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.095 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.558 ' HB3' ' CB ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.472 0.654 . . . . 0.0 109.736 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.858 HD11 ' OG ' ' A' ' 15' ' ' SER . 13.6 tp -49.51 95.91 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -41.25 146.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 109.899 -179.808 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 14' ' ' ASN . . . -64.48 67.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.09 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 12' ' ' SER . 21.6 t-20 179.9 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.541 -0.725 . . . . 0.0 109.782 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.858 ' OG ' HD11 ' A' ' 11' ' ' LEU . 13.5 t -50.62 -176.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.34 -0.85 . . . . 0.0 110.249 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.16 160.66 41.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.206 -0.934 . . . . 0.0 110.4 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 t -178.55 148.17 0.43 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.162 -0.962 . . . . 0.0 110.24 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.93 -29.42 1.02 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 0.0 110.753 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -170.19 43.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.969 -1.082 . . . . 0.0 110.59 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.18 179.01 5.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.252 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.4 82.64 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 109.807 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 35' ' ' THR . 46.1 mt -94.22 -177.96 4.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -0.89 . . . . 0.0 110.605 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 1.8 m -161.74 118.58 2.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.499 -0.751 . . . . 0.0 109.357 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.503 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 43.8 m-20 58.58 75.73 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.419 -0.8 . . . . 0.0 110.261 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 40' ' ' SER . 0.5 OUTLIER -145.5 -157.26 0.78 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.071 -1.018 . . . . 0.0 110.206 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -160.29 -39.56 0.05 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.715 HG13 ' HD2' ' A' ' 42' ' ' PHE . 9.3 t 53.25 160.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.011 0.91 . . . . 0.0 111.649 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.603 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.2 t70 -171.37 127.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 66.2 mttt 46.48 43.11 11.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -0.984 . . . . 0.0 109.587 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.717 ' OG ' HG22 ' A' ' 45' ' ' VAL . 58.6 m -129.97 157.69 41.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' O ' ' O ' ' A' ' 47' ' ' ILE . 1.1 mt-10 -121.17 98.07 5.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.283 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 40.6 t -99.93 159.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.413 -0.804 . . . . 0.0 110.53 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.459 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 39.3 m-85 -139.02 -45.85 0.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 110.808 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.437 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -146.0 28.51 1.71 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 50' ' ' SER . 2.3 m -73.47 154.29 40.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.233 -1.157 . . . . 0.0 110.338 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.1 m -114.78 80.73 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -0.831 . . . . 0.0 109.815 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -63.31 151.77 39.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -0.89 . . . . 0.0 110.533 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 38' ' ' THR . 66.8 m -138.22 41.17 2.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.315 -0.866 . . . . 0.0 109.982 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 104.64 33.49 3.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.51 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 14.4 m -122.41 -152.46 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -1.151 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.465 ' HG3' ' OD1' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -178.18 168.04 1.95 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.078 -1.014 . . . . 0.0 110.53 179.889 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.715 ' HD2' HG13 ' A' ' 27' ' ' VAL . 8.3 m-85 -122.49 -169.98 2.0 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -0.891 . . . . 0.0 110.559 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.409 ' HA ' ' OD2' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -175.21 48.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.106 179.698 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 119.62 61.49 0.26 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.717 HG22 ' OG ' ' A' ' 30' ' ' SER . 2.4 m -137.34 -158.84 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.988 -1.301 . . . . 0.0 111.279 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.562 ' N ' HG23 ' A' ' 45' ' ' VAL . 94.5 m -167.09 58.79 0.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 14.3 tt -85.81 169.41 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 111.234 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 78.0 p -142.24 -148.9 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 109.175 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 66' ' ' THR . 59.8 m -46.05 111.97 0.42 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.17 -0.957 . . . . 0.0 108.699 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' THR . 4.3 t -173.36 158.46 3.54 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.125 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -116.98 131.6 56.91 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.044 -1.035 . . . . 0.0 109.783 179.57 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.8 125.65 13.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 109.961 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.7 m -105.48 123.42 47.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.967 . . . . 0.0 109.94 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 45.0 83.33 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 72' ' ' GLY . 78.7 p -158.15 128.98 6.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.231 -1.158 . . . . 0.0 110.432 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 6.6 ttp180 -94.18 107.55 19.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 110.12 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.642 ' O ' HG22 ' A' ' 57' ' ' ILE . 2.5 mp -84.52 12.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.94 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 57' ' ' ILE . 1.1 m -42.54 139.78 1.44 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 110.3 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 172.72 175.53 40.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.63 63.24 6.5 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.078 1.568 . . . . 0.0 110.128 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 94.99 2.5 62.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.561 ' C ' ' O ' ' A' ' 61' ' ' GLY . 2.4 t -11.37 121.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -105.98 144.13 33.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.223 -0.923 . . . . 0.0 109.817 179.356 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 63' ' ' LYS . 5.4 mt -152.96 127.18 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.977 . . . . 0.0 110.029 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.445 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -130.99 117.2 18.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 -179.84 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' THR . 3.1 m 54.05 86.15 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' THR . 0.5 OUTLIER -145.7 117.02 7.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.277 -0.89 . . . . 0.0 109.66 179.369 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.836 ' N ' HD12 ' A' ' 68' ' ' ILE . 3.4 mp -86.15 74.14 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.844 -1.16 . . . . 0.0 108.551 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.691 HG23 ' O ' ' A' ' 73' ' ' VAL . 13.7 mt -80.91 160.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.962 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.816 ' O ' HG22 ' A' ' 73' ' ' VAL . 97.1 m -158.71 98.85 1.53 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.004 . . . . 0.0 110.985 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 89.24 30.25 14.7 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.37 14.28 76.79 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.816 HG22 ' O ' ' A' ' 70' ' ' THR . 11.4 m -124.32 135.95 27.09 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.468 -1.019 . . . . 0.0 110.412 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HB2' HD11 ' A' ' 82' ' ' ILE . 49.6 Cg_endo -85.58 119.88 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.89 1.468 . . . . 0.0 110.466 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.533 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -77.47 167.09 39.22 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.273 -0.892 . . . . 0.0 109.788 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.533 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 42.2 Cg_endo -68.87 84.55 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.688 1.362 . . . . 0.0 109.409 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 78' ' ' ALA . 66.9 m -85.92 -6.35 59.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.631 -0.668 . . . . 0.0 111.155 -178.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 43.8 25.65 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 109.545 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -158.59 -40.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.523 -0.736 . . . . 0.0 109.301 -179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 29.1 t -46.95 169.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.555 -0.716 . . . . 0.0 109.738 179.424 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.547 ' HE3' ' CA ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -108.99 -32.23 7.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.936 -1.103 . . . . 0.0 112.156 -178.108 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.724 ' O ' HG22 ' A' ' 82' ' ' ILE . 4.1 mt 34.15 79.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.403 -0.81 . . . . 0.0 110.322 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.523 ' H ' ' HZ1' ' A' ' 81' ' ' LYS . 61.5 m -122.74 -98.14 0.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.92 -1.113 . . . . 0.0 111.088 -179.131 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.58 21.25 33.61 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -97.33 -163.54 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.253 . . . . 0.0 110.766 -179.726 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.539 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.9 OUTLIER 175.62 148.85 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.55 -0.719 . . . . 0.0 109.941 179.815 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -120.38 173.42 7.15 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.421 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.78 24.35 0.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.012 -1.055 . . . . 0.0 110.228 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 46.87 61.77 2.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.911 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.155 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.513 0.673 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.772 HD12 ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -165.23 69.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.726 . . . . 0.0 109.675 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.532 ' HB3' ' CA ' ' A' ' 28' ' ' ASP . 3.4 p 42.36 23.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.801 . . . . 0.0 110.896 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 41.66 23.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.985 -1.072 . . . . 0.0 110.641 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 28.6 p30 174.4 30.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.494 -0.754 . . . . 0.0 109.682 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.772 ' CB ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -69.8 -168.66 0.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 0.0 109.844 -179.674 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.544 ' CE ' ' HG3' ' A' ' 31' ' ' GLU . 1.3 mptp? -119.38 107.38 13.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 110.09 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -91.07 -140.23 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.528 -179.632 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 67.35 107.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.881 . . . . 0.0 109.867 -179.503 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 5.2 tttt 66.21 54.85 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 12.6 m -119.63 155.78 31.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 110.964 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 36' ' ' THR . 17.7 m -150.62 82.18 1.35 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.494 -0.754 . . . . 0.0 109.566 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -124.76 -163.54 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 0.0 110.775 -179.122 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 10.1 m -165.85 113.53 0.93 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.412 -0.805 . . . . 0.0 109.812 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.6 m-20 59.05 127.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.432 -0.793 . . . . 0.0 110.047 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER 172.9 -169.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 110.12 179.98 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' O ' ' O ' ' A' ' 27' ' ' VAL . 10.5 t80 -142.35 -46.63 0.34 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 108.679 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.892 HG13 ' HD2' ' A' ' 42' ' ' PHE . 3.5 t 57.14 133.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.673 0.749 . . . . 0.0 111.166 179.082 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.532 ' CA ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -137.66 124.33 21.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.226 179.336 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.2 mtmp? 42.21 55.37 3.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.777 ' OG ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -134.98 163.5 29.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.985 -1.072 . . . . 0.0 110.835 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.544 ' HG3' ' CE ' ' A' ' 16' ' ' LYS . 3.8 tt0 -96.74 -71.02 0.69 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.417 -0.802 . . . . 0.0 109.846 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.821 HG22 ' CG2' ' A' ' 47' ' ' ILE . 13.6 t 59.9 138.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.838 . . . . 0.0 110.614 179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.655 ' CD1' HG22 ' A' ' 48' ' ' THR . 60.5 m-85 -140.33 -81.21 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 109.551 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.43 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -94.41 29.65 8.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.503 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -73.65 161.85 29.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -1.028 . . . . 0.0 110.373 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 36' ' ' THR . 63.7 m -116.39 57.32 0.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.795 . . . . 0.0 109.733 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.567 ' CB ' ' HB2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -40.84 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 110.336 -179.839 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 38' ' ' THR . 85.8 m -89.66 48.91 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 110.261 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.47 24.94 37.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 86.4 p -99.44 -154.39 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -1.057 . . . . 0.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.444 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -167.7 156.29 9.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.099 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.892 ' HD2' HG13 ' A' ' 27' ' ' VAL . 10.0 m-85 -119.88 176.63 5.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.219 -0.926 . . . . 0.0 110.582 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -157.49 61.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.5 -0.75 . . . . 0.0 109.814 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 96.92 67.37 0.94 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.777 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.4 m -135.92 -160.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.972 -1.311 . . . . 0.0 111.274 -179.323 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.664 ' O ' HG22 ' A' ' 46' ' ' THR . 69.8 m -166.17 54.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.391 0.615 . . . . 0.0 109.403 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.821 ' CG2' HG22 ' A' ' 32' ' ' VAL . 11.9 tt -80.46 172.17 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 110.551 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.655 HG22 ' CD1' ' A' ' 33' ' ' TYR . 14.8 p -140.1 -113.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.54 ' O ' HG22 ' A' ' 49' ' ' THR . 55.3 m -83.55 71.66 10.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.917 -1.114 . . . . 0.0 109.632 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.588 ' HB2' HD11 ' A' ' 47' ' ' ILE . 4.8 m -128.67 141.76 51.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 110.649 -179.451 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -89.46 133.64 34.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.692 179.593 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.42 121.08 12.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 110.33 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.3 93.73 5.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 109.789 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 62.21 92.69 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 87.5 p -161.21 122.09 2.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -1.099 . . . . 0.0 110.418 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' HB2' ' CB ' ' A' ' 90' ' ' ASN . 10.3 ttp180 -77.6 103.59 7.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.318 -0.864 . . . . 0.0 109.657 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.555 ' O ' HG12 ' A' ' 45' ' ' VAL . 32.4 mm -78.63 9.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 110.763 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.474 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 53.1 p -40.84 150.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.143 -0.973 . . . . 0.0 110.602 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 168.09 140.75 3.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.66 57.93 3.12 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.089 1.573 . . . . 0.0 109.762 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.4 20.61 3.23 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -42.83 148.92 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -1.113 . . . . 0.0 110.589 -179.865 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -152.27 112.73 4.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.766 HG23 ' CE ' ' A' ' 81' ' ' LYS . 1.9 mp -128.81 157.53 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.161 -0.962 . . . . 0.0 110.868 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.479 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -156.87 106.88 2.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.376 -0.828 . . . . 0.0 109.909 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.2 m 63.33 82.18 0.19 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.255 -0.903 . . . . 0.0 110.325 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.487 ' N ' ' OG ' ' A' ' 50' ' ' SER . 16.1 m -146.52 109.09 4.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.441 -0.787 . . . . 0.0 109.662 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.738 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -73.44 90.21 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.046 -1.033 . . . . 0.0 109.624 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.718 HG23 ' C ' ' A' ' 73' ' ' VAL . 10.0 mt -98.25 156.88 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.397 -0.814 . . . . 0.0 110.292 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.815 ' O ' HG22 ' A' ' 73' ' ' VAL . 5.2 m -155.01 100.79 2.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.193 -0.942 . . . . 0.0 110.45 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.43 35.07 8.88 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 76.61 15.93 81.16 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 70' ' ' THR . 7.9 m -126.01 132.97 24.49 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.314 -1.109 . . . . 0.0 110.838 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.64 153.46 20.26 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.917 1.483 . . . . 0.0 110.601 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -96.25 162.62 23.06 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.907 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.8 Cg_endo -73.27 75.77 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.062 1.559 . . . . 0.0 110.569 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.57 140.03 45.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.15 -27.92 53.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.31 -2.92 57.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 0.0 110.278 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 66' ' ' THR . 2.5 t -90.03 146.94 23.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 110.061 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.766 ' CE ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -103.02 -164.12 1.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.351 -0.843 . . . . 0.0 111.282 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 82' ' ' ILE . 2.3 tp 175.99 34.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.1 m -70.32 -100.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.471 -0.768 . . . . 0.0 111.569 -179.038 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -99.8 78.96 0.48 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.702 -178.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.54 ' SG ' HD11 ' A' ' 64' ' ' ILE . 3.8 t -158.43 -174.02 4.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.172 -1.193 . . . . 0.0 109.221 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.571 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 8.0 t -179.7 158.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 0.0 111.153 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -128.35 161.53 29.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.586 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.716 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 5.8 t -145.05 12.24 1.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.953 -1.092 . . . . 0.0 110.015 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 68.21 5.11 4.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.213 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.546 ' OXT' ' CG ' ' A' ' 90' ' ' ASN . 1.6 p30 . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 117.375 -1.298 . . . . 0.0 112.152 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.56 ' NE2' ' CE2' ' A' ' 26' ' ' TYR . 1.3 mt-30 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.05 0.452 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.626 HD11 ' OG ' ' A' ' 15' ' ' SER . 6.8 tp 48.02 82.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 108.995 -178.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.481 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 79.7 p -39.46 137.8 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.7 -0.625 . . . . 0.0 110.683 -179.208 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.02 -20.68 2.56 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 109.248 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.583 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -77.39 -7.09 55.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.507 -0.746 . . . . 0.0 110.146 179.813 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.626 ' OG ' HD11 ' A' ' 11' ' ' LEU . 39.8 t -85.7 -163.01 0.79 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 109.915 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.19 133.32 21.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.056 -1.027 . . . . 0.0 110.172 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 25.7 p -132.31 132.92 43.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.164 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -160.48 -84.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 110.234 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.7 39.82 2.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 110.444 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.536 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 48.1 m -105.49 153.32 21.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 110.468 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.446 ' C ' HD23 ' A' ' 22' ' ' LEU . 52.1 m -111.54 84.81 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.362 -0.836 . . . . 0.0 109.165 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 37' ' ' CYS . 6.2 mt -101.03 175.58 5.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.139 -0.975 . . . . 0.0 111.102 -178.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 22.9 m -157.09 107.27 2.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.638 -0.664 . . . . 0.0 109.737 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 39' ' ' GLY . 3.7 m-20 56.99 100.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 110.427 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -157.92 -173.65 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.162 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.56 ' CE2' ' NE2' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -134.69 -48.43 0.75 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 179.021 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.663 HG13 ' HD2' ' A' ' 42' ' ' PHE . 14.1 t 55.22 144.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 122.027 0.917 . . . . 0.0 111.532 178.235 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.52 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -152.19 121.96 6.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.53 -0.731 . . . . 0.0 109.716 179.271 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 54.99 39.19 31.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.015 . . . . 0.0 109.97 -179.602 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.741 ' CB ' HG22 ' A' ' 45' ' ' VAL . 50.3 m -123.36 -163.08 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.257 -0.902 . . . . 0.0 110.52 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.685 ' C ' HG23 ' A' ' 32' ' ' VAL . 1.1 mt-10 -146.21 -72.0 0.24 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.352 -0.842 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.685 HG23 ' C ' ' A' ' 31' ' ' GLU . 2.6 t 73.15 141.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.602 -0.686 . . . . 0.0 111.038 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 38.8 m-85 -145.75 35.89 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.453 -0.779 . . . . 0.0 110.154 179.835 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 145.86 -7.7 1.47 Allowed Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.292 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.652 ' HB ' HG13 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -57.87 167.29 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.969 -1.312 . . . . 0.0 110.165 -179.857 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 36' ' ' THR . 9.2 t -108.45 62.14 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 0.0 110.309 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -47.02 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.2 179.899 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' THR . 2.3 m -100.96 101.43 12.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.153 -0.967 . . . . 0.0 109.724 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 44.21 52.33 7.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 3.8 m -128.16 179.89 5.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.072 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 41.5 mtt180 -149.53 147.85 28.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.873 . . . . 0.0 110.38 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.663 ' HD2' HG13 ' A' ' 27' ' ' VAL . 17.9 m-30 -116.74 175.84 5.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -0.839 . . . . 0.0 109.593 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.538 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 2.3 t0 -157.85 50.03 0.42 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.058 -1.027 . . . . 0.0 110.376 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 114.34 63.14 0.41 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.741 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -132.25 -166.86 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.028 -1.278 . . . . 0.0 110.625 -179.72 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.67 ' O ' HG22 ' A' ' 46' ' ' THR . 51.4 m -166.16 56.47 0.1 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 50' ' ' SER . 17.5 tt -82.44 170.74 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.584 -0.697 . . . . 0.0 111.102 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 44.9 p -133.25 -127.06 0.17 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.661 -0.649 . . . . 0.0 109.615 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.632 ' O ' HG22 ' A' ' 49' ' ' THR . 20.5 m -76.43 74.49 3.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.998 -1.064 . . . . 0.0 109.935 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.553 ' HB2' HD11 ' A' ' 47' ' ' ILE . 7.7 m -128.88 142.92 50.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.043 -1.036 . . . . 0.0 110.372 -179.427 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -86.61 135.13 33.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.021 -1.049 . . . . 0.0 110.19 179.909 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.405 ' H ' HG22 ' A' ' 36' ' ' THR . 3.1 p -154.69 125.46 7.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 110.149 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -111.68 121.06 44.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.32 -0.863 . . . . 0.0 110.014 -179.843 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 44.97 85.32 0.01 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 74.9 p -153.42 123.74 7.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.999 . . . . 0.0 110.581 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -86.24 99.87 11.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.178 -0.951 . . . . 0.0 109.466 179.358 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.677 ' O ' HG22 ' A' ' 57' ' ' ILE . 2.7 mp -82.93 18.49 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 110.533 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.538 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -41.17 155.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.386 -0.821 . . . . 0.0 110.031 179.488 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 157.54 151.7 6.11 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.72 53.63 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.088 1.573 . . . . 0.0 110.263 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 119.87 22.47 3.27 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.478 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -39.78 108.23 0.08 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.236 -1.155 . . . . 0.0 110.766 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.471 ' C ' HD12 ' A' ' 64' ' ' ILE . 17.2 tttp -101.56 122.43 43.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.034 . . . . 0.0 109.669 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.725 ' N ' HD12 ' A' ' 64' ' ' ILE . 4.5 mp -128.4 139.83 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.083 -1.011 . . . . 0.0 110.447 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.51 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -143.25 112.43 6.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.015 -1.053 . . . . 0.0 111.065 -179.908 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 1.9 m 48.37 80.37 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.566 -0.709 . . . . 0.0 112.055 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 80' ' ' CYS . 40.0 t -139.2 136.99 35.61 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.805 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.0 mp -90.75 88.07 2.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.27 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.738 HG21 ' CD2' ' A' ' 87' ' ' PHE . 12.3 mt -96.6 158.71 3.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.787 -0.571 . . . . 0.0 110.223 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.902 ' O ' HG22 ' A' ' 73' ' ' VAL . 3.2 m -166.21 106.49 0.68 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -0.91 . . . . 0.0 110.445 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.527 ' O ' HG13 ' A' ' 73' ' ' VAL . . . 86.29 34.53 12.17 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.563 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 71.28 21.09 78.53 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 70' ' ' THR . 3.5 m -125.74 120.84 24.41 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.29 -1.124 . . . . 0.0 110.65 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.83 141.06 18.91 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.721 1.379 . . . . 0.0 110.354 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -95.29 138.66 21.89 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.773 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.22 70.84 3.77 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.9 1.474 . . . . 0.0 110.219 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -97.66 166.55 11.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.35 -15.28 62.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.36 -36.93 5.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.14 -0.975 . . . . 0.0 110.745 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 67' ' ' CYS . 15.5 t -44.64 127.11 5.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.099 -1.0 . . . . 0.0 110.777 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.582 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -94.71 -172.34 2.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 110.135 179.751 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.781 HG23 ' O ' ' A' ' 82' ' ' ILE . 2.6 tp 179.09 39.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.492 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.0 m -104.82 87.27 2.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.052 -1.03 . . . . 0.0 111.766 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.11 52.75 2.67 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.459 178.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.448 ' SG ' HD11 ' A' ' 64' ' ' ILE . 10.0 t -165.46 170.46 14.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.263 -1.139 . . . . 0.0 109.927 179.229 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.541 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 9.2 t -176.38 159.53 1.99 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.96 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.738 ' CD2' HG21 ' A' ' 69' ' ' ILE . 1.7 m-85 -126.03 151.66 46.82 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.066 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.54 29.41 4.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.313 -0.867 . . . . 0.0 109.239 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 51.41 83.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.402 -0.811 . . . . 0.0 109.648 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.447 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.264 0.554 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.02 -162.27 21.91 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.44 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER 46.99 -158.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -1.126 . . . . 0.0 110.246 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.468 ' O ' ' OG1' ' A' ' 5' ' ' THR . 0.0 OUTLIER 65.22 142.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.892 . . . . 0.0 110.14 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.759 HG23 ' HB2' ' A' ' 9' ' ' SER . 84.1 m -167.62 84.26 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.452 -0.78 . . . . 0.0 109.357 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 24.7 p30 -62.35 72.48 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.58 -0.7 . . . . 0.0 110.059 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 5' ' ' THR . 4.5 m 70.53 2.59 4.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.575 -0.703 . . . . 0.0 110.359 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 7' ' ' THR . 30.5 t30 175.02 -31.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.617 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.759 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.2 OUTLIER 73.8 111.59 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.648 -0.658 . . . . 0.0 110.981 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 2.1 tt0 -139.61 33.14 2.03 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.485 -0.759 . . . . 0.0 109.531 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.846 HD12 ' OG ' ' A' ' 15' ' ' SER . 2.8 mm? -48.13 113.81 0.81 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.459 -0.776 . . . . 0.0 109.897 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 57.1 p -32.93 -67.21 0.12 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.982 -0.449 . . . . 0.0 110.938 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 12' ' ' SER . . . 179.93 -32.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.113 -0.992 . . . . 0.0 110.709 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -114.07 15.39 18.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 110.373 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.846 ' OG ' HD12 ' A' ' 11' ' ' LEU . 11.2 t -68.26 -171.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.548 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 1.3 tttp -143.96 142.32 30.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.976 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.67 126.83 8.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.04 -51.71 1.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.895 . . . . 0.0 110.404 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.02 55.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.379 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.4 p -101.17 -171.8 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 110.065 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -135.14 63.9 1.6 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.067 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.649 HD23 ' N ' ' A' ' 22' ' ' LEU . 4.0 mt -78.89 -179.01 6.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 0.0 110.539 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 23.6 m -164.25 119.09 1.48 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 110.045 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.466 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 2.4 m120 57.97 45.75 17.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.882 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -155.54 0.55 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.301 -0.875 . . . . 0.0 110.784 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.534 ' HA ' ' HB3' ' A' ' 10' ' ' GLN . 4.1 t80 -167.51 -40.78 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.833 HG13 ' HD2' ' A' ' 42' ' ' PHE . 11.4 t 54.63 149.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.982 0.896 . . . . 0.0 111.773 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 42' ' ' PHE . 4.9 t0 -156.4 122.3 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 11.1 mtpp 49.67 55.01 10.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.915 -1.116 . . . . 0.0 109.512 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.661 ' OG ' HG22 ' A' ' 45' ' ' VAL . 46.2 m -142.98 -175.63 4.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.111 -0.993 . . . . 0.0 110.436 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 5.6 mt-10 -128.2 -67.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.0 110.612 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.703 HG22 ' CG2' ' A' ' 47' ' ' ILE . 7.7 t 62.64 154.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.202 -0.936 . . . . 0.0 110.28 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.427 ' CD2' HG22 ' A' ' 48' ' ' THR . 22.6 m-85 -150.08 -43.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -138.0 25.37 2.92 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.52 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 10.6 m -71.75 151.47 43.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.32 -1.106 . . . . 0.0 110.51 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 36' ' ' THR . 52.1 m -109.13 55.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 109.917 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 17.5 t -40.31 140.76 0.58 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.465 -0.772 . . . . 0.0 110.348 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 38' ' ' THR . 99.6 m -123.69 13.3 9.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.921 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 128.46 51.84 0.13 Allowed Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.52 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 1.3 m -134.71 -169.22 2.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.355 -1.085 . . . . 0.0 110.205 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -147.38 170.71 16.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.277 -0.889 . . . . 0.0 110.183 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.833 ' HD2' HG13 ' A' ' 27' ' ' VAL . 19.8 m-85 -130.88 178.25 6.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.106 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -169.43 65.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 103.27 49.24 1.15 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.661 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -125.66 -176.5 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.729 -1.453 . . . . 0.0 110.962 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.654 ' O ' HG22 ' A' ' 46' ' ' THR . 55.3 m -153.21 55.48 0.76 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.727 HD12 HG21 ' A' ' 64' ' ' ILE . 10.6 tt -82.25 174.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.382 -0.824 . . . . 0.0 110.898 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 50' ' ' SER . 45.1 p -146.24 -136.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -0.755 . . . . 0.0 109.31 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 66' ' ' THR . 99.9 m -58.33 82.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.054 -1.029 . . . . 0.0 110.046 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 48' ' ' THR . 29.3 t -142.36 145.61 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.996 -1.065 . . . . 0.0 110.926 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -98.41 128.16 44.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.142 -0.974 . . . . 0.0 110.231 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -141.16 130.35 23.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.194 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.01 105.3 15.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 109.889 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA2' ' OG ' ' A' ' 40' ' ' SER . . . 51.27 91.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 8.5 p -154.86 119.2 4.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.12 . . . . 0.0 110.53 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.53 ' CD ' ' HB2' ' A' ' 58' ' ' SER . 1.6 ttm180 -72.76 101.96 3.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.696 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.471 ' O ' HG12 ' A' ' 45' ' ' VAL . 7.9 mm -84.07 12.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.956 . . . . 0.0 110.28 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.53 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -42.68 153.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.402 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.53 147.63 4.95 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.56 55.27 4.7 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.911 1.48 . . . . 0.0 109.762 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 63' ' ' LYS . . . 123.6 21.51 2.43 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -46.97 123.31 5.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -1.156 . . . . 0.0 111.108 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.543 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -112.41 145.65 39.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.233 -0.917 . . . . 0.0 109.649 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.727 HG21 HD12 ' A' ' 47' ' ' ILE . 11.3 mt -155.0 126.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.0 110.352 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.482 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -136.31 103.07 5.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.821 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.9 OUTLIER 68.17 80.12 0.21 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.526 -0.734 . . . . 0.0 110.382 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.7 t -138.96 120.38 14.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.846 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.6 mp -88.53 79.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 108.512 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.685 HG23 ' C ' ' A' ' 73' ' ' VAL . 11.1 mt -89.42 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.243 0.544 . . . . 0.0 110.193 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.845 ' O ' HG22 ' A' ' 73' ' ' VAL . 7.2 m -150.52 100.79 2.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.297 -0.877 . . . . 0.0 110.424 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.78 33.14 10.2 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 77.95 15.46 81.14 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 70' ' ' THR . 6.1 m -125.79 129.75 24.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.337 -1.096 . . . . 0.0 110.682 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 46.7 Cg_endo -75.96 144.59 27.37 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.831 1.437 . . . . 0.0 110.253 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -90.86 162.0 34.28 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.693 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.97 66.16 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.793 1.418 . . . . 0.0 110.121 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.489 ' OG ' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -108.07 125.78 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 110.345 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.79 -1.88 15.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 110.304 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.2 -23.73 17.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.091 -1.006 . . . . 0.0 110.493 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 49.3 t -72.87 167.4 21.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.523 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -108.63 -41.31 4.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.014 -1.054 . . . . 0.0 111.765 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.533 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 34.0 mm 47.13 74.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.894 -1.128 . . . . 0.0 109.683 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.59 -80.98 0.6 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.069 -1.019 . . . . 0.0 110.939 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.23 37.99 3.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.5 t -132.04 178.64 6.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.053 -1.263 . . . . 0.0 109.872 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.555 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t -173.87 155.0 2.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.228 -0.92 . . . . 0.0 109.662 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.592 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -125.57 158.28 35.01 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.904 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 26.4 t -141.36 22.87 2.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.719 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.71 80.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.411 -0.806 . . . . 0.0 109.84 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.52 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.394 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.8 t0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.294 0.569 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.68 -90.39 1.16 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 m -115.33 -81.05 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.128 -1.219 . . . . 0.0 110.409 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 1.007 ' HB3' HD23 ' A' ' 11' ' ' LEU . 0.5 OUTLIER 59.32 174.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 110.022 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 5' ' ' THR . 44.0 m -161.87 17.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.56 ' ND2' ' HB2' ' A' ' 9' ' ' SER . 0.7 OUTLIER 32.16 59.11 0.36 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.441 0.639 . . . . 0.0 110.126 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.581 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 0.2 OUTLIER 72.88 -54.42 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.43 -0.794 . . . . 0.0 109.827 -178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER 170.5 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.03 -1.044 . . . . 0.0 110.922 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.56 ' HB2' ' ND2' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -172.08 -86.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.042 -1.036 . . . . 0.0 110.565 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 9' ' ' SER . 0.6 OUTLIER -173.08 103.51 0.13 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.628 -1.295 . . . . 0.0 111.327 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.007 HD23 ' HB3' ' A' ' 4' ' ' CYS . 14.4 tp -102.14 96.25 6.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.101 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -36.34 134.6 0.42 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.53 0.681 . . . . 0.0 111.117 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.85 -21.27 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 110.54 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -96.65 -2.55 44.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.998 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.848 ' OG ' HG11 ' A' ' 27' ' ' VAL . 19.4 t -73.08 -169.15 0.57 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.842 -1.161 . . . . 0.0 110.073 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.75 130.99 14.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.152 -0.968 . . . . 0.0 110.981 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 18' ' ' GLU . 10.3 p -139.64 -179.28 5.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.897 . . . . 0.0 109.804 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 169.65 -80.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 109.74 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.34 13.27 9.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.845 . . . . 0.0 109.602 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -77.0 -147.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.765 . . . . 0.0 110.297 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.621 ' C ' HD22 ' A' ' 22' ' ' LEU . 18.9 m -153.23 88.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 110.321 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.869 HD21 HG11 ' A' ' 32' ' ' VAL . 3.5 mm? -106.31 90.5 3.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.64 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 9.3 m -93.32 139.93 30.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.189 -0.944 . . . . 0.0 111.176 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.471 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 4.4 m120 37.05 40.91 0.17 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.765 -0.584 . . . . 0.0 110.76 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -81.69 -152.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.19 -0.944 . . . . 0.0 110.676 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.564 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 56.5 t80 179.46 42.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.848 HG11 ' OG ' ' A' ' 15' ' ' SER . 6.6 t -53.46 149.95 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.857 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.493 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.1 OUTLIER -130.95 -29.03 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.441 0.639 . . . . 0.0 109.746 179.095 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.52 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 2.4 mtmt -168.86 68.48 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.307 -0.871 . . . . 0.0 109.329 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.759 ' HB2' HG22 ' A' ' 45' ' ' VAL . 84.0 p -141.34 168.68 19.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.119 -0.988 . . . . 0.0 111.706 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 47' ' ' ILE . 5.6 mt-10 -124.03 113.32 18.26 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.869 HG11 HD21 ' A' ' 22' ' ' LEU . 9.3 t -112.57 149.07 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 111.094 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CD1' HG22 ' A' ' 48' ' ' THR . 58.6 m-85 -128.77 -25.95 2.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -0.875 . . . . 0.0 110.905 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -167.82 32.59 0.19 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.576 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 4.8 m -81.98 146.44 29.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -1.157 . . . . 0.0 110.328 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 m -100.91 85.62 2.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.421 -0.8 . . . . 0.0 109.37 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.584 ' HB2' HD13 ' A' ' 22' ' ' LEU . 44.9 t -73.79 101.2 3.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.523 -0.735 . . . . 0.0 110.927 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 38' ' ' THR . 4.3 t -89.08 28.38 1.21 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.3 -0.875 . . . . 0.0 110.101 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 113.49 62.73 0.43 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 9.8 t -139.87 -173.94 3.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.44 -1.035 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.564 ' CB ' ' HB3' ' A' ' 26' ' ' TYR . 13.4 ptt180 -153.46 154.63 34.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.902 -1.124 . . . . 0.0 110.757 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.486 ' HD2' HG13 ' A' ' 27' ' ' VAL . 6.0 m-85 -119.15 -168.99 1.66 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.438 -0.789 . . . . 0.0 109.016 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.505 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 3.5 t0 -179.91 61.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.607 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 106.27 57.61 0.63 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.759 HG22 ' HB2' ' A' ' 30' ' ' SER . 1.0 OUTLIER -138.59 -157.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.887 -1.361 . . . . 0.0 110.601 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.702 ' N ' HG23 ' A' ' 45' ' ' VAL . 65.8 m -167.75 57.28 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.693 -0.629 . . . . 0.0 109.925 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 31' ' ' GLU . 16.0 tt -75.13 162.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 110.155 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' SER . 31.8 p -131.96 -134.34 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.068 -1.02 . . . . 0.0 109.963 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.524 ' O ' HG22 ' A' ' 49' ' ' THR . 95.5 m -65.89 64.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.981 -1.074 . . . . 0.0 110.257 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 48' ' ' THR . 3.1 t -128.08 139.85 52.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 0.0 110.588 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.459 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -90.05 146.71 24.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.859 . . . . 0.0 109.691 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.38 130.99 11.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.04 -1.038 . . . . 0.0 110.597 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.29 111.66 22.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.106 -0.997 . . . . 0.0 110.068 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.9 79.03 0.08 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 13.4 p -148.26 134.82 19.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -1.184 . . . . 0.0 110.111 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -89.99 108.54 19.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.453 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.599 HG23 ' CD1' ' A' ' 64' ' ' ILE . 17.4 mm -88.04 -1.46 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.178 -0.951 . . . . 0.0 109.998 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.505 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 1.1 m -42.56 150.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.36 -0.838 . . . . 0.0 110.864 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 164.16 153.56 7.44 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.94 -2.08 11.45 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.064 1.56 . . . . 0.0 109.903 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.76 34.08 0.08 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.415 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.3 t -65.82 130.26 42.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -1.117 . . . . 0.0 110.452 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 14.5 tttm -135.3 125.1 25.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 110.402 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.605 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 4.3 mt -126.64 146.54 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.99 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 66' ' ' THR . 30.6 p -142.04 126.15 17.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.926 . . . . 0.0 110.516 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 49' ' ' THR . 25.0 m 39.77 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.57 -0.706 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 2.8 t -152.92 108.08 3.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -0.876 . . . . 0.0 110.047 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.733 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -72.3 87.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.488 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.758 HG23 ' C ' ' A' ' 73' ' ' VAL . 3.9 mt -90.22 155.7 3.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.555 -0.716 . . . . 0.0 110.62 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.793 ' O ' HG22 ' A' ' 73' ' ' VAL . 18.7 m -156.31 102.65 2.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.334 -0.854 . . . . 0.0 110.553 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.6 26.76 24.16 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.576 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.77 16.31 70.76 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 70' ' ' THR . 4.0 m -127.24 133.72 25.37 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.536 -0.979 . . . . 0.0 110.155 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.18 148.09 16.66 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.793 1.417 . . . . 0.0 110.666 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -93.77 149.28 36.8 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.563 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.02 114.74 4.06 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.937 1.493 . . . . 0.0 110.85 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.675 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 1.3 t -134.14 -0.6 3.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 110.44 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 66.2 6.84 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.966 . . . . 0.0 110.409 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.28 -32.34 1.37 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.404 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -57.15 151.89 14.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.985 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.66 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -104.13 175.18 5.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.504 -0.747 . . . . 0.0 109.958 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.752 ' O ' HG22 ' A' ' 82' ' ' ILE . 46.1 mm -155.99 38.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.9 m -59.71 -104.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.73 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.92 89.52 0.48 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.708 ' C ' HG22 ' A' ' 86' ' ' THR . 1.6 t -147.18 -149.39 0.29 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.235 . . . . 0.0 110.311 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.708 HG22 ' C ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER 169.98 142.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.391 -0.818 . . . . 0.0 109.539 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.576 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.4 m-85 -116.99 -19.62 9.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.517 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.773 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 0.4 OUTLIER 45.72 -92.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 110.031 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . 157.36 64.92 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.904 -0.498 . . . . 0.0 110.031 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.43 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.004 -1.06 . . . . 0.0 109.978 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 2' ' ' GLY . 22.5 m-20 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.288 0.566 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 1' ' ' ASP . . . 43.76 -163.25 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -137.3 121.25 17.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -1.096 . . . . 0.0 110.358 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' C ' ' HG1' ' A' ' 5' ' ' THR . 2.6 p -166.54 -109.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.362 -0.836 . . . . 0.0 110.015 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 23' ' ' THR . 4.1 m -157.41 -3.9 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.718 -1.239 . . . . 0.0 110.938 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.934 ' HB3' HD12 ' A' ' 22' ' ' LEU . 8.4 p30 -50.67 -22.75 2.2 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.501 -1.374 . . . . 0.0 107.524 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 6' ' ' ASN 0.251 1.4 m -41.77 -61.89 1.01 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -54.85 -29.49 55.37 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 6' ' ' ASN . 9.4 p -86.04 -125.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.596 -0.69 . . . . 0.0 109.827 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.52 ' N ' ' OG ' ' A' ' 9' ' ' SER . 3.9 tt0 -131.39 -71.73 0.56 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.661 -1.274 . . . . 0.0 110.877 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.845 HD22 ' ND2' ' A' ' 6' ' ' ASN . 17.3 tp 57.03 111.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.11 -0.994 . . . . 0.0 109.922 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 12.9 t -68.39 161.11 28.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.284 -0.885 . . . . 0.0 110.405 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.74 -8.01 31.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.968 . . . . 0.0 110.073 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -97.74 -11.47 23.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.645 ' OG ' HG11 ' A' ' 27' ' ' VAL . 41.5 t -76.27 -163.29 0.29 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.972 . . . . 0.0 110.046 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.25 134.84 15.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.554 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.1 t -135.7 32.67 3.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.934 . . . . 0.0 110.2 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 19' ' ' LYS . 1.4 tm-20 -55.61 127.21 28.78 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 43.01 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -159.52 -171.07 3.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.044 -1.035 . . . . 0.0 111.005 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' THR . 8.5 m -156.55 72.78 0.75 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.486 -0.759 . . . . 0.0 109.71 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 6' ' ' ASN . 4.0 mt -75.44 -116.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 110.369 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.662 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 1.1 m 146.21 -62.59 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.479 ' N ' HG22 ' A' ' 23' ' ' THR . 73.7 m-20 -132.03 34.87 3.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.444 -0.785 . . . . 0.0 110.162 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -67.85 -159.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.02 0.914 . . . . 0.0 110.904 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 25' ' ' CYS . 46.9 m-85 -162.96 -54.74 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.654 HG12 ' H ' ' A' ' 28' ' ' ASP . 3.3 t 44.59 -179.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 122.14 0.971 . . . . 0.0 111.727 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.654 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -175.81 -33.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 46.8 mtmt -150.45 56.3 0.93 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.534 ' HB2' HG13 ' A' ' 27' ' ' VAL . 75.5 m -135.5 164.11 28.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.953 -1.092 . . . . 0.0 111.86 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 2.4 tt0 -120.64 107.62 13.02 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.63 HG22 ' CG2' ' A' ' 47' ' ' ILE . 17.9 t -110.29 160.1 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.052 -1.03 . . . . 0.0 111.379 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.556 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 94.9 m-85 -157.33 44.66 0.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.427 -0.796 . . . . 0.0 110.455 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' ' OG ' ' A' ' 20' ' ' SER . . . 138.72 33.08 0.19 Allowed Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.15 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.606 ' HB ' HG11 ' A' ' 32' ' ' VAL . 5.6 m -95.24 144.07 26.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.24 . . . . 0.0 110.257 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 36' ' ' THR . 32.0 m -94.61 53.35 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.36 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.499 ' HB2' ' CB ' ' A' ' 22' ' ' LEU . 1.2 m -50.4 87.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.425 -0.797 . . . . 0.0 110.888 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 36' ' ' THR . 5.2 t -104.78 36.07 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.21 46.6 0.18 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -141.24 167.17 22.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.314 -1.11 . . . . 0.0 109.856 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.471 ' CB ' ' HB2' ' A' ' 26' ' ' TYR . 5.3 ptt180 -146.12 152.11 38.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.961 -1.087 . . . . 0.0 110.803 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.628 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 6.8 m-85 -116.64 -167.63 1.32 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 7.1 t0 -177.46 53.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.414 -0.804 . . . . 0.0 110.165 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 114.88 60.2 0.37 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.512 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.4 m -139.28 -169.98 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.997 -1.296 . . . . 0.0 110.297 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.456 ' O ' HG22 ' A' ' 46' ' ' THR . 35.8 m -149.47 51.02 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.309 -0.869 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.63 ' CG2' HG22 ' A' ' 32' ' ' VAL . 7.9 tt -68.2 173.58 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 110.45 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 12.0 p -142.73 -98.76 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 110.067 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.737 ' O ' HG22 ' A' ' 49' ' ' THR . 15.8 m -104.05 69.83 0.96 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.986 -1.071 . . . . 0.0 109.715 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB2' HD11 ' A' ' 47' ' ' ILE . 10.6 m -121.13 147.19 45.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.116 -0.99 . . . . 0.0 111.161 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -99.66 121.57 41.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.436 -0.79 . . . . 0.0 109.168 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -139.85 136.54 34.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.345 -0.847 . . . . 0.0 110.406 -179.333 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -121.63 89.27 3.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.824 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.09 76.29 1.21 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 p -148.97 124.53 10.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -1.094 . . . . 0.0 110.551 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.46 ' HD2' ' HB2' ' A' ' 58' ' ' SER . 0.1 OUTLIER -90.35 96.66 10.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.242 -0.911 . . . . 0.0 109.896 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.628 ' CD1' ' CE1' ' A' ' 42' ' ' PHE . 3.1 mt -84.15 17.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.671 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -43.8 151.03 0.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.01 -1.057 . . . . 0.0 110.078 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 162.59 162.27 13.33 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.02 -1.35 11.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.134 1.597 . . . . 0.0 109.852 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.68 33.88 0.02 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.447 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.7 t -50.68 123.34 8.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.216 -1.167 . . . . 0.0 110.006 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.515 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 8.6 tttt -102.64 128.2 49.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.07 -1.019 . . . . 0.0 110.174 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 28.8 mm -133.81 141.3 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.907 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -151.62 126.38 9.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.298 -0.876 . . . . 0.0 110.101 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.5 m 39.02 71.59 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.573 0.702 . . . . 0.0 110.756 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.466 ' C ' HD12 ' A' ' 68' ' ' ILE . 73.4 m -130.13 125.6 35.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.428 -0.795 . . . . 0.0 109.252 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.9 mp -93.47 88.48 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.836 -1.165 . . . . 0.0 110.131 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.536 HG12 ' CE2' ' A' ' 87' ' ' PHE . 14.3 mt -96.23 156.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.522 -0.736 . . . . 0.0 110.061 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.787 ' O ' HG22 ' A' ' 73' ' ' VAL . 34.7 m -152.25 93.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 110.224 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.94 31.88 9.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 80.0 16.63 76.44 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 70' ' ' THR . 16.1 m -124.73 120.11 25.73 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.391 -1.064 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -73.72 145.81 37.4 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.949 1.5 . . . . 0.0 110.509 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -90.68 166.61 18.7 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.365 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.4 Cg_endo -72.03 56.3 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.723 1.38 . . . . 0.0 109.603 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.563 ' OG ' HD13 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -84.92 126.09 33.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.242 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.26 -9.13 59.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.837 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.94 -12.61 23.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.353 -0.842 . . . . 0.0 110.526 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' SER . 38.2 t -77.44 168.84 19.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.107 -0.996 . . . . 0.0 109.619 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HE3' ' N ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -98.64 -32.18 11.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.793 -1.192 . . . . 0.0 111.399 -178.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.527 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 28.3 mm 38.19 57.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.186 -0.946 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 m -113.37 -100.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.0 -1.062 . . . . 0.0 110.422 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -101.19 89.58 0.8 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -166.36 -172.72 2.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.147 -1.208 . . . . 0.0 110.759 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.512 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 2.6 t -178.02 157.51 1.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.484 -0.76 . . . . 0.0 109.52 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 2.2 m-30 -114.33 -54.68 2.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 110.076 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 65.07 11.08 6.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.087 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 47.14 95.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 109.963 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 89' ' ' ALA . 5.1 p30 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.305 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.241 0.543 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.85 -80.22 0.54 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 p -162.93 47.12 0.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -1.162 . . . . 0.0 110.135 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.528 ' O ' ' HB ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -50.86 -50.65 56.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 110.325 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' A' ' 4' ' ' CYS . 4.3 m 73.17 0.24 3.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.608 ' ND2' ' HB2' ' A' ' 25' ' ' CYS . 7.1 t-20 45.34 33.33 1.22 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.506 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER 69.39 70.14 0.25 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.029 -1.044 . . . . 0.0 108.25 -178.29 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 7' ' ' THR . 1.3 m-80 67.45 93.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.63 -0.668 . . . . 0.0 109.727 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' ' 25' ' ' CYS . 6.4 p -167.65 -139.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.19 -0.943 . . . . 0.0 110.4 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.476 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -126.17 -46.45 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 110.155 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.619 HD11 ' OG ' ' A' ' 15' ' ' SER . 12.3 tp 41.19 84.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.365 -0.834 . . . . 0.0 109.892 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.543 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 86.1 p -45.46 164.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 110.187 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 -14.03 60.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.846 . . . . 0.0 110.299 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -93.95 -6.62 45.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.164 -0.96 . . . . 0.0 110.5 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.619 ' OG ' HD11 ' A' ' 11' ' ' LEU . 4.8 t -74.08 -176.65 2.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.957 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.418 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -142.09 131.43 23.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.274 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 t -138.6 159.88 40.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.262 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -172.86 -87.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.014 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -114.55 72.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.134 -0.979 . . . . 0.0 110.1 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -117.92 -164.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.855 . . . . 0.0 110.216 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 21' ' ' THR . 5.2 t -150.15 60.42 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.765 HD23 ' O ' ' A' ' 35' ' ' THR . 13.7 mt -84.62 -171.59 3.71 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.873 0.844 . . . . 0.0 111.455 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 1.5 m -164.78 101.63 0.79 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.484 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 5.6 m-20 59.18 118.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.415 -0.803 . . . . 0.0 109.766 -178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.608 ' HB2' ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -171.0 -151.68 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.136 -0.978 . . . . 0.0 110.361 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.474 ' CD2' ' CB ' ' A' ' 10' ' ' GLN . 17.9 t80 -157.68 -42.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.837 0.827 . . . . 0.0 108.958 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.838 HG13 ' HD2' ' A' ' 42' ' ' PHE . 6.9 t 39.22 101.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.305 0.574 . . . . 0.0 112.174 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 4.6 t0 -88.71 -130.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.5 mttp -62.36 81.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.783 -1.198 . . . . 0.0 109.072 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.772 ' OG ' HG22 ' A' ' 45' ' ' VAL . 16.9 m -148.87 159.54 44.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.91 -1.119 . . . . 0.0 111.301 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 47' ' ' ILE . 2.2 mt-10 -119.1 115.66 24.73 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.624 HG22 ' CG2' ' A' ' 47' ' ' ILE . 34.2 t -117.21 156.28 18.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.225 -0.922 . . . . 0.0 111.065 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.518 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 41.9 m-85 -135.06 -71.75 0.48 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.143 -0.973 . . . . 0.0 110.913 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 48' ' ' THR . . . -118.36 41.83 1.94 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.765 ' O ' HD23 ' A' ' 22' ' ' LEU . 1.7 m -87.24 172.24 10.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -1.106 . . . . 0.0 110.334 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 6.8 m -112.0 -13.07 13.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.859 -1.151 . . . . 0.0 110.933 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.69 ' HB2' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 35.67 63.34 0.56 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.468 -0.77 . . . . 0.0 110.758 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.632 HG21 HG23 ' A' ' 53' ' ' THR . 88.3 m -65.57 78.57 0.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.411 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 52.27 36.0 44.21 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 41' ' ' ARG . 94.2 p -107.09 -138.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.179 -1.189 . . . . 0.0 109.811 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HB3' ' ND2' ' A' ' 90' ' ' ASN . 32.3 ttt-85 175.96 154.58 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 110.429 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.838 ' HD2' HG13 ' A' ' 27' ' ' VAL . 13.1 m-85 -120.11 168.85 10.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.923 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 3.9 t0 -159.6 73.49 0.57 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.998 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 96.57 49.85 1.92 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.772 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.2 m -131.6 -165.02 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.947 -1.325 . . . . 0.0 111.152 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.675 ' O ' HG22 ' A' ' 46' ' ' THR . 35.9 m -159.92 58.55 0.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.876 HD11 ' HB3' ' A' ' 50' ' ' SER . 13.2 tt -72.55 173.65 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.511 -0.743 . . . . 0.0 110.311 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -137.18 -92.07 0.24 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.373 -0.829 . . . . 0.0 109.886 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.807 ' O ' HG22 ' A' ' 49' ' ' THR . 7.8 m -111.97 65.96 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.876 ' HB3' HD11 ' A' ' 47' ' ' ILE . 1.5 t -108.77 143.27 38.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.551 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.533 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 m -91.85 21.18 5.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.471 -0.768 . . . . 0.0 110.85 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -38.12 128.02 1.31 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.446 -0.783 . . . . 0.0 110.759 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.632 HG23 HG21 ' A' ' 38' ' ' THR . 13.3 m -111.37 101.52 9.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 110.102 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 61.17 77.76 0.18 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.5 p -148.82 122.35 9.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -1.11 . . . . 0.0 110.219 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.553 ' CB ' ' HB3' ' A' ' 88' ' ' SER . 3.7 ttp180 -72.23 103.88 3.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.137 -0.977 . . . . 0.0 110.089 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.494 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 22.6 mm -83.92 11.88 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.319 -0.863 . . . . 0.0 109.827 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -41.73 148.91 0.14 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.347 -0.846 . . . . 0.0 110.244 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 158.06 157.27 8.36 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.27 52.53 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.062 1.559 . . . . 0.0 109.951 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' O ' ' HD2' ' A' ' 63' ' ' LYS . . . 118.69 18.74 4.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.522 ' HB3' ' CG1' ' A' ' 45' ' ' VAL . 1.7 t -40.77 126.81 2.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.406 -1.055 . . . . 0.0 110.148 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -108.43 143.21 37.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 110.734 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.096 HD13 ' NZ ' ' A' ' 81' ' ' LYS . 17.4 mm -143.06 125.07 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 109.042 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -133.94 121.49 21.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 110.602 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 49' ' ' THR . 15.6 m 37.76 53.64 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.705 -0.622 . . . . 0.0 111.145 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.587 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 4.8 t -118.47 109.79 16.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.948 . . . . 0.0 109.339 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 68' ' ' ILE . 2.0 mp -52.52 -66.28 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.711 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 73' ' ' VAL . 9.5 mt 56.74 157.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -0.784 . . . . 0.0 109.923 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.853 ' O ' HG22 ' A' ' 73' ' ' VAL . 5.7 m -169.66 107.51 0.39 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.898 -1.126 . . . . 0.0 111.186 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.41 28.08 31.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.572 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 85.38 10.9 76.4 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 70' ' ' THR . 11.7 m -120.5 136.73 25.5 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.207 -1.172 . . . . 0.0 110.033 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.454 ' HA ' HG12 ' A' ' 69' ' ' ILE . 48.3 Cg_endo -77.4 138.02 17.22 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.993 1.523 . . . . 0.0 110.849 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -107.6 160.83 25.25 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 109.998 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.26 122.15 8.11 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.923 1.486 . . . . 0.0 110.365 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.77 4.1 2.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 110.551 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.46 23.96 2.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.112 -0.992 . . . . 0.0 110.143 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 80' ' ' CYS . . . -160.45 -37.4 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.89 . . . . 0.0 109.913 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 1.2 t -39.46 158.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.684 0.754 . . . . 0.0 110.931 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.096 ' NZ ' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.56 -167.91 1.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 0.0 109.438 179.46 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.719 HG23 ' O ' ' A' ' 82' ' ' ILE . 1.3 tp 177.51 31.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.178 -0.951 . . . . 0.0 110.042 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -70.71 -101.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.935 -1.103 . . . . 0.0 110.652 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.84 100.75 1.43 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -161.7 -159.64 0.64 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.29 -1.124 . . . . 0.0 109.887 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.553 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t 169.1 150.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.615 -0.678 . . . . 0.0 109.636 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.572 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -122.79 143.28 49.94 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.267 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.658 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -122.02 9.66 9.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 65.17 66.94 0.53 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 110.088 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.534 ' HB2' ' CB ' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.127 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.287 0.565 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.28 -80.99 0.03 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 5' ' ' THR . 34.3 m -101.17 -101.39 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -1.162 . . . . 0.0 110.602 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.552 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 1.1 m 58.78 -80.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.038 -1.039 . . . . 0.0 110.052 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 5' ' ' THR . 0.3 OUTLIER 58.23 15.96 3.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.135 -0.978 . . . . 0.0 109.22 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.682 ' HB2' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER 50.44 28.29 3.25 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.042 -1.036 . . . . 0.0 108.453 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.562 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.9 m 77.61 -3.16 2.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.731 -0.606 . . . . 0.0 109.759 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.56 ' N ' HG23 ' A' ' 5' ' ' THR . 0.5 OUTLIER 162.68 86.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.666 -0.646 . . . . 0.0 110.136 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.526 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 61.9 p -177.11 -149.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.349 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 2.6 tt0 -111.98 -44.12 3.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.014 . . . . 0.0 110.532 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.552 ' CD2' ' HB3' ' A' ' 4' ' ' CYS . 41.8 tp 46.34 86.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 109.996 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.504 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -42.71 148.66 0.22 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.358 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.65 -21.32 64.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.198 -0.939 . . . . 0.0 110.093 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -87.56 -4.09 58.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 110.209 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.507 ' OG ' HG11 ' A' ' 27' ' ' VAL . 39.0 t -79.42 -163.7 0.54 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.233 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 9.5 tttp -156.39 178.98 9.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.134 -0.979 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 3.9 p 174.69 47.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 110.068 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 4.0 tt0 -41.83 -50.18 4.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.648 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -161.68 77.07 0.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.646 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 21' ' ' THR . 0.8 OUTLIER -115.31 -153.24 0.52 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.206 -0.934 . . . . 0.0 110.048 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -155.62 77.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 109.775 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.805 HD22 ' HB2' ' A' ' 37' ' ' CYS . 5.0 mt -96.24 -167.3 1.56 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.365 -0.835 . . . . 0.0 110.456 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.514 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 53.4 m -155.02 -47.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.503 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 25' ' ' CYS . 12.0 m-20 -144.25 23.51 1.66 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.545 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 9' ' ' SER . 0.1 OUTLIER -58.16 -152.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.024 . . . . 0.0 110.513 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -160.59 -52.85 0.05 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.599 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 30' ' ' SER . 4.7 t 49.39 117.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.905 0.86 . . . . 0.0 112.226 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -108.72 -20.83 12.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.944 . . . . 0.0 108.884 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -167.4 84.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.746 -0.596 . . . . 0.0 109.671 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.909 ' OG ' HG22 ' A' ' 45' ' ' VAL . 24.5 m -159.58 164.28 34.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.784 -1.197 . . . . 0.0 111.51 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 47' ' ' ILE . 3.6 tt0 -119.68 96.58 5.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.547 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 6.5 t -94.67 168.68 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.141 -0.974 . . . . 0.0 110.531 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 19.1 m-85 -150.18 -42.86 0.13 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.064 -1.022 . . . . 0.0 111.315 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.97 27.56 1.88 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.547 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.7 m -82.01 150.03 27.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.08 -1.247 . . . . 0.0 110.526 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 36' ' ' THR . 13.9 t -95.95 54.49 1.49 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.539 -0.726 . . . . 0.0 109.443 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.805 ' HB2' HD22 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -38.31 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.689 -0.632 . . . . 0.0 110.691 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' THR . 19.0 m -104.38 69.62 0.92 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 110.077 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.72 59.45 3.48 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.6 m -136.88 -168.97 2.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -1.143 . . . . 0.0 109.783 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -162.78 143.38 9.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 110.673 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.544 ' CE1' HG13 ' A' ' 57' ' ' ILE . 10.8 m-85 -114.42 173.4 6.48 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.419 -0.8 . . . . 0.0 109.181 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -155.86 42.98 0.42 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 123.8 72.88 0.25 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.909 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -148.91 -168.74 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.043 -1.269 . . . . 0.0 110.475 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.557 ' N ' HG23 ' A' ' 45' ' ' VAL . 50.2 m -155.38 58.82 0.64 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.579 ' HB ' HD13 ' A' ' 64' ' ' ILE . 8.8 tt -80.98 168.34 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.269 -0.894 . . . . 0.0 110.298 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' SER . 74.8 p -142.61 -138.05 0.11 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.621 -0.675 . . . . 0.0 109.233 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' THR . 52.8 m -58.24 83.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.984 -1.073 . . . . 0.0 110.145 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 48' ' ' THR . 73.0 m -141.57 139.41 33.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.961 -1.087 . . . . 0.0 110.502 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -88.88 117.77 28.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.373 -0.83 . . . . 0.0 109.592 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.5 p -133.78 113.49 12.36 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.567 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -98.37 91.42 5.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 109.485 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 72' ' ' GLY . . . 72.16 106.25 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 89.1 p -175.42 102.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -1.166 . . . . 0.0 110.467 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.539 ' HB2' ' CA ' ' A' ' 90' ' ' ASN . 7.6 ttm180 -62.79 106.26 0.78 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.929 -1.107 . . . . 0.0 108.984 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.544 HG13 ' CE1' ' A' ' 42' ' ' PHE . 16.5 mm -83.23 11.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.1 -1.0 . . . . 0.0 110.545 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.501 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -36.99 151.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.611 -0.681 . . . . 0.0 110.411 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 166.48 147.11 5.1 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.275 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -79.87 63.35 8.73 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 124.301 1.685 . . . . 0.0 109.461 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 106.05 24.3 6.97 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -41.58 161.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.409 -1.053 . . . . 0.0 110.323 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.479 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 17.1 tttm -152.89 110.48 3.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.012 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.579 HD13 ' HB ' ' A' ' 47' ' ' ILE . 3.1 mp -125.7 152.68 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.022 -1.049 . . . . 0.0 111.291 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.48 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.7 OUTLIER -156.12 107.91 2.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 0.0 109.895 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER 63.0 73.25 0.46 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 111.12 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 3.8 t -132.91 120.3 21.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.234 -0.917 . . . . 0.0 109.955 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.798 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.0 mp -83.29 85.24 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.027 -1.045 . . . . 0.0 108.839 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.697 HG21 ' CD2' ' A' ' 87' ' ' PHE . 9.6 mt -96.05 160.75 2.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.785 -0.572 . . . . 0.0 109.889 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.793 ' O ' HG22 ' A' ' 73' ' ' VAL . 13.1 m -162.63 100.93 1.03 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.221 -0.924 . . . . 0.0 110.504 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 89.03 34.52 8.79 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 54' ' ' GLY . . . 75.42 17.95 80.03 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 70' ' ' THR . 9.5 m -123.56 128.94 25.04 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.24 -1.153 . . . . 0.0 110.834 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -83.33 142.56 10.73 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.967 1.509 . . . . 0.0 109.939 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -91.76 158.37 40.22 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.149 -0.969 . . . . 0.0 110.261 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.36 59.48 6.09 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.883 1.465 . . . . 0.0 110.12 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.06 134.1 42.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.499 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.72 -8.11 25.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.071 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 66' ' ' THR . . . -91.97 -16.96 25.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.869 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 66' ' ' THR . 40.4 t -78.87 165.61 23.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.902 -1.124 . . . . 0.0 110.18 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HE3' ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -101.21 -12.18 18.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.166 -0.959 . . . . 0.0 112.11 -178.106 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 82' ' ' ILE . 37.1 mm 25.11 51.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.155 0.502 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 85' ' ' CYS . 0.4 OUTLIER -117.76 -141.75 0.36 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 111.375 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -59.35 83.5 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 6.0 t -177.96 178.37 0.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.11 . . . . 0.0 109.543 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.533 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -179.16 156.75 0.79 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.04 . . . . 0.0 110.491 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.697 ' CD2' HG21 ' A' ' 69' ' ' ILE . 2.3 m-85 -123.25 164.44 18.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -0.855 . . . . 0.0 110.287 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.747 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -142.21 12.58 1.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.841 . . . . 0.0 109.585 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 72.5 0.02 3.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 110.358 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.539 ' CA ' ' HB2' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.444 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 2' ' ' GLY . 24.8 p-10 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.071 0.463 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 1' ' ' ASP . . . -136.52 20.53 3.49 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m 50.37 29.31 3.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -1.125 . . . . 0.0 110.326 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.3 m -78.26 131.86 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 110.324 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.894 HG23 ' HB3' ' A' ' 9' ' ' SER . 20.6 m -117.12 -16.35 10.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 110.344 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.521 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 13.8 p30 35.76 50.8 0.65 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.964 -1.085 . . . . 0.0 111.196 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.2 m 73.03 4.37 4.93 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.412 -0.805 . . . . 0.0 112.067 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.642 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.2 t-20 -171.06 -48.87 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.724 -1.235 . . . . 0.0 110.772 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.894 ' HB3' HG23 ' A' ' 5' ' ' THR . 3.5 p 92.71 86.23 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.613 0.721 . . . . 0.0 111.646 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.558 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -130.66 14.59 5.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.148 -0.97 . . . . 0.0 108.448 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.681 HD12 ' HB ' ' A' ' 27' ' ' VAL . 9.9 tp -40.48 117.48 0.81 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.801 -0.562 . . . . 0.0 110.017 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.545 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -37.73 158.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.725 -0.609 . . . . 0.0 110.342 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.8 -6.96 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.987 . . . . 0.0 110.583 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -138.61 23.78 2.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.914 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.607 ' OG ' HG12 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -84.67 -159.56 0.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.009 -1.057 . . . . 0.0 110.33 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 4.8 tttp -155.95 152.58 28.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 110.362 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 29.9 p -164.63 56.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 11.3 tp10 -88.65 111.57 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 110.386 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 4.6 tttp 67.63 56.3 0.58 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.273 -0.892 . . . . 0.0 110.429 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.66 ' HB2' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -136.86 166.49 23.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.1 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 36' ' ' THR . 3.1 m -113.55 101.97 9.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.869 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.831 ' N ' HD22 ' A' ' 22' ' ' LEU . 1.7 mm? -107.16 147.77 29.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 110.639 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 17.9 m -148.15 109.8 4.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.354 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 6' ' ' ASN . 1.1 m120 60.73 56.99 2.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.186 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -109.47 -169.12 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.191 0.996 . . . . 0.0 111.582 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 26' ' ' TYR . 52.6 t80 -173.26 34.68 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.681 ' HB ' HD12 ' A' ' 11' ' ' LEU . 12.1 t -33.16 142.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.532 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.545 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -143.5 121.5 12.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.525 -0.734 . . . . 0.0 109.867 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.429 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 53.35 38.77 28.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.318 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.979 ' OG ' HG22 ' A' ' 45' ' ' VAL . 21.0 m -132.1 179.31 6.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.641 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG2' ' HD2' ' A' ' 16' ' ' LYS . 2.8 tt0 -119.94 -64.2 1.29 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.377 -0.827 . . . . 0.0 110.556 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.834 HG22 ' CG2' ' A' ' 47' ' ' ILE . 11.7 t 62.05 150.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 110.004 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.551 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 19.3 m-85 -142.35 -47.43 0.34 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.059 -1.026 . . . . 0.0 110.803 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -132.59 20.32 4.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.533 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 8.6 m -66.68 154.91 39.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -1.18 . . . . 0.0 110.277 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 21' ' ' THR . 5.7 m -95.86 -21.46 18.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.547 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 11.9 t 48.86 76.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.805 . . . . 0.0 110.961 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.4 m -80.23 73.5 7.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 109.1 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 66.08 49.88 55.3 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -135.92 -178.08 4.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.266 -1.138 . . . . 0.0 110.018 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -153.4 176.4 12.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.034 -1.042 . . . . 0.0 110.56 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.598 ' CE2' HG21 ' A' ' 47' ' ' ILE . 52.7 m-85 -123.18 -170.15 2.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.006 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 58' ' ' SER . 9.8 t70 -178.35 63.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.773 . . . . 0.0 109.67 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 99.65 60.02 0.86 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.979 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.4 m -137.37 -159.53 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.95 -1.324 . . . . 0.0 111.324 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.621 ' N ' HG23 ' A' ' 45' ' ' VAL . 85.4 m -166.89 57.81 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.834 ' CG2' HG22 ' A' ' 32' ' ' VAL . 12.4 tt -83.7 171.65 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.47 -0.769 . . . . 0.0 111.088 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.551 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 22.4 p -135.51 -134.03 0.15 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' THR . 23.1 m -66.12 89.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.737 -1.227 . . . . 0.0 109.758 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.684 ' CB ' HD11 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -132.13 139.05 48.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.012 -1.055 . . . . 0.0 110.495 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.567 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 m -85.5 21.45 1.79 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 111.056 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 89.9 p -37.18 122.01 0.84 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.465 -0.772 . . . . 0.0 110.803 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 2.6 m -112.02 111.13 21.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.136 -0.978 . . . . 0.0 109.973 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 51.55 79.85 0.07 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 8.0 p -155.51 122.63 5.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -1.165 . . . . 0.0 110.528 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' CA ' ' A' ' 90' ' ' ASN . 36.9 ttt85 -75.97 103.85 6.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 109.675 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.53 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 18.1 mm -83.29 12.67 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 0.0 110.358 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.535 ' CB ' ' HB3' ' A' ' 43' ' ' ASP . 42.9 p -42.71 162.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.347 -0.846 . . . . 0.0 110.716 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 150.67 163.04 11.01 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -75.8 57.44 5.06 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.935 1.492 . . . . 0.0 109.844 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 106.43 21.82 8.15 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 1.8 t -38.96 126.57 1.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.662 -0.905 . . . . 0.0 110.649 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 35.4 ttpt -115.08 140.47 49.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.053 -1.029 . . . . 0.0 110.593 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.973 HD13 ' HE2' ' A' ' 81' ' ' LYS . 25.4 mm -143.34 145.72 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.24 -0.912 . . . . 0.0 109.844 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.469 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 1.1 m -147.99 126.13 12.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.057 -1.027 . . . . 0.0 110.043 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.5 m 41.57 59.61 2.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.392 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.591 ' SG ' HD11 ' A' ' 69' ' ' ILE . 5.1 t -123.95 109.95 14.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.819 . . . . 0.0 109.532 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.567 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 1.9 mp -55.65 -64.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.979 -1.076 . . . . 0.0 109.697 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.591 HD11 ' SG ' ' A' ' 67' ' ' CYS . 8.1 mt 54.88 162.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.48 -0.763 . . . . 0.0 110.787 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.541 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 9.0 m -146.33 -121.78 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.83 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.781 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -65.18 77.5 0.08 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 58.54 16.73 30.45 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 71' ' ' GLY . 33.8 m -121.91 141.05 33.2 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.472 -1.017 . . . . 0.0 110.544 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 73' ' ' VAL . 49.1 Cg_endo -85.11 128.28 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.943 1.496 . . . . 0.0 110.133 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.82 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -83.56 174.65 5.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 110.081 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.82 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 43.0 Cg_endo -70.72 59.12 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.942 1.496 . . . . 0.0 110.106 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -88.09 112.93 23.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.382 -0.824 . . . . 0.0 110.223 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.32 -4.95 20.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.86 . . . . 0.0 110.347 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.07 -31.85 8.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.52 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 43.1 t -46.36 166.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.169 -0.957 . . . . 0.0 109.836 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.973 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -108.15 -41.19 4.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.043 -1.035 . . . . 0.0 111.43 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.714 ' O ' HG22 ' A' ' 82' ' ' ILE . 19.0 mm 49.25 62.13 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.816 -1.177 . . . . 0.0 109.615 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.401 ' H ' ' NZ ' ' A' ' 81' ' ' LYS . 23.2 t -109.33 -73.19 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 110.815 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.43 67.79 0.54 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -134.53 -153.0 0.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -1.151 . . . . 0.0 110.009 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.566 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.2 t 176.91 143.21 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.566 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -128.24 153.06 47.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.55 -0.719 . . . . 0.0 109.158 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.74 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 1.3 m -140.95 12.17 2.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.978 . . . . 0.0 109.758 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.74 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 72.07 0.13 3.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.443 -0.786 . . . . 0.0 110.201 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.533 ' CA ' ' HB2' ' A' ' 56' ' ' ARG . 1.5 p-10 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.013 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.285 0.565 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.6 67.46 0.53 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t 49.21 95.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.331 -1.1 . . . . 0.0 110.445 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p -159.33 160.03 34.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.096 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.762 HG22 ' O ' ' A' ' 5' ' ' THR . 30.6 m -154.1 25.89 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 109.427 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 5' ' ' THR . 0.2 OUTLIER 65.85 -61.84 0.26 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.673 0.749 . . . . 0.0 108.992 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 5' ' ' THR . 25.1 m -161.86 -38.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 177.21 32.94 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.657 -0.652 . . . . 0.0 109.45 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 13.4 m -111.78 -107.07 0.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.855 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.599 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 3.9 pt20 -140.39 -43.56 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.863 -1.148 . . . . 0.0 111.511 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' N ' ' CG ' ' A' ' 10' ' ' GLN . 16.5 tp 47.68 81.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.015 -1.053 . . . . 0.0 108.934 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -44.44 149.93 0.35 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 110.25 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.91 -10.1 12.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.858 . . . . 0.0 110.076 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -90.18 -7.77 52.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.968 . . . . 0.0 110.268 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 30' ' ' SER . 32.1 t -80.42 -157.61 0.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.067 -1.02 . . . . 0.0 110.099 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.516 ' CE ' ' OH ' ' A' ' 33' ' ' TYR . 12.5 tttt -135.74 140.17 44.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.079 -1.013 . . . . 0.0 110.088 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.0 m -113.41 137.35 51.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 110.291 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.8 -129.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.246 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.63 19.55 15.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.817 -1.177 . . . . 0.0 110.667 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.525 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -58.98 167.49 1.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.0 109.865 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.804 ' C ' HD23 ' A' ' 22' ' ' LEU . 1.6 t -140.24 97.13 3.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.019 -1.051 . . . . 0.0 109.985 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.804 HD23 ' C ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -131.45 -165.56 1.59 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.431 -0.793 . . . . 0.0 110.139 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 98.2 m -166.94 142.03 4.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.351 -0.843 . . . . 0.0 110.363 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.472 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 4.2 m120 45.88 36.83 3.1 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.369 -0.832 . . . . 0.0 110.697 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.501 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.7 OUTLIER -78.83 -154.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.091 -1.006 . . . . 0.0 110.683 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' CE1' ' HB3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER 176.26 40.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.491 HG13 ' HD2' ' A' ' 42' ' ' PHE . 40.3 t -52.78 153.92 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.984 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.7 OUTLIER -158.83 129.14 5.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.476 -0.765 . . . . 0.0 110.138 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.7 mtmp? 50.78 34.53 10.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 15' ' ' SER . 49.3 m -124.47 -161.13 0.98 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.499 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 3.5 tt0 -138.2 -63.13 0.56 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.513 -0.742 . . . . 0.0 110.089 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.562 HG22 ' CG2' ' A' ' 47' ' ' ILE . 15.9 t 61.16 156.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.516 ' OH ' ' CE ' ' A' ' 16' ' ' LYS . 9.9 m-85 -153.95 -39.11 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.199 -0.938 . . . . 0.0 110.477 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.2 34.07 1.66 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 37' ' ' CYS . 1.1 m -79.27 158.33 27.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.397 -1.061 . . . . 0.0 110.73 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -111.52 50.23 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.96 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 3.5 t -40.82 121.38 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 111.012 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 38' ' ' THR . 24.1 m -113.66 22.86 13.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 109.269 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 122.85 41.56 0.44 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.734 ' HA ' HD22 ' A' ' 90' ' ' ASN . 0.1 OUTLIER -115.52 -159.29 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -1.178 . . . . 0.0 110.372 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 26' ' ' TYR . 28.4 ttt180 -166.88 145.06 5.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.914 . . . . 0.0 110.701 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.491 ' HD2' HG13 ' A' ' 27' ' ' VAL . 10.1 m-85 -115.16 172.39 7.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.0 109.301 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.54 42.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.921 -1.112 . . . . 0.0 110.407 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 127.0 57.5 0.13 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -136.34 -171.16 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.269 -1.136 . . . . 0.0 110.997 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 46' ' ' THR . 87.9 m -152.89 58.2 0.79 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.562 ' CG2' HG22 ' A' ' 32' ' ' VAL . 9.7 tt -81.3 169.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.245 -0.909 . . . . 0.0 110.14 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 50' ' ' SER . 58.9 p -146.09 -139.7 0.1 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.048 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 66' ' ' THR . 51.9 m -52.94 91.48 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.07 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' THR . 2.4 m -152.96 143.72 22.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.155 -0.966 . . . . 0.0 110.286 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -98.66 135.32 40.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 59.9 p -155.64 130.88 9.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.33 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 71' ' ' GLY . 11.5 m -111.85 112.94 24.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.103 -0.998 . . . . 0.0 109.82 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.7 86.41 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 79.6 p -154.74 112.25 3.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -1.144 . . . . 0.0 110.514 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 4.1 ttt180 -67.03 118.6 10.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 109.66 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 26.8 mm -97.82 11.18 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 0.0 110.831 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -40.7 145.34 0.19 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.203 -0.936 . . . . 0.0 110.34 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 175.12 145.85 5.54 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -80.18 1.34 9.33 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.038 1.547 . . . . 0.0 109.629 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.06 33.23 0.07 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.508 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -60.74 152.73 26.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.535 -0.979 . . . . 0.0 110.804 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -156.95 113.93 3.07 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.653 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.0 mt -118.9 148.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.067 -1.021 . . . . 0.0 110.862 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.51 117.14 5.41 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.0 OUTLIER 51.21 71.14 0.46 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.101 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 50' ' ' SER . 60.5 m -139.11 111.04 7.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.447 -0.783 . . . . 0.0 110.478 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -77.92 137.06 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.946 -1.096 . . . . 0.0 109.42 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.641 HG23 ' C ' ' A' ' 73' ' ' VAL . 9.3 mt -146.51 158.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.079 -1.013 . . . . 0.0 110.309 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.74 ' O ' HG22 ' A' ' 73' ' ' VAL . 5.7 m -156.39 99.0 1.88 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.04 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.835 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 91.51 20.67 37.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.525 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 88.29 15.55 60.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 70' ' ' THR . 4.1 m -124.3 132.87 24.35 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.476 -1.014 . . . . 0.0 109.507 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.36 144.93 23.47 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.59 1.311 . . . . 0.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.82 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -99.17 176.02 2.17 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.82 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 47.6 Cg_endo -73.15 102.6 1.48 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.94 1.495 . . . . 0.0 110.635 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 1.1 t -119.04 -23.52 6.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.34 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 61.15 12.35 4.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.255 -0.903 . . . . 0.0 109.966 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.7 -15.27 1.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.311 -0.868 . . . . 0.0 110.998 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 33.1 t -62.89 168.48 3.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.968 -1.082 . . . . 0.0 110.406 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HD2' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.99 -35.29 8.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.981 -1.074 . . . . 0.0 111.826 -178.481 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.489 ' N ' ' HE2' ' A' ' 81' ' ' LYS . 32.4 mm 43.66 60.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.093 -1.004 . . . . 0.0 109.35 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 85' ' ' CYS . 46.5 m -114.95 -130.11 0.31 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.31 -0.869 . . . . 0.0 110.594 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -65.12 66.05 0.08 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.653 ' SG ' HD11 ' A' ' 64' ' ' ILE . 5.0 t -160.94 -175.99 5.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.023 -1.281 . . . . 0.0 109.854 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.562 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 2.0 t -179.09 160.67 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.117 -0.989 . . . . 0.0 110.745 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.604 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -127.92 155.08 44.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.32 -0.863 . . . . 0.0 109.431 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.91 24.91 1.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.047 -1.033 . . . . 0.0 110.313 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.835 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 52.84 85.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 109.944 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.734 HD22 ' HA ' ' A' ' 40' ' ' SER . 2.8 p-10 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.035 -1.04 . . . . 0.0 110.365 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.353 0.597 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.43 123.33 0.65 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -55.99 -60.92 2.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -1.159 . . . . 0.0 110.022 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' O ' ' OG1' ' A' ' 5' ' ' THR . 14.3 m 56.67 -147.38 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 110.425 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 8' ' ' ASN . 1.3 m 178.91 -29.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.612 ' ND2' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER 62.91 55.42 2.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.38 1.086 . . . . 0.0 108.257 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.469 HG21 HG23 ' A' ' 23' ' ' THR . 1.8 m 63.66 -63.81 0.13 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.473 -1.392 . . . . 0.0 108.912 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.637 ' O ' ' CB ' ' A' ' 9' ' ' SER . 4.7 t30 -73.16 -88.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.637 ' CB ' ' O ' ' A' ' 8' ' ' ASN . 2.5 p 152.93 58.4 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 122.124 -0.36 . . . . 0.0 111.678 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 22.2 mt-30 -140.69 16.56 2.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.312 -1.493 . . . . 0.0 110.538 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.782 HD11 ' OG ' ' A' ' 15' ' ' SER . 8.7 tp -62.96 81.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 10' ' ' GLN . 97.9 p -30.62 134.16 0.06 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.529 0.681 . . . . 0.0 111.93 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.33 -22.51 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 109.81 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.589 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.2 OUTLIER -80.99 -10.28 59.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.473 -0.767 . . . . 0.0 110.086 -179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.782 ' OG ' HD11 ' A' ' 11' ' ' LEU . 45.6 t -79.38 -171.62 2.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.131 -0.98 . . . . 0.0 109.757 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.89 163.79 17.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.105 -0.997 . . . . 0.0 109.612 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.491 ' SG ' HD23 ' A' ' 11' ' ' LEU . 6.4 m -134.66 -29.29 1.19 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.066 -1.022 . . . . 0.0 111.191 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' LYS . 10.4 tp10 -43.45 118.22 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.07 -1.018 . . . . 0.0 110.244 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 52.83 108.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.781 . . . . 0.0 110.552 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 5.9 p 178.69 146.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.048 -1.032 . . . . 0.0 110.899 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -139.14 84.08 1.98 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -0.792 . . . . 0.0 109.529 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 38.9 mt -101.91 -174.42 2.58 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.834 0.826 . . . . 0.0 111.267 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.469 HG23 HG21 ' A' ' 7' ' ' THR . 91.7 m -164.42 125.02 2.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.637 -0.665 . . . . 0.0 109.298 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.2 m120 51.07 66.47 1.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 108.878 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.612 ' HB2' ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -123.78 169.91 11.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.78 0.8 . . . . 0.0 110.471 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.637 ' HA ' ' HB3' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -147.0 34.33 0.91 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 179.002 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.868 HG13 ' HD2' ' A' ' 42' ' ' PHE . 7.6 t -30.52 147.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.587 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.522 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -150.47 123.31 8.68 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 9.8 mmmt 48.04 56.26 7.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 0.0 109.34 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.574 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 14.7 m -143.25 171.69 13.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.963 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.648 ' OE1' HG23 ' A' ' 46' ' ' THR . 1.4 tt0 -115.06 -68.88 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.382 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.53 HG23 ' C ' ' A' ' 31' ' ' GLU . 3.1 t 67.15 143.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.327 -0.858 . . . . 0.0 110.383 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CD1' HG22 ' A' ' 48' ' ' THR . 45.2 m-85 -137.62 -52.71 0.65 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.337 -0.852 . . . . 0.0 110.674 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.452 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -129.46 18.88 5.42 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.525 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.2 m -69.75 153.69 43.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -1.167 . . . . 0.0 110.216 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.2 m -111.95 58.24 0.63 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.462 -0.774 . . . . 0.0 109.594 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 52.8 t -36.87 137.77 0.3 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.609 -0.682 . . . . 0.0 111.01 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 95.2 m -137.85 74.34 1.48 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.468 -0.77 . . . . 0.0 109.461 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.48 57.43 3.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.412 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -147.08 178.57 8.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.159 -1.201 . . . . 0.0 110.177 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 42' ' ' PHE . 4.0 ttt180 -150.65 153.02 34.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.302 -0.874 . . . . 0.0 110.176 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.868 ' HD2' HG13 ' A' ' 27' ' ' VAL . 8.1 m-85 -116.04 -176.2 2.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.995 . . . . 0.0 110.566 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.522 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.9 t0 -170.09 50.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 110.179 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 118.44 61.36 0.28 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -140.98 -168.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.914 -1.345 . . . . 0.0 110.6 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.65 ' O ' HG22 ' A' ' 46' ' ' THR . 91.6 m -160.73 53.25 0.3 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.62 -0.675 . . . . 0.0 109.908 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 19.8 tt -73.54 169.45 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.783 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 50' ' ' SER . 71.9 p -138.21 -139.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.206 -0.934 . . . . 0.0 109.666 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 31.3 m -58.33 80.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' THR . 28.5 t -141.55 140.33 33.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 110.454 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -83.49 131.47 35.01 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.221 -0.924 . . . . 0.0 109.916 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 2.9 t -151.86 128.67 10.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.939 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.598 ' OG1' HG23 ' A' ' 70' ' ' THR . 36.8 p -128.22 110.62 12.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.978 . . . . 0.0 110.212 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.41 84.03 0.13 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 p -161.37 127.87 3.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -1.13 . . . . 0.0 110.658 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' CD ' ' HB2' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.55 103.27 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 7.4 mm -85.07 10.78 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.083 -1.011 . . . . 0.0 110.498 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -36.02 142.77 0.07 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.457 -0.777 . . . . 0.0 110.727 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 176.85 146.09 5.96 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.313 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.77 -8.31 17.95 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.965 1.508 . . . . 0.0 110.051 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.48 39.23 0.12 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.505 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -56.15 159.42 3.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.525 -0.985 . . . . 0.0 111.37 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 27.5 tttt -161.08 98.71 1.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.694 -0.629 . . . . 0.0 109.347 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.791 HD11 ' SG ' ' A' ' 85' ' ' CYS . 12.8 mt -117.82 163.41 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.671 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -145.47 -163.35 1.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.405 -0.809 . . . . 0.0 110.155 179.332 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.0 m -33.36 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.603 ' C ' HD12 ' A' ' 68' ' ' ILE . 44.4 t -138.38 139.52 39.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.515 -0.741 . . . . 0.0 109.107 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.723 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.6 mp -97.22 82.73 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.884 -1.135 . . . . 0.0 108.704 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.59 HG23 ' C ' ' A' ' 73' ' ' VAL . 13.1 mt -90.85 154.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.67 -0.644 . . . . 0.0 110.328 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.732 ' O ' HG22 ' A' ' 73' ' ' VAL . 52.8 m -162.01 98.82 1.08 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.174 -0.954 . . . . 0.0 110.597 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.767 ' O ' HG13 ' A' ' 73' ' ' VAL . . . 94.39 39.98 4.61 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.561 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 65.32 24.02 70.4 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 71' ' ' GLY . 6.1 m -129.24 129.2 23.3 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.485 -1.009 . . . . 0.0 110.893 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HB2' HD11 ' A' ' 82' ' ' ILE . 46.4 Cg_endo -83.58 131.89 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.922 1.486 . . . . 0.0 110.228 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -79.04 150.85 75.37 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.002 -1.061 . . . . 0.0 110.057 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.56 58.47 1.94 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.118 1.588 . . . . 0.0 110.683 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.48 150.48 22.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 110.235 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.24 -10.96 55.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.926 . . . . 0.0 109.962 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 80' ' ' CYS . . . -112.66 -31.6 6.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.92 . . . . 0.0 111.002 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 67' ' ' CYS . 13.0 t -44.53 137.06 3.94 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.945 -1.097 . . . . 0.0 110.141 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.548 ' C ' HD12 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -110.28 164.88 12.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 111.49 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.798 ' O ' HG22 ' A' ' 82' ' ' ILE . 1.0 OUTLIER -161.59 75.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.494 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -112.08 -86.55 0.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 0.0 110.56 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -104.79 65.91 0.3 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.791 ' SG ' HD11 ' A' ' 64' ' ' ILE . 4.4 t -162.48 -175.49 4.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -1.189 . . . . 0.0 110.26 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.559 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.5 t 179.81 158.87 0.73 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.288 -0.882 . . . . 0.0 110.108 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.3 OUTLIER -123.22 154.35 38.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 89' ' ' ALA . 2.7 m -134.96 32.67 3.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 109.591 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 88' ' ' SER . . . 37.87 72.01 0.14 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.757 -0.589 . . . . 0.0 110.199 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.452 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.307 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 2' ' ' GLY . 7.5 t0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.317 0.579 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 1' ' ' ASP . . . -56.57 -161.29 0.02 OUTLIER Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 t -125.14 48.48 2.01 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.314 -1.109 . . . . 0.0 110.839 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.8 173.73 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.181 -0.949 . . . . 0.0 111.034 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 5' ' ' THR . 1.2 m -136.19 5.37 3.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.496 -0.753 . . . . 0.0 109.321 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.87 ' ND2' HD12 ' A' ' 22' ' ' LEU . 0.7 OUTLIER 50.93 69.43 0.64 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.182 -0.949 . . . . 0.0 109.165 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.872 HG21 ' HA ' ' A' ' 23' ' ' THR . 1.5 p 63.8 -56.15 0.21 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.193 -0.942 . . . . 0.0 110.648 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.551 ' N ' ' O ' ' A' ' 6' ' ' ASN . 1.2 t-20 177.11 64.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.918 -1.113 . . . . 0.0 110.162 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.7 m -131.2 -121.98 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.919 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 11' ' ' LEU . 1.4 pt20 -131.08 -41.55 1.12 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.855 -1.153 . . . . 0.0 109.895 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.656 HD12 ' HB ' ' A' ' 27' ' ' VAL . 18.1 tp 43.46 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.549 -0.719 . . . . 0.0 110.149 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -37.91 150.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.693 -0.63 . . . . 0.0 110.451 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -24.98 67.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 110.24 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 14' ' ' ASN . 0.6 OUTLIER -103.93 6.26 36.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 111.129 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.496 ' OG ' HD11 ' A' ' 11' ' ' LEU . 28.8 t -69.21 -154.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.16 . . . . 0.0 109.391 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.545 ' CD ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -140.69 150.71 43.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 110.528 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' A' ' 18' ' ' GLU . 7.8 t -135.99 -92.18 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -0.917 . . . . 0.0 109.779 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.491 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 13.2 mt-10 38.05 -125.68 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.412 -0.805 . . . . 0.0 110.844 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 20' ' ' SER . 10.4 tptt -66.98 123.55 20.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.956 -1.09 . . . . 0.0 110.356 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.533 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . 10.3 p 175.94 172.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.115 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 21' ' ' THR . 1.8 t -154.04 76.41 1.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.36 -0.837 . . . . 0.0 109.56 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.87 HD12 ' ND2' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -114.48 -170.56 1.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.793 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.872 ' HA ' HG21 ' A' ' 7' ' ' THR . 3.9 m -164.89 124.94 1.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.849 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.6 m120 57.17 33.38 23.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 110.713 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -64.31 -141.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.754 -1.216 . . . . 0.0 109.929 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' CG ' ' O ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER 166.34 45.82 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.687 HG13 ' HB2' ' A' ' 30' ' ' SER . 8.0 t -66.96 140.45 19.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.762 0.791 . . . . 0.0 111.715 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.9 t0 -123.05 -14.03 7.66 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.429 0.633 . . . . 0.0 109.728 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER 179.99 67.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.98 ' OG ' HG22 ' A' ' 45' ' ' VAL . 14.8 m -147.26 151.31 36.44 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.176 -0.953 . . . . 0.0 111.442 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' HG3' ' CD ' ' A' ' 16' ' ' LYS . 6.5 tt0 -107.49 101.23 10.59 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 18.0 t -99.2 174.32 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.237 -0.915 . . . . 0.0 110.379 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.531 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 47.1 m-85 -149.16 -32.0 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.193 -0.942 . . . . 0.0 111.391 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -164.48 26.79 0.2 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 50' ' ' SER . 0.9 OUTLIER -76.99 144.94 38.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.137 . . . . 0.0 110.398 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -91.13 60.04 4.16 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.417 -0.802 . . . . 0.0 110.501 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 2.0 t -47.04 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.0 110.157 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.84 HG21 HG23 ' A' ' 53' ' ' THR . 1.7 t -85.91 31.88 0.61 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.071 -1.018 . . . . 0.0 110.445 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.42 27.83 4.01 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 16.0 t -94.06 -163.09 1.0 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.384 -1.068 . . . . 0.0 110.229 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HB2' ' CB ' ' A' ' 26' ' ' TYR . 2.7 ttp180 -165.73 144.69 6.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.65 ' CE1' HD13 ' A' ' 57' ' ' ILE . 2.9 m-85 -119.45 -172.44 2.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.971 -1.081 . . . . 0.0 110.227 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.22 55.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 110.204 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 115.29 54.64 0.37 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.274 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.98 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.1 m -133.6 -169.66 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.732 -1.452 . . . . 0.0 111.325 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.478 ' N ' HG23 ' A' ' 45' ' ' VAL . 33.5 m -151.89 60.01 0.86 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.583 HG12 ' HG ' ' A' ' 50' ' ' SER . 14.6 tt -81.14 -179.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.751 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.531 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -139.77 -89.82 0.19 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.789 -1.195 . . . . 0.0 110.195 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 49' ' ' THR . 5.9 m -114.3 74.35 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.022 -1.049 . . . . 0.0 110.451 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.583 ' HG ' HG12 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -114.53 152.34 31.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.144 -0.973 . . . . 0.0 111.413 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.429 ' H ' ' HA ' ' A' ' 68' ' ' ILE . 1.5 m -99.79 27.91 5.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.462 -0.773 . . . . 0.0 111.085 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' ILE . 1.4 p -40.92 136.62 1.41 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.187 -0.946 . . . . 0.0 110.893 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.84 HG23 HG21 ' A' ' 38' ' ' THR . 87.2 m -126.17 87.58 2.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.45 65.88 1.93 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.8 p -145.91 123.11 11.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.448 -1.031 . . . . 0.0 109.844 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -76.68 102.22 6.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.551 -0.718 . . . . 0.0 110.75 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.65 HD13 ' CE1' ' A' ' 42' ' ' PHE . 3.1 mp -85.37 15.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.988 -1.07 . . . . 0.0 110.217 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.9 p -47.15 161.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.337 -0.852 . . . . 0.0 110.968 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 155.24 154.29 6.86 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -74.41 -0.84 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.825 1.434 . . . . 0.0 110.098 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.31 29.83 0.07 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.3 t -52.28 114.55 1.38 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.451 -1.029 . . . . 0.0 110.491 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -110.57 130.22 55.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.829 HG23 ' HD2' ' A' ' 81' ' ' LYS . 41.0 mt -140.95 147.89 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.073 -1.017 . . . . 0.0 110.587 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.492 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -140.53 108.87 5.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 110.64 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 49' ' ' THR . 5.9 m 50.33 71.86 0.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.522 -0.736 . . . . 0.0 112.027 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.532 ' SG ' ' CG1' ' A' ' 69' ' ' ILE . 43.9 t -132.81 112.31 11.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.359 -0.838 . . . . 0.0 109.235 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.7 mp -47.25 -68.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.556 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.532 ' CG1' ' SG ' ' A' ' 67' ' ' CYS . 27.3 mt 63.42 155.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.306 -0.871 . . . . 0.0 110.171 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.528 ' HB ' HG23 ' A' ' 73' ' ' VAL . 12.4 m -147.73 -115.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.51 ' C ' HG22 ' A' ' 73' ' ' VAL . . . -74.06 81.69 0.78 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.6 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 54.46 19.82 14.45 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.528 HG23 ' HB ' ' A' ' 70' ' ' THR . 4.3 m -125.64 133.91 25.34 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.611 -0.935 . . . . 0.0 110.138 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 48.3 Cg_endo -82.84 129.99 5.67 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.59 1.311 . . . . 0.0 110.373 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.508 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -95.36 150.55 37.73 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 110.345 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.62 144.14 35.2 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.063 1.559 . . . . 0.0 110.375 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.454 ' HB2' HD13 ' A' ' 68' ' ' ILE . 23.3 t -165.93 24.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.138 -0.977 . . . . 0.0 110.559 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 44.51 27.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.44 -34.43 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.898 . . . . 0.0 110.796 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 1.7 t -50.82 145.35 7.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.012 -1.055 . . . . 0.0 110.731 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.829 ' HD2' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -97.35 167.52 10.96 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.668 -0.645 . . . . 0.0 109.606 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.719 ' O ' HG22 ' A' ' 82' ' ' ILE . 29.9 mm -154.59 60.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.967 -1.083 . . . . 0.0 109.714 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.5 m -98.35 -116.94 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 111.009 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.39 83.41 0.54 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -141.72 -165.05 1.91 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -1.156 . . . . 0.0 109.504 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.8 t -175.83 145.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.953 -1.092 . . . . 0.0 110.267 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.6 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.0 m-85 -111.71 -67.76 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.153 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER 69.66 11.84 7.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 110.4 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 48.13 91.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.169 -0.957 . . . . 0.0 109.867 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.417 -179.392 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 8.9 m-20 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.009 0.433 . . . . 0.0 109.855 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.11 -148.51 19.93 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.63 134.87 50.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -1.084 . . . . 0.0 110.508 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.6 ' O ' ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -132.65 -29.35 1.53 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.096 -1.002 . . . . 0.0 111.023 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 4' ' ' CYS . 92.7 m 65.96 7.58 4.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.3 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.535 ' H ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER 67.31 -59.31 0.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.367 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.504 ' N ' ' CG ' ' A' ' 6' ' ' ASN . 21.3 m -162.17 -37.8 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.59 42.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.462 -0.774 . . . . 0.0 109.916 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 25' ' ' CYS . 97.7 p -129.2 -74.92 0.55 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.03 -1.044 . . . . 0.0 110.951 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.427 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -161.58 -57.75 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.917 -1.115 . . . . 0.0 111.198 -179.249 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.885 HD11 ' OG ' ' A' ' 15' ' ' SER . 19.2 tp 52.61 89.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.118 -0.989 . . . . 0.0 108.958 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -41.08 141.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.573 -0.704 . . . . 0.0 110.509 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.39 -17.11 4.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 110.458 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 17.5 p30 -94.01 -8.89 38.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 110.885 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.885 ' OG ' HD11 ' A' ' 11' ' ' LEU . 1.1 t -66.78 -174.59 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.858 -1.151 . . . . 0.0 109.213 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -122.39 159.88 26.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 110.252 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.3 t -151.79 111.97 4.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -175.43 125.1 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.804 . . . . 0.0 109.798 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt 51.74 55.32 9.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.754 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.491 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -140.35 161.97 36.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.0 110.719 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 36' ' ' THR . 2.9 t -135.43 61.77 1.65 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 109.248 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 22' ' ' LEU . 3.0 mt -74.26 176.96 6.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 111.167 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 24' ' ' ASN . 3.1 m -164.13 118.86 1.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.468 -0.77 . . . . 0.0 109.841 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.535 ' O ' ' N ' ' A' ' 39' ' ' GLY . 27.3 m120 50.43 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.337 -0.852 . . . . 0.0 109.646 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -157.81 -160.38 0.91 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.59 -1.318 . . . . 0.0 110.913 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.512 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 13.8 t80 -164.29 34.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.789 ' HB ' HD12 ' A' ' 11' ' ' LEU . 5.0 t -33.05 151.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.536 0.684 . . . . 0.0 110.783 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 1.3 t70 -153.21 118.78 5.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 44' ' ' GLY . 6.4 mtpm? 48.11 72.88 0.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.422 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 45.3 m -157.71 157.92 34.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.973 -1.079 . . . . 0.0 111.095 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 3.8 mt-10 -120.58 119.75 33.82 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.567 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 46.9 t -123.04 156.32 28.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.101 -0.999 . . . . 0.0 110.623 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 32' ' ' VAL . 48.2 m-85 -154.42 32.14 0.42 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.186 -0.946 . . . . 0.0 111.223 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 162.28 -31.2 0.3 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.669 HG22 ' H ' ' A' ' 37' ' ' CYS . 19.3 m -38.66 162.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.516 -0.991 . . . . 0.0 111.541 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -104.65 -13.43 15.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.4 -0.812 . . . . 0.0 110.648 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.669 ' H ' HG22 ' A' ' 35' ' ' THR . 0.1 OUTLIER 38.59 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.266 -0.896 . . . . 0.0 110.932 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.5 m -105.09 94.31 5.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.122 -0.986 . . . . 0.0 109.975 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 48.25 26.73 4.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.514 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -104.79 -166.09 1.2 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.175 -1.191 . . . . 0.0 110.361 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HG2' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -164.85 155.57 14.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 110.388 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.788 ' HD2' HG13 ' A' ' 27' ' ' VAL . 7.4 m-85 -120.62 -175.06 2.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.338 -0.851 . . . . 0.0 109.403 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -165.95 46.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.139 -0.976 . . . . 0.0 109.932 179.46 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 121.65 53.34 0.22 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -132.94 -175.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.801 -1.411 . . . . 0.0 110.885 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.527 ' O ' HG22 ' A' ' 46' ' ' THR . 88.0 m -151.39 59.17 0.89 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.712 -0.618 . . . . 0.0 109.778 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 50' ' ' SER . 7.9 tt -81.0 167.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.767 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 50' ' ' SER . 54.3 p -139.36 -128.2 0.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.063 -1.023 . . . . 0.0 109.844 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 66' ' ' THR . 88.4 m -65.96 73.28 0.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.971 -1.08 . . . . 0.0 109.521 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.522 ' HB2' HD11 ' A' ' 47' ' ' ILE . 73.2 m -133.52 135.35 44.35 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.483 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 67' ' ' CYS . 1.6 m -88.62 139.09 30.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 53.9 p -153.69 130.08 10.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.412 -0.805 . . . . 0.0 110.075 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -111.54 112.4 24.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.008 -1.057 . . . . 0.0 109.696 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 50.53 90.76 0.01 OUTLIER Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.494 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 95.7 p -156.74 123.47 5.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.374 -1.074 . . . . 0.0 109.643 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.6 ttt180 -85.54 100.7 12.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.962 . . . . 0.0 110.69 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 64' ' ' ILE . 2.9 mt -89.11 23.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.487 -0.758 . . . . 0.0 110.446 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -43.75 155.28 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.915 -1.115 . . . . 0.0 109.711 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 165.88 143.61 3.8 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.195 -1.478 . . . . 0.0 110.325 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.01 -19.37 23.18 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.061 1.559 . . . . 0.0 110.276 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.5 36.95 0.52 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.44 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -57.88 160.38 4.69 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -1.045 . . . . 0.0 111.505 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.554 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 30.3 tttp -160.51 114.02 2.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.584 -0.698 . . . . 0.0 109.822 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.686 ' CD1' HG21 ' A' ' 57' ' ' ILE . 12.1 mt -128.77 155.28 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.825 -1.172 . . . . 0.0 111.477 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.44 126.16 6.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.503 ' N ' ' OG ' ' A' ' 50' ' ' SER . 0.7 OUTLIER 51.97 77.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 110.638 -179.291 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' A' ' 64' ' ' ILE . 89.5 m -138.9 118.41 12.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.134 -0.979 . . . . 0.0 109.63 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.812 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.5 mp -90.98 80.87 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 118.836 -1.146 . . . . 0.0 108.868 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 73' ' ' VAL . 18.6 mt -89.91 159.27 2.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.294 0.569 . . . . 0.0 110.544 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.629 ' O ' HG22 ' A' ' 73' ' ' VAL . 18.2 m -158.28 97.82 1.53 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 110.421 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 94.63 16.78 41.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 87' ' ' PHE . . . 91.53 16.01 53.63 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 70' ' ' THR . 14.2 m -124.32 132.94 24.36 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.423 -1.046 . . . . 0.0 110.124 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.447 ' HB3' HD11 ' A' ' 82' ' ' ILE . 52.1 Cg_endo -81.24 137.39 10.61 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.93 1.49 . . . . 0.0 110.65 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -90.75 159.16 41.23 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.91 . . . . 0.0 109.794 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.5 66.66 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.787 1.414 . . . . 0.0 110.282 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 78' ' ' ALA . 18.6 t -80.52 4.53 18.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.235 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 41.73 31.07 0.18 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 110.004 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -151.35 -38.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 44.8 t -49.52 170.45 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.311 -0.868 . . . . 0.0 108.849 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.554 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -106.99 -39.52 5.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.95 -1.094 . . . . 0.0 111.689 -178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.494 ' CA ' ' HE3' ' A' ' 81' ' ' LYS . 43.0 mm 43.62 68.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.879 -1.138 . . . . 0.0 109.501 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.445 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 45.1 t -125.38 -116.03 0.28 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 110.48 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -68.68 59.92 0.48 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.517 ' SG ' HD11 ' A' ' 64' ' ' ILE . 3.6 t -163.32 -171.76 2.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.265 . . . . 0.0 110.814 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.57 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.9 t 176.62 170.04 0.48 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.46 -0.775 . . . . 0.0 109.772 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -134.05 149.01 51.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.005 -1.06 . . . . 0.0 110.079 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 t -129.73 30.5 4.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.273 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 47.75 61.79 2.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.985 . . . . 0.0 110.065 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.288 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.501 ' OD2' ' N ' ' A' ' 2' ' ' GLY . 3.6 p-10 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.17 0.51 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.501 ' N ' ' OD2' ' A' ' 1' ' ' ASP . . . -69.54 88.52 0.27 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 19.7 m 48.29 -140.24 0.66 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.23 -1.159 . . . . 0.0 110.784 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.597 ' C ' ' HG1' ' A' ' 5' ' ' THR . 2.9 t 71.59 145.08 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.305 -0.872 . . . . 0.0 110.244 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.644 HG23 ' HB2' ' A' ' 9' ' ' SER . 20.1 m -172.73 169.92 4.82 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.597 ' N ' HG22 ' A' ' 5' ' ' THR . 0.5 OUTLIER -143.08 64.35 1.36 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.189 -0.944 . . . . 0.0 109.865 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.467 ' OG1' ' N ' ' A' ' 24' ' ' ASN . 2.1 m 67.52 18.84 10.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.562 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.5 OUTLIER 178.17 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.727 -0.608 . . . . 0.0 110.151 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.644 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.3 OUTLIER 78.8 85.35 0.06 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.823 -0.548 . . . . 0.0 110.701 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -127.98 17.87 6.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.097 -1.002 . . . . 0.0 109.494 179.069 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.568 ' CD1' ' HB3' ' A' ' 15' ' ' SER . 6.7 tp -47.74 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.752 -0.592 . . . . 0.0 109.772 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 10' ' ' GLN . 4.9 t -38.24 137.0 0.59 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.059 -0.657 . . . . 0.0 109.866 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.1 -17.51 0.43 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.21 -0.931 . . . . 0.0 111.289 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -90.72 -3.36 57.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.005 -1.06 . . . . 0.0 110.342 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.71 ' OG ' HG12 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -89.03 -157.48 0.45 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.098 -1.001 . . . . 0.0 110.054 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 8.4 tttm -165.7 156.27 13.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 110.057 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 40.7 t -144.14 156.41 44.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 110.48 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER 174.02 104.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.697 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 74.08 14.94 3.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.83 . . . . 0.0 110.052 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.433 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -102.48 165.97 10.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 0.0 110.474 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' CB ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -113.82 -43.65 3.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.429 -0.794 . . . . 0.0 110.121 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 5' ' ' THR . 1.1 tp 62.24 159.03 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.062 -1.024 . . . . 0.0 110.479 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' CYS . 1.7 m -174.61 117.66 0.2 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.413 -0.804 . . . . 0.0 109.256 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.467 ' N ' ' OG1' ' A' ' 7' ' ' THR . 26.1 m120 53.59 63.19 2.3 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.565 ' C ' ' CG ' ' A' ' 26' ' ' TYR . 1.3 m -146.21 -166.66 2.53 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.736 0.779 . . . . 0.0 111.096 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CG ' ' C ' ' A' ' 25' ' ' CYS . 11.0 m-85 -155.13 -40.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.831 HG13 ' HD2' ' A' ' 42' ' ' PHE . 11.8 t 56.39 137.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.643 0.735 . . . . 0.0 111.618 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 0.4 OUTLIER -151.6 130.72 12.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.53 -0.731 . . . . 0.0 109.816 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 34.8 mttp 54.31 37.5 27.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.116 -0.99 . . . . 0.0 109.098 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.605 ' HB3' HG22 ' A' ' 45' ' ' VAL . 8.3 m -126.59 169.62 12.9 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.487 -0.758 . . . . 0.0 110.353 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.91 ' OE1' HG23 ' A' ' 46' ' ' THR . 1.2 tt0 -113.02 -63.03 1.5 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.432 -0.793 . . . . 0.0 110.126 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 5.4 t 62.58 144.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -0.865 . . . . 0.0 110.141 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.501 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 42.4 m-85 -152.4 34.23 0.51 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 110.629 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 19' ' ' LYS . . . 156.28 -31.32 0.59 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 50' ' ' SER . 8.9 m -40.34 151.02 0.05 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.462 -1.023 . . . . 0.0 111.072 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.416 ' O ' ' CA ' ' A' ' 22' ' ' LEU . 76.1 m -97.49 -16.55 20.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.423 -0.798 . . . . 0.0 109.261 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.482 ' H ' HG22 ' A' ' 35' ' ' THR . 1.6 t 52.21 83.68 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.572 -0.705 . . . . 0.0 110.057 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 m -93.71 102.62 14.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.37 -0.831 . . . . 0.0 110.303 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.12 61.51 5.33 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 45.2 t -150.81 -168.91 3.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -1.112 . . . . 0.0 109.914 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' A' ' 42' ' ' PHE . 5.2 ttt180 -168.75 156.4 7.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.09 -1.006 . . . . 0.0 110.03 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.831 ' HD2' HG13 ' A' ' 27' ' ' VAL . 5.5 m-85 -117.93 179.35 4.11 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.273 -0.892 . . . . 0.0 110.161 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -168.14 41.1 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.401 -0.812 . . . . 0.0 109.474 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 59' ' ' GLY . . . 129.16 53.96 0.11 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.605 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -129.03 -165.84 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.065 -1.256 . . . . 0.0 110.324 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.91 HG23 ' OE1' ' A' ' 31' ' ' GLU . 23.5 m -163.44 57.9 0.18 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.683 HD11 ' CB ' ' A' ' 50' ' ' SER . 10.4 tt -86.01 172.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.641 0.734 . . . . 0.0 111.695 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' SER . 32.7 p -129.93 -156.32 0.75 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.508 -0.745 . . . . 0.0 109.327 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.572 ' O ' HG22 ' A' ' 49' ' ' THR . 3.6 m -48.5 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.813 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.683 ' CB ' HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -125.24 140.29 52.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.636 -1.29 . . . . 0.0 110.488 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 51' ' ' THR . 14.7 m -86.88 18.36 3.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.142 -0.974 . . . . 0.0 110.732 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.495 ' HA ' ' HB ' ' A' ' 69' ' ' ILE . 12.4 p -39.06 114.45 0.4 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.314 -0.866 . . . . 0.0 111.006 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.2 m -112.02 93.34 4.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.0 109.387 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 82.99 77.47 1.09 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.564 ' CB ' ' HB3' ' A' ' 87' ' ' PHE . 1.6 p -156.26 123.03 5.2 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.273 -1.134 . . . . 0.0 110.974 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -87.16 103.09 15.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 109.884 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 57' ' ' ILE . 2.8 mp -89.03 14.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.056 -1.028 . . . . 0.0 110.122 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -42.58 141.45 1.02 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.335 -0.853 . . . . 0.0 109.789 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.491 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . 172.89 155.5 11.53 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.185 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.56 -2.61 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.173 1.617 . . . . 0.0 110.566 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.28 31.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -49.63 128.41 17.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 110.336 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -114.75 127.81 55.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.427 -0.796 . . . . 0.0 110.528 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.578 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 4.6 mt -138.99 149.87 23.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.139 -0.976 . . . . 0.0 109.853 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 81' ' ' LYS . 83.8 p -147.04 106.04 3.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.051 -1.031 . . . . 0.0 110.699 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.0 m 50.96 73.06 0.31 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 111.583 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.574 ' HB3' HD11 ' A' ' 69' ' ' ILE . 14.6 t -129.1 119.92 25.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.475 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 69' ' ' ILE . 1.7 mp -48.32 -75.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 109.918 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.934 HD13 ' CZ ' ' A' ' 87' ' ' PHE . 10.8 mt 62.81 140.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 0.0 109.683 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.771 ' O ' HG22 ' A' ' 73' ' ' VAL . 81.3 m -165.74 101.8 0.68 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.118 -0.989 . . . . 0.0 111.315 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.85 23.73 24.82 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.58 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 85.19 8.92 80.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 70' ' ' THR . 20.3 m -112.48 121.89 37.78 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.55 -0.971 . . . . 0.0 109.814 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.27 124.09 6.99 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.712 1.375 . . . . 0.0 110.381 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -86.22 139.34 34.29 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.879 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.68 91.99 0.79 Allowed 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.105 1.582 . . . . 0.0 111.035 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.46 147.35 45.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.107 -0.996 . . . . 0.0 110.464 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.76 -12.11 32.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 110.543 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' SER . . . -103.82 -18.14 14.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.93 . . . . 0.0 110.664 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 14.1 t -71.9 157.95 36.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.147 -0.971 . . . . 0.0 109.939 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.558 ' HE3' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -101.53 -11.78 19.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.028 -1.045 . . . . 0.0 112.925 -177.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 81' ' ' LYS . 26.7 mm 26.41 50.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.443 -0.786 . . . . 0.0 111.423 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.6 m -108.21 -157.67 0.62 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.867 -1.146 . . . . 0.0 110.946 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.25 98.63 0.17 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.498 ' SG ' HG23 ' A' ' 57' ' ' ILE . 3.7 t -170.87 -168.43 0.66 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.354 -1.086 . . . . 0.0 109.662 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 2.7 t -177.03 158.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.919 -1.113 . . . . 0.0 109.653 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.934 ' CZ ' HD13 ' A' ' 69' ' ' ILE . 10.4 m-85 -118.95 -49.44 2.42 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 110.548 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 89' ' ' ALA . 15.4 m 61.89 11.92 4.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.283 -0.885 . . . . 0.0 109.858 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 88' ' ' SER . . . 57.15 119.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.439 -0.788 . . . . 0.0 110.392 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 1.6 t-20 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.183 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.297 0.57 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.19 -177.56 35.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.6 m -129.33 45.07 2.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -1.132 . . . . 0.0 110.032 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 5' ' ' THR . 6.8 m -78.19 -61.4 2.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 109.84 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.952 HG23 ' HB2' ' A' ' 9' ' ' SER . 3.2 m 76.91 -13.78 0.9 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.878 -0.514 . . . . 0.0 111.398 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 24' ' ' ASN . 13.6 p30 35.82 40.61 0.09 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.065 -1.022 . . . . 0.0 110.611 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER 70.8 35.37 1.78 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.109 -0.995 . . . . 0.0 111.195 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.666 ' H ' HG22 ' A' ' 5' ' ' THR . 0.7 OUTLIER 168.93 -42.32 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.932 -1.105 . . . . 0.0 110.602 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.952 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.2 OUTLIER 73.16 89.55 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.467 -0.771 . . . . 0.0 110.751 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -131.24 18.33 4.92 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.155 -0.966 . . . . 0.0 109.565 179.127 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.866 HD12 ' CB ' ' A' ' 15' ' ' SER . 1.6 mm? -39.42 101.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.544 0.687 . . . . 0.0 110.251 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.519 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -87.0 163.02 17.3 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.641 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' HB3' ' C ' ' A' ' 28' ' ' ASP . . . 49.43 -157.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.068 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 14' ' ' ASN . 19.9 p-10 -90.49 57.58 3.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 111.482 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.866 ' CB ' HD12 ' A' ' 11' ' ' LEU . 22.0 p -58.54 -168.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.832 -1.167 . . . . 0.0 110.249 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.501 ' CB ' ' HG2' ' A' ' 31' ' ' GLU . 34.8 tttt -154.32 146.93 24.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.05 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.58 167.52 16.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.074 -1.016 . . . . 0.0 110.709 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -176.3 -154.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.504 -0.747 . . . . 0.0 109.651 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.44 54.09 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.017 . . . . 0.0 110.033 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 33' ' ' TYR . 7.9 t -111.99 168.63 9.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.223 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.62 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -104.67 105.92 16.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 109.709 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.62 HD22 ' C ' ' A' ' 21' ' ' THR . 4.3 mm? -107.93 145.8 33.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.774 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 15.7 m -161.13 118.83 2.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 0.0 109.615 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 6' ' ' ASN . 26.5 m-20 59.01 64.07 1.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 110.057 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 6' ' ' ASN . 0.6 OUTLIER -142.67 169.93 16.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.916 . . . . 0.0 110.581 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 13.5 m-85 -129.13 -40.83 1.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.725 HG13 ' HD2' ' A' ' 42' ' ' PHE . 3.6 t 47.24 112.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.586 0.707 . . . . 0.0 112.017 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.519 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -98.13 -91.91 0.26 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.157 -0.964 . . . . 0.0 109.219 178.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -93.63 68.85 4.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.079 -1.013 . . . . 0.0 109.632 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.664 ' HB3' HG22 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -135.76 -172.98 3.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 110.604 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.643 ' C ' HG23 ' A' ' 32' ' ' VAL . 9.5 mt-10 -137.72 -66.4 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.396 -0.815 . . . . 0.0 110.242 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.643 HG23 ' C ' ' A' ' 31' ' ' GLU . 2.5 t 69.99 150.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.348 -0.845 . . . . 0.0 110.371 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.922 ' CD2' HG22 ' A' ' 48' ' ' THR . 51.0 m-85 -138.68 -46.39 0.49 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.192 -0.942 . . . . 0.0 110.687 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.4 18.36 3.27 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.551 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 33.0 m -67.37 162.14 23.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.181 -1.188 . . . . 0.0 110.369 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 21' ' ' THR . 6.4 m -121.11 64.93 0.87 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.511 ' O ' ' HB ' ' A' ' 23' ' ' THR . 5.3 t -42.42 97.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.495 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 38' ' ' THR . 27.9 m -89.95 20.36 4.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.98 -1.075 . . . . 0.0 109.622 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.16 47.1 0.19 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.592 ' HA ' HD22 ' A' ' 90' ' ' ASN . 53.9 p -126.54 -156.11 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 110.443 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.62 ' HG2' HD21 ' A' ' 90' ' ' ASN . 1.1 ptt85 -169.77 153.8 5.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.894 . . . . 0.0 110.199 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.725 ' HD2' HG13 ' A' ' 27' ' ' VAL . 4.2 m-85 -121.63 -175.11 3.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 110.172 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER 178.59 61.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.982 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 111.1 52.01 0.58 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.664 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.01 -167.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.969 -1.312 . . . . 0.0 110.627 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.549 ' N ' HG23 ' A' ' 45' ' ' VAL . 32.8 m -160.85 54.81 0.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 50' ' ' SER . 17.3 tt -85.08 169.61 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.461 -0.774 . . . . 0.0 110.33 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.922 HG22 ' CD2' ' A' ' 33' ' ' TYR . 41.7 p -135.78 -127.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.307 -0.87 . . . . 0.0 109.962 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.611 ' O ' HG22 ' A' ' 49' ' ' THR . 38.3 m -69.74 72.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.907 -1.12 . . . . 0.0 110.398 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.619 ' HB2' HD11 ' A' ' 47' ' ' ILE . 57.8 m -130.06 136.31 49.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -95.81 117.77 31.2 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.107 -0.996 . . . . 0.0 109.788 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 1.5 m -125.2 137.73 54.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 109.845 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.508 ' HB ' HG23 ' A' ' 70' ' ' THR . 1.0 OUTLIER -115.35 126.37 54.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.046 -1.034 . . . . 0.0 110.535 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 43.64 50.67 6.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 7.8 p -127.33 141.52 51.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -1.112 . . . . 0.0 110.187 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -99.41 101.53 12.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 110.067 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 57' ' ' ILE . 3.0 mp -82.15 7.64 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 m -56.15 163.3 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.056 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.0 155.7 7.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.03 55.37 2.85 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.054 1.555 . . . . 0.0 110.27 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.79 17.19 3.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -45.79 136.57 6.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -1.194 . . . . 0.0 110.518 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.525 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -140.98 120.22 12.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.195 -0.941 . . . . 0.0 110.033 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.562 ' CD1' HG23 ' A' ' 57' ' ' ILE . 21.6 mt -135.39 164.95 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.99 -1.069 . . . . 0.0 111.187 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.481 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -155.46 115.6 3.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.567 -0.708 . . . . 0.0 109.498 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.6 m 53.29 86.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.057 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.409 ' H ' ' CB ' ' A' ' 50' ' ' SER . 54.4 m -150.4 99.9 2.82 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.303 -0.873 . . . . 0.0 109.986 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.823 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.7 mp -67.6 96.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.98 -1.075 . . . . 0.0 109.445 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 73' ' ' VAL . 9.6 mt -104.2 160.75 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.953 . . . . 0.0 110.717 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.913 ' O ' HG22 ' A' ' 73' ' ' VAL . 25.5 m -163.38 110.07 1.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 109.983 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.83 20.47 55.79 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.569 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 86.58 12.22 69.91 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.913 HG22 ' O ' ' A' ' 70' ' ' THR . 6.5 m -118.65 138.34 25.8 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.41 -1.053 . . . . 0.0 110.292 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -80.64 154.05 20.51 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.939 1.494 . . . . 0.0 110.106 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.823 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -83.31 162.36 54.2 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 110.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.3 Cg_endo -74.46 53.43 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.119 1.589 . . . . 0.0 110.281 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.9 m -103.85 138.65 40.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 110.274 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.09 -23.81 35.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 110.23 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.98 6.04 17.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.428 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 66' ' ' THR . 1.2 t -100.76 154.14 18.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.937 . . . . 0.0 109.874 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.559 ' CD ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.56 -168.98 1.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 110.927 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.742 HG23 ' O ' ' A' ' 82' ' ' ILE . 2.1 tp 179.03 33.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.8 0.809 . . . . 0.0 109.201 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -62.21 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.454 -0.779 . . . . 0.0 111.266 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.95 82.82 0.34 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.704 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.549 ' SG ' HD11 ' A' ' 64' ' ' ILE . 1.8 t -144.82 -152.47 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 110.055 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER 172.9 148.44 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 109.893 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 1.4 m-85 -119.08 -28.31 5.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.346 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.778 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 68.0 m 52.85 -90.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.944 -1.098 . . . . 0.0 109.482 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.778 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . 157.41 74.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.269 0.557 . . . . 0.0 109.725 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.62 HD21 ' HG2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.034 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.331 0.586 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.06 48.55 0.05 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -152.11 63.51 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -1.128 . . . . 0.0 110.241 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.45 ' O ' ' OG1' ' A' ' 5' ' ' THR . 55.8 m -108.8 -117.34 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 109.836 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.988 HG22 ' H ' ' A' ' 8' ' ' ASN . 86.7 m -166.78 -36.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.889 -1.132 . . . . 0.0 109.335 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.554 ' HB3' ' CB ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER 49.94 68.05 0.81 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.493 -0.754 . . . . 0.0 109.309 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 7' ' ' THR . 95.7 m 50.41 42.71 26.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 109.4 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.988 ' H ' HG22 ' A' ' 5' ' ' THR . 1.3 t-20 70.2 83.58 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.42 -0.8 . . . . 0.0 109.81 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 5' ' ' THR . 3.0 m -138.84 -95.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.201 -0.937 . . . . 0.0 110.421 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER 173.28 -44.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.07 -1.019 . . . . 0.0 110.049 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 24.5 tp 48.91 89.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.061 -1.024 . . . . 0.0 109.994 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.564 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -44.48 156.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.747 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.91 -8.71 39.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.0 109.903 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -97.65 -10.32 25.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.325 -0.859 . . . . 0.0 110.135 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -78.18 -158.71 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -141.27 147.11 37.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 t -127.55 85.77 2.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 0.0 110.014 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' LYS . 21.1 tt0 -132.45 84.66 2.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 110.526 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' GLU . 1.2 mttp 52.41 104.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.326 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 21' ' ' THR . 35.3 t -158.95 -158.72 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 110.192 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 35' ' ' THR . 0.3 OUTLIER -152.48 86.57 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.277 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.554 ' CB ' ' HB3' ' A' ' 6' ' ' ASN . 4.0 mp -109.46 116.77 32.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.129 -0.982 . . . . 0.0 110.133 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.575 HG23 HG21 ' A' ' 7' ' ' THR . 85.8 m -104.29 119.67 39.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -0.956 . . . . 0.0 110.114 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 23' ' ' THR . 11.8 m-20 56.93 22.2 6.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.987 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.472 ' SG ' ' HG ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -71.2 -145.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 110.42 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.506 ' O ' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -179.34 -50.67 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 26' ' ' TYR . 2.6 t 52.05 121.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.775 0.798 . . . . 0.0 111.41 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.564 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 3.2 t70 -111.49 -25.74 9.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 110.191 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.533 ' CD ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -166.65 58.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 109.955 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.892 ' OG ' HG22 ' A' ' 45' ' ' VAL . 16.9 m -132.89 154.83 50.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 111.237 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.61 96.35 6.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.619 -0.676 . . . . 0.0 109.192 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.554 HG11 HD11 ' A' ' 22' ' ' LEU . 12.0 t -91.03 164.52 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 110.941 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.566 ' HB2' HG22 ' A' ' 48' ' ' THR . 20.5 m-85 -143.19 -36.6 0.37 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . -159.37 29.37 0.4 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' SER . 15.5 m -77.06 159.67 29.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.298 -1.119 . . . . 0.0 110.624 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -112.45 53.36 0.74 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.441 -0.787 . . . . 0.0 109.695 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 5.1 t -39.48 103.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.487 -0.758 . . . . 0.0 110.839 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.531 HG22 ' O ' ' A' ' 38' ' ' THR . 23.4 m -103.56 79.37 1.68 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.989 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.51 69.22 1.43 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.55 ' HG ' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -161.27 -148.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -1.099 . . . . 0.0 110.184 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 40' ' ' SER . 1.3 ttp180 172.79 158.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.917 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CD1' ' CG1' ' A' ' 57' ' ' ILE . 2.5 m-85 -121.72 -173.2 2.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 0.0 110.166 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -173.65 57.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.252 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 117.17 47.71 0.46 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.892 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.73 -166.15 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.724 -1.457 . . . . 0.0 111.156 -179.288 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.56 ' N ' HG23 ' A' ' 45' ' ' VAL . 22.1 m -156.16 58.16 0.58 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.339 0.59 . . . . 0.0 109.433 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.75 HD11 ' OG ' ' A' ' 50' ' ' SER . 11.1 tt -84.76 154.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 111.239 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.595 ' C ' HG23 ' A' ' 49' ' ' THR . 72.8 p -148.98 148.5 29.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.605 -0.684 . . . . 0.0 109.913 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.595 HG23 ' C ' ' A' ' 48' ' ' THR . 0.1 OUTLIER 43.28 33.32 0.57 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.009 -1.057 . . . . 0.0 110.772 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.75 ' OG ' HD11 ' A' ' 47' ' ' ILE . 28.3 t -100.77 128.79 46.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.904 -1.122 . . . . 0.0 110.059 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 52' ' ' SER . 3.4 m -92.48 22.35 4.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 110.417 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -40.4 125.62 2.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.427 -0.796 . . . . 0.0 110.868 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 1.6 m -106.95 94.81 5.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 109.511 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.55 ' HA2' ' HG ' ' A' ' 40' ' ' SER . . . 72.45 77.09 0.58 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.501 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 1.3 p -147.2 117.53 7.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.352 -1.087 . . . . 0.0 110.366 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.548 ' CG ' ' HB2' ' A' ' 90' ' ' ASN . 2.8 ttt-85 -68.4 107.25 2.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.665 ' O ' HG11 ' A' ' 45' ' ' VAL . 15.2 mm -88.44 0.22 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.108 -0.995 . . . . 0.0 109.763 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -40.41 125.0 2.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.385 -0.822 . . . . 0.0 110.424 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -167.1 144.77 9.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.05 81.47 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.927 1.488 . . . . 0.0 109.952 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.0 15.73 53.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.647 ' SG ' HD11 ' A' ' 64' ' ' ILE . 15.7 t -44.18 164.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.334 -1.098 . . . . 0.0 111.221 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 62' ' ' CYS . 8.0 ttpp -150.45 114.03 4.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.483 -0.76 . . . . 0.0 110.168 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.647 HD11 ' SG ' ' A' ' 62' ' ' CYS . 4.4 mt -129.83 155.95 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.911 -1.118 . . . . 0.0 111.012 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.453 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -156.01 120.48 4.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.311 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 48' ' ' THR . 9.4 m 44.55 71.49 0.25 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -0.845 . . . . 0.0 111.008 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 98.1 m -122.58 120.8 34.86 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.407 -0.808 . . . . 0.0 109.64 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.841 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.3 mp -88.92 86.02 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.103 -0.998 . . . . 0.0 109.777 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.767 HG23 ' C ' ' A' ' 73' ' ' VAL . 3.7 mt -102.49 157.22 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.435 -0.791 . . . . 0.0 110.356 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.815 ' O ' HG22 ' A' ' 73' ' ' VAL . 53.6 m -153.95 105.49 2.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 0.0 110.24 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 88.02 17.27 58.08 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.565 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 92.36 13.49 57.16 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 70' ' ' THR . 12.9 m -121.76 129.2 25.27 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.454 -1.027 . . . . 0.0 110.436 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -81.24 132.76 8.37 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.928 1.489 . . . . 0.0 110.822 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 77' ' ' SER . . . -76.28 161.08 76.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.262 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.7 64.41 1.24 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.765 1.403 . . . . 0.0 109.953 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.9 t -99.58 118.08 35.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 0.0 110.242 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.62 -4.6 24.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 110.006 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.59 -19.13 18.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.854 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.855 ' SG ' HD12 ' A' ' 82' ' ' ILE . 26.0 t -68.6 165.48 19.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.09 -1.006 . . . . 0.0 109.934 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.599 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -105.14 7.21 33.67 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.289 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.855 HD12 ' SG ' ' A' ' 80' ' ' CYS . 0.9 OUTLIER -15.01 82.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.543 0 CA-C-N 118.909 0.777 . . . . 0.0 111.56 -178.277 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -128.89 -70.21 0.68 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 111.308 -178.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -129.21 86.87 0.31 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.173 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 86' ' ' THR . 3.8 t -177.05 -150.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -1.161 . . . . 0.0 110.084 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 85' ' ' CYS . 1.7 t 174.0 161.87 0.17 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.634 ' CD2' HG21 ' A' ' 69' ' ' ILE . 3.1 m-85 -113.03 -52.56 2.77 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.945 -1.097 . . . . 0.0 110.011 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER 65.22 7.85 4.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 110.312 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 55.65 112.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 110.675 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.548 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . 8.0 t-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.16 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 28.6 p-10 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.155 0.502 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.47 -65.99 0.3 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -123.93 124.91 43.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.171 -1.194 . . . . 0.0 110.216 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' HB3' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -161.58 -157.21 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.123 -0.986 . . . . 0.0 110.453 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.95 HG23 ' O ' ' A' ' 9' ' ' SER . 7.3 m -171.23 35.15 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.981 ' OD1' HD12 ' A' ' 22' ' ' LEU . 8.1 t-20 55.94 -88.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.562 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 3.2 m -142.5 -0.71 1.21 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.573 -0.704 . . . . 0.0 109.744 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.948 HD22 ' HA ' ' A' ' 24' ' ' ASN . 11.6 p-10 173.13 -19.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.534 -0.729 . . . . 0.0 111.061 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.95 ' O ' HG23 ' A' ' 5' ' ' THR . 60.4 p -87.91 -115.9 0.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.908 -1.12 . . . . 0.0 112.448 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' CG ' ' N ' ' A' ' 11' ' ' LEU . 3.9 pt20 -128.36 -43.53 1.44 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.974 -1.079 . . . . 0.0 111.264 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.766 HD12 ' HB ' ' A' ' 27' ' ' VAL . 14.4 tp 59.82 106.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.199 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -35.67 144.26 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.286 0.565 . . . . 0.0 110.747 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -13.78 6.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.421 -0.8 . . . . 0.0 110.13 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' CG ' ' HG ' ' A' ' 12' ' ' SER . 2.4 p-10 -112.53 8.52 19.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 110.71 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.557 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 2.0 t -82.46 -152.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.891 -1.131 . . . . 0.0 109.955 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.464 ' O ' HD21 ' A' ' 11' ' ' LEU . 26.7 tttm -147.19 152.93 39.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.933 -1.104 . . . . 0.0 110.955 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.545 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 9.5 p -142.27 -153.44 0.46 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.313 -0.867 . . . . 0.0 109.911 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' CYS . 14.6 mm-40 57.05 159.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.114 -0.991 . . . . 0.0 110.173 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 44.31 63.21 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.0 109.946 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.737 ' HB2' HD21 ' A' ' 22' ' ' LEU . 68.9 p -170.55 160.95 7.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.441 -0.787 . . . . 0.0 109.834 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.844 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -125.37 104.47 8.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.087 -1.008 . . . . 0.0 108.79 179.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.981 HD12 ' OD1' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -144.2 -168.62 2.92 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.308 -178.515 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 24' ' ' ASN . 1.3 m -177.78 146.66 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.948 ' HA ' HD22 ' A' ' 8' ' ' ASN . 4.3 m-20 45.8 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -0.956 . . . . 0.0 109.871 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 26' ' ' TYR . 60.3 m -140.24 -155.4 0.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.093 -1.005 . . . . 0.0 111.007 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.535 ' CB ' ' O ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER 163.19 43.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.766 ' HB ' HD12 ' A' ' 11' ' ' LEU . 21.6 t -62.11 145.4 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.469 0.652 . . . . 0.0 110.961 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 16.0 m-20 -129.01 3.5 5.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 110.313 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.5 OUTLIER 175.67 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.322 -0.861 . . . . 0.0 109.837 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.809 ' OG ' HG22 ' A' ' 45' ' ' VAL . 54.3 m -165.26 -160.48 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.953 -1.092 . . . . 0.0 110.343 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 2.5 mt-10 -137.66 -62.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 0.0 110.542 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 47' ' ' ILE . 3.9 t 64.61 153.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.892 . . . . 0.0 110.74 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.691 ' CD1' HG22 ' A' ' 48' ' ' THR . 25.9 m-85 -149.86 -77.04 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.504 -0.748 . . . . 0.0 109.336 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 48' ' ' THR . . . -107.95 36.47 4.36 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 36' ' ' THR . 1.0 OUTLIER -82.96 171.79 13.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -1.081 . . . . 0.0 110.46 -179.475 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.528 ' N ' ' CG2' ' A' ' 35' ' ' THR . 1.7 m -119.52 58.81 0.87 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 110.234 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.644 ' HB3' ' CB ' ' A' ' 22' ' ' LEU . 36.2 t -39.03 103.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.443 -0.785 . . . . 0.0 110.579 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 38' ' ' THR . 24.3 m -106.39 75.84 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.981 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.74 49.03 71.47 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 4.9 p -138.9 169.08 18.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -1.119 . . . . 0.0 110.18 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.403 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -147.44 157.44 43.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 109.994 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 41' ' ' ARG . 2.5 m-85 -119.98 -179.44 3.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.154 -0.967 . . . . 0.0 110.454 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -155.71 46.93 0.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 109.47 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 123.94 75.03 0.28 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.809 HG22 ' OG ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -150.28 -168.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.196 -1.179 . . . . 0.0 110.453 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' VAL . 39.9 m -155.28 57.86 0.64 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.572 -0.705 . . . . 0.0 109.332 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.879 HD11 ' HB2' ' A' ' 50' ' ' SER . 11.3 tt -78.33 168.05 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 110.054 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.691 HG22 ' CD1' ' A' ' 33' ' ' TYR . 2.4 p -143.06 -81.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -110.61 39.91 2.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.233 -0.917 . . . . 0.0 109.386 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.879 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -96.31 124.36 40.28 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.351 -0.843 . . . . 0.0 110.943 -179.442 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -71.13 135.66 47.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.355 -0.841 . . . . 0.0 108.963 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.6 p -140.82 119.37 12.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.909 -1.12 . . . . 0.0 110.663 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.401 ' H ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -117.49 70.15 0.78 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 109.43 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 96.01 91.1 1.79 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 87.3 p -171.92 128.09 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -1.202 . . . . 0.0 110.811 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.543 ' CD ' ' HB2' ' A' ' 88' ' ' SER . 1.4 ptp180 -87.71 105.05 17.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 109.365 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.534 HD13 ' N ' ' A' ' 57' ' ' ILE . 5.1 mm -81.66 16.08 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.023 . . . . 0.0 110.992 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.91 156.06 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.025 -1.047 . . . . 0.0 110.038 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.59 143.77 3.77 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.29 -3.35 13.78 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.985 1.519 . . . . 0.0 110.225 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.49 27.65 0.28 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -58.28 141.03 52.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -1.126 . . . . 0.0 110.472 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 6.1 ttpp -151.66 117.04 5.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.529 -0.732 . . . . 0.0 109.2 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.609 ' HA ' ' CD ' ' A' ' 81' ' ' LYS . 2.2 mp -129.36 147.11 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.956 -1.09 . . . . 0.0 111.172 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.541 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -143.2 111.93 6.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 110.181 179.398 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.527 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 19.8 m 51.76 57.54 6.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.647 -0.658 . . . . 0.0 111.108 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 2.0 t -110.46 129.3 55.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.425 -0.797 . . . . 0.0 110.154 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.715 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.0 mp -87.03 93.36 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.029 . . . . 0.0 108.676 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.706 HG21 ' CD2' ' A' ' 87' ' ' PHE . 10.1 mt -106.9 149.55 10.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.392 -0.818 . . . . 0.0 110.489 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.801 ' O ' HG22 ' A' ' 73' ' ' VAL . 7.5 m -156.04 103.81 2.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 110.734 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.5 24.85 27.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 87' ' ' PHE . . . 83.09 17.14 67.86 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 70' ' ' THR . 14.2 m -124.0 128.53 25.06 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.523 -0.986 . . . . 0.0 110.701 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -82.04 130.65 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.904 1.476 . . . . 0.0 110.313 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -93.02 147.3 33.6 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.09 -1.006 . . . . 0.0 110.153 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.24 101.31 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.948 1.499 . . . . 0.0 109.796 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.721 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 40.3 t -111.73 -5.63 14.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 110.72 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 70.45 3.63 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.157 -0.964 . . . . 0.0 109.57 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 80' ' ' CYS . . . -125.65 -34.03 2.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 109.318 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 18.2 t -45.09 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.59 -0.694 . . . . 0.0 109.536 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.609 ' CD ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.96 7.45 46.61 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.961 -1.087 . . . . 0.0 112.357 -178.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.579 ' C ' ' O ' ' A' ' 81' ' ' LYS . 17.6 mm -6.69 73.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 81' ' ' LYS . 43.9 t -124.35 -52.06 1.74 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 109.864 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' CYS . . . -147.82 -114.95 0.81 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' GLY . 2.9 t 44.07 -167.82 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.343 -1.092 . . . . 0.0 109.972 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.467 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.6 OUTLIER 175.18 140.22 0.05 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 110.459 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CD2' HG21 ' A' ' 69' ' ' ILE . 1.6 m-30 -115.69 170.26 8.58 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.4 -0.813 . . . . 0.0 109.677 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.543 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 6.7 m -165.52 25.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 109.644 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.498 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.02 83.41 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.36 -0.837 . . . . 0.0 109.967 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.452 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.317 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.201 0.524 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.88 -121.78 5.35 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 p -59.62 -38.9 82.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -1.158 . . . . 0.0 110.163 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.454 ' O ' ' OG1' ' A' ' 5' ' ' THR . 6.9 t -44.9 141.75 2.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.155 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.785 HG21 ' HA ' ' A' ' 9' ' ' SER . 9.0 m -171.87 -84.69 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.701 HD22 HD23 ' A' ' 22' ' ' LEU . 4.3 p30 166.13 71.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.684 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.676 HG21 ' OD1' ' A' ' 24' ' ' ASN . 3.9 m 63.06 -70.94 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.476 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.729 ' ND2' ' CD2' ' A' ' 26' ' ' TYR . 5.0 t30 -52.22 -47.23 65.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 109.737 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.785 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.3 OUTLIER 74.14 50.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.525 -0.735 . . . . 0.0 112.116 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.665 ' HB3' ' ND2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -109.13 -29.78 8.36 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.867 -1.146 . . . . 0.0 108.289 178.085 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 10' ' ' GLN . 14.2 tp 10.2 107.24 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.356 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.624 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -39.56 155.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.636 -0.665 . . . . 0.0 110.328 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.28 -8.46 25.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 110.203 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.7 -9.39 6.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.09 -1.006 . . . . 0.0 110.454 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.697 ' OG ' HG12 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -66.24 -161.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.865 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 24.6 tttt -165.34 150.28 9.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.126 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 p -126.02 -35.93 2.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.917 . . . . 0.0 110.242 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 58.14 -162.77 0.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.765 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -87.86 62.66 7.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.861 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.531 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 77.9 p -97.63 -172.25 2.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 110.743 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.5 ' C ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -106.65 10.74 30.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.701 HD23 HD22 ' A' ' 6' ' ' ASN . 2.3 tp -37.95 159.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.496 0.665 . . . . 0.0 110.814 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 94.6 m -162.36 123.69 2.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.69 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.676 ' OD1' HG21 ' A' ' 7' ' ' THR . 3.1 m120 56.52 60.51 3.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 110.314 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.598 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -120.59 -157.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 110.448 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.729 ' CD2' ' ND2' ' A' ' 8' ' ' ASN . 47.2 m-85 -154.82 -55.98 0.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.697 HG12 ' OG ' ' A' ' 15' ' ' SER . 2.4 t 57.72 119.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.477 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.624 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 4.1 m-20 -112.58 -24.68 9.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.49 -0.756 . . . . 0.0 109.817 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 28' ' ' ASP . 5.1 mtpp -163.41 59.23 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.528 -0.732 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.927 ' OG ' HG22 ' A' ' 45' ' ' VAL . 39.1 m -139.88 153.53 47.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.026 . . . . 0.0 111.562 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' OE2' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -115.9 112.2 21.54 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.566 HG11 HD13 ' A' ' 22' ' ' LEU . 7.0 t -106.84 159.06 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -0.957 . . . . 0.0 110.93 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.567 ' CD1' HG22 ' A' ' 48' ' ' THR . 46.1 m-85 -130.91 -36.41 1.36 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.354 -0.841 . . . . 0.0 110.946 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -151.0 12.76 0.83 Allowed Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.582 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' SER . 27.5 m -62.44 162.13 10.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.989 -1.301 . . . . 0.0 110.648 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.5 ' HA ' ' C ' ' A' ' 21' ' ' THR . 19.9 m -109.94 -22.52 11.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.358 -0.839 . . . . 0.0 110.266 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.496 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 4.0 t 42.24 81.13 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.24 -0.913 . . . . 0.0 110.42 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 38' ' ' THR . 88.8 m -77.06 57.2 1.34 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 109.421 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.39 74.11 1.28 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -157.35 -161.77 1.11 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.261 -1.14 . . . . 0.0 110.008 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 10.7 ptt180 -167.56 162.33 14.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.031 . . . . 0.0 110.658 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.601 ' CE1' HD13 ' A' ' 57' ' ' ILE . 2.6 m-85 -120.31 -162.72 0.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.371 -0.831 . . . . 0.0 110.217 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER 171.98 53.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 29' ' ' LYS . . . 117.27 56.49 0.3 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.927 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.3 m -139.35 -164.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.09 -1.241 . . . . 0.0 110.475 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.545 ' O ' HG22 ' A' ' 46' ' ' THR . 91.5 m -161.07 56.52 0.3 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 17.4 tt -83.86 165.47 2.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.378 -0.826 . . . . 0.0 110.589 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.567 HG22 ' CD1' ' A' ' 33' ' ' TYR . 66.4 p -129.53 -140.04 0.23 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 109.131 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.517 ' HA ' ' CA ' ' A' ' 34' ' ' GLY . 41.6 m -51.32 129.44 24.84 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.057 -1.027 . . . . 0.0 108.941 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' THR . 41.0 t -171.21 163.18 7.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.006 -1.059 . . . . 0.0 110.587 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.677 ' O ' HG22 ' A' ' 51' ' ' THR . 52.9 m -116.83 13.99 15.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.079 -1.013 . . . . 0.0 110.339 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.474 ' C ' ' O ' ' A' ' 51' ' ' THR . 54.5 p -36.18 133.94 0.45 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.644 -0.66 . . . . 0.0 110.653 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 69' ' ' ILE . 6.9 m -127.22 107.64 10.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 110.19 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 64.84 78.93 0.19 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.453 ' O ' HD12 ' A' ' 57' ' ' ILE . 51.8 p -158.3 127.47 5.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.153 -1.204 . . . . 0.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HB3' ' CB ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -78.54 103.6 8.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.656 ' O ' HG22 ' A' ' 57' ' ' ILE . 3.1 mp -89.48 16.47 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.963 -1.085 . . . . 0.0 110.66 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.49 159.73 0.69 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.2 -0.937 . . . . 0.0 110.266 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.29 166.82 18.99 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.77 54.03 3.87 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.073 1.565 . . . . 0.0 109.873 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 107.56 22.51 7.35 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.527 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 5.0 t -40.56 103.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.584 -0.95 . . . . 0.0 110.384 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 64' ' ' ILE . 13.2 tttt -97.12 146.06 25.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.572 -0.705 . . . . 0.0 109.725 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.672 HG23 ' NZ ' ' A' ' 81' ' ' LYS . 19.2 mt -154.5 144.08 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.052 -1.03 . . . . 0.0 110.783 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.438 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -136.4 107.87 6.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.284 -0.885 . . . . 0.0 110.653 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' THR . 5.9 m 58.02 79.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.37 -0.831 . . . . 0.0 111.469 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.523 ' O ' HG13 ' A' ' 69' ' ' ILE . 0.9 OUTLIER -135.63 117.4 15.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 109.981 178.183 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.665 ' HB ' ' HB3' ' A' ' 75' ' ' ALA . 1.1 mm -76.33 101.75 2.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 17.4 mt -115.2 155.87 16.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 O-C-N 120.899 -1.126 . . . . 0.0 109.97 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.845 ' O ' HG22 ' A' ' 73' ' ' VAL . 86.4 m -159.98 103.02 1.48 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 0.0 110.426 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.73 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 88.94 25.93 28.03 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.17 17.29 69.75 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 70' ' ' THR . 12.4 m -127.63 132.86 24.55 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.393 -1.063 . . . . 0.0 110.859 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -81.46 147.06 15.69 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.02 1.537 . . . . 0.0 110.656 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.853 ' HB1' ' CD ' ' A' ' 76' ' ' PRO . . . -73.15 -153.59 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.154 -0.966 . . . . 0.0 108.403 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.853 ' CD ' ' HB1' ' A' ' 75' ' ' ALA . 43.5 Cg_endo -75.62 9.48 2.24 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 O-C-N 122.404 0.686 . . . . 0.0 111.018 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.503 ' CB ' ' HB3' ' A' ' 80' ' ' CYS . 5.3 p 45.0 50.17 9.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.89 . . . . 0.0 111.448 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.07 -23.6 3.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.02 -1.05 . . . . 0.0 109.153 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.54 40.88 0.25 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 1.2 t -109.49 164.64 12.32 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.902 0.858 . . . . 0.0 110.98 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.672 ' NZ ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.27 173.71 7.25 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.342 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.797 ' O ' HG22 ' A' ' 82' ' ' ILE . 17.9 mm -160.1 53.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 t -97.95 -126.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 110.386 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.48 91.54 1.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.428 ' SG ' ' C ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER -162.76 177.51 9.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.147 . . . . 0.0 109.874 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.527 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -177.43 149.57 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.35 -0.844 . . . . 0.0 110.022 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.63 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -117.13 166.6 12.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.113 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.491 ' CB ' ' HB3' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -148.58 23.91 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.901 -1.125 . . . . 0.0 110.371 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 47.16 62.7 2.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.257 -0.902 . . . . 0.0 109.695 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 40' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.21 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 47.7 t0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.211 0.529 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.45 -126.49 1.84 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.22 42.57 1.9 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -1.158 . . . . 0.0 109.728 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.3 m -93.6 119.37 32.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.459 -0.776 . . . . 0.0 110.49 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.655 HG23 ' HB3' ' A' ' 9' ' ' SER . 27.6 m -125.09 -12.67 6.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 110.329 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 7' ' ' THR . 8.4 p30 41.07 43.37 1.83 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.904 -1.123 . . . . 0.0 110.321 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.553 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.0 m 76.48 -5.02 2.25 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.5 -0.75 . . . . 0.0 111.443 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 9' ' ' SER . 18.5 t30 -160.45 -51.1 0.05 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.812 -1.18 . . . . 0.0 110.633 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.655 ' HB3' HG23 ' A' ' 5' ' ' THR . 0.9 OUTLIER 85.18 92.79 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.787 0.803 . . . . 0.0 111.267 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.54 ' CD ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -131.21 26.97 4.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.945 -1.097 . . . . 0.0 108.265 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.052 HD12 ' CB ' ' A' ' 15' ' ' SER . 3.4 mm? -41.25 103.18 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.95 0.881 . . . . 0.0 109.35 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' ALA . 50.8 m -64.94 55.49 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.842 -0.536 . . . . 0.0 111.5 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 56.76 154.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 110.627 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 70.51 -4.68 1.57 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.209 -0.932 . . . . 0.0 111.807 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 1.052 ' CB ' HD12 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -74.42 176.69 6.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.458 -1.401 . . . . 0.0 110.574 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HD3' ' CG ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -160.42 151.53 19.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.392 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 p -166.65 -172.01 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 110.263 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 22.3 tt0 -169.61 -39.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.384 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -177.62 54.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.366 -0.834 . . . . 0.0 109.987 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.482 ' HB2' ' N ' ' A' ' 34' ' ' GLY . 52.0 p -102.92 -163.44 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 110.557 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' THR . 68.8 m -126.77 77.0 1.68 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.979 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 37' ' ' CYS . 3.5 tp -95.19 165.83 12.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.483 HG23 ' OG1' ' A' ' 7' ' ' THR . 21.7 m -167.51 128.81 1.52 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.426 -0.796 . . . . 0.0 109.902 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 6' ' ' ASN . 8.7 m120 56.34 29.14 14.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.075 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -101.8 154.57 18.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.86 . . . . 0.0 110.375 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' CD1' ' CD ' ' A' ' 10' ' ' GLN . 1.9 m-85 -116.69 -40.31 3.2 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.784 ' HB ' HD13 ' A' ' 11' ' ' LEU . 6.5 t 52.99 137.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.107 0.956 . . . . 0.0 113.096 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 14.7 t0 -142.2 118.08 10.54 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 14' ' ' ASN . 30.8 mttm 53.11 66.07 1.34 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.009 -1.057 . . . . 0.0 109.301 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 45' ' ' VAL . 69.3 m -153.51 151.97 30.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.038 -1.039 . . . . 0.0 110.65 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' CG ' ' HD3' ' A' ' 16' ' ' LYS . 11.0 mt-10 -121.12 112.91 19.28 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.534 -0.729 . . . . 0.0 109.166 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.515 HG11 ' HB ' ' A' ' 35' ' ' THR . 17.0 t -111.13 152.55 13.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.57 -0.707 . . . . 0.0 110.392 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.456 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 51.2 m-85 -144.93 34.71 1.12 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.263 -0.898 . . . . 0.0 110.841 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.482 ' N ' ' HB2' ' A' ' 20' ' ' SER . . . 140.9 41.46 0.07 OUTLIER Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.122 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.515 ' HB ' HG11 ' A' ' 32' ' ' VAL . 3.5 m -97.41 124.9 41.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.075 -1.25 . . . . 0.0 110.582 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 36' ' ' THR . 90.4 m -79.98 55.49 2.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.143 -0.973 . . . . 0.0 109.71 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 29.8 t -46.11 143.6 2.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.534 -0.728 . . . . 0.0 110.689 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -124.08 10.3 8.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 129.89 40.92 0.25 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.405 ' HA ' HD21 ' A' ' 90' ' ' ASN . 47.2 m -122.38 -167.74 1.61 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 110.075 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 42' ' ' PHE . 2.6 ttt180 -158.19 165.83 33.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 110.35 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.648 ' HD2' HG13 ' A' ' 27' ' ' VAL . 7.0 m-85 -121.97 -172.2 2.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.814 . . . . 0.0 109.692 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 20.2 t0 -167.8 49.37 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.0 110.562 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 118.47 51.17 0.32 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 46' ' ' THR . 1.1 m -127.87 -166.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.092 -1.24 . . . . 0.0 110.828 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.548 ' N ' HG23 ' A' ' 45' ' ' VAL . 24.6 m -161.37 56.28 0.28 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 50' ' ' SER . 13.7 tt -76.56 172.04 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.498 -0.751 . . . . 0.0 110.735 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.462 ' N ' HG12 ' A' ' 47' ' ' ILE . 47.0 p -138.28 -137.04 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 109.551 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 40.5 m -65.34 81.99 0.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.835 -1.165 . . . . 0.0 109.888 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.676 ' HB3' HD11 ' A' ' 47' ' ' ILE . 23.2 t -135.89 148.5 48.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.04 -1.037 . . . . 0.0 111.357 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.555 ' CB ' ' HA ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -95.49 126.36 40.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.078 -1.014 . . . . 0.0 109.12 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.04 105.08 5.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 110.004 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -95.11 102.54 14.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.477 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 61.12 92.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 83.7 p -166.15 121.08 1.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -1.213 . . . . 0.0 110.414 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -81.25 112.72 18.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.008 -1.057 . . . . 0.0 109.458 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.494 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 18.0 mm -88.57 13.27 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.339 -0.851 . . . . 0.0 110.823 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -42.59 141.21 1.07 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.233 -0.917 . . . . 0.0 110.286 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 178.8 146.03 6.4 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -76.39 55.82 4.82 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.024 1.539 . . . . 0.0 109.103 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 117.23 20.17 4.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -39.43 147.25 0.08 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.381 -1.07 . . . . 0.0 110.964 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 24.1 tttt -147.16 100.74 3.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.867 . . . . 0.0 110.048 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.85 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.4 mt -116.19 149.92 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.0 110.431 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -142.18 118.05 10.54 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.202 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.1 m 54.35 80.57 0.12 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 111.892 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.8 t -137.99 128.78 26.9 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 68' ' ' ILE . 1.7 mp -82.66 9.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.879 -1.138 . . . . 0.0 110.55 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.533 HG13 ' SG ' ' A' ' 67' ' ' CYS . 62.5 mt -18.35 138.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 CA-C-O 121.434 0.635 . . . . 0.0 112.04 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.815 ' O ' HG22 ' A' ' 73' ' ' VAL . 52.3 m -148.66 100.9 3.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.961 -1.087 . . . . 0.0 111.477 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.538 ' O ' HG13 ' A' ' 73' ' ' VAL . . . 91.67 37.75 6.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.448 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 72.07 13.2 76.09 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 70' ' ' THR . 5.3 m -120.3 136.52 25.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.39 -1.065 . . . . 0.0 110.013 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HA ' HG12 ' A' ' 69' ' ' ILE . 44.8 Cg_endo -75.93 142.13 24.82 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.789 1.415 . . . . 0.0 110.682 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -94.59 167.77 12.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 109.604 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 45.4 Cg_endo -72.09 72.95 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.683 1.36 . . . . 0.0 110.031 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.555 ' HB3' ' CB ' ' A' ' 80' ' ' CYS . 4.9 t -115.29 107.41 15.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.477 -0.764 . . . . 0.0 110.242 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.34 -13.9 15.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.964 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.71 -14.44 23.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.392 -0.818 . . . . 0.0 110.108 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 7.2 t -72.39 161.34 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.419 -0.801 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.909 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -124.55 154.84 40.0 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.53 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.909 HD13 ' O ' ' A' ' 81' ' ' LYS . 18.1 mm -140.77 70.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -137.48 106.54 6.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.828 . . . . 0.0 111.684 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.5 30.23 53.96 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.652 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.85 ' SG ' HD11 ' A' ' 64' ' ' ILE . 5.5 t -150.31 179.31 8.23 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.984 -1.304 . . . . 0.0 110.231 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.0 t -177.31 161.25 1.78 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.383 -0.823 . . . . 0.0 109.726 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -121.68 169.91 10.25 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 109.525 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.48 24.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.8 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 46.61 78.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.463 -0.773 . . . . 0.0 109.965 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.552 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.394 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.202 0.525 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.31 64.32 0.83 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.0 25.86 3.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -1.156 . . . . 0.0 109.916 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.7 p -134.69 150.2 50.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.332 -0.855 . . . . 0.0 109.798 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.758 HG22 ' H ' ' A' ' 8' ' ' ASN . 79.3 m -126.82 4.32 6.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.585 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.557 ' OD1' ' N ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER 28.54 41.84 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.602 -0.686 . . . . 0.0 111.873 -179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.543 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER 75.96 22.37 1.45 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.441 -0.787 . . . . 0.0 112.681 178.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.758 ' H ' HG22 ' A' ' 5' ' ' THR . 0.5 OUTLIER 167.81 -25.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.778 -1.201 . . . . 0.0 111.293 179.149 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.635 ' HB3' HG23 ' A' ' 5' ' ' THR . 0.3 OUTLIER 63.75 90.51 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.869 . . . . 0.0 110.121 -178.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 1.6 tt0 -129.46 20.3 5.69 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.68 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.794 HD12 ' CB ' ' A' ' 15' ' ' SER . 2.3 mm? -43.44 117.42 1.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.538 ' OG ' ' CZ ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -58.6 71.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.517 -0.74 . . . . 0.0 111.134 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 11' ' ' LEU . . . 21.89 59.87 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 120.963 0.411 . . . . 0.0 111.79 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -178.46 -32.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.964 . . . . 0.0 110.307 -179.647 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.794 ' CB ' HD12 ' A' ' 11' ' ' LEU . 15.1 t -58.42 -176.56 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.558 -0.714 . . . . 0.0 110.998 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 9.9 ttmt -139.47 147.38 41.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 109.791 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.55 127.22 14.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.966 . . . . 0.0 110.32 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -120.72 -38.29 2.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.088 -1.008 . . . . 0.0 110.551 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -174.12 34.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -0.93 . . . . 0.0 109.686 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 p -84.68 -167.97 2.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 110.691 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 21' ' ' THR . 5.7 t -142.47 66.53 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.063 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 22' ' ' LEU . 5.3 mt -77.97 177.07 8.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.996 -1.065 . . . . 0.0 109.988 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 37' ' ' CYS . 55.5 m -164.7 121.44 1.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.866 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 6' ' ' ASN . 31.0 m120 56.57 48.7 16.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 109.407 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -119.19 164.84 15.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.59 0.709 . . . . 0.0 110.839 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.592 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 25.1 t80 -138.22 26.06 2.67 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.798 HG13 ' HD2' ' A' ' 42' ' ' PHE . 15.1 t -21.67 144.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.016 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 42.8 t0 -145.56 147.05 31.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.467 -0.771 . . . . 0.0 109.801 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 41.9 mtpt 35.43 41.5 0.09 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.569 -0.707 . . . . 0.0 110.34 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.822 ' CB ' HG22 ' A' ' 45' ' ' VAL . 75.3 m -133.19 150.8 51.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 110.851 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 47' ' ' ILE . 7.7 mt-10 -118.29 99.66 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 0.0 109.64 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.589 HG22 ' CG2' ' A' ' 47' ' ' ILE . 21.8 t -99.17 163.62 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.512 -0.742 . . . . 0.0 110.528 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.427 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 49.4 m-85 -148.44 -14.23 0.34 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.073 -1.017 . . . . 0.0 111.926 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.15 26.45 0.2 Allowed Glycine 0 N--CA 1.494 2.549 0 O-C-N 120.556 -1.34 . . . . 0.0 109.962 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 36' ' ' THR . 43.5 m -82.07 168.83 17.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -1.126 . . . . 0.0 110.732 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.566 ' N ' HG22 ' A' ' 35' ' ' THR . 40.0 m -129.33 52.65 1.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.383 -0.823 . . . . 0.0 109.62 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.503 ' O ' ' N ' ' A' ' 23' ' ' THR . 5.9 t -44.02 102.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 110.158 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 38' ' ' THR . 13.5 t -95.84 35.64 1.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 0.0 110.142 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.02 24.5 2.48 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -115.14 -166.98 1.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -1.075 . . . . 0.0 109.489 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.501 ' N ' ' OG ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -164.66 164.53 21.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.898 -1.126 . . . . 0.0 111.159 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.798 ' HD2' HG13 ' A' ' 27' ' ' VAL . 7.0 m-85 -123.13 -177.4 3.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.316 -0.865 . . . . 0.0 109.922 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.1 t70 -165.81 53.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.237 -0.914 . . . . 0.0 110.482 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 117.53 66.96 0.36 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.822 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.7 m -143.68 -160.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.911 -1.347 . . . . 0.0 111.604 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.557 ' N ' HG23 ' A' ' 45' ' ' VAL . 97.5 m -165.08 58.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.589 ' CG2' HG22 ' A' ' 32' ' ' VAL . 10.1 tt -81.42 165.29 2.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.345 -0.847 . . . . 0.0 110.923 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 25.0 p -131.34 -143.34 0.24 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 66' ' ' THR . 26.8 m -56.42 110.45 0.77 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.581 -1.325 . . . . 0.0 108.236 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' THR . 1.4 t -161.61 136.96 7.54 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.706 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -98.48 122.03 41.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.335 -0.853 . . . . 0.0 109.637 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.465 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -135.77 129.49 32.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.114 -0.991 . . . . 0.0 110.507 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.1 101.7 10.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.365 -0.834 . . . . 0.0 109.427 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 64.74 99.21 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.482 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 85.6 p -174.42 110.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -1.163 . . . . 0.0 110.564 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.548 ' CA ' ' HB3' ' A' ' 90' ' ' ASN . 3.8 ptp180 -77.4 112.12 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.104 -0.997 . . . . 0.0 109.166 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.528 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 32.6 mm -87.57 21.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.083 -1.011 . . . . 0.0 110.548 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.6 m -45.36 160.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 110.144 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.69 163.36 11.59 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.7 47.83 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.005 1.529 . . . . 0.0 109.826 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 123.8 16.22 3.38 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.495 ' HB3' ' CB ' ' A' ' 45' ' ' VAL . 3.1 t -36.62 116.75 0.45 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.604 -0.939 . . . . 0.0 110.998 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.558 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 32.2 tttm -107.79 153.76 22.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.882 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.038 HD13 ' HE2' ' A' ' 81' ' ' LYS . 30.1 mm -152.38 130.66 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.83 -1.168 . . . . 0.0 109.642 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.497 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 62.4 p -132.58 118.51 19.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 0.0 110.257 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.6 OUTLIER 43.44 56.95 4.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.475 -0.766 . . . . 0.0 110.056 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HB2' HG23 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -113.17 99.05 7.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.943 . . . . 0.0 109.862 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.9 mp -69.49 86.56 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.978 -1.076 . . . . 0.0 109.114 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.609 HG23 ' C ' ' A' ' 73' ' ' VAL . 9.0 mt -89.64 159.9 2.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.624 -0.673 . . . . 0.0 110.189 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.776 ' O ' HG22 ' A' ' 73' ' ' VAL . 8.6 m -157.99 96.27 1.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 110.281 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.59 33.25 8.07 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 75.52 16.98 80.31 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 70' ' ' THR . 13.8 m -126.18 131.44 23.96 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.376 -1.073 . . . . 0.0 110.177 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -79.68 151.0 21.86 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.768 1.404 . . . . 0.0 110.453 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -82.82 173.53 7.41 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.093 -1.004 . . . . 0.0 110.094 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -82.4 9.98 3.77 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.759 1.399 . . . . 0.0 109.751 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.9 t -54.97 132.94 48.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.539 -0.725 . . . . 0.0 110.343 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.67 -10.84 55.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.419 -0.801 . . . . 0.0 110.391 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.69 -14.25 25.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 109.732 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 67' ' ' CYS . 36.4 t -77.03 123.55 26.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.331 -0.856 . . . . 0.0 109.444 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.038 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.42 172.89 6.85 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.054 -1.029 . . . . 0.0 110.476 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.76 ' O ' HG22 ' A' ' 82' ' ' ILE . 0.6 OUTLIER -163.23 82.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.46 74.67 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.718 -0.614 . . . . 0.0 111.4 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.18 -13.82 44.27 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.371 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -82.04 -164.63 0.84 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.969 -1.312 . . . . 0.0 109.961 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.573 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t 168.82 147.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 109.657 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.642 ' HE1' HD11 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -130.57 156.08 45.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.825 . . . . 0.0 109.395 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.447 ' HB3' ' CD ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -145.25 30.34 1.14 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.142 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.482 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 51.72 82.14 0.07 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.411 -0.805 . . . . 0.0 108.867 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.548 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.68 -178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.208 0.528 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.41 -47.75 1.0 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m -124.42 -76.97 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.131 -1.217 . . . . 0.0 110.511 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 5' ' ' THR . 59.6 m 49.42 -154.29 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.746 -1.221 . . . . 0.0 110.705 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 4' ' ' CYS . 1.0 OUTLIER 167.47 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.545 HD21 HD22 ' A' ' 11' ' ' LEU . 0.9 OUTLIER 64.58 58.12 1.06 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.5 m 75.55 -52.05 0.64 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.316 0.579 . . . . 0.0 109.568 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER 176.2 56.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 179.381 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 3.7 m -117.45 -140.54 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.423 -0.798 . . . . 0.0 110.341 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -132.06 -37.31 1.13 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.955 . . . . 0.0 110.593 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.877 HD21 ' HB2' ' A' ' 17' ' ' CYS . 22.8 tp 47.57 81.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.11 -0.994 . . . . 0.0 108.478 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -43.05 147.13 0.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.825 . . . . 0.0 110.387 -178.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.21 -13.37 12.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.964 . . . . 0.0 109.651 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 53.7 t-20 -90.4 -1.95 57.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.516 -0.74 . . . . 0.0 110.216 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 39.8 t -91.72 -157.52 0.51 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.042 -1.036 . . . . 0.0 109.843 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 4.8 tttt -138.79 159.14 42.85 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 110.113 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.877 ' HB2' HD21 ' A' ' 11' ' ' LEU . 34.9 t -148.87 116.7 6.3 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.286 -0.884 . . . . 0.0 110.744 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 19' ' ' LYS . 2.2 mt-10 -147.68 71.7 1.21 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.493 -0.755 . . . . 0.0 109.272 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 61.83 117.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 108.996 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -158.02 173.43 16.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.025 . . . . 0.0 110.722 -178.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -119.79 30.26 7.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 0.0 109.736 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 37' ' ' CYS . 11.2 mt -60.95 -178.79 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 109.963 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 24.2 m -166.24 122.23 1.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.787 . . . . 0.0 109.507 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 47.48 46.73 17.47 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.118 -0.989 . . . . 0.0 109.059 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 40' ' ' SER . 0.9 OUTLIER -88.08 -151.12 0.19 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.971 0.891 . . . . 0.0 111.254 -178.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 1.2 t80 174.35 41.77 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 42' ' ' PHE . 26.1 t -50.7 149.43 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.7 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -157.05 131.18 8.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 1.2 mtpt 55.6 19.37 3.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -0.985 . . . . 0.0 110.154 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.47 ' HB3' HG22 ' A' ' 45' ' ' VAL . 69.8 m -122.48 -178.15 3.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.969 -1.082 . . . . 0.0 110.612 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' C ' HG23 ' A' ' 32' ' ' VAL . 3.6 tt0 -116.33 -71.91 0.72 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -0.858 . . . . 0.0 110.419 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG23 ' C ' ' A' ' 31' ' ' GLU . 3.7 t 66.45 140.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.594 -0.691 . . . . 0.0 110.266 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 32' ' ' VAL . 44.1 m-85 -141.34 -70.81 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 110.587 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.61 22.06 33.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.556 ' O ' HD23 ' A' ' 22' ' ' LEU . 98.3 m -70.54 160.14 33.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.397 -1.061 . . . . 0.0 111.29 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 37' ' ' CYS . 22.2 m -116.01 49.97 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.495 -0.753 . . . . 0.0 109.742 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.576 ' HB2' HD22 ' A' ' 22' ' ' LEU . 31.2 t -39.38 104.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 111.162 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.4 m -98.95 89.84 4.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.156 -0.965 . . . . 0.0 109.838 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.78 38.44 95.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -130.8 -150.65 0.44 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.171 -1.194 . . . . 0.0 110.063 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 40' ' ' SER . 18.7 ptt180 177.66 -176.68 0.18 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.317 -0.865 . . . . 0.0 110.518 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' A' ' 47' ' ' ILE . 20.4 m-85 -133.16 -169.4 2.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.387 -0.821 . . . . 0.0 109.301 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.88 50.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 109.814 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 115.72 58.14 0.34 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 2.3 m -138.53 -159.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.989 -1.301 . . . . 0.0 110.709 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.572 ' O ' HG22 ' A' ' 46' ' ' THR . 87.8 m -161.79 51.04 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.44 -0.788 . . . . 0.0 109.809 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.652 HG21 ' CE2' ' A' ' 42' ' ' PHE . 6.6 tt -80.27 164.41 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.368 -0.833 . . . . 0.0 110.435 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 46.2 p -136.48 -120.04 0.16 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.347 -0.846 . . . . 0.0 110.333 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' THR . 94.3 m -70.33 70.54 0.41 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.674 -1.266 . . . . 0.0 110.114 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.615 ' OG ' HD11 ' A' ' 47' ' ' ILE . 1.1 t -124.27 144.79 49.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.147 -0.97 . . . . 0.0 110.529 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -104.65 125.43 50.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.881 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -136.66 136.17 38.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.999 -1.063 . . . . 0.0 110.122 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.84 89.69 3.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.916 -1.115 . . . . 0.0 109.545 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.1 92.37 0.17 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.9 p -165.2 130.19 2.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -1.143 . . . . 0.0 110.532 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 88' ' ' SER . 14.7 ttp85 -93.38 106.66 18.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.125 -0.984 . . . . 0.0 109.157 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.695 HG23 HD11 ' A' ' 64' ' ' ILE . 8.7 mm -81.63 13.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 110.435 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -34.43 146.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 0.0 110.8 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.94 153.65 9.68 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.22 36.46 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.972 1.511 . . . . 0.0 109.683 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.92 32.72 0.5 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 45' ' ' VAL . 1.6 t -49.87 166.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.29 -1.123 . . . . 0.0 110.086 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' SG ' ' A' ' 62' ' ' CYS . 31.8 tttp -149.13 106.24 3.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 109.555 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.695 HD11 HG23 ' A' ' 57' ' ' ILE . 1.7 mt -121.7 158.56 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.888 -1.133 . . . . 0.0 111.046 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 65' ' ' SER . 1.3 p -163.09 105.76 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.548 -0.72 . . . . 0.0 109.479 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.3 m 67.07 78.2 0.25 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.216 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' A' ' 64' ' ' ILE . 74.1 m -140.37 121.8 15.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.431 -0.793 . . . . 0.0 109.598 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.763 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.9 mp -93.47 83.62 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.937 -1.102 . . . . 0.0 109.324 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' THR . 29.1 mt -86.54 162.46 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.618 -0.676 . . . . 0.0 110.791 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.817 ' O ' HG22 ' A' ' 73' ' ' VAL . 27.9 m -158.81 95.29 1.29 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.253 -0.905 . . . . 0.0 110.76 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.57 30.32 13.91 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.55 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 81.45 15.32 76.53 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 70' ' ' THR . 10.6 m -127.83 123.78 23.0 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.412 -1.052 . . . . 0.0 110.604 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 44.8 Cg_endo -75.1 138.88 23.35 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.837 1.441 . . . . 0.0 111.274 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -73.55 164.29 62.16 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.359 -0.838 . . . . 0.0 109.466 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 44.0 Cg_endo -71.0 58.91 2.2 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.75 1.395 . . . . 0.0 110.115 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 m -92.63 119.04 31.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.469 -0.77 . . . . 0.0 110.675 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.15 1.51 15.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.259 -0.9 . . . . 0.0 111.064 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.67 -16.73 14.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.954 -1.091 . . . . 0.0 110.174 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 82' ' ' ILE . 4.4 t -69.91 165.78 20.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 110.952 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.573 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -60.17 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.651 -0.655 . . . . 0.0 111.876 -179.358 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 80' ' ' CYS . 4.9 mm 71.96 33.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.2 m -112.12 -84.76 0.58 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.705 -0.622 . . . . 0.0 111.571 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -117.35 84.79 0.38 Allowed Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.737 -1.22 . . . . 0.0 111.0 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 8.7 t -178.95 174.66 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -1.137 . . . . 0.0 110.255 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.505 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 7.4 t -169.6 168.79 9.03 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.609 ' CD1' HD12 ' A' ' 57' ' ' ILE . 1.6 m-85 -126.41 157.06 39.54 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.022 -1.049 . . . . 0.0 109.389 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 56' ' ' ARG . 4.0 m -129.3 20.42 5.75 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 90' ' ' ASN . . . 53.37 59.58 4.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.5 -0.75 . . . . 0.0 109.921 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.356 0.598 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 3' ' ' SER . . . -74.37 -135.04 0.34 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 2' ' ' GLY . 0.5 OUTLIER 59.65 13.35 3.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -1.181 . . . . 0.0 110.197 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.624 ' HB2' HD23 ' A' ' 11' ' ' LEU . 5.1 m -87.38 -177.75 6.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 109.406 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 5' ' ' THR . 31.0 m -129.14 1.18 5.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.079 -1.013 . . . . 0.0 110.114 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 7' ' ' THR . 8.9 p30 35.93 66.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.847 -0.533 . . . . 0.0 110.123 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.5 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.7 OUTLIER 70.31 -57.59 0.57 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 109.297 -178.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER 169.58 81.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.495 ' CB ' ' OD1' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -166.74 -144.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.931 . . . . 0.0 110.313 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.576 ' NE2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -105.6 170.93 7.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.002 . . . . 0.0 110.417 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.627 ' CD1' HG21 ' A' ' 27' ' ' VAL . 11.5 tp -178.66 92.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.716 . . . . 0.0 109.843 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -40.62 146.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.537 -0.727 . . . . 0.0 110.581 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.27 -13.85 14.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.128 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.71 -5.36 51.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 109.989 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.626 ' OG ' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -68.63 -170.22 0.2 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.16 -0.962 . . . . 0.0 110.245 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 1.5 tttp -146.77 116.01 7.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 110.231 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 15.5 p -110.96 -164.25 0.9 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 0.0 110.242 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 17' ' ' CYS . 17.6 tp10 69.71 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 64.39 40.16 6.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.248 -0.907 . . . . 0.0 109.892 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 t -160.85 169.29 22.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.785 . . . . 0.0 109.575 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.557 ' CG2' ' HA ' ' A' ' 36' ' ' THR . 32.7 m -106.88 104.61 14.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.008 -1.058 . . . . 0.0 109.64 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.843 ' N ' HD22 ' A' ' 22' ' ' LEU . 1.5 mm? -101.29 150.52 22.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.106 -0.996 . . . . 0.0 110.888 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 16.5 m -163.67 95.0 0.8 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.623 -0.673 . . . . 0.0 109.216 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.464 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 66.33 32.93 7.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.552 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 6' ' ' ASN . 98.3 m -59.69 -159.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.663 0.744 . . . . 0.0 110.901 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.581 ' CD1' ' HD2' ' A' ' 41' ' ' ARG . 1.9 t80 179.77 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.818 HG13 ' HD2' ' A' ' 42' ' ' PHE . 1.9 t 36.6 -159.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.58 0.705 . . . . 0.0 111.148 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.744 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER 171.93 -31.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 5.6 mtmt -169.28 51.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.984 ' OG ' HG22 ' A' ' 45' ' ' VAL . 35.2 m -127.34 -166.63 1.63 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 111.051 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 2.2 tt0 -129.09 -65.02 0.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.553 -0.717 . . . . 0.0 110.073 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.719 HG22 ' CG2' ' A' ' 47' ' ' ILE . 3.8 t 67.71 147.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.427 -0.796 . . . . 0.0 110.278 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.927 ' CD1' HG22 ' A' ' 48' ' ' THR . 33.1 m-85 -134.77 -50.98 0.78 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.14 -0.975 . . . . 0.0 110.614 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -135.56 35.06 2.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.845 HG22 ' H ' ' A' ' 37' ' ' CYS . 5.6 m -83.21 136.45 34.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.169 -1.195 . . . . 0.0 109.888 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.557 ' HA ' ' CG2' ' A' ' 21' ' ' THR . 28.3 m -69.0 -10.92 59.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.265 -0.897 . . . . 0.0 110.43 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.845 ' H ' HG22 ' A' ' 35' ' ' THR . 5.9 t 42.62 49.59 4.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 110.54 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 38' ' ' THR . 85.8 m -67.37 66.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.73 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 37' ' ' CYS . . . 68.95 75.17 0.55 Allowed Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.66 158.4 43.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 0.0 110.125 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.581 ' HD2' ' CD1' ' A' ' 26' ' ' TYR . 5.3 ttp180 -131.73 160.54 35.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.343 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.818 ' HD2' HG13 ' A' ' 27' ' ' VAL . 10.4 m-85 -133.21 -169.0 2.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.325 -0.859 . . . . 0.0 109.914 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.475 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 0.4 OUTLIER -174.48 49.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 110.076 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 115.41 60.58 0.36 Allowed Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.984 HG22 ' OG ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -134.91 -167.4 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.812 -1.405 . . . . 0.0 110.651 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' VAL . 57.7 m -155.7 56.24 0.61 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.719 ' CG2' HG22 ' A' ' 32' ' ' VAL . 9.2 tt -78.62 170.02 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.38 -0.825 . . . . 0.0 110.544 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.927 HG22 ' CD1' ' A' ' 33' ' ' TYR . 44.2 p -139.36 -131.63 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 66' ' ' THR . 23.9 m -60.87 123.8 18.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.762 -1.211 . . . . 0.0 109.008 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 35' ' ' THR . 0.4 OUTLIER -166.26 154.83 10.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.007 -1.058 . . . . 0.0 110.605 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 52' ' ' SER . 1.9 m -107.68 17.27 22.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.021 -1.05 . . . . 0.0 109.991 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -39.61 125.02 1.74 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.482 -0.761 . . . . 0.0 110.495 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 25.0 m -114.97 111.8 21.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.017 . . . . 0.0 110.143 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.72 86.14 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 p -162.06 131.08 4.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -1.165 . . . . 0.0 110.409 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.502 ' CA ' ' HB3' ' A' ' 90' ' ' ASN . 4.1 ttm180 -88.66 107.53 18.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.793 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.475 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 19.0 mm -87.47 21.29 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 110.611 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -41.86 143.25 0.56 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.221 -0.924 . . . . 0.0 110.324 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 175.92 153.02 10.0 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.263 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 59' ' ' GLY . 50.7 Cg_endo -87.13 62.72 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.036 1.545 . . . . 0.0 109.744 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 62' ' ' CYS . . . 109.16 19.63 8.38 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.532 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -42.55 170.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.597 -0.943 . . . . 0.0 111.238 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 17.3 ttmm -157.15 112.61 2.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.509 -0.744 . . . . 0.0 110.092 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.73 HD13 ' HE2' ' A' ' 81' ' ' LYS . 3.8 mm -119.85 164.41 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.006 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -168.37 113.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.3 m 49.46 65.63 1.35 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 110.376 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 63.7 m -122.45 97.24 5.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.619 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.678 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.9 mp -64.31 82.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 109.7 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.643 HG23 ' C ' ' A' ' 73' ' ' VAL . 18.8 mt -97.71 155.36 3.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.821 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.809 ' O ' HG22 ' A' ' 73' ' ' VAL . 12.8 m -155.02 101.69 2.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.038 -1.039 . . . . 0.0 110.213 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.03 29.0 16.3 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 79.18 16.6 78.24 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 70' ' ' THR . 5.5 m -122.91 128.56 25.31 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.364 -1.08 . . . . 0.0 110.537 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.882 ' HB3' HD11 ' A' ' 82' ' ' ILE . 45.1 Cg_endo -76.01 149.28 32.52 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.893 1.47 . . . . 0.0 110.652 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -96.49 164.52 18.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.332 -0.855 . . . . 0.0 109.953 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -71.31 57.84 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.915 1.482 . . . . 0.0 109.862 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.3 m -91.62 149.76 21.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 0.0 110.535 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.96 -17.96 22.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 110.248 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.86 -9.25 37.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.651 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.536 ' SG ' HG12 ' A' ' 82' ' ' ILE . 31.2 t -75.98 166.32 23.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -1.0 . . . . 0.0 110.013 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.73 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -111.28 -46.76 3.26 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.977 -1.077 . . . . 0.0 112.761 -178.504 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.882 HD11 ' HB3' ' A' ' 74' ' ' PRO . 16.7 mm 46.77 71.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.564 -1.335 . . . . 0.0 109.961 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.458 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 18.6 t -128.79 -106.67 0.3 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 0.0 110.46 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.35 63.69 2.92 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.574 ' CB ' ' HZ1' ' A' ' 81' ' ' LYS . 2.0 t -167.52 -172.54 1.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.082 -1.246 . . . . 0.0 110.787 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.538 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.7 t 177.44 162.61 0.52 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.475 -0.766 . . . . 0.0 109.333 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.542 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.5 OUTLIER -120.19 166.52 13.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.021 -1.049 . . . . 0.0 110.048 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 7.9 t -146.16 22.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.437 -0.79 . . . . 0.0 109.74 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 54.25 63.06 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.718 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.502 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.278 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.208 0.528 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.05 161.8 30.56 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t -63.32 -49.48 73.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.305 -1.115 . . . . 0.0 109.941 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' HB3' HD23 ' A' ' 11' ' ' LEU . 0.5 OUTLIER 59.47 -173.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 110.15 179.536 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 8' ' ' ASN . 28.4 m -153.82 18.82 0.52 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.151 -0.968 . . . . 0.0 109.699 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.544 ' OD1' ' CB ' ' A' ' 9' ' ' SER . 7.1 p30 18.74 57.39 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.177 0.513 . . . . 0.0 112.151 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 7' ' ' THR . 97.9 m 55.17 55.4 7.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 5' ' ' THR . 17.6 m-20 60.89 89.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.267 0.556 . . . . 0.0 111.316 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.544 ' CB ' ' OD1' ' A' ' 6' ' ' ASN . 0.5 OUTLIER -165.93 -149.22 0.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.147 -0.971 . . . . 0.0 109.857 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -126.78 101.16 6.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.224 -0.922 . . . . 0.0 110.449 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.715 HD12 ' HB ' ' A' ' 27' ' ' VAL . 41.3 tp -105.01 97.45 7.3 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.248 -0.908 . . . . 0.0 109.903 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -35.67 133.41 0.4 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.359 0.6 . . . . 0.0 111.205 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.55 -22.66 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 0.0 110.477 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 12' ' ' SER . 0.6 OUTLIER -95.83 -12.57 25.04 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.971 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.791 ' OG ' HG11 ' A' ' 27' ' ' VAL . 4.1 t -64.54 -176.85 0.27 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.928 -1.107 . . . . 0.0 109.729 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 7.2 tttp -127.58 146.2 50.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.033 -1.042 . . . . 0.0 110.61 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.94 110.81 14.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.031 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.63 -143.42 0.39 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.222 -0.924 . . . . 0.0 110.514 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.24 11.42 28.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.256 -0.902 . . . . 0.0 110.444 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 1.2 p -62.53 169.3 3.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.601 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 36' ' ' THR . 55.3 m -99.11 109.63 22.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.995 -1.066 . . . . 0.0 109.578 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.844 ' N ' HD22 ' A' ' 22' ' ' LEU . 2.5 mm? -99.57 144.03 29.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 110.847 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 19.9 m -150.87 107.97 3.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.397 -0.814 . . . . 0.0 109.443 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 54.07 44.43 29.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -0.936 . . . . 0.0 109.007 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 92.8 m -67.59 -157.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.416 -0.803 . . . . 0.0 111.011 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.6 OUTLIER 167.11 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.401 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.791 HG11 ' OG ' ' A' ' 15' ' ' SER . 5.1 t -70.66 168.16 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.113 0.959 . . . . 0.0 111.409 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.559 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 2.8 t70 -148.39 -35.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.42 0.629 . . . . 0.0 109.512 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -157.85 64.54 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.529 -0.732 . . . . 0.0 109.825 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.001 ' OG ' HG22 ' A' ' 45' ' ' VAL . 25.7 m -143.84 -175.95 4.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.854 -1.154 . . . . 0.0 111.093 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.586 ' OE1' HG23 ' A' ' 46' ' ' THR . 1.0 OUTLIER -123.43 -66.14 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.6 -0.687 . . . . 0.0 110.353 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.581 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 6.8 t 69.07 165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.628 -0.67 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 50.2 m-85 -159.85 -51.0 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.386 -0.821 . . . . 0.0 110.417 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.436 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -123.49 -2.7 8.85 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.676 HG22 ' H ' ' A' ' 37' ' ' CYS . 34.0 m -49.82 162.16 0.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -1.226 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.495 ' HA ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -102.81 -16.68 15.86 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.171 -0.955 . . . . 0.0 110.063 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.676 ' H ' HG22 ' A' ' 35' ' ' THR . 12.6 t 50.85 99.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 0.0 111.18 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.699 HG21 HG23 ' A' ' 53' ' ' THR . 20.9 m -114.34 89.88 3.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.113 -0.992 . . . . 0.0 109.483 178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 38' ' ' THR . . . 45.32 56.93 5.95 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 1.3 t -132.62 -175.99 3.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.135 -1.215 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.471 ' HD3' ' CE2' ' A' ' 26' ' ' TYR . 15.4 ptt180 -155.52 151.16 27.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.119 -0.988 . . . . 0.0 110.498 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.539 ' HD2' HG13 ' A' ' 27' ' ' VAL . 4.8 m-85 -117.46 -175.4 2.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.861 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.481 ' HB3' ' OG ' ' A' ' 58' ' ' SER . 24.0 t70 -166.75 38.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.421 -0.8 . . . . 0.0 109.778 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 129.78 66.7 0.11 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.001 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -141.78 -166.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.574 -1.545 . . . . 0.0 111.445 -179.228 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.597 ' O ' HG22 ' A' ' 46' ' ' THR . 72.3 m -164.95 56.17 0.13 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.549 ' CG2' HG22 ' A' ' 32' ' ' VAL . 7.8 tt -76.6 171.44 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.63 -0.669 . . . . 0.0 110.924 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.513 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 44.2 p -135.39 -138.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.827 . . . . 0.0 109.91 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 66' ' ' THR . 53.0 m -65.02 90.28 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.996 -1.065 . . . . 0.0 110.4 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' THR . 44.6 m -145.94 145.9 30.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.858 -1.151 . . . . 0.0 110.558 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -99.8 117.97 35.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.952 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -136.88 124.18 21.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.845 . . . . 0.0 110.124 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.699 HG23 HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER -109.1 100.33 9.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.915 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.7 83.72 0.48 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 5.8 p -159.01 116.46 2.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -1.108 . . . . 0.0 110.428 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -75.36 109.87 9.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 109.729 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.521 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 11.1 mm -87.9 3.02 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.071 -1.018 . . . . 0.0 111.171 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 74.8 m -42.03 163.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.218 -0.926 . . . . 0.0 110.403 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 145.92 150.45 5.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.35 59.33 1.91 Allowed 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.902 1.475 . . . . 0.0 109.523 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . 112.53 28.64 3.42 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 2.0 t -52.6 128.8 27.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.345 -1.091 . . . . 0.0 110.337 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.563 ' HD2' ' HB ' ' A' ' 46' ' ' THR . 2.0 mmtm -120.97 149.77 42.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.095 -1.003 . . . . 0.0 110.968 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.923 HD13 ' HE2' ' A' ' 81' ' ' LYS . 12.6 mm -149.27 135.06 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.48 -0.762 . . . . 0.0 109.334 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.461 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -140.27 116.73 10.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.996 -1.065 . . . . 0.0 110.778 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.7 OUTLIER 45.89 70.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.613 -0.679 . . . . 0.0 111.644 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 52.9 t -133.72 125.88 29.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.833 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.3 mp -88.01 81.08 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.237 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.598 HG21 ' CD2' ' A' ' 87' ' ' PHE . 4.4 mt -88.9 160.43 2.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.706 -0.621 . . . . 0.0 109.742 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.763 ' O ' HG22 ' A' ' 73' ' ' VAL . 55.4 m -161.0 96.61 1.11 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.104 -0.998 . . . . 0.0 110.619 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 91.47 30.07 11.29 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.582 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 81.22 14.76 78.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 70' ' ' THR . 11.6 m -123.63 127.36 25.53 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.489 -1.006 . . . . 0.0 110.098 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -80.01 143.02 15.9 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.706 1.372 . . . . 0.0 110.075 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -87.5 149.96 47.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.139 -0.975 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.13 57.73 1.21 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.152 1.606 . . . . 0.0 110.498 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.06 150.74 20.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.758 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.67 -7.1 50.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.55 -16.46 14.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 111.241 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 15.0 t -68.16 129.56 40.29 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.813 -1.179 . . . . 0.0 109.573 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.923 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.12 171.78 7.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.916 -1.115 . . . . 0.0 110.305 -179.621 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.716 ' O ' HG22 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -166.64 91.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.524 -0.735 . . . . 0.0 109.027 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.48 -59.18 1.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.056 -1.027 . . . . 0.0 110.555 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.28 52.22 0.64 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.697 ' C ' HG22 ' A' ' 86' ' ' THR . 1.7 t -124.55 -150.04 0.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 110.032 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.697 HG22 ' C ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER 165.05 143.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.497 -0.752 . . . . 0.0 110.54 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.79 ' HE1' HD11 ' A' ' 64' ' ' ILE . 1.8 m-30 -107.1 -65.0 1.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.537 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER 71.4 8.34 6.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.432 -0.792 . . . . 0.0 110.45 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 54.21 85.73 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.99 . . . . 0.0 109.635 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.621 ' C ' HD21 ' A' ' 90' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.358 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.182 0.515 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.56 69.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.54 61.0 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -1.099 . . . . 0.0 110.514 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -96.14 -19.09 19.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.274 -0.891 . . . . 0.0 109.973 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 5' ' ' THR . 42.0 m 63.26 6.74 2.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.708 -0.62 . . . . 0.0 110.651 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER 66.59 -59.83 0.35 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.127 -0.983 . . . . 0.0 109.702 179.733 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 5' ' ' THR . 90.0 m -160.76 -37.25 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.474 -0.766 . . . . 0.0 109.451 179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.08 31.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.393 -0.817 . . . . 0.0 109.834 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.476 ' OG ' ' CZ ' ' A' ' 26' ' ' TYR . 21.0 t -138.21 -73.21 0.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 110.084 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.59 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -170.25 179.61 3.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.122 -0.986 . . . . 0.0 110.844 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.723 HD11 ' OG ' ' A' ' 15' ' ' SER . 18.9 tp -176.0 90.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 31.0 t -36.53 137.05 0.31 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.636 -0.665 . . . . 0.0 110.54 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.6 -17.33 2.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 110.567 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.431 ' OD1' ' HA ' ' A' ' 29' ' ' LYS . 20.9 t-20 -90.88 -7.16 52.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 110.324 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.723 ' OG ' HD11 ' A' ' 11' ' ' LEU . 39.7 t -74.66 -158.76 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.027 . . . . 0.0 109.732 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 5.5 tttp -148.57 125.92 11.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 109.576 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.551 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 9.8 t -109.89 120.74 43.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.714 -179.199 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 19' ' ' LYS . 8.3 tt0 -167.79 114.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.432 -0.792 . . . . 0.0 110.064 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' GLU . 11.7 mttt 41.73 -123.33 0.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.0 110.309 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.4 160.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.889 -1.132 . . . . 0.0 110.071 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.541 ' HB ' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -100.38 23.63 9.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.078 -1.014 . . . . 0.0 109.497 179.754 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.648 HD13 HG11 ' A' ' 32' ' ' VAL . 2.3 tp -51.53 152.26 2.77 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.49 -0.756 . . . . 0.0 110.496 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.505 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 41.6 m -164.83 134.58 3.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.409 -0.807 . . . . 0.0 109.829 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 3.5 m120 50.45 63.52 2.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.032 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -132.55 165.1 25.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.327 -179.9 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 10' ' ' GLN . 44.7 m-85 -121.5 -40.15 2.59 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.692 HG11 ' OG ' ' A' ' 15' ' ' SER . 3.6 t 55.21 141.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 122.11 0.957 . . . . 0.0 111.637 178.148 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -144.87 113.01 6.47 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.551 -0.718 . . . . 0.0 109.347 179.384 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HA ' ' OD1' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 54.81 57.53 5.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 109.354 -179.044 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 45' ' ' VAL . 6.0 m -134.82 -157.49 0.81 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.758 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 0.8 OUTLIER -152.34 -62.55 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.567 -0.708 . . . . 0.0 109.968 179.876 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.648 HG11 HD13 ' A' ' 22' ' ' LEU . 13.0 t 61.91 162.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.435 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.488 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 11.7 m-85 -155.66 -46.91 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.3 -0.875 . . . . 0.0 110.455 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.73 21.6 3.75 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.544 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 6.5 m -74.76 146.52 42.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.134 . . . . 0.0 110.944 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.541 HG23 ' HB ' ' A' ' 21' ' ' THR . 48.0 m -106.68 70.31 0.81 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.452 -0.78 . . . . 0.0 109.37 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.509 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 13.9 t -60.7 113.6 2.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.519 -0.738 . . . . 0.0 111.273 -179.097 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.798 HG22 ' O ' ' A' ' 38' ' ' THR . 14.3 m -106.03 60.22 0.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 178.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 91.04 71.69 1.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.523 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 70.4 m -154.34 171.58 19.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -1.125 . . . . 0.0 110.315 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -141.12 154.82 46.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.912 . . . . 0.0 110.434 179.77 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.663 ' HD2' HG13 ' A' ' 27' ' ' VAL . 8.5 m-85 -118.36 -174.0 2.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 0.0 110.533 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.49 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -173.18 81.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 109.971 179.816 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 84.66 54.23 3.0 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.633 ' HB ' ' HB3' ' A' ' 62' ' ' CYS . 0.8 OUTLIER -128.95 -172.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.752 -1.44 . . . . 0.0 110.939 -179.53 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.526 ' N ' HG23 ' A' ' 45' ' ' VAL . 9.3 m -160.4 56.63 0.34 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.629 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 50' ' ' SER . 11.5 tt -80.99 168.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.454 -0.779 . . . . 0.0 110.573 -179.253 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 43.2 p -136.16 -150.26 0.36 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.395 -0.816 . . . . 0.0 108.834 179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.7 m -46.75 108.23 0.13 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.878 -1.139 . . . . 0.0 109.185 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' THR . 70.9 m -164.13 140.64 6.51 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 110.131 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -101.05 123.3 45.02 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 109.758 179.608 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -136.11 129.8 32.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 110.234 -179.804 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.57 100.16 9.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 66.88 80.19 0.19 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.22 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.4 p -151.32 113.74 4.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -1.02 . . . . 0.0 110.312 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -73.24 111.36 8.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.165 -0.96 . . . . 0.0 110.134 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 11.6 mm -88.41 7.18 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.49 ' OG ' ' HB2' ' A' ' 43' ' ' ASP . 43.3 m -44.83 141.16 2.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.0 110.486 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 171.41 164.24 26.74 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.989 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.53 56.62 6.04 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.06 1.558 . . . . 0.0 109.796 179.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 110.91 19.93 7.47 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.633 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -37.24 113.7 0.27 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.421 -1.047 . . . . 0.0 110.884 179.96 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 10.1 tttm -107.19 122.21 46.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.984 -1.072 . . . . 0.0 109.809 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.865 HD11 ' SG ' ' A' ' 85' ' ' CYS . 5.3 mp -131.54 148.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.111 -0.993 . . . . 0.0 111.223 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -148.08 120.73 8.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 110.724 179.395 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.7 OUTLIER 48.06 57.35 6.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.402 -0.811 . . . . 0.0 111.277 179.615 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.3 m -115.88 106.6 14.0 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.022 -1.049 . . . . 0.0 109.976 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.4 mp -76.73 95.77 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.955 . . . . 0.0 109.316 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.697 HG23 ' C ' ' A' ' 73' ' ' VAL . 6.0 mt -103.87 158.99 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 110.595 -179.197 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 73' ' ' VAL . 29.8 m -159.22 98.33 1.43 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.33 -0.856 . . . . 0.0 109.589 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.03 23.5 22.48 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 83.39 15.9 70.31 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.697 ' C ' HG23 ' A' ' 69' ' ' ILE . 11.4 m -120.34 124.41 27.73 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.522 -0.987 . . . . 0.0 110.124 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.48 147.48 28.66 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.916 1.482 . . . . 0.0 111.191 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -92.5 144.95 29.6 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.447 -0.783 . . . . 0.0 108.896 178.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.44 60.35 2.64 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 O-C-N 123.814 1.428 . . . . 0.0 110.393 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -81.91 161.63 23.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 109.909 179.697 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.39 -18.16 57.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.131 -0.981 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.31 -25.66 10.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.969 -1.082 . . . . 0.0 110.62 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 19.5 t -47.49 128.42 12.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.106 -0.996 . . . . 0.0 109.958 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.92 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -90.59 161.94 15.21 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.984 -1.073 . . . . 0.0 110.259 -179.731 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.92 HD13 ' O ' ' A' ' 81' ' ' LYS . 18.4 mm -143.79 67.99 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -146.1 107.85 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 112.417 -177.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . 65.22 73.02 0.63 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.334 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.865 ' SG ' HD11 ' A' ' 64' ' ' ILE . 4.6 t -175.39 -174.91 0.76 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -1.227 . . . . 0.0 110.075 178.377 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.419 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -179.44 152.15 0.51 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.016 -1.053 . . . . 0.0 110.484 -179.066 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.691 ' CD2' HG21 ' A' ' 69' ' ' ILE . 2.9 m-30 -109.0 -63.54 1.34 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.438 -0.788 . . . . 0.0 109.422 179.194 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER 71.14 4.13 4.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.535 -0.728 . . . . 0.0 110.699 179.74 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 57.15 96.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.072 -1.017 . . . . 0.0 109.992 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.136 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 8.8 p-10 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.177 0.513 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.2 -69.21 1.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.3 t -125.18 81.37 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -1.11 . . . . 0.0 109.62 179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.534 ' O ' ' HB ' ' A' ' 5' ' ' THR . 4.3 m -99.07 -23.34 15.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.835 . . . . 0.0 110.304 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.641 HG22 ' H ' ' A' ' 9' ' ' SER . 31.3 m 66.44 1.87 2.24 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.519 -0.738 . . . . 0.0 110.995 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.736 ' ND2' ' H ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER 65.59 -54.78 0.35 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.206 -0.934 . . . . 0.0 110.194 -179.812 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 5' ' ' THR . 53.4 m -163.09 -35.56 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.06 -1.025 . . . . 0.0 109.702 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.74 28.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 110.493 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.641 ' H ' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -132.75 -85.47 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.024 -1.048 . . . . 0.0 110.62 -179.843 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.56 ' O ' HD22 ' A' ' 11' ' ' LEU . 1.8 tt0 -165.87 -164.03 0.68 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.043 -1.035 . . . . 0.0 111.18 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.071 HD12 ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -173.39 117.36 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.582 -0.699 . . . . 0.0 109.396 -179.936 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 27' ' ' VAL . 45.3 p -35.14 144.74 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.642 -0.661 . . . . 0.0 110.801 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.16 -25.1 30.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 110.588 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -106.22 3.83 28.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 110.375 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . 1.071 ' CB ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -55.56 -173.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 110.582 -179.827 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -150.36 119.81 6.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 179.902 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 31.7 p -116.24 72.02 0.8 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.015 -1.053 . . . . 0.0 110.491 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.89 136.37 35.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.145 -0.972 . . . . 0.0 110.15 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 mttt 54.35 36.75 26.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 109.868 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.439 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 6.8 m -143.89 162.91 34.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.557 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -113.8 106.17 14.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.408 -0.807 . . . . 0.0 109.612 179.557 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 6' ' ' ASN . 4.6 mm? -92.87 156.99 16.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 110.6 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 11.2 m -166.25 121.24 1.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.421 -0.8 . . . . 0.0 109.772 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' THR . 3.6 m-20 42.98 66.17 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.173 -0.955 . . . . 0.0 110.023 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.736 ' H ' ' ND2' ' A' ' 6' ' ' ASN . 14.5 m -137.1 166.24 24.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.189 -0.944 . . . . 0.0 110.671 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 7.9 m-85 -130.09 -47.27 1.11 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.244 179.646 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.739 HG13 ' HD2' ' A' ' 42' ' ' PHE . 2.8 t 57.46 123.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.539 0.685 . . . . 0.0 110.668 179.025 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.468 ' C ' ' HB2' ' A' ' 12' ' ' SER . 1.9 m-20 -115.13 -14.97 11.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.284 -0.885 . . . . 0.0 110.362 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -175.65 66.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.898 . . . . 0.0 110.064 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.7 ' OG ' HG22 ' A' ' 45' ' ' VAL . 68.0 m -138.81 -170.47 2.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.183 -0.948 . . . . 0.0 110.24 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.622 ' C ' HG23 ' A' ' 32' ' ' VAL . 3.3 tt0 -127.88 -63.4 1.02 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.708 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.622 HG23 ' C ' ' A' ' 31' ' ' GLU . 2.4 t 68.0 135.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.438 -0.789 . . . . 0.0 110.093 179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.469 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 10.4 m-85 -147.52 46.61 1.12 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 110.505 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . 142.95 -10.39 2.31 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.83 HG22 ' H ' ' A' ' 37' ' ' CYS . 45.3 m -61.27 151.38 31.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.237 . . . . 0.0 110.609 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 21' ' ' THR . 51.5 m -88.37 -14.03 39.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.749 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.83 ' H ' HG22 ' A' ' 35' ' ' THR . 0.5 OUTLIER 47.42 70.92 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 179.696 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.503 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 99.6 m -87.71 100.77 13.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.133 -0.979 . . . . 0.0 110.15 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 90' ' ' ASN . . . 45.0 67.19 1.24 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.47 ' O ' ' NE ' ' A' ' 41' ' ' ARG . 32.3 t -153.01 173.18 15.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -1.093 . . . . 0.0 110.281 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -149.79 159.68 44.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.393 -0.817 . . . . 0.0 110.044 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.739 ' HD2' HG13 ' A' ' 27' ' ' VAL . 5.5 m-85 -125.28 -177.91 4.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.986 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -170.25 48.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.892 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 123.48 56.62 0.19 Allowed Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.7 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.27 -163.34 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.829 -1.395 . . . . 0.0 110.884 -179.775 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.608 ' N ' HG23 ' A' ' 45' ' ' VAL . 13.8 m -166.06 55.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.593 HD11 ' CB ' ' A' ' 50' ' ' SER . 21.4 tt -83.52 170.39 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.419 -0.801 . . . . 0.0 110.786 -179.239 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.469 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 62.6 p -128.63 -140.23 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.456 -0.777 . . . . 0.0 109.598 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.614 ' O ' HG22 ' A' ' 49' ' ' THR . 6.4 m -60.17 83.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.959 . . . . 0.0 110.092 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.593 ' CB ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -117.13 140.12 49.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.099 -1.001 . . . . 0.0 110.447 -179.753 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.529 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 26.6 m -91.18 19.37 5.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.213 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 68' ' ' ILE . 13.0 p -44.34 125.69 4.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 110.521 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.503 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 32.2 m -104.85 97.17 7.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.695 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 62.62 90.19 0.03 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 7.1 p -157.33 122.95 4.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.541 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.517 ' HB2' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -75.4 101.51 4.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.074 179.731 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 57' ' ' ILE . 4.0 mt -90.13 16.25 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.62 156.83 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.259 -0.9 . . . . 0.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.68 147.83 5.44 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.67 63.24 7.34 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.978 1.515 . . . . 0.0 110.009 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 113.98 17.4 7.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -40.28 159.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.543 -0.975 . . . . 0.0 110.946 -179.702 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 12.4 tttt -158.85 117.07 2.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.504 -0.747 . . . . 0.0 109.648 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 64' ' ' ILE . 3.0 mp -135.14 161.56 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.551 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.408 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -150.76 121.35 7.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 110.321 -179.874 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 49' ' ' THR . 3.5 m 46.45 69.85 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.395 -0.816 . . . . 0.0 110.738 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.618 ' HB3' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -123.48 104.39 9.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.467 -0.771 . . . . 0.0 109.541 179.164 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.529 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 1.7 mp -48.5 -64.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.739 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.819 HD13 ' CE2' ' A' ' 87' ' ' PHE . 20.4 mt 55.04 164.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 110.308 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.513 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 55.7 m -145.23 -106.33 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.905 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.789 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -83.96 76.08 2.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 87' ' ' PHE . . . 63.28 12.32 44.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 71' ' ' GLY . 13.9 m -116.34 136.33 23.04 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.383 -1.069 . . . . 0.0 110.254 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HA ' HG12 ' A' ' 69' ' ' ILE . 47.5 Cg_endo -78.12 138.24 16.05 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.897 1.472 . . . . 0.0 110.088 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -84.53 159.28 58.85 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.408 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.41 53.21 4.62 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 124.04 1.547 . . . . 0.0 110.555 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 t -89.96 158.17 17.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.608 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.2 -14.15 50.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.267 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.06 -22.45 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.336 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.481 ' CB ' ' HA ' ' A' ' 67' ' ' CYS . 34.7 t -63.79 123.14 18.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 110.054 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.63 ' HE2' HG23 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -93.15 -169.95 2.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.927 . . . . 0.0 110.481 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 82' ' ' ILE . 3.2 tp -179.94 40.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.803 0.811 . . . . 0.0 109.501 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 m -72.78 -96.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 111.64 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.84 66.31 0.95 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.111 -1.043 . . . . 0.0 110.637 -178.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 64' ' ' ILE . 4.8 t -160.3 -175.31 4.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.254 . . . . 0.0 110.022 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.547 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.5 t -177.23 159.29 1.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.98 . . . . 0.0 110.423 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.819 ' CE2' HD13 ' A' ' 69' ' ' ILE . 1.8 m-85 -118.87 156.68 29.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.787 . . . . 0.0 109.7 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -139.41 20.35 2.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.243 -0.91 . . . . 0.0 110.38 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 56.6 83.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.235 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 56' ' ' ARG . 3.2 t-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.095 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 1' ' ' ASP . 54.7 p30 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.264 0.554 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -134.44 -129.62 2.93 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.5 p -94.14 0.03 55.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.309 -1.112 . . . . 0.0 110.208 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.581 ' O ' HD22 ' A' ' 11' ' ' LEU . 8.8 t -78.43 152.75 32.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.326 -0.859 . . . . 0.0 110.519 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . 1.019 HG21 ' HA ' ' A' ' 9' ' ' SER . 3.3 m -169.9 -83.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.727 ' OD1' HG22 ' A' ' 5' ' ' THR . 7.5 p30 163.47 50.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.386 0.612 . . . . 0.0 109.863 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.6 OUTLIER 64.64 -64.64 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 110.568 179.893 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.542 ' HB2' ' HA ' ' A' ' 24' ' ' ASN . 11.1 t-20 -49.26 -34.46 15.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.097 -1.002 . . . . 0.0 109.964 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . 1.019 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.7 OUTLIER 72.94 55.53 0.13 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.516 -0.74 . . . . 0.0 111.662 179.49 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.558 ' HB3' ' CB ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -126.7 18.31 7.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.731 -1.23 . . . . 0.0 109.736 178.811 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.858 HD11 ' OG ' ' A' ' 15' ' ' SER . 13.6 tp -49.51 95.91 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -41.25 146.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 109.899 -179.808 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 14' ' ' ASN . . . -64.48 67.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.09 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 12' ' ' SER . 21.6 t-20 179.9 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.541 -0.725 . . . . 0.0 109.782 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.858 ' OG ' HD11 ' A' ' 11' ' ' LEU . 13.5 t -50.62 -176.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.34 -0.85 . . . . 0.0 110.249 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.16 160.66 41.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.206 -0.934 . . . . 0.0 110.4 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 t -178.55 148.17 0.43 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.162 -0.962 . . . . 0.0 110.24 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.93 -29.42 1.02 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 0.0 110.753 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -170.19 43.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.969 -1.082 . . . . 0.0 110.59 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.18 179.01 5.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.252 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.4 82.64 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 109.807 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 46.1 mt -94.22 -177.96 4.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -0.89 . . . . 0.0 110.605 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 1.8 m -161.74 118.58 2.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.499 -0.751 . . . . 0.0 109.357 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 43.8 m-20 58.58 75.73 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.419 -0.8 . . . . 0.0 110.261 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.536 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 0.5 OUTLIER -145.5 -157.26 0.78 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.071 -1.018 . . . . 0.0 110.206 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -160.29 -39.56 0.05 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.715 HG13 ' HD2' ' A' ' 42' ' ' PHE . 9.3 t 53.25 160.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.011 0.91 . . . . 0.0 111.649 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.603 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.2 t70 -171.37 127.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 66.2 mttt 46.48 43.11 11.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -0.984 . . . . 0.0 109.587 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.717 ' OG ' HG22 ' A' ' 45' ' ' VAL . 58.6 m -129.97 157.69 41.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' O ' ' O ' ' A' ' 47' ' ' ILE . 1.1 mt-10 -121.17 98.07 5.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.283 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 40.6 t -99.93 159.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.413 -0.804 . . . . 0.0 110.53 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.459 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 39.3 m-85 -139.02 -45.85 0.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 110.808 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.437 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -146.0 28.51 1.71 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 50' ' ' SER . 2.3 m -73.47 154.29 40.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.233 -1.157 . . . . 0.0 110.338 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.1 m -114.78 80.73 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -0.831 . . . . 0.0 109.815 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -63.31 151.77 39.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -0.89 . . . . 0.0 110.533 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 38' ' ' THR . 66.8 m -138.22 41.17 2.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.315 -0.866 . . . . 0.0 109.982 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 104.64 33.49 3.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.51 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 14.4 m -122.41 -152.46 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -1.151 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.465 ' HG3' ' OD1' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -178.18 168.04 1.95 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.078 -1.014 . . . . 0.0 110.53 179.889 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.715 ' HD2' HG13 ' A' ' 27' ' ' VAL . 8.3 m-85 -122.49 -169.98 2.0 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -0.891 . . . . 0.0 110.559 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.409 ' HA ' ' OD2' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -175.21 48.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.106 179.698 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 119.62 61.49 0.26 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.717 HG22 ' OG ' ' A' ' 30' ' ' SER . 2.4 m -137.34 -158.84 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.988 -1.301 . . . . 0.0 111.279 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.562 ' N ' HG23 ' A' ' 45' ' ' VAL . 94.5 m -167.09 58.79 0.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 14.3 tt -85.81 169.41 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 111.234 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 78.0 p -142.24 -148.9 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 109.175 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 66' ' ' THR . 59.8 m -46.05 111.97 0.42 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.17 -0.957 . . . . 0.0 108.699 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' THR . 4.3 t -173.36 158.46 3.54 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.125 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -116.98 131.6 56.91 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.044 -1.035 . . . . 0.0 109.783 179.57 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.8 125.65 13.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 109.961 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.7 m -105.48 123.42 47.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.967 . . . . 0.0 109.94 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 45.0 83.33 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 72' ' ' GLY . 78.7 p -158.15 128.98 6.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.231 -1.158 . . . . 0.0 110.432 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 6.6 ttp180 -94.18 107.55 19.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 110.12 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.642 ' O ' HG22 ' A' ' 57' ' ' ILE . 2.5 mp -84.52 12.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.94 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 57' ' ' ILE . 1.1 m -42.54 139.78 1.44 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 110.3 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 172.72 175.53 40.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.63 63.24 6.5 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.078 1.568 . . . . 0.0 110.128 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 94.99 2.5 62.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.561 ' C ' ' O ' ' A' ' 61' ' ' GLY . 2.4 t -11.37 121.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -105.98 144.13 33.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.223 -0.923 . . . . 0.0 109.817 179.356 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 63' ' ' LYS . 5.4 mt -152.96 127.18 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.977 . . . . 0.0 110.029 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.445 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -130.99 117.2 18.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 -179.84 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' THR . 3.1 m 54.05 86.15 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' THR . 0.5 OUTLIER -145.7 117.02 7.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.277 -0.89 . . . . 0.0 109.66 179.369 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.836 ' N ' HD12 ' A' ' 68' ' ' ILE . 3.4 mp -86.15 74.14 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.844 -1.16 . . . . 0.0 108.551 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.691 HG23 ' O ' ' A' ' 73' ' ' VAL . 13.7 mt -80.91 160.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.962 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.816 ' O ' HG22 ' A' ' 73' ' ' VAL . 97.1 m -158.71 98.85 1.53 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.004 . . . . 0.0 110.985 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 89.24 30.25 14.7 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.37 14.28 76.79 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.816 HG22 ' O ' ' A' ' 70' ' ' THR . 11.4 m -124.32 135.95 27.09 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.468 -1.019 . . . . 0.0 110.412 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HB2' HD11 ' A' ' 82' ' ' ILE . 49.6 Cg_endo -85.58 119.88 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.89 1.468 . . . . 0.0 110.466 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.533 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -77.47 167.09 39.22 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.273 -0.892 . . . . 0.0 109.788 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.533 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 42.2 Cg_endo -68.87 84.55 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.688 1.362 . . . . 0.0 109.409 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 78' ' ' ALA . 66.9 m -85.92 -6.35 59.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.631 -0.668 . . . . 0.0 111.155 -178.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 43.8 25.65 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 109.545 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -158.59 -40.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.523 -0.736 . . . . 0.0 109.301 -179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 29.1 t -46.95 169.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.555 -0.716 . . . . 0.0 109.738 179.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.547 ' HE3' ' CA ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -108.99 -32.23 7.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.936 -1.103 . . . . 0.0 112.156 -178.108 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.724 ' O ' HG22 ' A' ' 82' ' ' ILE . 4.1 mt 34.15 79.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.403 -0.81 . . . . 0.0 110.322 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.523 ' H ' ' HZ1' ' A' ' 81' ' ' LYS . 61.5 m -122.74 -98.14 0.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.92 -1.113 . . . . 0.0 111.088 -179.131 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.58 21.25 33.61 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -97.33 -163.54 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.253 . . . . 0.0 110.766 -179.726 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.539 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.9 OUTLIER 175.62 148.85 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.55 -0.719 . . . . 0.0 109.941 179.815 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -120.38 173.42 7.15 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.421 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.78 24.35 0.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.012 -1.055 . . . . 0.0 110.228 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 46.87 61.77 2.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.911 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.155 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.2 0.524 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.31 -140.94 3.82 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.0 t -116.69 106.51 13.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.164 -1.198 . . . . 0.0 110.223 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 5' ' ' THR . 4.3 m -92.94 -10.66 35.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 9' ' ' SER . 3.8 m 71.95 10.91 6.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 110.737 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.588 ' O ' ' CB ' ' A' ' 7' ' ' THR . 4.2 p-10 36.38 46.17 0.4 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.661 . . . . 0.0 109.978 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.588 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.8 m 84.96 -33.81 0.05 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.052 -0.405 . . . . 0.0 110.738 -179.372 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 5' ' ' THR . 1.9 t-20 179.97 44.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.664 -1.273 . . . . 0.0 112.18 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.626 ' N ' HG22 ' A' ' 5' ' ' THR . 0.7 OUTLIER -160.99 -132.41 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.766 -1.209 . . . . 0.0 110.472 178.763 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -113.94 -168.48 1.36 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.699 -1.251 . . . . 0.0 111.268 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.772 HD12 ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -165.23 69.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.726 . . . . 0.0 109.675 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.532 ' HB3' ' CA ' ' A' ' 28' ' ' ASP . 3.4 p 42.36 23.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.801 . . . . 0.0 110.896 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 41.66 23.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.985 -1.072 . . . . 0.0 110.641 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 28.6 p30 174.4 30.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.494 -0.754 . . . . 0.0 109.682 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.772 ' CB ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -69.8 -168.66 0.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 0.0 109.844 -179.674 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.544 ' CE ' ' HG3' ' A' ' 31' ' ' GLU . 1.3 mptp? -119.38 107.38 13.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 110.09 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -91.07 -140.23 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.528 -179.632 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 67.35 107.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.881 . . . . 0.0 109.867 -179.503 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 5.2 tttt 66.21 54.85 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 12.6 m -119.63 155.78 31.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 110.964 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 36' ' ' THR . 17.7 m -150.62 82.18 1.35 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.494 -0.754 . . . . 0.0 109.566 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -124.76 -163.54 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 0.0 110.775 -179.122 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 10.1 m -165.85 113.53 0.93 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.412 -0.805 . . . . 0.0 109.812 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.6 m-20 59.05 127.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.432 -0.793 . . . . 0.0 110.047 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 9' ' ' SER . 0.5 OUTLIER 172.9 -169.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 110.12 179.98 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' O ' ' O ' ' A' ' 27' ' ' VAL . 10.5 t80 -142.35 -46.63 0.34 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 108.679 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.892 HG13 ' HD2' ' A' ' 42' ' ' PHE . 3.5 t 57.14 133.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.673 0.749 . . . . 0.0 111.166 179.082 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.532 ' CA ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -137.66 124.33 21.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.226 179.336 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.2 mtmp? 42.21 55.37 3.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.777 ' OG ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -134.98 163.5 29.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.985 -1.072 . . . . 0.0 110.835 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.544 ' HG3' ' CE ' ' A' ' 16' ' ' LYS . 3.8 tt0 -96.74 -71.02 0.69 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.417 -0.802 . . . . 0.0 109.846 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.821 HG22 ' CG2' ' A' ' 47' ' ' ILE . 13.6 t 59.9 138.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.838 . . . . 0.0 110.614 179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.655 ' CD1' HG22 ' A' ' 48' ' ' THR . 60.5 m-85 -140.33 -81.21 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 109.551 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.43 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -94.41 29.65 8.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.503 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -73.65 161.85 29.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -1.028 . . . . 0.0 110.373 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 36' ' ' THR . 63.7 m -116.39 57.32 0.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.795 . . . . 0.0 109.733 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.567 ' CB ' ' HB2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -40.84 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 110.336 -179.839 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 38' ' ' THR . 85.8 m -89.66 48.91 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 110.261 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.47 24.94 37.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 86.4 p -99.44 -154.39 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -1.057 . . . . 0.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.444 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -167.7 156.29 9.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.099 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.892 ' HD2' HG13 ' A' ' 27' ' ' VAL . 10.0 m-85 -119.88 176.63 5.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.219 -0.926 . . . . 0.0 110.582 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -157.49 61.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.5 -0.75 . . . . 0.0 109.814 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 96.92 67.37 0.94 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.777 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.4 m -135.92 -160.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.972 -1.311 . . . . 0.0 111.274 -179.323 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.664 ' O ' HG22 ' A' ' 46' ' ' THR . 69.8 m -166.17 54.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.391 0.615 . . . . 0.0 109.403 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.821 ' CG2' HG22 ' A' ' 32' ' ' VAL . 11.9 tt -80.46 172.17 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 110.551 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.655 HG22 ' CD1' ' A' ' 33' ' ' TYR . 14.8 p -140.1 -113.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.54 ' O ' HG22 ' A' ' 49' ' ' THR . 55.3 m -83.55 71.66 10.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.917 -1.114 . . . . 0.0 109.632 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.588 ' HB2' HD11 ' A' ' 47' ' ' ILE . 4.8 m -128.67 141.76 51.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 110.649 -179.451 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -89.46 133.64 34.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.692 179.593 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.42 121.08 12.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 110.33 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.3 93.73 5.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 109.789 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 62.21 92.69 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 87.5 p -161.21 122.09 2.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -1.099 . . . . 0.0 110.418 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' HB2' ' CB ' ' A' ' 90' ' ' ASN . 10.3 ttp180 -77.6 103.59 7.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.318 -0.864 . . . . 0.0 109.657 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.555 ' O ' HG12 ' A' ' 45' ' ' VAL . 32.4 mm -78.63 9.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 110.763 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.474 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 53.1 p -40.84 150.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.143 -0.973 . . . . 0.0 110.602 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 168.09 140.75 3.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.66 57.93 3.12 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.089 1.573 . . . . 0.0 109.762 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.4 20.61 3.23 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -42.83 148.92 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -1.113 . . . . 0.0 110.589 -179.865 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -152.27 112.73 4.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.766 HG23 ' CE ' ' A' ' 81' ' ' LYS . 1.9 mp -128.81 157.53 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.161 -0.962 . . . . 0.0 110.868 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.479 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -156.87 106.88 2.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.376 -0.828 . . . . 0.0 109.909 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.2 m 63.33 82.18 0.19 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.255 -0.903 . . . . 0.0 110.325 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.487 ' N ' ' OG ' ' A' ' 50' ' ' SER . 16.1 m -146.52 109.09 4.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.441 -0.787 . . . . 0.0 109.662 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.738 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -73.44 90.21 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.046 -1.033 . . . . 0.0 109.624 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.718 HG23 ' C ' ' A' ' 73' ' ' VAL . 10.0 mt -98.25 156.88 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.397 -0.814 . . . . 0.0 110.292 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.815 ' O ' HG22 ' A' ' 73' ' ' VAL . 5.2 m -155.01 100.79 2.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.193 -0.942 . . . . 0.0 110.45 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.43 35.07 8.88 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 76.61 15.93 81.16 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 70' ' ' THR . 7.9 m -126.01 132.97 24.49 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.314 -1.109 . . . . 0.0 110.838 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.64 153.46 20.26 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.917 1.483 . . . . 0.0 110.601 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -96.25 162.62 23.06 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.907 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.8 Cg_endo -73.27 75.77 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.062 1.559 . . . . 0.0 110.569 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.57 140.03 45.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.15 -27.92 53.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.31 -2.92 57.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 0.0 110.278 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 66' ' ' THR . 2.5 t -90.03 146.94 23.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 110.061 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.766 ' CE ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -103.02 -164.12 1.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.351 -0.843 . . . . 0.0 111.282 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 82' ' ' ILE . 2.3 tp 175.99 34.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.1 m -70.32 -100.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.471 -0.768 . . . . 0.0 111.569 -179.038 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -99.8 78.96 0.48 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.702 -178.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.54 ' SG ' HD11 ' A' ' 64' ' ' ILE . 3.8 t -158.43 -174.02 4.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.172 -1.193 . . . . 0.0 109.221 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.571 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 8.0 t -179.7 158.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 0.0 111.153 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -128.35 161.53 29.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.586 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.716 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 5.8 t -145.05 12.24 1.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.953 -1.092 . . . . 0.0 110.015 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 68.21 5.11 4.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.213 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.546 ' OXT' ' CG ' ' A' ' 90' ' ' ASN . 1.6 p30 . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 117.375 -1.298 . . . . 0.0 112.152 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.433 ' O ' ' OD1' ' A' ' 1' ' ' ASP . 18.5 t0 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.212 0.53 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.57 161.81 12.62 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.56 92.66 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -1.154 . . . . 0.0 110.208 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.662 ' CB ' HD23 ' A' ' 11' ' ' LEU . 63.5 m -79.03 -160.11 0.22 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.941 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 5' ' ' THR . 72.6 m -158.56 10.59 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.004 . . . . 0.0 111.072 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.593 ' O ' ' CB ' ' A' ' 7' ' ' THR . 6.1 t30 42.37 40.35 1.81 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.087 -1.008 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.593 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.6 m 80.71 -25.81 0.17 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.581 -0.699 . . . . 0.0 110.794 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 7' ' ' THR . 1.5 m-80 166.87 65.6 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.857 -1.152 . . . . 0.0 110.494 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 10' ' ' GLN . 10.9 p -160.33 -121.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.924 -1.11 . . . . 0.0 111.126 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.56 ' NE2' ' CE2' ' A' ' 26' ' ' TYR . 1.3 mt-30 -122.65 -54.83 1.84 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.806 -1.184 . . . . 0.0 110.987 -178.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.662 HD23 ' CB ' ' A' ' 4' ' ' CYS . 6.8 tp 48.02 82.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 108.995 -178.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.481 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 79.7 p -39.46 137.8 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.7 -0.625 . . . . 0.0 110.683 -179.208 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.02 -20.68 2.56 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 109.248 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.583 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -77.39 -7.09 55.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.507 -0.746 . . . . 0.0 110.146 179.813 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.626 ' OG ' HD11 ' A' ' 11' ' ' LEU . 39.8 t -85.7 -163.01 0.79 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 109.915 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.19 133.32 21.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.056 -1.027 . . . . 0.0 110.172 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 25.7 p -132.31 132.92 43.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.164 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -160.48 -84.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 110.234 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.7 39.82 2.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 110.444 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.536 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 48.1 m -105.49 153.32 21.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 110.468 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.446 ' C ' HD23 ' A' ' 22' ' ' LEU . 52.1 m -111.54 84.81 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.362 -0.836 . . . . 0.0 109.165 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 37' ' ' CYS . 6.2 mt -101.03 175.58 5.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.139 -0.975 . . . . 0.0 111.102 -178.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 22.9 m -157.09 107.27 2.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.638 -0.664 . . . . 0.0 109.737 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 39' ' ' GLY . 3.7 m-20 56.99 100.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 110.427 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.545 ' N ' ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -157.92 -173.65 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.162 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.56 ' CE2' ' NE2' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -134.69 -48.43 0.75 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 179.021 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.663 HG13 ' HD2' ' A' ' 42' ' ' PHE . 14.1 t 55.22 144.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 122.027 0.917 . . . . 0.0 111.532 178.235 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.52 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -152.19 121.96 6.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.53 -0.731 . . . . 0.0 109.716 179.271 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 54.99 39.19 31.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.015 . . . . 0.0 109.97 -179.602 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.741 ' CB ' HG22 ' A' ' 45' ' ' VAL . 50.3 m -123.36 -163.08 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.257 -0.902 . . . . 0.0 110.52 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.685 ' C ' HG23 ' A' ' 32' ' ' VAL . 1.1 mt-10 -146.21 -72.0 0.24 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.352 -0.842 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.685 HG23 ' C ' ' A' ' 31' ' ' GLU . 2.6 t 73.15 141.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.602 -0.686 . . . . 0.0 111.038 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 38.8 m-85 -145.75 35.89 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.453 -0.779 . . . . 0.0 110.154 179.835 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 145.86 -7.7 1.47 Allowed Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.292 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.652 ' HB ' HG13 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -57.87 167.29 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.969 -1.312 . . . . 0.0 110.165 -179.857 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 36' ' ' THR . 9.2 t -108.45 62.14 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 0.0 110.309 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -47.02 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.2 179.899 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' THR . 2.3 m -100.96 101.43 12.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.153 -0.967 . . . . 0.0 109.724 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 44.21 52.33 7.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 3.8 m -128.16 179.89 5.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.072 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 41.5 mtt180 -149.53 147.85 28.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.873 . . . . 0.0 110.38 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.663 ' HD2' HG13 ' A' ' 27' ' ' VAL . 17.9 m-30 -116.74 175.84 5.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -0.839 . . . . 0.0 109.593 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.538 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 2.3 t0 -157.85 50.03 0.42 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.058 -1.027 . . . . 0.0 110.376 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 114.34 63.14 0.41 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.741 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -132.25 -166.86 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.028 -1.278 . . . . 0.0 110.625 -179.72 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.67 ' O ' HG22 ' A' ' 46' ' ' THR . 51.4 m -166.16 56.47 0.1 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 50' ' ' SER . 17.5 tt -82.44 170.74 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.584 -0.697 . . . . 0.0 111.102 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 44.9 p -133.25 -127.06 0.17 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.661 -0.649 . . . . 0.0 109.615 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.632 ' O ' HG22 ' A' ' 49' ' ' THR . 20.5 m -76.43 74.49 3.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.998 -1.064 . . . . 0.0 109.935 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.553 ' HB2' HD11 ' A' ' 47' ' ' ILE . 7.7 m -128.88 142.92 50.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.043 -1.036 . . . . 0.0 110.372 -179.427 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -86.61 135.13 33.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.021 -1.049 . . . . 0.0 110.19 179.909 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.405 ' H ' HG22 ' A' ' 36' ' ' THR . 3.1 p -154.69 125.46 7.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 110.149 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -111.68 121.06 44.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.32 -0.863 . . . . 0.0 110.014 -179.843 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 44.97 85.32 0.01 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 74.9 p -153.42 123.74 7.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.999 . . . . 0.0 110.581 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -86.24 99.87 11.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.178 -0.951 . . . . 0.0 109.466 179.358 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.677 ' O ' HG22 ' A' ' 57' ' ' ILE . 2.7 mp -82.93 18.49 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 110.533 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.538 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -41.17 155.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.386 -0.821 . . . . 0.0 110.031 179.488 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 157.54 151.7 6.11 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.72 53.63 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.088 1.573 . . . . 0.0 110.263 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 119.87 22.47 3.27 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.478 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -39.78 108.23 0.08 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.236 -1.155 . . . . 0.0 110.766 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.471 ' C ' HD12 ' A' ' 64' ' ' ILE . 17.2 tttp -101.56 122.43 43.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.034 . . . . 0.0 109.669 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.725 ' N ' HD12 ' A' ' 64' ' ' ILE . 4.5 mp -128.4 139.83 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.083 -1.011 . . . . 0.0 110.447 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.51 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -143.25 112.43 6.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.015 -1.053 . . . . 0.0 111.065 -179.908 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 1.9 m 48.37 80.37 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.566 -0.709 . . . . 0.0 112.055 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 80' ' ' CYS . 40.0 t -139.2 136.99 35.61 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.805 ' N ' HD12 ' A' ' 68' ' ' ILE . 2.0 mp -90.75 88.07 2.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.27 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.738 HG21 ' CD2' ' A' ' 87' ' ' PHE . 12.3 mt -96.6 158.71 3.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.787 -0.571 . . . . 0.0 110.223 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.902 ' O ' HG22 ' A' ' 73' ' ' VAL . 3.2 m -166.21 106.49 0.68 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -0.91 . . . . 0.0 110.445 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.527 ' O ' HG13 ' A' ' 73' ' ' VAL . . . 86.29 34.53 12.17 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.563 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 71.28 21.09 78.53 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 70' ' ' THR . 3.5 m -125.74 120.84 24.41 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.29 -1.124 . . . . 0.0 110.65 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.83 141.06 18.91 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.721 1.379 . . . . 0.0 110.354 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -95.29 138.66 21.89 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.773 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.22 70.84 3.77 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.9 1.474 . . . . 0.0 110.219 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -97.66 166.55 11.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.35 -15.28 62.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.36 -36.93 5.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.14 -0.975 . . . . 0.0 110.745 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 67' ' ' CYS . 15.5 t -44.64 127.11 5.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.099 -1.0 . . . . 0.0 110.777 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.582 ' HD3' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -94.71 -172.34 2.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 110.135 179.751 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.781 HG23 ' O ' ' A' ' 82' ' ' ILE . 2.6 tp 179.09 39.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.492 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.0 m -104.82 87.27 2.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.052 -1.03 . . . . 0.0 111.766 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.11 52.75 2.67 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.459 178.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.448 ' SG ' HD11 ' A' ' 64' ' ' ILE . 10.0 t -165.46 170.46 14.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.263 -1.139 . . . . 0.0 109.927 179.229 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.541 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 9.2 t -176.38 159.53 1.99 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.96 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.738 ' CD2' HG21 ' A' ' 69' ' ' ILE . 1.7 m-85 -126.03 151.66 46.82 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.066 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.54 29.41 4.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.313 -0.867 . . . . 0.0 109.239 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 51.41 83.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.402 -0.811 . . . . 0.0 109.648 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.447 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 2.1 tt0 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 121.415 0.626 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.846 HD12 ' OG ' ' A' ' 15' ' ' SER . 2.8 mm? -48.13 113.81 0.81 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.459 -0.776 . . . . 0.0 109.897 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 57.1 p -32.93 -67.21 0.12 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.982 -0.449 . . . . 0.0 110.938 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 12' ' ' SER . . . 179.93 -32.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.113 -0.992 . . . . 0.0 110.709 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -114.07 15.39 18.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 110.373 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.846 ' OG ' HD12 ' A' ' 11' ' ' LEU . 11.2 t -68.26 -171.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.548 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 1.3 tttp -143.96 142.32 30.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.976 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.67 126.83 8.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.04 -51.71 1.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.895 . . . . 0.0 110.404 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.02 55.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.379 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.4 p -101.17 -171.8 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 110.065 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -135.14 63.9 1.6 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.067 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.649 HD23 ' N ' ' A' ' 22' ' ' LEU . 4.0 mt -78.89 -179.01 6.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 0.0 110.539 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 23.6 m -164.25 119.09 1.48 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 110.045 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.466 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 2.4 m120 57.97 45.75 17.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.882 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -155.54 0.55 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.301 -0.875 . . . . 0.0 110.784 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.534 ' HA ' ' HB3' ' A' ' 10' ' ' GLN . 4.1 t80 -167.51 -40.78 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.833 HG13 ' HD2' ' A' ' 42' ' ' PHE . 11.4 t 54.63 149.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.982 0.896 . . . . 0.0 111.773 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 42' ' ' PHE . 4.9 t0 -156.4 122.3 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 11.1 mtpp 49.67 55.01 10.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.915 -1.116 . . . . 0.0 109.512 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.661 ' OG ' HG22 ' A' ' 45' ' ' VAL . 46.2 m -142.98 -175.63 4.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.111 -0.993 . . . . 0.0 110.436 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 5.6 mt-10 -128.2 -67.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.0 110.612 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.703 HG22 ' CG2' ' A' ' 47' ' ' ILE . 7.7 t 62.64 154.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.202 -0.936 . . . . 0.0 110.28 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.427 ' CD2' HG22 ' A' ' 48' ' ' THR . 22.6 m-85 -150.08 -43.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -138.0 25.37 2.92 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.52 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 10.6 m -71.75 151.47 43.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.32 -1.106 . . . . 0.0 110.51 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 36' ' ' THR . 52.1 m -109.13 55.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 109.917 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 17.5 t -40.31 140.76 0.58 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.465 -0.772 . . . . 0.0 110.348 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.61 ' O ' HG22 ' A' ' 38' ' ' THR . 99.6 m -123.69 13.3 9.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.921 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 128.46 51.84 0.13 Allowed Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.52 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 1.3 m -134.71 -169.22 2.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.355 -1.085 . . . . 0.0 110.205 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -147.38 170.71 16.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.277 -0.889 . . . . 0.0 110.183 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.833 ' HD2' HG13 ' A' ' 27' ' ' VAL . 19.8 m-85 -130.88 178.25 6.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.106 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -169.43 65.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 103.27 49.24 1.15 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.661 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -125.66 -176.5 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.729 -1.453 . . . . 0.0 110.962 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 46' ' ' THR . 55.3 m -153.21 55.48 0.76 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.727 HD12 HG21 ' A' ' 64' ' ' ILE . 10.6 tt -82.25 174.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.382 -0.824 . . . . 0.0 110.898 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 50' ' ' SER . 45.1 p -146.24 -136.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -0.755 . . . . 0.0 109.31 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 66' ' ' THR . 99.9 m -58.33 82.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.054 -1.029 . . . . 0.0 110.046 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 48' ' ' THR . 29.3 t -142.36 145.61 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.996 -1.065 . . . . 0.0 110.926 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -98.41 128.16 44.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.142 -0.974 . . . . 0.0 110.231 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -141.16 130.35 23.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.194 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.01 105.3 15.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 109.889 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA2' ' OG ' ' A' ' 40' ' ' SER . . . 51.27 91.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 8.5 p -154.86 119.2 4.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.12 . . . . 0.0 110.53 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.53 ' CD ' ' HB2' ' A' ' 58' ' ' SER . 1.6 ttm180 -72.76 101.96 3.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.696 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.471 ' O ' HG12 ' A' ' 45' ' ' VAL . 7.9 mm -84.07 12.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.956 . . . . 0.0 110.28 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.53 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -42.68 153.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.402 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.53 147.63 4.95 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.56 55.27 4.7 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.911 1.48 . . . . 0.0 109.762 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 63' ' ' LYS . . . 123.6 21.51 2.43 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -46.97 123.31 5.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -1.156 . . . . 0.0 111.108 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.543 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -112.41 145.65 39.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.233 -0.917 . . . . 0.0 109.649 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.727 HG21 HD12 ' A' ' 47' ' ' ILE . 11.3 mt -155.0 126.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.0 110.352 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.482 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -136.31 103.07 5.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.821 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.9 OUTLIER 68.17 80.12 0.21 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.526 -0.734 . . . . 0.0 110.382 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.7 t -138.96 120.38 14.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.846 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.6 mp -88.53 79.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 108.512 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.685 HG23 ' C ' ' A' ' 73' ' ' VAL . 11.1 mt -89.42 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.243 0.544 . . . . 0.0 110.193 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.845 ' O ' HG22 ' A' ' 73' ' ' VAL . 7.2 m -150.52 100.79 2.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.297 -0.877 . . . . 0.0 110.424 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.78 33.14 10.2 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 77.95 15.46 81.14 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 70' ' ' THR . 6.1 m -125.79 129.75 24.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.337 -1.096 . . . . 0.0 110.682 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 46.7 Cg_endo -75.96 144.59 27.37 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.831 1.437 . . . . 0.0 110.253 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -90.86 162.0 34.28 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.693 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.97 66.16 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.793 1.418 . . . . 0.0 110.121 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.489 ' OG ' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -108.07 125.78 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 110.345 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.79 -1.88 15.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 110.304 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.2 -23.73 17.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.091 -1.006 . . . . 0.0 110.493 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 49.3 t -72.87 167.4 21.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.523 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -108.63 -41.31 4.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.014 -1.054 . . . . 0.0 111.765 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.533 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 34.0 mm 47.13 74.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.894 -1.128 . . . . 0.0 109.683 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.59 -80.98 0.6 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.069 -1.019 . . . . 0.0 110.939 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.23 37.99 3.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.5 t -132.04 178.64 6.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.053 -1.263 . . . . 0.0 109.872 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.555 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t -173.87 155.0 2.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.228 -0.92 . . . . 0.0 109.662 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -125.57 158.28 35.01 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.904 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 26.4 t -141.36 22.87 2.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.719 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.71 80.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.411 -0.806 . . . . 0.0 109.84 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.52 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.394 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.205 0.526 . . . . 0.0 111.327 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.707 HD11 ' OG ' ' A' ' 15' ' ' SER . 14.4 tp -102.14 96.25 6.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.101 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -36.34 134.6 0.42 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.53 0.681 . . . . 0.0 111.117 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.85 -21.27 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 110.54 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -96.65 -2.55 44.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.998 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.848 ' OG ' HG11 ' A' ' 27' ' ' VAL . 19.4 t -73.08 -169.15 0.57 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.842 -1.161 . . . . 0.0 110.073 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.75 130.99 14.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.152 -0.968 . . . . 0.0 110.981 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 18' ' ' GLU . 10.3 p -139.64 -179.28 5.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.897 . . . . 0.0 109.804 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 169.65 -80.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 109.74 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.34 13.27 9.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.845 . . . . 0.0 109.602 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -77.0 -147.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.765 . . . . 0.0 110.297 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.621 ' C ' HD22 ' A' ' 22' ' ' LEU . 18.9 m -153.23 88.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 110.321 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.869 HD21 HG11 ' A' ' 32' ' ' VAL . 3.5 mm? -106.31 90.5 3.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.64 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 9.3 m -93.32 139.93 30.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.189 -0.944 . . . . 0.0 111.176 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.471 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 2.5 m-80 37.05 40.91 0.17 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.765 -0.584 . . . . 0.0 110.76 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -81.69 -152.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.19 -0.944 . . . . 0.0 110.676 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.564 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 56.5 t80 179.46 42.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.848 HG11 ' OG ' ' A' ' 15' ' ' SER . 6.6 t -53.46 149.95 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.857 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.493 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.1 OUTLIER -130.95 -29.03 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.441 0.639 . . . . 0.0 109.746 179.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.52 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 2.4 mtmt -168.86 68.48 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.307 -0.871 . . . . 0.0 109.329 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.759 ' CB ' HG22 ' A' ' 45' ' ' VAL . 84.0 p -141.34 168.68 19.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.119 -0.988 . . . . 0.0 111.706 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 47' ' ' ILE . 5.6 mt-10 -124.03 113.32 18.26 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.869 HG11 HD21 ' A' ' 22' ' ' LEU . 9.3 t -112.57 149.07 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 111.094 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CD1' HG22 ' A' ' 48' ' ' THR . 58.6 m-85 -128.77 -25.95 2.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -0.875 . . . . 0.0 110.905 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -167.82 32.59 0.19 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.576 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 4.8 m -81.98 146.44 29.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -1.157 . . . . 0.0 110.328 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 m -100.91 85.62 2.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.421 -0.8 . . . . 0.0 109.37 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.584 ' HB2' HD13 ' A' ' 22' ' ' LEU . 44.9 t -73.79 101.2 3.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.523 -0.735 . . . . 0.0 110.927 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 38' ' ' THR . 4.3 t -89.08 28.38 1.21 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.3 -0.875 . . . . 0.0 110.101 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 113.49 62.73 0.43 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 9.8 t -139.87 -173.94 3.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.44 -1.035 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.564 ' CB ' ' HB3' ' A' ' 26' ' ' TYR . 13.4 ptt180 -153.46 154.63 34.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.902 -1.124 . . . . 0.0 110.757 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.486 ' HD2' HG13 ' A' ' 27' ' ' VAL . 6.0 m-85 -119.15 -168.99 1.66 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.438 -0.789 . . . . 0.0 109.016 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.505 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 3.5 t0 -179.91 61.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.607 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 106.27 57.61 0.63 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.759 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -138.59 -157.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.887 -1.361 . . . . 0.0 110.601 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.702 ' N ' HG23 ' A' ' 45' ' ' VAL . 65.8 m -167.75 57.28 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.693 -0.629 . . . . 0.0 109.925 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 31' ' ' GLU . 16.0 tt -75.13 162.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 110.155 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' SER . 31.8 p -131.96 -134.34 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.068 -1.02 . . . . 0.0 109.963 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 49' ' ' THR . 95.5 m -65.89 64.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.981 -1.074 . . . . 0.0 110.257 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 48' ' ' THR . 3.1 t -128.08 139.85 52.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 0.0 110.588 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.459 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -90.05 146.71 24.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.859 . . . . 0.0 109.691 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.38 130.99 11.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.04 -1.038 . . . . 0.0 110.597 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.29 111.66 22.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.106 -0.997 . . . . 0.0 110.068 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.9 79.03 0.08 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 13.4 p -148.26 134.82 19.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -1.184 . . . . 0.0 110.111 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -89.99 108.54 19.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.453 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.599 HG23 ' CD1' ' A' ' 64' ' ' ILE . 17.4 mm -88.04 -1.46 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.178 -0.951 . . . . 0.0 109.998 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.505 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 1.1 m -42.56 150.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.36 -0.838 . . . . 0.0 110.864 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 164.16 153.56 7.44 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.94 -2.08 11.45 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.064 1.56 . . . . 0.0 109.903 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.76 34.08 0.08 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.415 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.3 t -65.82 130.26 42.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -1.117 . . . . 0.0 110.452 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 14.5 tttm -135.3 125.1 25.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 110.402 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.605 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 4.3 mt -126.64 146.54 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.99 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 66' ' ' THR . 30.6 p -142.04 126.15 17.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.926 . . . . 0.0 110.516 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 49' ' ' THR . 25.0 m 39.77 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.57 -0.706 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 2.8 t -152.92 108.08 3.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -0.876 . . . . 0.0 110.047 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.733 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.8 mp -72.3 87.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.488 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.758 HG23 ' C ' ' A' ' 73' ' ' VAL . 3.9 mt -90.22 155.7 3.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.555 -0.716 . . . . 0.0 110.62 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.793 ' O ' HG22 ' A' ' 73' ' ' VAL . 18.7 m -156.31 102.65 2.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.334 -0.854 . . . . 0.0 110.553 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.6 26.76 24.16 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.576 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.77 16.31 70.76 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 70' ' ' THR . 4.0 m -127.24 133.72 25.37 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.536 -0.979 . . . . 0.0 110.155 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.18 148.09 16.66 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.793 1.417 . . . . 0.0 110.666 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -93.77 149.28 36.8 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.563 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.02 114.74 4.06 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.937 1.493 . . . . 0.0 110.85 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.675 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 1.3 t -134.14 -0.6 3.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 110.44 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 66.2 6.84 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.966 . . . . 0.0 110.409 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.28 -32.34 1.37 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.404 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -57.15 151.89 14.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.985 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.66 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -104.13 175.18 5.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.504 -0.747 . . . . 0.0 109.958 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 82' ' ' ILE . 46.1 mm -155.99 38.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.9 m -59.71 -104.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.73 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.92 89.52 0.48 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.708 ' C ' HG22 ' A' ' 86' ' ' THR . 1.6 t -147.18 -149.39 0.29 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.235 . . . . 0.0 110.311 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.708 HG22 ' C ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER 169.98 142.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.391 -0.818 . . . . 0.0 109.539 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.576 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.4 m-85 -116.99 -19.62 9.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.517 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.773 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 0.4 OUTLIER 45.72 -92.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 110.031 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . 157.36 64.92 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.904 -0.498 . . . . 0.0 110.031 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.43 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.004 -1.06 . . . . 0.0 109.978 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 1.6 tt0 . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.198 0.523 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 17.3 tp 57.03 111.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.11 -0.994 . . . . 0.0 109.922 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 12.9 t -68.39 161.11 28.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.284 -0.885 . . . . 0.0 110.405 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.74 -8.01 31.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.968 . . . . 0.0 110.073 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -97.74 -11.47 23.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.645 ' OG ' HG11 ' A' ' 27' ' ' VAL . 41.5 t -76.27 -163.29 0.29 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.972 . . . . 0.0 110.046 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.25 134.84 15.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.554 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.1 t -135.7 32.67 3.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.934 . . . . 0.0 110.2 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 19' ' ' LYS . 1.4 tm-20 -55.61 127.21 28.78 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 43.01 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -159.52 -171.07 3.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.044 -1.035 . . . . 0.0 111.005 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' THR . 8.5 m -156.55 72.78 0.75 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.486 -0.759 . . . . 0.0 109.71 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.662 ' O ' ' CB ' ' A' ' 23' ' ' THR . 4.0 mt -75.44 -116.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 110.369 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.662 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 1.1 m 146.21 -62.59 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.479 ' N ' HG22 ' A' ' 23' ' ' THR . 73.7 m-20 -132.03 34.87 3.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.444 -0.785 . . . . 0.0 110.162 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -67.85 -159.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.02 0.914 . . . . 0.0 110.904 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 25' ' ' CYS . 46.9 m-85 -162.96 -54.74 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.654 HG12 ' H ' ' A' ' 28' ' ' ASP . 3.3 t 44.59 -179.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 122.14 0.971 . . . . 0.0 111.727 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.654 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -175.81 -33.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 46.8 mtmt -150.45 56.3 0.93 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.534 ' HB2' HG13 ' A' ' 27' ' ' VAL . 75.5 m -135.5 164.11 28.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.953 -1.092 . . . . 0.0 111.86 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 2.4 tt0 -120.64 107.62 13.02 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.63 HG22 ' CG2' ' A' ' 47' ' ' ILE . 17.9 t -110.29 160.1 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.052 -1.03 . . . . 0.0 111.379 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.556 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 94.9 m-85 -157.33 44.66 0.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.427 -0.796 . . . . 0.0 110.455 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' ' OG ' ' A' ' 20' ' ' SER . . . 138.72 33.08 0.19 Allowed Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.15 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.606 ' HB ' HG11 ' A' ' 32' ' ' VAL . 5.6 m -95.24 144.07 26.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.24 . . . . 0.0 110.257 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.724 ' O ' HG22 ' A' ' 36' ' ' THR . 32.0 m -94.61 53.35 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.36 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.499 ' HB2' ' CB ' ' A' ' 22' ' ' LEU . 1.2 m -50.4 87.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.425 -0.797 . . . . 0.0 110.888 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 36' ' ' THR . 5.2 t -104.78 36.07 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.21 46.6 0.18 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -141.24 167.17 22.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.314 -1.11 . . . . 0.0 109.856 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.471 ' CB ' ' HB2' ' A' ' 26' ' ' TYR . 5.3 ptt180 -146.12 152.11 38.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.961 -1.087 . . . . 0.0 110.803 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.628 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 6.8 m-85 -116.64 -167.63 1.32 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 7.1 t0 -177.46 53.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.414 -0.804 . . . . 0.0 110.165 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 114.88 60.2 0.37 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.512 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.4 m -139.28 -169.98 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.997 -1.296 . . . . 0.0 110.297 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 46' ' ' THR . 35.8 m -149.47 51.02 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.309 -0.869 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.63 ' CG2' HG22 ' A' ' 32' ' ' VAL . 7.9 tt -68.2 173.58 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 110.45 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 12.0 p -142.73 -98.76 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 110.067 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.737 HG22 ' O ' ' A' ' 49' ' ' THR . 15.8 m -104.05 69.83 0.96 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.986 -1.071 . . . . 0.0 109.715 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB2' HD11 ' A' ' 47' ' ' ILE . 10.6 m -121.13 147.19 45.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.116 -0.99 . . . . 0.0 111.161 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -99.66 121.57 41.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.436 -0.79 . . . . 0.0 109.168 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -139.85 136.54 34.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.345 -0.847 . . . . 0.0 110.406 -179.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -121.63 89.27 3.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.824 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.09 76.29 1.21 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 p -148.97 124.53 10.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -1.094 . . . . 0.0 110.551 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.46 ' HD2' ' HB2' ' A' ' 58' ' ' SER . 0.1 OUTLIER -90.35 96.66 10.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.242 -0.911 . . . . 0.0 109.896 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.628 ' CD1' ' CE1' ' A' ' 42' ' ' PHE . 3.1 mt -84.15 17.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.671 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -43.8 151.03 0.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.01 -1.057 . . . . 0.0 110.078 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 162.59 162.27 13.33 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.02 -1.35 11.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.134 1.597 . . . . 0.0 109.852 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.68 33.88 0.02 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.447 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.7 t -50.68 123.34 8.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.216 -1.167 . . . . 0.0 110.006 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.515 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 8.6 tttt -102.64 128.2 49.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.07 -1.019 . . . . 0.0 110.174 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 28.8 mm -133.81 141.3 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.907 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -151.62 126.38 9.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.298 -0.876 . . . . 0.0 110.101 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.5 m 39.02 71.59 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.573 0.702 . . . . 0.0 110.756 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.466 ' C ' HD12 ' A' ' 68' ' ' ILE . 73.4 m -130.13 125.6 35.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.428 -0.795 . . . . 0.0 109.252 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.777 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.9 mp -93.47 88.48 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.836 -1.165 . . . . 0.0 110.131 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.536 HG12 ' CE2' ' A' ' 87' ' ' PHE . 14.3 mt -96.23 156.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.522 -0.736 . . . . 0.0 110.061 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.787 ' O ' HG22 ' A' ' 73' ' ' VAL . 34.7 m -152.25 93.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 110.224 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.94 31.88 9.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 80.0 16.63 76.44 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 70' ' ' THR . 16.1 m -124.73 120.11 25.73 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.391 -1.064 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -73.72 145.81 37.4 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.949 1.5 . . . . 0.0 110.509 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -90.68 166.61 18.7 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.365 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.4 Cg_endo -72.03 56.3 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.723 1.38 . . . . 0.0 109.603 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.563 ' OG ' HD13 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -84.92 126.09 33.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.242 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.26 -9.13 59.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.837 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.94 -12.61 23.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.353 -0.842 . . . . 0.0 110.526 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' SER . 38.2 t -77.44 168.84 19.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.107 -0.996 . . . . 0.0 109.619 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HE3' ' N ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -98.64 -32.18 11.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.793 -1.192 . . . . 0.0 111.399 -178.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.527 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 28.3 mm 38.19 57.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.186 -0.946 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 m -113.37 -100.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.0 -1.062 . . . . 0.0 110.422 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -101.19 89.58 0.8 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -166.36 -172.72 2.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.147 -1.208 . . . . 0.0 110.759 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.512 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 2.6 t -178.02 157.51 1.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.484 -0.76 . . . . 0.0 109.52 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 2.2 m-30 -114.33 -54.68 2.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 110.076 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 65.07 11.08 6.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.087 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 47.14 95.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 109.963 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 89' ' ' ALA . 5.1 p30 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.305 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.474 ' CB ' ' CD2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.137 0.494 . . . . 0.0 110.155 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.619 HD11 ' OG ' ' A' ' 15' ' ' SER . 12.3 tp 41.19 84.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.365 -0.834 . . . . 0.0 109.892 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.543 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 86.1 p -45.46 164.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 110.187 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 -14.03 60.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.846 . . . . 0.0 110.299 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -93.95 -6.62 45.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.164 -0.96 . . . . 0.0 110.5 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.619 ' OG ' HD11 ' A' ' 11' ' ' LEU . 4.8 t -74.08 -176.65 2.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.957 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.418 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -142.09 131.43 23.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.274 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 t -138.6 159.88 40.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.262 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -172.86 -87.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.014 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -114.55 72.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.134 -0.979 . . . . 0.0 110.1 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -117.92 -164.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.855 . . . . 0.0 110.216 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 21' ' ' THR . 5.2 t -150.15 60.42 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.765 HD23 ' O ' ' A' ' 35' ' ' THR . 13.7 mt -84.62 -171.59 3.71 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.873 0.844 . . . . 0.0 111.455 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 1.5 m -164.78 101.63 0.79 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.484 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 0.8 OUTLIER 59.18 118.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.415 -0.803 . . . . 0.0 109.766 -178.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -171.0 -151.68 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.136 -0.978 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.474 ' CD2' ' CB ' ' A' ' 10' ' ' GLN . 17.9 t80 -157.68 -42.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.837 0.827 . . . . 0.0 108.958 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.838 HG13 ' HD2' ' A' ' 42' ' ' PHE . 6.9 t 39.22 101.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.305 0.574 . . . . 0.0 112.174 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 4.6 t0 -88.71 -130.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.5 mttp -62.36 81.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.783 -1.198 . . . . 0.0 109.072 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.772 ' OG ' HG22 ' A' ' 45' ' ' VAL . 16.9 m -148.87 159.54 44.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.91 -1.119 . . . . 0.0 111.301 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 47' ' ' ILE . 2.2 mt-10 -119.1 115.66 24.73 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.624 HG22 ' CG2' ' A' ' 47' ' ' ILE . 34.2 t -117.21 156.28 18.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.225 -0.922 . . . . 0.0 111.065 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.518 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 41.9 m-85 -135.06 -71.75 0.48 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.143 -0.973 . . . . 0.0 110.913 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 48' ' ' THR . . . -118.36 41.83 1.94 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.765 ' O ' HD23 ' A' ' 22' ' ' LEU . 1.7 m -87.24 172.24 10.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -1.106 . . . . 0.0 110.334 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 6.8 m -112.0 -13.07 13.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.859 -1.151 . . . . 0.0 110.933 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.69 ' HB2' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 35.67 63.34 0.56 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.468 -0.77 . . . . 0.0 110.758 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.632 HG21 HG23 ' A' ' 53' ' ' THR . 88.3 m -65.57 78.57 0.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.411 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 52.27 36.0 44.21 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 41' ' ' ARG . 94.2 p -107.09 -138.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.179 -1.189 . . . . 0.0 109.811 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HB3' ' ND2' ' A' ' 90' ' ' ASN . 32.3 ttt-85 175.96 154.58 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 110.429 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.838 ' HD2' HG13 ' A' ' 27' ' ' VAL . 13.1 m-85 -120.11 168.85 10.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.923 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 3.9 t0 -159.6 73.49 0.57 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.998 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 96.57 49.85 1.92 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.772 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.2 m -131.6 -165.02 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.947 -1.325 . . . . 0.0 111.152 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 46' ' ' THR . 35.9 m -159.92 58.55 0.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.876 HD11 ' HB3' ' A' ' 50' ' ' SER . 13.2 tt -72.55 173.65 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.511 -0.743 . . . . 0.0 110.311 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -137.18 -92.07 0.24 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.373 -0.829 . . . . 0.0 109.886 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 49' ' ' THR . 7.8 m -111.97 65.96 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.876 ' HB3' HD11 ' A' ' 47' ' ' ILE . 1.5 t -108.77 143.27 38.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.551 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.533 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 m -91.85 21.18 5.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.471 -0.768 . . . . 0.0 110.85 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -38.12 128.02 1.31 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.446 -0.783 . . . . 0.0 110.759 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.632 HG23 HG21 ' A' ' 38' ' ' THR . 13.3 m -111.37 101.52 9.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 110.102 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 61.17 77.76 0.18 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.5 p -148.82 122.35 9.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -1.11 . . . . 0.0 110.219 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.553 ' CB ' ' HB3' ' A' ' 88' ' ' SER . 3.7 ttp180 -72.23 103.88 3.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.137 -0.977 . . . . 0.0 110.089 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.494 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 22.6 mm -83.92 11.88 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.319 -0.863 . . . . 0.0 109.827 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -41.73 148.91 0.14 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.347 -0.846 . . . . 0.0 110.244 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 158.06 157.27 8.36 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.27 52.53 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.062 1.559 . . . . 0.0 109.951 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.459 ' O ' ' HD2' ' A' ' 63' ' ' LYS . . . 118.69 18.74 4.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.522 ' HB3' ' CG1' ' A' ' 45' ' ' VAL . 1.7 t -40.77 126.81 2.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.406 -1.055 . . . . 0.0 110.148 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.526 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -108.43 143.21 37.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 110.734 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.096 HD13 ' NZ ' ' A' ' 81' ' ' LYS . 17.4 mm -143.06 125.07 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 109.042 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -133.94 121.49 21.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 110.602 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 49' ' ' THR . 15.6 m 37.76 53.64 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.705 -0.622 . . . . 0.0 111.145 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.587 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 4.8 t -118.47 109.79 16.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.948 . . . . 0.0 109.339 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.548 HD12 ' H ' ' A' ' 68' ' ' ILE . 2.0 mp -52.52 -66.28 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.711 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 73' ' ' VAL . 9.5 mt 56.74 157.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -0.784 . . . . 0.0 109.923 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.853 ' O ' HG22 ' A' ' 73' ' ' VAL . 5.7 m -169.66 107.51 0.39 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.898 -1.126 . . . . 0.0 111.186 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.41 28.08 31.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.572 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 85.38 10.9 76.4 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 70' ' ' THR . 11.7 m -120.5 136.73 25.5 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.207 -1.172 . . . . 0.0 110.033 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.454 ' HA ' HG12 ' A' ' 69' ' ' ILE . 48.3 Cg_endo -77.4 138.02 17.22 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.993 1.523 . . . . 0.0 110.849 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -107.6 160.83 25.25 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 109.998 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.26 122.15 8.11 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.923 1.486 . . . . 0.0 110.365 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.77 4.1 2.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 110.551 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.46 23.96 2.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.112 -0.992 . . . . 0.0 110.143 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 80' ' ' CYS . . . -160.45 -37.4 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.89 . . . . 0.0 109.913 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 1.2 t -39.46 158.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.684 0.754 . . . . 0.0 110.931 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 1.096 ' NZ ' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.56 -167.91 1.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 0.0 109.438 179.46 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.719 ' O ' HG23 ' A' ' 82' ' ' ILE . 1.3 tp 177.51 31.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.178 -0.951 . . . . 0.0 110.042 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -70.71 -101.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.935 -1.103 . . . . 0.0 110.652 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.84 100.75 1.43 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -161.7 -159.64 0.64 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.29 -1.124 . . . . 0.0 109.887 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.553 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t 169.1 150.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.615 -0.678 . . . . 0.0 109.636 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.572 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -122.79 143.28 49.94 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.267 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.658 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -122.02 9.66 9.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 65.17 66.94 0.53 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 110.088 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.534 ' HB2' ' CB ' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.127 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 2.6 tt0 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.115 0.483 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 26' ' ' TYR . 41.8 tp 46.34 86.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 109.996 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.504 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -42.71 148.66 0.22 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.358 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.65 -21.32 64.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.198 -0.939 . . . . 0.0 110.093 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -87.56 -4.09 58.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 110.209 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.507 ' OG ' HG11 ' A' ' 27' ' ' VAL . 39.0 t -79.42 -163.7 0.54 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.233 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 9.5 tttp -156.39 178.98 9.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.134 -0.979 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 3.9 p 174.69 47.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 110.068 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 4.0 tt0 -41.83 -50.18 4.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.648 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -161.68 77.07 0.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.646 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 21' ' ' THR . 0.8 OUTLIER -115.31 -153.24 0.52 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.206 -0.934 . . . . 0.0 110.048 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -155.62 77.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 109.775 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.805 HD22 ' HB2' ' A' ' 37' ' ' CYS . 5.0 mt -96.24 -167.3 1.56 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.365 -0.835 . . . . 0.0 110.456 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.4 m -155.02 -47.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.503 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 25' ' ' CYS . 12.0 m-20 -144.25 23.51 1.66 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.545 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -58.16 -152.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.024 . . . . 0.0 110.513 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -160.59 -52.85 0.05 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 30' ' ' SER . 4.7 t 49.39 117.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.905 0.86 . . . . 0.0 112.226 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -108.72 -20.83 12.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.944 . . . . 0.0 108.884 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -167.4 84.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.746 -0.596 . . . . 0.0 109.671 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.909 ' OG ' HG22 ' A' ' 45' ' ' VAL . 24.5 m -159.58 164.28 34.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.784 -1.197 . . . . 0.0 111.51 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 47' ' ' ILE . 3.6 tt0 -119.68 96.58 5.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.547 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 6.5 t -94.67 168.68 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.141 -0.974 . . . . 0.0 110.531 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 19.1 m-85 -150.18 -42.86 0.13 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.064 -1.022 . . . . 0.0 111.315 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.97 27.56 1.88 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.547 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.7 m -82.01 150.03 27.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.08 -1.247 . . . . 0.0 110.526 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 36' ' ' THR . 13.9 t -95.95 54.49 1.49 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.539 -0.726 . . . . 0.0 109.443 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.805 ' HB2' HD22 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -38.31 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.689 -0.632 . . . . 0.0 110.691 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' THR . 19.0 m -104.38 69.62 0.92 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 110.077 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.72 59.45 3.48 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.6 m -136.88 -168.97 2.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -1.143 . . . . 0.0 109.783 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -162.78 143.38 9.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 110.673 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.544 ' CE1' HG13 ' A' ' 57' ' ' ILE . 10.8 m-85 -114.42 173.4 6.48 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.419 -0.8 . . . . 0.0 109.181 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -155.86 42.98 0.42 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 123.8 72.88 0.25 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.909 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -148.91 -168.74 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.043 -1.269 . . . . 0.0 110.475 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.557 ' N ' HG23 ' A' ' 45' ' ' VAL . 50.2 m -155.38 58.82 0.64 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.579 ' HB ' HD13 ' A' ' 64' ' ' ILE . 8.8 tt -80.98 168.34 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.269 -0.894 . . . . 0.0 110.298 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' SER . 74.8 p -142.61 -138.05 0.11 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.621 -0.675 . . . . 0.0 109.233 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' THR . 52.8 m -58.24 83.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.984 -1.073 . . . . 0.0 110.145 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 48' ' ' THR . 73.0 m -141.57 139.41 33.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.961 -1.087 . . . . 0.0 110.502 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -88.88 117.77 28.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.373 -0.83 . . . . 0.0 109.592 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.5 p -133.78 113.49 12.36 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.567 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -98.37 91.42 5.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 109.485 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 72' ' ' GLY . . . 72.16 106.25 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 89.1 p -175.42 102.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -1.166 . . . . 0.0 110.467 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.539 ' HB2' ' CA ' ' A' ' 90' ' ' ASN . 7.6 ttm180 -62.79 106.26 0.78 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.929 -1.107 . . . . 0.0 108.984 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.544 HG13 ' CE1' ' A' ' 42' ' ' PHE . 16.5 mm -83.23 11.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.1 -1.0 . . . . 0.0 110.545 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.501 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -36.99 151.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.611 -0.681 . . . . 0.0 110.411 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 166.48 147.11 5.1 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.275 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -79.87 63.35 8.73 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 124.301 1.685 . . . . 0.0 109.461 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 106.05 24.3 6.97 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -41.58 161.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.409 -1.053 . . . . 0.0 110.323 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.479 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 17.1 tttm -152.89 110.48 3.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.012 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.579 HD13 ' HB ' ' A' ' 47' ' ' ILE . 3.1 mp -125.7 152.68 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.022 -1.049 . . . . 0.0 111.291 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.48 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.7 OUTLIER -156.12 107.91 2.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 0.0 109.895 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER 63.0 73.25 0.46 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 111.12 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 3.8 t -132.91 120.3 21.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.234 -0.917 . . . . 0.0 109.955 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.798 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.0 mp -83.29 85.24 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.027 -1.045 . . . . 0.0 108.839 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.697 HG21 ' CD2' ' A' ' 87' ' ' PHE . 9.6 mt -96.05 160.75 2.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.785 -0.572 . . . . 0.0 109.889 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.793 ' O ' HG22 ' A' ' 73' ' ' VAL . 13.1 m -162.63 100.93 1.03 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.221 -0.924 . . . . 0.0 110.504 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 89.03 34.52 8.79 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 54' ' ' GLY . . . 75.42 17.95 80.03 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 70' ' ' THR . 9.5 m -123.56 128.94 25.04 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.24 -1.153 . . . . 0.0 110.834 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -83.33 142.56 10.73 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.967 1.509 . . . . 0.0 109.939 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -91.76 158.37 40.22 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.149 -0.969 . . . . 0.0 110.261 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.36 59.48 6.09 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.883 1.465 . . . . 0.0 110.12 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.06 134.1 42.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.499 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.72 -8.11 25.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.071 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 66' ' ' THR . . . -91.97 -16.96 25.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.869 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 66' ' ' THR . 40.4 t -78.87 165.61 23.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.902 -1.124 . . . . 0.0 110.18 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HE3' ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -101.21 -12.18 18.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.166 -0.959 . . . . 0.0 112.11 -178.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 82' ' ' ILE . 37.1 mm 25.11 51.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.155 0.502 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 85' ' ' CYS . 0.4 OUTLIER -117.76 -141.75 0.36 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 111.375 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -59.35 83.5 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 6.0 t -177.96 178.37 0.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.11 . . . . 0.0 109.543 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.533 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -179.16 156.75 0.79 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.04 . . . . 0.0 110.491 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.697 ' CD2' HG21 ' A' ' 69' ' ' ILE . 2.3 m-85 -123.25 164.44 18.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -0.855 . . . . 0.0 110.287 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.747 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -142.21 12.58 1.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.841 . . . . 0.0 109.585 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 72.5 0.02 3.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 110.358 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.539 ' CA ' ' HB2' ' A' ' 56' ' ' ARG . 3.3 p30 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.444 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.558 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.681 HD12 ' HB ' ' A' ' 27' ' ' VAL . 9.9 tp -40.48 117.48 0.81 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.801 -0.562 . . . . 0.0 110.017 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.545 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -37.73 158.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.725 -0.609 . . . . 0.0 110.342 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.8 -6.96 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.987 . . . . 0.0 110.583 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -138.61 23.78 2.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.914 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.607 ' OG ' HG12 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -84.67 -159.56 0.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.009 -1.057 . . . . 0.0 110.33 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 4.8 tttp -155.95 152.58 28.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 110.362 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 29.9 p -164.63 56.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 11.3 tp10 -88.65 111.57 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 110.386 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 4.6 tttp 67.63 56.3 0.58 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.273 -0.892 . . . . 0.0 110.429 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.66 ' HB2' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -136.86 166.49 23.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.1 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 36' ' ' THR . 3.1 m -113.55 101.97 9.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.869 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.831 HD22 ' N ' ' A' ' 22' ' ' LEU . 1.7 mm? -107.16 147.77 29.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 110.639 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 17.9 m -148.15 109.8 4.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.354 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 23' ' ' THR . 1.1 m120 60.73 56.99 2.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.186 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -109.47 -169.12 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.191 0.996 . . . . 0.0 111.582 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 52.6 t80 -173.26 34.68 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.681 ' HB ' HD12 ' A' ' 11' ' ' LEU . 12.1 t -33.16 142.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.532 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.545 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -143.5 121.5 12.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.525 -0.734 . . . . 0.0 109.867 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.429 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 53.35 38.77 28.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.318 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.979 ' OG ' HG22 ' A' ' 45' ' ' VAL . 21.0 m -132.1 179.31 6.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.641 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG2' ' HD2' ' A' ' 16' ' ' LYS . 2.8 tt0 -119.94 -64.2 1.29 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.377 -0.827 . . . . 0.0 110.556 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.834 HG22 ' CG2' ' A' ' 47' ' ' ILE . 11.7 t 62.05 150.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 110.004 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.551 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 19.3 m-85 -142.35 -47.43 0.34 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.059 -1.026 . . . . 0.0 110.803 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.433 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -132.59 20.32 4.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.533 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 8.6 m -66.68 154.91 39.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -1.18 . . . . 0.0 110.277 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 21' ' ' THR . 5.7 m -95.86 -21.46 18.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.547 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 11.9 t 48.86 76.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.805 . . . . 0.0 110.961 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.4 m -80.23 73.5 7.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 109.1 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 66.08 49.88 55.3 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -135.92 -178.08 4.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.266 -1.138 . . . . 0.0 110.018 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -153.4 176.4 12.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.034 -1.042 . . . . 0.0 110.56 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.598 ' CE2' HG21 ' A' ' 47' ' ' ILE . 52.7 m-85 -123.18 -170.15 2.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.006 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 58' ' ' SER . 9.8 t70 -178.35 63.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.773 . . . . 0.0 109.67 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 99.65 60.02 0.86 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.979 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.4 m -137.37 -159.53 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.95 -1.324 . . . . 0.0 111.324 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.621 ' N ' HG23 ' A' ' 45' ' ' VAL . 85.4 m -166.89 57.81 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.834 ' CG2' HG22 ' A' ' 32' ' ' VAL . 12.4 tt -83.7 171.65 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.47 -0.769 . . . . 0.0 111.088 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.551 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 22.4 p -135.51 -134.03 0.15 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' THR . 23.1 m -66.12 89.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.737 -1.227 . . . . 0.0 109.758 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.684 ' CB ' HD11 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -132.13 139.05 48.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.012 -1.055 . . . . 0.0 110.495 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.567 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 m -85.5 21.45 1.79 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 111.056 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 89.9 p -37.18 122.01 0.84 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.465 -0.772 . . . . 0.0 110.803 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 2.6 m -112.02 111.13 21.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.136 -0.978 . . . . 0.0 109.973 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 51.55 79.85 0.07 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 8.0 p -155.51 122.63 5.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -1.165 . . . . 0.0 110.528 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' CA ' ' A' ' 90' ' ' ASN . 36.9 ttt85 -75.97 103.85 6.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 109.675 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.53 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 18.1 mm -83.29 12.67 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 0.0 110.358 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.535 ' CB ' ' HB3' ' A' ' 43' ' ' ASP . 42.9 p -42.71 162.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.347 -0.846 . . . . 0.0 110.716 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 150.67 163.04 11.01 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -75.8 57.44 5.06 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.935 1.492 . . . . 0.0 109.844 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 106.43 21.82 8.15 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 1.8 t -38.96 126.57 1.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.662 -0.905 . . . . 0.0 110.649 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 35.4 ttpt -115.08 140.47 49.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.053 -1.029 . . . . 0.0 110.593 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.973 HD13 ' HE2' ' A' ' 81' ' ' LYS . 25.4 mm -143.34 145.72 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.24 -0.912 . . . . 0.0 109.844 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.469 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 1.1 m -147.99 126.13 12.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.057 -1.027 . . . . 0.0 110.043 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.5 m 41.57 59.61 2.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.392 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.591 ' SG ' HD11 ' A' ' 69' ' ' ILE . 5.1 t -123.95 109.95 14.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.819 . . . . 0.0 109.532 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.567 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 1.9 mp -55.65 -64.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.979 -1.076 . . . . 0.0 109.697 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.591 HD11 ' SG ' ' A' ' 67' ' ' CYS . 8.1 mt 54.88 162.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.48 -0.763 . . . . 0.0 110.787 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.541 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 9.0 m -146.33 -121.78 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.83 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.781 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -65.18 77.5 0.08 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 58.54 16.73 30.45 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 71' ' ' GLY . 33.8 m -121.91 141.05 33.2 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.472 -1.017 . . . . 0.0 110.544 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 73' ' ' VAL . 49.1 Cg_endo -85.11 128.28 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.943 1.496 . . . . 0.0 110.133 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.82 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -83.56 174.65 5.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 110.081 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.82 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 43.0 Cg_endo -70.72 59.12 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.942 1.496 . . . . 0.0 110.106 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -88.09 112.93 23.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.382 -0.824 . . . . 0.0 110.223 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.32 -4.95 20.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.86 . . . . 0.0 110.347 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.07 -31.85 8.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.52 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 43.1 t -46.36 166.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.169 -0.957 . . . . 0.0 109.836 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.973 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -108.15 -41.19 4.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.043 -1.035 . . . . 0.0 111.43 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.714 HG22 ' O ' ' A' ' 82' ' ' ILE . 19.0 mm 49.25 62.13 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.816 -1.177 . . . . 0.0 109.615 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.401 ' H ' ' NZ ' ' A' ' 81' ' ' LYS . 23.2 t -109.33 -73.19 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 110.815 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.43 67.79 0.54 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -134.53 -153.0 0.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -1.151 . . . . 0.0 110.009 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.566 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.2 t 176.91 143.21 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.566 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -128.24 153.06 47.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.55 -0.719 . . . . 0.0 109.158 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.74 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 1.3 m -140.95 12.17 2.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.978 . . . . 0.0 109.758 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.74 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 72.07 0.13 3.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.443 -0.786 . . . . 0.0 110.201 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.533 ' CA ' ' HB2' ' A' ' 56' ' ' ARG . 2.7 p30 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.013 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.599 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 3.9 pt20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.015 0.436 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.537 ' N ' ' CG ' ' A' ' 10' ' ' GLN . 16.5 tp 47.68 81.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.015 -1.053 . . . . 0.0 108.934 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -44.44 149.93 0.35 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 110.25 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.91 -10.1 12.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.858 . . . . 0.0 110.076 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.509 ' ND2' ' HG2' ' A' ' 29' ' ' LYS . 50.7 t-20 -90.18 -7.77 52.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.968 . . . . 0.0 110.268 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 30' ' ' SER . 32.1 t -80.42 -157.61 0.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.067 -1.02 . . . . 0.0 110.099 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.516 ' CE ' ' OH ' ' A' ' 33' ' ' TYR . 12.5 tttt -135.74 140.17 44.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.079 -1.013 . . . . 0.0 110.088 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.0 m -113.41 137.35 51.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 110.291 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.8 -129.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.246 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.63 19.55 15.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.817 -1.177 . . . . 0.0 110.667 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.525 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -58.98 167.49 1.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.0 109.865 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.804 ' C ' HD23 ' A' ' 22' ' ' LEU . 1.6 t -140.24 97.13 3.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.019 -1.051 . . . . 0.0 109.985 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.804 HD23 ' C ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -131.45 -165.56 1.59 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.431 -0.793 . . . . 0.0 110.139 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 98.2 m -166.94 142.03 4.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.351 -0.843 . . . . 0.0 110.363 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.472 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 4.2 m120 45.88 36.83 3.1 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.369 -0.832 . . . . 0.0 110.697 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -154.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.091 -1.006 . . . . 0.0 110.683 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.599 ' CE1' ' HB3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER 176.26 40.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.491 HG13 ' HD2' ' A' ' 42' ' ' PHE . 40.3 t -52.78 153.92 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.984 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.7 OUTLIER -158.83 129.14 5.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.476 -0.765 . . . . 0.0 110.138 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HG2' ' ND2' ' A' ' 14' ' ' ASN . 4.7 mtmp? 50.78 34.53 10.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 15' ' ' SER . 49.3 m -124.47 -161.13 0.98 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.499 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 3.5 tt0 -138.2 -63.13 0.56 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.513 -0.742 . . . . 0.0 110.089 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.562 HG22 ' CG2' ' A' ' 47' ' ' ILE . 15.9 t 61.16 156.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.516 ' OH ' ' CE ' ' A' ' 16' ' ' LYS . 9.9 m-85 -153.95 -39.11 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.199 -0.938 . . . . 0.0 110.477 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.2 34.07 1.66 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 37' ' ' CYS . 1.1 m -79.27 158.33 27.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.397 -1.061 . . . . 0.0 110.73 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -111.52 50.23 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.96 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 3.5 t -40.82 121.38 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 111.012 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.485 ' O ' HG22 ' A' ' 38' ' ' THR . 24.1 m -113.66 22.86 13.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 109.269 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 122.85 41.56 0.44 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.41 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -115.52 -159.29 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -1.178 . . . . 0.0 110.372 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 26' ' ' TYR . 28.4 ttt180 -166.88 145.06 5.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.914 . . . . 0.0 110.701 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.491 ' HD2' HG13 ' A' ' 27' ' ' VAL . 10.1 m-85 -115.16 172.39 7.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.0 109.301 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.54 42.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.921 -1.112 . . . . 0.0 110.407 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 127.0 57.5 0.13 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -136.34 -171.16 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.269 -1.136 . . . . 0.0 110.997 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 46' ' ' THR . 87.9 m -152.89 58.2 0.79 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.562 ' CG2' HG22 ' A' ' 32' ' ' VAL . 9.7 tt -81.3 169.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.245 -0.909 . . . . 0.0 110.14 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 50' ' ' SER . 58.9 p -146.09 -139.7 0.1 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.048 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 66' ' ' THR . 51.9 m -52.94 91.48 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.07 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' THR . 2.4 m -152.96 143.72 22.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.155 -0.966 . . . . 0.0 110.286 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -98.66 135.32 40.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 59.9 p -155.64 130.88 9.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.33 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 71' ' ' GLY . 11.5 m -111.85 112.94 24.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.103 -0.998 . . . . 0.0 109.82 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.7 86.41 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 79.6 p -154.74 112.25 3.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -1.144 . . . . 0.0 110.514 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 4.1 ttt180 -67.03 118.6 10.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 109.66 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 26.8 mm -97.82 11.18 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 0.0 110.831 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -40.7 145.34 0.19 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.203 -0.936 . . . . 0.0 110.34 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 175.12 145.85 5.54 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -80.18 1.34 9.33 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.038 1.547 . . . . 0.0 109.629 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.06 33.23 0.07 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.508 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -60.74 152.73 26.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.535 -0.979 . . . . 0.0 110.804 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -156.95 113.93 3.07 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.653 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.0 mt -118.9 148.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.067 -1.021 . . . . 0.0 110.862 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.51 117.14 5.41 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.0 OUTLIER 51.21 71.14 0.46 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.101 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 50' ' ' SER . 60.5 m -139.11 111.04 7.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.447 -0.783 . . . . 0.0 110.478 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -77.92 137.06 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.946 -1.096 . . . . 0.0 109.42 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.641 HG23 ' C ' ' A' ' 73' ' ' VAL . 9.3 mt -146.51 158.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.079 -1.013 . . . . 0.0 110.309 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.74 ' O ' HG22 ' A' ' 73' ' ' VAL . 5.7 m -156.39 99.0 1.88 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.04 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.835 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 91.51 20.67 37.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.525 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 88.29 15.55 60.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 70' ' ' THR . 4.1 m -124.3 132.87 24.35 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.476 -1.014 . . . . 0.0 109.507 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.36 144.93 23.47 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.59 1.311 . . . . 0.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.82 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -99.17 176.02 2.17 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.82 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 47.6 Cg_endo -73.15 102.6 1.48 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.94 1.495 . . . . 0.0 110.635 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 1.1 t -119.04 -23.52 6.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.34 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 61.15 12.35 4.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.255 -0.903 . . . . 0.0 109.966 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.7 -15.27 1.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.311 -0.868 . . . . 0.0 110.998 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 33.1 t -62.89 168.48 3.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.968 -1.082 . . . . 0.0 110.406 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HD2' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.99 -35.29 8.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.981 -1.074 . . . . 0.0 111.826 -178.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.489 ' N ' ' HE2' ' A' ' 81' ' ' LYS . 32.4 mm 43.66 60.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.093 -1.004 . . . . 0.0 109.35 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 85' ' ' CYS . 46.5 m -114.95 -130.11 0.31 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.31 -0.869 . . . . 0.0 110.594 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -65.12 66.05 0.08 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.653 ' SG ' HD11 ' A' ' 64' ' ' ILE . 5.0 t -160.94 -175.99 5.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.023 -1.281 . . . . 0.0 109.854 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.562 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 2.0 t -179.09 160.67 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.117 -0.989 . . . . 0.0 110.745 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -127.92 155.08 44.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.32 -0.863 . . . . 0.0 109.431 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.91 24.91 1.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.047 -1.033 . . . . 0.0 110.313 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.835 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 52.84 85.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 109.944 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.035 -1.04 . . . . 0.0 110.365 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 22.6 mt-30 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.268 0.556 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.782 HD11 ' OG ' ' A' ' 15' ' ' SER . 8.7 tp -62.96 81.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 10' ' ' GLN . 97.9 p -30.62 134.16 0.06 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.529 0.681 . . . . 0.0 111.93 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.33 -22.51 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 109.81 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 61.4 t-20 -80.99 -10.28 59.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.473 -0.767 . . . . 0.0 110.086 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.782 ' OG ' HD11 ' A' ' 11' ' ' LEU . 45.6 t -79.38 -171.62 2.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.131 -0.98 . . . . 0.0 109.757 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.89 163.79 17.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.105 -0.997 . . . . 0.0 109.612 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.491 ' SG ' HD23 ' A' ' 11' ' ' LEU . 6.4 m -134.66 -29.29 1.19 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.066 -1.022 . . . . 0.0 111.191 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' LYS . 10.4 tp10 -43.45 118.22 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.07 -1.018 . . . . 0.0 110.244 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 52.83 108.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.781 . . . . 0.0 110.552 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 5.9 p 178.69 146.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.048 -1.032 . . . . 0.0 110.899 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -139.14 84.08 1.98 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -0.792 . . . . 0.0 109.529 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 38.9 mt -101.91 -174.42 2.58 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.834 0.826 . . . . 0.0 111.267 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.539 HG22 HD22 ' A' ' 24' ' ' ASN . 91.7 m -164.42 125.02 2.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.637 -0.665 . . . . 0.0 109.298 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.539 HD22 HG22 ' A' ' 23' ' ' THR . 56.9 m-80 51.07 66.47 1.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 108.878 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -123.78 169.91 11.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.78 0.8 . . . . 0.0 110.471 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.637 ' HA ' ' HB3' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -147.0 34.33 0.91 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 179.002 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.868 HG13 ' HD2' ' A' ' 42' ' ' PHE . 7.6 t -30.52 147.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.587 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.522 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -150.47 123.31 8.68 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 9.8 mmmt 48.04 56.26 7.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 0.0 109.34 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.574 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 14.7 m -143.25 171.69 13.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.963 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.648 ' OE1' HG23 ' A' ' 46' ' ' THR . 1.4 tt0 -115.06 -68.88 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.382 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.53 HG23 ' C ' ' A' ' 31' ' ' GLU . 3.1 t 67.15 143.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.327 -0.858 . . . . 0.0 110.383 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CD1' HG22 ' A' ' 48' ' ' THR . 45.2 m-85 -137.62 -52.71 0.65 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.337 -0.852 . . . . 0.0 110.674 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.452 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -129.46 18.88 5.42 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.525 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.2 m -69.75 153.69 43.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -1.167 . . . . 0.0 110.216 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.2 m -111.95 58.24 0.63 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.462 -0.774 . . . . 0.0 109.594 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 52.8 t -36.87 137.77 0.3 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.609 -0.682 . . . . 0.0 111.01 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 95.2 m -137.85 74.34 1.48 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.468 -0.77 . . . . 0.0 109.461 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.48 57.43 3.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.412 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -147.08 178.57 8.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.159 -1.201 . . . . 0.0 110.177 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 42' ' ' PHE . 4.0 ttt180 -150.65 153.02 34.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.302 -0.874 . . . . 0.0 110.176 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.868 ' HD2' HG13 ' A' ' 27' ' ' VAL . 8.1 m-85 -116.04 -176.2 2.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.995 . . . . 0.0 110.566 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.522 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.9 t0 -170.09 50.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 110.179 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 118.44 61.36 0.28 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -140.98 -168.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.914 -1.345 . . . . 0.0 110.6 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 46' ' ' THR . 91.6 m -160.73 53.25 0.3 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.62 -0.675 . . . . 0.0 109.908 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 19.8 tt -73.54 169.45 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.783 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 50' ' ' SER . 71.9 p -138.21 -139.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.206 -0.934 . . . . 0.0 109.666 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 31.3 m -58.33 80.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' THR . 28.5 t -141.55 140.33 33.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 110.454 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -83.49 131.47 35.01 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.221 -0.924 . . . . 0.0 109.916 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 2.9 t -151.86 128.67 10.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.939 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.598 ' OG1' HG23 ' A' ' 70' ' ' THR . 36.8 p -128.22 110.62 12.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.978 . . . . 0.0 110.212 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.41 84.03 0.13 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 p -161.37 127.87 3.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -1.13 . . . . 0.0 110.658 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' CD ' ' HB2' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.55 103.27 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 7.4 mm -85.07 10.78 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.083 -1.011 . . . . 0.0 110.498 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -36.02 142.77 0.07 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.457 -0.777 . . . . 0.0 110.727 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 176.85 146.09 5.96 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.313 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.77 -8.31 17.95 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.965 1.508 . . . . 0.0 110.051 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.48 39.23 0.12 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.505 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -56.15 159.42 3.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.525 -0.985 . . . . 0.0 111.37 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 27.5 tttt -161.08 98.71 1.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.694 -0.629 . . . . 0.0 109.347 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.791 HD11 ' SG ' ' A' ' 85' ' ' CYS . 12.8 mt -117.82 163.41 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.671 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -145.47 -163.35 1.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.405 -0.809 . . . . 0.0 110.155 179.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.0 m -33.36 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.603 ' C ' HD12 ' A' ' 68' ' ' ILE . 44.4 t -138.38 139.52 39.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.515 -0.741 . . . . 0.0 109.107 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.6 mp -97.22 82.73 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.884 -1.135 . . . . 0.0 108.704 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.59 HG23 ' C ' ' A' ' 73' ' ' VAL . 13.1 mt -90.85 154.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.67 -0.644 . . . . 0.0 110.328 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.732 ' O ' HG22 ' A' ' 73' ' ' VAL . 52.8 m -162.01 98.82 1.08 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.174 -0.954 . . . . 0.0 110.597 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.767 ' O ' HG13 ' A' ' 73' ' ' VAL . . . 94.39 39.98 4.61 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.561 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 65.32 24.02 70.4 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 71' ' ' GLY . 6.1 m -129.24 129.2 23.3 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.485 -1.009 . . . . 0.0 110.893 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HB2' HD11 ' A' ' 82' ' ' ILE . 46.4 Cg_endo -83.58 131.89 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.922 1.486 . . . . 0.0 110.228 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -79.04 150.85 75.37 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.002 -1.061 . . . . 0.0 110.057 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.56 58.47 1.94 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.118 1.588 . . . . 0.0 110.683 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.48 150.48 22.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 110.235 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.24 -10.96 55.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.926 . . . . 0.0 109.962 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 80' ' ' CYS . . . -112.66 -31.6 6.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.92 . . . . 0.0 111.002 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 67' ' ' CYS . 13.0 t -44.53 137.06 3.94 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.945 -1.097 . . . . 0.0 110.141 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.548 ' C ' HD12 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -110.28 164.88 12.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 111.49 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.798 HG22 ' O ' ' A' ' 82' ' ' ILE . 1.0 OUTLIER -161.59 75.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -112.08 -86.55 0.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 0.0 110.56 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -104.79 65.91 0.3 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.791 ' SG ' HD11 ' A' ' 64' ' ' ILE . 4.4 t -162.48 -175.49 4.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -1.189 . . . . 0.0 110.26 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.559 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.5 t 179.81 158.87 0.73 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.288 -0.882 . . . . 0.0 110.108 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.3 OUTLIER -123.22 154.35 38.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 89' ' ' ALA . 2.7 m -134.96 32.67 3.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 109.591 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 88' ' ' SER . . . 37.87 72.01 0.14 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.757 -0.589 . . . . 0.0 110.199 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.452 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.307 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 11' ' ' LEU . 1.4 pt20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.261 0.553 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.656 HD12 ' HB ' ' A' ' 27' ' ' VAL . 18.1 tp 43.46 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.549 -0.719 . . . . 0.0 110.149 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -37.91 150.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.693 -0.63 . . . . 0.0 110.451 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -24.98 67.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 110.24 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 14' ' ' ASN . 0.6 OUTLIER -103.93 6.26 36.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 111.129 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.496 ' OG ' HD11 ' A' ' 11' ' ' LEU . 28.8 t -69.21 -154.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.16 . . . . 0.0 109.391 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.545 ' CD ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -140.69 150.71 43.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 110.528 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' A' ' 18' ' ' GLU . 7.8 t -135.99 -92.18 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -0.917 . . . . 0.0 109.779 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.491 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 13.2 mt-10 38.05 -125.68 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.412 -0.805 . . . . 0.0 110.844 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 20' ' ' SER . 10.4 tptt -66.98 123.55 20.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.956 -1.09 . . . . 0.0 110.356 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.533 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . 10.3 p 175.94 172.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.115 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 21' ' ' THR . 1.8 t -154.04 76.41 1.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.36 -0.837 . . . . 0.0 109.56 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.783 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -114.48 -170.56 1.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.793 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 3.9 m -164.89 124.94 1.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.849 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.6 m120 57.17 33.38 23.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 110.713 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -64.31 -141.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.754 -1.216 . . . . 0.0 109.929 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.557 ' CG ' ' O ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER 166.34 45.82 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.687 HG13 ' HB2' ' A' ' 30' ' ' SER . 8.0 t -66.96 140.45 19.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.762 0.791 . . . . 0.0 111.715 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.9 t0 -123.05 -14.03 7.66 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.429 0.633 . . . . 0.0 109.728 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER 179.99 67.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.98 ' OG ' HG22 ' A' ' 45' ' ' VAL . 14.8 m -147.26 151.31 36.44 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.176 -0.953 . . . . 0.0 111.442 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' HG3' ' CD ' ' A' ' 16' ' ' LYS . 6.5 tt0 -107.49 101.23 10.59 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 18.0 t -99.2 174.32 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.237 -0.915 . . . . 0.0 110.379 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.531 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 47.1 m-85 -149.16 -32.0 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.193 -0.942 . . . . 0.0 111.391 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -164.48 26.79 0.2 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 50' ' ' SER . 0.9 OUTLIER -76.99 144.94 38.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.137 . . . . 0.0 110.398 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -91.13 60.04 4.16 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.417 -0.802 . . . . 0.0 110.501 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 2.0 t -47.04 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.0 110.157 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.84 HG21 HG23 ' A' ' 53' ' ' THR . 1.7 t -85.91 31.88 0.61 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.071 -1.018 . . . . 0.0 110.445 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.42 27.83 4.01 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 16.0 t -94.06 -163.09 1.0 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.384 -1.068 . . . . 0.0 110.229 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HB2' ' CB ' ' A' ' 26' ' ' TYR . 2.7 ttp180 -165.73 144.69 6.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.65 ' CE1' HD13 ' A' ' 57' ' ' ILE . 2.9 m-85 -119.45 -172.44 2.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.971 -1.081 . . . . 0.0 110.227 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.22 55.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 110.204 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 115.29 54.64 0.37 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.274 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.98 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.1 m -133.6 -169.66 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.732 -1.452 . . . . 0.0 111.325 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.478 ' N ' HG23 ' A' ' 45' ' ' VAL . 33.5 m -151.89 60.01 0.86 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.583 HG12 ' HG ' ' A' ' 50' ' ' SER . 14.6 tt -81.14 -179.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.751 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.531 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -139.77 -89.82 0.19 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.789 -1.195 . . . . 0.0 110.195 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.744 HG22 ' O ' ' A' ' 49' ' ' THR . 5.9 m -114.3 74.35 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.022 -1.049 . . . . 0.0 110.451 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.583 ' HG ' HG12 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -114.53 152.34 31.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.144 -0.973 . . . . 0.0 111.413 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.429 ' H ' ' HA ' ' A' ' 68' ' ' ILE . 1.5 m -99.79 27.91 5.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.462 -0.773 . . . . 0.0 111.085 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' ILE . 1.4 p -40.92 136.62 1.41 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.187 -0.946 . . . . 0.0 110.893 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.84 HG23 HG21 ' A' ' 38' ' ' THR . 87.2 m -126.17 87.58 2.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.45 65.88 1.93 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.8 p -145.91 123.11 11.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.448 -1.031 . . . . 0.0 109.844 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -76.68 102.22 6.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.551 -0.718 . . . . 0.0 110.75 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.65 HD13 ' CE1' ' A' ' 42' ' ' PHE . 3.1 mp -85.37 15.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.988 -1.07 . . . . 0.0 110.217 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.9 p -47.15 161.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.337 -0.852 . . . . 0.0 110.968 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 155.24 154.29 6.86 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -74.41 -0.84 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.825 1.434 . . . . 0.0 110.098 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.31 29.83 0.07 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.3 t -52.28 114.55 1.38 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.451 -1.029 . . . . 0.0 110.491 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -110.57 130.22 55.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.829 HG23 ' HD2' ' A' ' 81' ' ' LYS . 41.0 mt -140.95 147.89 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.073 -1.017 . . . . 0.0 110.587 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.492 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -140.53 108.87 5.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 110.64 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 49' ' ' THR . 5.9 m 50.33 71.86 0.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.522 -0.736 . . . . 0.0 112.027 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.532 ' SG ' ' CG1' ' A' ' 69' ' ' ILE . 43.9 t -132.81 112.31 11.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.359 -0.838 . . . . 0.0 109.235 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.7 mp -47.25 -68.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.556 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.532 ' CG1' ' SG ' ' A' ' 67' ' ' CYS . 27.3 mt 63.42 155.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.306 -0.871 . . . . 0.0 110.171 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.528 ' HB ' HG23 ' A' ' 73' ' ' VAL . 12.4 m -147.73 -115.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.51 ' C ' HG22 ' A' ' 73' ' ' VAL . . . -74.06 81.69 0.78 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.6 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 54.46 19.82 14.45 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.528 HG23 ' HB ' ' A' ' 70' ' ' THR . 4.3 m -125.64 133.91 25.34 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.611 -0.935 . . . . 0.0 110.138 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 48.3 Cg_endo -82.84 129.99 5.67 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.59 1.311 . . . . 0.0 110.373 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.508 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -95.36 150.55 37.73 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 110.345 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.62 144.14 35.2 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.063 1.559 . . . . 0.0 110.375 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.454 ' HB2' HD13 ' A' ' 68' ' ' ILE . 23.3 t -165.93 24.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.138 -0.977 . . . . 0.0 110.559 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 44.51 27.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.44 -34.43 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.898 . . . . 0.0 110.796 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 1.7 t -50.82 145.35 7.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.012 -1.055 . . . . 0.0 110.731 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.829 ' HD2' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -97.35 167.52 10.96 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.668 -0.645 . . . . 0.0 109.606 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.719 HG22 ' O ' ' A' ' 82' ' ' ILE . 29.9 mm -154.59 60.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.967 -1.083 . . . . 0.0 109.714 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.5 m -98.35 -116.94 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 111.009 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.39 83.41 0.54 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -141.72 -165.05 1.91 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -1.156 . . . . 0.0 109.504 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.8 t -175.83 145.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.953 -1.092 . . . . 0.0 110.267 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.6 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.0 m-85 -111.71 -67.76 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.153 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER 69.66 11.84 7.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 110.4 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 48.13 91.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.169 -0.957 . . . . 0.0 109.867 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.417 -179.392 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.112 0.482 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.885 HD11 ' OG ' ' A' ' 15' ' ' SER . 19.2 tp 52.61 89.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.118 -0.989 . . . . 0.0 108.958 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -41.08 141.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.573 -0.704 . . . . 0.0 110.509 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.39 -17.11 4.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 110.458 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 17.5 p30 -94.01 -8.89 38.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 110.885 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.885 ' OG ' HD11 ' A' ' 11' ' ' LEU . 1.1 t -66.78 -174.59 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.858 -1.151 . . . . 0.0 109.213 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -122.39 159.88 26.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 110.252 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.3 t -151.79 111.97 4.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -175.43 125.1 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.804 . . . . 0.0 109.798 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt 51.74 55.32 9.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.754 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.491 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -140.35 161.97 36.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.0 110.719 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 36' ' ' THR . 2.9 t -135.43 61.77 1.65 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 109.248 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 22' ' ' LEU . 3.0 mt -74.26 176.96 6.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 111.167 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 24' ' ' ASN . 3.1 m -164.13 118.86 1.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.468 -0.77 . . . . 0.0 109.841 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.535 ' O ' ' N ' ' A' ' 39' ' ' GLY . 27.3 m120 50.43 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.337 -0.852 . . . . 0.0 109.646 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.81 -160.38 0.91 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.59 -1.318 . . . . 0.0 110.913 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.512 ' CG ' ' O ' ' A' ' 26' ' ' TYR . 13.8 t80 -164.29 34.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.789 ' HB ' HD12 ' A' ' 11' ' ' LEU . 5.0 t -33.05 151.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.536 0.684 . . . . 0.0 110.783 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 1.3 t70 -153.21 118.78 5.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 44' ' ' GLY . 6.4 mtpm? 48.11 72.88 0.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.422 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 45.3 m -157.71 157.92 34.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.973 -1.079 . . . . 0.0 111.095 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 3.8 mt-10 -120.58 119.75 33.82 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.567 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 46.9 t -123.04 156.32 28.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.101 -0.999 . . . . 0.0 110.623 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 32' ' ' VAL . 48.2 m-85 -154.42 32.14 0.42 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.186 -0.946 . . . . 0.0 111.223 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 162.28 -31.2 0.3 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.669 HG22 ' H ' ' A' ' 37' ' ' CYS . 19.3 m -38.66 162.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.516 -0.991 . . . . 0.0 111.541 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -104.65 -13.43 15.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.4 -0.812 . . . . 0.0 110.648 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.669 ' H ' HG22 ' A' ' 35' ' ' THR . 0.1 OUTLIER 38.59 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.266 -0.896 . . . . 0.0 110.932 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.5 m -105.09 94.31 5.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.122 -0.986 . . . . 0.0 109.975 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 48.25 26.73 4.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.514 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -104.79 -166.09 1.2 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.175 -1.191 . . . . 0.0 110.361 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HG2' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -164.85 155.57 14.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 110.388 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.788 ' HD2' HG13 ' A' ' 27' ' ' VAL . 7.4 m-85 -120.62 -175.06 2.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.338 -0.851 . . . . 0.0 109.403 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -165.95 46.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.139 -0.976 . . . . 0.0 109.932 179.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 121.65 53.34 0.22 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -132.94 -175.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.801 -1.411 . . . . 0.0 110.885 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 46' ' ' THR . 88.0 m -151.39 59.17 0.89 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.712 -0.618 . . . . 0.0 109.778 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 50' ' ' SER . 7.9 tt -81.0 167.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.767 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 50' ' ' SER . 54.3 p -139.36 -128.2 0.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.063 -1.023 . . . . 0.0 109.844 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 66' ' ' THR . 88.4 m -65.96 73.28 0.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.971 -1.08 . . . . 0.0 109.521 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.522 ' HB2' HD11 ' A' ' 47' ' ' ILE . 73.2 m -133.52 135.35 44.35 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.483 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 67' ' ' CYS . 1.6 m -88.62 139.09 30.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 53.9 p -153.69 130.08 10.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.412 -0.805 . . . . 0.0 110.075 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -111.54 112.4 24.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.008 -1.057 . . . . 0.0 109.696 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 50.53 90.76 0.01 OUTLIER Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.494 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 95.7 p -156.74 123.47 5.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.374 -1.074 . . . . 0.0 109.643 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.6 ttt180 -85.54 100.7 12.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.962 . . . . 0.0 110.69 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 64' ' ' ILE . 2.9 mt -89.11 23.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.487 -0.758 . . . . 0.0 110.446 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -43.75 155.28 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.915 -1.115 . . . . 0.0 109.711 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 165.88 143.61 3.8 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.195 -1.478 . . . . 0.0 110.325 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.01 -19.37 23.18 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.061 1.559 . . . . 0.0 110.276 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.5 36.95 0.52 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.44 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -57.88 160.38 4.69 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -1.045 . . . . 0.0 111.505 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.554 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 30.3 tttp -160.51 114.02 2.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.584 -0.698 . . . . 0.0 109.822 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.686 ' CD1' HG21 ' A' ' 57' ' ' ILE . 12.1 mt -128.77 155.28 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.825 -1.172 . . . . 0.0 111.477 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.44 126.16 6.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.503 ' N ' ' OG ' ' A' ' 50' ' ' SER . 0.7 OUTLIER 51.97 77.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 110.638 -179.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' A' ' 64' ' ' ILE . 89.5 m -138.9 118.41 12.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.134 -0.979 . . . . 0.0 109.63 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.812 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.5 mp -90.98 80.87 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 118.836 -1.146 . . . . 0.0 108.868 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 73' ' ' VAL . 18.6 mt -89.91 159.27 2.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.294 0.569 . . . . 0.0 110.544 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.629 ' O ' HG22 ' A' ' 73' ' ' VAL . 18.2 m -158.28 97.82 1.53 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 110.421 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 94.63 16.78 41.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 87' ' ' PHE . . . 91.53 16.01 53.63 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 70' ' ' THR . 14.2 m -124.32 132.94 24.36 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.423 -1.046 . . . . 0.0 110.124 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.447 ' HB3' HD11 ' A' ' 82' ' ' ILE . 52.1 Cg_endo -81.24 137.39 10.61 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.93 1.49 . . . . 0.0 110.65 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -90.75 159.16 41.23 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.91 . . . . 0.0 109.794 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.5 66.66 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.787 1.414 . . . . 0.0 110.282 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 78' ' ' ALA . 18.6 t -80.52 4.53 18.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.235 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 41.73 31.07 0.18 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 110.004 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -151.35 -38.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 44.8 t -49.52 170.45 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.311 -0.868 . . . . 0.0 108.849 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.554 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -106.99 -39.52 5.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.95 -1.094 . . . . 0.0 111.689 -178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.494 ' CA ' ' HE3' ' A' ' 81' ' ' LYS . 43.0 mm 43.62 68.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.879 -1.138 . . . . 0.0 109.501 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.445 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 45.1 t -125.38 -116.03 0.28 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 110.48 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -68.68 59.92 0.48 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.517 ' SG ' HD11 ' A' ' 64' ' ' ILE . 3.6 t -163.32 -171.76 2.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.265 . . . . 0.0 110.814 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.57 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.9 t 176.62 170.04 0.48 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.46 -0.775 . . . . 0.0 109.772 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -134.05 149.01 51.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.005 -1.06 . . . . 0.0 110.079 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 t -129.73 30.5 4.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.273 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 47.75 61.79 2.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.985 . . . . 0.0 110.065 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.288 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.478 0.656 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.568 ' CD1' ' HB3' ' A' ' 15' ' ' SER . 6.7 tp -47.74 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.752 -0.592 . . . . 0.0 109.772 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 10' ' ' GLN . 4.9 t -38.24 137.0 0.59 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.059 -0.657 . . . . 0.0 109.866 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.1 -17.51 0.43 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.21 -0.931 . . . . 0.0 111.289 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -90.72 -3.36 57.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.005 -1.06 . . . . 0.0 110.342 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.71 ' OG ' HG12 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -89.03 -157.48 0.45 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.098 -1.001 . . . . 0.0 110.054 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 8.4 tttm -165.7 156.27 13.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 110.057 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 40.7 t -144.14 156.41 44.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 110.48 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER 174.02 104.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.697 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 74.08 14.94 3.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.83 . . . . 0.0 110.052 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.433 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -102.48 165.97 10.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 0.0 110.474 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' CB ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -113.82 -43.65 3.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.429 -0.794 . . . . 0.0 110.121 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.425 ' CB ' ' O ' ' A' ' 21' ' ' THR . 1.1 tp 62.24 159.03 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.062 -1.024 . . . . 0.0 110.479 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' CYS . 1.7 m -174.61 117.66 0.2 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.413 -0.804 . . . . 0.0 109.256 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 23' ' ' THR . 26.1 m120 53.59 63.19 2.3 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.565 ' C ' ' CG ' ' A' ' 26' ' ' TYR . 1.3 m -146.21 -166.66 2.53 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.736 0.779 . . . . 0.0 111.096 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CG ' ' C ' ' A' ' 25' ' ' CYS . 11.0 m-85 -155.13 -40.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.831 HG13 ' HD2' ' A' ' 42' ' ' PHE . 11.8 t 56.39 137.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.643 0.735 . . . . 0.0 111.618 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.452 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 0.4 OUTLIER -151.6 130.72 12.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.53 -0.731 . . . . 0.0 109.816 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 34.8 mttp 54.31 37.5 27.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.116 -0.99 . . . . 0.0 109.098 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.605 ' HB3' HG22 ' A' ' 45' ' ' VAL . 8.3 m -126.59 169.62 12.9 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.487 -0.758 . . . . 0.0 110.353 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.91 ' OE1' HG23 ' A' ' 46' ' ' THR . 1.2 tt0 -113.02 -63.03 1.5 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.432 -0.793 . . . . 0.0 110.126 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 5.4 t 62.58 144.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -0.865 . . . . 0.0 110.141 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.501 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 42.4 m-85 -152.4 34.23 0.51 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 110.629 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 19' ' ' LYS . . . 156.28 -31.32 0.59 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 50' ' ' SER . 8.9 m -40.34 151.02 0.05 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.462 -1.023 . . . . 0.0 111.072 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.416 ' O ' ' CA ' ' A' ' 22' ' ' LEU . 76.1 m -97.49 -16.55 20.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.423 -0.798 . . . . 0.0 109.261 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.482 ' H ' HG22 ' A' ' 35' ' ' THR . 1.6 t 52.21 83.68 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.572 -0.705 . . . . 0.0 110.057 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 m -93.71 102.62 14.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.37 -0.831 . . . . 0.0 110.303 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.12 61.51 5.33 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 45.2 t -150.81 -168.91 3.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -1.112 . . . . 0.0 109.914 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' A' ' 42' ' ' PHE . 5.2 ttt180 -168.75 156.4 7.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.09 -1.006 . . . . 0.0 110.03 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.831 ' HD2' HG13 ' A' ' 27' ' ' VAL . 5.5 m-85 -117.93 179.35 4.11 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.273 -0.892 . . . . 0.0 110.161 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -168.14 41.1 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.401 -0.812 . . . . 0.0 109.474 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 59' ' ' GLY . . . 129.16 53.96 0.11 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.605 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -129.03 -165.84 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.065 -1.256 . . . . 0.0 110.324 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.91 HG23 ' OE1' ' A' ' 31' ' ' GLU . 23.5 m -163.44 57.9 0.18 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.683 HD11 ' CB ' ' A' ' 50' ' ' SER . 10.4 tt -86.01 172.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.641 0.734 . . . . 0.0 111.695 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' SER . 32.7 p -129.93 -156.32 0.75 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.508 -0.745 . . . . 0.0 109.327 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 49' ' ' THR . 3.6 m -48.5 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.813 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.683 ' CB ' HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -125.24 140.29 52.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.636 -1.29 . . . . 0.0 110.488 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 51' ' ' THR . 14.7 m -86.88 18.36 3.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.142 -0.974 . . . . 0.0 110.732 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.495 ' HA ' ' HB ' ' A' ' 69' ' ' ILE . 12.4 p -39.06 114.45 0.4 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.314 -0.866 . . . . 0.0 111.006 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.2 m -112.02 93.34 4.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.0 109.387 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 82.99 77.47 1.09 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.564 ' CB ' ' HB3' ' A' ' 87' ' ' PHE . 1.6 p -156.26 123.03 5.2 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.273 -1.134 . . . . 0.0 110.974 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -87.16 103.09 15.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 109.884 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 57' ' ' ILE . 2.8 mp -89.03 14.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.056 -1.028 . . . . 0.0 110.122 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -42.58 141.45 1.02 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.335 -0.853 . . . . 0.0 109.789 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.491 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . 172.89 155.5 11.53 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.185 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.56 -2.61 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.173 1.617 . . . . 0.0 110.566 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.28 31.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -49.63 128.41 17.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 110.336 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -114.75 127.81 55.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.427 -0.796 . . . . 0.0 110.528 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.578 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 4.6 mt -138.99 149.87 23.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.139 -0.976 . . . . 0.0 109.853 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 81' ' ' LYS . 83.8 p -147.04 106.04 3.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.051 -1.031 . . . . 0.0 110.699 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.0 m 50.96 73.06 0.31 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 111.583 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.574 ' HB3' HD11 ' A' ' 69' ' ' ILE . 14.6 t -129.1 119.92 25.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.475 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 69' ' ' ILE . 1.7 mp -48.32 -75.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 109.918 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.934 HD13 ' CZ ' ' A' ' 87' ' ' PHE . 10.8 mt 62.81 140.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 0.0 109.683 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.771 ' O ' HG22 ' A' ' 73' ' ' VAL . 81.3 m -165.74 101.8 0.68 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.118 -0.989 . . . . 0.0 111.315 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.85 23.73 24.82 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.58 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 85.19 8.92 80.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 70' ' ' THR . 20.3 m -112.48 121.89 37.78 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.55 -0.971 . . . . 0.0 109.814 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.27 124.09 6.99 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.712 1.375 . . . . 0.0 110.381 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -86.22 139.34 34.29 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.879 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.68 91.99 0.79 Allowed 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.105 1.582 . . . . 0.0 111.035 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.46 147.35 45.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.107 -0.996 . . . . 0.0 110.464 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.76 -12.11 32.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 110.543 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' SER . . . -103.82 -18.14 14.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.93 . . . . 0.0 110.664 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 14.1 t -71.9 157.95 36.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.147 -0.971 . . . . 0.0 109.939 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.558 ' HE3' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -101.53 -11.78 19.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.028 -1.045 . . . . 0.0 112.925 -177.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 81' ' ' LYS . 26.7 mm 26.41 50.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.443 -0.786 . . . . 0.0 111.423 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.6 m -108.21 -157.67 0.62 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.867 -1.146 . . . . 0.0 110.946 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.25 98.63 0.17 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.498 ' SG ' HG23 ' A' ' 57' ' ' ILE . 3.7 t -170.87 -168.43 0.66 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.354 -1.086 . . . . 0.0 109.662 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 2.7 t -177.03 158.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.919 -1.113 . . . . 0.0 109.653 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.934 ' CZ ' HD13 ' A' ' 69' ' ' ILE . 10.4 m-85 -118.95 -49.44 2.42 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 110.548 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 89' ' ' ALA . 15.4 m 61.89 11.92 4.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.283 -0.885 . . . . 0.0 109.858 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 88' ' ' SER . . . 57.15 119.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.439 -0.788 . . . . 0.0 110.392 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 3.8 t30 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.183 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.866 HD12 ' CB ' ' A' ' 15' ' ' SER . 1.6 mm? -39.42 101.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.544 0.687 . . . . 0.0 110.251 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.519 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -87.0 163.02 17.3 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.641 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.427 ' HB3' ' C ' ' A' ' 28' ' ' ASP . . . 49.43 -157.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.068 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -90.49 57.58 3.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 111.482 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.866 ' CB ' HD12 ' A' ' 11' ' ' LEU . 22.0 p -58.54 -168.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.832 -1.167 . . . . 0.0 110.249 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.501 ' CB ' ' HG2' ' A' ' 31' ' ' GLU . 34.8 tttt -154.32 146.93 24.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.05 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.58 167.52 16.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.074 -1.016 . . . . 0.0 110.709 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -176.3 -154.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.504 -0.747 . . . . 0.0 109.651 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.44 54.09 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.017 . . . . 0.0 110.033 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 33' ' ' TYR . 7.9 t -111.99 168.63 9.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.223 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.62 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -104.67 105.92 16.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 109.709 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.62 HD22 ' C ' ' A' ' 21' ' ' THR . 4.3 mm? -107.93 145.8 33.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.774 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 15.7 m -161.13 118.83 2.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 0.0 109.615 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 23' ' ' THR . 26.5 m-20 59.01 64.07 1.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 110.057 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -142.67 169.93 16.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.916 . . . . 0.0 110.581 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 13.5 m-85 -129.13 -40.83 1.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.725 HG13 ' HD2' ' A' ' 42' ' ' PHE . 3.6 t 47.24 112.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.586 0.707 . . . . 0.0 112.017 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.519 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -98.13 -91.91 0.26 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.157 -0.964 . . . . 0.0 109.219 178.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -93.63 68.85 4.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.079 -1.013 . . . . 0.0 109.632 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.664 ' HB3' HG22 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -135.76 -172.98 3.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 110.604 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.643 ' C ' HG23 ' A' ' 32' ' ' VAL . 9.5 mt-10 -137.72 -66.4 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.396 -0.815 . . . . 0.0 110.242 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.643 HG23 ' C ' ' A' ' 31' ' ' GLU . 2.5 t 69.99 150.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.348 -0.845 . . . . 0.0 110.371 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.922 ' CD2' HG22 ' A' ' 48' ' ' THR . 51.0 m-85 -138.68 -46.39 0.49 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.192 -0.942 . . . . 0.0 110.687 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.4 18.36 3.27 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.551 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 33.0 m -67.37 162.14 23.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.181 -1.188 . . . . 0.0 110.369 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 21' ' ' THR . 6.4 m -121.11 64.93 0.87 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.511 ' O ' ' HB ' ' A' ' 23' ' ' THR . 5.3 t -42.42 97.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.495 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.498 ' O ' HG22 ' A' ' 38' ' ' THR . 27.9 m -89.95 20.36 4.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.98 -1.075 . . . . 0.0 109.622 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.16 47.1 0.19 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.9 p -126.54 -156.11 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 110.443 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HG2' ' OD1' ' A' ' 90' ' ' ASN . 1.1 ptt85 -169.77 153.8 5.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.894 . . . . 0.0 110.199 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.725 ' HD2' HG13 ' A' ' 27' ' ' VAL . 4.2 m-85 -121.63 -175.11 3.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 110.172 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER 178.59 61.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.982 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 111.1 52.01 0.58 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.664 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.01 -167.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.969 -1.312 . . . . 0.0 110.627 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.549 ' N ' HG23 ' A' ' 45' ' ' VAL . 32.8 m -160.85 54.81 0.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 50' ' ' SER . 17.3 tt -85.08 169.61 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.461 -0.774 . . . . 0.0 110.33 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.922 HG22 ' CD2' ' A' ' 33' ' ' TYR . 41.7 p -135.78 -127.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.307 -0.87 . . . . 0.0 109.962 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 49' ' ' THR . 38.3 m -69.74 72.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.907 -1.12 . . . . 0.0 110.398 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.619 ' HB2' HD11 ' A' ' 47' ' ' ILE . 57.8 m -130.06 136.31 49.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -95.81 117.77 31.2 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.107 -0.996 . . . . 0.0 109.788 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 1.5 m -125.2 137.73 54.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 109.845 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.508 ' HB ' HG23 ' A' ' 70' ' ' THR . 1.0 OUTLIER -115.35 126.37 54.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.046 -1.034 . . . . 0.0 110.535 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 43.64 50.67 6.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 7.8 p -127.33 141.52 51.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -1.112 . . . . 0.0 110.187 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -99.41 101.53 12.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 110.067 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 57' ' ' ILE . 3.0 mp -82.15 7.64 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 m -56.15 163.3 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.056 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.0 155.7 7.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.03 55.37 2.85 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.054 1.555 . . . . 0.0 110.27 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.79 17.19 3.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -45.79 136.57 6.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -1.194 . . . . 0.0 110.518 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.525 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -140.98 120.22 12.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.195 -0.941 . . . . 0.0 110.033 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.562 ' CD1' HG23 ' A' ' 57' ' ' ILE . 21.6 mt -135.39 164.95 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.99 -1.069 . . . . 0.0 111.187 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.481 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -155.46 115.6 3.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.567 -0.708 . . . . 0.0 109.498 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.6 m 53.29 86.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.057 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.409 ' H ' ' CB ' ' A' ' 50' ' ' SER . 54.4 m -150.4 99.9 2.82 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.303 -0.873 . . . . 0.0 109.986 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.823 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.7 mp -67.6 96.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.98 -1.075 . . . . 0.0 109.445 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 73' ' ' VAL . 9.6 mt -104.2 160.75 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.953 . . . . 0.0 110.717 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.913 ' O ' HG22 ' A' ' 73' ' ' VAL . 25.5 m -163.38 110.07 1.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 109.983 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.83 20.47 55.79 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.569 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 86.58 12.22 69.91 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.913 HG22 ' O ' ' A' ' 70' ' ' THR . 6.5 m -118.65 138.34 25.8 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.41 -1.053 . . . . 0.0 110.292 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -80.64 154.05 20.51 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.939 1.494 . . . . 0.0 110.106 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.823 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -83.31 162.36 54.2 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 110.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.3 Cg_endo -74.46 53.43 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.119 1.589 . . . . 0.0 110.281 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.9 m -103.85 138.65 40.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 110.274 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.09 -23.81 35.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 110.23 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.98 6.04 17.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.428 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 66' ' ' THR . 1.2 t -100.76 154.14 18.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.937 . . . . 0.0 109.874 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.559 ' CD ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.56 -168.98 1.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 110.927 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' ' 82' ' ' ILE . 2.1 tp 179.03 33.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.8 0.809 . . . . 0.0 109.201 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -62.21 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.454 -0.779 . . . . 0.0 111.266 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.95 82.82 0.34 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.704 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.549 ' SG ' HD11 ' A' ' 64' ' ' ILE . 1.8 t -144.82 -152.47 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 110.055 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER 172.9 148.44 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 109.893 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 1.4 m-85 -119.08 -28.31 5.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.346 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.778 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 68.0 m 52.85 -90.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.944 -1.098 . . . . 0.0 109.482 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.778 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . 157.41 74.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.269 0.557 . . . . 0.0 109.725 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.455 ' OD1' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.034 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.189 0.519 . . . . 0.0 110.049 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 24.5 tp 48.91 89.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.061 -1.024 . . . . 0.0 109.994 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.564 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -44.48 156.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.747 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.91 -8.71 39.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.0 109.903 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -97.65 -10.32 25.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.325 -0.859 . . . . 0.0 110.135 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -78.18 -158.71 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -141.27 147.11 37.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 t -127.55 85.77 2.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 0.0 110.014 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' LYS . 21.1 tt0 -132.45 84.66 2.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 110.526 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' GLU . 1.2 mttp 52.41 104.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.326 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 21' ' ' THR . 35.3 t -158.95 -158.72 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 110.192 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 35' ' ' THR . 0.3 OUTLIER -152.48 86.57 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.277 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.554 HD11 HG11 ' A' ' 32' ' ' VAL . 4.0 mp -109.46 116.77 32.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.129 -0.982 . . . . 0.0 110.133 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 85.8 m -104.29 119.67 39.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -0.956 . . . . 0.0 110.114 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 23' ' ' THR . 11.8 m-20 56.93 22.2 6.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.987 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.472 ' SG ' ' HG ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -71.2 -145.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 110.42 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.506 ' O ' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -179.34 -50.67 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 26' ' ' TYR . 2.6 t 52.05 121.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.775 0.798 . . . . 0.0 111.41 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.564 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 3.2 t70 -111.49 -25.74 9.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 110.191 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.533 ' CD ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -166.65 58.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 109.955 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.892 ' OG ' HG22 ' A' ' 45' ' ' VAL . 16.9 m -132.89 154.83 50.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 111.237 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.61 96.35 6.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.619 -0.676 . . . . 0.0 109.192 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.554 HG11 HD11 ' A' ' 22' ' ' LEU . 12.0 t -91.03 164.52 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 110.941 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.566 ' HB2' HG22 ' A' ' 48' ' ' THR . 20.5 m-85 -143.19 -36.6 0.37 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . -159.37 29.37 0.4 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' SER . 15.5 m -77.06 159.67 29.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.298 -1.119 . . . . 0.0 110.624 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -112.45 53.36 0.74 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.441 -0.787 . . . . 0.0 109.695 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 5.1 t -39.48 103.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.487 -0.758 . . . . 0.0 110.839 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.531 ' O ' HG22 ' A' ' 38' ' ' THR . 23.4 m -103.56 79.37 1.68 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.989 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.51 69.22 1.43 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.55 ' HG ' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -161.27 -148.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -1.099 . . . . 0.0 110.184 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 40' ' ' SER . 1.3 ttp180 172.79 158.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.917 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CD1' ' CG1' ' A' ' 57' ' ' ILE . 2.5 m-85 -121.72 -173.2 2.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 0.0 110.166 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -173.65 57.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.252 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 117.17 47.71 0.46 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.892 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.73 -166.15 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.724 -1.457 . . . . 0.0 111.156 -179.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.56 ' N ' HG23 ' A' ' 45' ' ' VAL . 22.1 m -156.16 58.16 0.58 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.339 0.59 . . . . 0.0 109.433 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.75 HD11 ' OG ' ' A' ' 50' ' ' SER . 11.1 tt -84.76 154.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 111.239 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.595 ' C ' HG23 ' A' ' 49' ' ' THR . 72.8 p -148.98 148.5 29.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.605 -0.684 . . . . 0.0 109.913 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.595 HG23 ' C ' ' A' ' 48' ' ' THR . 0.1 OUTLIER 43.28 33.32 0.57 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.009 -1.057 . . . . 0.0 110.772 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.75 ' OG ' HD11 ' A' ' 47' ' ' ILE . 28.3 t -100.77 128.79 46.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.904 -1.122 . . . . 0.0 110.059 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 52' ' ' SER . 3.4 m -92.48 22.35 4.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 110.417 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -40.4 125.62 2.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.427 -0.796 . . . . 0.0 110.868 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 1.6 m -106.95 94.81 5.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 109.511 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.55 ' HA2' ' HG ' ' A' ' 40' ' ' SER . . . 72.45 77.09 0.58 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.501 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 1.3 p -147.2 117.53 7.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.352 -1.087 . . . . 0.0 110.366 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.548 ' CG ' ' HB2' ' A' ' 90' ' ' ASN . 2.8 ttt-85 -68.4 107.25 2.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.665 ' O ' HG11 ' A' ' 45' ' ' VAL . 15.2 mm -88.44 0.22 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.108 -0.995 . . . . 0.0 109.763 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -40.41 125.0 2.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.385 -0.822 . . . . 0.0 110.424 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -167.1 144.77 9.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.05 81.47 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.927 1.488 . . . . 0.0 109.952 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.0 15.73 53.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.647 ' SG ' HD11 ' A' ' 64' ' ' ILE . 15.7 t -44.18 164.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.334 -1.098 . . . . 0.0 111.221 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 62' ' ' CYS . 8.0 ttpp -150.45 114.03 4.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.483 -0.76 . . . . 0.0 110.168 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.647 HD11 ' SG ' ' A' ' 62' ' ' CYS . 4.4 mt -129.83 155.95 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.911 -1.118 . . . . 0.0 111.012 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.453 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -156.01 120.48 4.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.311 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 48' ' ' THR . 9.4 m 44.55 71.49 0.25 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -0.845 . . . . 0.0 111.008 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 98.1 m -122.58 120.8 34.86 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.407 -0.808 . . . . 0.0 109.64 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.3 mp -88.92 86.02 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.103 -0.998 . . . . 0.0 109.777 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.767 HG23 ' C ' ' A' ' 73' ' ' VAL . 3.7 mt -102.49 157.22 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.435 -0.791 . . . . 0.0 110.356 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.815 ' O ' HG22 ' A' ' 73' ' ' VAL . 53.6 m -153.95 105.49 2.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 0.0 110.24 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 88.02 17.27 58.08 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.565 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 92.36 13.49 57.16 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 70' ' ' THR . 12.9 m -121.76 129.2 25.27 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.454 -1.027 . . . . 0.0 110.436 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -81.24 132.76 8.37 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.928 1.489 . . . . 0.0 110.822 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 77' ' ' SER . . . -76.28 161.08 76.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.262 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.7 64.41 1.24 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.765 1.403 . . . . 0.0 109.953 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.9 t -99.58 118.08 35.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 0.0 110.242 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.62 -4.6 24.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 110.006 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.59 -19.13 18.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.854 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.855 ' SG ' HD12 ' A' ' 82' ' ' ILE . 26.0 t -68.6 165.48 19.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.09 -1.006 . . . . 0.0 109.934 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.599 ' N ' ' HD3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -105.14 7.21 33.67 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.289 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.855 HD12 ' SG ' ' A' ' 80' ' ' CYS . 0.9 OUTLIER -15.01 82.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.543 0 CA-C-N 118.909 0.777 . . . . 0.0 111.56 -178.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -128.89 -70.21 0.68 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 111.308 -178.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -129.21 86.87 0.31 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.173 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 86' ' ' THR . 3.8 t -177.05 -150.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -1.161 . . . . 0.0 110.084 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 85' ' ' CYS . 1.7 t 174.0 161.87 0.17 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.634 ' CD2' HG21 ' A' ' 69' ' ' ILE . 3.1 m-85 -113.03 -52.56 2.77 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.945 -1.097 . . . . 0.0 110.011 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER 65.22 7.85 4.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 110.312 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 55.65 112.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 110.675 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.548 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . 7.9 t30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.16 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.562 ' CG ' ' N ' ' A' ' 11' ' ' LEU . 8.4 pt20 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 121.21 0.529 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.766 HD12 ' HB ' ' A' ' 27' ' ' VAL . 14.4 tp 59.82 106.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.199 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -35.67 144.26 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.286 0.565 . . . . 0.0 110.747 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -13.78 6.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.421 -0.8 . . . . 0.0 110.13 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -112.53 8.52 19.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 110.71 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.557 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 2.0 t -82.46 -152.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.891 -1.131 . . . . 0.0 109.955 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.464 ' O ' HD21 ' A' ' 11' ' ' LEU . 26.7 tttm -147.19 152.93 39.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.933 -1.104 . . . . 0.0 110.955 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.545 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 9.5 p -142.27 -153.44 0.46 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.313 -0.867 . . . . 0.0 109.911 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' CYS . 14.6 mm-40 57.05 159.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.114 -0.991 . . . . 0.0 110.173 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 44.31 63.21 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.0 109.946 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.737 ' HB2' HD21 ' A' ' 22' ' ' LEU . 68.9 p -170.55 160.95 7.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.441 -0.787 . . . . 0.0 109.834 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.844 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -125.37 104.47 8.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.087 -1.008 . . . . 0.0 108.79 179.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.844 HD23 ' C ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -144.2 -168.62 2.92 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.308 -178.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 24' ' ' ASN . 1.3 m -177.78 146.66 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 23' ' ' THR . 4.3 m-20 45.8 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -0.956 . . . . 0.0 109.871 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 26' ' ' TYR . 60.3 m -140.24 -155.4 0.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.093 -1.005 . . . . 0.0 111.007 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.535 ' CB ' ' O ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER 163.19 43.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.766 ' HB ' HD12 ' A' ' 11' ' ' LEU . 21.6 t -62.11 145.4 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.469 0.652 . . . . 0.0 110.961 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 16.0 m-20 -129.01 3.5 5.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 110.313 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.5 OUTLIER 175.67 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.322 -0.861 . . . . 0.0 109.837 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.809 ' OG ' HG22 ' A' ' 45' ' ' VAL . 54.3 m -165.26 -160.48 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.953 -1.092 . . . . 0.0 110.343 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 2.5 mt-10 -137.66 -62.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 0.0 110.542 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 47' ' ' ILE . 3.9 t 64.61 153.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.892 . . . . 0.0 110.74 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.691 ' CD1' HG22 ' A' ' 48' ' ' THR . 25.9 m-85 -149.86 -77.04 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.504 -0.748 . . . . 0.0 109.336 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 48' ' ' THR . . . -107.95 36.47 4.36 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 36' ' ' THR . 1.0 OUTLIER -82.96 171.79 13.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -1.081 . . . . 0.0 110.46 -179.475 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.528 ' N ' ' CG2' ' A' ' 35' ' ' THR . 1.7 m -119.52 58.81 0.87 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 110.234 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.644 ' HB3' ' CB ' ' A' ' 22' ' ' LEU . 36.2 t -39.03 103.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.443 -0.785 . . . . 0.0 110.579 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.574 ' O ' HG22 ' A' ' 38' ' ' THR . 24.3 m -106.39 75.84 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.981 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.74 49.03 71.47 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 4.9 p -138.9 169.08 18.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -1.119 . . . . 0.0 110.18 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.403 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -147.44 157.44 43.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 109.994 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 41' ' ' ARG . 2.5 m-85 -119.98 -179.44 3.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.154 -0.967 . . . . 0.0 110.454 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -155.71 46.93 0.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 109.47 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 123.94 75.03 0.28 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.809 HG22 ' OG ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -150.28 -168.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.196 -1.179 . . . . 0.0 110.453 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' VAL . 39.9 m -155.28 57.86 0.64 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.572 -0.705 . . . . 0.0 109.332 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.879 HD11 ' HB2' ' A' ' 50' ' ' SER . 11.3 tt -78.33 168.05 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 110.054 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.691 HG22 ' CD1' ' A' ' 33' ' ' TYR . 2.4 p -143.06 -81.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -110.61 39.91 2.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.233 -0.917 . . . . 0.0 109.386 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.879 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -96.31 124.36 40.28 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.351 -0.843 . . . . 0.0 110.943 -179.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -71.13 135.66 47.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.355 -0.841 . . . . 0.0 108.963 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.6 p -140.82 119.37 12.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.909 -1.12 . . . . 0.0 110.663 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.401 ' H ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -117.49 70.15 0.78 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 109.43 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 96.01 91.1 1.79 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 87.3 p -171.92 128.09 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -1.202 . . . . 0.0 110.811 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.543 ' CD ' ' HB2' ' A' ' 88' ' ' SER . 1.4 ptp180 -87.71 105.05 17.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 109.365 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.534 ' N ' HD13 ' A' ' 57' ' ' ILE . 5.1 mm -81.66 16.08 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.023 . . . . 0.0 110.992 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.91 156.06 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.025 -1.047 . . . . 0.0 110.038 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.59 143.77 3.77 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.29 -3.35 13.78 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.985 1.519 . . . . 0.0 110.225 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.49 27.65 0.28 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -58.28 141.03 52.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -1.126 . . . . 0.0 110.472 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 6.1 ttpp -151.66 117.04 5.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.529 -0.732 . . . . 0.0 109.2 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.609 ' HA ' ' CD ' ' A' ' 81' ' ' LYS . 2.2 mp -129.36 147.11 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.956 -1.09 . . . . 0.0 111.172 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.541 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -143.2 111.93 6.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 110.181 179.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.527 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 19.8 m 51.76 57.54 6.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.647 -0.658 . . . . 0.0 111.108 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 2.0 t -110.46 129.3 55.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.425 -0.797 . . . . 0.0 110.154 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.715 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.0 mp -87.03 93.36 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.029 . . . . 0.0 108.676 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.706 HG21 ' CD2' ' A' ' 87' ' ' PHE . 10.1 mt -106.9 149.55 10.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.392 -0.818 . . . . 0.0 110.489 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.801 ' O ' HG22 ' A' ' 73' ' ' VAL . 7.5 m -156.04 103.81 2.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 110.734 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.5 24.85 27.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 87' ' ' PHE . . . 83.09 17.14 67.86 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 70' ' ' THR . 14.2 m -124.0 128.53 25.06 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.523 -0.986 . . . . 0.0 110.701 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -82.04 130.65 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.904 1.476 . . . . 0.0 110.313 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -93.02 147.3 33.6 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.09 -1.006 . . . . 0.0 110.153 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.24 101.31 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.948 1.499 . . . . 0.0 109.796 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.721 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 40.3 t -111.73 -5.63 14.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 110.72 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 70.45 3.63 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.157 -0.964 . . . . 0.0 109.57 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 80' ' ' CYS . . . -125.65 -34.03 2.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 109.318 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 18.2 t -45.09 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.59 -0.694 . . . . 0.0 109.536 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.609 ' CD ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.96 7.45 46.61 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.961 -1.087 . . . . 0.0 112.357 -178.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.579 ' C ' ' O ' ' A' ' 81' ' ' LYS . 17.6 mm -6.69 73.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 81' ' ' LYS . 43.9 t -124.35 -52.06 1.74 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 109.864 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' CYS . . . -147.82 -114.95 0.81 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' GLY . 2.9 t 44.07 -167.82 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.343 -1.092 . . . . 0.0 109.972 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.467 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.6 OUTLIER 175.18 140.22 0.05 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 110.459 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CD2' HG21 ' A' ' 69' ' ' ILE . 1.6 m-30 -115.69 170.26 8.58 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.4 -0.813 . . . . 0.0 109.677 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.543 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 6.7 m -165.52 25.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 109.644 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.498 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.02 83.41 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.36 -0.837 . . . . 0.0 109.967 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.452 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.317 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.55 ' O ' ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 10' ' ' GLN . 14.2 tp 10.2 107.24 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.356 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.624 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -39.56 155.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.636 -0.665 . . . . 0.0 110.328 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.28 -8.46 25.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 110.203 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.7 -9.39 6.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.09 -1.006 . . . . 0.0 110.454 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.697 ' OG ' HG12 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -66.24 -161.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.865 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 24.6 tttt -165.34 150.28 9.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.126 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 p -126.02 -35.93 2.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.917 . . . . 0.0 110.242 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 58.14 -162.77 0.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.765 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -87.86 62.66 7.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.861 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.531 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 77.9 p -97.63 -172.25 2.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 110.743 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.5 ' C ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -106.65 10.74 30.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.566 HD13 HG11 ' A' ' 32' ' ' VAL . 2.3 tp -37.95 159.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.496 0.665 . . . . 0.0 110.814 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 94.6 m -162.36 123.69 2.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.69 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.1 m120 56.52 60.51 3.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 110.314 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.598 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -120.59 -157.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 110.448 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 25' ' ' CYS . 47.2 m-85 -154.82 -55.98 0.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.697 HG12 ' OG ' ' A' ' 15' ' ' SER . 2.4 t 57.72 119.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.477 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.624 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 4.1 m-20 -112.58 -24.68 9.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.49 -0.756 . . . . 0.0 109.817 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 28' ' ' ASP . 5.1 mtpp -163.41 59.23 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.528 -0.732 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.927 ' OG ' HG22 ' A' ' 45' ' ' VAL . 39.1 m -139.88 153.53 47.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.026 . . . . 0.0 111.562 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' OE2' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -115.9 112.2 21.54 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.566 HG11 HD13 ' A' ' 22' ' ' LEU . 7.0 t -106.84 159.06 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -0.957 . . . . 0.0 110.93 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.567 ' CD1' HG22 ' A' ' 48' ' ' THR . 46.1 m-85 -130.91 -36.41 1.36 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.354 -0.841 . . . . 0.0 110.946 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -151.0 12.76 0.83 Allowed Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.582 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' SER . 27.5 m -62.44 162.13 10.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.989 -1.301 . . . . 0.0 110.648 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.5 ' HA ' ' C ' ' A' ' 21' ' ' THR . 19.9 m -109.94 -22.52 11.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.358 -0.839 . . . . 0.0 110.266 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.496 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 4.0 t 42.24 81.13 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.24 -0.913 . . . . 0.0 110.42 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.529 ' O ' HG22 ' A' ' 38' ' ' THR . 88.8 m -77.06 57.2 1.34 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 109.421 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.39 74.11 1.28 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -157.35 -161.77 1.11 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.261 -1.14 . . . . 0.0 110.008 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 10.7 ptt180 -167.56 162.33 14.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.031 . . . . 0.0 110.658 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.601 ' CE1' HD13 ' A' ' 57' ' ' ILE . 2.6 m-85 -120.31 -162.72 0.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.371 -0.831 . . . . 0.0 110.217 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER 171.98 53.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 29' ' ' LYS . . . 117.27 56.49 0.3 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.927 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.3 m -139.35 -164.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.09 -1.241 . . . . 0.0 110.475 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 46' ' ' THR . 91.5 m -161.07 56.52 0.3 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 17.4 tt -83.86 165.47 2.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.378 -0.826 . . . . 0.0 110.589 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.567 HG22 ' CD1' ' A' ' 33' ' ' TYR . 66.4 p -129.53 -140.04 0.23 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 109.131 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.517 ' HA ' ' CA ' ' A' ' 34' ' ' GLY . 41.6 m -51.32 129.44 24.84 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.057 -1.027 . . . . 0.0 108.941 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' THR . 41.0 t -171.21 163.18 7.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.006 -1.059 . . . . 0.0 110.587 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 51' ' ' THR . 52.9 m -116.83 13.99 15.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.079 -1.013 . . . . 0.0 110.339 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.474 ' C ' ' O ' ' A' ' 51' ' ' THR . 54.5 p -36.18 133.94 0.45 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.644 -0.66 . . . . 0.0 110.653 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 69' ' ' ILE . 6.9 m -127.22 107.64 10.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 110.19 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 64.84 78.93 0.19 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.453 ' O ' HD12 ' A' ' 57' ' ' ILE . 51.8 p -158.3 127.47 5.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.153 -1.204 . . . . 0.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HB3' ' CB ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -78.54 103.6 8.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 57' ' ' ILE . 3.1 mp -89.48 16.47 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.963 -1.085 . . . . 0.0 110.66 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.49 159.73 0.69 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.2 -0.937 . . . . 0.0 110.266 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.29 166.82 18.99 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.77 54.03 3.87 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.073 1.565 . . . . 0.0 109.873 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 107.56 22.51 7.35 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.527 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 5.0 t -40.56 103.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.584 -0.95 . . . . 0.0 110.384 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 64' ' ' ILE . 13.2 tttt -97.12 146.06 25.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.572 -0.705 . . . . 0.0 109.725 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.672 HG23 ' NZ ' ' A' ' 81' ' ' LYS . 19.2 mt -154.5 144.08 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.052 -1.03 . . . . 0.0 110.783 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.438 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -136.4 107.87 6.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.284 -0.885 . . . . 0.0 110.653 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' THR . 5.9 m 58.02 79.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.37 -0.831 . . . . 0.0 111.469 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.523 ' O ' HG13 ' A' ' 69' ' ' ILE . 0.9 OUTLIER -135.63 117.4 15.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 109.981 178.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.665 ' HB ' ' HB3' ' A' ' 75' ' ' ALA . 1.1 mm -76.33 101.75 2.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 17.4 mt -115.2 155.87 16.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 O-C-N 120.899 -1.126 . . . . 0.0 109.97 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.845 ' O ' HG22 ' A' ' 73' ' ' VAL . 86.4 m -159.98 103.02 1.48 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 0.0 110.426 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.73 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 88.94 25.93 28.03 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.17 17.29 69.75 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 70' ' ' THR . 12.4 m -127.63 132.86 24.55 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.393 -1.063 . . . . 0.0 110.859 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -81.46 147.06 15.69 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.02 1.537 . . . . 0.0 110.656 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.853 ' HB1' ' CD ' ' A' ' 76' ' ' PRO . . . -73.15 -153.59 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.154 -0.966 . . . . 0.0 108.403 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.853 ' CD ' ' HB1' ' A' ' 75' ' ' ALA . 43.5 Cg_endo -75.62 9.48 2.24 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 O-C-N 122.404 0.686 . . . . 0.0 111.018 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.503 ' CB ' ' HB3' ' A' ' 80' ' ' CYS . 5.3 p 45.0 50.17 9.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.89 . . . . 0.0 111.448 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.07 -23.6 3.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.02 -1.05 . . . . 0.0 109.153 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.54 40.88 0.25 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 1.2 t -109.49 164.64 12.32 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.902 0.858 . . . . 0.0 110.98 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.672 ' NZ ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.27 173.71 7.25 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 82' ' ' ILE . 17.9 mm -160.1 53.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 t -97.95 -126.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 110.386 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.48 91.54 1.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.428 ' SG ' ' C ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER -162.76 177.51 9.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.147 . . . . 0.0 109.874 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.527 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -177.43 149.57 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.35 -0.844 . . . . 0.0 110.022 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -117.13 166.6 12.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.113 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.491 ' CB ' ' HB3' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -148.58 23.91 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.901 -1.125 . . . . 0.0 110.371 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 47.16 62.7 2.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.257 -0.902 . . . . 0.0 109.695 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.462 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.21 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.54 ' CD ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.052 HD12 ' CB ' ' A' ' 15' ' ' SER . 3.4 mm? -41.25 103.18 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.95 0.881 . . . . 0.0 109.35 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' ALA . 50.8 m -64.94 55.49 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.842 -0.536 . . . . 0.0 111.5 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 56.76 154.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 110.627 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 70.51 -4.68 1.57 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.209 -0.932 . . . . 0.0 111.807 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 1.052 ' CB ' HD12 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -74.42 176.69 6.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.458 -1.401 . . . . 0.0 110.574 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HD3' ' CG ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -160.42 151.53 19.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.392 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 p -166.65 -172.01 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 110.263 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 22.3 tt0 -169.61 -39.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.384 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -177.62 54.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.366 -0.834 . . . . 0.0 109.987 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.482 ' HB2' ' N ' ' A' ' 34' ' ' GLY . 52.0 p -102.92 -163.44 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 110.557 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' THR . 68.8 m -126.77 77.0 1.68 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.979 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 37' ' ' CYS . 3.5 tp -95.19 165.83 12.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 21.7 m -167.51 128.81 1.52 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.426 -0.796 . . . . 0.0 109.902 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.46 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 28.8 m-80 56.34 29.14 14.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.075 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -101.8 154.57 18.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.86 . . . . 0.0 110.375 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' CD1' ' CD ' ' A' ' 10' ' ' GLN . 1.9 m-85 -116.69 -40.31 3.2 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.784 ' HB ' HD13 ' A' ' 11' ' ' LEU . 6.5 t 52.99 137.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.107 0.956 . . . . 0.0 113.096 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 14.7 t0 -142.2 118.08 10.54 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 14' ' ' ASN . 30.8 mttm 53.11 66.07 1.34 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.009 -1.057 . . . . 0.0 109.301 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 45' ' ' VAL . 69.3 m -153.51 151.97 30.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.038 -1.039 . . . . 0.0 110.65 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' CG ' ' HD3' ' A' ' 16' ' ' LYS . 11.0 mt-10 -121.12 112.91 19.28 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.534 -0.729 . . . . 0.0 109.166 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.515 HG11 ' HB ' ' A' ' 35' ' ' THR . 17.0 t -111.13 152.55 13.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.57 -0.707 . . . . 0.0 110.392 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.456 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 51.2 m-85 -144.93 34.71 1.12 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.263 -0.898 . . . . 0.0 110.841 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.482 ' N ' ' HB2' ' A' ' 20' ' ' SER . . . 140.9 41.46 0.07 OUTLIER Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.122 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.515 ' HB ' HG11 ' A' ' 32' ' ' VAL . 3.5 m -97.41 124.9 41.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.075 -1.25 . . . . 0.0 110.582 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.543 ' O ' HG22 ' A' ' 36' ' ' THR . 90.4 m -79.98 55.49 2.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.143 -0.973 . . . . 0.0 109.71 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 29.8 t -46.11 143.6 2.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.534 -0.728 . . . . 0.0 110.689 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -124.08 10.3 8.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 129.89 40.92 0.25 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.405 ' HA ' HD21 ' A' ' 90' ' ' ASN . 47.2 m -122.38 -167.74 1.61 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 110.075 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 42' ' ' PHE . 2.6 ttt180 -158.19 165.83 33.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 110.35 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.648 ' HD2' HG13 ' A' ' 27' ' ' VAL . 7.0 m-85 -121.97 -172.2 2.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.814 . . . . 0.0 109.692 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 20.2 t0 -167.8 49.37 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.0 110.562 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 118.47 51.17 0.32 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 46' ' ' THR . 1.1 m -127.87 -166.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.092 -1.24 . . . . 0.0 110.828 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.548 ' N ' HG23 ' A' ' 45' ' ' VAL . 24.6 m -161.37 56.28 0.28 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 50' ' ' SER . 13.7 tt -76.56 172.04 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.498 -0.751 . . . . 0.0 110.735 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.462 ' N ' HG12 ' A' ' 47' ' ' ILE . 47.0 p -138.28 -137.04 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 109.551 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 40.5 m -65.34 81.99 0.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.835 -1.165 . . . . 0.0 109.888 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.676 ' HB3' HD11 ' A' ' 47' ' ' ILE . 23.2 t -135.89 148.5 48.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.04 -1.037 . . . . 0.0 111.357 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.555 ' CB ' ' HA ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -95.49 126.36 40.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.078 -1.014 . . . . 0.0 109.12 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.04 105.08 5.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 110.004 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -95.11 102.54 14.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.477 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 61.12 92.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 83.7 p -166.15 121.08 1.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -1.213 . . . . 0.0 110.414 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -81.25 112.72 18.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.008 -1.057 . . . . 0.0 109.458 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.494 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 18.0 mm -88.57 13.27 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.339 -0.851 . . . . 0.0 110.823 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -42.59 141.21 1.07 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.233 -0.917 . . . . 0.0 110.286 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 178.8 146.03 6.4 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -76.39 55.82 4.82 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.024 1.539 . . . . 0.0 109.103 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 117.23 20.17 4.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -39.43 147.25 0.08 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.381 -1.07 . . . . 0.0 110.964 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 24.1 tttt -147.16 100.74 3.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.867 . . . . 0.0 110.048 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.85 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.4 mt -116.19 149.92 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.0 110.431 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -142.18 118.05 10.54 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.202 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.1 m 54.35 80.57 0.12 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 111.892 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.8 t -137.99 128.78 26.9 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 68' ' ' ILE . 1.7 mp -82.66 9.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.879 -1.138 . . . . 0.0 110.55 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.533 HG13 ' SG ' ' A' ' 67' ' ' CYS . 62.5 mt -18.35 138.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 CA-C-O 121.434 0.635 . . . . 0.0 112.04 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.815 ' O ' HG22 ' A' ' 73' ' ' VAL . 52.3 m -148.66 100.9 3.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.961 -1.087 . . . . 0.0 111.477 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.538 ' O ' HG13 ' A' ' 73' ' ' VAL . . . 91.67 37.75 6.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.448 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 72.07 13.2 76.09 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 70' ' ' THR . 5.3 m -120.3 136.52 25.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.39 -1.065 . . . . 0.0 110.013 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HA ' HG12 ' A' ' 69' ' ' ILE . 44.8 Cg_endo -75.93 142.13 24.82 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.789 1.415 . . . . 0.0 110.682 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -94.59 167.77 12.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 109.604 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 45.4 Cg_endo -72.09 72.95 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.683 1.36 . . . . 0.0 110.031 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.555 ' HB3' ' CB ' ' A' ' 80' ' ' CYS . 4.9 t -115.29 107.41 15.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.477 -0.764 . . . . 0.0 110.242 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.34 -13.9 15.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.964 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.71 -14.44 23.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.392 -0.818 . . . . 0.0 110.108 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 7.2 t -72.39 161.34 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.419 -0.801 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.909 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -124.55 154.84 40.0 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.53 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.909 HD13 ' O ' ' A' ' 81' ' ' LYS . 18.1 mm -140.77 70.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -137.48 106.54 6.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.828 . . . . 0.0 111.684 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.5 30.23 53.96 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.652 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.85 ' SG ' HD11 ' A' ' 64' ' ' ILE . 5.5 t -150.31 179.31 8.23 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.984 -1.304 . . . . 0.0 110.231 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.0 t -177.31 161.25 1.78 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.383 -0.823 . . . . 0.0 109.726 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -121.68 169.91 10.25 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 109.525 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.48 24.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.8 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 46.61 78.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.463 -0.773 . . . . 0.0 109.965 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.552 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.394 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.322 0.582 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.794 HD12 ' CB ' ' A' ' 15' ' ' SER . 2.3 mm? -43.44 117.42 1.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.538 ' OG ' ' CZ ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -58.6 71.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.517 -0.74 . . . . 0.0 111.134 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 11' ' ' LEU . . . 21.89 59.87 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 120.963 0.411 . . . . 0.0 111.79 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 41.1 t-20 -178.46 -32.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.964 . . . . 0.0 110.307 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.794 ' CB ' HD12 ' A' ' 11' ' ' LEU . 15.1 t -58.42 -176.56 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.558 -0.714 . . . . 0.0 110.998 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 9.9 ttmt -139.47 147.38 41.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 109.791 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.55 127.22 14.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.966 . . . . 0.0 110.32 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -120.72 -38.29 2.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.088 -1.008 . . . . 0.0 110.551 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -174.12 34.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -0.93 . . . . 0.0 109.686 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 p -84.68 -167.97 2.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 110.691 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 21' ' ' THR . 5.7 t -142.47 66.53 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.063 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 22' ' ' LEU . 5.3 mt -77.97 177.07 8.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.996 -1.065 . . . . 0.0 109.988 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 37' ' ' CYS . 55.5 m -164.7 121.44 1.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.866 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 23' ' ' THR . 31.0 m120 56.57 48.7 16.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 109.407 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.19 164.84 15.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.59 0.709 . . . . 0.0 110.839 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 26' ' ' TYR . 25.1 t80 -138.22 26.06 2.67 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.798 HG13 ' HD2' ' A' ' 42' ' ' PHE . 15.1 t -21.67 144.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.016 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 42.8 t0 -145.56 147.05 31.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.467 -0.771 . . . . 0.0 109.801 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 41.9 mtpt 35.43 41.5 0.09 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.569 -0.707 . . . . 0.0 110.34 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.822 ' CB ' HG22 ' A' ' 45' ' ' VAL . 75.3 m -133.19 150.8 51.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 110.851 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 47' ' ' ILE . 7.7 mt-10 -118.29 99.66 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 0.0 109.64 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.589 HG22 ' CG2' ' A' ' 47' ' ' ILE . 21.8 t -99.17 163.62 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.512 -0.742 . . . . 0.0 110.528 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.427 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 49.4 m-85 -148.44 -14.23 0.34 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.073 -1.017 . . . . 0.0 111.926 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.15 26.45 0.2 Allowed Glycine 0 N--CA 1.494 2.549 0 O-C-N 120.556 -1.34 . . . . 0.0 109.962 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 36' ' ' THR . 43.5 m -82.07 168.83 17.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -1.126 . . . . 0.0 110.732 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.566 ' N ' HG22 ' A' ' 35' ' ' THR . 40.0 m -129.33 52.65 1.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.383 -0.823 . . . . 0.0 109.62 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.503 ' O ' ' N ' ' A' ' 23' ' ' THR . 5.9 t -44.02 102.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 110.158 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 38' ' ' THR . 13.5 t -95.84 35.64 1.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 0.0 110.142 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.02 24.5 2.48 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -115.14 -166.98 1.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -1.075 . . . . 0.0 109.489 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' N ' ' OG ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -164.66 164.53 21.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.898 -1.126 . . . . 0.0 111.159 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.798 ' HD2' HG13 ' A' ' 27' ' ' VAL . 7.0 m-85 -123.13 -177.4 3.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.316 -0.865 . . . . 0.0 109.922 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.1 t70 -165.81 53.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.237 -0.914 . . . . 0.0 110.482 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 117.53 66.96 0.36 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.822 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.7 m -143.68 -160.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.911 -1.347 . . . . 0.0 111.604 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.557 ' N ' HG23 ' A' ' 45' ' ' VAL . 97.5 m -165.08 58.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.589 ' CG2' HG22 ' A' ' 32' ' ' VAL . 10.1 tt -81.42 165.29 2.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.345 -0.847 . . . . 0.0 110.923 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 25.0 p -131.34 -143.34 0.24 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 66' ' ' THR . 26.8 m -56.42 110.45 0.77 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.581 -1.325 . . . . 0.0 108.236 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' THR . 1.4 t -161.61 136.96 7.54 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.706 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -98.48 122.03 41.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.335 -0.853 . . . . 0.0 109.637 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.465 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -135.77 129.49 32.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.114 -0.991 . . . . 0.0 110.507 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.1 101.7 10.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.365 -0.834 . . . . 0.0 109.427 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 64.74 99.21 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.482 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 85.6 p -174.42 110.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -1.163 . . . . 0.0 110.564 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.548 ' CA ' ' HB3' ' A' ' 90' ' ' ASN . 3.8 ptp180 -77.4 112.12 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.104 -0.997 . . . . 0.0 109.166 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.528 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 32.6 mm -87.57 21.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.083 -1.011 . . . . 0.0 110.548 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.6 m -45.36 160.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 110.144 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.69 163.36 11.59 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.7 47.83 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.005 1.529 . . . . 0.0 109.826 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 123.8 16.22 3.38 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.495 ' HB3' ' CB ' ' A' ' 45' ' ' VAL . 3.1 t -36.62 116.75 0.45 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.604 -0.939 . . . . 0.0 110.998 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.558 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 32.2 tttm -107.79 153.76 22.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.882 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.038 HD13 ' HE2' ' A' ' 81' ' ' LYS . 30.1 mm -152.38 130.66 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.83 -1.168 . . . . 0.0 109.642 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.497 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 62.4 p -132.58 118.51 19.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 0.0 110.257 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.6 OUTLIER 43.44 56.95 4.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.475 -0.766 . . . . 0.0 110.056 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HB2' HG23 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -113.17 99.05 7.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.943 . . . . 0.0 109.862 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.674 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.9 mp -69.49 86.56 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.978 -1.076 . . . . 0.0 109.114 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.609 HG23 ' C ' ' A' ' 73' ' ' VAL . 9.0 mt -89.64 159.9 2.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.624 -0.673 . . . . 0.0 110.189 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.776 ' O ' HG22 ' A' ' 73' ' ' VAL . 8.6 m -157.99 96.27 1.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 110.281 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.59 33.25 8.07 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 75.52 16.98 80.31 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 70' ' ' THR . 13.8 m -126.18 131.44 23.96 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.376 -1.073 . . . . 0.0 110.177 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -79.68 151.0 21.86 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.768 1.404 . . . . 0.0 110.453 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -82.82 173.53 7.41 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.093 -1.004 . . . . 0.0 110.094 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -82.4 9.98 3.77 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.759 1.399 . . . . 0.0 109.751 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.9 t -54.97 132.94 48.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.539 -0.725 . . . . 0.0 110.343 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.67 -10.84 55.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.419 -0.801 . . . . 0.0 110.391 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.69 -14.25 25.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 109.732 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 67' ' ' CYS . 36.4 t -77.03 123.55 26.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.331 -0.856 . . . . 0.0 109.444 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 1.038 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.42 172.89 6.85 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.054 -1.029 . . . . 0.0 110.476 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.76 HG22 ' O ' ' A' ' 82' ' ' ILE . 0.6 OUTLIER -163.23 82.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.46 74.67 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.718 -0.614 . . . . 0.0 111.4 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.18 -13.82 44.27 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.371 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -82.04 -164.63 0.84 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.969 -1.312 . . . . 0.0 109.961 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.573 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t 168.82 147.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 109.657 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.642 ' HE1' HD11 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -130.57 156.08 45.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.825 . . . . 0.0 109.395 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.447 ' HB3' ' CD ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -145.25 30.34 1.14 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.142 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.482 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 51.72 82.14 0.07 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.411 -0.805 . . . . 0.0 108.867 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.548 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.68 -178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.022 0.439 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.877 HD21 ' HB2' ' A' ' 17' ' ' CYS . 22.8 tp 47.57 81.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.11 -0.994 . . . . 0.0 108.478 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -43.05 147.13 0.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.825 . . . . 0.0 110.387 -178.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.21 -13.37 12.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.964 . . . . 0.0 109.651 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 53.7 t-20 -90.4 -1.95 57.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.516 -0.74 . . . . 0.0 110.216 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 39.8 t -91.72 -157.52 0.51 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.042 -1.036 . . . . 0.0 109.843 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 4.8 tttt -138.79 159.14 42.85 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 110.113 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.877 ' HB2' HD21 ' A' ' 11' ' ' LEU . 34.9 t -148.87 116.7 6.3 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.286 -0.884 . . . . 0.0 110.744 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 19' ' ' LYS . 2.2 mt-10 -147.68 71.7 1.21 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.493 -0.755 . . . . 0.0 109.272 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 61.83 117.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 108.996 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -158.02 173.43 16.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.025 . . . . 0.0 110.722 -178.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -119.79 30.26 7.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 0.0 109.736 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 37' ' ' CYS . 11.2 mt -60.95 -178.79 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 109.963 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 24.2 m -166.24 122.23 1.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.787 . . . . 0.0 109.507 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 47.48 46.73 17.47 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.118 -0.989 . . . . 0.0 109.059 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 40' ' ' SER . 0.9 OUTLIER -88.08 -151.12 0.19 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.971 0.891 . . . . 0.0 111.254 -178.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.613 ' CD1' ' O ' ' A' ' 26' ' ' TYR . 1.2 t80 174.35 41.77 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 42' ' ' PHE . 26.1 t -50.7 149.43 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.7 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -157.05 131.18 8.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 1.2 mtpt 55.6 19.37 3.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -0.985 . . . . 0.0 110.154 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.47 ' HB3' HG22 ' A' ' 45' ' ' VAL . 69.8 m -122.48 -178.15 3.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.969 -1.082 . . . . 0.0 110.612 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' C ' HG23 ' A' ' 32' ' ' VAL . 3.6 tt0 -116.33 -71.91 0.72 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -0.858 . . . . 0.0 110.419 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG23 ' C ' ' A' ' 31' ' ' GLU . 3.7 t 66.45 140.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.594 -0.691 . . . . 0.0 110.266 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 32' ' ' VAL . 44.1 m-85 -141.34 -70.81 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 110.587 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.61 22.06 33.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.556 ' O ' HD23 ' A' ' 22' ' ' LEU . 98.3 m -70.54 160.14 33.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.397 -1.061 . . . . 0.0 111.29 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 37' ' ' CYS . 22.2 m -116.01 49.97 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.495 -0.753 . . . . 0.0 109.742 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.576 ' HB2' HD22 ' A' ' 22' ' ' LEU . 31.2 t -39.38 104.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 111.162 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.4 m -98.95 89.84 4.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.156 -0.965 . . . . 0.0 109.838 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.78 38.44 95.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -130.8 -150.65 0.44 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.171 -1.194 . . . . 0.0 110.063 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 40' ' ' SER . 18.7 ptt180 177.66 -176.68 0.18 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.317 -0.865 . . . . 0.0 110.518 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' A' ' 47' ' ' ILE . 20.4 m-85 -133.16 -169.4 2.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.387 -0.821 . . . . 0.0 109.301 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.88 50.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 109.814 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 115.72 58.14 0.34 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 2.3 m -138.53 -159.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.989 -1.301 . . . . 0.0 110.709 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 46' ' ' THR . 87.8 m -161.79 51.04 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.44 -0.788 . . . . 0.0 109.809 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.652 HG21 ' CE2' ' A' ' 42' ' ' PHE . 6.6 tt -80.27 164.41 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.368 -0.833 . . . . 0.0 110.435 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 46.2 p -136.48 -120.04 0.16 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.347 -0.846 . . . . 0.0 110.333 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' THR . 94.3 m -70.33 70.54 0.41 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.674 -1.266 . . . . 0.0 110.114 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.615 ' OG ' HD11 ' A' ' 47' ' ' ILE . 1.1 t -124.27 144.79 49.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.147 -0.97 . . . . 0.0 110.529 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -104.65 125.43 50.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.881 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -136.66 136.17 38.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.999 -1.063 . . . . 0.0 110.122 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.84 89.69 3.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.916 -1.115 . . . . 0.0 109.545 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.1 92.37 0.17 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.9 p -165.2 130.19 2.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -1.143 . . . . 0.0 110.532 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 88' ' ' SER . 14.7 ttp85 -93.38 106.66 18.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.125 -0.984 . . . . 0.0 109.157 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.695 HG23 HD11 ' A' ' 64' ' ' ILE . 8.7 mm -81.63 13.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 110.435 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -34.43 146.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 0.0 110.8 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.94 153.65 9.68 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.22 36.46 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.972 1.511 . . . . 0.0 109.683 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.92 32.72 0.5 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 45' ' ' VAL . 1.6 t -49.87 166.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.29 -1.123 . . . . 0.0 110.086 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' SG ' ' A' ' 62' ' ' CYS . 31.8 tttp -149.13 106.24 3.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 109.555 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.695 HD11 HG23 ' A' ' 57' ' ' ILE . 1.7 mt -121.7 158.56 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.888 -1.133 . . . . 0.0 111.046 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 65' ' ' SER . 1.3 p -163.09 105.76 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.548 -0.72 . . . . 0.0 109.479 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.3 m 67.07 78.2 0.25 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.216 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' A' ' 64' ' ' ILE . 74.1 m -140.37 121.8 15.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.431 -0.793 . . . . 0.0 109.598 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.9 mp -93.47 83.62 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.937 -1.102 . . . . 0.0 109.324 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' THR . 29.1 mt -86.54 162.46 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.618 -0.676 . . . . 0.0 110.791 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.817 ' O ' HG22 ' A' ' 73' ' ' VAL . 27.9 m -158.81 95.29 1.29 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.253 -0.905 . . . . 0.0 110.76 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.57 30.32 13.91 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.55 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 81.45 15.32 76.53 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 70' ' ' THR . 10.6 m -127.83 123.78 23.0 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.412 -1.052 . . . . 0.0 110.604 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 44.8 Cg_endo -75.1 138.88 23.35 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.837 1.441 . . . . 0.0 111.274 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -73.55 164.29 62.16 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.359 -0.838 . . . . 0.0 109.466 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 44.0 Cg_endo -71.0 58.91 2.2 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.75 1.395 . . . . 0.0 110.115 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 m -92.63 119.04 31.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.469 -0.77 . . . . 0.0 110.675 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.15 1.51 15.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.259 -0.9 . . . . 0.0 111.064 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.67 -16.73 14.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.954 -1.091 . . . . 0.0 110.174 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 82' ' ' ILE . 4.4 t -69.91 165.78 20.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 110.952 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.573 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -60.17 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.651 -0.655 . . . . 0.0 111.876 -179.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 80' ' ' CYS . 4.9 mm 71.96 33.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.2 m -112.12 -84.76 0.58 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.705 -0.622 . . . . 0.0 111.571 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -117.35 84.79 0.38 Allowed Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.737 -1.22 . . . . 0.0 111.0 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 8.7 t -178.95 174.66 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -1.137 . . . . 0.0 110.255 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.505 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 7.4 t -169.6 168.79 9.03 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.609 ' CD1' HD12 ' A' ' 57' ' ' ILE . 1.6 m-85 -126.41 157.06 39.54 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.022 -1.049 . . . . 0.0 109.389 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 56' ' ' ARG . 4.0 m -129.3 20.42 5.75 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 90' ' ' ASN . . . 53.37 59.58 4.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.5 -0.75 . . . . 0.0 109.921 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.576 ' NE2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.311 0.577 . . . . 0.0 110.417 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.627 ' CD1' HG21 ' A' ' 27' ' ' VAL . 11.5 tp -178.66 92.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.716 . . . . 0.0 109.843 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -40.62 146.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.537 -0.727 . . . . 0.0 110.581 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.27 -13.85 14.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.128 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -92.71 -5.36 51.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 109.989 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.626 ' OG ' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -68.63 -170.22 0.2 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.16 -0.962 . . . . 0.0 110.245 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 1.5 tttp -146.77 116.01 7.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 110.231 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 15.5 p -110.96 -164.25 0.9 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 0.0 110.242 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 17' ' ' CYS . 17.6 tp10 69.71 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 64.39 40.16 6.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.248 -0.907 . . . . 0.0 109.892 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 t -160.85 169.29 22.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.785 . . . . 0.0 109.575 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.557 ' CG2' ' HA ' ' A' ' 36' ' ' THR . 32.7 m -106.88 104.61 14.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.008 -1.058 . . . . 0.0 109.64 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.843 HD22 ' N ' ' A' ' 22' ' ' LEU . 1.5 mm? -101.29 150.52 22.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.106 -0.996 . . . . 0.0 110.888 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 16.5 m -163.67 95.0 0.8 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.623 -0.673 . . . . 0.0 109.216 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.464 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 66.33 32.93 7.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.552 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 98.3 m -59.69 -159.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.663 0.744 . . . . 0.0 110.901 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.581 ' CD1' ' HD2' ' A' ' 41' ' ' ARG . 1.9 t80 179.77 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.818 HG13 ' HD2' ' A' ' 42' ' ' PHE . 1.9 t 36.6 -159.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.58 0.705 . . . . 0.0 111.148 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.744 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER 171.93 -31.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 5.6 mtmt -169.28 51.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.984 ' OG ' HG22 ' A' ' 45' ' ' VAL . 35.2 m -127.34 -166.63 1.63 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 111.051 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 2.2 tt0 -129.09 -65.02 0.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.553 -0.717 . . . . 0.0 110.073 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.719 HG22 ' CG2' ' A' ' 47' ' ' ILE . 3.8 t 67.71 147.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.427 -0.796 . . . . 0.0 110.278 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.927 ' CD1' HG22 ' A' ' 48' ' ' THR . 33.1 m-85 -134.77 -50.98 0.78 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.14 -0.975 . . . . 0.0 110.614 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.44 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -135.56 35.06 2.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.845 HG22 ' H ' ' A' ' 37' ' ' CYS . 5.6 m -83.21 136.45 34.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.169 -1.195 . . . . 0.0 109.888 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.557 ' HA ' ' CG2' ' A' ' 21' ' ' THR . 28.3 m -69.0 -10.92 59.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.265 -0.897 . . . . 0.0 110.43 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.845 ' H ' HG22 ' A' ' 35' ' ' THR . 5.9 t 42.62 49.59 4.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 110.54 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.517 ' O ' HG22 ' A' ' 38' ' ' THR . 85.8 m -67.37 66.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.73 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 37' ' ' CYS . . . 68.95 75.17 0.55 Allowed Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.66 158.4 43.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 0.0 110.125 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.581 ' HD2' ' CD1' ' A' ' 26' ' ' TYR . 5.3 ttp180 -131.73 160.54 35.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.343 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.818 ' HD2' HG13 ' A' ' 27' ' ' VAL . 10.4 m-85 -133.21 -169.0 2.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.325 -0.859 . . . . 0.0 109.914 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.475 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 0.4 OUTLIER -174.48 49.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 110.076 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 115.41 60.58 0.36 Allowed Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.984 HG22 ' OG ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -134.91 -167.4 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.812 -1.405 . . . . 0.0 110.651 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' VAL . 57.7 m -155.7 56.24 0.61 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.719 ' CG2' HG22 ' A' ' 32' ' ' VAL . 9.2 tt -78.62 170.02 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.38 -0.825 . . . . 0.0 110.544 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.927 HG22 ' CD1' ' A' ' 33' ' ' TYR . 44.2 p -139.36 -131.63 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 66' ' ' THR . 23.9 m -60.87 123.8 18.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.762 -1.211 . . . . 0.0 109.008 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 35' ' ' THR . 0.4 OUTLIER -166.26 154.83 10.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.007 -1.058 . . . . 0.0 110.605 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 52' ' ' SER . 1.9 m -107.68 17.27 22.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.021 -1.05 . . . . 0.0 109.991 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -39.61 125.02 1.74 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.482 -0.761 . . . . 0.0 110.495 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 25.0 m -114.97 111.8 21.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.017 . . . . 0.0 110.143 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.72 86.14 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 p -162.06 131.08 4.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -1.165 . . . . 0.0 110.409 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.502 ' CA ' ' HB3' ' A' ' 90' ' ' ASN . 4.1 ttm180 -88.66 107.53 18.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.793 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.475 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 19.0 mm -87.47 21.29 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 110.611 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -41.86 143.25 0.56 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.221 -0.924 . . . . 0.0 110.324 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 175.92 153.02 10.0 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.263 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 59' ' ' GLY . 50.7 Cg_endo -87.13 62.72 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.036 1.545 . . . . 0.0 109.744 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 62' ' ' CYS . . . 109.16 19.63 8.38 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.532 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -42.55 170.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.597 -0.943 . . . . 0.0 111.238 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 17.3 ttmm -157.15 112.61 2.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.509 -0.744 . . . . 0.0 110.092 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.73 HD13 ' HE2' ' A' ' 81' ' ' LYS . 3.8 mm -119.85 164.41 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.006 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -168.37 113.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.3 m 49.46 65.63 1.35 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 110.376 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 63.7 m -122.45 97.24 5.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.619 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.678 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.9 mp -64.31 82.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 109.7 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.643 HG23 ' C ' ' A' ' 73' ' ' VAL . 18.8 mt -97.71 155.36 3.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.821 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.809 ' O ' HG22 ' A' ' 73' ' ' VAL . 12.8 m -155.02 101.69 2.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.038 -1.039 . . . . 0.0 110.213 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.03 29.0 16.3 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 79.18 16.6 78.24 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 70' ' ' THR . 5.5 m -122.91 128.56 25.31 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.364 -1.08 . . . . 0.0 110.537 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.882 ' HB3' HD11 ' A' ' 82' ' ' ILE . 45.1 Cg_endo -76.01 149.28 32.52 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.893 1.47 . . . . 0.0 110.652 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -96.49 164.52 18.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.332 -0.855 . . . . 0.0 109.953 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -71.31 57.84 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.915 1.482 . . . . 0.0 109.862 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.3 m -91.62 149.76 21.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 0.0 110.535 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.96 -17.96 22.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 110.248 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.86 -9.25 37.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.651 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.536 ' SG ' HG12 ' A' ' 82' ' ' ILE . 31.2 t -75.98 166.32 23.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -1.0 . . . . 0.0 110.013 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.73 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -111.28 -46.76 3.26 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.977 -1.077 . . . . 0.0 112.761 -178.504 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.882 HD11 ' HB3' ' A' ' 74' ' ' PRO . 16.7 mm 46.77 71.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.564 -1.335 . . . . 0.0 109.961 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.458 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 18.6 t -128.79 -106.67 0.3 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 0.0 110.46 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.35 63.69 2.92 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.574 ' CB ' ' HZ1' ' A' ' 81' ' ' LYS . 2.0 t -167.52 -172.54 1.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.082 -1.246 . . . . 0.0 110.787 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.538 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.7 t 177.44 162.61 0.52 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.475 -0.766 . . . . 0.0 109.333 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.542 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.5 OUTLIER -120.19 166.52 13.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.021 -1.049 . . . . 0.0 110.048 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 7.9 t -146.16 22.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.437 -0.79 . . . . 0.0 109.74 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 54.25 63.06 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.718 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.502 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.278 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.197 0.523 . . . . 0.0 110.449 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.715 HD12 ' HB ' ' A' ' 27' ' ' VAL . 41.3 tp -105.01 97.45 7.3 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.248 -0.908 . . . . 0.0 109.903 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -35.67 133.41 0.4 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.359 0.6 . . . . 0.0 111.205 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.55 -22.66 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 0.0 110.477 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 12' ' ' SER . 0.6 OUTLIER -95.83 -12.57 25.04 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.971 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.791 ' OG ' HG11 ' A' ' 27' ' ' VAL . 4.1 t -64.54 -176.85 0.27 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.928 -1.107 . . . . 0.0 109.729 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 7.2 tttp -127.58 146.2 50.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.033 -1.042 . . . . 0.0 110.61 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.94 110.81 14.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.031 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.63 -143.42 0.39 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.222 -0.924 . . . . 0.0 110.514 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.24 11.42 28.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.256 -0.902 . . . . 0.0 110.444 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 1.2 p -62.53 169.3 3.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.601 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 36' ' ' THR . 55.3 m -99.11 109.63 22.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.995 -1.066 . . . . 0.0 109.578 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 22' ' ' LEU . 2.5 mm? -99.57 144.03 29.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 110.847 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 19.9 m -150.87 107.97 3.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.397 -0.814 . . . . 0.0 109.443 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 54.07 44.43 29.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -0.936 . . . . 0.0 109.007 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 92.8 m -67.59 -157.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.416 -0.803 . . . . 0.0 111.011 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.613 ' CD1' ' O ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER 167.11 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.791 HG11 ' OG ' ' A' ' 15' ' ' SER . 5.1 t -70.66 168.16 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.113 0.959 . . . . 0.0 111.409 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.559 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 2.8 t70 -148.39 -35.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.42 0.629 . . . . 0.0 109.512 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -157.85 64.54 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.529 -0.732 . . . . 0.0 109.825 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.001 ' OG ' HG22 ' A' ' 45' ' ' VAL . 25.7 m -143.84 -175.95 4.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.854 -1.154 . . . . 0.0 111.093 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.586 ' OE1' HG23 ' A' ' 46' ' ' THR . 1.0 OUTLIER -123.43 -66.14 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.6 -0.687 . . . . 0.0 110.353 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.581 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 6.8 t 69.07 165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.628 -0.67 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 50.2 m-85 -159.85 -51.0 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.386 -0.821 . . . . 0.0 110.417 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.436 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -123.49 -2.7 8.85 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.676 HG22 ' H ' ' A' ' 37' ' ' CYS . 34.0 m -49.82 162.16 0.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -1.226 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.495 ' HA ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -102.81 -16.68 15.86 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.171 -0.955 . . . . 0.0 110.063 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.676 ' H ' HG22 ' A' ' 35' ' ' THR . 12.6 t 50.85 99.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 0.0 111.18 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.699 HG21 HG23 ' A' ' 53' ' ' THR . 20.9 m -114.34 89.88 3.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.113 -0.992 . . . . 0.0 109.483 178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 38' ' ' THR . . . 45.32 56.93 5.95 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 1.3 t -132.62 -175.99 3.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.135 -1.215 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.471 ' HD3' ' CE2' ' A' ' 26' ' ' TYR . 15.4 ptt180 -155.52 151.16 27.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.119 -0.988 . . . . 0.0 110.498 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.539 ' HD2' HG13 ' A' ' 27' ' ' VAL . 4.8 m-85 -117.46 -175.4 2.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.861 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.481 ' HB3' ' OG ' ' A' ' 58' ' ' SER . 24.0 t70 -166.75 38.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.421 -0.8 . . . . 0.0 109.778 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 129.78 66.7 0.11 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.001 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -141.78 -166.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.574 -1.545 . . . . 0.0 111.445 -179.228 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 46' ' ' THR . 72.3 m -164.95 56.17 0.13 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.549 ' CG2' HG22 ' A' ' 32' ' ' VAL . 7.8 tt -76.6 171.44 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.63 -0.669 . . . . 0.0 110.924 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.513 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 44.2 p -135.39 -138.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.827 . . . . 0.0 109.91 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 66' ' ' THR . 53.0 m -65.02 90.28 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.996 -1.065 . . . . 0.0 110.4 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' THR . 44.6 m -145.94 145.9 30.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.858 -1.151 . . . . 0.0 110.558 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -99.8 117.97 35.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.952 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -136.88 124.18 21.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.845 . . . . 0.0 110.124 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.699 HG23 HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER -109.1 100.33 9.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.915 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.7 83.72 0.48 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 5.8 p -159.01 116.46 2.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -1.108 . . . . 0.0 110.428 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -75.36 109.87 9.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 109.729 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.521 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 11.1 mm -87.9 3.02 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.071 -1.018 . . . . 0.0 111.171 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 74.8 m -42.03 163.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.218 -0.926 . . . . 0.0 110.403 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 145.92 150.45 5.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.35 59.33 1.91 Allowed 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.902 1.475 . . . . 0.0 109.523 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . 112.53 28.64 3.42 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 2.0 t -52.6 128.8 27.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.345 -1.091 . . . . 0.0 110.337 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.563 ' HD2' ' HB ' ' A' ' 46' ' ' THR . 2.0 mmtm -120.97 149.77 42.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.095 -1.003 . . . . 0.0 110.968 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.923 HD13 ' HE2' ' A' ' 81' ' ' LYS . 12.6 mm -149.27 135.06 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.48 -0.762 . . . . 0.0 109.334 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.461 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -140.27 116.73 10.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.996 -1.065 . . . . 0.0 110.778 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.7 OUTLIER 45.89 70.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.613 -0.679 . . . . 0.0 111.644 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 52.9 t -133.72 125.88 29.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.833 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.3 mp -88.01 81.08 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.237 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.598 HG21 ' CD2' ' A' ' 87' ' ' PHE . 4.4 mt -88.9 160.43 2.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.706 -0.621 . . . . 0.0 109.742 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.763 ' O ' HG22 ' A' ' 73' ' ' VAL . 55.4 m -161.0 96.61 1.11 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.104 -0.998 . . . . 0.0 110.619 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 91.47 30.07 11.29 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.582 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 81.22 14.76 78.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 70' ' ' THR . 11.6 m -123.63 127.36 25.53 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.489 -1.006 . . . . 0.0 110.098 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -80.01 143.02 15.9 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.706 1.372 . . . . 0.0 110.075 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -87.5 149.96 47.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.139 -0.975 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.13 57.73 1.21 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.152 1.606 . . . . 0.0 110.498 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.06 150.74 20.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.758 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.67 -7.1 50.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.55 -16.46 14.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 111.241 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 15.0 t -68.16 129.56 40.29 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.813 -1.179 . . . . 0.0 109.573 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.923 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.12 171.78 7.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.916 -1.115 . . . . 0.0 110.305 -179.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -166.64 91.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.524 -0.735 . . . . 0.0 109.027 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.48 -59.18 1.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.056 -1.027 . . . . 0.0 110.555 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.28 52.22 0.64 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.697 ' C ' HG22 ' A' ' 86' ' ' THR . 1.7 t -124.55 -150.04 0.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 110.032 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.697 HG22 ' C ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER 165.05 143.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.497 -0.752 . . . . 0.0 110.54 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.79 ' HE1' HD11 ' A' ' 64' ' ' ILE . 1.8 m-30 -107.1 -65.0 1.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.537 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER 71.4 8.34 6.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.432 -0.792 . . . . 0.0 110.45 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 54.21 85.73 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.99 . . . . 0.0 109.635 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.446 ' OD1' ' C ' ' A' ' 90' ' ' ASN . 4.5 p30 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.358 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.59 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.532 0.682 . . . . 0.0 110.844 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.723 HD11 ' OG ' ' A' ' 15' ' ' SER . 18.9 tp -176.0 90.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 31.0 t -36.53 137.05 0.31 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.636 -0.665 . . . . 0.0 110.54 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.6 -17.33 2.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 110.567 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.588 ' ND2' ' HA ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -90.88 -7.16 52.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 110.324 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.723 ' OG ' HD11 ' A' ' 11' ' ' LEU . 39.7 t -74.66 -158.76 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.027 . . . . 0.0 109.732 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 5.5 tttp -148.57 125.92 11.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 109.576 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.551 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 9.8 t -109.89 120.74 43.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.714 -179.199 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 19' ' ' LYS . 8.3 tt0 -167.79 114.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.432 -0.792 . . . . 0.0 110.064 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' GLU . 11.7 mttt 41.73 -123.33 0.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.0 110.309 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.4 160.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.889 -1.132 . . . . 0.0 110.071 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.541 ' HB ' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -100.38 23.63 9.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.078 -1.014 . . . . 0.0 109.497 179.754 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.648 HD13 HG11 ' A' ' 32' ' ' VAL . 2.3 tp -51.53 152.26 2.77 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.49 -0.756 . . . . 0.0 110.496 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 37' ' ' CYS . 41.6 m -164.83 134.58 3.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.409 -0.807 . . . . 0.0 109.829 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 3.5 m120 50.45 63.52 2.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.032 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -132.55 165.1 25.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.327 -179.9 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 10' ' ' GLN . 44.7 m-85 -121.5 -40.15 2.59 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.692 HG11 ' OG ' ' A' ' 15' ' ' SER . 3.6 t 55.21 141.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 122.11 0.957 . . . . 0.0 111.637 178.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -144.87 113.01 6.47 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.551 -0.718 . . . . 0.0 109.347 179.384 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.588 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 54.81 57.53 5.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 109.354 -179.044 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 45' ' ' VAL . 6.0 m -134.82 -157.49 0.81 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.758 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 0.8 OUTLIER -152.34 -62.55 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.567 -0.708 . . . . 0.0 109.968 179.876 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.648 HG11 HD13 ' A' ' 22' ' ' LEU . 13.0 t 61.91 162.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.435 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.488 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 11.7 m-85 -155.66 -46.91 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.3 -0.875 . . . . 0.0 110.455 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.73 21.6 3.75 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.544 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 6.5 m -74.76 146.52 42.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.134 . . . . 0.0 110.944 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.541 HG23 ' HB ' ' A' ' 21' ' ' THR . 48.0 m -106.68 70.31 0.81 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.452 -0.78 . . . . 0.0 109.37 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.509 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 13.9 t -60.7 113.6 2.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.519 -0.738 . . . . 0.0 111.273 -179.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.798 ' O ' HG22 ' A' ' 38' ' ' THR . 14.3 m -106.03 60.22 0.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 178.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 91.04 71.69 1.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.523 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 70.4 m -154.34 171.58 19.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -1.125 . . . . 0.0 110.315 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -141.12 154.82 46.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.912 . . . . 0.0 110.434 179.77 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.663 ' HD2' HG13 ' A' ' 27' ' ' VAL . 8.5 m-85 -118.36 -174.0 2.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 0.0 110.533 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.49 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -173.18 81.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 109.971 179.816 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 84.66 54.23 3.0 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.633 ' HB ' ' HB3' ' A' ' 62' ' ' CYS . 0.8 OUTLIER -128.95 -172.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.752 -1.44 . . . . 0.0 110.939 -179.53 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.526 ' N ' HG23 ' A' ' 45' ' ' VAL . 9.3 m -160.4 56.63 0.34 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 50' ' ' SER . 11.5 tt -80.99 168.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.454 -0.779 . . . . 0.0 110.573 -179.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 43.2 p -136.16 -150.26 0.36 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.395 -0.816 . . . . 0.0 108.834 179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.7 m -46.75 108.23 0.13 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.878 -1.139 . . . . 0.0 109.185 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' THR . 70.9 m -164.13 140.64 6.51 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 110.131 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -101.05 123.3 45.02 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 109.758 179.608 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -136.11 129.8 32.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 110.234 -179.804 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.57 100.16 9.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 66.88 80.19 0.19 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.4 p -151.32 113.74 4.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -1.02 . . . . 0.0 110.312 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -73.24 111.36 8.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.165 -0.96 . . . . 0.0 110.134 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.409 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 11.6 mm -88.41 7.18 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.49 ' OG ' ' HB2' ' A' ' 43' ' ' ASP . 43.3 m -44.83 141.16 2.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.0 110.486 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 171.41 164.24 26.74 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.989 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.53 56.62 6.04 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.06 1.558 . . . . 0.0 109.796 179.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 110.91 19.93 7.47 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.633 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -37.24 113.7 0.27 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.421 -1.047 . . . . 0.0 110.884 179.96 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.522 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 10.1 tttm -107.19 122.21 46.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.984 -1.072 . . . . 0.0 109.809 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.865 HD11 ' SG ' ' A' ' 85' ' ' CYS . 5.3 mp -131.54 148.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.111 -0.993 . . . . 0.0 111.223 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -148.08 120.73 8.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 110.724 179.395 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.7 OUTLIER 48.06 57.35 6.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.402 -0.811 . . . . 0.0 111.277 179.615 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.3 m -115.88 106.6 14.0 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.022 -1.049 . . . . 0.0 109.976 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.4 mp -76.73 95.77 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.955 . . . . 0.0 109.316 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.697 HG23 ' C ' ' A' ' 73' ' ' VAL . 6.0 mt -103.87 158.99 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 110.595 -179.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 73' ' ' VAL . 29.8 m -159.22 98.33 1.43 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.33 -0.856 . . . . 0.0 109.589 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.03 23.5 22.48 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 83.39 15.9 70.31 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.697 ' C ' HG23 ' A' ' 69' ' ' ILE . 11.4 m -120.34 124.41 27.73 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.522 -0.987 . . . . 0.0 110.124 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.48 147.48 28.66 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.916 1.482 . . . . 0.0 111.191 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -92.5 144.95 29.6 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.447 -0.783 . . . . 0.0 108.896 178.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.44 60.35 2.64 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 O-C-N 123.814 1.428 . . . . 0.0 110.393 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -81.91 161.63 23.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 109.909 179.697 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.39 -18.16 57.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.131 -0.981 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.31 -25.66 10.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.969 -1.082 . . . . 0.0 110.62 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 19.5 t -47.49 128.42 12.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.106 -0.996 . . . . 0.0 109.958 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.92 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -90.59 161.94 15.21 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.984 -1.073 . . . . 0.0 110.259 -179.731 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.92 HD13 ' O ' ' A' ' 81' ' ' LYS . 18.4 mm -143.79 67.99 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -146.1 107.85 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 112.417 -177.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . 65.22 73.02 0.63 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.334 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.865 ' SG ' HD11 ' A' ' 64' ' ' ILE . 4.6 t -175.39 -174.91 0.76 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -1.227 . . . . 0.0 110.075 178.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.419 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -179.44 152.15 0.51 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.016 -1.053 . . . . 0.0 110.484 -179.066 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.691 ' CD2' HG21 ' A' ' 69' ' ' ILE . 2.9 m-30 -109.0 -63.54 1.34 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.438 -0.788 . . . . 0.0 109.422 179.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER 71.14 4.13 4.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.535 -0.728 . . . . 0.0 110.699 179.74 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 57.15 96.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.072 -1.017 . . . . 0.0 109.992 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.136 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.56 ' O ' HD22 ' A' ' 11' ' ' LEU . 1.8 tt0 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.468 0.651 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.071 HD12 ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -173.39 117.36 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.582 -0.699 . . . . 0.0 109.396 -179.936 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 27' ' ' VAL . 45.3 p -35.14 144.74 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.642 -0.661 . . . . 0.0 110.801 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.16 -25.1 30.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 110.588 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -106.22 3.83 28.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 110.375 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 1.071 ' CB ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -55.56 -173.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 110.582 -179.827 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -150.36 119.81 6.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 179.902 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 31.7 p -116.24 72.02 0.8 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.015 -1.053 . . . . 0.0 110.491 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.89 136.37 35.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.145 -0.972 . . . . 0.0 110.15 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 mttt 54.35 36.75 26.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 109.868 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.439 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 6.8 m -143.89 162.91 34.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.557 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -113.8 106.17 14.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.408 -0.807 . . . . 0.0 109.612 179.557 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 22' ' ' LEU . 4.6 mm? -92.87 156.99 16.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 110.6 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 11.2 m -166.25 121.24 1.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.421 -0.8 . . . . 0.0 109.772 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' THR . 3.6 m-20 42.98 66.17 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.173 -0.955 . . . . 0.0 110.023 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.5 m -137.1 166.24 24.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.189 -0.944 . . . . 0.0 110.671 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 7.9 m-85 -130.09 -47.27 1.11 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.244 179.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.739 HG13 ' HD2' ' A' ' 42' ' ' PHE . 2.8 t 57.46 123.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.539 0.685 . . . . 0.0 110.668 179.025 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.468 ' C ' ' HB2' ' A' ' 12' ' ' SER . 1.9 m-20 -115.13 -14.97 11.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.284 -0.885 . . . . 0.0 110.362 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -175.65 66.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.898 . . . . 0.0 110.064 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.7 ' OG ' HG22 ' A' ' 45' ' ' VAL . 68.0 m -138.81 -170.47 2.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.183 -0.948 . . . . 0.0 110.24 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.622 ' C ' HG23 ' A' ' 32' ' ' VAL . 3.3 tt0 -127.88 -63.4 1.02 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.708 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.622 HG23 ' C ' ' A' ' 31' ' ' GLU . 2.4 t 68.0 135.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.438 -0.789 . . . . 0.0 110.093 179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.469 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 10.4 m-85 -147.52 46.61 1.12 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 110.505 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.465 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . 142.95 -10.39 2.31 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.83 HG22 ' H ' ' A' ' 37' ' ' CYS . 45.3 m -61.27 151.38 31.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.237 . . . . 0.0 110.609 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 21' ' ' THR . 51.5 m -88.37 -14.03 39.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.749 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.83 ' H ' HG22 ' A' ' 35' ' ' THR . 0.5 OUTLIER 47.42 70.92 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 179.696 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.503 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 99.6 m -87.71 100.77 13.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.133 -0.979 . . . . 0.0 110.15 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 90' ' ' ASN . . . 45.0 67.19 1.24 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.47 ' O ' ' NE ' ' A' ' 41' ' ' ARG . 32.3 t -153.01 173.18 15.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -1.093 . . . . 0.0 110.281 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HB2' ' ND2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -149.79 159.68 44.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.393 -0.817 . . . . 0.0 110.044 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.739 ' HD2' HG13 ' A' ' 27' ' ' VAL . 5.5 m-85 -125.28 -177.91 4.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.986 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -170.25 48.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.892 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 123.48 56.62 0.19 Allowed Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.7 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.27 -163.34 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.829 -1.395 . . . . 0.0 110.884 -179.775 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.608 ' N ' HG23 ' A' ' 45' ' ' VAL . 13.8 m -166.06 55.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.593 HD11 ' CB ' ' A' ' 50' ' ' SER . 21.4 tt -83.52 170.39 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.419 -0.801 . . . . 0.0 110.786 -179.239 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.469 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 62.6 p -128.63 -140.23 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.456 -0.777 . . . . 0.0 109.598 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 49' ' ' THR . 6.4 m -60.17 83.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.959 . . . . 0.0 110.092 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.593 ' CB ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -117.13 140.12 49.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.099 -1.001 . . . . 0.0 110.447 -179.753 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.529 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 26.6 m -91.18 19.37 5.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.213 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 68' ' ' ILE . 13.0 p -44.34 125.69 4.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 110.521 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.503 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 32.2 m -104.85 97.17 7.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.695 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 62.62 90.19 0.03 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 7.1 p -157.33 122.95 4.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.541 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.517 ' HB2' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -75.4 101.51 4.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.074 179.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 57' ' ' ILE . 4.0 mt -90.13 16.25 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.62 156.83 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.259 -0.9 . . . . 0.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.68 147.83 5.44 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.67 63.24 7.34 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.978 1.515 . . . . 0.0 110.009 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 113.98 17.4 7.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -40.28 159.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.543 -0.975 . . . . 0.0 110.946 -179.702 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 12.4 tttt -158.85 117.07 2.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.504 -0.747 . . . . 0.0 109.648 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.666 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -135.14 161.56 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.551 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.408 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -150.76 121.35 7.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 110.321 -179.874 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 49' ' ' THR . 3.5 m 46.45 69.85 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.395 -0.816 . . . . 0.0 110.738 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.618 ' HB3' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -123.48 104.39 9.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.467 -0.771 . . . . 0.0 109.541 179.164 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.529 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 1.7 mp -48.5 -64.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.739 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.819 HD13 ' CE2' ' A' ' 87' ' ' PHE . 20.4 mt 55.04 164.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 110.308 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.513 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 55.7 m -145.23 -106.33 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.905 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.789 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -83.96 76.08 2.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 87' ' ' PHE . . . 63.28 12.32 44.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 71' ' ' GLY . 13.9 m -116.34 136.33 23.04 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.383 -1.069 . . . . 0.0 110.254 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HA ' HG12 ' A' ' 69' ' ' ILE . 47.5 Cg_endo -78.12 138.24 16.05 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.897 1.472 . . . . 0.0 110.088 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -84.53 159.28 58.85 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.408 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.41 53.21 4.62 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 124.04 1.547 . . . . 0.0 110.555 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 t -89.96 158.17 17.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.608 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.2 -14.15 50.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.267 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.06 -22.45 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.336 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.481 ' CB ' ' HA ' ' A' ' 67' ' ' CYS . 34.7 t -63.79 123.14 18.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 110.054 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.63 ' HE2' HG23 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -93.15 -169.95 2.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.927 . . . . 0.0 110.481 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 82' ' ' ILE . 3.2 tp -179.94 40.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.803 0.811 . . . . 0.0 109.501 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 m -72.78 -96.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 111.64 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.84 66.31 0.95 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.111 -1.043 . . . . 0.0 110.637 -178.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 64' ' ' ILE . 4.8 t -160.3 -175.31 4.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.254 . . . . 0.0 110.022 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.547 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.5 t -177.23 159.29 1.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.98 . . . . 0.0 110.423 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.819 ' CE2' HD13 ' A' ' 69' ' ' ILE . 1.8 m-85 -118.87 156.68 29.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.787 . . . . 0.0 109.7 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -139.41 20.35 2.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.243 -0.91 . . . . 0.0 110.38 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 56.6 83.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.235 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 56' ' ' ARG . 43.4 t30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.095 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.558 ' HB3' ' CB ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.472 0.654 . . . . 0.0 109.736 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.858 HD11 ' OG ' ' A' ' 15' ' ' SER . 13.6 tp -49.51 95.91 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -41.25 146.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 109.899 -179.808 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 14' ' ' ASN . . . -64.48 67.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.09 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 12' ' ' SER . 0.5 OUTLIER 179.9 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.541 -0.725 . . . . 0.0 109.782 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.858 ' OG ' HD11 ' A' ' 11' ' ' LEU . 13.5 t -50.62 -176.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.34 -0.85 . . . . 0.0 110.249 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.16 160.66 41.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.206 -0.934 . . . . 0.0 110.4 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 t -178.55 148.17 0.43 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.162 -0.962 . . . . 0.0 110.24 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.93 -29.42 1.02 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 0.0 110.753 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -170.19 43.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.969 -1.082 . . . . 0.0 110.59 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.18 179.01 5.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.252 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.4 82.64 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 109.807 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 35' ' ' THR . 46.1 mt -94.22 -177.96 4.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -0.89 . . . . 0.0 110.605 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 1.8 m -161.74 118.58 2.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.499 -0.751 . . . . 0.0 109.357 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.503 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 43.8 m-20 58.58 75.73 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.419 -0.8 . . . . 0.0 110.261 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 40' ' ' SER . 0.5 OUTLIER -145.5 -157.26 0.78 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.071 -1.018 . . . . 0.0 110.206 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -160.29 -39.56 0.05 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.715 HG13 ' HD2' ' A' ' 42' ' ' PHE . 9.3 t 53.25 160.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.011 0.91 . . . . 0.0 111.649 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.603 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.2 t70 -171.37 127.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 66.2 mttt 46.48 43.11 11.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -0.984 . . . . 0.0 109.587 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.717 ' CB ' HG22 ' A' ' 45' ' ' VAL . 58.6 m -129.97 157.69 41.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' O ' ' O ' ' A' ' 47' ' ' ILE . 1.1 mt-10 -121.17 98.07 5.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.283 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 40.6 t -99.93 159.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.413 -0.804 . . . . 0.0 110.53 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.459 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 39.3 m-85 -139.02 -45.85 0.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 110.808 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.437 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -146.0 28.51 1.71 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 50' ' ' SER . 2.3 m -73.47 154.29 40.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.233 -1.157 . . . . 0.0 110.338 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.1 m -114.78 80.73 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -0.831 . . . . 0.0 109.815 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -63.31 151.77 39.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -0.89 . . . . 0.0 110.533 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 38' ' ' THR . 66.8 m -138.22 41.17 2.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.315 -0.866 . . . . 0.0 109.982 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 104.64 33.49 3.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.51 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 14.4 m -122.41 -152.46 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -1.151 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.465 ' HG3' ' OD1' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -178.18 168.04 1.95 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.078 -1.014 . . . . 0.0 110.53 179.889 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.715 ' HD2' HG13 ' A' ' 27' ' ' VAL . 8.3 m-85 -122.49 -169.98 2.0 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -0.891 . . . . 0.0 110.559 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.409 ' HA ' ' OD2' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -175.21 48.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.106 179.698 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 119.62 61.49 0.26 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.717 HG22 ' CB ' ' A' ' 30' ' ' SER . 2.4 m -137.34 -158.84 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.988 -1.301 . . . . 0.0 111.279 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.562 ' N ' HG23 ' A' ' 45' ' ' VAL . 94.5 m -167.09 58.79 0.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 14.3 tt -85.81 169.41 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 111.234 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 78.0 p -142.24 -148.9 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 109.175 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 66' ' ' THR . 59.8 m -46.05 111.97 0.42 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.17 -0.957 . . . . 0.0 108.699 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' THR . 4.3 t -173.36 158.46 3.54 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.125 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -116.98 131.6 56.91 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.044 -1.035 . . . . 0.0 109.783 179.57 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.8 125.65 13.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 109.961 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.7 m -105.48 123.42 47.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.967 . . . . 0.0 109.94 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 45.0 83.33 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 72' ' ' GLY . 78.7 p -158.15 128.98 6.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.231 -1.158 . . . . 0.0 110.432 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 6.6 ttp180 -94.18 107.55 19.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 110.12 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.642 HG22 ' O ' ' A' ' 57' ' ' ILE . 2.5 mp -84.52 12.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.94 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 57' ' ' ILE . 1.1 m -42.54 139.78 1.44 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 110.3 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 172.72 175.53 40.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.63 63.24 6.5 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.078 1.568 . . . . 0.0 110.128 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 94.99 2.5 62.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.561 ' C ' ' O ' ' A' ' 61' ' ' GLY . 2.4 t -11.37 121.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -105.98 144.13 33.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.223 -0.923 . . . . 0.0 109.817 179.356 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 63' ' ' LYS . 5.4 mt -152.96 127.18 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.977 . . . . 0.0 110.029 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.445 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -130.99 117.2 18.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 -179.84 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 49' ' ' THR . 3.1 m 54.05 86.15 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' THR . 0.5 OUTLIER -145.7 117.02 7.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.277 -0.89 . . . . 0.0 109.66 179.369 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.836 HD12 ' N ' ' A' ' 68' ' ' ILE . 3.4 mp -86.15 74.14 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.844 -1.16 . . . . 0.0 108.551 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.691 HG23 ' O ' ' A' ' 73' ' ' VAL . 13.7 mt -80.91 160.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.962 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.816 ' O ' HG22 ' A' ' 73' ' ' VAL . 97.1 m -158.71 98.85 1.53 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.004 . . . . 0.0 110.985 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 89.24 30.25 14.7 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.37 14.28 76.79 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.816 HG22 ' O ' ' A' ' 70' ' ' THR . 11.4 m -124.32 135.95 27.09 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.468 -1.019 . . . . 0.0 110.412 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HB2' HD11 ' A' ' 82' ' ' ILE . 49.6 Cg_endo -85.58 119.88 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.89 1.468 . . . . 0.0 110.466 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.533 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -77.47 167.09 39.22 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.273 -0.892 . . . . 0.0 109.788 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.533 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 42.2 Cg_endo -68.87 84.55 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.688 1.362 . . . . 0.0 109.409 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 78' ' ' ALA . 66.9 m -85.92 -6.35 59.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.631 -0.668 . . . . 0.0 111.155 -178.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 43.8 25.65 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 109.545 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -158.59 -40.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.523 -0.736 . . . . 0.0 109.301 -179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 29.1 t -46.95 169.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.555 -0.716 . . . . 0.0 109.738 179.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.547 ' HE3' ' CA ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -108.99 -32.23 7.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.936 -1.103 . . . . 0.0 112.156 -178.108 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.724 HG22 ' O ' ' A' ' 82' ' ' ILE . 4.1 mt 34.15 79.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.403 -0.81 . . . . 0.0 110.322 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.523 ' H ' ' HZ1' ' A' ' 81' ' ' LYS . 61.5 m -122.74 -98.14 0.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.92 -1.113 . . . . 0.0 111.088 -179.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.58 21.25 33.61 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -97.33 -163.54 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.253 . . . . 0.0 110.766 -179.726 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.539 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.9 OUTLIER 175.62 148.85 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.55 -0.719 . . . . 0.0 109.941 179.815 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -120.38 173.42 7.15 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.421 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.78 24.35 0.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.012 -1.055 . . . . 0.0 110.228 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 46.87 61.77 2.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.911 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.155 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.513 0.673 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.772 HD12 ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -165.23 69.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.726 . . . . 0.0 109.675 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.532 ' HB3' ' CA ' ' A' ' 28' ' ' ASP . 3.4 p 42.36 23.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.801 . . . . 0.0 110.896 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 41.66 23.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.985 -1.072 . . . . 0.0 110.641 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 28.6 p30 174.4 30.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.494 -0.754 . . . . 0.0 109.682 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.772 ' CB ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -69.8 -168.66 0.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 0.0 109.844 -179.674 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.544 ' CE ' ' HG3' ' A' ' 31' ' ' GLU . 1.3 mptp? -119.38 107.38 13.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 110.09 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -91.07 -140.23 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.528 -179.632 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 67.35 107.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.881 . . . . 0.0 109.867 -179.503 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 5.2 tttt 66.21 54.85 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 12.6 m -119.63 155.78 31.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 110.964 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 36' ' ' THR . 17.7 m -150.62 82.18 1.35 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.494 -0.754 . . . . 0.0 109.566 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -124.76 -163.54 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 0.0 110.775 -179.122 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 10.1 m -165.85 113.53 0.93 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.412 -0.805 . . . . 0.0 109.812 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 23' ' ' THR . 1.0 OUTLIER 59.05 127.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.432 -0.793 . . . . 0.0 110.047 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 0.5 OUTLIER 172.9 -169.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 110.12 179.98 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.49 ' O ' ' O ' ' A' ' 27' ' ' VAL . 10.5 t80 -142.35 -46.63 0.34 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 108.679 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.892 HG13 ' HD2' ' A' ' 42' ' ' PHE . 3.5 t 57.14 133.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.673 0.749 . . . . 0.0 111.166 179.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.532 ' CA ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -137.66 124.33 21.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.226 179.336 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.2 mtmp? 42.21 55.37 3.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.777 ' OG ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -134.98 163.5 29.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.985 -1.072 . . . . 0.0 110.835 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.544 ' HG3' ' CE ' ' A' ' 16' ' ' LYS . 3.8 tt0 -96.74 -71.02 0.69 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.417 -0.802 . . . . 0.0 109.846 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.821 HG22 ' CG2' ' A' ' 47' ' ' ILE . 13.6 t 59.9 138.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.838 . . . . 0.0 110.614 179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.655 ' CD1' HG22 ' A' ' 48' ' ' THR . 60.5 m-85 -140.33 -81.21 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 109.551 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.43 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -94.41 29.65 8.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.503 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -73.65 161.85 29.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -1.028 . . . . 0.0 110.373 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.491 ' O ' HG22 ' A' ' 36' ' ' THR . 63.7 m -116.39 57.32 0.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.795 . . . . 0.0 109.733 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.567 ' CB ' ' HB2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -40.84 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 110.336 -179.839 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.59 ' O ' HG22 ' A' ' 38' ' ' THR . 85.8 m -89.66 48.91 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 110.261 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.47 24.94 37.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 86.4 p -99.44 -154.39 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -1.057 . . . . 0.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.444 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -167.7 156.29 9.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.099 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.892 ' HD2' HG13 ' A' ' 27' ' ' VAL . 10.0 m-85 -119.88 176.63 5.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.219 -0.926 . . . . 0.0 110.582 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -157.49 61.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.5 -0.75 . . . . 0.0 109.814 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 96.92 67.37 0.94 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.777 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.4 m -135.92 -160.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.972 -1.311 . . . . 0.0 111.274 -179.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 46' ' ' THR . 69.8 m -166.17 54.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.391 0.615 . . . . 0.0 109.403 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.821 ' CG2' HG22 ' A' ' 32' ' ' VAL . 11.9 tt -80.46 172.17 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 110.551 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.655 HG22 ' CD1' ' A' ' 33' ' ' TYR . 14.8 p -140.1 -113.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 49' ' ' THR . 55.3 m -83.55 71.66 10.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.917 -1.114 . . . . 0.0 109.632 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.588 ' HB2' HD11 ' A' ' 47' ' ' ILE . 4.8 m -128.67 141.76 51.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 110.649 -179.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -89.46 133.64 34.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.692 179.593 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.42 121.08 12.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 110.33 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.3 93.73 5.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 109.789 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 62.21 92.69 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 87.5 p -161.21 122.09 2.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -1.099 . . . . 0.0 110.418 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' HB2' ' CB ' ' A' ' 90' ' ' ASN . 10.3 ttp180 -77.6 103.59 7.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.318 -0.864 . . . . 0.0 109.657 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.555 ' O ' HG12 ' A' ' 45' ' ' VAL . 32.4 mm -78.63 9.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 110.763 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.474 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 53.1 p -40.84 150.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.143 -0.973 . . . . 0.0 110.602 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 168.09 140.75 3.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.66 57.93 3.12 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.089 1.573 . . . . 0.0 109.762 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.4 20.61 3.23 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -42.83 148.92 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -1.113 . . . . 0.0 110.589 -179.865 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -152.27 112.73 4.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.766 HG23 ' CE ' ' A' ' 81' ' ' LYS . 1.9 mp -128.81 157.53 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.161 -0.962 . . . . 0.0 110.868 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.479 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -156.87 106.88 2.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.376 -0.828 . . . . 0.0 109.909 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.2 m 63.33 82.18 0.19 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.255 -0.903 . . . . 0.0 110.325 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.487 ' N ' ' OG ' ' A' ' 50' ' ' SER . 16.1 m -146.52 109.09 4.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.441 -0.787 . . . . 0.0 109.662 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.738 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.8 mp -73.44 90.21 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.046 -1.033 . . . . 0.0 109.624 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.718 HG23 ' C ' ' A' ' 73' ' ' VAL . 10.0 mt -98.25 156.88 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.397 -0.814 . . . . 0.0 110.292 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.815 ' O ' HG22 ' A' ' 73' ' ' VAL . 5.2 m -155.01 100.79 2.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.193 -0.942 . . . . 0.0 110.45 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.43 35.07 8.88 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 76.61 15.93 81.16 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 70' ' ' THR . 7.9 m -126.01 132.97 24.49 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.314 -1.109 . . . . 0.0 110.838 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.64 153.46 20.26 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.917 1.483 . . . . 0.0 110.601 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -96.25 162.62 23.06 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.907 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.8 Cg_endo -73.27 75.77 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.062 1.559 . . . . 0.0 110.569 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.57 140.03 45.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.15 -27.92 53.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.31 -2.92 57.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 0.0 110.278 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 66' ' ' THR . 2.5 t -90.03 146.94 23.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 110.061 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.766 ' CE ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -103.02 -164.12 1.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.351 -0.843 . . . . 0.0 111.282 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 82' ' ' ILE . 2.3 tp 175.99 34.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.1 m -70.32 -100.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.471 -0.768 . . . . 0.0 111.569 -179.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -99.8 78.96 0.48 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.702 -178.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.54 ' SG ' HD11 ' A' ' 64' ' ' ILE . 3.8 t -158.43 -174.02 4.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.172 -1.193 . . . . 0.0 109.221 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.571 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 8.0 t -179.7 158.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 0.0 111.153 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -128.35 161.53 29.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.586 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.716 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 5.8 t -145.05 12.24 1.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.953 -1.092 . . . . 0.0 110.015 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 68.21 5.11 4.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.213 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.546 ' OXT' ' CG ' ' A' ' 90' ' ' ASN . 1.6 p30 . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 117.375 -1.298 . . . . 0.0 112.152 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.56 ' NE2' ' CE2' ' A' ' 26' ' ' TYR . 1.3 mt-30 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.05 0.452 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.626 HD11 ' OG ' ' A' ' 15' ' ' SER . 6.8 tp 48.02 82.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 108.995 -178.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.481 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 79.7 p -39.46 137.8 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.7 -0.625 . . . . 0.0 110.683 -179.208 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.02 -20.68 2.56 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 109.248 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.517 ' ND2' ' HG3' ' A' ' 29' ' ' LYS . 59.2 t-20 -77.39 -7.09 55.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.507 -0.746 . . . . 0.0 110.146 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.626 ' OG ' HD11 ' A' ' 11' ' ' LEU . 39.8 t -85.7 -163.01 0.79 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 109.915 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.19 133.32 21.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.056 -1.027 . . . . 0.0 110.172 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 25.7 p -132.31 132.92 43.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.164 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -160.48 -84.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 110.234 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.7 39.82 2.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 110.444 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.536 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 48.1 m -105.49 153.32 21.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 110.468 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.446 ' C ' HD23 ' A' ' 22' ' ' LEU . 52.1 m -111.54 84.81 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.362 -0.836 . . . . 0.0 109.165 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 37' ' ' CYS . 6.2 mt -101.03 175.58 5.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.139 -0.975 . . . . 0.0 111.102 -178.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 22.9 m -157.09 107.27 2.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.638 -0.664 . . . . 0.0 109.737 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 39' ' ' GLY . 3.7 m-20 56.99 100.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 110.427 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -157.92 -173.65 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.162 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.56 ' CE2' ' NE2' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -134.69 -48.43 0.75 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 179.021 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.663 HG13 ' HD2' ' A' ' 42' ' ' PHE . 14.1 t 55.22 144.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 122.027 0.917 . . . . 0.0 111.532 178.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.52 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -152.19 121.96 6.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.53 -0.731 . . . . 0.0 109.716 179.271 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HG3' ' ND2' ' A' ' 14' ' ' ASN . 0.1 OUTLIER 54.99 39.19 31.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.015 . . . . 0.0 109.97 -179.602 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.741 ' CB ' HG22 ' A' ' 45' ' ' VAL . 50.3 m -123.36 -163.08 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.257 -0.902 . . . . 0.0 110.52 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.685 ' C ' HG23 ' A' ' 32' ' ' VAL . 1.1 mt-10 -146.21 -72.0 0.24 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.352 -0.842 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.685 HG23 ' C ' ' A' ' 31' ' ' GLU . 2.6 t 73.15 141.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.602 -0.686 . . . . 0.0 111.038 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 38.8 m-85 -145.75 35.89 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.453 -0.779 . . . . 0.0 110.154 179.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 145.86 -7.7 1.47 Allowed Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.292 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.652 ' HB ' HG13 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -57.87 167.29 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.969 -1.312 . . . . 0.0 110.165 -179.857 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 36' ' ' THR . 9.2 t -108.45 62.14 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 0.0 110.309 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -47.02 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.2 179.899 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' THR . 2.3 m -100.96 101.43 12.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.153 -0.967 . . . . 0.0 109.724 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 44.21 52.33 7.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 3.8 m -128.16 179.89 5.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.072 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 41.5 mtt180 -149.53 147.85 28.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.873 . . . . 0.0 110.38 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.663 ' HD2' HG13 ' A' ' 27' ' ' VAL . 17.9 m-30 -116.74 175.84 5.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -0.839 . . . . 0.0 109.593 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.538 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 2.3 t0 -157.85 50.03 0.42 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.058 -1.027 . . . . 0.0 110.376 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 114.34 63.14 0.41 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.741 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -132.25 -166.86 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.028 -1.278 . . . . 0.0 110.625 -179.72 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 46' ' ' THR . 51.4 m -166.16 56.47 0.1 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 50' ' ' SER . 17.5 tt -82.44 170.74 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.584 -0.697 . . . . 0.0 111.102 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 44.9 p -133.25 -127.06 0.17 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.661 -0.649 . . . . 0.0 109.615 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 49' ' ' THR . 20.5 m -76.43 74.49 3.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.998 -1.064 . . . . 0.0 109.935 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.553 ' HB2' HD11 ' A' ' 47' ' ' ILE . 7.7 m -128.88 142.92 50.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.043 -1.036 . . . . 0.0 110.372 -179.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -86.61 135.13 33.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.021 -1.049 . . . . 0.0 110.19 179.909 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.405 ' H ' HG22 ' A' ' 36' ' ' THR . 3.1 p -154.69 125.46 7.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 110.149 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -111.68 121.06 44.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.32 -0.863 . . . . 0.0 110.014 -179.843 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 44.97 85.32 0.01 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 74.9 p -153.42 123.74 7.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.999 . . . . 0.0 110.581 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -86.24 99.87 11.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.178 -0.951 . . . . 0.0 109.466 179.358 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 57' ' ' ILE . 2.7 mp -82.93 18.49 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 110.533 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.538 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -41.17 155.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.386 -0.821 . . . . 0.0 110.031 179.488 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 157.54 151.7 6.11 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.72 53.63 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.088 1.573 . . . . 0.0 110.263 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 119.87 22.47 3.27 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.478 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -39.78 108.23 0.08 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.236 -1.155 . . . . 0.0 110.766 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.471 ' C ' HD12 ' A' ' 64' ' ' ILE . 17.2 tttp -101.56 122.43 43.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.034 . . . . 0.0 109.669 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.725 HD12 ' N ' ' A' ' 64' ' ' ILE . 4.5 mp -128.4 139.83 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.083 -1.011 . . . . 0.0 110.447 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.51 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -143.25 112.43 6.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.015 -1.053 . . . . 0.0 111.065 -179.908 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 1.9 m 48.37 80.37 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.566 -0.709 . . . . 0.0 112.055 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 80' ' ' CYS . 40.0 t -139.2 136.99 35.61 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.805 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.0 mp -90.75 88.07 2.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.27 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.738 HG21 ' CD2' ' A' ' 87' ' ' PHE . 12.3 mt -96.6 158.71 3.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.787 -0.571 . . . . 0.0 110.223 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.902 ' O ' HG22 ' A' ' 73' ' ' VAL . 3.2 m -166.21 106.49 0.68 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -0.91 . . . . 0.0 110.445 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.527 ' O ' HG13 ' A' ' 73' ' ' VAL . . . 86.29 34.53 12.17 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.563 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 71.28 21.09 78.53 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 70' ' ' THR . 3.5 m -125.74 120.84 24.41 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.29 -1.124 . . . . 0.0 110.65 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.83 141.06 18.91 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.721 1.379 . . . . 0.0 110.354 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -95.29 138.66 21.89 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.773 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.22 70.84 3.77 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.9 1.474 . . . . 0.0 110.219 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -97.66 166.55 11.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.35 -15.28 62.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.36 -36.93 5.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.14 -0.975 . . . . 0.0 110.745 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 67' ' ' CYS . 15.5 t -44.64 127.11 5.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.099 -1.0 . . . . 0.0 110.777 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.582 ' N ' ' HD3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -94.71 -172.34 2.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 110.135 179.751 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.781 ' O ' HG23 ' A' ' 82' ' ' ILE . 2.6 tp 179.09 39.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.492 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.0 m -104.82 87.27 2.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.052 -1.03 . . . . 0.0 111.766 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.11 52.75 2.67 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.459 178.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.448 ' SG ' HD11 ' A' ' 64' ' ' ILE . 10.0 t -165.46 170.46 14.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.263 -1.139 . . . . 0.0 109.927 179.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.541 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 9.2 t -176.38 159.53 1.99 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.96 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.738 ' CD2' HG21 ' A' ' 69' ' ' ILE . 1.7 m-85 -126.03 151.66 46.82 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.066 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.54 29.41 4.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.313 -0.867 . . . . 0.0 109.239 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 51.41 83.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.402 -0.811 . . . . 0.0 109.648 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.447 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.264 0.554 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.02 -162.27 21.91 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.44 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER 46.99 -158.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -1.126 . . . . 0.0 110.246 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.468 ' O ' ' OG1' ' A' ' 5' ' ' THR . 0.0 OUTLIER 65.22 142.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.892 . . . . 0.0 110.14 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.759 HG23 ' HB2' ' A' ' 9' ' ' SER . 84.1 m -167.62 84.26 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.452 -0.78 . . . . 0.0 109.357 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 24.7 p30 -62.35 72.48 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.58 -0.7 . . . . 0.0 110.059 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 5' ' ' THR . 4.5 m 70.53 2.59 4.14 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.575 -0.703 . . . . 0.0 110.359 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 7' ' ' THR . 2.2 t-20 175.02 -31.27 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.585 -0.697 . . . . 0.0 109.617 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.759 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.2 OUTLIER 73.8 111.59 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.648 -0.658 . . . . 0.0 110.981 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 2.1 tt0 -139.61 33.14 2.03 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.485 -0.759 . . . . 0.0 109.531 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.846 HD12 ' OG ' ' A' ' 15' ' ' SER . 2.8 mm? -48.13 113.81 0.81 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.459 -0.776 . . . . 0.0 109.897 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 57.1 p -32.93 -67.21 0.12 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.982 -0.449 . . . . 0.0 110.938 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 12' ' ' SER . . . 179.93 -32.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.113 -0.992 . . . . 0.0 110.709 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -114.07 15.39 18.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.978 . . . . 0.0 110.373 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.846 ' OG ' HD12 ' A' ' 11' ' ' LEU . 11.2 t -68.26 -171.52 0.25 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.196 -0.94 . . . . 0.0 110.279 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.548 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 1.3 tttp -143.96 142.32 30.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.976 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.67 126.83 8.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 110.048 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.04 -51.71 1.55 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.895 . . . . 0.0 110.404 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.02 55.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.379 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.4 p -101.17 -171.8 2.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 110.065 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -135.14 63.9 1.6 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.067 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.649 HD23 ' N ' ' A' ' 22' ' ' LEU . 4.0 mt -78.89 -179.01 6.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.841 . . . . 0.0 110.539 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 23.6 m -164.25 119.09 1.48 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 110.045 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.466 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 2.4 m120 57.97 45.75 17.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.882 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -155.54 0.55 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.301 -0.875 . . . . 0.0 110.784 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.534 ' HA ' ' HB3' ' A' ' 10' ' ' GLN . 4.1 t80 -167.51 -40.78 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.833 HG13 ' HD2' ' A' ' 42' ' ' PHE . 11.4 t 54.63 149.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.982 0.896 . . . . 0.0 111.773 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 42' ' ' PHE . 4.9 t0 -156.4 122.3 4.92 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 11.1 mtpp 49.67 55.01 10.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.915 -1.116 . . . . 0.0 109.512 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.661 ' OG ' HG22 ' A' ' 45' ' ' VAL . 46.2 m -142.98 -175.63 4.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.111 -0.993 . . . . 0.0 110.436 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 5.6 mt-10 -128.2 -67.09 0.82 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.0 110.612 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.703 HG22 ' CG2' ' A' ' 47' ' ' ILE . 7.7 t 62.64 154.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.202 -0.936 . . . . 0.0 110.28 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.427 ' CD2' HG22 ' A' ' 48' ' ' THR . 22.6 m-85 -150.08 -43.04 0.13 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -138.0 25.37 2.92 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.52 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 10.6 m -71.75 151.47 43.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.32 -1.106 . . . . 0.0 110.51 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 36' ' ' THR . 52.1 m -109.13 55.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.893 . . . . 0.0 109.917 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 17.5 t -40.31 140.76 0.58 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.465 -0.772 . . . . 0.0 110.348 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.61 ' O ' HG22 ' A' ' 38' ' ' THR . 99.6 m -123.69 13.3 9.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.292 -0.88 . . . . 0.0 109.921 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 128.46 51.84 0.13 Allowed Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.52 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 1.3 m -134.71 -169.22 2.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.355 -1.085 . . . . 0.0 110.205 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.504 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -147.38 170.71 16.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.277 -0.889 . . . . 0.0 110.183 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.833 ' HD2' HG13 ' A' ' 27' ' ' VAL . 19.8 m-85 -130.88 178.25 6.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.239 -0.913 . . . . 0.0 110.106 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -169.43 65.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 103.27 49.24 1.15 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.661 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -125.66 -176.5 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.729 -1.453 . . . . 0.0 110.962 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 46' ' ' THR . 55.3 m -153.21 55.48 0.76 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.727 HD12 HG21 ' A' ' 64' ' ' ILE . 10.6 tt -82.25 174.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.382 -0.824 . . . . 0.0 110.898 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 50' ' ' SER . 45.1 p -146.24 -136.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.493 -0.755 . . . . 0.0 109.31 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 66' ' ' THR . 99.9 m -58.33 82.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.054 -1.029 . . . . 0.0 110.046 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 48' ' ' THR . 29.3 t -142.36 145.61 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.996 -1.065 . . . . 0.0 110.926 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -98.41 128.16 44.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.142 -0.974 . . . . 0.0 110.231 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -141.16 130.35 23.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.194 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.01 105.3 15.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.243 -0.911 . . . . 0.0 109.889 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA2' ' OG ' ' A' ' 40' ' ' SER . . . 51.27 91.07 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 8.5 p -154.86 119.2 4.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.12 . . . . 0.0 110.53 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.53 ' CD ' ' HB2' ' A' ' 58' ' ' SER . 1.6 ttm180 -72.76 101.96 3.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.696 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.471 ' O ' HG12 ' A' ' 45' ' ' VAL . 7.9 mm -84.07 12.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.956 . . . . 0.0 110.28 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.53 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -42.68 153.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.858 . . . . 0.0 110.402 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.53 147.63 4.95 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.56 55.27 4.7 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.911 1.48 . . . . 0.0 109.762 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' O ' ' CD ' ' A' ' 63' ' ' LYS . . . 123.6 21.51 2.43 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -46.97 123.31 5.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.235 -1.156 . . . . 0.0 111.108 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.543 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -112.41 145.65 39.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.233 -0.917 . . . . 0.0 109.649 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.727 HG21 HD12 ' A' ' 47' ' ' ILE . 11.3 mt -155.0 126.78 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.0 110.352 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.482 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -136.31 103.07 5.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.083 -1.011 . . . . 0.0 109.821 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.9 OUTLIER 68.17 80.12 0.21 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.526 -0.734 . . . . 0.0 110.382 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.7 t -138.96 120.38 14.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.846 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.6 mp -88.53 79.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 108.512 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.685 HG23 ' C ' ' A' ' 73' ' ' VAL . 11.1 mt -89.42 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.243 0.544 . . . . 0.0 110.193 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.845 ' O ' HG22 ' A' ' 73' ' ' VAL . 7.2 m -150.52 100.79 2.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.297 -0.877 . . . . 0.0 110.424 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.78 33.14 10.2 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 77.95 15.46 81.14 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 70' ' ' THR . 6.1 m -125.79 129.75 24.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.337 -1.096 . . . . 0.0 110.682 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 46.7 Cg_endo -75.96 144.59 27.37 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.831 1.437 . . . . 0.0 110.253 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -90.86 162.0 34.28 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.693 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.97 66.16 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.793 1.418 . . . . 0.0 110.121 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.489 ' OG ' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -108.07 125.78 51.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.0 110.345 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.79 -1.88 15.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 110.304 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.2 -23.73 17.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.091 -1.006 . . . . 0.0 110.493 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 49.3 t -72.87 167.4 21.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.523 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -108.63 -41.31 4.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.014 -1.054 . . . . 0.0 111.765 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.533 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 34.0 mm 47.13 74.38 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.894 -1.128 . . . . 0.0 109.683 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.59 -80.98 0.6 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.069 -1.019 . . . . 0.0 110.939 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.23 37.99 3.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.5 t -132.04 178.64 6.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.053 -1.263 . . . . 0.0 109.872 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.555 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t -173.87 155.0 2.5 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.228 -0.92 . . . . 0.0 109.662 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -125.57 158.28 35.01 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.904 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 26.4 t -141.36 22.87 2.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -0.852 . . . . 0.0 109.719 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.71 80.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.411 -0.806 . . . . 0.0 109.84 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.52 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.394 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.8 t0 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.294 0.569 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.68 -90.39 1.16 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 m -115.33 -81.05 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.128 -1.219 . . . . 0.0 110.409 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 1.007 ' HB3' HD23 ' A' ' 11' ' ' LEU . 0.5 OUTLIER 59.32 174.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 110.022 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.738 ' O ' HG22 ' A' ' 5' ' ' THR . 44.0 m -161.87 17.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.212 -0.93 . . . . 0.0 110.18 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.56 ' ND2' ' HB2' ' A' ' 9' ' ' SER . 0.7 OUTLIER 32.16 59.11 0.36 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.441 0.639 . . . . 0.0 110.126 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER 72.88 -54.42 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.43 -0.794 . . . . 0.0 109.827 -178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.8 OUTLIER 170.5 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.03 -1.044 . . . . 0.0 110.922 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.56 ' HB2' ' ND2' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -172.08 -86.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.042 -1.036 . . . . 0.0 110.565 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -173.08 103.51 0.13 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.628 -1.295 . . . . 0.0 111.327 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.007 HD23 ' HB3' ' A' ' 4' ' ' CYS . 14.4 tp -102.14 96.25 6.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.101 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -36.34 134.6 0.42 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.53 0.681 . . . . 0.0 111.117 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.85 -21.27 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 110.54 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.8 OUTLIER -96.65 -2.55 44.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.998 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.848 ' OG ' HG11 ' A' ' 27' ' ' VAL . 19.4 t -73.08 -169.15 0.57 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.842 -1.161 . . . . 0.0 110.073 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.75 130.99 14.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.152 -0.968 . . . . 0.0 110.981 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 18' ' ' GLU . 10.3 p -139.64 -179.28 5.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.897 . . . . 0.0 109.804 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 169.65 -80.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 0.0 109.74 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.34 13.27 9.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.845 . . . . 0.0 109.602 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -77.0 -147.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.765 . . . . 0.0 110.297 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.621 ' C ' HD22 ' A' ' 22' ' ' LEU . 18.9 m -153.23 88.58 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 110.321 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.869 HD21 HG11 ' A' ' 32' ' ' VAL . 3.5 mm? -106.31 90.5 3.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.971 . . . . 0.0 109.64 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 9.3 m -93.32 139.93 30.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.189 -0.944 . . . . 0.0 111.176 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.471 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 2.5 m-80 37.05 40.91 0.17 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.765 -0.584 . . . . 0.0 110.76 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -81.69 -152.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.19 -0.944 . . . . 0.0 110.676 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.564 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 56.5 t80 179.46 42.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.848 HG11 ' OG ' ' A' ' 15' ' ' SER . 6.6 t -53.46 149.95 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.857 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.493 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.1 OUTLIER -130.95 -29.03 1.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.441 0.639 . . . . 0.0 109.746 179.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.52 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 2.4 mtmt -168.86 68.48 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.307 -0.871 . . . . 0.0 109.329 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.759 ' CB ' HG22 ' A' ' 45' ' ' VAL . 84.0 p -141.34 168.68 19.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.119 -0.988 . . . . 0.0 111.706 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 47' ' ' ILE . 5.6 mt-10 -124.03 113.32 18.26 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.869 HG11 HD21 ' A' ' 22' ' ' LEU . 9.3 t -112.57 149.07 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 111.094 -178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CD1' HG22 ' A' ' 48' ' ' THR . 58.6 m-85 -128.77 -25.95 2.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -0.875 . . . . 0.0 110.905 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -167.82 32.59 0.19 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.576 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 4.8 m -81.98 146.44 29.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.234 -1.157 . . . . 0.0 110.328 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 m -100.91 85.62 2.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.421 -0.8 . . . . 0.0 109.37 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.584 ' HB2' HD13 ' A' ' 22' ' ' LEU . 44.9 t -73.79 101.2 3.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.523 -0.735 . . . . 0.0 110.927 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 38' ' ' THR . 4.3 t -89.08 28.38 1.21 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.3 -0.875 . . . . 0.0 110.101 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 113.49 62.73 0.43 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 9.8 t -139.87 -173.94 3.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.44 -1.035 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.564 ' CB ' ' HB3' ' A' ' 26' ' ' TYR . 13.4 ptt180 -153.46 154.63 34.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.902 -1.124 . . . . 0.0 110.757 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.486 ' HD2' HG13 ' A' ' 27' ' ' VAL . 6.0 m-85 -119.15 -168.99 1.66 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.438 -0.789 . . . . 0.0 109.016 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.505 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 3.5 t0 -179.91 61.88 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.607 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 106.27 57.61 0.63 Allowed Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.759 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -138.59 -157.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.887 -1.361 . . . . 0.0 110.601 -179.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.702 ' N ' HG23 ' A' ' 45' ' ' VAL . 65.8 m -167.75 57.28 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.693 -0.629 . . . . 0.0 109.925 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 31' ' ' GLU . 16.0 tt -75.13 162.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 110.155 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' SER . 31.8 p -131.96 -134.34 0.19 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.068 -1.02 . . . . 0.0 109.963 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 49' ' ' THR . 95.5 m -65.89 64.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.981 -1.074 . . . . 0.0 110.257 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 48' ' ' THR . 3.1 t -128.08 139.85 52.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 0.0 110.588 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.459 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -90.05 146.71 24.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.859 . . . . 0.0 109.691 179.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.38 130.99 11.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.04 -1.038 . . . . 0.0 110.597 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.29 111.66 22.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.106 -0.997 . . . . 0.0 110.068 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 51.9 79.03 0.08 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 13.4 p -148.26 134.82 19.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -1.184 . . . . 0.0 110.111 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -89.99 108.54 19.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 110.453 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.599 HG23 ' CD1' ' A' ' 64' ' ' ILE . 17.4 mm -88.04 -1.46 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.178 -0.951 . . . . 0.0 109.998 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.505 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 1.1 m -42.56 150.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.36 -0.838 . . . . 0.0 110.864 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 164.16 153.56 7.44 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.94 -2.08 11.45 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.064 1.56 . . . . 0.0 109.903 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.76 34.08 0.08 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.415 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.3 t -65.82 130.26 42.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -1.117 . . . . 0.0 110.452 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 14.5 tttm -135.3 125.1 25.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 110.402 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.605 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 4.3 mt -126.64 146.54 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.99 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 66' ' ' THR . 30.6 p -142.04 126.15 17.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.218 -0.926 . . . . 0.0 110.516 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 49' ' ' THR . 25.0 m 39.77 85.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.57 -0.706 . . . . 0.0 110.662 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 2.8 t -152.92 108.08 3.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -0.876 . . . . 0.0 110.047 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.733 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.8 mp -72.3 87.71 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.488 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.758 HG23 ' C ' ' A' ' 73' ' ' VAL . 3.9 mt -90.22 155.7 3.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.555 -0.716 . . . . 0.0 110.62 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.793 ' O ' HG22 ' A' ' 73' ' ' VAL . 18.7 m -156.31 102.65 2.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.334 -0.854 . . . . 0.0 110.553 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.6 26.76 24.16 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.576 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.77 16.31 70.76 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 70' ' ' THR . 4.0 m -127.24 133.72 25.37 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.536 -0.979 . . . . 0.0 110.155 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.18 148.09 16.66 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.793 1.417 . . . . 0.0 110.666 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -93.77 149.28 36.8 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.563 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.02 114.74 4.06 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.937 1.493 . . . . 0.0 110.85 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.675 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 1.3 t -134.14 -0.6 3.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 110.44 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 66.2 6.84 4.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.154 -0.966 . . . . 0.0 110.409 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -132.28 -32.34 1.37 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.244 -0.91 . . . . 0.0 110.404 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -57.15 151.89 14.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -0.908 . . . . 0.0 109.985 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.66 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -104.13 175.18 5.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.504 -0.747 . . . . 0.0 109.958 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.752 HG22 ' O ' ' A' ' 82' ' ' ILE . 46.1 mm -155.99 38.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.9 m -59.71 -104.4 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.73 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.92 89.52 0.48 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.708 ' C ' HG22 ' A' ' 86' ' ' THR . 1.6 t -147.18 -149.39 0.29 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.1 -1.235 . . . . 0.0 110.311 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.708 HG22 ' C ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER 169.98 142.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.391 -0.818 . . . . 0.0 109.539 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.576 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.4 m-85 -116.99 -19.62 9.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.517 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.773 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 0.4 OUTLIER 45.72 -92.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 110.031 -179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.773 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . 157.36 64.92 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.904 -0.498 . . . . 0.0 110.031 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.43 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.004 -1.06 . . . . 0.0 109.978 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 2' ' ' GLY . 22.5 m-20 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.288 0.566 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 1' ' ' ASP . . . 43.76 -163.25 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -137.3 121.25 17.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.336 -1.096 . . . . 0.0 110.358 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' C ' ' HG1' ' A' ' 5' ' ' THR . 2.6 p -166.54 -109.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.362 -0.836 . . . . 0.0 110.015 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 23' ' ' THR . 4.1 m -157.41 -3.9 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.718 -1.239 . . . . 0.0 110.938 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.934 ' HB3' HD12 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -50.67 -22.75 2.2 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.501 -1.374 . . . . 0.0 107.524 178.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 6' ' ' ASN 0.251 1.4 m -41.77 -61.89 1.01 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -54.85 -29.49 55.37 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 6' ' ' ASN . 9.4 p -86.04 -125.98 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.596 -0.69 . . . . 0.0 109.827 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.52 ' N ' ' OG ' ' A' ' 9' ' ' SER . 1.6 tt0 -131.39 -71.73 0.56 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.661 -1.274 . . . . 0.0 110.877 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.694 HD22 ' CG ' ' A' ' 6' ' ' ASN . 17.3 tp 57.03 111.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.11 -0.994 . . . . 0.0 109.922 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 28' ' ' ASP . 12.9 t -68.39 161.11 28.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.284 -0.885 . . . . 0.0 110.405 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.74 -8.01 31.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.152 -0.968 . . . . 0.0 110.073 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -97.74 -11.47 23.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.645 ' OG ' HG11 ' A' ' 27' ' ' VAL . 41.5 t -76.27 -163.29 0.29 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.972 . . . . 0.0 110.046 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.25 134.84 15.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.303 -0.873 . . . . 0.0 110.554 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.1 t -135.7 32.67 3.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.934 . . . . 0.0 110.2 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 19' ' ' LYS . 1.4 tm-20 -55.61 127.21 28.78 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 43.01 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.215 -0.928 . . . . 0.0 109.724 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER -159.52 -171.07 3.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.044 -1.035 . . . . 0.0 111.005 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' THR . 8.5 m -156.55 72.78 0.75 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.486 -0.759 . . . . 0.0 109.71 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 6' ' ' ASN . 4.0 mt -75.44 -116.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 110.369 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.662 ' CB ' ' O ' ' A' ' 22' ' ' LEU . 1.1 m 146.21 -62.59 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.479 ' N ' HG22 ' A' ' 23' ' ' THR . 73.7 m-20 -132.03 34.87 3.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.444 -0.785 . . . . 0.0 110.162 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -67.85 -159.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.02 0.914 . . . . 0.0 110.904 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 25' ' ' CYS . 46.9 m-85 -162.96 -54.74 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.654 HG12 ' H ' ' A' ' 28' ' ' ASP . 3.3 t 44.59 -179.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 122.14 0.971 . . . . 0.0 111.727 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.654 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -175.81 -33.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 46.8 mtmt -150.45 56.3 0.93 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.534 ' HB2' HG13 ' A' ' 27' ' ' VAL . 75.5 m -135.5 164.11 28.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.953 -1.092 . . . . 0.0 111.86 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 2.4 tt0 -120.64 107.62 13.02 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.63 HG22 ' CG2' ' A' ' 47' ' ' ILE . 17.9 t -110.29 160.1 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.052 -1.03 . . . . 0.0 111.379 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.556 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 94.9 m-85 -157.33 44.66 0.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.427 -0.796 . . . . 0.0 110.455 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.521 ' N ' ' OG ' ' A' ' 20' ' ' SER . . . 138.72 33.08 0.19 Allowed Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.15 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.606 ' HB ' HG11 ' A' ' 32' ' ' VAL . 5.6 m -95.24 144.07 26.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.24 . . . . 0.0 110.257 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.724 ' O ' HG22 ' A' ' 36' ' ' THR . 32.0 m -94.61 53.35 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.36 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.499 ' HB2' ' CB ' ' A' ' 22' ' ' LEU . 1.2 m -50.4 87.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.425 -0.797 . . . . 0.0 110.888 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 36' ' ' THR . 5.2 t -104.78 36.07 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.21 46.6 0.18 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -141.24 167.17 22.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.314 -1.11 . . . . 0.0 109.856 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.471 ' CB ' ' HB2' ' A' ' 26' ' ' TYR . 5.3 ptt180 -146.12 152.11 38.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.961 -1.087 . . . . 0.0 110.803 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.628 ' CE1' ' CD1' ' A' ' 57' ' ' ILE . 6.8 m-85 -116.64 -167.63 1.32 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 110.114 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 7.1 t0 -177.46 53.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.414 -0.804 . . . . 0.0 110.165 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 114.88 60.2 0.37 Allowed Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.512 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.4 m -139.28 -169.98 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.997 -1.296 . . . . 0.0 110.297 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 46' ' ' THR . 35.8 m -149.47 51.02 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.309 -0.869 . . . . 0.0 110.103 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.63 ' CG2' HG22 ' A' ' 32' ' ' VAL . 7.9 tt -68.2 173.58 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.294 -0.879 . . . . 0.0 110.45 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 12.0 p -142.73 -98.76 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -0.881 . . . . 0.0 110.067 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.737 HG22 ' O ' ' A' ' 49' ' ' THR . 15.8 m -104.05 69.83 0.96 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.986 -1.071 . . . . 0.0 109.715 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB2' HD11 ' A' ' 47' ' ' ILE . 10.6 m -121.13 147.19 45.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.116 -0.99 . . . . 0.0 111.161 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -99.66 121.57 41.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.436 -0.79 . . . . 0.0 109.168 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -139.85 136.54 34.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.345 -0.847 . . . . 0.0 110.406 -179.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -121.63 89.27 3.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.824 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.09 76.29 1.21 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 p -148.97 124.53 10.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.34 -1.094 . . . . 0.0 110.551 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.46 ' HD2' ' HB2' ' A' ' 58' ' ' SER . 0.1 OUTLIER -90.35 96.66 10.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.242 -0.911 . . . . 0.0 109.896 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.628 ' CD1' ' CE1' ' A' ' 42' ' ' PHE . 3.1 mt -84.15 17.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.671 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 56' ' ' ARG . 0.5 OUTLIER -43.8 151.03 0.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.01 -1.057 . . . . 0.0 110.078 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 162.59 162.27 13.33 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.02 -1.35 11.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.134 1.597 . . . . 0.0 109.852 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.68 33.88 0.02 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.447 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.7 t -50.68 123.34 8.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.216 -1.167 . . . . 0.0 110.006 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.515 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 8.6 tttt -102.64 128.2 49.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.07 -1.019 . . . . 0.0 110.174 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 28.8 mm -133.81 141.3 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.907 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -151.62 126.38 9.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.298 -0.876 . . . . 0.0 110.101 -179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.5 m 39.02 71.59 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.573 0.702 . . . . 0.0 110.756 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.466 ' C ' HD12 ' A' ' 68' ' ' ILE . 73.4 m -130.13 125.6 35.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.428 -0.795 . . . . 0.0 109.252 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.777 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.9 mp -93.47 88.48 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.836 -1.165 . . . . 0.0 110.131 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.536 HG12 ' CE2' ' A' ' 87' ' ' PHE . 14.3 mt -96.23 156.58 3.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.522 -0.736 . . . . 0.0 110.061 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.787 ' O ' HG22 ' A' ' 73' ' ' VAL . 34.7 m -152.25 93.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 110.224 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.94 31.88 9.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 80.0 16.63 76.44 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 70' ' ' THR . 16.1 m -124.73 120.11 25.73 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.391 -1.064 . . . . 0.0 110.503 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -73.72 145.81 37.4 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.949 1.5 . . . . 0.0 110.509 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -90.68 166.61 18.7 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.365 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.4 Cg_endo -72.03 56.3 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.723 1.38 . . . . 0.0 109.603 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.563 ' OG ' HD13 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -84.92 126.09 33.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 110.633 -179.242 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.26 -9.13 59.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.837 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.94 -12.61 23.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.353 -0.842 . . . . 0.0 110.526 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' SER . 38.2 t -77.44 168.84 19.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.107 -0.996 . . . . 0.0 109.619 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HE3' ' N ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -98.64 -32.18 11.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.793 -1.192 . . . . 0.0 111.399 -178.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.527 ' N ' ' HE3' ' A' ' 81' ' ' LYS . 28.3 mm 38.19 57.75 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.186 -0.946 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.4 m -113.37 -100.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.0 -1.062 . . . . 0.0 110.422 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -101.19 89.58 0.8 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -166.36 -172.72 2.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.147 -1.208 . . . . 0.0 110.759 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.512 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 2.6 t -178.02 157.51 1.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.484 -0.76 . . . . 0.0 109.52 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 2.2 m-30 -114.33 -54.68 2.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 110.076 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 65.07 11.08 6.84 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.929 . . . . 0.0 110.087 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 47.14 95.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 109.963 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 89' ' ' ALA . 5.1 p30 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.305 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.241 0.543 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.85 -80.22 0.54 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 p -162.93 47.12 0.14 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -1.162 . . . . 0.0 110.135 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.528 ' O ' ' HB ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -50.86 -50.65 56.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 110.325 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' A' ' 4' ' ' CYS . 4.3 m 73.17 0.24 3.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.608 ' ND2' ' HB2' ' A' ' 25' ' ' CYS . 7.1 t-20 45.34 33.33 1.22 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.506 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER 69.39 70.14 0.25 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.029 -1.044 . . . . 0.0 108.25 -178.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 7' ' ' THR . 1.3 m-80 67.45 93.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.63 -0.668 . . . . 0.0 109.727 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 6' ' ' ASN . 6.4 p -167.65 -139.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.19 -0.943 . . . . 0.0 110.4 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.476 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -126.17 -46.45 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 110.155 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.619 HD11 ' OG ' ' A' ' 15' ' ' SER . 12.3 tp 41.19 84.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.365 -0.834 . . . . 0.0 109.892 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.543 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 86.1 p -45.46 164.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.927 . . . . 0.0 110.187 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 -14.03 60.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.346 -0.846 . . . . 0.0 110.299 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 1.0 OUTLIER -93.95 -6.62 45.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.164 -0.96 . . . . 0.0 110.5 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.619 ' OG ' HD11 ' A' ' 11' ' ' LEU . 4.8 t -74.08 -176.65 2.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.957 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.418 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -142.09 131.43 23.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 110.274 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 t -138.6 159.88 40.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 0.0 110.262 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -172.86 -87.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.014 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -114.55 72.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.134 -0.979 . . . . 0.0 110.1 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -117.92 -164.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.855 . . . . 0.0 110.216 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 21' ' ' THR . 5.2 t -150.15 60.42 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.765 HD23 ' O ' ' A' ' 35' ' ' THR . 13.7 mt -84.62 -171.59 3.71 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.873 0.844 . . . . 0.0 111.455 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 1.5 m -164.78 101.63 0.79 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.484 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 0.8 OUTLIER 59.18 118.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.415 -0.803 . . . . 0.0 109.766 -178.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.608 ' HB2' ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -171.0 -151.68 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.136 -0.978 . . . . 0.0 110.361 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.474 ' CD2' ' CB ' ' A' ' 10' ' ' GLN . 17.9 t80 -157.68 -42.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.837 0.827 . . . . 0.0 108.958 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.838 HG13 ' HD2' ' A' ' 42' ' ' PHE . 6.9 t 39.22 101.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.305 0.574 . . . . 0.0 112.174 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 4.6 t0 -88.71 -130.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.5 mttp -62.36 81.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.783 -1.198 . . . . 0.0 109.072 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.772 ' OG ' HG22 ' A' ' 45' ' ' VAL . 16.9 m -148.87 159.54 44.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.91 -1.119 . . . . 0.0 111.301 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 47' ' ' ILE . 2.2 mt-10 -119.1 115.66 24.73 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.624 HG22 ' CG2' ' A' ' 47' ' ' ILE . 34.2 t -117.21 156.28 18.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.225 -0.922 . . . . 0.0 111.065 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.518 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 41.9 m-85 -135.06 -71.75 0.48 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.143 -0.973 . . . . 0.0 110.913 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 48' ' ' THR . . . -118.36 41.83 1.94 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.765 ' O ' HD23 ' A' ' 22' ' ' LEU . 1.7 m -87.24 172.24 10.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -1.106 . . . . 0.0 110.334 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 6.8 m -112.0 -13.07 13.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.859 -1.151 . . . . 0.0 110.933 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.69 ' HB2' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER 35.67 63.34 0.56 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.468 -0.77 . . . . 0.0 110.758 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.632 HG21 HG23 ' A' ' 53' ' ' THR . 88.3 m -65.57 78.57 0.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.411 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 52.27 36.0 44.21 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 41' ' ' ARG . 94.2 p -107.09 -138.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.179 -1.189 . . . . 0.0 109.811 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HB3' ' ND2' ' A' ' 90' ' ' ASN . 32.3 ttt-85 175.96 154.58 0.19 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 110.429 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.838 ' HD2' HG13 ' A' ' 27' ' ' VAL . 13.1 m-85 -120.11 168.85 10.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.923 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 3.9 t0 -159.6 73.49 0.57 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.998 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 96.57 49.85 1.92 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.772 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.2 m -131.6 -165.02 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.947 -1.325 . . . . 0.0 111.152 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 46' ' ' THR . 35.9 m -159.92 58.55 0.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.876 HD11 ' HB3' ' A' ' 50' ' ' SER . 13.2 tt -72.55 173.65 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.511 -0.743 . . . . 0.0 110.311 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.518 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -137.18 -92.07 0.24 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.373 -0.829 . . . . 0.0 109.886 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 49' ' ' THR . 7.8 m -111.97 65.96 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 110.046 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.876 ' HB3' HD11 ' A' ' 47' ' ' ILE . 1.5 t -108.77 143.27 38.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.551 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.533 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 m -91.85 21.18 5.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.471 -0.768 . . . . 0.0 110.85 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -38.12 128.02 1.31 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.446 -0.783 . . . . 0.0 110.759 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.632 HG23 HG21 ' A' ' 38' ' ' THR . 13.3 m -111.37 101.52 9.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 110.102 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 61.17 77.76 0.18 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.5 p -148.82 122.35 9.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -1.11 . . . . 0.0 110.219 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.553 ' CB ' ' HB3' ' A' ' 88' ' ' SER . 3.7 ttp180 -72.23 103.88 3.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.137 -0.977 . . . . 0.0 110.089 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.494 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 22.6 mm -83.92 11.88 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.319 -0.863 . . . . 0.0 109.827 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -41.73 148.91 0.14 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.347 -0.846 . . . . 0.0 110.244 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 158.06 157.27 8.36 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.27 52.53 3.56 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.062 1.559 . . . . 0.0 109.951 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.459 ' O ' ' HD2' ' A' ' 63' ' ' LYS . . . 118.69 18.74 4.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.522 ' HB3' ' CG1' ' A' ' 45' ' ' VAL . 1.7 t -40.77 126.81 2.49 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.406 -1.055 . . . . 0.0 110.148 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.526 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -108.43 143.21 37.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 110.734 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.096 HD13 ' NZ ' ' A' ' 81' ' ' LYS . 17.4 mm -143.06 125.07 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.328 -0.858 . . . . 0.0 109.042 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -133.94 121.49 21.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.065 -1.022 . . . . 0.0 110.602 -179.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 49' ' ' THR . 15.6 m 37.76 53.64 1.5 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.705 -0.622 . . . . 0.0 111.145 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.587 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 4.8 t -118.47 109.79 16.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -0.948 . . . . 0.0 109.339 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.548 HD12 ' H ' ' A' ' 68' ' ' ILE . 2.0 mp -52.52 -66.28 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.711 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 73' ' ' VAL . 9.5 mt 56.74 157.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -0.784 . . . . 0.0 109.923 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.853 ' O ' HG22 ' A' ' 73' ' ' VAL . 5.7 m -169.66 107.51 0.39 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.898 -1.126 . . . . 0.0 111.186 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.41 28.08 31.15 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.572 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 85.38 10.9 76.4 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 70' ' ' THR . 11.7 m -120.5 136.73 25.5 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.207 -1.172 . . . . 0.0 110.033 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.454 ' HA ' HG12 ' A' ' 69' ' ' ILE . 48.3 Cg_endo -77.4 138.02 17.22 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.993 1.523 . . . . 0.0 110.849 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -107.6 160.83 25.25 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.864 . . . . 0.0 109.998 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.26 122.15 8.11 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.923 1.486 . . . . 0.0 110.365 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.77 4.1 2.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.942 . . . . 0.0 110.551 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.46 23.96 2.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.112 -0.992 . . . . 0.0 110.143 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 80' ' ' CYS . . . -160.45 -37.4 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.89 . . . . 0.0 109.913 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 1.2 t -39.46 158.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.684 0.754 . . . . 0.0 110.931 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.096 ' NZ ' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.56 -167.91 1.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 0.0 109.438 179.46 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.719 ' O ' HG23 ' A' ' 82' ' ' ILE . 1.3 tp 177.51 31.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.178 -0.951 . . . . 0.0 110.042 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -70.71 -101.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.935 -1.103 . . . . 0.0 110.652 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.84 100.75 1.43 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -161.7 -159.64 0.64 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.29 -1.124 . . . . 0.0 109.887 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.553 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t 169.1 150.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.615 -0.678 . . . . 0.0 109.636 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.572 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -122.79 143.28 49.94 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.267 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.658 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -122.02 9.66 9.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 65.17 66.94 0.53 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 110.088 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.534 ' HB2' ' CB ' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.127 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.287 0.565 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.28 -80.99 0.03 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 5' ' ' THR . 34.3 m -101.17 -101.39 0.26 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -1.162 . . . . 0.0 110.602 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.552 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 1.1 m 58.78 -80.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.038 -1.039 . . . . 0.0 110.052 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 5' ' ' THR . 0.3 OUTLIER 58.23 15.96 3.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.135 -0.978 . . . . 0.0 109.22 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.682 ' HB2' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER 50.44 28.29 3.25 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.042 -1.036 . . . . 0.0 108.453 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.562 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.9 m 77.61 -3.16 2.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.731 -0.606 . . . . 0.0 109.759 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.56 ' N ' HG23 ' A' ' 5' ' ' THR . 0.5 OUTLIER 162.68 86.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.666 -0.646 . . . . 0.0 110.136 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.526 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 61.9 p -177.11 -149.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.349 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 2.6 tt0 -111.98 -44.12 3.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.014 . . . . 0.0 110.532 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.552 ' CD2' ' HB3' ' A' ' 4' ' ' CYS . 41.8 tp 46.34 86.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 109.996 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.504 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -42.71 148.66 0.22 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 0.0 110.358 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.65 -21.32 64.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.198 -0.939 . . . . 0.0 110.093 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -87.56 -4.09 58.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 110.209 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.507 ' OG ' HG11 ' A' ' 27' ' ' VAL . 39.0 t -79.42 -163.7 0.54 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.233 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 9.5 tttp -156.39 178.98 9.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.134 -0.979 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 16' ' ' LYS . 3.9 p 174.69 47.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 110.068 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 4.0 tt0 -41.83 -50.18 4.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 110.648 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -161.68 77.07 0.52 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.646 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 21' ' ' THR . 0.8 OUTLIER -115.31 -153.24 0.52 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.206 -0.934 . . . . 0.0 110.048 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -155.62 77.09 0.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 109.775 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.805 HD22 ' HB2' ' A' ' 37' ' ' CYS . 5.0 mt -96.24 -167.3 1.56 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.365 -0.835 . . . . 0.0 110.456 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.514 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 53.4 m -155.02 -47.97 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.503 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.45 ' O ' ' O ' ' A' ' 25' ' ' CYS . 12.0 m-20 -144.25 23.51 1.66 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.225 -0.922 . . . . 0.0 110.545 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 9' ' ' SER . 0.1 OUTLIER -58.16 -152.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.024 . . . . 0.0 110.513 -179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.499 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -160.59 -52.85 0.05 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.555 HG13 ' HB2' ' A' ' 30' ' ' SER . 4.7 t 49.39 117.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.905 0.86 . . . . 0.0 112.226 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -108.72 -20.83 12.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.944 . . . . 0.0 108.884 178.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -167.4 84.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.746 -0.596 . . . . 0.0 109.671 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.909 ' OG ' HG22 ' A' ' 45' ' ' VAL . 24.5 m -159.58 164.28 34.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.784 -1.197 . . . . 0.0 111.51 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 47' ' ' ILE . 3.6 tt0 -119.68 96.58 5.25 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.547 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 6.5 t -94.67 168.68 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.141 -0.974 . . . . 0.0 110.531 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 19.1 m-85 -150.18 -42.86 0.13 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.064 -1.022 . . . . 0.0 111.315 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.97 27.56 1.88 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.547 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.7 m -82.01 150.03 27.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.08 -1.247 . . . . 0.0 110.526 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 36' ' ' THR . 13.9 t -95.95 54.49 1.49 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.539 -0.726 . . . . 0.0 109.443 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.805 ' HB2' HD22 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -38.31 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.689 -0.632 . . . . 0.0 110.691 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 36' ' ' THR . 19.0 m -104.38 69.62 0.92 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -0.945 . . . . 0.0 110.077 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.72 59.45 3.48 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.6 m -136.88 -168.97 2.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -1.143 . . . . 0.0 109.783 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -162.78 143.38 9.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 110.673 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.544 ' CE1' HG13 ' A' ' 57' ' ' ILE . 10.8 m-85 -114.42 173.4 6.48 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.419 -0.8 . . . . 0.0 109.181 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -155.86 42.98 0.42 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 123.8 72.88 0.25 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.909 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -148.91 -168.74 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.043 -1.269 . . . . 0.0 110.475 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.557 ' N ' HG23 ' A' ' 45' ' ' VAL . 50.2 m -155.38 58.82 0.64 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.579 ' HB ' HD13 ' A' ' 64' ' ' ILE . 8.8 tt -80.98 168.34 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.269 -0.894 . . . . 0.0 110.298 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 50' ' ' SER . 74.8 p -142.61 -138.05 0.11 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.621 -0.675 . . . . 0.0 109.233 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' THR . 52.8 m -58.24 83.81 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.984 -1.073 . . . . 0.0 110.145 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 48' ' ' THR . 73.0 m -141.57 139.41 33.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.961 -1.087 . . . . 0.0 110.502 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -88.88 117.77 28.11 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.373 -0.83 . . . . 0.0 109.592 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.5 p -133.78 113.49 12.36 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.567 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -98.37 91.42 5.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 109.485 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 72' ' ' GLY . . . 72.16 106.25 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 89.1 p -175.42 102.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -1.166 . . . . 0.0 110.467 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.539 ' HB2' ' CA ' ' A' ' 90' ' ' ASN . 7.6 ttm180 -62.79 106.26 0.78 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.929 -1.107 . . . . 0.0 108.984 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.544 HG13 ' CE1' ' A' ' 42' ' ' PHE . 16.5 mm -83.23 11.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.1 -1.0 . . . . 0.0 110.545 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.501 ' HB2' ' HG2' ' A' ' 56' ' ' ARG . 0.4 OUTLIER -36.99 151.33 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.611 -0.681 . . . . 0.0 110.411 179.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 166.48 147.11 5.1 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.275 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -79.87 63.35 8.73 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 124.301 1.685 . . . . 0.0 109.461 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 106.05 24.3 6.97 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -41.58 161.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.409 -1.053 . . . . 0.0 110.323 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.479 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 17.1 tttm -152.89 110.48 3.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.012 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.579 HD13 ' HB ' ' A' ' 47' ' ' ILE . 3.1 mp -125.7 152.68 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.022 -1.049 . . . . 0.0 111.291 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.48 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.7 OUTLIER -156.12 107.91 2.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -0.847 . . . . 0.0 109.895 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER 63.0 73.25 0.46 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 111.12 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 3.8 t -132.91 120.3 21.29 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.234 -0.917 . . . . 0.0 109.955 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.798 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.0 mp -83.29 85.24 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.027 -1.045 . . . . 0.0 108.839 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.697 HG21 ' CD2' ' A' ' 87' ' ' PHE . 9.6 mt -96.05 160.75 2.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.785 -0.572 . . . . 0.0 109.889 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.793 ' O ' HG22 ' A' ' 73' ' ' VAL . 13.1 m -162.63 100.93 1.03 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.221 -0.924 . . . . 0.0 110.504 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 89.03 34.52 8.79 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 54' ' ' GLY . . . 75.42 17.95 80.03 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 70' ' ' THR . 9.5 m -123.56 128.94 25.04 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.24 -1.153 . . . . 0.0 110.834 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -83.33 142.56 10.73 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.967 1.509 . . . . 0.0 109.939 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -91.76 158.37 40.22 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.149 -0.969 . . . . 0.0 110.261 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.36 59.48 6.09 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.883 1.465 . . . . 0.0 110.12 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.06 134.1 42.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 110.499 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.72 -8.11 25.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 110.071 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 66' ' ' THR . . . -91.97 -16.96 25.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 0.0 110.869 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 66' ' ' THR . 40.4 t -78.87 165.61 23.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.902 -1.124 . . . . 0.0 110.18 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HE3' ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -101.21 -12.18 18.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.166 -0.959 . . . . 0.0 112.11 -178.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 82' ' ' ILE . 37.1 mm 25.11 51.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.155 0.502 . . . . 0.0 110.979 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 85' ' ' CYS . 0.4 OUTLIER -117.76 -141.75 0.36 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.178 -0.951 . . . . 0.0 111.375 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -59.35 83.5 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 6.0 t -177.96 178.37 0.96 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.11 . . . . 0.0 109.543 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.533 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -179.16 156.75 0.79 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.04 . . . . 0.0 110.491 -179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.697 ' CD2' HG21 ' A' ' 69' ' ' ILE . 2.3 m-85 -123.25 164.44 18.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -0.855 . . . . 0.0 110.287 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.747 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -142.21 12.58 1.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.841 . . . . 0.0 109.585 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 72.5 0.02 3.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 110.358 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.539 ' CA ' ' HB2' ' A' ' 56' ' ' ARG . 3.3 p30 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.444 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 2' ' ' GLY . 24.8 p-10 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.071 0.463 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.47 ' N ' ' OD1' ' A' ' 1' ' ' ASP . . . -136.52 20.53 3.49 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m 50.37 29.31 3.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -1.125 . . . . 0.0 110.326 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.3 m -78.26 131.86 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 110.324 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.894 HG23 ' HB3' ' A' ' 9' ' ' SER . 20.6 m -117.12 -16.35 10.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.098 -1.001 . . . . 0.0 110.344 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.521 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 13.8 p30 35.76 50.8 0.65 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.964 -1.085 . . . . 0.0 111.196 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 4.2 m 73.03 4.37 4.93 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.412 -0.805 . . . . 0.0 112.067 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.642 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.2 t-20 -171.06 -48.87 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.724 -1.235 . . . . 0.0 110.772 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.894 ' HB3' HG23 ' A' ' 5' ' ' THR . 3.5 p 92.71 86.23 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.613 0.721 . . . . 0.0 111.646 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.558 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -130.66 14.59 5.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.148 -0.97 . . . . 0.0 108.448 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.681 HD12 ' HB ' ' A' ' 27' ' ' VAL . 9.9 tp -40.48 117.48 0.81 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.801 -0.562 . . . . 0.0 110.017 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.545 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -37.73 158.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.725 -0.609 . . . . 0.0 110.342 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.8 -6.96 13.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -0.987 . . . . 0.0 110.583 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -138.61 23.78 2.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.096 -1.003 . . . . 0.0 110.914 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.607 ' OG ' HG12 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -84.67 -159.56 0.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.009 -1.057 . . . . 0.0 110.33 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 4.8 tttp -155.95 152.58 28.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.889 . . . . 0.0 110.362 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 29.9 p -164.63 56.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 110.155 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 11.3 tp10 -88.65 111.57 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 110.386 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 4.6 tttp 67.63 56.3 0.58 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.273 -0.892 . . . . 0.0 110.429 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.66 ' HB2' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -136.86 166.49 23.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.1 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 36' ' ' THR . 3.1 m -113.55 101.97 9.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.869 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.831 HD22 ' N ' ' A' ' 22' ' ' LEU . 1.7 mm? -107.16 147.77 29.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 110.639 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 17.9 m -148.15 109.8 4.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.354 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 6' ' ' ASN . 1.1 m120 60.73 56.99 2.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.186 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' O ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -109.47 -169.12 1.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.191 0.996 . . . . 0.0 111.582 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 26' ' ' TYR . 52.6 t80 -173.26 34.68 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.681 ' HB ' HD12 ' A' ' 11' ' ' LEU . 12.1 t -33.16 142.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.532 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.545 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -143.5 121.5 12.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.525 -0.734 . . . . 0.0 109.867 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.429 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER 53.35 38.77 28.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.318 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.979 ' OG ' HG22 ' A' ' 45' ' ' VAL . 21.0 m -132.1 179.31 6.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.095 -1.003 . . . . 0.0 110.641 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG2' ' HD2' ' A' ' 16' ' ' LYS . 2.8 tt0 -119.94 -64.2 1.29 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.377 -0.827 . . . . 0.0 110.556 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.834 HG22 ' CG2' ' A' ' 47' ' ' ILE . 11.7 t 62.05 150.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.831 . . . . 0.0 110.004 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.551 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 19.3 m-85 -142.35 -47.43 0.34 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.059 -1.026 . . . . 0.0 110.803 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -132.59 20.32 4.39 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.533 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 8.6 m -66.68 154.91 39.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -1.18 . . . . 0.0 110.277 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 21' ' ' THR . 5.7 m -95.86 -21.46 18.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.547 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 11.9 t 48.86 76.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.805 . . . . 0.0 110.961 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.4 m -80.23 73.5 7.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 109.1 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 66.08 49.88 55.3 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.0 OUTLIER -135.92 -178.08 4.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.266 -1.138 . . . . 0.0 110.018 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -153.4 176.4 12.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.034 -1.042 . . . . 0.0 110.56 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.598 ' CE2' HG21 ' A' ' 47' ' ' ILE . 52.7 m-85 -123.18 -170.15 2.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.006 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 58' ' ' SER . 9.8 t70 -178.35 63.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.773 . . . . 0.0 109.67 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 99.65 60.02 0.86 Allowed Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.979 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.4 m -137.37 -159.53 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.95 -1.324 . . . . 0.0 111.324 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.621 ' N ' HG23 ' A' ' 45' ' ' VAL . 85.4 m -166.89 57.81 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.834 ' CG2' HG22 ' A' ' 32' ' ' VAL . 12.4 tt -83.7 171.65 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.47 -0.769 . . . . 0.0 111.088 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.551 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 22.4 p -135.51 -134.03 0.15 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' THR . 23.1 m -66.12 89.9 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.737 -1.227 . . . . 0.0 109.758 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.684 ' CB ' HD11 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -132.13 139.05 48.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.012 -1.055 . . . . 0.0 110.495 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.567 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 1.3 m -85.5 21.45 1.79 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 111.056 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 89.9 p -37.18 122.01 0.84 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.465 -0.772 . . . . 0.0 110.803 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 2.6 m -112.02 111.13 21.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.136 -0.978 . . . . 0.0 109.973 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 51.55 79.85 0.07 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 8.0 p -155.51 122.63 5.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -1.165 . . . . 0.0 110.528 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' CA ' ' A' ' 90' ' ' ASN . 36.9 ttt85 -75.97 103.85 6.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 109.675 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.53 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 18.1 mm -83.29 12.67 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 0.0 110.358 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.535 ' CB ' ' HB3' ' A' ' 43' ' ' ASP . 42.9 p -42.71 162.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.347 -0.846 . . . . 0.0 110.716 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 150.67 163.04 11.01 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -75.8 57.44 5.06 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.935 1.492 . . . . 0.0 109.844 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 106.43 21.82 8.15 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 1.8 t -38.96 126.57 1.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.662 -0.905 . . . . 0.0 110.649 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.487 ' N ' ' SG ' ' A' ' 85' ' ' CYS . 35.4 ttpt -115.08 140.47 49.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.053 -1.029 . . . . 0.0 110.593 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.973 HD13 ' HE2' ' A' ' 81' ' ' LYS . 25.4 mm -143.34 145.72 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.24 -0.912 . . . . 0.0 109.844 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.469 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 1.1 m -147.99 126.13 12.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.057 -1.027 . . . . 0.0 110.043 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.5 m 41.57 59.61 2.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 110.392 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.591 ' SG ' HD11 ' A' ' 69' ' ' ILE . 5.1 t -123.95 109.95 14.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.819 . . . . 0.0 109.532 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.567 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 1.9 mp -55.65 -64.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.979 -1.076 . . . . 0.0 109.697 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.591 HD11 ' SG ' ' A' ' 67' ' ' CYS . 8.1 mt 54.88 162.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.48 -0.763 . . . . 0.0 110.787 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.541 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 9.0 m -146.33 -121.78 0.07 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.83 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.781 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -65.18 77.5 0.08 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 58.54 16.73 30.45 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 71' ' ' GLY . 33.8 m -121.91 141.05 33.2 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.472 -1.017 . . . . 0.0 110.544 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 73' ' ' VAL . 49.1 Cg_endo -85.11 128.28 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.943 1.496 . . . . 0.0 110.133 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.82 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -83.56 174.65 5.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 110.081 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.82 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 43.0 Cg_endo -70.72 59.12 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.942 1.496 . . . . 0.0 110.106 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -88.09 112.93 23.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.382 -0.824 . . . . 0.0 110.223 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.32 -4.95 20.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.323 -0.86 . . . . 0.0 110.347 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.07 -31.85 8.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.52 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 43.1 t -46.36 166.3 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.169 -0.957 . . . . 0.0 109.836 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.973 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -108.15 -41.19 4.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.043 -1.035 . . . . 0.0 111.43 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.714 HG22 ' O ' ' A' ' 82' ' ' ILE . 19.0 mm 49.25 62.13 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.816 -1.177 . . . . 0.0 109.615 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.401 ' H ' ' NZ ' ' A' ' 81' ' ' LYS . 23.2 t -109.33 -73.19 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 110.815 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.43 67.79 0.54 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -134.53 -153.0 0.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -1.151 . . . . 0.0 110.009 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.566 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.2 t 176.91 143.21 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.566 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -128.24 153.06 47.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.55 -0.719 . . . . 0.0 109.158 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.74 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 1.3 m -140.95 12.17 2.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.978 . . . . 0.0 109.758 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.74 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 72.07 0.13 3.44 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.443 -0.786 . . . . 0.0 110.201 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.533 ' CA ' ' HB2' ' A' ' 56' ' ' ARG . 2.7 p30 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.013 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.285 0.565 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.6 67.46 0.53 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 t 49.21 95.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.331 -1.1 . . . . 0.0 110.445 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.4 p -159.33 160.03 34.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.096 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.762 ' O ' HG22 ' A' ' 5' ' ' THR . 30.6 m -154.1 25.89 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 109.427 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 5' ' ' THR . 0.2 OUTLIER 65.85 -61.84 0.26 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.673 0.749 . . . . 0.0 108.992 -179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 5' ' ' THR . 25.1 m -161.86 -38.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 177.21 32.94 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.657 -0.652 . . . . 0.0 109.45 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 13.4 m -111.78 -107.07 0.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.855 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.599 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 3.9 pt20 -140.39 -43.56 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.863 -1.148 . . . . 0.0 111.511 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' N ' ' CG ' ' A' ' 10' ' ' GLN . 16.5 tp 47.68 81.77 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.015 -1.053 . . . . 0.0 108.934 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -44.44 149.93 0.35 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.368 -0.832 . . . . 0.0 110.25 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.91 -10.1 12.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.858 . . . . 0.0 110.076 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.509 ' ND2' ' HG2' ' A' ' 29' ' ' LYS . 50.7 t-20 -90.18 -7.77 52.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.152 -0.968 . . . . 0.0 110.268 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 30' ' ' SER . 32.1 t -80.42 -157.61 0.16 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.067 -1.02 . . . . 0.0 110.099 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.516 ' CE ' ' OH ' ' A' ' 33' ' ' TYR . 12.5 tttt -135.74 140.17 44.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.079 -1.013 . . . . 0.0 110.088 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.0 m -113.41 137.35 51.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 110.291 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.8 -129.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.931 . . . . 0.0 110.246 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.63 19.55 15.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.817 -1.177 . . . . 0.0 110.667 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.525 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -58.98 167.49 1.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.049 -1.032 . . . . 0.0 109.865 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.804 ' C ' HD23 ' A' ' 22' ' ' LEU . 1.6 t -140.24 97.13 3.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.019 -1.051 . . . . 0.0 109.985 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.804 HD23 ' C ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -131.45 -165.56 1.59 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.431 -0.793 . . . . 0.0 110.139 -179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 98.2 m -166.94 142.03 4.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.351 -0.843 . . . . 0.0 110.363 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.472 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 4.2 m120 45.88 36.83 3.1 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.369 -0.832 . . . . 0.0 110.697 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.501 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.7 OUTLIER -78.83 -154.34 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.091 -1.006 . . . . 0.0 110.683 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' CE1' ' HB3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER 176.26 40.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.491 HG13 ' HD2' ' A' ' 42' ' ' PHE . 40.3 t -52.78 153.92 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.984 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.7 OUTLIER -158.83 129.14 5.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.476 -0.765 . . . . 0.0 110.138 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HG2' ' ND2' ' A' ' 14' ' ' ASN . 4.7 mtmp? 50.78 34.53 10.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.233 -0.917 . . . . 0.0 110.37 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 15' ' ' SER . 49.3 m -124.47 -161.13 0.98 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 110.499 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 3.5 tt0 -138.2 -63.13 0.56 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.513 -0.742 . . . . 0.0 110.089 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.562 HG22 ' CG2' ' A' ' 47' ' ' ILE . 15.9 t 61.16 156.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 110.211 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.516 ' OH ' ' CE ' ' A' ' 16' ' ' LYS . 9.9 m-85 -153.95 -39.11 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.199 -0.938 . . . . 0.0 110.477 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.2 34.07 1.66 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 37' ' ' CYS . 1.1 m -79.27 158.33 27.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.397 -1.061 . . . . 0.0 110.73 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -111.52 50.23 0.85 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.96 179.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.584 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 3.5 t -40.82 121.38 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.266 -0.896 . . . . 0.0 111.012 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.485 ' O ' HG22 ' A' ' 38' ' ' THR . 24.1 m -113.66 22.86 13.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 109.269 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 122.85 41.56 0.44 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.41 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -115.52 -159.29 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -1.178 . . . . 0.0 110.372 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 26' ' ' TYR . 28.4 ttt180 -166.88 145.06 5.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.914 . . . . 0.0 110.701 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.491 ' HD2' HG13 ' A' ' 27' ' ' VAL . 10.1 m-85 -115.16 172.39 7.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.0 109.301 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.54 42.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.921 -1.112 . . . . 0.0 110.407 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 127.0 57.5 0.13 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 1.0 OUTLIER -136.34 -171.16 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.269 -1.136 . . . . 0.0 110.997 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 46' ' ' THR . 87.9 m -152.89 58.2 0.79 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.562 ' CG2' HG22 ' A' ' 32' ' ' VAL . 9.7 tt -81.3 169.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.245 -0.909 . . . . 0.0 110.14 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 50' ' ' SER . 58.9 p -146.09 -139.7 0.1 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.048 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 66' ' ' THR . 51.9 m -52.94 91.48 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.233 -0.987 . . . . 0.0 109.07 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 48' ' ' THR . 2.4 m -152.96 143.72 22.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.155 -0.966 . . . . 0.0 110.286 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -98.66 135.32 40.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 59.9 p -155.64 130.88 9.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.33 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 71' ' ' GLY . 11.5 m -111.85 112.94 24.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.103 -0.998 . . . . 0.0 109.82 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.7 86.41 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 79.6 p -154.74 112.25 3.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -1.144 . . . . 0.0 110.514 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 4.1 ttt180 -67.03 118.6 10.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 109.66 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.523 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 26.8 mm -97.82 11.18 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.119 -0.988 . . . . 0.0 110.831 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -40.7 145.34 0.19 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.203 -0.936 . . . . 0.0 110.34 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 175.12 145.85 5.54 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -80.18 1.34 9.33 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.038 1.547 . . . . 0.0 109.629 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -178.06 33.23 0.07 OUTLIER Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.508 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -60.74 152.73 26.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.535 -0.979 . . . . 0.0 110.804 -179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -156.95 113.93 3.07 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.653 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.0 mt -118.9 148.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.067 -1.021 . . . . 0.0 110.862 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.51 117.14 5.41 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.0 OUTLIER 51.21 71.14 0.46 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.101 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 50' ' ' SER . 60.5 m -139.11 111.04 7.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.447 -0.783 . . . . 0.0 110.478 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -77.92 137.06 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.946 -1.096 . . . . 0.0 109.42 179.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.641 HG23 ' C ' ' A' ' 73' ' ' VAL . 9.3 mt -146.51 158.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.079 -1.013 . . . . 0.0 110.309 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.74 ' O ' HG22 ' A' ' 73' ' ' VAL . 5.7 m -156.39 99.0 1.88 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.04 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.835 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 91.51 20.67 37.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.525 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 88.29 15.55 60.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 70' ' ' THR . 4.1 m -124.3 132.87 24.35 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.476 -1.014 . . . . 0.0 109.507 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.36 144.93 23.47 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.59 1.311 . . . . 0.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.82 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -99.17 176.02 2.17 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.82 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 47.6 Cg_endo -73.15 102.6 1.48 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.94 1.495 . . . . 0.0 110.635 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 1.1 t -119.04 -23.52 6.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.0 110.34 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 61.15 12.35 4.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.255 -0.903 . . . . 0.0 109.966 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.7 -15.27 1.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.311 -0.868 . . . . 0.0 110.998 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 33.1 t -62.89 168.48 3.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.968 -1.082 . . . . 0.0 110.406 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HD2' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.99 -35.29 8.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.981 -1.074 . . . . 0.0 111.826 -178.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.489 ' N ' ' HE2' ' A' ' 81' ' ' LYS . 32.4 mm 43.66 60.26 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.093 -1.004 . . . . 0.0 109.35 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 85' ' ' CYS . 46.5 m -114.95 -130.11 0.31 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.31 -0.869 . . . . 0.0 110.594 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -65.12 66.05 0.08 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.653 ' SG ' HD11 ' A' ' 64' ' ' ILE . 5.0 t -160.94 -175.99 5.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.023 -1.281 . . . . 0.0 109.854 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.562 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 2.0 t -179.09 160.67 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.117 -0.989 . . . . 0.0 110.745 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -127.92 155.08 44.76 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.32 -0.863 . . . . 0.0 109.431 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.91 24.91 1.46 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.047 -1.033 . . . . 0.0 110.313 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.835 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 52.84 85.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 109.944 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.035 -1.04 . . . . 0.0 110.365 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.353 0.597 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.43 123.33 0.65 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -55.99 -60.92 2.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -1.159 . . . . 0.0 110.022 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' O ' ' OG1' ' A' ' 5' ' ' THR . 14.3 m 56.67 -147.38 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 110.425 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 8' ' ' ASN . 1.3 m 178.91 -29.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.612 ' ND2' ' HB2' ' A' ' 25' ' ' CYS . 0.1 OUTLIER 62.91 55.42 2.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.38 1.086 . . . . 0.0 108.257 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.469 HG21 HG23 ' A' ' 23' ' ' THR . 1.8 m 63.66 -63.81 0.13 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.473 -1.392 . . . . 0.0 108.912 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.637 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.6 OUTLIER -73.16 -88.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.637 ' CB ' ' O ' ' A' ' 8' ' ' ASN . 2.5 p 152.93 58.4 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 122.124 -0.36 . . . . 0.0 111.678 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 22.6 mt-30 -140.69 16.56 2.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.312 -1.493 . . . . 0.0 110.538 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.782 HD11 ' OG ' ' A' ' 15' ' ' SER . 8.7 tp -62.96 81.89 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 10' ' ' GLN . 97.9 p -30.62 134.16 0.06 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.529 0.681 . . . . 0.0 111.93 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -49.33 -22.51 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.384 -0.822 . . . . 0.0 109.81 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 61.4 t-20 -80.99 -10.28 59.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.473 -0.767 . . . . 0.0 110.086 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.782 ' OG ' HD11 ' A' ' 11' ' ' LEU . 45.6 t -79.38 -171.62 2.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.131 -0.98 . . . . 0.0 109.757 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.89 163.79 17.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.105 -0.997 . . . . 0.0 109.612 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.491 ' SG ' HD23 ' A' ' 11' ' ' LEU . 6.4 m -134.66 -29.29 1.19 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.066 -1.022 . . . . 0.0 111.191 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' LYS . 10.4 tp10 -43.45 118.22 1.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.07 -1.018 . . . . 0.0 110.244 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 52.83 108.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.451 -0.781 . . . . 0.0 110.552 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 5.9 p 178.69 146.69 0.16 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.048 -1.032 . . . . 0.0 110.899 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -139.14 84.08 1.98 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.432 -0.792 . . . . 0.0 109.529 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 38.9 mt -101.91 -174.42 2.58 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.834 0.826 . . . . 0.0 111.267 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.539 HG22 HD22 ' A' ' 24' ' ' ASN . 91.7 m -164.42 125.02 2.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.637 -0.665 . . . . 0.0 109.298 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.539 HD22 HG22 ' A' ' 23' ' ' THR . 56.9 m-80 51.07 66.47 1.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 0.0 108.878 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.612 ' HB2' ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -123.78 169.91 11.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.78 0.8 . . . . 0.0 110.471 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.637 ' HA ' ' HB3' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -147.0 34.33 0.91 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 179.002 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.868 HG13 ' HD2' ' A' ' 42' ' ' PHE . 7.6 t -30.52 147.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.587 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.522 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 0.5 OUTLIER -150.47 123.31 8.68 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 9.8 mmmt 48.04 56.26 7.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.153 -0.967 . . . . 0.0 109.34 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.574 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 14.7 m -143.25 171.69 13.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.963 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.648 ' OE1' HG23 ' A' ' 46' ' ' THR . 1.4 tt0 -115.06 -68.88 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.382 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.53 HG23 ' C ' ' A' ' 31' ' ' GLU . 3.1 t 67.15 143.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.327 -0.858 . . . . 0.0 110.383 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CD1' HG22 ' A' ' 48' ' ' THR . 45.2 m-85 -137.62 -52.71 0.65 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.337 -0.852 . . . . 0.0 110.674 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.452 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -129.46 18.88 5.42 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.525 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.2 m -69.75 153.69 43.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -1.167 . . . . 0.0 110.216 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.2 m -111.95 58.24 0.63 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.462 -0.774 . . . . 0.0 109.594 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 52.8 t -36.87 137.77 0.3 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.609 -0.682 . . . . 0.0 111.01 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 95.2 m -137.85 74.34 1.48 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.468 -0.77 . . . . 0.0 109.461 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.48 57.43 3.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.412 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -147.08 178.57 8.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.159 -1.201 . . . . 0.0 110.177 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 42' ' ' PHE . 4.0 ttt180 -150.65 153.02 34.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.302 -0.874 . . . . 0.0 110.176 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.868 ' HD2' HG13 ' A' ' 27' ' ' VAL . 8.1 m-85 -116.04 -176.2 2.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -0.995 . . . . 0.0 110.566 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.522 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.9 t0 -170.09 50.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 110.179 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 118.44 61.36 0.28 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -140.98 -168.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.914 -1.345 . . . . 0.0 110.6 -179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 46' ' ' THR . 91.6 m -160.73 53.25 0.3 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.62 -0.675 . . . . 0.0 109.908 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 19.8 tt -73.54 169.45 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.783 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 50' ' ' SER . 71.9 p -138.21 -139.71 0.14 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.206 -0.934 . . . . 0.0 109.666 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 31.3 m -58.33 80.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.74 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' THR . 28.5 t -141.55 140.33 33.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.174 -0.954 . . . . 0.0 110.454 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -83.49 131.47 35.01 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.221 -0.924 . . . . 0.0 109.916 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 2.9 t -151.86 128.67 10.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.939 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.598 ' OG1' HG23 ' A' ' 70' ' ' THR . 36.8 p -128.22 110.62 12.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.978 . . . . 0.0 110.212 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.41 84.03 0.13 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 p -161.37 127.87 3.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.28 -1.13 . . . . 0.0 110.658 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' CD ' ' HB2' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.55 103.27 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 7.4 mm -85.07 10.78 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.083 -1.011 . . . . 0.0 110.498 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -36.02 142.77 0.07 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.457 -0.777 . . . . 0.0 110.727 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 176.85 146.09 5.96 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.739 -1.22 . . . . 0.0 110.313 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.77 -8.31 17.95 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.965 1.508 . . . . 0.0 110.051 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.48 39.23 0.12 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.505 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -56.15 159.42 3.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.525 -0.985 . . . . 0.0 111.37 -179.063 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 27.5 tttt -161.08 98.71 1.18 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.694 -0.629 . . . . 0.0 109.347 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.791 HD11 ' SG ' ' A' ' 85' ' ' CYS . 12.8 mt -117.82 163.41 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.242 -0.911 . . . . 0.0 110.671 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 67' ' ' CYS . 0.9 OUTLIER -145.47 -163.35 1.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.405 -0.809 . . . . 0.0 110.155 179.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.0 m -33.36 85.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.603 ' C ' HD12 ' A' ' 68' ' ' ILE . 44.4 t -138.38 139.52 39.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.515 -0.741 . . . . 0.0 109.107 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.6 mp -97.22 82.73 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 120.884 -1.135 . . . . 0.0 108.704 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.59 HG23 ' C ' ' A' ' 73' ' ' VAL . 13.1 mt -90.85 154.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.67 -0.644 . . . . 0.0 110.328 -178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.732 ' O ' HG22 ' A' ' 73' ' ' VAL . 52.8 m -162.01 98.82 1.08 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.174 -0.954 . . . . 0.0 110.597 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.767 ' O ' HG13 ' A' ' 73' ' ' VAL . . . 94.39 39.98 4.61 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.561 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 65.32 24.02 70.4 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 71' ' ' GLY . 6.1 m -129.24 129.2 23.3 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.485 -1.009 . . . . 0.0 110.893 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HB2' HD11 ' A' ' 82' ' ' ILE . 46.4 Cg_endo -83.58 131.89 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.922 1.486 . . . . 0.0 110.228 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -79.04 150.85 75.37 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.002 -1.061 . . . . 0.0 110.057 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.56 58.47 1.94 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.118 1.588 . . . . 0.0 110.683 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.48 150.48 22.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 110.235 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.24 -10.96 55.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.926 . . . . 0.0 109.962 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 80' ' ' CYS . . . -112.66 -31.6 6.7 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.92 . . . . 0.0 111.002 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.546 ' HA ' ' HB2' ' A' ' 67' ' ' CYS . 13.0 t -44.53 137.06 3.94 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.945 -1.097 . . . . 0.0 110.141 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.548 ' C ' HD12 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -110.28 164.88 12.23 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 111.49 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.798 HG22 ' O ' ' A' ' 82' ' ' ILE . 1.0 OUTLIER -161.59 75.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.6 m -112.08 -86.55 0.56 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 0.0 110.56 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -104.79 65.91 0.3 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.791 ' SG ' HD11 ' A' ' 64' ' ' ILE . 4.4 t -162.48 -175.49 4.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -1.189 . . . . 0.0 110.26 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.559 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.5 t 179.81 158.87 0.73 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.288 -0.882 . . . . 0.0 110.108 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.3 OUTLIER -123.22 154.35 38.88 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 89' ' ' ALA . 2.7 m -134.96 32.67 3.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 109.591 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 88' ' ' SER . . . 37.87 72.01 0.14 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.757 -0.589 . . . . 0.0 110.199 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.452 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.307 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 2' ' ' GLY . 7.5 t0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.317 0.579 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 1' ' ' ASP . . . -56.57 -161.29 0.02 OUTLIER Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 t -125.14 48.48 2.01 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.314 -1.109 . . . . 0.0 110.839 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.8 173.73 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.181 -0.949 . . . . 0.0 111.034 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.535 ' O ' ' CG2' ' A' ' 5' ' ' THR . 1.2 m -136.19 5.37 3.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.496 -0.753 . . . . 0.0 109.321 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.87 ' ND2' HD12 ' A' ' 22' ' ' LEU . 0.7 OUTLIER 50.93 69.43 0.64 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.182 -0.949 . . . . 0.0 109.165 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.872 HG21 ' HA ' ' A' ' 23' ' ' THR . 1.5 p 63.8 -56.15 0.21 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.193 -0.942 . . . . 0.0 110.648 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.551 ' N ' ' O ' ' A' ' 6' ' ' ASN . 1.2 t-20 177.11 64.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.918 -1.113 . . . . 0.0 110.162 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.7 m -131.2 -121.98 0.21 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.919 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.538 ' CG ' ' N ' ' A' ' 11' ' ' LEU . 1.4 pt20 -131.08 -41.55 1.12 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.855 -1.153 . . . . 0.0 109.895 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.656 HD12 ' HB ' ' A' ' 27' ' ' VAL . 18.1 tp 43.46 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.549 -0.719 . . . . 0.0 110.149 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -37.91 150.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.693 -0.63 . . . . 0.0 110.451 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.03 -24.98 67.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 110.24 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.408 ' ND2' ' C ' ' A' ' 14' ' ' ASN . 0.6 OUTLIER -103.93 6.26 36.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 111.129 -179.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.496 ' OG ' HD11 ' A' ' 11' ' ' LEU . 28.8 t -69.21 -154.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.16 . . . . 0.0 109.391 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.545 ' CD ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -140.69 150.71 43.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.091 -1.006 . . . . 0.0 110.528 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.491 ' SG ' ' N ' ' A' ' 18' ' ' GLU . 7.8 t -135.99 -92.18 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.233 -0.917 . . . . 0.0 109.779 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.491 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 13.2 mt-10 38.05 -125.68 0.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.412 -0.805 . . . . 0.0 110.844 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 20' ' ' SER . 10.4 tptt -66.98 123.55 20.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.956 -1.09 . . . . 0.0 110.356 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.533 ' HB2' ' CD2' ' A' ' 22' ' ' LEU . 10.3 p 175.94 172.68 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 110.115 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 21' ' ' THR . 1.8 t -154.04 76.41 1.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.36 -0.837 . . . . 0.0 109.56 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.87 HD12 ' ND2' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -114.48 -170.56 1.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.793 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.872 ' HA ' HG21 ' A' ' 7' ' ' THR . 3.9 m -164.89 124.94 1.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.434 -0.791 . . . . 0.0 109.849 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 23' ' ' THR . 3.6 m120 57.17 33.38 23.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 110.713 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' O ' ' CG ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -64.31 -141.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.754 -1.216 . . . . 0.0 109.929 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' CG ' ' O ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER 166.34 45.82 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -179.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.687 HG13 ' HB2' ' A' ' 30' ' ' SER . 8.0 t -66.96 140.45 19.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.762 0.791 . . . . 0.0 111.715 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.9 t0 -123.05 -14.03 7.66 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.429 0.633 . . . . 0.0 109.728 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.527 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER 179.99 67.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.98 ' OG ' HG22 ' A' ' 45' ' ' VAL . 14.8 m -147.26 151.31 36.44 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.176 -0.953 . . . . 0.0 111.442 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' HG3' ' CD ' ' A' ' 16' ' ' LYS . 6.5 tt0 -107.49 101.23 10.59 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 18.0 t -99.2 174.32 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.237 -0.915 . . . . 0.0 110.379 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.531 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 47.1 m-85 -149.16 -32.0 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.193 -0.942 . . . . 0.0 111.391 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -164.48 26.79 0.2 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 50' ' ' SER . 0.9 OUTLIER -76.99 144.94 38.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.137 . . . . 0.0 110.398 -179.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -91.13 60.04 4.16 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.417 -0.802 . . . . 0.0 110.501 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 22' ' ' LEU . 2.0 t -47.04 97.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.0 110.157 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.84 HG21 HG23 ' A' ' 53' ' ' THR . 1.7 t -85.91 31.88 0.61 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.071 -1.018 . . . . 0.0 110.445 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.42 27.83 4.01 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 16.0 t -94.06 -163.09 1.0 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.384 -1.068 . . . . 0.0 110.229 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.509 ' HB2' ' CB ' ' A' ' 26' ' ' TYR . 2.7 ttp180 -165.73 144.69 6.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.396 -0.815 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.65 ' CE1' HD13 ' A' ' 57' ' ' ILE . 2.9 m-85 -119.45 -172.44 2.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.971 -1.081 . . . . 0.0 110.227 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.22 55.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 110.204 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 115.29 54.64 0.37 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.274 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.98 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.1 m -133.6 -169.66 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.732 -1.452 . . . . 0.0 111.325 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.478 ' N ' HG23 ' A' ' 45' ' ' VAL . 33.5 m -151.89 60.01 0.86 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.583 HG12 ' HG ' ' A' ' 50' ' ' SER . 14.6 tt -81.14 -179.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.751 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.531 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -139.77 -89.82 0.19 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.789 -1.195 . . . . 0.0 110.195 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.744 HG22 ' O ' ' A' ' 49' ' ' THR . 5.9 m -114.3 74.35 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.022 -1.049 . . . . 0.0 110.451 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.583 ' HG ' HG12 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -114.53 152.34 31.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.144 -0.973 . . . . 0.0 111.413 -179.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.429 ' H ' ' HA ' ' A' ' 68' ' ' ILE . 1.5 m -99.79 27.91 5.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.462 -0.773 . . . . 0.0 111.085 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' ILE . 1.4 p -40.92 136.62 1.41 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.187 -0.946 . . . . 0.0 110.893 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.84 HG23 HG21 ' A' ' 38' ' ' THR . 87.2 m -126.17 87.58 2.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.45 65.88 1.93 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.8 p -145.91 123.11 11.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.448 -1.031 . . . . 0.0 109.844 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER -76.68 102.22 6.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.551 -0.718 . . . . 0.0 110.75 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.65 HD13 ' CE1' ' A' ' 42' ' ' PHE . 3.1 mp -85.37 15.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.988 -1.07 . . . . 0.0 110.217 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.9 p -47.15 161.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.337 -0.852 . . . . 0.0 110.968 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 155.24 154.29 6.86 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -74.41 -0.84 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.825 1.434 . . . . 0.0 110.098 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.31 29.83 0.07 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 1.3 t -52.28 114.55 1.38 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.451 -1.029 . . . . 0.0 110.491 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -110.57 130.22 55.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 109.981 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.829 HG23 ' HD2' ' A' ' 81' ' ' LYS . 41.0 mt -140.95 147.89 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.073 -1.017 . . . . 0.0 110.587 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.492 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -140.53 108.87 5.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 110.64 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 49' ' ' THR . 5.9 m 50.33 71.86 0.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.522 -0.736 . . . . 0.0 112.027 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.532 ' SG ' ' CG1' ' A' ' 69' ' ' ILE . 43.9 t -132.81 112.31 11.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.359 -0.838 . . . . 0.0 109.235 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.7 mp -47.25 -68.4 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.556 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.532 ' CG1' ' SG ' ' A' ' 67' ' ' CYS . 27.3 mt 63.42 155.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.306 -0.871 . . . . 0.0 110.171 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.528 ' HB ' HG23 ' A' ' 73' ' ' VAL . 12.4 m -147.73 -115.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.318 -0.864 . . . . 0.0 110.279 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.51 ' C ' HG22 ' A' ' 73' ' ' VAL . . . -74.06 81.69 0.78 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.6 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 54.46 19.82 14.45 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.528 HG23 ' HB ' ' A' ' 70' ' ' THR . 4.3 m -125.64 133.91 25.34 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.611 -0.935 . . . . 0.0 110.138 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 48.3 Cg_endo -82.84 129.99 5.67 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.59 1.311 . . . . 0.0 110.373 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.508 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -95.36 150.55 37.73 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 110.345 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.62 144.14 35.2 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.063 1.559 . . . . 0.0 110.375 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.454 ' HB2' HD13 ' A' ' 68' ' ' ILE . 23.3 t -165.93 24.36 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.138 -0.977 . . . . 0.0 110.559 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 44.51 27.39 0.23 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.012 -1.055 . . . . 0.0 110.061 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.44 -34.43 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.898 . . . . 0.0 110.796 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 1.7 t -50.82 145.35 7.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.012 -1.055 . . . . 0.0 110.731 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.829 ' HD2' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -97.35 167.52 10.96 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.668 -0.645 . . . . 0.0 109.606 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.719 HG22 ' O ' ' A' ' 82' ' ' ILE . 29.9 mm -154.59 60.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.967 -1.083 . . . . 0.0 109.714 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.5 m -98.35 -116.94 0.14 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 111.009 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.39 83.41 0.54 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -141.72 -165.05 1.91 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.235 -1.156 . . . . 0.0 109.504 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.8 t -175.83 145.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.953 -1.092 . . . . 0.0 110.267 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.6 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 2.0 m-85 -111.71 -67.76 0.98 Allowed 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.153 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER 69.66 11.84 7.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 0.0 110.4 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 48.13 91.99 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.169 -0.957 . . . . 0.0 109.867 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.417 -179.392 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 8.9 m-20 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.009 0.433 . . . . 0.0 109.855 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.11 -148.51 19.93 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.63 134.87 50.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -1.084 . . . . 0.0 110.508 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.6 ' O ' ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -132.65 -29.35 1.53 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.096 -1.002 . . . . 0.0 111.023 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 4' ' ' CYS . 92.7 m 65.96 7.58 4.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.3 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.535 ' H ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER 67.31 -59.31 0.4 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.504 ' N ' ' CG ' ' A' ' 6' ' ' ASN . 21.3 m -162.17 -37.8 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.59 42.21 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.462 -0.774 . . . . 0.0 109.916 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 25' ' ' CYS . 97.7 p -129.2 -74.92 0.55 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.03 -1.044 . . . . 0.0 110.951 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.427 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -161.58 -57.75 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.917 -1.115 . . . . 0.0 111.198 -179.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.885 HD11 ' OG ' ' A' ' 15' ' ' SER . 19.2 tp 52.61 89.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.118 -0.989 . . . . 0.0 108.958 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -41.08 141.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.573 -0.704 . . . . 0.0 110.509 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.39 -17.11 4.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 110.458 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 17.5 p30 -94.01 -8.89 38.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 110.885 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.885 ' OG ' HD11 ' A' ' 11' ' ' LEU . 1.1 t -66.78 -174.59 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.858 -1.151 . . . . 0.0 109.213 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -122.39 159.88 26.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 110.252 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.3 t -151.79 111.97 4.09 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -175.43 125.1 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.804 . . . . 0.0 109.798 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt 51.74 55.32 9.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 109.754 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.491 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -140.35 161.97 36.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.0 110.719 -179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 36' ' ' THR . 2.9 t -135.43 61.77 1.65 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 109.248 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 22' ' ' LEU . 3.0 mt -74.26 176.96 6.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.448 -0.783 . . . . 0.0 111.167 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 24' ' ' ASN . 3.1 m -164.13 118.86 1.49 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.468 -0.77 . . . . 0.0 109.841 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.535 ' O ' ' N ' ' A' ' 39' ' ' GLY . 27.3 m120 50.43 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.337 -0.852 . . . . 0.0 109.646 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -157.81 -160.38 0.91 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.59 -1.318 . . . . 0.0 110.913 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.512 ' CG ' ' O ' ' A' ' 26' ' ' TYR . 13.8 t80 -164.29 34.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.789 ' HB ' HD12 ' A' ' 11' ' ' LEU . 5.0 t -33.05 151.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.536 0.684 . . . . 0.0 110.783 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 1.3 t70 -153.21 118.78 5.27 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 44' ' ' GLY . 6.4 mtpm? 48.11 72.88 0.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.422 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 45.3 m -157.71 157.92 34.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.973 -1.079 . . . . 0.0 111.095 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 3.8 mt-10 -120.58 119.75 33.82 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.567 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 46.9 t -123.04 156.32 28.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.101 -0.999 . . . . 0.0 110.623 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.54 ' CD2' ' O ' ' A' ' 32' ' ' VAL . 48.2 m-85 -154.42 32.14 0.42 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.186 -0.946 . . . . 0.0 111.223 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 162.28 -31.2 0.3 Allowed Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.669 HG22 ' H ' ' A' ' 37' ' ' CYS . 19.3 m -38.66 162.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.516 -0.991 . . . . 0.0 111.541 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -104.65 -13.43 15.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.4 -0.812 . . . . 0.0 110.648 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.669 ' H ' HG22 ' A' ' 35' ' ' THR . 0.1 OUTLIER 38.59 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.266 -0.896 . . . . 0.0 110.932 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 99.5 m -105.09 94.31 5.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.122 -0.986 . . . . 0.0 109.975 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 48.25 26.73 4.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.514 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 0.7 OUTLIER -104.79 -166.09 1.2 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.175 -1.191 . . . . 0.0 110.361 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HG2' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -164.85 155.57 14.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 110.388 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.788 ' HD2' HG13 ' A' ' 27' ' ' VAL . 7.4 m-85 -120.62 -175.06 2.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.338 -0.851 . . . . 0.0 109.403 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -165.95 46.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.139 -0.976 . . . . 0.0 109.932 179.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 121.65 53.34 0.22 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -132.94 -175.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.801 -1.411 . . . . 0.0 110.885 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 46' ' ' THR . 88.0 m -151.39 59.17 0.89 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.712 -0.618 . . . . 0.0 109.778 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 50' ' ' SER . 7.9 tt -81.0 167.85 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.249 -0.907 . . . . 0.0 109.767 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 50' ' ' SER . 54.3 p -139.36 -128.2 0.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.063 -1.023 . . . . 0.0 109.844 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 66' ' ' THR . 88.4 m -65.96 73.28 0.07 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.971 -1.08 . . . . 0.0 109.521 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.522 ' HB2' HD11 ' A' ' 47' ' ' ILE . 73.2 m -133.52 135.35 44.35 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.483 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 67' ' ' CYS . 1.6 m -88.62 139.09 30.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 53.9 p -153.69 130.08 10.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.412 -0.805 . . . . 0.0 110.075 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -111.54 112.4 24.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.008 -1.057 . . . . 0.0 109.696 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 50.53 90.76 0.01 OUTLIER Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.494 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 95.7 p -156.74 123.47 5.11 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.374 -1.074 . . . . 0.0 109.643 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.6 ttt180 -85.54 100.7 12.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.16 -0.962 . . . . 0.0 110.69 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 64' ' ' ILE . 2.9 mt -89.11 23.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.487 -0.758 . . . . 0.0 110.446 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -43.75 155.28 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.915 -1.115 . . . . 0.0 109.711 179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 165.88 143.61 3.8 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.195 -1.478 . . . . 0.0 110.325 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.01 -19.37 23.18 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.061 1.559 . . . . 0.0 110.276 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.5 36.95 0.52 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.44 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -57.88 160.38 4.69 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.424 -1.045 . . . . 0.0 111.505 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.554 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 30.3 tttp -160.51 114.02 2.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.584 -0.698 . . . . 0.0 109.822 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.686 ' CD1' HG21 ' A' ' 57' ' ' ILE . 12.1 mt -128.77 155.28 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.825 -1.172 . . . . 0.0 111.477 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.44 126.16 6.32 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.503 ' N ' ' OG ' ' A' ' 50' ' ' SER . 0.7 OUTLIER 51.97 77.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 110.638 -179.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' A' ' 64' ' ' ILE . 89.5 m -138.9 118.41 12.93 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.134 -0.979 . . . . 0.0 109.63 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.812 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.5 mp -90.98 80.87 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 118.836 -1.146 . . . . 0.0 108.868 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 73' ' ' VAL . 18.6 mt -89.91 159.27 2.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.294 0.569 . . . . 0.0 110.544 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.629 ' O ' HG22 ' A' ' 73' ' ' VAL . 18.2 m -158.28 97.82 1.53 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 110.421 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 94.63 16.78 41.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 87' ' ' PHE . . . 91.53 16.01 53.63 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 70' ' ' THR . 14.2 m -124.32 132.94 24.36 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.423 -1.046 . . . . 0.0 110.124 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.447 ' HB3' HD11 ' A' ' 82' ' ' ILE . 52.1 Cg_endo -81.24 137.39 10.61 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.93 1.49 . . . . 0.0 110.65 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -90.75 159.16 41.23 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.91 . . . . 0.0 109.794 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.5 66.66 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.787 1.414 . . . . 0.0 110.282 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 78' ' ' ALA . 18.6 t -80.52 4.53 18.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.235 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 41.73 31.07 0.18 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 110.004 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -151.35 -38.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 44.8 t -49.52 170.45 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.311 -0.868 . . . . 0.0 108.849 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.554 ' NZ ' ' O ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -106.99 -39.52 5.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.95 -1.094 . . . . 0.0 111.689 -178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.494 ' CA ' ' HE3' ' A' ' 81' ' ' LYS . 43.0 mm 43.62 68.92 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.879 -1.138 . . . . 0.0 109.501 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.445 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 45.1 t -125.38 -116.03 0.28 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 110.48 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -68.68 59.92 0.48 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.517 ' SG ' HD11 ' A' ' 64' ' ' ILE . 3.6 t -163.32 -171.76 2.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.05 -1.265 . . . . 0.0 110.814 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.57 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.9 t 176.62 170.04 0.48 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.46 -0.775 . . . . 0.0 109.772 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.57 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -134.05 149.01 51.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.005 -1.06 . . . . 0.0 110.079 179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.3 t -129.73 30.5 4.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.273 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 47.75 61.79 2.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.985 . . . . 0.0 110.065 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.288 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.501 ' OD2' ' N ' ' A' ' 2' ' ' GLY . 3.6 p-10 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.17 0.51 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.501 ' N ' ' OD2' ' A' ' 1' ' ' ASP . . . -69.54 88.52 0.27 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 19.7 m 48.29 -140.24 0.66 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.23 -1.159 . . . . 0.0 110.784 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.597 ' C ' ' HG1' ' A' ' 5' ' ' THR . 2.9 t 71.59 145.08 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.305 -0.872 . . . . 0.0 110.244 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.644 HG23 ' HB2' ' A' ' 9' ' ' SER . 20.1 m -172.73 169.92 4.82 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.597 ' N ' HG22 ' A' ' 5' ' ' THR . 0.5 OUTLIER -143.08 64.35 1.36 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.189 -0.944 . . . . 0.0 109.865 -179.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.467 ' OG1' ' N ' ' A' ' 24' ' ' ASN . 2.1 m 67.52 18.84 10.02 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.562 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 178.17 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.727 -0.608 . . . . 0.0 110.151 -179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.644 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.3 OUTLIER 78.8 85.35 0.06 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.823 -0.548 . . . . 0.0 110.701 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -127.98 17.87 6.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.097 -1.002 . . . . 0.0 109.494 179.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.568 ' CD1' ' HB3' ' A' ' 15' ' ' SER . 6.7 tp -47.74 91.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.752 -0.592 . . . . 0.0 109.772 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 10' ' ' GLN . 4.9 t -38.24 137.0 0.59 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 120.059 -0.657 . . . . 0.0 109.866 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -50.1 -17.51 0.43 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.21 -0.931 . . . . 0.0 111.289 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -90.72 -3.36 57.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.005 -1.06 . . . . 0.0 110.342 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.71 ' OG ' HG12 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -89.03 -157.48 0.45 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.098 -1.001 . . . . 0.0 110.054 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 8.4 tttm -165.7 156.27 13.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -0.962 . . . . 0.0 110.057 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 40.7 t -144.14 156.41 44.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 110.48 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER 174.02 104.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 109.697 179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER 74.08 14.94 3.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.83 . . . . 0.0 110.052 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.433 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -102.48 165.97 10.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 0.0 110.474 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' CB ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -113.82 -43.65 3.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.429 -0.794 . . . . 0.0 110.121 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 5' ' ' THR . 1.1 tp 62.24 159.03 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.062 -1.024 . . . . 0.0 110.479 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 37' ' ' CYS . 1.7 m -174.61 117.66 0.2 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.413 -0.804 . . . . 0.0 109.256 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.467 ' N ' ' OG1' ' A' ' 7' ' ' THR . 26.1 m120 53.59 63.19 2.3 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.565 ' C ' ' CG ' ' A' ' 26' ' ' TYR . 1.3 m -146.21 -166.66 2.53 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.736 0.779 . . . . 0.0 111.096 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CG ' ' C ' ' A' ' 25' ' ' CYS . 11.0 m-85 -155.13 -40.55 0.09 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.831 HG13 ' HD2' ' A' ' 42' ' ' PHE . 11.8 t 56.39 137.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.643 0.735 . . . . 0.0 111.618 178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' HA ' ' HB3' ' A' ' 12' ' ' SER . 0.4 OUTLIER -151.6 130.72 12.68 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.53 -0.731 . . . . 0.0 109.816 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.486 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 34.8 mttp 54.31 37.5 27.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.116 -0.99 . . . . 0.0 109.098 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.605 ' HB3' HG22 ' A' ' 45' ' ' VAL . 8.3 m -126.59 169.62 12.9 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.487 -0.758 . . . . 0.0 110.353 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.91 ' OE1' HG23 ' A' ' 46' ' ' THR . 1.2 tt0 -113.02 -63.03 1.5 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.432 -0.793 . . . . 0.0 110.126 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 5.4 t 62.58 144.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -0.865 . . . . 0.0 110.141 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.501 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 42.4 m-85 -152.4 34.23 0.51 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.156 -0.965 . . . . 0.0 110.629 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 19' ' ' LYS . . . 156.28 -31.32 0.59 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 50' ' ' SER . 8.9 m -40.34 151.02 0.05 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.462 -1.023 . . . . 0.0 111.072 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.416 ' O ' ' CA ' ' A' ' 22' ' ' LEU . 76.1 m -97.49 -16.55 20.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.423 -0.798 . . . . 0.0 109.261 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.482 ' H ' HG22 ' A' ' 35' ' ' THR . 1.6 t 52.21 83.68 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.572 -0.705 . . . . 0.0 110.057 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.3 m -93.71 102.62 14.78 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.37 -0.831 . . . . 0.0 110.303 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 49.12 61.51 5.33 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.442 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 45.2 t -150.81 -168.91 3.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -1.112 . . . . 0.0 109.914 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' A' ' 42' ' ' PHE . 5.2 ttt180 -168.75 156.4 7.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.09 -1.006 . . . . 0.0 110.03 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.831 ' HD2' HG13 ' A' ' 27' ' ' VAL . 5.5 m-85 -117.93 179.35 4.11 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.273 -0.892 . . . . 0.0 110.161 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -168.14 41.1 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.401 -0.812 . . . . 0.0 109.474 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 59' ' ' GLY . . . 129.16 53.96 0.11 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.605 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -129.03 -165.84 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.065 -1.256 . . . . 0.0 110.324 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.91 HG23 ' OE1' ' A' ' 31' ' ' GLU . 23.5 m -163.44 57.9 0.18 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.683 HD11 ' CB ' ' A' ' 50' ' ' SER . 10.4 tt -86.01 172.48 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.641 0.734 . . . . 0.0 111.695 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' SER . 32.7 p -129.93 -156.32 0.75 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.508 -0.745 . . . . 0.0 109.327 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 49' ' ' THR . 3.6 m -48.5 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.813 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.683 ' CB ' HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -125.24 140.29 52.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.636 -1.29 . . . . 0.0 110.488 -179.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 51' ' ' THR . 14.7 m -86.88 18.36 3.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.142 -0.974 . . . . 0.0 110.732 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.495 ' HA ' ' HB ' ' A' ' 69' ' ' ILE . 12.4 p -39.06 114.45 0.4 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.314 -0.866 . . . . 0.0 111.006 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.2 m -112.02 93.34 4.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.0 109.387 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 82.99 77.47 1.09 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.564 ' CB ' ' HB3' ' A' ' 87' ' ' PHE . 1.6 p -156.26 123.03 5.2 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.273 -1.134 . . . . 0.0 110.974 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -87.16 103.09 15.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 0.0 109.884 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 57' ' ' ILE . 2.8 mp -89.03 14.69 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.056 -1.028 . . . . 0.0 110.122 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -42.58 141.45 1.02 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.335 -0.853 . . . . 0.0 109.789 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.491 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . 172.89 155.5 11.53 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.185 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.56 -2.61 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 124.173 1.617 . . . . 0.0 110.566 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.28 31.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -49.63 128.41 17.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 110.336 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -114.75 127.81 55.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.427 -0.796 . . . . 0.0 110.528 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.578 ' HB ' ' CB ' ' A' ' 47' ' ' ILE . 4.6 mt -138.99 149.87 23.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.139 -0.976 . . . . 0.0 109.853 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 81' ' ' LYS . 83.8 p -147.04 106.04 3.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.051 -1.031 . . . . 0.0 110.699 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 49' ' ' THR . 4.0 m 50.96 73.06 0.31 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 111.583 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.574 ' HB3' HD11 ' A' ' 69' ' ' ILE . 14.6 t -129.1 119.92 25.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.872 . . . . 0.0 109.475 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 69' ' ' ILE . 1.7 mp -48.32 -75.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 109.918 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.934 HD13 ' CZ ' ' A' ' 87' ' ' PHE . 10.8 mt 62.81 140.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.826 . . . . 0.0 109.683 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.771 ' O ' HG22 ' A' ' 73' ' ' VAL . 81.3 m -165.74 101.8 0.68 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.118 -0.989 . . . . 0.0 111.315 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.85 23.73 24.82 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.58 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 85.19 8.92 80.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 70' ' ' THR . 20.3 m -112.48 121.89 37.78 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.55 -0.971 . . . . 0.0 109.814 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -77.27 124.09 6.99 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.712 1.375 . . . . 0.0 110.381 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.525 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -86.22 139.34 34.29 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.316 -0.865 . . . . 0.0 109.879 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.68 91.99 0.79 Allowed 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 124.105 1.582 . . . . 0.0 111.035 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.46 147.35 45.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.107 -0.996 . . . . 0.0 110.464 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.76 -12.11 32.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.343 -0.848 . . . . 0.0 110.543 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' SER . . . -103.82 -18.14 14.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.211 -0.93 . . . . 0.0 110.664 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 14.1 t -71.9 157.95 36.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.147 -0.971 . . . . 0.0 109.939 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.558 ' HE3' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -101.53 -11.78 19.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.028 -1.045 . . . . 0.0 112.925 -177.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 81' ' ' LYS . 26.7 mm 26.41 50.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.443 -0.786 . . . . 0.0 111.423 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.6 m -108.21 -157.67 0.62 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.867 -1.146 . . . . 0.0 110.946 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.25 98.63 0.17 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.498 ' SG ' HG23 ' A' ' 57' ' ' ILE . 3.7 t -170.87 -168.43 0.66 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.354 -1.086 . . . . 0.0 109.662 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 2.7 t -177.03 158.22 1.51 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.919 -1.113 . . . . 0.0 109.653 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.934 ' CZ ' HD13 ' A' ' 69' ' ' ILE . 10.4 m-85 -118.95 -49.44 2.42 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 110.548 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 89' ' ' ALA . 15.4 m 61.89 11.92 4.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.283 -0.885 . . . . 0.0 109.858 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 88' ' ' SER . . . 57.15 119.22 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.439 -0.788 . . . . 0.0 110.392 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 3.8 t30 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.183 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.297 0.57 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.19 -177.56 35.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.6 m -129.33 45.07 2.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.276 -1.132 . . . . 0.0 110.032 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 5' ' ' THR . 6.8 m -78.19 -61.4 2.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 109.84 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.952 HG23 ' HB2' ' A' ' 9' ' ' SER . 3.2 m 76.91 -13.78 0.9 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.878 -0.514 . . . . 0.0 111.398 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 24' ' ' ASN . 13.6 p30 35.82 40.61 0.09 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.065 -1.022 . . . . 0.0 110.611 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER 70.8 35.37 1.78 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.109 -0.995 . . . . 0.0 111.195 179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.666 ' H ' HG22 ' A' ' 5' ' ' THR . 0.2 OUTLIER 168.93 -42.32 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.932 -1.105 . . . . 0.0 110.602 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.952 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.2 OUTLIER 73.16 89.55 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.467 -0.771 . . . . 0.0 110.751 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -131.24 18.33 4.92 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.155 -0.966 . . . . 0.0 109.565 179.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.866 HD12 ' CB ' ' A' ' 15' ' ' SER . 1.6 mm? -39.42 101.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.544 0.687 . . . . 0.0 110.251 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.519 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -87.0 163.02 17.3 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.641 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' HB3' ' C ' ' A' ' 28' ' ' ASP . . . 49.43 -157.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.139 -0.976 . . . . 0.0 110.068 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -90.49 57.58 3.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 111.482 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.866 ' CB ' HD12 ' A' ' 11' ' ' LEU . 22.0 p -58.54 -168.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.832 -1.167 . . . . 0.0 110.249 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.501 ' CB ' ' HG2' ' A' ' 31' ' ' GLU . 34.8 tttt -154.32 146.93 24.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.05 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.58 167.52 16.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.074 -1.016 . . . . 0.0 110.709 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -176.3 -154.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.504 -0.747 . . . . 0.0 109.651 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.44 54.09 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.017 . . . . 0.0 110.033 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 33' ' ' TYR . 7.9 t -111.99 168.63 9.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 110.223 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.62 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -104.67 105.92 16.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 109.709 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.62 HD22 ' C ' ' A' ' 21' ' ' THR . 4.3 mm? -107.93 145.8 33.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 110.774 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 15.7 m -161.13 118.83 2.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.463 -0.773 . . . . 0.0 109.615 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 6' ' ' ASN . 26.5 m-20 59.01 64.07 1.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 110.057 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 6' ' ' ASN . 0.6 OUTLIER -142.67 169.93 16.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.235 -0.916 . . . . 0.0 110.581 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 13.5 m-85 -129.13 -40.83 1.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.725 HG13 ' HD2' ' A' ' 42' ' ' PHE . 3.6 t 47.24 112.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 121.586 0.707 . . . . 0.0 112.017 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.519 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -98.13 -91.91 0.26 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.157 -0.964 . . . . 0.0 109.219 178.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -93.63 68.85 4.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.079 -1.013 . . . . 0.0 109.632 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.664 ' HB3' HG22 ' A' ' 45' ' ' VAL . 0.7 OUTLIER -135.76 -172.98 3.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 110.604 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.643 ' C ' HG23 ' A' ' 32' ' ' VAL . 9.5 mt-10 -137.72 -66.4 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.396 -0.815 . . . . 0.0 110.242 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.643 HG23 ' C ' ' A' ' 31' ' ' GLU . 2.5 t 69.99 150.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.348 -0.845 . . . . 0.0 110.371 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.922 ' CD2' HG22 ' A' ' 48' ' ' THR . 51.0 m-85 -138.68 -46.39 0.49 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.192 -0.942 . . . . 0.0 110.687 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.4 18.36 3.27 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.551 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 33.0 m -67.37 162.14 23.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.181 -1.188 . . . . 0.0 110.369 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 21' ' ' THR . 6.4 m -121.11 64.93 0.87 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.511 ' O ' ' HB ' ' A' ' 23' ' ' THR . 5.3 t -42.42 97.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.495 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.498 ' O ' HG22 ' A' ' 38' ' ' THR . 27.9 m -89.95 20.36 4.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.98 -1.075 . . . . 0.0 109.622 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.16 47.1 0.19 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 53.9 p -126.54 -156.11 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 110.443 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HG2' ' OD1' ' A' ' 90' ' ' ASN . 1.1 ptt85 -169.77 153.8 5.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.894 . . . . 0.0 110.199 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.725 ' HD2' HG13 ' A' ' 27' ' ' VAL . 4.2 m-85 -121.63 -175.11 3.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 110.172 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER 178.59 61.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.982 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 111.1 52.01 0.58 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.664 HG22 ' HB3' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.01 -167.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.969 -1.312 . . . . 0.0 110.627 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.549 ' N ' HG23 ' A' ' 45' ' ' VAL . 32.8 m -160.85 54.81 0.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 50' ' ' SER . 17.3 tt -85.08 169.61 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.461 -0.774 . . . . 0.0 110.33 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.922 HG22 ' CD2' ' A' ' 33' ' ' TYR . 41.7 p -135.78 -127.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.307 -0.87 . . . . 0.0 109.962 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 49' ' ' THR . 38.3 m -69.74 72.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.907 -1.12 . . . . 0.0 110.398 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.619 ' HB2' HD11 ' A' ' 47' ' ' ILE . 57.8 m -130.06 136.31 49.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -95.81 117.77 31.2 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.107 -0.996 . . . . 0.0 109.788 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 1.5 m -125.2 137.73 54.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.302 -0.874 . . . . 0.0 109.845 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.508 ' HB ' HG23 ' A' ' 70' ' ' THR . 1.0 OUTLIER -115.35 126.37 54.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.046 -1.034 . . . . 0.0 110.535 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 53' ' ' THR . . . 43.64 50.67 6.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 7.8 p -127.33 141.52 51.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -1.112 . . . . 0.0 110.187 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -99.41 101.53 12.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 110.067 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 57' ' ' ILE . 3.0 mp -82.15 7.64 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 m -56.15 163.3 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 110.056 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.0 155.7 7.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.03 55.37 2.85 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.054 1.555 . . . . 0.0 110.27 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.79 17.19 3.88 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -45.79 136.57 6.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -1.194 . . . . 0.0 110.518 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.525 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -140.98 120.22 12.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.195 -0.941 . . . . 0.0 110.033 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.562 ' CD1' HG23 ' A' ' 57' ' ' ILE . 21.6 mt -135.39 164.95 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.99 -1.069 . . . . 0.0 111.187 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.481 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -155.46 115.6 3.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.567 -0.708 . . . . 0.0 109.498 179.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.6 m 53.29 86.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.175 -0.953 . . . . 0.0 110.057 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.409 ' H ' ' CB ' ' A' ' 50' ' ' SER . 54.4 m -150.4 99.9 2.82 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.303 -0.873 . . . . 0.0 109.986 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.823 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.7 mp -67.6 96.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.98 -1.075 . . . . 0.0 109.445 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.739 HG23 ' O ' ' A' ' 73' ' ' VAL . 9.6 mt -104.2 160.75 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.953 . . . . 0.0 110.717 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.913 ' O ' HG22 ' A' ' 73' ' ' VAL . 25.5 m -163.38 110.07 1.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.876 . . . . 0.0 109.983 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.83 20.47 55.79 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.569 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 86.58 12.22 69.91 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.913 HG22 ' O ' ' A' ' 70' ' ' THR . 6.5 m -118.65 138.34 25.8 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.41 -1.053 . . . . 0.0 110.292 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -80.64 154.05 20.51 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.939 1.494 . . . . 0.0 110.106 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.823 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -83.31 162.36 54.2 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 110.342 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.3 Cg_endo -74.46 53.43 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.119 1.589 . . . . 0.0 110.281 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.9 m -103.85 138.65 40.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 110.274 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.09 -23.81 35.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 110.23 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.98 6.04 17.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.207 -0.933 . . . . 0.0 110.428 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 66' ' ' THR . 1.2 t -100.76 154.14 18.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.937 . . . . 0.0 109.874 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.559 ' CD ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -102.56 -168.98 1.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 110.927 -179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' ' 82' ' ' ILE . 2.1 tp 179.03 33.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.8 0.809 . . . . 0.0 109.201 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 m -62.21 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.454 -0.779 . . . . 0.0 111.266 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.95 82.82 0.34 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.704 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.549 ' SG ' HD11 ' A' ' 64' ' ' ILE . 1.8 t -144.82 -152.47 0.42 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -1.206 . . . . 0.0 110.055 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.7 OUTLIER 172.9 148.44 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.393 -0.817 . . . . 0.0 109.893 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 1.4 m-85 -119.08 -28.31 5.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.346 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.778 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 68.0 m 52.85 -90.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.944 -1.098 . . . . 0.0 109.482 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.778 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . 157.41 74.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.269 0.557 . . . . 0.0 109.725 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.455 ' OD1' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.034 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.331 0.586 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.06 48.55 0.05 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -152.11 63.51 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -1.128 . . . . 0.0 110.241 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.45 ' O ' ' OG1' ' A' ' 5' ' ' THR . 55.8 m -108.8 -117.34 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 109.836 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.988 HG22 ' H ' ' A' ' 8' ' ' ASN . 86.7 m -166.78 -36.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.889 -1.132 . . . . 0.0 109.335 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.554 ' HB3' ' CB ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER 49.94 68.05 0.81 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.493 -0.754 . . . . 0.0 109.309 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 7' ' ' THR . 95.7 m 50.41 42.71 26.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 109.4 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.988 ' H ' HG22 ' A' ' 5' ' ' THR . 1.3 t-20 70.2 83.58 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.42 -0.8 . . . . 0.0 109.81 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 5' ' ' THR . 3.0 m -138.84 -95.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.201 -0.937 . . . . 0.0 110.421 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER 173.28 -44.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.07 -1.019 . . . . 0.0 110.049 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' HA ' ' HB ' ' A' ' 27' ' ' VAL . 24.5 tp 48.91 89.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.061 -1.024 . . . . 0.0 109.994 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.564 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -44.48 156.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.747 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.91 -8.71 39.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.0 109.903 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -97.65 -10.32 25.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.325 -0.859 . . . . 0.0 110.135 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -78.18 -158.71 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 110.064 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -141.27 147.11 37.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 t -127.55 85.77 2.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 0.0 110.014 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' LYS . 21.1 tt0 -132.45 84.66 2.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 110.526 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' GLU . 1.2 mttp 52.41 104.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.899 . . . . 0.0 110.326 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.423 ' OG ' ' N ' ' A' ' 21' ' ' THR . 35.3 t -158.95 -158.72 0.71 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 110.192 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 35' ' ' THR . 0.3 OUTLIER -152.48 86.57 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.277 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.554 ' CB ' ' HB3' ' A' ' 6' ' ' ASN . 4.0 mp -109.46 116.77 32.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.129 -0.982 . . . . 0.0 110.133 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.575 HG23 HG21 ' A' ' 7' ' ' THR . 85.8 m -104.29 119.67 39.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.17 -0.956 . . . . 0.0 110.114 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 23' ' ' THR . 11.8 m-20 56.93 22.2 6.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.987 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.472 ' SG ' ' HG ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -71.2 -145.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 110.42 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.506 ' O ' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -179.34 -50.67 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' O ' ' O ' ' A' ' 26' ' ' TYR . 2.6 t 52.05 121.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.775 0.798 . . . . 0.0 111.41 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.564 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 3.2 t70 -111.49 -25.74 9.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.094 -1.004 . . . . 0.0 110.191 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.533 ' CD ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -166.65 58.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.331 -0.856 . . . . 0.0 109.955 179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.892 ' OG ' HG22 ' A' ' 45' ' ' VAL . 16.9 m -132.89 154.83 50.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 111.237 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -108.61 96.35 6.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.619 -0.676 . . . . 0.0 109.192 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.554 HG11 HD11 ' A' ' 22' ' ' LEU . 12.0 t -91.03 164.52 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 110.941 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.566 ' HB2' HG22 ' A' ' 48' ' ' THR . 20.5 m-85 -143.19 -36.6 0.37 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 0.0 110.439 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . -159.37 29.37 0.4 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' SER . 15.5 m -77.06 159.67 29.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.298 -1.119 . . . . 0.0 110.624 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 21' ' ' THR . 0.6 OUTLIER -112.45 53.36 0.74 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.441 -0.787 . . . . 0.0 109.695 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 5.1 t -39.48 103.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.487 -0.758 . . . . 0.0 110.839 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.531 ' O ' HG22 ' A' ' 38' ' ' THR . 23.4 m -103.56 79.37 1.68 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.989 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.51 69.22 1.43 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.55 ' HG ' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -161.27 -148.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -1.099 . . . . 0.0 110.184 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 40' ' ' SER . 1.3 ttp180 172.79 158.72 0.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.385 -0.822 . . . . 0.0 109.917 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CD1' ' CG1' ' A' ' 57' ' ' ILE . 2.5 m-85 -121.72 -173.2 2.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 0.0 110.166 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -173.65 57.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.899 . . . . 0.0 110.252 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 29' ' ' LYS . . . 117.17 47.71 0.46 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.892 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.73 -166.15 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.724 -1.457 . . . . 0.0 111.156 -179.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.56 ' N ' HG23 ' A' ' 45' ' ' VAL . 22.1 m -156.16 58.16 0.58 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.339 0.59 . . . . 0.0 109.433 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.75 HD11 ' OG ' ' A' ' 50' ' ' SER . 11.1 tt -84.76 154.04 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 111.239 -178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.595 ' C ' HG23 ' A' ' 49' ' ' THR . 72.8 p -148.98 148.5 29.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.605 -0.684 . . . . 0.0 109.913 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.595 HG23 ' C ' ' A' ' 48' ' ' THR . 0.1 OUTLIER 43.28 33.32 0.57 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.009 -1.057 . . . . 0.0 110.772 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.75 ' OG ' HD11 ' A' ' 47' ' ' ILE . 28.3 t -100.77 128.79 46.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.904 -1.122 . . . . 0.0 110.059 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 52' ' ' SER . 3.4 m -92.48 22.35 4.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.28 -0.887 . . . . 0.0 110.417 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -40.4 125.62 2.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.427 -0.796 . . . . 0.0 110.868 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 1.6 m -106.95 94.81 5.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 109.511 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.55 ' HA2' ' HG ' ' A' ' 40' ' ' SER . . . 72.45 77.09 0.58 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.501 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 1.3 p -147.2 117.53 7.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.352 -1.087 . . . . 0.0 110.366 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.548 ' CG ' ' HB2' ' A' ' 90' ' ' ASN . 2.8 ttt-85 -68.4 107.25 2.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.57 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.665 ' O ' HG11 ' A' ' 45' ' ' VAL . 15.2 mm -88.44 0.22 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.108 -0.995 . . . . 0.0 109.763 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -40.41 125.0 2.06 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.385 -0.822 . . . . 0.0 110.424 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . -167.1 144.77 9.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -76.05 81.47 2.41 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.927 1.488 . . . . 0.0 109.952 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.0 15.73 53.23 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.647 ' SG ' HD11 ' A' ' 64' ' ' ILE . 15.7 t -44.18 164.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.334 -1.098 . . . . 0.0 111.221 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 62' ' ' CYS . 8.0 ttpp -150.45 114.03 4.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.483 -0.76 . . . . 0.0 110.168 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.647 HD11 ' SG ' ' A' ' 62' ' ' CYS . 4.4 mt -129.83 155.95 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.911 -1.118 . . . . 0.0 111.012 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.453 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -156.01 120.48 4.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.311 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 48' ' ' THR . 9.4 m 44.55 71.49 0.25 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.347 -0.845 . . . . 0.0 111.008 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 98.1 m -122.58 120.8 34.86 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.407 -0.808 . . . . 0.0 109.64 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.3 mp -88.92 86.02 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.103 -0.998 . . . . 0.0 109.777 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.767 HG23 ' C ' ' A' ' 73' ' ' VAL . 3.7 mt -102.49 157.22 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.435 -0.791 . . . . 0.0 110.356 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.815 ' O ' HG22 ' A' ' 73' ' ' VAL . 53.6 m -153.95 105.49 2.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.899 . . . . 0.0 110.24 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 88.02 17.27 58.08 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.565 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 92.36 13.49 57.16 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 70' ' ' THR . 12.9 m -121.76 129.2 25.27 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.454 -1.027 . . . . 0.0 110.436 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -81.24 132.76 8.37 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.928 1.489 . . . . 0.0 110.822 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 77' ' ' SER . . . -76.28 161.08 76.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.262 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.7 64.41 1.24 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.765 1.403 . . . . 0.0 109.953 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 75' ' ' ALA . 1.9 t -99.58 118.08 35.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 0.0 110.242 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.62 -4.6 24.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 110.006 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.59 -19.13 18.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.854 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.855 ' SG ' HD12 ' A' ' 82' ' ' ILE . 26.0 t -68.6 165.48 19.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.09 -1.006 . . . . 0.0 109.934 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.599 ' N ' ' HD3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -105.14 7.21 33.67 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.289 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.855 HD12 ' SG ' ' A' ' 80' ' ' CYS . 0.9 OUTLIER -15.01 82.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.543 0 CA-C-N 118.909 0.777 . . . . 0.0 111.56 -178.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.567 ' N ' ' O ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -128.89 -70.21 0.68 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 111.308 -178.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -129.21 86.87 0.31 Allowed Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.455 -1.355 . . . . 0.0 111.173 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 86' ' ' THR . 3.8 t -177.05 -150.47 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -1.161 . . . . 0.0 110.084 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 85' ' ' CYS . 1.7 t 174.0 161.87 0.17 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.634 ' CD2' HG21 ' A' ' 69' ' ' ILE . 3.1 m-85 -113.03 -52.56 2.77 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.945 -1.097 . . . . 0.0 110.011 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER 65.22 7.85 4.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 110.312 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 55.65 112.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 110.675 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.548 ' HB2' ' CG ' ' A' ' 56' ' ' ARG . 7.9 t30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.16 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 28.6 p-10 . . . . . 0 N--CA 1.494 1.766 0 CA-C-O 121.155 0.502 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.47 -65.99 0.3 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -123.93 124.91 43.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.171 -1.194 . . . . 0.0 110.216 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' HB3' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -161.58 -157.21 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.123 -0.986 . . . . 0.0 110.453 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.95 HG23 ' O ' ' A' ' 9' ' ' SER . 7.3 m -171.23 35.15 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.981 ' OD1' HD12 ' A' ' 22' ' ' LEU . 8.1 t-20 55.94 -88.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.562 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 3.2 m -142.5 -0.71 1.21 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.573 -0.704 . . . . 0.0 109.744 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.562 ' HB3' ' O ' ' A' ' 7' ' ' THR . 1.2 p30 173.13 -19.52 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.534 -0.729 . . . . 0.0 111.061 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.95 ' O ' HG23 ' A' ' 5' ' ' THR . 60.4 p -87.91 -115.9 0.05 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.908 -1.12 . . . . 0.0 112.448 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.562 ' CG ' ' N ' ' A' ' 11' ' ' LEU . 8.4 pt20 -128.36 -43.53 1.44 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.974 -1.079 . . . . 0.0 111.264 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.766 HD12 ' HB ' ' A' ' 27' ' ' VAL . 14.4 tp 59.82 106.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.199 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 27' ' ' VAL . 0.4 OUTLIER -35.67 144.26 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.286 0.565 . . . . 0.0 110.747 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.71 -13.78 6.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.421 -0.8 . . . . 0.0 110.13 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -112.53 8.52 19.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 110.71 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.557 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 2.0 t -82.46 -152.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.891 -1.131 . . . . 0.0 109.955 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.464 ' O ' HD21 ' A' ' 11' ' ' LEU . 26.7 tttm -147.19 152.93 39.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.933 -1.104 . . . . 0.0 110.955 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.545 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 9.5 p -142.27 -153.44 0.46 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.313 -0.867 . . . . 0.0 109.911 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' CYS . 14.6 mm-40 57.05 159.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.114 -0.991 . . . . 0.0 110.173 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 44.31 63.21 1.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.143 -0.973 . . . . 0.0 109.946 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.737 ' HB2' HD21 ' A' ' 22' ' ' LEU . 68.9 p -170.55 160.95 7.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.441 -0.787 . . . . 0.0 109.834 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.844 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -125.37 104.47 8.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.087 -1.008 . . . . 0.0 108.79 179.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.981 HD12 ' OD1' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -144.2 -168.62 2.92 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.308 -178.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 24' ' ' ASN . 1.3 m -177.78 146.66 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.492 ' HA ' ' OD1' ' A' ' 8' ' ' ASN . 4.3 m-20 45.8 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.171 -0.956 . . . . 0.0 109.871 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 26' ' ' TYR . 60.3 m -140.24 -155.4 0.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.093 -1.005 . . . . 0.0 111.007 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.535 ' CB ' ' O ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER 163.19 43.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.484 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.766 ' HB ' HD12 ' A' ' 11' ' ' LEU . 21.6 t -62.11 145.4 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.469 0.652 . . . . 0.0 110.961 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 16.0 m-20 -129.01 3.5 5.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 110.313 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.5 OUTLIER 175.67 79.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.322 -0.861 . . . . 0.0 109.837 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.809 ' OG ' HG22 ' A' ' 45' ' ' VAL . 54.3 m -165.26 -160.48 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.953 -1.092 . . . . 0.0 110.343 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 2.5 mt-10 -137.66 -62.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 0.0 110.542 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.61 HG22 HG22 ' A' ' 47' ' ' ILE . 3.9 t 64.61 153.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.272 -0.892 . . . . 0.0 110.74 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.691 ' CD1' HG22 ' A' ' 48' ' ' THR . 25.9 m-85 -149.86 -77.04 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.504 -0.748 . . . . 0.0 109.336 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 48' ' ' THR . . . -107.95 36.47 4.36 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.528 ' CG2' ' N ' ' A' ' 36' ' ' THR . 1.0 OUTLIER -82.96 171.79 13.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -1.081 . . . . 0.0 110.46 -179.475 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.528 ' N ' ' CG2' ' A' ' 35' ' ' THR . 1.7 m -119.52 58.81 0.87 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.0 110.234 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.644 ' HB3' ' CB ' ' A' ' 22' ' ' LEU . 36.2 t -39.03 103.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.443 -0.785 . . . . 0.0 110.579 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.574 ' O ' HG22 ' A' ' 38' ' ' THR . 24.3 m -106.39 75.84 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.981 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.74 49.03 71.47 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 4.9 p -138.9 169.08 18.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -1.119 . . . . 0.0 110.18 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.403 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -147.44 157.44 43.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 109.994 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 41' ' ' ARG . 2.5 m-85 -119.98 -179.44 3.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.154 -0.967 . . . . 0.0 110.454 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -155.71 46.93 0.49 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.0 109.47 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 29' ' ' LYS . . . 123.94 75.03 0.28 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.809 HG22 ' OG ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -150.28 -168.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.196 -1.179 . . . . 0.0 110.453 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.589 ' N ' HG23 ' A' ' 45' ' ' VAL . 39.9 m -155.28 57.86 0.64 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.572 -0.705 . . . . 0.0 109.332 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.879 HD11 ' HB2' ' A' ' 50' ' ' SER . 11.3 tt -78.33 168.05 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 110.054 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.691 HG22 ' CD1' ' A' ' 33' ' ' TYR . 2.4 p -143.06 -81.23 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 110.279 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -110.61 39.91 2.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.233 -0.917 . . . . 0.0 109.386 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.879 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -96.31 124.36 40.28 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.351 -0.843 . . . . 0.0 110.943 -179.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -71.13 135.66 47.77 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.355 -0.841 . . . . 0.0 108.963 178.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.6 p -140.82 119.37 12.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.909 -1.12 . . . . 0.0 110.663 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.401 ' H ' ' HA ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -117.49 70.15 0.78 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 109.43 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 96.01 91.1 1.79 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 87.3 p -171.92 128.09 0.61 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -1.202 . . . . 0.0 110.811 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.543 ' CD ' ' HB2' ' A' ' 88' ' ' SER . 1.4 ptp180 -87.71 105.05 17.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 109.365 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.534 ' N ' HD13 ' A' ' 57' ' ' ILE . 5.1 mm -81.66 16.08 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.023 . . . . 0.0 110.992 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.91 156.06 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.025 -1.047 . . . . 0.0 110.038 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.59 143.77 3.77 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.29 -3.35 13.78 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.985 1.519 . . . . 0.0 110.225 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.49 27.65 0.28 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -58.28 141.03 52.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -1.126 . . . . 0.0 110.472 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 6.1 ttpp -151.66 117.04 5.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.529 -0.732 . . . . 0.0 109.2 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.609 ' HA ' ' CD ' ' A' ' 81' ' ' LYS . 2.2 mp -129.36 147.11 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.956 -1.09 . . . . 0.0 111.172 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.541 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -143.2 111.93 6.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 110.181 179.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.527 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 19.8 m 51.76 57.54 6.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.647 -0.658 . . . . 0.0 111.108 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 2.0 t -110.46 129.3 55.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.425 -0.797 . . . . 0.0 110.154 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.715 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.0 mp -87.03 93.36 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.053 -1.029 . . . . 0.0 108.676 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.706 HG21 ' CD2' ' A' ' 87' ' ' PHE . 10.1 mt -106.9 149.55 10.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.392 -0.818 . . . . 0.0 110.489 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.801 ' O ' HG22 ' A' ' 73' ' ' VAL . 7.5 m -156.04 103.81 2.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 110.734 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.5 24.85 27.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 87' ' ' PHE . . . 83.09 17.14 67.86 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 70' ' ' THR . 14.2 m -124.0 128.53 25.06 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.523 -0.986 . . . . 0.0 110.701 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -82.04 130.65 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.904 1.476 . . . . 0.0 110.313 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 68' ' ' ILE . . . -93.02 147.3 33.6 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.09 -1.006 . . . . 0.0 110.153 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.24 101.31 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.948 1.499 . . . . 0.0 109.796 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.721 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 40.3 t -111.73 -5.63 14.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 110.72 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 77' ' ' SER . . . 70.45 3.63 4.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.157 -0.964 . . . . 0.0 109.57 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 80' ' ' CYS . . . -125.65 -34.03 2.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.436 -0.79 . . . . 0.0 109.318 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 18.2 t -45.09 167.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.59 -0.694 . . . . 0.0 109.536 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.609 ' CD ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.96 7.45 46.61 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.961 -1.087 . . . . 0.0 112.357 -178.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.579 ' C ' ' O ' ' A' ' 81' ' ' LYS . 17.6 mm -6.69 73.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 81' ' ' LYS . 43.9 t -124.35 -52.06 1.74 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.245 -0.909 . . . . 0.0 109.864 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' CYS . . . -147.82 -114.95 0.81 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' GLY . 2.9 t 44.07 -167.82 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.343 -1.092 . . . . 0.0 109.972 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.467 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.6 OUTLIER 175.18 140.22 0.05 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 110.459 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CD2' HG21 ' A' ' 69' ' ' ILE . 1.6 m-30 -115.69 170.26 8.58 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.4 -0.813 . . . . 0.0 109.677 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.543 ' HB2' ' CD ' ' A' ' 56' ' ' ARG . 6.7 m -165.52 25.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 109.644 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.498 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.02 83.41 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.36 -0.837 . . . . 0.0 109.967 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.452 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.317 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.201 0.524 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.88 -121.78 5.35 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 p -59.62 -38.9 82.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -1.158 . . . . 0.0 110.163 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.454 ' O ' ' OG1' ' A' ' 5' ' ' THR . 6.9 t -44.9 141.75 2.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.155 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.785 HG21 ' HA ' ' A' ' 9' ' ' SER . 9.0 m -171.87 -84.69 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.701 HD22 HD23 ' A' ' 22' ' ' LEU . 4.3 p30 166.13 71.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.684 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.676 HG21 ' OD1' ' A' ' 24' ' ' ASN . 3.9 m 63.06 -70.94 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.476 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.573 ' OD1' ' CD2' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -52.22 -47.23 65.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 109.737 179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.785 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.3 OUTLIER 74.14 50.53 0.11 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.525 -0.735 . . . . 0.0 112.116 178.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.55 ' O ' ' C ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -109.13 -29.78 8.36 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.867 -1.146 . . . . 0.0 108.289 178.085 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.55 ' C ' ' O ' ' A' ' 10' ' ' GLN . 14.2 tp 10.2 107.24 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.356 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.624 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -39.56 155.4 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.636 -0.665 . . . . 0.0 110.328 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.28 -8.46 25.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 110.203 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.7 -9.39 6.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.09 -1.006 . . . . 0.0 110.454 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.697 ' OG ' HG12 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -66.24 -161.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.087 -1.008 . . . . 0.0 109.865 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HD3' ' OE2' ' A' ' 31' ' ' GLU . 24.6 tttt -165.34 150.28 9.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.126 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.0 p -126.02 -35.93 2.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.232 -0.917 . . . . 0.0 110.242 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 58.14 -162.77 0.21 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.765 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -87.86 62.66 7.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.861 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.531 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 77.9 p -97.63 -172.25 2.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 110.743 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.5 ' C ' ' HA ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -106.65 10.74 30.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.733 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.701 HD23 HD22 ' A' ' 6' ' ' ASN . 2.3 tp -37.95 159.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.496 0.665 . . . . 0.0 110.814 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 94.6 m -162.36 123.69 2.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.69 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.676 ' OD1' HG21 ' A' ' 7' ' ' THR . 3.1 m120 56.52 60.51 3.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.862 . . . . 0.0 110.314 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.598 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -120.59 -157.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 110.448 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 25' ' ' CYS . 47.2 m-85 -154.82 -55.98 0.1 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.697 HG12 ' OG ' ' A' ' 15' ' ' SER . 2.4 t 57.72 119.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.64 -1.163 . . . . 0.0 110.477 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.624 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 4.1 m-20 -112.58 -24.68 9.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.49 -0.756 . . . . 0.0 109.817 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 28' ' ' ASP . 5.1 mtpp -163.41 59.23 0.18 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.528 -0.732 . . . . 0.0 109.426 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.927 ' OG ' HG22 ' A' ' 45' ' ' VAL . 39.1 m -139.88 153.53 47.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.026 . . . . 0.0 111.562 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' OE2' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -115.9 112.2 21.54 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.566 HG11 HD13 ' A' ' 22' ' ' LEU . 7.0 t -106.84 159.06 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -0.957 . . . . 0.0 110.93 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.567 ' CD1' HG22 ' A' ' 48' ' ' THR . 46.1 m-85 -130.91 -36.41 1.36 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.354 -0.841 . . . . 0.0 110.946 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . -151.0 12.76 0.83 Allowed Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.582 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' SER . 27.5 m -62.44 162.13 10.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.989 -1.301 . . . . 0.0 110.648 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.5 ' HA ' ' C ' ' A' ' 21' ' ' THR . 19.9 m -109.94 -22.52 11.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.358 -0.839 . . . . 0.0 110.266 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.496 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 4.0 t 42.24 81.13 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.24 -0.913 . . . . 0.0 110.42 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.529 ' O ' HG22 ' A' ' 38' ' ' THR . 88.8 m -77.06 57.2 1.34 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 109.421 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.39 74.11 1.28 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -157.35 -161.77 1.11 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.261 -1.14 . . . . 0.0 110.008 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 10.7 ptt180 -167.56 162.33 14.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.051 -1.031 . . . . 0.0 110.658 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.601 ' CE1' HD13 ' A' ' 57' ' ' ILE . 2.6 m-85 -120.31 -162.72 0.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.371 -0.831 . . . . 0.0 110.217 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER 171.98 53.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 110.139 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 29' ' ' LYS . . . 117.27 56.49 0.3 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.927 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.3 m -139.35 -164.75 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.09 -1.241 . . . . 0.0 110.475 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 46' ' ' THR . 91.5 m -161.07 56.52 0.3 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 64' ' ' ILE . 17.4 tt -83.86 165.47 2.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.378 -0.826 . . . . 0.0 110.589 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.567 HG22 ' CD1' ' A' ' 33' ' ' TYR . 66.4 p -129.53 -140.04 0.23 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 109.131 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.517 ' HA ' ' CA ' ' A' ' 34' ' ' GLY . 41.6 m -51.32 129.44 24.84 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.057 -1.027 . . . . 0.0 108.941 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' THR . 41.0 t -171.21 163.18 7.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.006 -1.059 . . . . 0.0 110.587 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.677 HG22 ' O ' ' A' ' 51' ' ' THR . 52.9 m -116.83 13.99 15.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.079 -1.013 . . . . 0.0 110.339 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.474 ' C ' ' O ' ' A' ' 51' ' ' THR . 54.5 p -36.18 133.94 0.45 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.644 -0.66 . . . . 0.0 110.653 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 69' ' ' ILE . 6.9 m -127.22 107.64 10.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 110.19 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 64.84 78.93 0.19 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.453 ' O ' HD12 ' A' ' 57' ' ' ILE . 51.8 p -158.3 127.47 5.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.153 -1.204 . . . . 0.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HB3' ' CB ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -78.54 103.6 8.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 57' ' ' ILE . 3.1 mp -89.48 16.47 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.963 -1.085 . . . . 0.0 110.66 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.49 159.73 0.69 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.2 -0.937 . . . . 0.0 110.266 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 159.29 166.82 18.99 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.77 54.03 3.87 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.073 1.565 . . . . 0.0 109.873 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 107.56 22.51 7.35 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.527 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 5.0 t -40.56 103.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.584 -0.95 . . . . 0.0 110.384 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' O ' ' CG1' ' A' ' 64' ' ' ILE . 13.2 tttt -97.12 146.06 25.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.572 -0.705 . . . . 0.0 109.725 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.672 HG23 ' NZ ' ' A' ' 81' ' ' LYS . 19.2 mt -154.5 144.08 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.052 -1.03 . . . . 0.0 110.783 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.438 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.0 OUTLIER -136.4 107.87 6.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.284 -0.885 . . . . 0.0 110.653 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' THR . 5.9 m 58.02 79.65 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.37 -0.831 . . . . 0.0 111.469 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.523 ' O ' HG13 ' A' ' 69' ' ' ILE . 0.9 OUTLIER -135.63 117.4 15.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 109.981 178.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.665 ' HB ' ' HB3' ' A' ' 75' ' ' ALA . 1.1 mm -76.33 101.75 2.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 17.4 mt -115.2 155.87 16.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 O-C-N 120.899 -1.126 . . . . 0.0 109.97 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.845 ' O ' HG22 ' A' ' 73' ' ' VAL . 86.4 m -159.98 103.02 1.48 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 0.0 110.426 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.73 ' O ' ' HB2' ' A' ' 89' ' ' ALA . . . 88.94 25.93 28.03 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.17 17.29 69.75 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 70' ' ' THR . 12.4 m -127.63 132.86 24.55 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.393 -1.063 . . . . 0.0 110.859 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -81.46 147.06 15.69 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.02 1.537 . . . . 0.0 110.656 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.853 ' HB1' ' CD ' ' A' ' 76' ' ' PRO . . . -73.15 -153.59 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.154 -0.966 . . . . 0.0 108.403 178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.853 ' CD ' ' HB1' ' A' ' 75' ' ' ALA . 43.5 Cg_endo -75.62 9.48 2.24 Favored 'Trans proline' 0 N--CA 1.485 0.994 0 O-C-N 122.404 0.686 . . . . 0.0 111.018 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.503 ' CB ' ' HB3' ' A' ' 80' ' ' CYS . 5.3 p 45.0 50.17 9.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.89 . . . . 0.0 111.448 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.07 -23.6 3.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.02 -1.05 . . . . 0.0 109.153 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.54 40.88 0.25 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 1.2 t -109.49 164.64 12.32 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.902 0.858 . . . . 0.0 110.98 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.672 ' NZ ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -96.27 173.71 7.25 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 82' ' ' ILE . 17.9 mm -160.1 53.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 t -97.95 -126.06 0.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.403 -0.811 . . . . 0.0 110.386 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.48 91.54 1.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.428 ' SG ' ' C ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER -162.76 177.51 9.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -1.147 . . . . 0.0 109.874 179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.527 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -177.43 149.57 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.35 -0.844 . . . . 0.0 110.022 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -117.13 166.6 12.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.113 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.491 ' CB ' ' HB3' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -148.58 23.91 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.901 -1.125 . . . . 0.0 110.371 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 71' ' ' GLY . . . 47.16 62.7 2.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.257 -0.902 . . . . 0.0 109.695 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.462 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.21 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 47.7 t0 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.211 0.529 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.45 -126.49 1.84 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.22 42.57 1.9 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -1.158 . . . . 0.0 109.728 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.3 m -93.6 119.37 32.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.459 -0.776 . . . . 0.0 110.49 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.655 HG23 ' HB3' ' A' ' 9' ' ' SER . 27.6 m -125.09 -12.67 6.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -0.894 . . . . 0.0 110.329 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 7' ' ' THR . 8.4 p30 41.07 43.37 1.83 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.904 -1.123 . . . . 0.0 110.321 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.553 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.0 m 76.48 -5.02 2.25 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.5 -0.75 . . . . 0.0 111.443 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.4 t-20 -160.45 -51.1 0.05 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.812 -1.18 . . . . 0.0 110.633 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.655 ' HB3' HG23 ' A' ' 5' ' ' THR . 0.9 OUTLIER 85.18 92.79 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.787 0.803 . . . . 0.0 111.267 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.54 ' CD ' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -131.21 26.97 4.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.945 -1.097 . . . . 0.0 108.265 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.052 HD12 ' CB ' ' A' ' 15' ' ' SER . 3.4 mm? -41.25 103.18 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 121.95 0.881 . . . . 0.0 109.35 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 13' ' ' ALA . 50.8 m -64.94 55.49 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.842 -0.536 . . . . 0.0 111.5 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' ASN . . . 56.76 154.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 110.627 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER 70.51 -4.68 1.57 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.209 -0.932 . . . . 0.0 111.807 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 1.052 ' CB ' HD12 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -74.42 176.69 6.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.458 -1.401 . . . . 0.0 110.574 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HD3' ' CG ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -160.42 151.53 19.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.071 179.392 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 p -166.65 -172.01 2.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 110.263 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 22.3 tt0 -169.61 -39.96 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.384 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -177.62 54.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.366 -0.834 . . . . 0.0 109.987 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.482 ' HB2' ' N ' ' A' ' 34' ' ' GLY . 52.0 p -102.92 -163.44 0.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.339 -0.85 . . . . 0.0 110.557 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' THR . 68.8 m -126.77 77.0 1.68 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.979 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 37' ' ' CYS . 3.5 tp -95.19 165.83 12.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 110.468 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.483 HG23 ' OG1' ' A' ' 7' ' ' THR . 21.7 m -167.51 128.81 1.52 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.426 -0.796 . . . . 0.0 109.902 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 6' ' ' ASN . 28.8 m-80 56.34 29.14 14.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.075 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -101.8 154.57 18.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.86 . . . . 0.0 110.375 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' CD1' ' CD ' ' A' ' 10' ' ' GLN . 1.9 m-85 -116.69 -40.31 3.2 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.784 ' HB ' HD13 ' A' ' 11' ' ' LEU . 6.5 t 52.99 137.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 122.107 0.956 . . . . 0.0 113.096 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.431 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 14.7 t0 -142.2 118.08 10.54 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 14' ' ' ASN . 30.8 mttm 53.11 66.07 1.34 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.009 -1.057 . . . . 0.0 109.301 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.523 ' HB3' HG22 ' A' ' 45' ' ' VAL . 69.3 m -153.51 151.97 30.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.038 -1.039 . . . . 0.0 110.65 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' CG ' ' HD3' ' A' ' 16' ' ' LYS . 11.0 mt-10 -121.12 112.91 19.28 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.534 -0.729 . . . . 0.0 109.166 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.515 HG11 ' HB ' ' A' ' 35' ' ' THR . 17.0 t -111.13 152.55 13.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.57 -0.707 . . . . 0.0 110.392 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.456 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 51.2 m-85 -144.93 34.71 1.12 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.263 -0.898 . . . . 0.0 110.841 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.482 ' N ' ' HB2' ' A' ' 20' ' ' SER . . . 140.9 41.46 0.07 OUTLIER Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.122 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.515 ' HB ' HG11 ' A' ' 32' ' ' VAL . 3.5 m -97.41 124.9 41.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.075 -1.25 . . . . 0.0 110.582 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.543 ' O ' HG22 ' A' ' 36' ' ' THR . 90.4 m -79.98 55.49 2.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.143 -0.973 . . . . 0.0 109.71 179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 22' ' ' LEU . 29.8 t -46.11 143.6 2.26 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.534 -0.728 . . . . 0.0 110.689 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 t -124.08 10.3 8.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 129.89 40.92 0.25 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.405 ' HA ' HD21 ' A' ' 90' ' ' ASN . 47.2 m -122.38 -167.74 1.61 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.328 -1.101 . . . . 0.0 110.075 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 42' ' ' PHE . 2.6 ttt180 -158.19 165.83 33.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 110.35 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.648 ' HD2' HG13 ' A' ' 27' ' ' VAL . 7.0 m-85 -121.97 -172.2 2.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.814 . . . . 0.0 109.692 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 20.2 t0 -167.8 49.37 0.05 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.988 -1.07 . . . . 0.0 110.562 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 118.47 51.17 0.32 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 ' N ' ' A' ' 46' ' ' THR . 1.1 m -127.87 -166.37 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.092 -1.24 . . . . 0.0 110.828 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.548 ' N ' HG23 ' A' ' 45' ' ' VAL . 24.6 m -161.37 56.28 0.28 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 50' ' ' SER . 13.7 tt -76.56 172.04 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.498 -0.751 . . . . 0.0 110.735 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.462 ' N ' HG12 ' A' ' 47' ' ' ILE . 47.0 p -138.28 -137.04 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.444 -0.785 . . . . 0.0 109.551 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 40.5 m -65.34 81.99 0.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.835 -1.165 . . . . 0.0 109.888 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.676 ' HB3' HD11 ' A' ' 47' ' ' ILE . 23.2 t -135.89 148.5 48.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.04 -1.037 . . . . 0.0 111.357 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.555 ' CB ' ' HA ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -95.49 126.36 40.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.078 -1.014 . . . . 0.0 109.12 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.04 105.08 5.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 110.004 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -95.11 102.54 14.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 0.0 109.477 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 61.12 92.52 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 83.7 p -166.15 121.08 1.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -1.213 . . . . 0.0 110.414 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.552 ' HG3' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -81.25 112.72 18.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.008 -1.057 . . . . 0.0 109.458 179.382 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.494 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 18.0 mm -88.57 13.27 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.339 -0.851 . . . . 0.0 110.823 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -42.59 141.21 1.07 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.233 -0.917 . . . . 0.0 110.286 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 178.8 146.03 6.4 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -76.39 55.82 4.82 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 O-C-N 124.024 1.539 . . . . 0.0 109.103 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 117.23 20.17 4.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -39.43 147.25 0.08 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.381 -1.07 . . . . 0.0 110.964 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 81' ' ' LYS . 24.1 tttt -147.16 100.74 3.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.867 . . . . 0.0 110.048 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.85 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.4 mt -116.19 149.92 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.0 110.431 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -142.18 118.05 10.54 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.202 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.1 m 54.35 80.57 0.12 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 111.892 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.8 t -137.99 128.78 26.9 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 68' ' ' ILE . 1.7 mp -82.66 9.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.879 -1.138 . . . . 0.0 110.55 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.533 HG13 ' SG ' ' A' ' 67' ' ' CYS . 62.5 mt -18.35 138.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 CA-C-O 121.434 0.635 . . . . 0.0 112.04 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.815 ' O ' HG22 ' A' ' 73' ' ' VAL . 52.3 m -148.66 100.9 3.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.961 -1.087 . . . . 0.0 111.477 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.538 ' O ' HG13 ' A' ' 73' ' ' VAL . . . 91.67 37.75 6.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.448 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 72.07 13.2 76.09 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 70' ' ' THR . 5.3 m -120.3 136.52 25.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.39 -1.065 . . . . 0.0 110.013 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HA ' HG12 ' A' ' 69' ' ' ILE . 44.8 Cg_endo -75.93 142.13 24.82 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.789 1.415 . . . . 0.0 110.682 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -94.59 167.77 12.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 109.604 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 45.4 Cg_endo -72.09 72.95 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.683 1.36 . . . . 0.0 110.031 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.555 ' HB3' ' CB ' ' A' ' 80' ' ' CYS . 4.9 t -115.29 107.41 15.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.477 -0.764 . . . . 0.0 110.242 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.34 -13.9 15.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.964 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.71 -14.44 23.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.392 -0.818 . . . . 0.0 110.108 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' ' 77' ' ' SER . 7.2 t -72.39 161.34 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.419 -0.801 . . . . 0.0 110.398 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.909 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -124.55 154.84 40.0 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.53 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.909 HD13 ' O ' ' A' ' 81' ' ' LYS . 18.1 mm -140.77 70.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -137.48 106.54 6.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.828 . . . . 0.0 111.684 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.5 30.23 53.96 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.652 178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.85 ' SG ' HD11 ' A' ' 64' ' ' ILE . 5.5 t -150.31 179.31 8.23 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.984 -1.304 . . . . 0.0 110.231 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.54 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.0 t -177.31 161.25 1.78 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.383 -0.823 . . . . 0.0 109.726 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -121.68 169.91 10.25 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 109.525 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.48 24.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.8 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 46.61 78.78 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.463 -0.773 . . . . 0.0 109.965 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.552 ' HB2' ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.394 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.202 0.525 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.31 64.32 0.83 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.0 25.86 3.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.234 -1.156 . . . . 0.0 109.916 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.7 p -134.69 150.2 50.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.332 -0.855 . . . . 0.0 109.798 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.758 HG22 ' H ' ' A' ' 8' ' ' ASN . 79.3 m -126.82 4.32 6.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.944 . . . . 0.0 110.585 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.557 ' OD1' ' N ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER 28.54 41.84 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.602 -0.686 . . . . 0.0 111.873 -179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.543 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER 75.96 22.37 1.45 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.441 -0.787 . . . . 0.0 112.681 178.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.758 ' H ' HG22 ' A' ' 5' ' ' THR . 0.1 OUTLIER 167.81 -25.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.778 -1.201 . . . . 0.0 111.293 179.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.635 ' HB3' HG23 ' A' ' 5' ' ' THR . 0.3 OUTLIER 63.75 90.51 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.31 -0.869 . . . . 0.0 110.121 -178.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -129.46 20.3 5.69 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.68 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.794 HD12 ' CB ' ' A' ' 15' ' ' SER . 2.3 mm? -43.44 117.42 1.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.538 ' OG ' ' CZ ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -58.6 71.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.517 -0.74 . . . . 0.0 111.134 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 11' ' ' LEU . . . 21.89 59.87 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 120.963 0.411 . . . . 0.0 111.79 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 41.1 t-20 -178.46 -32.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.158 -0.964 . . . . 0.0 110.307 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.794 ' CB ' HD12 ' A' ' 11' ' ' LEU . 15.1 t -58.42 -176.56 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.558 -0.714 . . . . 0.0 110.998 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 9.9 ttmt -139.47 147.38 41.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 109.791 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.55 127.22 14.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.966 . . . . 0.0 110.32 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -120.72 -38.29 2.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.088 -1.008 . . . . 0.0 110.551 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -174.12 34.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -0.93 . . . . 0.0 109.686 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 p -84.68 -167.97 2.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 110.691 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 21' ' ' THR . 5.7 t -142.47 66.53 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 110.063 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 22' ' ' LEU . 5.3 mt -77.97 177.07 8.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.996 -1.065 . . . . 0.0 109.988 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 37' ' ' CYS . 55.5 m -164.7 121.44 1.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.866 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 6' ' ' ASN . 31.0 m120 56.57 48.7 16.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 109.407 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -119.19 164.84 15.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.59 0.709 . . . . 0.0 110.839 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 26' ' ' TYR . 25.1 t80 -138.22 26.06 2.67 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.798 HG13 ' HD2' ' A' ' 42' ' ' PHE . 15.1 t -21.67 144.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 115.226 -0.897 . . . . 0.0 113.016 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 42.8 t0 -145.56 147.05 31.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.467 -0.771 . . . . 0.0 109.801 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 41.9 mtpt 35.43 41.5 0.09 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.569 -0.707 . . . . 0.0 110.34 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.822 ' CB ' HG22 ' A' ' 45' ' ' VAL . 75.3 m -133.19 150.8 51.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 110.851 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 47' ' ' ILE . 7.7 mt-10 -118.29 99.66 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 0.0 109.64 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.589 HG22 ' CG2' ' A' ' 47' ' ' ILE . 21.8 t -99.17 163.62 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.512 -0.742 . . . . 0.0 110.528 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.427 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 49.4 m-85 -148.44 -14.23 0.34 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.073 -1.017 . . . . 0.0 111.926 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.15 26.45 0.2 Allowed Glycine 0 N--CA 1.494 2.549 0 O-C-N 120.556 -1.34 . . . . 0.0 109.962 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 36' ' ' THR . 43.5 m -82.07 168.83 17.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -1.126 . . . . 0.0 110.732 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.566 ' N ' HG22 ' A' ' 35' ' ' THR . 40.0 m -129.33 52.65 1.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.383 -0.823 . . . . 0.0 109.62 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.503 ' O ' ' N ' ' A' ' 23' ' ' THR . 5.9 t -44.02 102.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 110.158 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 38' ' ' THR . 13.5 t -95.84 35.64 1.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 0.0 110.142 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.02 24.5 2.48 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.501 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -115.14 -166.98 1.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -1.075 . . . . 0.0 109.489 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.501 ' N ' ' OG ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -164.66 164.53 21.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.898 -1.126 . . . . 0.0 111.159 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.798 ' HD2' HG13 ' A' ' 27' ' ' VAL . 7.0 m-85 -123.13 -177.4 3.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.316 -0.865 . . . . 0.0 109.922 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 1.1 t70 -165.81 53.59 0.1 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.237 -0.914 . . . . 0.0 110.482 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 117.53 66.96 0.36 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.822 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.7 m -143.68 -160.44 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.911 -1.347 . . . . 0.0 111.604 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.557 ' N ' HG23 ' A' ' 45' ' ' VAL . 97.5 m -165.08 58.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.589 ' CG2' HG22 ' A' ' 32' ' ' VAL . 10.1 tt -81.42 165.29 2.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.345 -0.847 . . . . 0.0 110.923 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 25.0 p -131.34 -143.34 0.24 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 66' ' ' THR . 26.8 m -56.42 110.45 0.77 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.581 -1.325 . . . . 0.0 108.236 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' THR . 1.4 t -161.61 136.96 7.54 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.706 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -98.48 122.03 41.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.335 -0.853 . . . . 0.0 109.637 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.465 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -135.77 129.49 32.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.114 -0.991 . . . . 0.0 110.507 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.1 101.7 10.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.365 -0.834 . . . . 0.0 109.427 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 64.74 99.21 0.01 OUTLIER Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.482 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 85.6 p -174.42 110.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -1.163 . . . . 0.0 110.564 -179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.548 ' CA ' ' HB3' ' A' ' 90' ' ' ASN . 3.8 ptp180 -77.4 112.12 13.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.104 -0.997 . . . . 0.0 109.166 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.528 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 32.6 mm -87.57 21.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.083 -1.011 . . . . 0.0 110.548 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.6 m -45.36 160.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 110.144 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.69 163.36 11.59 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.7 47.83 2.69 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.005 1.529 . . . . 0.0 109.826 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 123.8 16.22 3.38 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.495 ' HB3' ' CB ' ' A' ' 45' ' ' VAL . 3.1 t -36.62 116.75 0.45 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.604 -0.939 . . . . 0.0 110.998 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.558 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 32.2 tttm -107.79 153.76 22.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.882 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.038 HD13 ' HE2' ' A' ' 81' ' ' LYS . 30.1 mm -152.38 130.66 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.83 -1.168 . . . . 0.0 109.642 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.497 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 62.4 p -132.58 118.51 19.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 0.0 110.257 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.6 OUTLIER 43.44 56.95 4.11 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.475 -0.766 . . . . 0.0 110.056 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HB2' HG23 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -113.17 99.05 7.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.192 -0.943 . . . . 0.0 109.862 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.674 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.9 mp -69.49 86.56 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.978 -1.076 . . . . 0.0 109.114 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.609 HG23 ' C ' ' A' ' 73' ' ' VAL . 9.0 mt -89.64 159.9 2.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.624 -0.673 . . . . 0.0 110.189 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.776 ' O ' HG22 ' A' ' 73' ' ' VAL . 8.6 m -157.99 96.27 1.45 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 110.281 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.59 33.25 8.07 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 87' ' ' PHE . . . 75.52 16.98 80.31 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 70' ' ' THR . 13.8 m -126.18 131.44 23.96 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.376 -1.073 . . . . 0.0 110.177 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -79.68 151.0 21.86 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.768 1.404 . . . . 0.0 110.453 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -82.82 173.53 7.41 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.093 -1.004 . . . . 0.0 110.094 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -82.4 9.98 3.77 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.759 1.399 . . . . 0.0 109.751 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.9 t -54.97 132.94 48.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.539 -0.725 . . . . 0.0 110.343 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.67 -10.84 55.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.419 -0.801 . . . . 0.0 110.391 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.69 -14.25 25.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 109.732 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 67' ' ' CYS . 36.4 t -77.03 123.55 26.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.331 -0.856 . . . . 0.0 109.444 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.038 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.42 172.89 6.85 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.054 -1.029 . . . . 0.0 110.476 -179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.76 HG22 ' O ' ' A' ' 82' ' ' ILE . 0.6 OUTLIER -163.23 82.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.46 74.67 1.57 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.718 -0.614 . . . . 0.0 111.4 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.18 -13.82 44.27 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.371 178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -82.04 -164.63 0.84 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.969 -1.312 . . . . 0.0 109.961 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.573 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 1.3 t 168.82 147.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 109.657 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.642 ' HE1' HD11 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -130.57 156.08 45.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.825 . . . . 0.0 109.395 179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.447 ' HB3' ' CD ' ' A' ' 56' ' ' ARG . 1.0 OUTLIER -145.25 30.34 1.14 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.398 -0.814 . . . . 0.0 109.142 179.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.482 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 51.72 82.14 0.07 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.411 -0.805 . . . . 0.0 108.867 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.548 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.68 -178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.208 0.528 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.41 -47.75 1.0 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m -124.42 -76.97 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.131 -1.217 . . . . 0.0 110.511 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 5' ' ' THR . 59.6 m 49.42 -154.29 0.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.746 -1.221 . . . . 0.0 110.705 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 4' ' ' CYS . 1.0 OUTLIER 167.47 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.545 HD21 HD22 ' A' ' 11' ' ' LEU . 0.9 OUTLIER 64.58 58.12 1.06 Allowed 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 2.5 m 75.55 -52.05 0.64 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.316 0.579 . . . . 0.0 109.568 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER 176.2 56.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 179.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 3.7 m -117.45 -140.54 0.36 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.423 -0.798 . . . . 0.0 110.341 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -132.06 -37.31 1.13 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.955 . . . . 0.0 110.593 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.877 HD21 ' HB2' ' A' ' 17' ' ' CYS . 22.8 tp 47.57 81.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.11 -0.994 . . . . 0.0 108.478 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -43.05 147.13 0.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.825 . . . . 0.0 110.387 -178.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.21 -13.37 12.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.158 -0.964 . . . . 0.0 109.651 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 53.7 t-20 -90.4 -1.95 57.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.516 -0.74 . . . . 0.0 110.216 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 39.8 t -91.72 -157.52 0.51 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.042 -1.036 . . . . 0.0 109.843 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 4.8 tttt -138.79 159.14 42.85 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.314 -0.866 . . . . 0.0 110.113 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.877 ' HB2' HD21 ' A' ' 11' ' ' LEU . 34.9 t -148.87 116.7 6.3 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.286 -0.884 . . . . 0.0 110.744 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 19' ' ' LYS . 2.2 mt-10 -147.68 71.7 1.21 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.493 -0.755 . . . . 0.0 109.272 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 61.83 117.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 108.996 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -158.02 173.43 16.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.025 . . . . 0.0 110.722 -178.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.5 m -119.79 30.26 7.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 0.0 109.736 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 37' ' ' CYS . 11.2 mt -60.95 -178.79 0.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 109.963 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 24.2 m -166.24 122.23 1.27 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.787 . . . . 0.0 109.507 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 47.48 46.73 17.47 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.118 -0.989 . . . . 0.0 109.059 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 40' ' ' SER . 0.9 OUTLIER -88.08 -151.12 0.19 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.971 0.891 . . . . 0.0 111.254 -178.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.613 ' CD1' ' O ' ' A' ' 26' ' ' TYR . 1.2 t80 174.35 41.77 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 42' ' ' PHE . 26.1 t -50.7 149.43 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.7 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -157.05 131.18 8.39 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 1.2 mtpt 55.6 19.37 3.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -0.985 . . . . 0.0 110.154 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.47 ' HB3' HG22 ' A' ' 45' ' ' VAL . 69.8 m -122.48 -178.15 3.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.969 -1.082 . . . . 0.0 110.612 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' C ' HG23 ' A' ' 32' ' ' VAL . 3.6 tt0 -116.33 -71.91 0.72 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -0.858 . . . . 0.0 110.419 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG23 ' C ' ' A' ' 31' ' ' GLU . 3.7 t 66.45 140.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.594 -0.691 . . . . 0.0 110.266 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 32' ' ' VAL . 44.1 m-85 -141.34 -70.81 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 110.587 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.61 22.06 33.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.556 ' O ' HD23 ' A' ' 22' ' ' LEU . 98.3 m -70.54 160.14 33.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.397 -1.061 . . . . 0.0 111.29 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 37' ' ' CYS . 22.2 m -116.01 49.97 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.495 -0.753 . . . . 0.0 109.742 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.576 ' HB2' HD22 ' A' ' 22' ' ' LEU . 31.2 t -39.38 104.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 111.162 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 64.4 m -98.95 89.84 4.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.156 -0.965 . . . . 0.0 109.838 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.78 38.44 95.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -130.8 -150.65 0.44 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.171 -1.194 . . . . 0.0 110.063 179.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 40' ' ' SER . 18.7 ptt180 177.66 -176.68 0.18 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.317 -0.865 . . . . 0.0 110.518 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' A' ' 47' ' ' ILE . 20.4 m-85 -133.16 -169.4 2.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.387 -0.821 . . . . 0.0 109.301 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.88 50.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.847 . . . . 0.0 109.814 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 115.72 58.14 0.34 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 2.3 m -138.53 -159.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.989 -1.301 . . . . 0.0 110.709 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 46' ' ' THR . 87.8 m -161.79 51.04 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.44 -0.788 . . . . 0.0 109.809 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.652 HG21 ' CE2' ' A' ' 42' ' ' PHE . 6.6 tt -80.27 164.41 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.368 -0.833 . . . . 0.0 110.435 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 46.2 p -136.48 -120.04 0.16 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.347 -0.846 . . . . 0.0 110.333 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' THR . 94.3 m -70.33 70.54 0.41 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.674 -1.266 . . . . 0.0 110.114 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.615 ' OG ' HD11 ' A' ' 47' ' ' ILE . 1.1 t -124.27 144.79 49.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.147 -0.97 . . . . 0.0 110.529 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -104.65 125.43 50.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.881 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -136.66 136.17 38.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.999 -1.063 . . . . 0.0 110.122 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.84 89.69 3.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.916 -1.115 . . . . 0.0 109.545 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.1 92.37 0.17 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.9 p -165.2 130.19 2.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -1.143 . . . . 0.0 110.532 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 88' ' ' SER . 14.7 ttp85 -93.38 106.66 18.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.125 -0.984 . . . . 0.0 109.157 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.695 HG23 HD11 ' A' ' 64' ' ' ILE . 8.7 mm -81.63 13.93 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.446 -0.784 . . . . 0.0 110.435 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -34.43 146.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 0.0 110.8 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.94 153.65 9.68 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -84.22 36.46 0.58 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.972 1.511 . . . . 0.0 109.683 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.92 32.72 0.5 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 45' ' ' VAL . 1.6 t -49.87 166.77 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.29 -1.123 . . . . 0.0 110.086 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' SG ' ' A' ' 62' ' ' CYS . 31.8 tttp -149.13 106.24 3.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 109.555 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.695 HD11 HG23 ' A' ' 57' ' ' ILE . 1.7 mt -121.7 158.56 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.888 -1.133 . . . . 0.0 111.046 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 65' ' ' SER . 1.3 p -163.09 105.76 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.548 -0.72 . . . . 0.0 109.479 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' THR . 2.3 m 67.07 78.2 0.25 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 0.0 110.216 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' A' ' 64' ' ' ILE . 74.1 m -140.37 121.8 15.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.431 -0.793 . . . . 0.0 109.598 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.9 mp -93.47 83.62 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.937 -1.102 . . . . 0.0 109.324 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' THR . 29.1 mt -86.54 162.46 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.618 -0.676 . . . . 0.0 110.791 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.817 ' O ' HG22 ' A' ' 73' ' ' VAL . 27.9 m -158.81 95.29 1.29 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.253 -0.905 . . . . 0.0 110.76 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.57 30.32 13.91 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.55 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 81.45 15.32 76.53 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 70' ' ' THR . 10.6 m -127.83 123.78 23.0 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.412 -1.052 . . . . 0.0 110.604 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 44.8 Cg_endo -75.1 138.88 23.35 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.837 1.441 . . . . 0.0 111.274 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -73.55 164.29 62.16 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.359 -0.838 . . . . 0.0 109.466 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 44.0 Cg_endo -71.0 58.91 2.2 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.75 1.395 . . . . 0.0 110.115 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 m -92.63 119.04 31.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.469 -0.77 . . . . 0.0 110.675 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.15 1.51 15.56 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.259 -0.9 . . . . 0.0 111.064 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.67 -16.73 14.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.954 -1.091 . . . . 0.0 110.174 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 82' ' ' ILE . 4.4 t -69.91 165.78 20.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 110.952 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.573 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -60.17 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.651 -0.655 . . . . 0.0 111.876 -179.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 80' ' ' CYS . 4.9 mm 71.96 33.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.2 m -112.12 -84.76 0.58 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.705 -0.622 . . . . 0.0 111.571 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . -117.35 84.79 0.38 Allowed Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.737 -1.22 . . . . 0.0 111.0 -178.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 8.7 t -178.95 174.66 1.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -1.137 . . . . 0.0 110.255 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.505 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 7.4 t -169.6 168.79 9.03 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.609 ' CD1' HD12 ' A' ' 57' ' ' ILE . 1.6 m-85 -126.41 157.06 39.54 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.022 -1.049 . . . . 0.0 109.389 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.499 ' HB2' ' HB3' ' A' ' 56' ' ' ARG . 4.0 m -129.3 20.42 5.75 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 90' ' ' ASN . . . 53.37 59.58 4.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.5 -0.75 . . . . 0.0 109.921 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.334 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.356 0.598 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 3' ' ' SER . . . -74.37 -135.04 0.34 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 2' ' ' GLY . 0.5 OUTLIER 59.65 13.35 3.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -1.181 . . . . 0.0 110.197 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.624 ' HB2' HD23 ' A' ' 11' ' ' LEU . 5.1 m -87.38 -177.75 6.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.907 . . . . 0.0 109.406 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.565 ' O ' HG22 ' A' ' 5' ' ' THR . 31.0 m -129.14 1.18 5.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.079 -1.013 . . . . 0.0 110.114 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 7' ' ' THR . 8.9 p30 35.93 66.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.847 -0.533 . . . . 0.0 110.123 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.5 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.7 OUTLIER 70.31 -57.59 0.57 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 109.297 -178.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER 169.58 81.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.936 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.495 ' CB ' ' OD1' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -166.74 -144.81 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.21 -0.931 . . . . 0.0 110.313 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.576 ' NE2' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -105.6 170.93 7.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.002 . . . . 0.0 110.417 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.627 ' CD1' HG21 ' A' ' 27' ' ' VAL . 11.5 tp -178.66 92.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.716 . . . . 0.0 109.843 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -40.62 146.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.537 -0.727 . . . . 0.0 110.581 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.27 -13.85 14.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.128 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -92.71 -5.36 51.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.398 -0.814 . . . . 0.0 109.989 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.626 ' OG ' HD11 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -68.63 -170.22 0.2 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.16 -0.962 . . . . 0.0 110.245 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 1.5 tttp -146.77 116.01 7.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 110.231 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 15.5 p -110.96 -164.25 0.9 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 0.0 110.242 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 17' ' ' CYS . 17.6 tp10 69.71 136.62 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 64.39 40.16 6.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.248 -0.907 . . . . 0.0 109.892 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 t -160.85 169.29 22.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.445 -0.785 . . . . 0.0 109.575 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.557 ' CG2' ' HA ' ' A' ' 36' ' ' THR . 32.7 m -106.88 104.61 14.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.008 -1.058 . . . . 0.0 109.64 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.843 HD22 ' N ' ' A' ' 22' ' ' LEU . 1.5 mm? -101.29 150.52 22.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.106 -0.996 . . . . 0.0 110.888 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 16.5 m -163.67 95.0 0.8 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.623 -0.673 . . . . 0.0 109.216 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.464 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.4 OUTLIER 66.33 32.93 7.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.552 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 6' ' ' ASN . 98.3 m -59.69 -159.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.663 0.744 . . . . 0.0 110.901 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.581 ' CD1' ' HD2' ' A' ' 41' ' ' ARG . 1.9 t80 179.77 -43.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.818 HG13 ' HD2' ' A' ' 42' ' ' PHE . 1.9 t 36.6 -159.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.58 0.705 . . . . 0.0 111.148 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.744 ' H ' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER 171.93 -31.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 5.6 mtmt -169.28 51.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.984 ' OG ' HG22 ' A' ' 45' ' ' VAL . 35.2 m -127.34 -166.63 1.63 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 111.051 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 2.2 tt0 -129.09 -65.02 0.88 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.553 -0.717 . . . . 0.0 110.073 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.719 HG22 ' CG2' ' A' ' 47' ' ' ILE . 3.8 t 67.71 147.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.427 -0.796 . . . . 0.0 110.278 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.927 ' CD1' HG22 ' A' ' 48' ' ' THR . 33.1 m-85 -134.77 -50.98 0.78 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.14 -0.975 . . . . 0.0 110.614 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -135.56 35.06 2.21 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.845 HG22 ' H ' ' A' ' 37' ' ' CYS . 5.6 m -83.21 136.45 34.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.169 -1.195 . . . . 0.0 109.888 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.557 ' HA ' ' CG2' ' A' ' 21' ' ' THR . 28.3 m -69.0 -10.92 59.95 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.265 -0.897 . . . . 0.0 110.43 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.845 ' H ' HG22 ' A' ' 35' ' ' THR . 5.9 t 42.62 49.59 4.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 110.54 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.517 ' O ' HG22 ' A' ' 38' ' ' THR . 85.8 m -67.37 66.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.73 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 37' ' ' CYS . . . 68.95 75.17 0.55 Allowed Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.66 158.4 43.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 0.0 110.125 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.581 ' HD2' ' CD1' ' A' ' 26' ' ' TYR . 5.3 ttp180 -131.73 160.54 35.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.343 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.818 ' HD2' HG13 ' A' ' 27' ' ' VAL . 10.4 m-85 -133.21 -169.0 2.18 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.325 -0.859 . . . . 0.0 109.914 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.475 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 0.4 OUTLIER -174.48 49.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 110.076 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 115.41 60.58 0.36 Allowed Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.984 HG22 ' OG ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -134.91 -167.4 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.812 -1.405 . . . . 0.0 110.651 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.59 ' N ' HG23 ' A' ' 45' ' ' VAL . 57.7 m -155.7 56.24 0.61 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.719 ' CG2' HG22 ' A' ' 32' ' ' VAL . 9.2 tt -78.62 170.02 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.38 -0.825 . . . . 0.0 110.544 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.927 HG22 ' CD1' ' A' ' 33' ' ' TYR . 44.2 p -139.36 -131.63 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 66' ' ' THR . 23.9 m -60.87 123.8 18.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.762 -1.211 . . . . 0.0 109.008 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 35' ' ' THR . 0.4 OUTLIER -166.26 154.83 10.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.007 -1.058 . . . . 0.0 110.605 -179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 52' ' ' SER . 1.9 m -107.68 17.27 22.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.021 -1.05 . . . . 0.0 109.991 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -39.61 125.02 1.74 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.482 -0.761 . . . . 0.0 110.495 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 70' ' ' THR . 25.0 m -114.97 111.8 21.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.017 . . . . 0.0 110.143 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.72 86.14 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 p -162.06 131.08 4.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -1.165 . . . . 0.0 110.409 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.502 ' CA ' ' HB3' ' A' ' 90' ' ' ASN . 4.1 ttm180 -88.66 107.53 18.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.793 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.475 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 19.0 mm -87.47 21.29 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 110.611 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -41.86 143.25 0.56 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.221 -0.924 . . . . 0.0 110.324 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 175.92 153.02 10.0 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.263 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 59' ' ' GLY . 50.7 Cg_endo -87.13 62.72 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.036 1.545 . . . . 0.0 109.744 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 62' ' ' CYS . . . 109.16 19.63 8.38 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.532 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -42.55 170.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.597 -0.943 . . . . 0.0 111.238 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' O ' ' NZ ' ' A' ' 81' ' ' LYS . 17.3 ttmm -157.15 112.61 2.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.509 -0.744 . . . . 0.0 110.092 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.73 HD13 ' HE2' ' A' ' 81' ' ' LYS . 3.8 mm -119.85 164.41 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.006 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -168.37 113.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.3 m 49.46 65.63 1.35 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 110.376 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 63.7 m -122.45 97.24 5.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.619 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.678 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.9 mp -64.31 82.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 109.7 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.643 HG23 ' C ' ' A' ' 73' ' ' VAL . 18.8 mt -97.71 155.36 3.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.356 -0.84 . . . . 0.0 109.821 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.809 ' O ' HG22 ' A' ' 73' ' ' VAL . 12.8 m -155.02 101.69 2.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.038 -1.039 . . . . 0.0 110.213 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.03 29.0 16.3 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 79.18 16.6 78.24 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 70' ' ' THR . 5.5 m -122.91 128.56 25.31 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.364 -1.08 . . . . 0.0 110.537 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.882 ' HB3' HD11 ' A' ' 82' ' ' ILE . 45.1 Cg_endo -76.01 149.28 32.52 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.893 1.47 . . . . 0.0 110.652 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -96.49 164.52 18.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.332 -0.855 . . . . 0.0 109.953 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 44.2 Cg_endo -71.31 57.84 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.915 1.482 . . . . 0.0 109.862 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.3 m -91.62 149.76 21.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 0.0 110.535 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.96 -17.96 22.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.421 -0.799 . . . . 0.0 110.248 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.86 -9.25 37.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.651 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.536 ' SG ' HG12 ' A' ' 82' ' ' ILE . 31.2 t -75.98 166.32 23.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -1.0 . . . . 0.0 110.013 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.73 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -111.28 -46.76 3.26 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.977 -1.077 . . . . 0.0 112.761 -178.504 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.882 HD11 ' HB3' ' A' ' 74' ' ' PRO . 16.7 mm 46.77 71.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.564 -1.335 . . . . 0.0 109.961 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.458 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 18.6 t -128.79 -106.67 0.3 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 0.0 110.46 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.35 63.69 2.92 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.574 ' CB ' ' HZ1' ' A' ' 81' ' ' LYS . 2.0 t -167.52 -172.54 1.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.082 -1.246 . . . . 0.0 110.787 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.538 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.7 t 177.44 162.61 0.52 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.475 -0.766 . . . . 0.0 109.333 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.542 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.5 OUTLIER -120.19 166.52 13.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.021 -1.049 . . . . 0.0 110.048 179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 7.9 t -146.16 22.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.437 -0.79 . . . . 0.0 109.74 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 54.25 63.06 2.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.718 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.502 ' HB3' ' CA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.278 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.208 0.528 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.05 161.8 30.56 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t -63.32 -49.48 73.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.305 -1.115 . . . . 0.0 109.941 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' HB3' HD23 ' A' ' 11' ' ' LEU . 0.5 OUTLIER 59.47 -173.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.09 -1.006 . . . . 0.0 110.15 179.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 8' ' ' ASN . 28.4 m -153.82 18.82 0.52 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.151 -0.968 . . . . 0.0 109.699 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.544 ' OD1' ' CB ' ' A' ' 9' ' ' SER . 7.1 p30 18.74 57.39 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 CA-C-O 121.177 0.513 . . . . 0.0 112.151 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 7' ' ' THR . 97.9 m 55.17 55.4 7.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 5' ' ' THR . 17.6 m-20 60.89 89.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.267 0.556 . . . . 0.0 111.316 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.544 ' CB ' ' OD1' ' A' ' 6' ' ' ASN . 0.5 OUTLIER -165.93 -149.22 0.11 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.147 -0.971 . . . . 0.0 109.857 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -126.78 101.16 6.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.224 -0.922 . . . . 0.0 110.449 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.715 HD12 ' HB ' ' A' ' 27' ' ' VAL . 41.3 tp -105.01 97.45 7.3 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.248 -0.908 . . . . 0.0 109.903 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -35.67 133.41 0.4 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.359 0.6 . . . . 0.0 111.205 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.55 -22.66 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 0.0 110.477 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 12' ' ' SER . 0.6 OUTLIER -95.83 -12.57 25.04 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.971 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.791 ' OG ' HG11 ' A' ' 27' ' ' VAL . 4.1 t -64.54 -176.85 0.27 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.928 -1.107 . . . . 0.0 109.729 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HD2' ' HG2' ' A' ' 31' ' ' GLU . 7.2 tttp -127.58 146.2 50.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.033 -1.042 . . . . 0.0 110.61 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.94 110.81 14.69 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.031 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.63 -143.42 0.39 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.222 -0.924 . . . . 0.0 110.514 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.24 11.42 28.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.256 -0.902 . . . . 0.0 110.444 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 33' ' ' TYR . 1.2 p -62.53 169.3 3.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.601 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 36' ' ' THR . 55.3 m -99.11 109.63 22.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.995 -1.066 . . . . 0.0 109.578 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.844 HD22 ' N ' ' A' ' 22' ' ' LEU . 2.5 mm? -99.57 144.03 29.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.439 -0.788 . . . . 0.0 110.847 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 19.9 m -150.87 107.97 3.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.397 -0.814 . . . . 0.0 109.443 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 54.07 44.43 29.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -0.936 . . . . 0.0 109.007 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.568 ' O ' ' HB2' ' A' ' 26' ' ' TYR . 92.8 m -67.59 -157.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.416 -0.803 . . . . 0.0 111.011 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.613 ' CD1' ' O ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER 167.11 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.791 HG11 ' OG ' ' A' ' 15' ' ' SER . 5.1 t -70.66 168.16 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 122.113 0.959 . . . . 0.0 111.409 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.559 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 2.8 t70 -148.39 -35.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.42 0.629 . . . . 0.0 109.512 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.9 OUTLIER -157.85 64.54 0.46 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.529 -0.732 . . . . 0.0 109.825 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.001 ' OG ' HG22 ' A' ' 45' ' ' VAL . 25.7 m -143.84 -175.95 4.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.854 -1.154 . . . . 0.0 111.093 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.586 ' OE1' HG23 ' A' ' 46' ' ' THR . 1.0 OUTLIER -123.43 -66.14 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.6 -0.687 . . . . 0.0 110.353 -179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.581 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 6.8 t 69.07 165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.628 -0.67 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 50.2 m-85 -159.85 -51.0 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.386 -0.821 . . . . 0.0 110.417 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.436 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -123.49 -2.7 8.85 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.676 HG22 ' H ' ' A' ' 37' ' ' CYS . 34.0 m -49.82 162.16 0.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -1.226 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.495 ' HA ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -102.81 -16.68 15.86 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.171 -0.955 . . . . 0.0 110.063 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.676 ' H ' HG22 ' A' ' 35' ' ' THR . 12.6 t 50.85 99.85 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 0.0 111.18 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.699 HG21 HG23 ' A' ' 53' ' ' THR . 20.9 m -114.34 89.88 3.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.113 -0.992 . . . . 0.0 109.483 178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 38' ' ' THR . . . 45.32 56.93 5.95 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.463 ' OG ' ' N ' ' A' ' 41' ' ' ARG . 1.3 t -132.62 -175.99 3.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.135 -1.215 . . . . 0.0 110.192 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.471 ' HD3' ' CE2' ' A' ' 26' ' ' TYR . 15.4 ptt180 -155.52 151.16 27.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.119 -0.988 . . . . 0.0 110.498 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.539 ' HD2' HG13 ' A' ' 27' ' ' VAL . 4.8 m-85 -117.46 -175.4 2.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.0 109.861 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.481 ' HB3' ' OG ' ' A' ' 58' ' ' SER . 24.0 t70 -166.75 38.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.421 -0.8 . . . . 0.0 109.778 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 129.78 66.7 0.11 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.001 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -141.78 -166.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.574 -1.545 . . . . 0.0 111.445 -179.228 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 46' ' ' THR . 72.3 m -164.95 56.17 0.13 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.549 ' CG2' HG22 ' A' ' 32' ' ' VAL . 7.8 tt -76.6 171.44 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.63 -0.669 . . . . 0.0 110.924 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.513 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 44.2 p -135.39 -138.01 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.376 -0.827 . . . . 0.0 109.91 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.56 ' O ' ' HA ' ' A' ' 66' ' ' THR . 53.0 m -65.02 90.28 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.996 -1.065 . . . . 0.0 110.4 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' THR . 44.6 m -145.94 145.9 30.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.858 -1.151 . . . . 0.0 110.558 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -99.8 117.97 35.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.952 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -136.88 124.18 21.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.845 . . . . 0.0 110.124 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.699 HG23 HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER -109.1 100.33 9.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.915 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.7 83.72 0.48 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.492 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 5.8 p -159.01 116.46 2.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -1.108 . . . . 0.0 110.428 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -75.36 109.87 9.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 109.729 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.521 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 11.1 mm -87.9 3.02 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.071 -1.018 . . . . 0.0 111.171 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 74.8 m -42.03 163.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.218 -0.926 . . . . 0.0 110.403 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 145.92 150.45 5.21 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.35 59.33 1.91 Allowed 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 123.902 1.475 . . . . 0.0 109.523 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 63' ' ' LYS . . . 112.53 28.64 3.42 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 2.0 t -52.6 128.8 27.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.345 -1.091 . . . . 0.0 110.337 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.563 ' HD2' ' HB ' ' A' ' 46' ' ' THR . 2.0 mmtm -120.97 149.77 42.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.095 -1.003 . . . . 0.0 110.968 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.923 HD13 ' HE2' ' A' ' 81' ' ' LYS . 12.6 mm -149.27 135.06 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.48 -0.762 . . . . 0.0 109.334 178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.461 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -140.27 116.73 10.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.996 -1.065 . . . . 0.0 110.778 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.7 OUTLIER 45.89 70.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.613 -0.679 . . . . 0.0 111.644 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 52.9 t -133.72 125.88 29.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.218 -0.926 . . . . 0.0 109.348 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.833 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.3 mp -88.01 81.08 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.237 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.598 HG21 ' CD2' ' A' ' 87' ' ' PHE . 4.4 mt -88.9 160.43 2.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.706 -0.621 . . . . 0.0 109.742 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.763 ' O ' HG22 ' A' ' 73' ' ' VAL . 55.4 m -161.0 96.61 1.11 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.104 -0.998 . . . . 0.0 110.619 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 91.47 30.07 11.29 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.582 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 81.22 14.76 78.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 70' ' ' THR . 11.6 m -123.63 127.36 25.53 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.489 -1.006 . . . . 0.0 110.098 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -80.01 143.02 15.9 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.706 1.372 . . . . 0.0 110.075 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -87.5 149.96 47.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.139 -0.975 . . . . 0.0 110.24 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.13 57.73 1.21 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.152 1.606 . . . . 0.0 110.498 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.06 150.74 20.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.758 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.67 -7.1 50.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.55 -16.46 14.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 111.241 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 15.0 t -68.16 129.56 40.29 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.813 -1.179 . . . . 0.0 109.573 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.923 ' HE2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.12 171.78 7.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.916 -1.115 . . . . 0.0 110.305 -179.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -166.64 91.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.524 -0.735 . . . . 0.0 109.027 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.48 -59.18 1.96 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.056 -1.027 . . . . 0.0 110.555 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.28 52.22 0.64 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.697 ' C ' HG22 ' A' ' 86' ' ' THR . 1.7 t -124.55 -150.04 0.44 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 110.032 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.697 HG22 ' C ' ' A' ' 85' ' ' CYS . 0.0 OUTLIER 165.05 143.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.497 -0.752 . . . . 0.0 110.54 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.79 ' HE1' HD11 ' A' ' 64' ' ' ILE . 1.8 m-30 -107.1 -65.0 1.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.537 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER 71.4 8.34 6.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.432 -0.792 . . . . 0.0 110.45 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 54.21 85.73 0.05 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.99 . . . . 0.0 109.635 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.446 ' OD1' ' C ' ' A' ' 90' ' ' ASN . 4.5 p30 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.358 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.182 0.515 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.56 69.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.54 61.0 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -1.099 . . . . 0.0 110.514 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.536 ' O ' ' HB ' ' A' ' 5' ' ' THR . 0.5 OUTLIER -96.14 -19.09 19.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.274 -0.891 . . . . 0.0 109.973 179.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.619 ' O ' HG22 ' A' ' 5' ' ' THR . 42.0 m 63.26 6.74 2.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.708 -0.62 . . . . 0.0 110.651 -179.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER 66.59 -59.83 0.35 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.127 -0.983 . . . . 0.0 109.702 179.733 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 5' ' ' THR . 90.0 m -160.76 -37.25 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.474 -0.766 . . . . 0.0 109.451 179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.08 31.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.393 -0.817 . . . . 0.0 109.834 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.476 ' OG ' ' CZ ' ' A' ' 26' ' ' TYR . 21.0 t -138.21 -73.21 0.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 110.084 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.59 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -170.25 179.61 3.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.122 -0.986 . . . . 0.0 110.844 179.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.723 HD11 ' OG ' ' A' ' 15' ' ' SER . 18.9 tp -176.0 90.38 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 31.0 t -36.53 137.05 0.31 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.636 -0.665 . . . . 0.0 110.54 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.6 -17.33 2.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 110.567 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.588 ' ND2' ' HA ' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -90.88 -7.16 52.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 110.324 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.723 ' OG ' HD11 ' A' ' 11' ' ' LEU . 39.7 t -74.66 -158.76 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.027 . . . . 0.0 109.732 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 31' ' ' GLU . 5.5 tttp -148.57 125.92 11.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.925 . . . . 0.0 109.576 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.551 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 9.8 t -109.89 120.74 43.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.714 -179.199 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 19' ' ' LYS . 8.3 tt0 -167.79 114.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.432 -0.792 . . . . 0.0 110.064 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' GLU . 11.7 mttt 41.73 -123.33 0.58 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.0 110.309 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 60.4 160.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.889 -1.132 . . . . 0.0 110.071 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.541 ' HB ' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -100.38 23.63 9.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.078 -1.014 . . . . 0.0 109.497 179.754 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.648 HD13 HG11 ' A' ' 32' ' ' VAL . 2.3 tp -51.53 152.26 2.77 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.49 -0.756 . . . . 0.0 110.496 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.505 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 41.6 m -164.83 134.58 3.74 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.409 -0.807 . . . . 0.0 109.829 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' O ' ' HA2' ' A' ' 39' ' ' GLY . 3.5 m120 50.45 63.52 2.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.032 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -132.55 165.1 25.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.327 -179.9 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 10' ' ' GLN . 44.7 m-85 -121.5 -40.15 2.59 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.692 HG11 ' OG ' ' A' ' 15' ' ' SER . 3.6 t 55.21 141.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 122.11 0.957 . . . . 0.0 111.637 178.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -144.87 113.01 6.47 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.551 -0.718 . . . . 0.0 109.347 179.384 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.588 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 0.2 OUTLIER 54.81 57.53 5.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 0.0 109.354 -179.044 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.571 ' HB3' HG22 ' A' ' 45' ' ' VAL . 6.0 m -134.82 -157.49 0.81 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.758 -179.175 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 0.8 OUTLIER -152.34 -62.55 0.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.567 -0.708 . . . . 0.0 109.968 179.876 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.648 HG11 HD13 ' A' ' 22' ' ' LEU . 13.0 t 61.91 162.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 110.435 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.488 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 11.7 m-85 -155.66 -46.91 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.3 -0.875 . . . . 0.0 110.455 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.73 21.6 3.75 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.544 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 6.5 m -74.76 146.52 42.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.134 . . . . 0.0 110.944 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.541 HG23 ' HB ' ' A' ' 21' ' ' THR . 48.0 m -106.68 70.31 0.81 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.452 -0.78 . . . . 0.0 109.37 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.509 ' HB3' ' HG ' ' A' ' 22' ' ' LEU . 13.9 t -60.7 113.6 2.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.519 -0.738 . . . . 0.0 111.273 -179.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.798 ' O ' HG22 ' A' ' 38' ' ' THR . 14.3 m -106.03 60.22 0.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 108.905 178.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 24' ' ' ASN . . . 91.04 71.69 1.22 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.523 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 70.4 m -154.34 171.58 19.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -1.125 . . . . 0.0 110.315 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -141.12 154.82 46.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.912 . . . . 0.0 110.434 179.77 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.663 ' HD2' HG13 ' A' ' 27' ' ' VAL . 8.5 m-85 -118.36 -174.0 2.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 0.0 110.533 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.49 ' HB2' ' OG ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -173.18 81.44 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.319 -0.863 . . . . 0.0 109.971 179.816 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 84.66 54.23 3.0 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.633 ' HB ' ' HB3' ' A' ' 62' ' ' CYS . 0.8 OUTLIER -128.95 -172.98 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.752 -1.44 . . . . 0.0 110.939 -179.53 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.526 ' N ' HG23 ' A' ' 45' ' ' VAL . 9.3 m -160.4 56.63 0.34 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 50' ' ' SER . 11.5 tt -80.99 168.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.454 -0.779 . . . . 0.0 110.573 -179.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 43.2 p -136.16 -150.26 0.36 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.395 -0.816 . . . . 0.0 108.834 179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.7 m -46.75 108.23 0.13 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.878 -1.139 . . . . 0.0 109.185 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' THR . 70.9 m -164.13 140.64 6.51 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.004 -1.06 . . . . 0.0 110.131 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -101.05 123.3 45.02 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.179 -0.951 . . . . 0.0 109.758 179.608 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -136.11 129.8 32.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 110.234 -179.804 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.57 100.16 9.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.539 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 66.88 80.19 0.19 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.4 p -151.32 113.74 4.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -1.02 . . . . 0.0 110.312 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -73.24 111.36 8.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.165 -0.96 . . . . 0.0 110.134 179.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 11.6 mm -88.41 7.18 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.412 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.49 ' OG ' ' HB2' ' A' ' 43' ' ' ASP . 43.3 m -44.83 141.16 2.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.0 110.486 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 171.41 164.24 26.74 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.388 -1.387 . . . . 0.0 109.989 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.53 56.62 6.04 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 124.06 1.558 . . . . 0.0 109.796 179.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 110.91 19.93 7.47 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.633 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -37.24 113.7 0.27 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.421 -1.047 . . . . 0.0 110.884 179.96 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' O ' ' HE2' ' A' ' 81' ' ' LYS . 10.1 tttm -107.19 122.21 46.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.984 -1.072 . . . . 0.0 109.809 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.865 HD11 ' SG ' ' A' ' 85' ' ' CYS . 5.3 mp -131.54 148.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.111 -0.993 . . . . 0.0 111.223 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -148.08 120.73 8.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.871 . . . . 0.0 110.724 179.395 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' THR . 0.7 OUTLIER 48.06 57.35 6.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.402 -0.811 . . . . 0.0 111.277 179.615 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 80' ' ' CYS . 1.3 m -115.88 106.6 14.0 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.022 -1.049 . . . . 0.0 109.976 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.661 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 1.4 mp -76.73 95.77 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.955 . . . . 0.0 109.316 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.697 HG23 ' C ' ' A' ' 73' ' ' VAL . 6.0 mt -103.87 158.99 5.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 110.595 -179.197 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 73' ' ' VAL . 29.8 m -159.22 98.33 1.43 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.33 -0.856 . . . . 0.0 109.589 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.03 23.5 22.48 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 83.39 15.9 70.31 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.697 ' C ' HG23 ' A' ' 69' ' ' ILE . 11.4 m -120.34 124.41 27.73 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.522 -0.987 . . . . 0.0 110.124 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.48 147.48 28.66 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.916 1.482 . . . . 0.0 111.191 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -92.5 144.95 29.6 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 121.447 -0.783 . . . . 0.0 108.896 178.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.44 60.35 2.64 Favored 'Trans proline' 0 C--N 1.299 -2.068 0 O-C-N 123.814 1.428 . . . . 0.0 110.393 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -81.91 161.63 23.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 109.909 179.697 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.39 -18.16 57.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.131 -0.981 . . . . 0.0 110.749 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.31 -25.66 10.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.969 -1.082 . . . . 0.0 110.62 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 19.5 t -47.49 128.42 12.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.106 -0.996 . . . . 0.0 109.958 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.92 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -90.59 161.94 15.21 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.984 -1.073 . . . . 0.0 110.259 -179.731 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.92 HD13 ' O ' ' A' ' 81' ' ' LYS . 18.4 mm -143.79 67.99 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -146.1 107.85 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 112.417 -177.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . 65.22 73.02 0.63 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.334 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.865 ' SG ' HD11 ' A' ' 64' ' ' ILE . 4.6 t -175.39 -174.91 0.76 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -1.227 . . . . 0.0 110.075 178.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.419 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -179.44 152.15 0.51 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.016 -1.053 . . . . 0.0 110.484 -179.066 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.691 ' CD2' HG21 ' A' ' 69' ' ' ILE . 2.9 m-30 -109.0 -63.54 1.34 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.438 -0.788 . . . . 0.0 109.422 179.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.4 OUTLIER 71.14 4.13 4.94 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.535 -0.728 . . . . 0.0 110.699 179.74 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 57.15 96.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.072 -1.017 . . . . 0.0 109.992 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.136 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 8.8 p-10 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.177 0.513 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.2 -69.21 1.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.3 t -125.18 81.37 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -1.11 . . . . 0.0 109.62 179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.534 ' O ' ' HB ' ' A' ' 5' ' ' THR . 4.3 m -99.07 -23.34 15.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.835 . . . . 0.0 110.304 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.641 HG22 ' H ' ' A' ' 9' ' ' SER . 31.3 m 66.44 1.87 2.24 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.519 -0.738 . . . . 0.0 110.995 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.64 ' HB2' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER 65.59 -54.78 0.35 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.206 -0.934 . . . . 0.0 110.194 -179.812 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 5' ' ' THR . 53.4 m -163.09 -35.56 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.06 -1.025 . . . . 0.0 109.702 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.74 28.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 110.493 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.641 ' H ' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -132.75 -85.47 0.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.024 -1.048 . . . . 0.0 110.62 -179.843 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.56 ' O ' HD22 ' A' ' 11' ' ' LEU . 1.8 tt0 -165.87 -164.03 0.68 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.043 -1.035 . . . . 0.0 111.18 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.071 HD12 ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -173.39 117.36 0.28 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.582 -0.699 . . . . 0.0 109.396 -179.936 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 27' ' ' VAL . 45.3 p -35.14 144.74 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.642 -0.661 . . . . 0.0 110.801 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.16 -25.1 30.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.22 -0.925 . . . . 0.0 110.588 -179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -106.22 3.83 28.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 0.0 110.375 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 1.071 ' CB ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -55.56 -173.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.201 -0.937 . . . . 0.0 110.582 -179.827 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HD2' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -150.36 119.81 6.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.81 . . . . 0.0 109.783 179.902 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 31.7 p -116.24 72.02 0.8 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.015 -1.053 . . . . 0.0 110.491 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.89 136.37 35.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.145 -0.972 . . . . 0.0 110.15 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 mttt 54.35 36.75 26.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 109.868 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.439 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 6.8 m -143.89 162.91 34.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.557 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 36' ' ' THR . 0.1 OUTLIER -113.8 106.17 14.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.408 -0.807 . . . . 0.0 109.612 179.557 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' A' ' 6' ' ' ASN . 4.6 mm? -92.87 156.99 16.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 110.6 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 11.2 m -166.25 121.24 1.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.421 -0.8 . . . . 0.0 109.772 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 23' ' ' THR . 3.6 m-20 42.98 66.17 0.83 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.173 -0.955 . . . . 0.0 110.023 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 9' ' ' SER . 14.5 m -137.1 166.24 24.16 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.189 -0.944 . . . . 0.0 110.671 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 7.9 m-85 -130.09 -47.27 1.11 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.244 179.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.739 HG13 ' HD2' ' A' ' 42' ' ' PHE . 2.8 t 57.46 123.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.539 0.685 . . . . 0.0 110.668 179.025 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.468 ' C ' ' HB2' ' A' ' 12' ' ' SER . 1.9 m-20 -115.13 -14.97 11.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.284 -0.885 . . . . 0.0 110.362 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' O ' ' CA ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -175.65 66.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.898 . . . . 0.0 110.064 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.7 ' OG ' HG22 ' A' ' 45' ' ' VAL . 68.0 m -138.81 -170.47 2.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.183 -0.948 . . . . 0.0 110.24 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.622 ' C ' HG23 ' A' ' 32' ' ' VAL . 3.3 tt0 -127.88 -63.4 1.02 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.306 -0.871 . . . . 0.0 109.708 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.622 HG23 ' C ' ' A' ' 31' ' ' GLU . 2.4 t 68.0 135.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.438 -0.789 . . . . 0.0 110.093 179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.469 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 10.4 m-85 -147.52 46.61 1.12 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.186 -0.946 . . . . 0.0 110.505 -179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.465 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . 142.95 -10.39 2.31 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.83 HG22 ' H ' ' A' ' 37' ' ' CYS . 45.3 m -61.27 151.38 31.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.237 . . . . 0.0 110.609 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 21' ' ' THR . 51.5 m -88.37 -14.03 39.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.749 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.83 ' H ' HG22 ' A' ' 35' ' ' THR . 0.5 OUTLIER 47.42 70.92 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 110.305 179.696 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.503 ' HB ' ' HA ' ' A' ' 53' ' ' THR . 99.6 m -87.71 100.77 13.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.133 -0.979 . . . . 0.0 110.15 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 90' ' ' ASN . . . 45.0 67.19 1.24 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.47 ' O ' ' NE ' ' A' ' 41' ' ' ARG . 32.3 t -153.01 173.18 15.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.342 -1.093 . . . . 0.0 110.281 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HB2' ' ND2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -149.79 159.68 44.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.393 -0.817 . . . . 0.0 110.044 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.739 ' HD2' HG13 ' A' ' 27' ' ' VAL . 5.5 m-85 -125.28 -177.91 4.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.986 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -170.25 48.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.892 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 123.48 56.62 0.19 Allowed Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.7 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -133.27 -163.34 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.829 -1.395 . . . . 0.0 110.884 -179.775 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.608 ' N ' HG23 ' A' ' 45' ' ' VAL . 13.8 m -166.06 55.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.593 HD11 ' CB ' ' A' ' 50' ' ' SER . 21.4 tt -83.52 170.39 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.419 -0.801 . . . . 0.0 110.786 -179.239 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.469 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 62.6 p -128.63 -140.23 0.24 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.456 -0.777 . . . . 0.0 109.598 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 49' ' ' THR . 6.4 m -60.17 83.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.959 . . . . 0.0 110.092 179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.593 ' CB ' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -117.13 140.12 49.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.099 -1.001 . . . . 0.0 110.447 -179.753 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.529 ' HB ' ' HA ' ' A' ' 68' ' ' ILE . 26.6 m -91.18 19.37 5.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.213 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 68' ' ' ILE . 13.0 p -44.34 125.69 4.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 110.521 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.503 ' HA ' ' HB ' ' A' ' 38' ' ' THR . 32.2 m -104.85 97.17 7.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.695 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 62.62 90.19 0.03 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' A' ' 87' ' ' PHE . 7.1 p -157.33 122.95 4.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.541 -179.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.517 ' HB2' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -75.4 101.51 4.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.074 179.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 57' ' ' ILE . 4.0 mt -90.13 16.25 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.62 156.83 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.259 -0.9 . . . . 0.0 110.542 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.68 147.83 5.44 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.67 63.24 7.34 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.978 1.515 . . . . 0.0 110.009 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 113.98 17.4 7.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -40.28 159.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.543 -0.975 . . . . 0.0 110.946 -179.702 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 81' ' ' LYS . 12.4 tttt -158.85 117.07 2.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.504 -0.747 . . . . 0.0 109.648 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.666 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -135.14 161.56 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.939 . . . . 0.0 110.551 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.408 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.9 OUTLIER -150.76 121.35 7.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 110.321 -179.874 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 49' ' ' THR . 3.5 m 46.45 69.85 0.44 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.395 -0.816 . . . . 0.0 110.738 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.618 ' HB3' HD11 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -123.48 104.39 9.04 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.467 -0.771 . . . . 0.0 109.541 179.164 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.529 ' HA ' ' HB ' ' A' ' 51' ' ' THR . 1.7 mp -48.5 -64.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 109.739 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.819 HD13 ' CE2' ' A' ' 87' ' ' PHE . 20.4 mt 55.04 164.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 110.308 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.513 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 55.7 m -145.23 -106.33 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.905 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.789 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -83.96 76.08 2.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 87' ' ' PHE . . . 63.28 12.32 44.29 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 71' ' ' GLY . 13.9 m -116.34 136.33 23.04 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.383 -1.069 . . . . 0.0 110.254 -179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HA ' HG12 ' A' ' 69' ' ' ILE . 47.5 Cg_endo -78.12 138.24 16.05 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.897 1.472 . . . . 0.0 110.088 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' A' ' 68' ' ' ILE . . . -84.53 159.28 58.85 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.182 -0.949 . . . . 0.0 110.408 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.41 53.21 4.62 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 124.04 1.547 . . . . 0.0 110.555 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 t -89.96 158.17 17.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.608 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.2 -14.15 50.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.267 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.06 -22.45 12.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.336 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.481 ' CB ' ' HA ' ' A' ' 67' ' ' CYS . 34.7 t -63.79 123.14 18.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 110.054 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.63 ' HE2' HG23 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -93.15 -169.95 2.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.927 . . . . 0.0 110.481 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 82' ' ' ILE . 3.2 tp -179.94 40.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.803 0.811 . . . . 0.0 109.501 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.8 m -72.78 -96.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 111.64 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.84 66.31 0.95 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.111 -1.043 . . . . 0.0 110.637 -178.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 64' ' ' ILE . 4.8 t -160.3 -175.31 4.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.254 . . . . 0.0 110.022 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.547 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 3.5 t -177.23 159.29 1.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.98 . . . . 0.0 110.423 -179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.819 ' CE2' HD13 ' A' ' 69' ' ' ILE . 1.8 m-85 -118.87 156.68 29.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.44 -0.787 . . . . 0.0 109.7 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -139.41 20.35 2.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.243 -0.91 . . . . 0.0 110.38 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 56.6 83.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.235 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 56' ' ' ARG . 43.4 t30 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.095 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 1' ' ' ASP . 54.7 p30 . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.264 0.554 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -134.44 -129.62 2.93 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 99.5 p -94.14 0.03 55.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.309 -1.112 . . . . 0.0 110.208 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.581 ' O ' HD22 ' A' ' 11' ' ' LEU . 8.8 t -78.43 152.75 32.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.326 -0.859 . . . . 0.0 110.519 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 1.019 HG21 ' HA ' ' A' ' 9' ' ' SER . 3.3 m -169.9 -83.09 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.727 ' OD1' HG22 ' A' ' 5' ' ' THR . 7.5 p30 163.47 50.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.386 0.612 . . . . 0.0 109.863 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.6 OUTLIER 64.64 -64.64 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 110.568 179.893 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.553 ' ND2' ' HB2' ' A' ' 10' ' ' GLN . 0.6 OUTLIER -49.26 -34.46 15.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.097 -1.002 . . . . 0.0 109.964 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 1.019 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.7 OUTLIER 72.94 55.53 0.13 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.516 -0.74 . . . . 0.0 111.662 179.49 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.558 ' HB3' ' CB ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -126.7 18.31 7.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.731 -1.23 . . . . 0.0 109.736 178.811 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.858 HD11 ' OG ' ' A' ' 15' ' ' SER . 13.6 tp -49.51 95.91 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.454 -0.779 . . . . 0.0 109.729 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -41.25 146.64 0.18 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 109.899 -179.808 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 14' ' ' ASN . . . -64.48 67.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.09 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 12' ' ' SER . 0.5 OUTLIER 179.9 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.541 -0.725 . . . . 0.0 109.782 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.858 ' OG ' HD11 ' A' ' 11' ' ' LEU . 13.5 t -50.62 -176.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.34 -0.85 . . . . 0.0 110.249 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.16 160.66 41.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.206 -0.934 . . . . 0.0 110.4 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 t -178.55 148.17 0.43 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.162 -0.962 . . . . 0.0 110.24 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.93 -29.42 1.02 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 0.0 110.753 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -170.19 43.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.969 -1.082 . . . . 0.0 110.59 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.18 179.01 5.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.252 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.4 82.64 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 109.807 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 46.1 mt -94.22 -177.96 4.46 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -0.89 . . . . 0.0 110.605 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 1.8 m -161.74 118.58 2.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.499 -0.751 . . . . 0.0 109.357 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.542 ' HA ' ' HB2' ' A' ' 8' ' ' ASN . 43.8 m-20 58.58 75.73 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.419 -0.8 . . . . 0.0 110.261 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.536 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 0.5 OUTLIER -145.5 -157.26 0.78 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.071 -1.018 . . . . 0.0 110.206 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -160.29 -39.56 0.05 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.715 HG13 ' HD2' ' A' ' 42' ' ' PHE . 9.3 t 53.25 160.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.011 0.91 . . . . 0.0 111.649 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.603 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 1.2 t70 -171.37 127.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HA ' ' ND2' ' A' ' 14' ' ' ASN . 66.2 mttt 46.48 43.11 11.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -0.984 . . . . 0.0 109.587 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.717 ' CB ' HG22 ' A' ' 45' ' ' VAL . 58.6 m -129.97 157.69 41.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' O ' ' O ' ' A' ' 47' ' ' ILE . 1.1 mt-10 -121.17 98.07 5.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.283 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 40.6 t -99.93 159.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.413 -0.804 . . . . 0.0 110.53 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.459 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 39.3 m-85 -139.02 -45.85 0.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.194 -0.941 . . . . 0.0 110.808 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.437 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -146.0 28.51 1.71 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 50' ' ' SER . 2.3 m -73.47 154.29 40.0 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.233 -1.157 . . . . 0.0 110.338 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.1 m -114.78 80.73 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.371 -0.831 . . . . 0.0 109.815 179.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -63.31 151.77 39.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -0.89 . . . . 0.0 110.533 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 38' ' ' THR . 66.8 m -138.22 41.17 2.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.315 -0.866 . . . . 0.0 109.982 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 104.64 33.49 3.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.51 ' HA ' ' OD1' ' A' ' 90' ' ' ASN . 14.4 m -122.41 -152.46 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -1.151 . . . . 0.0 110.166 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.465 ' HG3' ' OD1' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -178.18 168.04 1.95 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.078 -1.014 . . . . 0.0 110.53 179.889 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.715 ' HD2' HG13 ' A' ' 27' ' ' VAL . 8.3 m-85 -122.49 -169.98 2.0 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.274 -0.891 . . . . 0.0 110.559 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.409 ' HA ' ' OD2' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -175.21 48.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 110.106 179.698 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 119.62 61.49 0.26 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.717 HG22 ' CB ' ' A' ' 30' ' ' SER . 2.4 m -137.34 -158.84 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.988 -1.301 . . . . 0.0 111.279 -179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.562 ' N ' HG23 ' A' ' 45' ' ' VAL . 94.5 m -167.09 58.79 0.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 14.3 tt -85.81 169.41 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 111.234 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 78.0 p -142.24 -148.9 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.362 -0.836 . . . . 0.0 109.175 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 66' ' ' THR . 59.8 m -46.05 111.97 0.42 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.17 -0.957 . . . . 0.0 108.699 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' THR . 4.3 t -173.36 158.46 3.54 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.161 -0.962 . . . . 0.0 110.125 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -116.98 131.6 56.91 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.044 -1.035 . . . . 0.0 109.783 179.57 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -145.8 125.65 13.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 109.961 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 71' ' ' GLY . 2.7 m -105.48 123.42 47.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -0.967 . . . . 0.0 109.94 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 45.0 83.33 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 72' ' ' GLY . 78.7 p -158.15 128.98 6.36 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.231 -1.158 . . . . 0.0 110.432 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 6.6 ttp180 -94.18 107.55 19.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 110.12 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.642 HG22 ' O ' ' A' ' 57' ' ' ILE . 2.5 mp -84.52 12.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -0.956 . . . . 0.0 109.94 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 57' ' ' ILE . 1.1 m -42.54 139.78 1.44 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 110.3 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 172.72 175.53 40.72 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.63 63.24 6.5 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.078 1.568 . . . . 0.0 110.128 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 94.99 2.5 62.49 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.561 ' C ' ' O ' ' A' ' 61' ' ' GLY . 2.4 t -11.37 121.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' CD ' ' O ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -105.98 144.13 33.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.223 -0.923 . . . . 0.0 109.817 179.356 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 63' ' ' LYS . 5.4 mt -152.96 127.18 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.136 -0.977 . . . . 0.0 110.029 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.445 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -130.99 117.2 18.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.309 -179.84 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 49' ' ' THR . 3.1 m 54.05 86.15 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.473 -0.767 . . . . 0.0 110.801 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 51' ' ' THR . 0.5 OUTLIER -145.7 117.02 7.93 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.277 -0.89 . . . . 0.0 109.66 179.369 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.836 HD12 ' N ' ' A' ' 68' ' ' ILE . 3.4 mp -86.15 74.14 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.844 -1.16 . . . . 0.0 108.551 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.691 HG23 ' O ' ' A' ' 73' ' ' VAL . 13.7 mt -80.91 160.5 3.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.962 -179.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.816 ' O ' HG22 ' A' ' 73' ' ' VAL . 97.1 m -158.71 98.85 1.53 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.093 -1.004 . . . . 0.0 110.985 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 53' ' ' THR . . . 89.24 30.25 14.7 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 82.37 14.28 76.79 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.816 HG22 ' O ' ' A' ' 70' ' ' THR . 11.4 m -124.32 135.95 27.09 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.468 -1.019 . . . . 0.0 110.412 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HB2' HD11 ' A' ' 82' ' ' ILE . 49.6 Cg_endo -85.58 119.88 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.89 1.468 . . . . 0.0 110.466 179.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.533 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -77.47 167.09 39.22 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.273 -0.892 . . . . 0.0 109.788 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.533 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 42.2 Cg_endo -68.87 84.55 0.52 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.688 1.362 . . . . 0.0 109.409 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 78' ' ' ALA . 66.9 m -85.92 -6.35 59.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.631 -0.668 . . . . 0.0 111.155 -178.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 43.8 25.65 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.05 -1.031 . . . . 0.0 109.545 -179.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -158.59 -40.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.523 -0.736 . . . . 0.0 109.301 -179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.451 ' HB2' ' HA ' ' A' ' 67' ' ' CYS . 29.1 t -46.95 169.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.555 -0.716 . . . . 0.0 109.738 179.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.547 ' HE3' ' CA ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -108.99 -32.23 7.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.936 -1.103 . . . . 0.0 112.156 -178.108 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.724 HG22 ' O ' ' A' ' 82' ' ' ILE . 4.1 mt 34.15 79.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.403 -0.81 . . . . 0.0 110.322 -179.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.523 ' H ' ' HZ1' ' A' ' 81' ' ' LYS . 61.5 m -122.74 -98.14 0.44 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.92 -1.113 . . . . 0.0 111.088 -179.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.58 21.25 33.61 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -97.33 -163.54 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.253 . . . . 0.0 110.766 -179.726 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.539 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.9 OUTLIER 175.62 148.85 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.55 -0.719 . . . . 0.0 109.941 179.815 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -120.38 173.42 7.15 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.421 179.487 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.78 24.35 0.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.012 -1.055 . . . . 0.0 110.228 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 46.87 61.77 2.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.911 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.155 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.2 0.524 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -142.31 -140.94 3.82 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.0 t -116.69 106.51 13.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.164 -1.198 . . . . 0.0 110.223 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 5' ' ' THR . 4.3 m -92.94 -10.66 35.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 9' ' ' SER . 3.8 m 71.95 10.91 6.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.495 -0.753 . . . . 0.0 110.737 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.588 ' O ' ' CB ' ' A' ' 7' ' ' THR . 4.2 p-10 36.38 46.17 0.4 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.642 -0.661 . . . . 0.0 109.978 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.588 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.8 m 84.96 -33.81 0.05 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 122.052 -0.405 . . . . 0.0 110.738 -179.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 5' ' ' THR . 1.9 t-20 179.97 44.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.664 -1.273 . . . . 0.0 112.18 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.626 ' N ' HG22 ' A' ' 5' ' ' THR . 0.7 OUTLIER -160.99 -132.41 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.766 -1.209 . . . . 0.0 110.472 178.763 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -113.94 -168.48 1.36 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.699 -1.251 . . . . 0.0 111.268 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.772 HD12 ' CB ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -165.23 69.15 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.726 . . . . 0.0 109.675 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.532 ' HB3' ' CA ' ' A' ' 28' ' ' ASP . 3.4 p 42.36 23.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.801 . . . . 0.0 110.896 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 41.66 23.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.985 -1.072 . . . . 0.0 110.641 -179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 28.6 p30 174.4 30.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.494 -0.754 . . . . 0.0 109.682 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.772 ' CB ' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -69.8 -168.66 0.2 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.207 -0.933 . . . . 0.0 109.844 -179.674 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.544 ' CE ' ' HG3' ' A' ' 31' ' ' GLU . 1.3 mptp? -119.38 107.38 13.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 110.09 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -91.07 -140.23 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 110.528 -179.632 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 67.35 107.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.881 . . . . 0.0 109.867 -179.503 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 5.2 tttt 66.21 54.85 0.92 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 12.6 m -119.63 155.78 31.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 0.0 110.964 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 36' ' ' THR . 17.7 m -150.62 82.18 1.35 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.494 -0.754 . . . . 0.0 109.566 179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -124.76 -163.54 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.311 -0.868 . . . . 0.0 110.775 -179.122 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 10.1 m -165.85 113.53 0.93 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.412 -0.805 . . . . 0.0 109.812 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 23' ' ' THR . 1.0 OUTLIER 59.05 127.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.432 -0.793 . . . . 0.0 110.047 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 9' ' ' SER . 0.5 OUTLIER 172.9 -169.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.156 -0.965 . . . . 0.0 110.12 179.98 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.49 ' O ' ' O ' ' A' ' 27' ' ' VAL . 10.5 t80 -142.35 -46.63 0.34 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 108.679 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.892 HG13 ' HD2' ' A' ' 42' ' ' PHE . 3.5 t 57.14 133.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.673 0.749 . . . . 0.0 111.166 179.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.532 ' CA ' ' HB3' ' A' ' 12' ' ' SER . 0.2 OUTLIER -137.66 124.33 21.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.326 -0.859 . . . . 0.0 109.226 179.336 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 4.2 mtmp? 42.21 55.37 3.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.999 -179.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.777 ' OG ' HG22 ' A' ' 45' ' ' VAL . 27.4 m -134.98 163.5 29.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.985 -1.072 . . . . 0.0 110.835 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.544 ' HG3' ' CE ' ' A' ' 16' ' ' LYS . 3.8 tt0 -96.74 -71.02 0.69 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.417 -0.802 . . . . 0.0 109.846 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.821 HG22 ' CG2' ' A' ' 47' ' ' ILE . 13.6 t 59.9 138.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.838 . . . . 0.0 110.614 179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.655 ' CD1' HG22 ' A' ' 48' ' ' THR . 60.5 m-85 -140.33 -81.21 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 109.551 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.43 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -94.41 29.65 8.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.503 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -73.65 161.85 29.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -1.028 . . . . 0.0 110.373 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.491 ' O ' HG22 ' A' ' 36' ' ' THR . 63.7 m -116.39 57.32 0.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.795 . . . . 0.0 109.733 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.567 ' CB ' ' HB2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -40.84 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.411 -0.806 . . . . 0.0 110.336 -179.839 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.59 ' O ' HG22 ' A' ' 38' ' ' THR . 85.8 m -89.66 48.91 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 110.261 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.47 24.94 37.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 86.4 p -99.44 -154.39 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.403 -1.057 . . . . 0.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.444 ' C ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -167.7 156.29 9.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.099 179.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.892 ' HD2' HG13 ' A' ' 27' ' ' VAL . 10.0 m-85 -119.88 176.63 5.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.219 -0.926 . . . . 0.0 110.582 -179.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -157.49 61.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.5 -0.75 . . . . 0.0 109.814 179.939 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 29' ' ' LYS . . . 96.92 67.37 0.94 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.777 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.4 m -135.92 -160.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.972 -1.311 . . . . 0.0 111.274 -179.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 46' ' ' THR . 69.8 m -166.17 54.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.391 0.615 . . . . 0.0 109.403 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.821 ' CG2' HG22 ' A' ' 32' ' ' VAL . 11.9 tt -80.46 172.17 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 110.551 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.655 HG22 ' CD1' ' A' ' 33' ' ' TYR . 14.8 p -140.1 -113.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 49' ' ' THR . 55.3 m -83.55 71.66 10.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.917 -1.114 . . . . 0.0 109.632 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.588 ' HB2' HD11 ' A' ' 47' ' ' ILE . 4.8 m -128.67 141.76 51.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.971 -1.081 . . . . 0.0 110.649 -179.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -89.46 133.64 34.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.692 179.593 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.42 121.08 12.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 110.33 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.3 93.73 5.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 109.789 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 62.21 92.69 0.02 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 87.5 p -161.21 122.09 2.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -1.099 . . . . 0.0 110.418 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' HB2' ' CB ' ' A' ' 90' ' ' ASN . 10.3 ttp180 -77.6 103.59 7.62 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.318 -0.864 . . . . 0.0 109.657 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.555 ' O ' HG12 ' A' ' 45' ' ' VAL . 32.4 mm -78.63 9.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 110.763 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.474 ' CB ' ' HB2' ' A' ' 43' ' ' ASP . 53.1 p -40.84 150.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.143 -0.973 . . . . 0.0 110.602 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 168.09 140.75 3.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.66 57.93 3.12 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.089 1.573 . . . . 0.0 109.762 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 121.4 20.61 3.23 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -42.83 148.92 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -1.113 . . . . 0.0 110.589 -179.865 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -152.27 112.73 4.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.348 179.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.766 HG23 ' CE ' ' A' ' 81' ' ' LYS . 1.9 mp -128.81 157.53 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.161 -0.962 . . . . 0.0 110.868 -178.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.479 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.1 OUTLIER -156.87 106.88 2.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.376 -0.828 . . . . 0.0 109.909 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 49' ' ' THR . 1.2 m 63.33 82.18 0.19 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.255 -0.903 . . . . 0.0 110.325 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.487 ' N ' ' OG ' ' A' ' 50' ' ' SER . 16.1 m -146.52 109.09 4.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.441 -0.787 . . . . 0.0 109.662 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.738 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.8 mp -73.44 90.21 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.046 -1.033 . . . . 0.0 109.624 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.718 HG23 ' C ' ' A' ' 73' ' ' VAL . 10.0 mt -98.25 156.88 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.397 -0.814 . . . . 0.0 110.292 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.815 ' O ' HG22 ' A' ' 73' ' ' VAL . 5.2 m -155.01 100.79 2.22 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.193 -0.942 . . . . 0.0 110.45 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.43 35.07 8.88 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 76.61 15.93 81.16 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 70' ' ' THR . 7.9 m -126.01 132.97 24.49 Favored Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.314 -1.109 . . . . 0.0 110.838 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.64 153.46 20.26 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.917 1.483 . . . . 0.0 110.601 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -96.25 162.62 23.06 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.907 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.8 Cg_endo -73.27 75.77 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.062 1.559 . . . . 0.0 110.569 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.57 140.03 45.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.15 -27.92 53.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.288 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.31 -2.92 57.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 0.0 110.278 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 66' ' ' THR . 2.5 t -90.03 146.94 23.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 110.061 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.766 ' CE ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -103.02 -164.12 1.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.351 -0.843 . . . . 0.0 111.282 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 82' ' ' ILE . 2.3 tp 175.99 34.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.1 m -70.32 -100.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.471 -0.768 . . . . 0.0 111.569 -179.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . -99.8 78.96 0.48 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.702 -178.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.54 ' SG ' HD11 ' A' ' 64' ' ' ILE . 3.8 t -158.43 -174.02 4.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.172 -1.193 . . . . 0.0 109.221 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.571 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 8.0 t -179.7 158.1 0.78 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 0.0 111.153 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD1' ' C ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -128.35 161.53 29.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.586 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.716 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 5.8 t -145.05 12.24 1.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.953 -1.092 . . . . 0.0 110.015 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 68.21 5.11 4.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.213 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.546 ' OXT' ' CG ' ' A' ' 90' ' ' ASN . 1.6 p30 . . . . . 0 N--CA 1.499 2.015 0 CA-C-O 117.375 -1.298 . . . . 0.0 112.152 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 1' ' ' ASP . 18.5 t0 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.212 0.53 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.57 161.81 12.62 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.56 92.66 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -1.154 . . . . 0.0 110.208 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.662 ' CB ' HD23 ' A' ' 11' ' ' LEU . 63.5 m -79.03 -160.11 0.22 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.941 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.574 ' O ' HG22 ' A' ' 5' ' ' THR . 72.6 m -158.56 10.59 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.004 . . . . 0.0 111.072 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.593 ' O ' ' CB ' ' A' ' 7' ' ' THR . 6.1 t30 42.37 40.35 1.81 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.087 -1.008 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.593 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.6 m 80.71 -25.81 0.17 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.581 -0.699 . . . . 0.0 110.794 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 7' ' ' THR . 1.5 m-80 166.87 65.6 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.857 -1.152 . . . . 0.0 110.494 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 10' ' ' GLN . 10.9 p -160.33 -121.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.924 -1.11 . . . . 0.0 111.126 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.56 ' NE2' ' CE2' ' A' ' 26' ' ' TYR . 1.3 mt-30 -122.65 -54.83 1.84 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.806 -1.184 . . . . 0.0 110.987 -178.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.662 HD23 ' CB ' ' A' ' 4' ' ' CYS . 6.8 tp 48.02 82.42 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 108.995 -178.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.481 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 79.7 p -39.46 137.8 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.7 -0.625 . . . . 0.0 110.683 -179.208 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.02 -20.68 2.56 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.294 -0.879 . . . . 0.0 109.248 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' ND2' ' HG3' ' A' ' 29' ' ' LYS . 59.2 t-20 -77.39 -7.09 55.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.507 -0.746 . . . . 0.0 110.146 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.626 ' OG ' HD11 ' A' ' 11' ' ' LEU . 39.8 t -85.7 -163.01 0.79 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.191 -0.943 . . . . 0.0 109.915 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.19 133.32 21.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.056 -1.027 . . . . 0.0 110.172 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 25.7 p -132.31 132.92 43.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.164 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -160.48 -84.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.164 -0.96 . . . . 0.0 110.234 -179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.7 39.82 2.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 110.444 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.536 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 48.1 m -105.49 153.32 21.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 110.468 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.446 ' C ' HD23 ' A' ' 22' ' ' LEU . 52.1 m -111.54 84.81 2.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.362 -0.836 . . . . 0.0 109.165 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 37' ' ' CYS . 6.2 mt -101.03 175.58 5.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.139 -0.975 . . . . 0.0 111.102 -178.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' ASN . 22.9 m -157.09 107.27 2.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.638 -0.664 . . . . 0.0 109.737 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 39' ' ' GLY . 3.7 m-20 56.99 100.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 110.427 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.545 ' N ' ' ND2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER -157.92 -173.65 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.162 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.56 ' CE2' ' NE2' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -134.69 -48.43 0.75 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 179.021 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.663 HG13 ' HD2' ' A' ' 42' ' ' PHE . 14.1 t 55.22 144.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 122.027 0.917 . . . . 0.0 111.532 178.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.52 ' HB3' ' HA ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -152.19 121.96 6.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.53 -0.731 . . . . 0.0 109.716 179.271 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HG3' ' ND2' ' A' ' 14' ' ' ASN . 0.1 OUTLIER 54.99 39.19 31.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.015 . . . . 0.0 109.97 -179.602 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.741 ' CB ' HG22 ' A' ' 45' ' ' VAL . 50.3 m -123.36 -163.08 1.09 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.257 -0.902 . . . . 0.0 110.52 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.685 ' C ' HG23 ' A' ' 32' ' ' VAL . 1.1 mt-10 -146.21 -72.0 0.24 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.352 -0.842 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.685 HG23 ' C ' ' A' ' 31' ' ' GLU . 2.6 t 73.15 141.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.602 -0.686 . . . . 0.0 111.038 179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 38.8 m-85 -145.75 35.89 1.05 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.453 -0.779 . . . . 0.0 110.154 179.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 20' ' ' SER . . . 145.86 -7.7 1.47 Allowed Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.618 -1.277 . . . . 0.0 110.292 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.652 ' HB ' HG13 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -57.87 167.29 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.969 -1.312 . . . . 0.0 110.165 -179.857 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 36' ' ' THR . 9.2 t -108.45 62.14 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -0.841 . . . . 0.0 110.309 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -47.02 92.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.2 179.899 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 36' ' ' THR . 2.3 m -100.96 101.43 12.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.153 -0.967 . . . . 0.0 109.724 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . 44.21 52.33 7.13 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.445 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 3.8 m -128.16 179.89 5.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.072 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.508 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 41.5 mtt180 -149.53 147.85 28.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.873 . . . . 0.0 110.38 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.663 ' HD2' HG13 ' A' ' 27' ' ' VAL . 17.9 m-30 -116.74 175.84 5.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.358 -0.839 . . . . 0.0 109.593 179.497 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.538 ' CB ' ' OG ' ' A' ' 58' ' ' SER . 2.3 t0 -157.85 50.03 0.42 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.058 -1.027 . . . . 0.0 110.376 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 114.34 63.14 0.41 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.741 HG22 ' CB ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -132.25 -166.86 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.028 -1.278 . . . . 0.0 110.625 -179.72 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 46' ' ' THR . 51.4 m -166.16 56.47 0.1 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 50' ' ' SER . 17.5 tt -82.44 170.74 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.584 -0.697 . . . . 0.0 111.102 -178.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 65' ' ' SER . 44.9 p -133.25 -127.06 0.17 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.661 -0.649 . . . . 0.0 109.615 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 49' ' ' THR . 20.5 m -76.43 74.49 3.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.998 -1.064 . . . . 0.0 109.935 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.553 ' HB2' HD11 ' A' ' 47' ' ' ILE . 7.7 m -128.88 142.92 50.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.043 -1.036 . . . . 0.0 110.372 -179.427 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -86.61 135.13 33.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.021 -1.049 . . . . 0.0 110.19 179.909 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.405 ' H ' HG22 ' A' ' 36' ' ' THR . 3.1 p -154.69 125.46 7.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 110.149 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -111.68 121.06 44.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.32 -0.863 . . . . 0.0 110.014 -179.843 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 89' ' ' ALA . . . 44.97 85.32 0.01 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 74.9 p -153.42 123.74 7.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.502 -0.999 . . . . 0.0 110.581 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -86.24 99.87 11.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.178 -0.951 . . . . 0.0 109.466 179.358 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 57' ' ' ILE . 2.7 mp -82.93 18.49 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 110.533 -179.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.538 ' OG ' ' CB ' ' A' ' 43' ' ' ASP . 0.6 OUTLIER -41.17 155.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.386 -0.821 . . . . 0.0 110.031 179.488 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 157.54 151.7 6.11 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.72 53.63 2.8 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.088 1.573 . . . . 0.0 110.263 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 62' ' ' CYS . . . 119.87 22.47 3.27 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.478 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -39.78 108.23 0.08 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.236 -1.155 . . . . 0.0 110.766 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.471 ' C ' HD12 ' A' ' 64' ' ' ILE . 17.2 tttp -101.56 122.43 43.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.034 . . . . 0.0 109.669 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.725 HD12 ' N ' ' A' ' 64' ' ' ILE . 4.5 mp -128.4 139.83 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.083 -1.011 . . . . 0.0 110.447 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.51 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -143.25 112.43 6.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.015 -1.053 . . . . 0.0 111.065 -179.908 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 80' ' ' CYS . 1.9 m 48.37 80.37 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.566 -0.709 . . . . 0.0 112.055 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 80' ' ' CYS . 40.0 t -139.2 136.99 35.61 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.805 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.0 mp -90.75 88.07 2.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.27 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.738 HG21 ' CD2' ' A' ' 87' ' ' PHE . 12.3 mt -96.6 158.71 3.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.787 -0.571 . . . . 0.0 110.223 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.902 ' O ' HG22 ' A' ' 73' ' ' VAL . 3.2 m -166.21 106.49 0.68 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -0.91 . . . . 0.0 110.445 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.527 ' O ' HG13 ' A' ' 73' ' ' VAL . . . 86.29 34.53 12.17 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.563 ' HA2' ' CB ' ' A' ' 87' ' ' PHE . . . 71.28 21.09 78.53 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 70' ' ' THR . 3.5 m -125.74 120.84 24.41 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.29 -1.124 . . . . 0.0 110.65 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.83 141.06 18.91 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.721 1.379 . . . . 0.0 110.354 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 68' ' ' ILE . . . -95.29 138.66 21.89 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.773 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.22 70.84 3.77 Favored 'Trans proline' 0 C--N 1.303 -1.832 0 O-C-N 123.9 1.474 . . . . 0.0 110.219 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -97.66 166.55 11.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.35 -15.28 62.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.36 -36.93 5.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.14 -0.975 . . . . 0.0 110.745 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 67' ' ' CYS . 15.5 t -44.64 127.11 5.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.099 -1.0 . . . . 0.0 110.777 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.582 ' N ' ' HD3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -94.71 -172.34 2.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.347 -0.846 . . . . 0.0 110.135 179.751 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.781 ' O ' HG23 ' A' ' 82' ' ' ILE . 2.6 tp 179.09 39.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.492 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.0 m -104.82 87.27 2.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.052 -1.03 . . . . 0.0 111.766 -179.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.11 52.75 2.67 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.824 -1.179 . . . . 0.0 110.459 178.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.448 ' SG ' HD11 ' A' ' 64' ' ' ILE . 10.0 t -165.46 170.46 14.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.263 -1.139 . . . . 0.0 109.927 179.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.541 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 9.2 t -176.38 159.53 1.99 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.96 -179.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.738 ' CD2' HG21 ' A' ' 69' ' ' ILE . 1.7 m-85 -126.03 151.66 46.82 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.066 179.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -132.54 29.41 4.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.313 -0.867 . . . . 0.0 109.239 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 54' ' ' GLY . . . 51.41 83.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.402 -0.811 . . . . 0.0 109.648 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.447 -179.391 . . . . . . . . 2 2 . 1 stop_ save_